Citrus Sinensis ID: 019304
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 343 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.521 | 0.458 | 0.446 | 3e-44 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.507 | 0.105 | 0.360 | 6e-30 | |
| P18160 | 2410 | Dual specificity protein | yes | no | 0.498 | 0.070 | 0.398 | 1e-28 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.533 | 0.199 | 0.342 | 4e-28 | |
| Q66L42 | 940 | Mitogen-activated protein | yes | no | 0.489 | 0.178 | 0.401 | 4e-27 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.533 | 0.142 | 0.346 | 2e-26 | |
| Q02779 | 954 | Mitogen-activated protein | yes | no | 0.489 | 0.176 | 0.401 | 2e-26 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.510 | 0.107 | 0.313 | 2e-26 | |
| Q55EC7 | 960 | RasGEF domain-containing | no | no | 0.516 | 0.184 | 0.376 | 9e-26 | |
| Q3U1V8 | 1077 | Mitogen-activated protein | no | no | 0.492 | 0.156 | 0.376 | 2e-25 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 179 bits (454), Expect = 3e-44, Method: Compositional matrix adjust.
Identities = 80/179 (44%), Positives = 120/179 (67%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV 187
+EWT DL +L +G FA GA ++YRG Y VA+K++ P + E +EQQF+ EV
Sbjct: 77 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEV 136
Query: 188 MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDV 247
+L+ L H NIV+FI AC+K V+CI+TEY G++R +L +++ ++ ++ ++ ALD+
Sbjct: 137 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDI 196
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+RGM Y+H G IHRDLKS+NLL++ + +K+ADFG + +E Q GTYRWMAP
Sbjct: 197 SRGMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQCREAKGNMGTYRWMAP 255
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 132 bits (331), Expect = 6e-30, Method: Compositional matrix adjust.
Identities = 66/183 (36%), Positives = 107/183 (58%), Gaps = 9/183 (4%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKA--QVMEQQFQQ 185
D+W ID +L +G GAFG++++GT+ G +VA+K++ +P+K + +E+ F+
Sbjct: 777 DDWEIDFHELELGEQLGTGAFGEVHKGTWRGTEVAVKMI-----SPDKTITKDIERNFKD 831
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
EV ++ TL+H N+V F+ A K CIV E+ GS+ L +P L VK A
Sbjct: 832 EVRVMTTLRHPNVVLFMAASTKPPKMCIVMEFMALGSLHDLLKNELIPDIPFALKVKIAY 891
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE--TGTYRW 303
++GM ++H G HRDLKS NLL+ ++K++DFG+ + + + + PE GT +W
Sbjct: 892 QASKGMHFLHSSGITHRDLKSLNLLLDIKWNVKVSDFGLTKFKSDVKSINPEKFAGTIQW 951
Query: 304 MAP 306
AP
Sbjct: 952 TAP 954
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function description |
|---|
Score = 127 bits (320), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 80/201 (39%), Positives = 112/201 (55%), Gaps = 30/201 (14%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
E+ ID +L G +G FG++ RG + DVAIKI+ R + + + VM FQ EV
Sbjct: 2107 EYEIDFNELEFGQTIGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSSLVM---FQNEVG 2163
Query: 189 MLATLKHLNIVRFIGACRK--RMVWCIVTEYAKGGSVRQFLTR-----RQNRAVPLKLAV 241
+L+ L+H N+V+F+GAC CIVTE+ GGS+RQFLT QN + LKL
Sbjct: 2164 ILSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKL-- 2221
Query: 242 KQALDVARGMAYVHGLG--FIHRDLKSDNLLIS-------------ADKSIKIADFGVAR 286
ALD+A+GM Y+HG +HRDL S N+L+ D KI+DFG++R
Sbjct: 2222 --ALDIAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSR 2279
Query: 287 IEV-QTEGMTPETGTYRWMAP 306
+++ Q MT G +MAP
Sbjct: 2280 LKMEQASQMTQSVGCIPYMAP 2300
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 125 bits (314), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 64/187 (34%), Positives = 113/187 (60%), Gaps = 4/187 (2%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
P++ + + + I +L + + +G FG +Y+G + G VAIK ++ E+ QV+
Sbjct: 645 PSQQQQYFSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINED--VNNQVL 702
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
E+ F++E+ +L+ L+H NIV + AC C +TEY GGS+ L ++ + + ++L
Sbjct: 703 EE-FRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIK-MNMQL 760
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
K A+ +A+GM Y+H G IHRD+KS NLL+ ++KI DFG+++++ ++ MT G
Sbjct: 761 YKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSIG 820
Query: 300 TYRWMAP 306
+ WM+P
Sbjct: 821 SPIWMSP 827
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q66L42|M3K10_MOUSE Mitogen-activated protein kinase kinase kinase 10 OS=Mus musculus GN=Map3k10 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 122 bits (306), Expect = 4e-27, Method: Compositional matrix adjust.
Identities = 75/187 (40%), Positives = 101/187 (54%), Gaps = 19/187 (10%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILE-RPENNPEKAQVMEQQFQQEVMML 190
I +L + G FGK+YR + GE+VA+K PE +P V +Q +QE +
Sbjct: 93 IPFHELQLEEIIGVGGFGKVYRAVWRGEEVAVKAARLDPERDP---AVTAEQVRQEARLF 149
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L+H NI+ GAC C+V EYA+GG++ + L R VP + V A+ VARG
Sbjct: 150 GALQHPNIIALRGACLSPPNLCLVMEYARGGALSRVLA---GRRVPPHVLVNWAVQVARG 206
Query: 251 MAYVHG---LGFIHRDLKSDNLLI--------SADKSIKIADFGVARIEVQTEGMTPETG 299
M Y+H + IHRDLKS N+LI AD +KI DFG+AR +T M+ G
Sbjct: 207 MNYLHNDAPVPIIHRDLKSINILILEAIENHNLADTVLKITDFGLAREWHKTTKMS-AAG 265
Query: 300 TYRWMAP 306
TY WMAP
Sbjct: 266 TYAWMAP 272
|
Activates the JUN N-terminal pathway. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 120 bits (301), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 70/202 (34%), Positives = 111/202 (54%), Gaps = 19/202 (9%)
Query: 116 DHRYPTEGL-------ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILER 168
DH++P + E EW + L ++ +G +G +G+++RG++ G +VA+K+L
Sbjct: 823 DHQFPVPTIPAKIIEVEKPFEWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFN 882
Query: 169 PENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLT 228
N + + ++EV +L L+H NIV F+GAC + CIVTEY GS+ L
Sbjct: 883 DNVNLK----LISDLRKEVDLLCKLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILL 938
Query: 229 RRQNRAVPLK--LAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSIKIADFGV 284
+ ++ + L ++ D ARGM Y+H IHRDLK+DNLL+ +K+ADFG+
Sbjct: 939 ---DESIEMDWGLRLQLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGL 995
Query: 285 ARIEVQTEGMTPETGTYRWMAP 306
A ++ T T GT W+AP
Sbjct: 996 ATVKSHTFAKT-MCGTTGWVAP 1016
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q02779|M3K10_HUMAN Mitogen-activated protein kinase kinase kinase 10 OS=Homo sapiens GN=MAP3K10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 120 bits (301), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 75/187 (40%), Positives = 100/187 (53%), Gaps = 19/187 (10%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILE-RPENNPEKAQVMEQQFQQEVMML 190
I +L + G FGK+YR + GE+VA+K PE +P V +Q QE +
Sbjct: 93 IPFHELQLEEIIGVGGFGKVYRALWRGEEVAVKAARLDPEKDP---AVTAEQVCQEARLF 149
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L+H NI+ GAC C+V EYA+GG++ + L R VP + V A+ VARG
Sbjct: 150 GALQHPNIIALRGACLNPPHLCLVMEYARGGALSRVLA---GRRVPPHVLVNWAVQVARG 206
Query: 251 MAYVHG---LGFIHRDLKSDNLLI--------SADKSIKIADFGVARIEVQTEGMTPETG 299
M Y+H + IHRDLKS N+LI AD +KI DFG+AR +T M+ G
Sbjct: 207 MNYLHNDAPVPIIHRDLKSINILILEAIENHNLADTVLKITDFGLAREWHKTTKMS-AAG 265
Query: 300 TYRWMAP 306
TY WMAP
Sbjct: 266 TYAWMAP 272
|
Activates the JUN N-terminal pathway. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 120 bits (300), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 57/182 (31%), Positives = 104/182 (57%), Gaps = 7/182 (3%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV 187
++W ID +L +G G +G++Y+ + G +VA+K++ ++ ++ ME+ F +EV
Sbjct: 777 NDWEIDFSELEIGETLGTGGYGEVYKSIWKGTEVAVKLI----SSKHVSKDMERSFFEEV 832
Query: 188 MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDV 247
++ +L+H N+V F+ A K CIV E+ GS+ L +P L +K A
Sbjct: 833 KIMTSLRHPNVVLFMAASTKSPNMCIVMEFMSLGSLYDLLGNELIPEIPYALKIKMAYQA 892
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE---TGTYRWM 304
++GM ++H G +HRDLKS NLL+ + ++K++DFG+ +++ + + GT W+
Sbjct: 893 SKGMHFLHSSGIVHRDLKSLNLLLDSKWNVKVSDFGLTKVKSELDKKKTNDNIIGTIHWI 952
Query: 305 AP 306
AP
Sbjct: 953 AP 954
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55EC7|GEFX_DICDI RasGEF domain-containing serine/threonine-protein kinase X OS=Dictyostelium discoideum GN=gefX PE=2 SV=1 | Back alignment and function description |
|---|
Score = 117 bits (294), Expect = 9e-26, Method: Compositional matrix adjust.
Identities = 70/186 (37%), Positives = 101/186 (54%), Gaps = 9/186 (4%)
Query: 123 GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQ 182
GL W I L +G+FG ++RG Y G DVAIK +E+ ++PE + +++
Sbjct: 7 GLPTQAIWDIPFESLEFNEKIGKGSFGSVFRGCYLGLDVAIKKIEK-ADDPEYLKYIDR- 64
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
EV ML +L+H IV F G C IVTE+ GG VRQ L ++ + V
Sbjct: 65 ---EVSMLQSLRHPFIVNFSGICVHSSGLYIVTEFVSGGDVRQLL--KKTPPIGWDKRVS 119
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GT 300
A+D+A+ M ++H IHRDLKS N+L+ + I++ DFG AR+ QT+ T GT
Sbjct: 120 IAVDLAKAMVFLHAKKIIHRDLKSKNILLDEFQRIRLCDFGFARMSEQTKKSRHMTMCGT 179
Query: 301 YRWMAP 306
W+AP
Sbjct: 180 EGWVAP 185
|
Promotes the exchange of Ras-bound GDP by GTP. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3U1V8|M3K9_MOUSE Mitogen-activated protein kinase kinase kinase 9 OS=Mus musculus GN=Map3k9 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 117 bits (292), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 70/186 (37%), Positives = 105/186 (56%), Gaps = 17/186 (9%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLA 191
ID +L + G FGK+YR + G++VA+K R + + + +Q +E +QE + A
Sbjct: 132 IDFAELTLEEIIGIGGFGKVYRAFWAGDEVAVKAA-RHDPDEDISQTIEN-VRQEAKLFA 189
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
LKH NI+ G C K C+V E+A+GG + + L+ + +P + V A+ +ARGM
Sbjct: 190 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGM 246
Query: 252 AYVHG---LGFIHRDLKSDNLLI--------SADKSIKIADFGVARIEVQTEGMTPETGT 300
Y+H + IHRDLKS N+LI ++K +KI DFG+AR +T M+ GT
Sbjct: 247 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS-AAGT 305
Query: 301 YRWMAP 306
Y WMAP
Sbjct: 306 YAWMAP 311
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade through the phosphorylation of MAP2K4/MKK4 and MAP2K7/MKK7 which in turn activate the JNKs. The MKK/JNK signaling pathway regulates stress response via activator protein-1 (JUN) and GATA4 transcription factors. Plays also a role in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 343 | ||||||
| 118488096 | 419 | unknown [Populus trichocarpa] | 0.892 | 0.730 | 0.951 | 1e-170 | |
| 224121260 | 415 | predicted protein [Populus trichocarpa] | 0.880 | 0.727 | 0.950 | 1e-168 | |
| 224115648 | 415 | predicted protein [Populus trichocarpa] | 0.880 | 0.727 | 0.940 | 1e-166 | |
| 255574169 | 414 | serine/thronine protein kinase, putative | 0.877 | 0.727 | 0.930 | 1e-161 | |
| 224121256 | 415 | predicted protein [Populus trichocarpa] | 0.880 | 0.727 | 0.900 | 1e-158 | |
| 255574171 | 418 | serine/thronine protein kinase, putative | 0.889 | 0.729 | 0.928 | 1e-156 | |
| 224115644 | 415 | predicted protein [Populus trichocarpa] | 0.880 | 0.727 | 0.914 | 1e-155 | |
| 225429872 | 417 | PREDICTED: serine/threonine-protein kina | 0.874 | 0.719 | 0.892 | 1e-151 | |
| 297798854 | 412 | kinase family protein [Arabidopsis lyrat | 0.871 | 0.725 | 0.848 | 1e-146 | |
| 334187055 | 307 | protein kinase family protein [Arabidops | 0.871 | 0.973 | 0.844 | 1e-145 |
| >gi|118488096|gb|ABK95868.1| unknown [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 604 bits (1558), Expect = e-170, Method: Compositional matrix adjust.
Identities = 292/307 (95%), Positives = 299/307 (97%), Gaps = 1/307 (0%)
Query: 1 MIGKMVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSV 60
MIGKMVEGPKFTG+IGGN NN+NNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSV
Sbjct: 1 MIGKMVEGPKFTGIIGGNTNNENNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSV 60
Query: 61 DNSSVGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRY 119
DNSSVGS+DSLTHILSHPGLKPV HNYSVSVGQSVFRPGKVTHALNDDALAQALMD +Y
Sbjct: 61 DNSSVGSSDSLTHILSHPGLKPVNHHNYSVSVGQSVFRPGKVTHALNDDALAQALMDPKY 120
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
PTEGL+NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN+PEKAQ+M
Sbjct: 121 PTEGLQNYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENSPEKAQLM 180
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
EQQFQQEVMMLA LKH NIVRFIG CRK MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL
Sbjct: 181 EQQFQQEVMMLANLKHPNIVRFIGGCRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 240
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG
Sbjct: 241 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 300
Query: 300 TYRWMAP 306
TYRWMAP
Sbjct: 301 TYRWMAP 307
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224121260|ref|XP_002330783.1| predicted protein [Populus trichocarpa] gi|222872585|gb|EEF09716.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 596 bits (1537), Expect = e-168, Method: Compositional matrix adjust.
Identities = 288/303 (95%), Positives = 295/303 (97%), Gaps = 1/303 (0%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 64
MVEGPKFTG+IGGN NN+NNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS
Sbjct: 1 MVEGPKFTGIIGGNTNNENNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 60
Query: 65 VGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
VGS+DSLTHILSHPGLKPV HNYSVSVGQSVFRPGKVTHALNDDALAQALMD +YPTEG
Sbjct: 61 VGSSDSLTHILSHPGLKPVNHHNYSVSVGQSVFRPGKVTHALNDDALAQALMDPKYPTEG 120
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L+NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN+PEKAQ+MEQQF
Sbjct: 121 LQNYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENSPEKAQLMEQQF 180
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEVMMLA LKH NIVRFIG CRK MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ
Sbjct: 181 QQEVMMLANLKHPNIVRFIGGCRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 240
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 241 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 300
Query: 304 MAP 306
MAP
Sbjct: 301 MAP 303
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115648|ref|XP_002332108.1| predicted protein [Populus trichocarpa] gi|222874928|gb|EEF12059.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 590 bits (1520), Expect = e-166, Method: Compositional matrix adjust.
Identities = 285/303 (94%), Positives = 293/303 (96%), Gaps = 1/303 (0%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 64
MVEGPKFTG+IGGN NN+NNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS
Sbjct: 1 MVEGPKFTGIIGGNTNNENNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 60
Query: 65 VGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
VGS+DSLTHILSHPGLKPV HNYS + GQSVFRPGKVTHALNDDALAQALM+ +YPTEG
Sbjct: 61 VGSSDSLTHILSHPGLKPVNHHNYSGTAGQSVFRPGKVTHALNDDALAQALMNPKYPTEG 120
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L+NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN+PEKAQVMEQQF
Sbjct: 121 LQNYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENSPEKAQVMEQQF 180
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEVMMLA LKH NIVRFIGACRK MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ
Sbjct: 181 QQEVMMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 240
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVH LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 241 ALDVARGMAYVHALGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 300
Query: 304 MAP 306
MAP
Sbjct: 301 MAP 303
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255574169|ref|XP_002528000.1| serine/thronine protein kinase, putative [Ricinus communis] gi|223532626|gb|EEF34412.1| serine/thronine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 573 bits (1476), Expect = e-161, Method: Compositional matrix adjust.
Identities = 282/303 (93%), Positives = 290/303 (95%), Gaps = 2/303 (0%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 64
MVEGPKFTGL+GG+++N NYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS
Sbjct: 1 MVEGPKFTGLVGGSDDN-VNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 59
Query: 65 VGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
VGS+DSLTHILSHPGLKPV HNYSVSVGQSVFRP KVTHALN+DALAQALMD RY TEG
Sbjct: 60 VGSSDSLTHILSHPGLKPVSHHNYSVSVGQSVFRPRKVTHALNEDALAQALMDSRYQTEG 119
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L+NYD+WTIDLRKLNMGTAFAQGAFGKLYRG YNGEDVAIKILERPEN EKAQVMEQQF
Sbjct: 120 LDNYDDWTIDLRKLNMGTAFAQGAFGKLYRGAYNGEDVAIKILERPENCHEKAQVMEQQF 179
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEVMMLATLKH NIVRFIGACRK MVWCIVTEYAKGGSVRQ LTRRQNRAVPLKLAVKQ
Sbjct: 180 QQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQALTRRQNRAVPLKLAVKQ 239
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 240 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 299
Query: 304 MAP 306
MAP
Sbjct: 300 MAP 302
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224121256|ref|XP_002330782.1| predicted protein [Populus trichocarpa] gi|222872584|gb|EEF09715.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 565 bits (1456), Expect = e-158, Method: Compositional matrix adjust.
Identities = 273/303 (90%), Positives = 290/303 (95%), Gaps = 1/303 (0%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 64
MVEG KFTGL+ +NNN N+YY FTQGFYQ++G+GTNMSIDSLQTS+AGGSVSMSVDNSS
Sbjct: 1 MVEGKKFTGLMAPSNNNGNDYYGFTQGFYQEIGDGTNMSIDSLQTSHAGGSVSMSVDNSS 60
Query: 65 VGSNDSLTHILSHPGLKPVRH-NYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
VGSNDSLTH+LSHPGLKPV H NY+VSVG SVFRPGKVTHALNDDALAQALMD+RYPTEG
Sbjct: 61 VGSNDSLTHMLSHPGLKPVNHRNYNVSVGASVFRPGKVTHALNDDALAQALMDNRYPTEG 120
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L++YD+WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN PEK+QVMEQQF
Sbjct: 121 LQHYDDWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENIPEKSQVMEQQF 180
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEVMMLA LKH NIVRFIGAC+K MVWCIVTEYAKGGSVRQFLTRR NRAVPLKLAV+Q
Sbjct: 181 QQEVMMLANLKHPNIVRFIGACQKPMVWCIVTEYAKGGSVRQFLTRRHNRAVPLKLAVQQ 240
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVHGLGFIHRDLKSDNLLI+ADKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 241 ALDVARGMAYVHGLGFIHRDLKSDNLLIAADKSIKIADFGVARIEVQTEGMTPETGTYRW 300
Query: 304 MAP 306
MAP
Sbjct: 301 MAP 303
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255574171|ref|XP_002528001.1| serine/thronine protein kinase, putative [Ricinus communis] gi|223532627|gb|EEF34413.1| serine/thronine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 558 bits (1437), Expect = e-156, Method: Compositional matrix adjust.
Identities = 285/307 (92%), Positives = 291/307 (94%), Gaps = 2/307 (0%)
Query: 1 MIGKMVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSV 60
MIGKMVEGPKFTG NN+N+NNYYDFTQ FYQKLGEGTNMSIDSLQTSNAGGSVSMSV
Sbjct: 1 MIGKMVEGPKFTGANI-NNDNENNYYDFTQSFYQKLGEGTNMSIDSLQTSNAGGSVSMSV 59
Query: 61 DNSSVGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRY 119
DNSSVGS+DSLTHILSHPGLKPV HNYSVSVGQSVFRPGKVTH LNDDALAQALMD RY
Sbjct: 60 DNSSVGSSDSLTHILSHPGLKPVNHHNYSVSVGQSVFRPGKVTHPLNDDALAQALMDSRY 119
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
PT GL NYDEWTIDLRKL+MGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN+PEKAQVM
Sbjct: 120 PTVGLANYDEWTIDLRKLSMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENSPEKAQVM 179
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
EQQFQQEVMMLATLKH NIVRFIGACRK MVWCIVTEYAKGGSVRQFL +RQNRAVPLKL
Sbjct: 180 EQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLAKRQNRAVPLKL 239
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
AVKQALDVARGMAYVHGLG IHRDLKSDNLLI ADKSIKIADFGVARIEVQTEGMTPETG
Sbjct: 240 AVKQALDVARGMAYVHGLGCIHRDLKSDNLLIFADKSIKIADFGVARIEVQTEGMTPETG 299
Query: 300 TYRWMAP 306
TYRWMAP
Sbjct: 300 TYRWMAP 306
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115644|ref|XP_002332107.1| predicted protein [Populus trichocarpa] gi|222874927|gb|EEF12058.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 555 bits (1430), Expect = e-155, Method: Compositional matrix adjust.
Identities = 277/303 (91%), Positives = 292/303 (96%), Gaps = 1/303 (0%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 64
MVEG KFTGLIG +NNN NNYY FTQGFYQ+LG+GTNMSIDSLQTS+AGGSVSMSVDNSS
Sbjct: 1 MVEGQKFTGLIGASNNNGNNYYGFTQGFYQELGDGTNMSIDSLQTSHAGGSVSMSVDNSS 60
Query: 65 VGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
VGSNDSLTH+LSHPGLKPV HNYSVSVGQSVFRPGKVTHALNDDALAQAL+D+RYPTEG
Sbjct: 61 VGSNDSLTHMLSHPGLKPVNHHNYSVSVGQSVFRPGKVTHALNDDALAQALVDNRYPTEG 120
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L++YD+WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERP N+PEK+QVMEQQF
Sbjct: 121 LQHYDDWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPGNSPEKSQVMEQQF 180
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEVMMLA LKH NIVRFIGACRK MVWCIVTEYAKGGSVRQFLTRR NRAVPLKLAV+Q
Sbjct: 181 QQEVMMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRHNRAVPLKLAVQQ 240
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVHGLGFIHRDLKSDNLLI+ADK+IKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 241 ALDVARGMAYVHGLGFIHRDLKSDNLLIAADKTIKIADFGVARIEVQTEGMTPETGTYRW 300
Query: 304 MAP 306
MAP
Sbjct: 301 MAP 303
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225429872|ref|XP_002283465.1| PREDICTED: serine/threonine-protein kinase HT1 [Vitis vinifera] gi|147839316|emb|CAN72362.1| hypothetical protein VITISV_000134 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 540 bits (1392), Expect = e-151, Method: Compositional matrix adjust.
Identities = 274/307 (89%), Positives = 287/307 (93%), Gaps = 7/307 (2%)
Query: 5 MVEGPKFTGLIGGNNNN--DNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDN 62
MVEGPKFTG+IGG N+ DNNY+DFTQGFYQKLGE +NMSIDSLQTSNAG SVSMSVDN
Sbjct: 1 MVEGPKFTGIIGGGGNHNHDNNYFDFTQGFYQKLGEDSNMSIDSLQTSNAGLSVSMSVDN 60
Query: 63 SSVGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGK--VTHALNDDALAQALMDHRY 119
SSVGSNDSLTHIL+HPGLKPV HNYSV G SV RPGK VTHALN+DALA+ALMD RY
Sbjct: 61 SSVGSNDSLTHILNHPGLKPVATHNYSV--GHSVLRPGKGKVTHALNEDALARALMDTRY 118
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRG YNG+DVAIKILERPEN+PE+AQVM
Sbjct: 119 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGEYNGDDVAIKILERPENSPERAQVM 178
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
EQQFQQEVMMLATLKH NIVRFIGACRK + WCIVTEYAKGGSVRQFL RRQNR+VPLKL
Sbjct: 179 EQQFQQEVMMLATLKHPNIVRFIGACRKPLAWCIVTEYAKGGSVRQFLMRRQNRSVPLKL 238
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
AVKQALDVARGMAYVHGLGFIHRDLKSDNLLI+ADKSIKIADFGVARIEVQTEGMTPETG
Sbjct: 239 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLIAADKSIKIADFGVARIEVQTEGMTPETG 298
Query: 300 TYRWMAP 306
TYRWMAP
Sbjct: 299 TYRWMAP 305
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297798854|ref|XP_002867311.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297313147|gb|EFH43570.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 525 bits (1351), Expect = e-146, Method: Compositional matrix adjust.
Identities = 257/303 (84%), Positives = 275/303 (90%), Gaps = 4/303 (1%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGE-GTNMSIDSLQTSNAGGSVSMSVDNS 63
M+E PKF GN+NNDNNYY FTQ FYQKLGE GTNMS+DS+QTSNAGGSVSMSVDNS
Sbjct: 1 MLENPKFNLHAVGNHNNDNNYYAFTQDFYQKLGEEGTNMSVDSMQTSNAGGSVSMSVDNS 60
Query: 64 SVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
SVGS+D+L + HPGLKP+RH YS+SVGQSVFRPGKVTHALNDDALAQALMD +YPTEG
Sbjct: 61 SVGSSDAL---IGHPGLKPMRHPYSLSVGQSVFRPGKVTHALNDDALAQALMDSKYPTEG 117
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L NY+EWTIDLRKL+MG AFAQGAFGKLYRGTYNGEDVAIK+LER ++NPEKAQ +EQQF
Sbjct: 118 LANYEEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQALEQQF 177
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEV MLA LKH NIVRFIGAC K MVWCIVTEYAKGGSVRQFLT+RQNRAVPLKLAV Q
Sbjct: 178 QQEVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQ 237
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVH FIHRDLKSDNLLISAD+SIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 238 ALDVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETGTYRW 297
Query: 304 MAP 306
MAP
Sbjct: 298 MAP 300
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334187055|ref|NP_001190878.1| protein kinase family protein [Arabidopsis thaliana] gi|332660471|gb|AEE85871.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 521 bits (1341), Expect = e-145, Method: Compositional matrix adjust.
Identities = 256/303 (84%), Positives = 274/303 (90%), Gaps = 4/303 (1%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGE-GTNMSIDSLQTSNAGGSVSMSVDNS 63
M+E PKF GN+NNDNNYY FTQ FYQKLGE GTNMS+DS+QTSNAGGSVSMSVDNS
Sbjct: 1 MLENPKFDLHAVGNHNNDNNYYAFTQDFYQKLGEEGTNMSVDSMQTSNAGGSVSMSVDNS 60
Query: 64 SVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
SVGS+D+L + HPGLKP+RH YS+S GQSVFRPGKVTHALNDDALAQALMD +YPTEG
Sbjct: 61 SVGSSDAL---IGHPGLKPMRHPYSLSDGQSVFRPGKVTHALNDDALAQALMDSKYPTEG 117
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L NY+EWTIDLRKL+MG AFAQGAFGKLYRGTYNGEDVAIK+LER ++NPEKAQ +EQQF
Sbjct: 118 LVNYEEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQALEQQF 177
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEV MLA LKH NIVRFIGAC K MVWCIVTEYAKGGSVRQFLT+RQNRAVPLKLAV Q
Sbjct: 178 QQEVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQ 237
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVH FIHRDLKSDNLLISAD+SIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 238 ALDVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETGTYRW 297
Query: 304 MAP 306
MAP
Sbjct: 298 MAP 300
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 343 | ||||||
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.868 | 0.725 | 0.759 | 1.9e-115 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.871 | 0.725 | 0.729 | 1.1e-110 | |
| TAIR|locus:2091423 | 356 | ATN1 [Arabidopsis thaliana (ta | 0.542 | 0.522 | 0.455 | 1.6e-38 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.548 | 0.326 | 0.424 | 3e-37 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.597 | 0.375 | 0.4 | 6.3e-37 | |
| TAIR|locus:2157717 | 346 | AT5G50180 [Arabidopsis thalian | 0.530 | 0.526 | 0.454 | 8e-37 | |
| TAIR|locus:2168778 | 353 | AT5G40540 [Arabidopsis thalian | 0.542 | 0.526 | 0.433 | 1.3e-36 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.551 | 0.331 | 0.411 | 7.5e-36 | |
| TAIR|locus:2077244 | 391 | ATMRK1 [Arabidopsis thaliana ( | 0.276 | 0.242 | 0.479 | 1.2e-35 | |
| TAIR|locus:2094329 | 378 | AT3G22750 [Arabidopsis thalian | 0.276 | 0.251 | 0.458 | 1.5e-34 |
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1138 (405.7 bits), Expect = 1.9e-115, P = 1.9e-115
Identities = 230/303 (75%), Positives = 241/303 (79%)
Query: 5 MVEGPKFTGL-IXXXXXXXXXXXXFTQGFYQKLGEGTNMSIDSLQTSNAXXXXXXXXXXX 63
M+EG KF L + FTQ FYQKL EG+NMS++S+QTSNA
Sbjct: 1 MLEGAKFNVLAVGNHHNNDNNYYAFTQEFYQKLNEGSNMSMESMQTSNAGGSVSMSVDNS 60
Query: 64 XXXXXXXLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
L + HPGLKPVRH YS+SVGQSVFRPG+VTHALNDDALAQALMD RYPTEG
Sbjct: 61 SVGSSDAL---IGHPGLKPVRH-YSLSVGQSVFRPGRVTHALNDDALAQALMDTRYPTEG 116
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAXXXXXXX 183
L NYDEWTIDLRKLNMG AFAQGAFGKLY+GTYNGEDVAIKILERPEN+PEKA
Sbjct: 117 LTNYDEWTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQFMEQQF 176
Query: 184 XXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
LA LKH NIVRFIGACRK MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ
Sbjct: 177 QQEVSMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 236
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVHG FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 237 ALDVARGMAYVHGRNFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 296
Query: 304 MAP 306
MAP
Sbjct: 297 MAP 299
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1093 (389.8 bits), Expect = 1.1e-110, P = 1.1e-110
Identities = 221/303 (72%), Positives = 235/303 (77%)
Query: 5 MVEGPKFTGLIXXXXXXXXXXXXFTQGFYQKLGE-GTNMSIDSLQTSNAXXXXXXXXXXX 63
M+E PKF FTQ FYQKLGE GTNMS+DS+QTSNA
Sbjct: 1 MLENPKFDLHAVGNHNNDNNYYAFTQDFYQKLGEEGTNMSVDSMQTSNAGGSVSMSVDNS 60
Query: 64 XXXXXXXLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
L + HPGLKP+RH YS+S GQSVFRPGKVTHALNDDALAQALMD +YPTEG
Sbjct: 61 SVGSSDAL---IGHPGLKPMRHPYSLSDGQSVFRPGKVTHALNDDALAQALMDSKYPTEG 117
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAXXXXXXX 183
L NY+EWTIDLRKL+MG AFAQGAFGKLYRGTYNGEDVAIK+LER ++NPEKA
Sbjct: 118 LVNYEEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQALEQQF 177
Query: 184 XXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
LA LKH NIVRFIGAC K MVWCIVTEYAKGGSVRQFLT+RQNRAVPLKLAV Q
Sbjct: 178 QQEVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQ 237
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVH FIHRDLKSDNLLISAD+SIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 238 ALDVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETGTYRW 297
Query: 304 MAP 306
MAP
Sbjct: 298 MAP 300
|
|
| TAIR|locus:2091423 ATN1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 412 (150.1 bits), Expect = 1.6e-38, P = 1.6e-38
Identities = 86/189 (45%), Positives = 122/189 (64%)
Query: 119 YPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAXX 178
Y E E +W +D R L +G +GA K+Y G Y + VAIKI++R E+ PE+
Sbjct: 8 YSNEEFELDPKWLVDPRHLFVGPKIGEGAHAKVYEGKYRNQTVAIKIIKRGES-PEEIAK 66
Query: 179 XXXXXXXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
L+ ++H N+V+FIGAC++ M+ IVTE GG++R++L + + + ++
Sbjct: 67 RDNRFAREIAMLSKVQHKNLVKFIGACKEPMM-VIVTELLLGGTLRKYLVSLRPKRLDIR 125
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTPE 297
LAV ALD+AR M +H G IHRDLK +NL++SAD K++K+ADFG+AR E TE MT E
Sbjct: 126 LAVGFALDIARAMECLHSHGIIHRDLKPENLILSADHKTVKLADFGLAREESLTEMMTAE 185
Query: 298 TGTYRWMAP 306
TGTYRWMAP
Sbjct: 186 TGTYRWMAP 194
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 400 (145.9 bits), Expect = 3.0e-37, P = 3.0e-37
Identities = 87/205 (42%), Positives = 123/205 (60%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKIL--ERPENNPEKAX 177
P +G D W I+L+ L G A G++G LY+GTY ++VAIK+L ER +++ EK
Sbjct: 276 PNDGT---DVWEINLKHLKFGHKIASGSYGDLYKGTYCSQEVAIKVLKPERLDSDLEKEF 332
Query: 178 XXXXXXXXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
+ ++H N+V+FIGAC K CIVTE+ GGSV +L +Q L
Sbjct: 333 AQEVFI------MRKVRHKNVVQFIGACTKPPHLCIVTEFMPGGSVYDYL-HKQKGVFKL 385
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE 297
K A+D+ +GM+Y+H IHRDLK+ NLL+ ++ +K+ADFGVAR++ QT MT E
Sbjct: 386 PTLFKVAIDICKGMSYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQTGVMTAE 445
Query: 298 TGTYRWMAPGNSFFSPLPHPSFEHK 322
TGTYRWMAP + H ++HK
Sbjct: 446 TGTYRWMAP-----EVIEHKPYDHK 465
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 397 (144.8 bits), Expect = 6.3e-37, P = 6.3e-37
Identities = 88/220 (40%), Positives = 128/220 (58%)
Query: 103 HALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVA 162
H + + L A ++ PT+G DEW ID+ +L + A G++G L+RGTY ++VA
Sbjct: 257 HDKSSNELIPACIE--IPTDGT---DEWEIDVTQLKIEKKVASGSYGDLHRGTYCSQEVA 311
Query: 163 IKILERPENNPEKAXXXXXXXXXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGS 222
IK L+ N E + ++H N+V+F+GAC + CIVTE+ GS
Sbjct: 312 IKFLKPDRVNNEMLREFSQEVFI----MRKVRHKNVVQFLGACTRSPTLCIVTEFMARGS 367
Query: 223 VRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282
+ FL +Q A L+ +K ALDVA+GM+Y+H IHRDLK+ NLL+ +K+ADF
Sbjct: 368 IYDFL-HKQKCAFKLQTLLKVALDVAKGMSYLHQNNIIHRDLKTANLLMDEHGLVKVADF 426
Query: 283 GVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHK 322
GVAR+++++ MT ETGTYRWMAP + H + HK
Sbjct: 427 GVARVQIESGVMTAETGTYRWMAP-----EVIEHKPYNHK 461
|
|
| TAIR|locus:2157717 AT5G50180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 396 (144.5 bits), Expect = 8.0e-37, P = 8.0e-37
Identities = 84/185 (45%), Positives = 116/185 (62%)
Query: 123 GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAXXXXXX 182
G +W ID + L +G +GA K+Y G Y + VAIKI+ R E PE+
Sbjct: 6 GFRMEPKWQIDPQLLFVGPKIGEGAHAKVYEGKYKNQTVAIKIVHRGET-PEEIAKRDSR 64
Query: 183 XXXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
L+ ++H N+V+FIGAC K V IVTE +GG++R++L + + ++A+
Sbjct: 65 FLREVEMLSRVQHKNLVKFIGAC-KEPVMVIVTELLQGGTLRKYLLNLRPACLETRVAIG 123
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTPETGTY 301
ALD+ARGM +H G IHRDLK +NLL++AD K++K+ADFG+AR E TE MT ETGTY
Sbjct: 124 FALDIARGMECLHSHGIIHRDLKPENLLLTADHKTVKLADFGLAREESLTEMMTAETGTY 183
Query: 302 RWMAP 306
RWMAP
Sbjct: 184 RWMAP 188
|
|
| TAIR|locus:2168778 AT5G40540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 394 (143.8 bits), Expect = 1.3e-36, P = 1.3e-36
Identities = 82/189 (43%), Positives = 120/189 (63%)
Query: 119 YPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAXX 178
Y E E +W +D + L +G +GA K+Y G Y + VAIKI++R E+ PE+
Sbjct: 8 YSNEVFELDPKWVVDPQHLFVGPKIGEGAHAKIYEGKYKNKTVAIKIVKRGES-PEEIAK 66
Query: 179 XXXXXXXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
L+ ++H N+V+FIGAC K + IVTE GG++R++L + ++ ++
Sbjct: 67 RESRFAREVSMLSRVQHKNLVKFIGAC-KEPIMVIVTELLLGGTLRKYLVSLRPGSLDIR 125
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTPE 297
+AV ALD+AR M +H G IHRDLK ++L+++AD K++K+ADFG+AR E TE MT E
Sbjct: 126 VAVGYALDIARAMECLHSHGVIHRDLKPESLILTADYKTVKLADFGLAREESLTEMMTAE 185
Query: 298 TGTYRWMAP 306
TGTYRWMAP
Sbjct: 186 TGTYRWMAP 194
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 388 (141.6 bits), Expect = 7.5e-36, P = 7.5e-36
Identities = 84/204 (41%), Positives = 125/204 (61%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN-NPEKAXX 178
PT+G DEW ID+++L + A G++G+L+RGTY ++VAIKIL +PE N E
Sbjct: 278 PTDGT---DEWEIDMKQLKIEKKVACGSYGELFRGTYCSQEVAIKIL-KPERVNAEMLRE 333
Query: 179 XXXXXXXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
+ ++H N+V+FIGAC + CIVTE+ GS+ FL + + ++
Sbjct: 334 FSQEVYI----MRKVRHKNVVQFIGACTRSPNLCIVTEFMTRGSIYDFLHKHKG-VFKIQ 388
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET 298
+K ALDV++GM Y+H IHRDLK+ NLL+ + +K+ADFGVAR++ ++ MT ET
Sbjct: 389 SLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHEVVKVADFGVARVQTESGVMTAET 448
Query: 299 GTYRWMAPGNSFFSPLPHPSFEHK 322
GTYRWMAP + H ++H+
Sbjct: 449 GTYRWMAP-----EVIEHKPYDHR 467
|
|
| TAIR|locus:2077244 ATMRK1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 263 (97.6 bits), Expect = 1.2e-35, Sum P(2) = 1.2e-35
Identities = 46/96 (47%), Positives = 72/96 (75%)
Query: 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271
C+V EY GG++++FL ++ +P+K ++ ALD+ARG++Y+H +HRD+KS+N+L+
Sbjct: 182 CVVVEYVAGGTLKKFLIKKYRAKLPIKDVIQLALDLARGLSYLHSKAIVHRDVKSENMLL 241
Query: 272 SADKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 306
+K++KIADFGVAR+E Q + MT ETGT +MAP
Sbjct: 242 QPNKTLKIADFGVARVEAQNPQDMTGETGTLGYMAP 277
|
|
| TAIR|locus:2094329 AT3G22750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 249 (92.7 bits), Expect = 1.5e-34, Sum P(2) = 1.5e-34
Identities = 44/96 (45%), Positives = 71/96 (73%)
Query: 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271
C+V EY GG+++Q+L R + + + K+ V+ ALD++RG++Y+H +HRD+K++N+L+
Sbjct: 169 CVVVEYIPGGTLKQYLFRNRRKKLAFKVVVQLALDLSRGLSYLHSERIVHRDVKTENMLL 228
Query: 272 SADKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 306
+++KIADFGVAR+E Q + MT ETGT +MAP
Sbjct: 229 DYQRNLKIADFGVARVEAQNPKDMTGETGTLGYMAP 264
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_scaffold_147000033 | SubName- Full=Putative uncharacterized protein; (415 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 343 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-49 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-42 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-40 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-29 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-28 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-27 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-26 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-26 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-25 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-25 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-24 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-24 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-21 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-21 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-21 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-20 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-19 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-19 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-13 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-12 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-09 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 5e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 5e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-04 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 2e-49
Identities = 56/169 (33%), Positives = 90/169 (53%), Gaps = 13/169 (7%)
Query: 146 GAFGKLYRGTYNG------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
GAFG++Y+GT G +VA+K L + ++ ++F +E ++ L H NIV
Sbjct: 10 GAFGEVYKGTLKGKGDGKEVEVAVKTL-----KEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ +G C + IV EY GG + +L + + + + L + AL +ARGM Y+ F
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNF 124
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG--TYRWMAP 306
IHRDL + N L+ + +KI+DFG++R + + G RWMAP
Sbjct: 125 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAP 173
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-48
Identities = 60/171 (35%), Positives = 95/171 (55%), Gaps = 15/171 (8%)
Query: 145 QGAFGKLYRGTYNGE------DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+GAFG++Y+GT G+ VA+K L E E+ + ++F +E ++ L H NI
Sbjct: 9 EGAFGEVYKGTLKGDGEGTETKVAVKTL--KEGASEEER---EEFLEEASIMKKLSHPNI 63
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
VR +G C + IVTEY GG + FL R+ + LK ++ AL +A+GM Y+
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLESKN 122
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY---RWMAP 306
F+HRDL + N L++ + +KI+DFG++R + + G +WMAP
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAP 173
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 5e-48
Identities = 55/171 (32%), Positives = 92/171 (53%), Gaps = 16/171 (9%)
Query: 145 QGAFGKLYRGTYNG------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+GAFG++Y+G G +VA+K L + ++ ++F +E ++ L H N+
Sbjct: 9 EGAFGEVYKGKLKGKGGKKKVEVAVKTL-----KEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
V+ +G C + IV EY +GG + +L R+ + L + AL +ARGM Y+
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLESKN 122
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 306
FIHRDL + N L+ + +KI+DFG++R ++ + + G RWMAP
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYRKRGGKLPIRWMAP 172
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-43
Identities = 50/166 (30%), Positives = 86/166 (51%), Gaps = 10/166 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG +Y G+ VAIKI+ E + + ++ +E+ +L L H NIV+
Sbjct: 3 EGGFGTVYLARDKKTGKKVAIKII-----KKEDSSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
G +V EY +GGS++ L + + + ++ L + G+ Y+H G IHR
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIHR 116
Query: 263 DLKSDNLLISADK-SIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
DLK +N+L+ +D +K+ADFG+++ + + GT +MAP
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAP 162
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 5e-43
Identities = 58/165 (35%), Positives = 93/165 (56%), Gaps = 9/165 (5%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G+FG +Y+ + G+ VA+KIL++ +K +Q ++E+ +L L H NIVR I
Sbjct: 9 SGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK----DQTARREIRILRRLSHPNIVRLI 64
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A + +V EY +GG + +L + + A K AL + RG+ Y+H G IHR
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLHSNGIIHR 122
Query: 263 DLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
DLK +N+L+ + +KIADFG+A+ + + +T GT +MAP
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAP 167
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 1e-42
Identities = 56/181 (30%), Positives = 93/181 (51%), Gaps = 28/181 (15%)
Query: 145 QGAFGKLYRGTYNGE-----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+GAFG++Y+G G+ +VA+K L+ + E+ + F +E ++ L H N+V
Sbjct: 5 EGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER-----KDFLKEARVMKKLGHPNVV 59
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA-------VPLKLAVKQALDVARGMA 252
R +G C + +V EY +GG + +L + + + LK + A+ +A+GM
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 253 YVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMA 305
Y+ F+HRDL + N L+ D +KI+DFG++R +T G P RWMA
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLP----IRWMA 175
Query: 306 P 306
P
Sbjct: 176 P 176
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 2e-41
Identities = 52/164 (31%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FGK+Y G+ VAIK++ +K + ++ +E+ +L LKH NIVR
Sbjct: 9 EGSFGKVYLARDKKTGKLVAIKVI-----KKKKIKKDRERILREIKILKKLKHPNIVRLY 63
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+V EY +GG + L ++ + A + + Y+H G +HR
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLHSKGIVHR 121
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
DLK +N+L+ D +K+ADFG+AR E +T GT +MAP
Sbjct: 122 DLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAP 165
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 1e-40
Identities = 55/169 (32%), Positives = 90/169 (53%), Gaps = 13/169 (7%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG +Y GE +A+K +E ++ E+ + ++E+ +L++L+H NIVR+
Sbjct: 10 RGSFGSVYLALDKDTGELMAVKSVELSGDSEEELE----ALEREIRILSSLQHPNIVRYY 65
Query: 203 GACRKR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
G+ R I EY GGS+ L ++ +P + K + G+AY+H G +
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQILEGLAYLHSNGIV 123
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI---EVQTEGMTPETGTYRWMAP 306
HRD+K N+L+ +D +K+ADFG A+ EG GT WMAP
Sbjct: 124 HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 7e-34
Identities = 63/175 (36%), Positives = 93/175 (53%), Gaps = 11/175 (6%)
Query: 136 KLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL 193
+G +GAFG +Y+G G+ VAIK + E E+A + QE+ +L L
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQIS-LEKIKEEAL---KSIMQEIDLLKNL 56
Query: 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
KH NIV++IG+ I+ EYA+ GS+RQ + + P L V +G+AY
Sbjct: 57 KHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLAY 114
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+H G IHRD+K+ N+L + D +K+ADFGVA ++ + GT WMAP
Sbjct: 115 LHEQGVIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAP 168
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 52/170 (30%), Positives = 95/170 (55%), Gaps = 21/170 (12%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG++Y+ + G++VAIK++ +++ +++ E+ +L KH NIV++
Sbjct: 10 KGGFGEVYKARHKRTGKEVAIKVI------KLESKEKKEKIINEIQILKKCKHPNIVKYY 63
Query: 203 GA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA-----VKQALDVARGMAYVHG 256
G+ +K +W IV E+ GGS++ L ++ L + K+ L +G+ Y+H
Sbjct: 64 GSYLKKDELW-IVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELL---KGLEYLHS 116
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G IHRD+K+ N+L+++D +K+ DFG++ T+ GT WMAP
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAP 166
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-29
Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 19/198 (9%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
W ++L+KL +G +G FG + +G Y G+ VA+K + K V Q F +E +
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNI--------KCDVTAQAFLEETAV 52
Query: 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
+ L H N+VR +G ++ IV E G++ FL R V + ++ +LDVA
Sbjct: 53 MTKLHHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAE 111
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNS 309
GM Y+ +HRDL + N+L+S D K++DFG+AR+ + G+ +W AP
Sbjct: 112 GMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVG--SMGVDNSKLPVKWTAP--- 166
Query: 310 FFSPLPHPSFEHK---WS 324
L H F K WS
Sbjct: 167 --EALKHKKFSSKSDVWS 182
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 5e-29
Identities = 59/179 (32%), Positives = 92/179 (51%), Gaps = 13/179 (7%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
W I+ ++L +G +G FG + G Y G+ VA+K L+ Q F E +
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-------AAQAFLAEASV 53
Query: 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
+ TL+H N+V+ +G + IVTEY GS+ +L R + L + ALDV
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCE 113
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GM Y+ F+HRDL + N+L+S D K++DFG+A+ Q + ++G +W AP
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----DSGKLPVKWTAP 168
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 31/196 (15%)
Query: 145 QGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G FGK+ Y+ GE VA+K L ++ F++E+ +L TL H NI
Sbjct: 14 EGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-----FEREIEILRTLDHENI 68
Query: 199 VRFIGACRK--RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
V++ G C K ++ EY GS+R +L R +++ + LK + + + +GM Y+
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQICKGMDYLGS 127
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPH 316
+IHRDL + N+L+ ++ +KI+DFG+A++ + + Y PG S
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKV------LPEDKDYYYVKEPGES------- 174
Query: 317 PSFEHKWSAKESCLKT 332
P F W A E CL+T
Sbjct: 175 PIF---WYAPE-CLRT 186
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 52/171 (30%), Positives = 91/171 (53%), Gaps = 7/171 (4%)
Query: 139 MGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
G G+FG +Y G +G+ A+K + ++ + Q +Q +QE+ +L+ L+H
Sbjct: 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDG-QTGQEAVKQLEQEIALLSKLQHP 62
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-KLAVKQALDVARGMAYVH 255
NIV+++G R+ I E GGS+ + L + + P+ +L +Q L G+ Y+H
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL---GLEYLH 119
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HRD+K N+L+ + +K+ADFG+A+ V+ G+ WMAP
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAP 170
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-27
Identities = 60/181 (33%), Positives = 91/181 (50%), Gaps = 12/181 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I L + G FG+++ GT+NG VA+K L+ +PE F QE
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-------AFLQEAQ 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ L+H +V+ C + IVTEY GS+ FL + + + L V A +A
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIA 113
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMA 305
GMAY+ +IHRDL + N+L+ + KIADFG+AR+ ++ + T G +W A
Sbjct: 114 EGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARL-IEDDEYTAREGAKFPIKWTA 172
Query: 306 P 306
P
Sbjct: 173 P 173
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 59/179 (32%), Positives = 87/179 (48%), Gaps = 39/179 (21%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GA G++Y+ T G++VAIK + + N E E++++ KH NIV +
Sbjct: 29 EGASGEVYKATDRATGKEVAIKKMRLRKQNKELII-------NEILIMKDCKHPNIVDYY 81
Query: 203 GACR-KRMVWCIVTEYAKGGS----VRQF---LTRRQNRAVPLKLAVKQALDVARGMAYV 254
+ +W +V EY GGS + Q + Q V +V +G+ Y+
Sbjct: 82 DSYLVGDELW-VVMEYMDGGSLTDIITQNFVRMNEPQIAYV--------CREVLQGLEYL 132
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-------GTYRWMAP 306
H IHRD+KSDN+L+S D S+K+ADFG A Q +T E GT WMAP
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSVKLADFGFA---AQ---LTKEKSKRNSVVGTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 57/180 (31%), Positives = 87/180 (48%), Gaps = 15/180 (8%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVM-EQQFQQEVMM 189
ID +L G FG ++ G + G+ DVAIK++ + M E F +E +
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMI--------REGAMSEDDFIEEAKV 52
Query: 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
+ L H N+V+ G C K+ IVTEY G + +L R + + + + DV
Sbjct: 53 MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL-RERKGKLGTEWLLDMCSDVCE 111
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 306
M Y+ GFIHRDL + N L+ D +K++DFG+AR + + T GT +W P
Sbjct: 112 AMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPP 170
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 65/212 (30%), Positives = 91/212 (42%), Gaps = 48/212 (22%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVMEQ 181
EW + +L +G +GAFG++ + G D VA+K+L K E+
Sbjct: 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML--------KDDATEK 57
Query: 182 QFQQEV----MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
V MM KH NI+ +G C + +V EYA G++R FL R R
Sbjct: 58 DLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL--RARRPPGE 115
Query: 238 KLA----------------VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281
+ V A VARGM ++ IHRDL + N+L++ D +KIAD
Sbjct: 116 YASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIAD 175
Query: 282 FGVAR-------IEVQTEGMTPETGTYRWMAP 306
FG+AR T G P +WMAP
Sbjct: 176 FGLARDIHHIDYYRKTTNGRLP----VKWMAP 203
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 60/190 (31%), Positives = 90/190 (47%), Gaps = 27/190 (14%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQFQQEVMMLA 191
+ + A GAFG++Y G Y G D + + + PE+ E+ E F E ++++
Sbjct: 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQD---ESDFLMEALIMS 64
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV-PLKLAVKQ----ALD 246
H NIVR IG +R+ I+ E GG ++ FL + R P L +K A D
Sbjct: 65 KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLIS---ADKSIKIADFGVARIEVQTE-------GMTP 296
VA+G Y+ FIHRD+ + N L++ + KIADFG+AR + M P
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184
Query: 297 ETGTYRWMAP 306
+WM P
Sbjct: 185 ----IKWMPP 190
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-25
Identities = 56/180 (31%), Positives = 90/180 (50%), Gaps = 11/180 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNG-EDVAIKILERPENNPEKAQVMEQQFQQEVM 188
W + L + G FG+++ G YNG VAIK L++ +PE F E
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-------FLAEAN 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ L+H +VR + ++ I+TEY + GS+ FL + + + + A +A
Sbjct: 54 LMKQLQHPRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIA 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMA++ +IHRDL++ N+L+S KIADFG+AR+ E E + +W AP
Sbjct: 113 EGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 172
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-25
Identities = 61/185 (32%), Positives = 94/185 (50%), Gaps = 11/185 (5%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I L + G FG+++ GT+NG VA+K L+ +PE F +E
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-------SFLEEAQ 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ L+H +V+ + ++ IVTEY GS+ FL + RA+ L V A VA
Sbjct: 54 IMKKLRHDKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVA 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMAY+ + +IHRDL+S N+L+ KIADFG+AR+ E + + +W AP
Sbjct: 113 AGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 307 GNSFF 311
+ +
Sbjct: 173 EAALY 177
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 59/179 (32%), Positives = 92/179 (51%), Gaps = 17/179 (9%)
Query: 140 GTAFAQGAFGKLYRG--TYNGEDVAIKILERP----ENNPEKAQVMEQQFQQEVMMLATL 193
G +G +G++Y GE +A+K +E P + + + M + + E+ L L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGM 251
HLNIV+++G I EY GGS+ L R R ++ +Q L G+
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGRFEEQLVRFFTEQVL---EGL 121
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR----IEVQTEGMTPETGTYRWMAP 306
AY+H G +HRDLK+DNLL+ AD KI+DFG+++ I + M+ + G+ WMAP
Sbjct: 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAP 179
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 57/173 (32%), Positives = 96/173 (55%), Gaps = 24/173 (13%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL---NIV 199
+GA+G +YRG + G VA+KI+ + + + + Q+EV +L+ L+ NI
Sbjct: 11 RGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDI-----QREVALLSQLRQSQPPNIT 65
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK-----LAVKQALDVARGMAYV 254
++ G+ K I+ EYA+GGSVR + +A P+ + +++ L VA + Y+
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLM-----KAGPIAEKYISVIIREVL-VA--LKYI 117
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM-TPETGTYRWMAP 306
H +G IHRD+K+ N+L++ ++K+ DFGVA + Q + GT WMAP
Sbjct: 118 HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAP 170
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 54/174 (31%), Positives = 86/174 (49%), Gaps = 11/174 (6%)
Query: 140 GTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPE-KAQVMEQQFQQEVMMLATLKHL 196
G QGAFG++Y G ++A+K + ++PE K +V + E+ +L L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEV--NALECEIQLLKNLQHE 64
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
IV++ G R I EY GGSV+ L + A+ + K + G+ Y+H
Sbjct: 65 RIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVAR----IEVQTEGMTPETGTYRWMAP 306
+HRD+K N+L + ++K+ DFG ++ I GM TGT WM+P
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 55/182 (30%), Positives = 86/182 (47%), Gaps = 14/182 (7%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVME-QQFQQEV 187
W ID + + G FG+++ G +N VA+K L K M+ + F E
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL--------KPGTMDPKDFLAEA 52
Query: 188 MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDV 247
++ L+H +++ C IVTE K GS+ ++L RA+ L + A V
Sbjct: 53 QIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWM 304
A GMAY+ +IHRDL + N+L+ + K+ADFG+AR+ + G +W
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YEAREGAKFPIKWT 171
Query: 305 AP 306
AP
Sbjct: 172 AP 173
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 3e-25
Identities = 59/185 (31%), Positives = 94/185 (50%), Gaps = 11/185 (5%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I L + QG FG+++ GT+NG VAIK L+ +PE F QE
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-------FLQEAQ 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ L+H +V+ + ++ IVTEY GS+ FL + + L V A +A
Sbjct: 54 VMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMAYV + ++HRDL++ N+L+ + K+ADFG+AR+ E + + +W AP
Sbjct: 113 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 307 GNSFF 311
+ +
Sbjct: 173 EAALY 177
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-25
Identities = 53/145 (36%), Positives = 84/145 (57%), Gaps = 7/145 (4%)
Query: 145 QGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
+G FG +Y+G G +VA+K R P+ ++++F QE +L H NIV+ IG
Sbjct: 5 KGNFGDVYKGVLKGNTEVAVKTC-RSTLPPD----LKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
C ++ IV E GGS+ FL +++NR + +K ++ +LD A GM Y+ IHRD
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKNCIHRD 118
Query: 264 LKSDNLLISADKSIKIADFGVARIE 288
L + N L+ + +KI+DFG++R E
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREE 143
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-25
Identities = 58/188 (30%), Positives = 88/188 (46%), Gaps = 35/188 (18%)
Query: 145 QGAFGKLYRGT-YNGED------VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN 197
+GAFGK++ G Y+ E VA+K L+ E A + F++E +L +H N
Sbjct: 15 EGAFGKVFLGECYHLEPENDKELVAVKTLK--ETASNDA---RKDFEREAELLTNFQHEN 69
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTR--------RQNRAVPLKLAVKQ----AL 245
IV+F G C + +V EY + G + +FL + + +L + Q A+
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEGMTPET 298
+A GM Y+ F+HRDL + N L+ D +KI DFG++R V M P
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP-- 187
Query: 299 GTYRWMAP 306
RWM P
Sbjct: 188 --IRWMPP 193
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 53/171 (30%), Positives = 88/171 (51%), Gaps = 17/171 (9%)
Query: 145 QGAFGKLYRGTY---NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
G FG + +G Y +G+ +VA+K L+ E +++F +E ++A L H IV
Sbjct: 5 HGNFGSVVKGVYLMKSGKEVEVAVKTLK-----QEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
R IG C+ +V E A G + ++L ++ R +P+ + A VA GMAY+ F
Sbjct: 60 RLIGVCKGEP-LMLVMELAPLGPLLKYL--KKRREIPVSDLKELAHQVAMGMAYLESKHF 116
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETG---TYRWMAP 306
+HRDL + N+L+ KI+DFG++R + ++ T +W AP
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAP 167
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 51/169 (30%), Positives = 82/169 (48%), Gaps = 19/169 (11%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG++Y+ + VAIK+++ E E + QQE+ L+ + I ++
Sbjct: 11 KGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDI-----QQEIQFLSQCRSPYITKYY 65
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALDVARGMAYVHGLG 258
G+ K I+ EY GGS L A L+ +V G+ Y+H G
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILR-------EVLLGLEYLHEEG 118
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 306
IHRD+K+ N+L+S + +K+ADFGV+ ++ GT WMAP
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAP 167
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 31/199 (15%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQ 182
W + K+ + QG+FG +Y G G VAIK + N + +E
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIE-- 55
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL--TRRQNRAVP---- 236
F E ++ ++VR +G +V E G ++ +L R + P
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115
Query: 237 --LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-- 292
L+ ++ A ++A GMAY+ F+HRDL + N +++ D ++KI DFG+ R +T+
Sbjct: 116 PTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY 175
Query: 293 -----GMTPETGTYRWMAP 306
G+ P RWMAP
Sbjct: 176 RKGGKGLLP----VRWMAP 190
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 102 bits (253), Expect = 2e-24
Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 15/191 (7%)
Query: 145 QGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL-NIVRFIG 203
+G+FG++Y + VA+K+L + + K ++F +E+ +LA+L H NIV+
Sbjct: 10 EGSFGEVYLARDR-KLVALKVLAKKLESKSKEV---ERFLREIQILASLNHPPNIVKLYD 65
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFL-TRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ +V EY GGS+ L + + A+ + + Y+H G IHR
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHR 125
Query: 263 DLKSDNLLISAD-KSIKIADFGVARI-------EVQTEGMTPETGTYRWMAPGNSFFSPL 314
D+K +N+L+ D + +K+ DFG+A++ + GT +MAP L
Sbjct: 126 DIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSL 185
Query: 315 PHPSFE-HKWS 324
+ S WS
Sbjct: 186 AYASSSSDIWS 196
|
Length = 384 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 2e-24
Identities = 50/168 (29%), Positives = 82/168 (48%), Gaps = 18/168 (10%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G++G +Y+ + G+ VAIK++ E+ Q+ +E+ +L IV++
Sbjct: 13 EGSYGSVYKAIHKETGQVVAIKVVPVEEDL--------QEIIKEISILKQCDSPYIVKYY 64
Query: 203 GACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--KQALDVARGMAYVHGLGF 259
G+ K +W IV EY GSV + ++A Q L +G+ Y+H
Sbjct: 65 GSYFKNTDLW-IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTL---KGLEYLHSNKK 120
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-GTYRWMAP 306
IHRD+K+ N+L++ + K+ADFGV+ T GT WMAP
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAP 168
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 2e-24
Identities = 62/180 (34%), Positives = 94/180 (52%), Gaps = 20/180 (11%)
Query: 140 GTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
G +GA+G +Y G N G+ +A+K +E +N A+ ++ Q+EV +L +LKH+NI
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV-----KQALDVARGMAY 253
V+++G C I E+ GGS+ L NR PL V KQ LD G+AY
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILD---GVAY 117
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-------EVQTEGMTPETGTYRWMAP 306
+H +HRD+K +N+++ + IK+ DFG AR + + GT WMAP
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 9e-24
Identities = 53/161 (32%), Positives = 76/161 (47%), Gaps = 25/161 (15%)
Query: 161 VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220
VA+K+L RP+ + + F +EV +L+ L NI R +G C C++ EY +
Sbjct: 49 VAVKVL-RPDASDNARE----DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMEN 103
Query: 221 GSVRQFLTRRQNRAVPLKLAVKQ---------ALDVARGMAYVHGLGFIHRDLKSDNLLI 271
G + QFL + L K A +A GM Y+ L F+HRDL + N L+
Sbjct: 104 GDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163
Query: 272 SADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMA 305
+ +IKIADFG++R VQ P RWMA
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLP----IRWMA 200
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-23
Identities = 50/184 (27%), Positives = 87/184 (47%), Gaps = 14/184 (7%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY---NGE--DVAIKILERPENNPEKAQVMEQQFQ 184
+ I + +G +G FG +Y+G Y E VA+K + +P + +F
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVRE----KFL 55
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
QE ++ H +IV+ IG + VW IV E A G +R +L + + L + +
Sbjct: 56 QEAYIMRQFDHPHIVKLIGVITENPVW-IVMELAPLGELRSYLQVNKYS-LDLASLILYS 113
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--R 302
++ +AY+ F+HRD+ + N+L+S+ +K+ DFG++R G +
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK 173
Query: 303 WMAP 306
WMAP
Sbjct: 174 WMAP 177
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 1e-23
Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 15/170 (8%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G+FGK L R +G+ +K ++ + E+ EV +L L H NI+++
Sbjct: 10 KGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDA-----LNEVKILKKLNHPNIIKY 64
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD----VARGMAYVHGL 257
+ ++ CIV EYA GG + Q + +++ P +Q LD + + Y+H
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFP--EEQILDWFVQLCLALKYLHSR 122
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-GTYRWMAP 306
+HRD+K N+ ++++ +K+ DFG++++ T + GT +++P
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSP 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 61/172 (35%), Positives = 92/172 (53%), Gaps = 26/172 (15%)
Query: 146 GAFGKLY--RGTYNGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
G +G +Y R GE VAIK+ LE ++ + QQE+ ML +H NIV +
Sbjct: 14 GTYGDVYKARDIATGELVAIKVIKLEPGDD--------FEIIQQEISMLKECRHPNIVAY 65
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP-LKLA--VKQALDVARGMAYVHGLG 258
G+ +R IV EY GGS+ Q + + + L++A ++ L +G+AY+H G
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSL-QDIYQVTRGPLSELQIAYVCRETL---KGLAYLHETG 121
Query: 259 FIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPET---GTYRWMAP 306
IHRD+K N+L++ D +K+ADFGV A++ T + GT WMAP
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQL---TATIAKRKSFIGTPYWMAP 170
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-23
Identities = 59/185 (31%), Positives = 92/185 (49%), Gaps = 11/185 (5%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I L + QG FG+++ GT+NG VAIK L+ PE F QE
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-------FLQEAQ 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ L+H +V + ++ IVTE+ GS+ FL + + L V A +A
Sbjct: 54 IMKKLRHDKLVPLYAVVSEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIA 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMAY+ + +IHRDL++ N+L+ + KIADFG+AR+ E + + +W AP
Sbjct: 113 DGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 307 GNSFF 311
+ +
Sbjct: 173 EAALY 177
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 4e-23
Identities = 49/183 (26%), Positives = 90/183 (49%), Gaps = 15/183 (8%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVME-QQFQQE 186
W ++ + M G +G++Y G + VA+K L K ME ++F +E
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--------KEDTMEVEEFLKE 52
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
++ +KH N+V+ +G C + + I+TE+ G++ +L + V + + A
Sbjct: 53 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ 112
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRW 303
++ M Y+ FIHRDL + N L+ + +K+ADFG++R+ + + T G +W
Sbjct: 113 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKW 171
Query: 304 MAP 306
AP
Sbjct: 172 TAP 174
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 6e-23
Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 32/199 (16%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGE------DVAIKILERPENNPEKAQVMEQQFQQEVMML 190
L GAFG +Y+G + E VAIK+L E KA ++ E ++
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR--EETSPKAN---KEILDEAYVM 63
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD---- 246
A++ H ++VR +G C V ++T+ G + ++ R ++ + + L+
Sbjct: 64 ASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYV--RNHKD---NIGSQYLLNWCVQ 117
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----EVQ---TEGMTPETG 299
+A+GM+Y+ +HRDL + N+L+ + +KI DFG+A++ E + G P
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP--- 174
Query: 300 TYRWMAPGNSFFSPLPHPS 318
+WMA + H S
Sbjct: 175 -IKWMALESILHRIYTHKS 192
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-22
Identities = 62/193 (32%), Positives = 94/193 (48%), Gaps = 37/193 (19%)
Query: 142 AFAQGAFGKLYRG---TYNGED----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194
+GAFGK+Y+G N VAIK L + P+ ++Q+F+QE +++ L+
Sbjct: 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTL-KENAEPK----VQQEFRQEAELMSDLQ 66
Query: 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ----NRAVPLKLAVKQALD---- 246
H NIV +G C K C++ EY G + +FL R A VK +LD
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 247 ------VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEG 293
+A GM Y+ F+HRDL + N L+ ++KI+DFG++R VQ++
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 294 MTPETGTYRWMAP 306
+ P RWM P
Sbjct: 187 LLP----VRWMPP 195
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 53/172 (30%), Positives = 82/172 (47%), Gaps = 20/172 (11%)
Query: 146 GAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQ---FQQEVMMLATLKHLN 197
G FG++ RG DVAIK L KA ++Q F E ++ H N
Sbjct: 15 GEFGEVCRGRLKLPGKKEIDVAIKTL--------KAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
I+R G K I+TEY + GS+ +FL + +L V +A GM Y+ +
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL-VGMLRGIASGMKYLSEM 125
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG---TYRWMAP 306
++HRDL + N+L++++ K++DFG++R +E G RW AP
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAP 177
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-22
Identities = 61/198 (30%), Positives = 94/198 (47%), Gaps = 35/198 (17%)
Query: 145 QGAFGKLYR----GTYNGED---VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN 197
QGAFG++++ G E VA+K+L+ E + M+ FQ+E ++A H N
Sbjct: 15 QGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-----EASADMQADFQREAALMAEFDHPN 69
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV----------------PLKLA- 240
IV+ +G C C++ EY G + +FL R RA PL L+
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 241 ---VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE---GM 294
+ A VA GMAY+ F+HRDL + N L+ + +KIADFG++R +
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 295 TPETGTYRWMAPGNSFFS 312
+ RWM P + F++
Sbjct: 190 ENDAIPIRWMPPESIFYN 207
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-22
Identities = 59/169 (34%), Positives = 91/169 (53%), Gaps = 13/169 (7%)
Query: 143 FAQGAFGKLYRGTYNGED-VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G FG++++GT + VA+K + E+ P++ ++ +F E +L H NIV+
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCK--EDLPQELKI---KFLSEARILKQYDHPNIVKL 57
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
IG C +R IV E GG FL R++ + K VK ALD A GMAY+ IH
Sbjct: 58 IGVCTQRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG----TYRWMAP 306
RDL + N L+ + +KI+DFG++R E +G+ +G +W AP
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQE--DDGIYSSSGLKQIPIKWTAP 163
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-22
Identities = 55/180 (30%), Positives = 90/180 (50%), Gaps = 15/180 (8%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
W +++++L + +G FG + G Y G VA+K + K Q F E +
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI--------KNDATAQAFLAEASV 52
Query: 190 LATLKHLNIVRFIGA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
+ L+H N+V+ +G ++ IVTEY GS+ +L R + +K +LDV
Sbjct: 53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
M Y+ F+HRDL + N+L+S D K++DFG+ + E + T +TG +W AP
Sbjct: 113 EAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASS---TQDTGKLPVKWTAP 168
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-22
Identities = 61/186 (32%), Positives = 89/186 (47%), Gaps = 34/186 (18%)
Query: 146 GAFGKLYRGTYNGED--------VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN 197
GAFG++Y GT VA+K L + + EK + F +E +++ H N
Sbjct: 6 GAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-----FLKEAHLMSNFNHPN 60
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFL-----TRRQNRAVPLKLAVKQALDVARGMA 252
IV+ +G C I+ E +GG + +L R + LK + LDVA+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 253 YVHGLGFIHRDLKSDNLLIS-----ADKSIKIADFGVAR-------IEVQTEGMTPETGT 300
Y+ + FIHRDL + N L+S AD+ +KI DFG+AR + EG+ P
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP---- 176
Query: 301 YRWMAP 306
RWMAP
Sbjct: 177 VRWMAP 182
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-22
Identities = 56/180 (31%), Positives = 89/180 (49%), Gaps = 11/180 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I L + G FG+++ TYN VA+K ++ P V + F E
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-----PGSMSV--EAFLAEAN 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ TL+H +V+ K ++ I+TE+ GS+ FL + PL + + +A
Sbjct: 54 VMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMA++ +IHRDL++ N+L+SA KIADFG+AR+ E E + +W AP
Sbjct: 113 EGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 172
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-22
Identities = 59/180 (32%), Positives = 87/180 (48%), Gaps = 10/180 (5%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I + + G FG+++ G Y N VA+K L+ P V Q F +E
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLK-----PGTMSV--QAFLEEAN 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ TL+H +VR K I+TEY GS+ FL + V L + + +A
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA 113
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMAY+ +IHRDL++ N+L+S KIADFG+AR+ E E + +W AP
Sbjct: 114 EGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 173
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 6e-22
Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 13/179 (7%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
I +L + G FG ++ G + VAIK + + + E+ F +E ++
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIR-------EGAMSEEDFIEEAQVM 53
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L H +V+ G C +R C+V E+ + G + +L R Q + + LDV G
Sbjct: 54 MKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVCEG 112
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 306
MAY+ IHRDL + N L+ ++ +K++DFG+ R V + T TGT +W +P
Sbjct: 113 MAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSP 170
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 8e-22
Identities = 57/179 (31%), Positives = 88/179 (49%), Gaps = 13/179 (7%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVMML 190
ID + L G FG + G + G+ DVAIK+++ + + E +F +E ++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-------EGSMSEDEFIEEAKVM 53
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L H +V+ G C K+ IVTEY G + +L R P +L ++ DV G
Sbjct: 54 MKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-LEMCKDVCEG 112
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 306
MAY+ FIHRDL + N L+ +K++DFG++R + E T G+ RW P
Sbjct: 113 MAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPP 170
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-21
Identities = 56/165 (33%), Positives = 89/165 (53%), Gaps = 10/165 (6%)
Query: 145 QGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G FG+++ G + N VAIKIL+ ++ K Q FQ+EV L L+H +++
Sbjct: 16 SGYFGEVWEGLWKNRVRVAIKILKS--DDLLKQQ----DFQKEVQALKRLRHKHLISLFA 69
Query: 204 AC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
C V+ I+TE + GS+ FL + + +P+ + A VA GMAY+ IHR
Sbjct: 70 VCSVGEPVY-IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHR 128
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT-YRWMAP 306
DL + N+L+ D K+ADFG+AR+ + ++ + Y+W AP
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAP 173
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 2e-21
Identities = 55/169 (32%), Positives = 81/169 (47%), Gaps = 33/169 (19%)
Query: 161 VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220
VA+KIL P+ + F +EV +L+ LK NI+R +G C C++TEY +
Sbjct: 49 VAVKILR-----PDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMEN 103
Query: 221 GSVRQFLTRRQ--NRAVPLKLAVKQ---------------ALDVARGMAYVHGLGFIHRD 263
G + QFL+ ++ AV AL +A GM Y+ L F+HRD
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163
Query: 264 LKSDNLLISADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMA 305
L + N L+ + +IKIADFG++R +Q + P RWMA
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLP----IRWMA 208
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-21
Identities = 45/148 (30%), Positives = 75/148 (50%), Gaps = 13/148 (8%)
Query: 145 QGAFGKLYRGTY---NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
G+FG + RG + G+ VA+K L+ +K + F +E ++ +L H N++
Sbjct: 5 DGSFGVVRRGEWSTSGGKVIPVAVKCLK-----SDKLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 200 RFIGACR-KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
R G ++ +VTE A GS+ L + + A+ +A GM Y+
Sbjct: 60 RLYGVVLTHPLM--MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVAR 286
FIHRDL + N+L+++D +KI DFG+ R
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-21
Identities = 63/197 (31%), Positives = 99/197 (50%), Gaps = 19/197 (9%)
Query: 127 YDE-WTIDLRKLNMGTAFAQGAFGKLYRGTYNG---ED----VAIKILERPENNPEKAQV 178
YD W L+ G GAFGK+ T G D VA+K+L+ ++ E+ +
Sbjct: 26 YDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREAL 85
Query: 179 MEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
M E+ +++ L H NIV +GAC ++TEY G + FL R++ + L
Sbjct: 86 M-----SELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL 140
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE 297
+ + + VA+GMA++ IHRDL + N+L++ K +KI DFG+AR ++ +
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-DIMNDSNYVV 199
Query: 298 TGTYR----WMAPGNSF 310
G R WMAP + F
Sbjct: 200 KGNARLPVKWMAPESIF 216
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-21
Identities = 49/187 (26%), Positives = 92/187 (49%), Gaps = 31/187 (16%)
Query: 141 TAFAQGAFGKLYRGTYNGED-------VAIKILE-RPENNPEKAQVMEQQFQQEVMMLAT 192
T +G FG+++ G + V +K L+ + N ++ +F++E+ M
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDEN------LQSEFRRELDMFRK 64
Query: 193 LKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK---LAVKQAL---- 245
L H N+VR +G CR+ ++ EY G ++QFL +++ LK L+ KQ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE------GMTPETG 299
+A GM ++ F+HRDL + N L+S+ + +K++ +++ +E + P
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP--- 181
Query: 300 TYRWMAP 306
RW+AP
Sbjct: 182 -LRWLAP 187
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 8e-21
Identities = 49/178 (27%), Positives = 85/178 (47%), Gaps = 19/178 (10%)
Query: 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194
L QG+ G +Y+ + G+ A+K + + + +Q +E+ L + +
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD-----EEFRKQLLRELKTLRSCE 57
Query: 195 HLNIVRFIGA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP---LKLAVKQALDVARG 250
+V+ GA ++ + IV EY GGS+ L ++ +P L +Q L G
Sbjct: 58 SPYVVKCYGAFYKEGEI-SIVLEYMDGGSLADLL--KKVGKIPEPVLAYIARQILK---G 111
Query: 251 MAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
+ Y+H IHRD+K NLLI++ +KIADFG++++ T GT +M+P
Sbjct: 112 LDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSP 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 9e-21
Identities = 56/181 (30%), Positives = 93/181 (51%), Gaps = 18/181 (9%)
Query: 140 GTAFAQGAFGKLYRG--TYNGEDVAIKILERP---ENNPEKAQVMEQQFQQEVMMLATLK 194
G G+FG +Y G +GE +A+K +E P ++ ++ + M +E+ +L L+
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-KLAVKQALDVARGMAY 253
H NIV+++G+ I EY GGSV L L + V+Q L +G+ Y
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL---KGLNY 121
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR--------WMA 305
+H G IHRD+K N+L+ IKI+DFG+++ +++ ++ +T R WMA
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISK-KLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 306 P 306
P
Sbjct: 181 P 181
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 2e-20
Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 38/220 (17%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQVM 179
+W +L +G +G FG++ R G D VA+K+L+ + + A ++
Sbjct: 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLI 65
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL------------ 227
+ E+M L KH NI+ +G C + ++ EYA G++R+FL
Sbjct: 66 SEM---ELMKLIG-KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTF 121
Query: 228 --TRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
T+ + K V A VARGM Y+ IHRDL + N+L++ D +KIADFG+A
Sbjct: 122 DITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 286 R-------IEVQTEGMTPETGTYRWMAPGNSFFSPLPHPS 318
R + + G P +WMAP F H S
Sbjct: 182 RGVHDIDYYKKTSNGRLP----VKWMAPEALFDRVYTHQS 217
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-20
Identities = 50/162 (30%), Positives = 83/162 (51%), Gaps = 26/162 (16%)
Query: 161 VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220
VA+K+L + + F +E+ +++ LK+ NI+R +G C C++TEY +
Sbjct: 47 VAVKMLR-----ADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMEN 101
Query: 221 GSVRQFLTRRQNRA----------VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270
G + QFL++R+ + V + + A+ +A GM Y+ L F+HRDL + N L
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161
Query: 271 ISADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMA 305
+ +IKIADFG++R +Q + P RWMA
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLP----IRWMA 199
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 3e-20
Identities = 57/162 (35%), Positives = 86/162 (53%), Gaps = 20/162 (12%)
Query: 135 RKLNMGTAFAQGAFGK--LYR------GTYNGEDVAIKILERPENNPEKAQVMEQQFQQE 186
R L +G FGK LY GT GE VA+K L+R E Q +++E
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGT--GEMVAVKTLKR-----ECGQQNTSGWKKE 56
Query: 187 VMMLATLKHLNIVRFIGACRKR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
+ +L TL H NIV++ G C ++ ++ EY GS+R +L + + L L +Q
Sbjct: 57 INILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ- 115
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ GMAY+H +IHRDL + N+L+ D+ +KI DFG+A+
Sbjct: 116 --ICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 6e-20
Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 38/220 (17%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQVM 179
+W + +L +G +G FG++ G D VA+K+L+ + + + ++
Sbjct: 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLV 65
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ-------- 231
+ MM KH NI+ +GAC + ++ EYA G++R++L R+
Sbjct: 66 SEM----EMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSF 121
Query: 232 ------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
+ K V A VARGM Y+ IHRDL + N+L++ D +KIADFG+A
Sbjct: 122 DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 286 R-------IEVQTEGMTPETGTYRWMAPGNSFFSPLPHPS 318
R + T G P +WMAP F H S
Sbjct: 182 RDVHNIDYYKKTTNGRLP----VKWMAPEALFDRVYTHQS 217
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 53/177 (29%), Positives = 90/177 (50%), Gaps = 23/177 (12%)
Query: 144 AQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVR 200
+G +GK+Y+ + G+ VAIKI++ E+ E++ ++E +L H NI
Sbjct: 15 GEGTYGKVYKARHKKTGQLVAIKIMDIIED-------EEEEIKEEYNILRKYSNHPNIAT 67
Query: 201 FIGACRKR-------MVWCIVTEYAKGGSVRQFL--TRRQNRAVPLKLAVKQALDVARGM 251
F GA K+ +W +V E GGSV + R++ + + + + RG+
Sbjct: 68 FYGAFIKKNPPGNDDQLW-LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGL 126
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
AY+H IHRD+K N+L++ + +K+ DFGV+ ++ + T GT WMAP
Sbjct: 127 AYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTLGRRNTFIGTPYWMAP 182
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 31/202 (15%)
Query: 135 RKLNMGTAFAQGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
R L +G FG + Y+ GE VA+K L+ A+ + + F++E+
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-----HSTAEHL-RDFEREIE 57
Query: 189 MLATLKHLNIVRFIGAC--RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
+L +L+H NIV++ G C R +V EY GS+R +L + + R KL + A
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKL-LLYASQ 116
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+ +GM Y+ ++HRDL + N+L+ ++ +KI DFG+ ++ Q + Y+ P
Sbjct: 117 ICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ------DKEYYKVREP 170
Query: 307 GNSFFSPLPHPSFEHKWSAKES 328
G S P F W A ES
Sbjct: 171 GES-------PIF---WYAPES 182
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-19
Identities = 51/170 (30%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA +Y N E VAIK + + EK Q + ++EV ++ H N+V++
Sbjct: 11 VGATAVVYAAICLPNNEKVAIKRI-----DLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV-PLKLAVKQALDVARGMAYVHGLGFIH 261
+ +V Y GGS+ + R + +V +G+ Y+H G IH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIH 125
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-----GTYRWMAP 306
RD+K+ N+L+ D S+KIADFGV+ T + GT WMAP
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 4e-19
Identities = 65/231 (28%), Positives = 101/231 (43%), Gaps = 43/231 (18%)
Query: 123 GLENYD-----EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILER 168
G+ Y+ W + +L +G +G FG++ G D VA+K+L+
Sbjct: 1 GVSEYELPEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKS 60
Query: 169 PENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLT 228
+ + ++ + MM KH NI+ +GAC + ++ EYA G++R++L
Sbjct: 61 DATEKDLSDLISEM----EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 116
Query: 229 RRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274
R+ + K V A VARGM Y+ IHRDL + N+L++ D
Sbjct: 117 ARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 176
Query: 275 KSIKIADFGVAR-------IEVQTEGMTPETGTYRWMAPGNSFFSPLPHPS 318
+KIADFG+AR + T G P +WMAP F H S
Sbjct: 177 NVMKIADFGLARDIHHIDYYKKTTNGRLP----VKWMAPEALFDRIYTHQS 223
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 4e-19
Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 13/170 (7%)
Query: 144 AQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
G FGK+Y GE +A+K + +N+P+ ++ E+ +L LKH N+V++
Sbjct: 9 GGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPK----TIKEIADEMKVLELLKHPNLVKY 64
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
G R I EY GG++ + L R + + L + G+AY+H G +H
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-----TGTYRWMAP 306
RD+K N+ + + IK+ DFG A E GT +MAP
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 7e-19
Identities = 44/171 (25%), Positives = 89/171 (52%), Gaps = 19/171 (11%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR- 200
+G++G +Y+ + A+K ++ + E+ + E+ +LA++ H NI+
Sbjct: 10 KGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-----NEIRILASVNHPNIISY 64
Query: 201 ---FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVH 255
F+ + CIV EYA G + + +++R+ + +P + + + + RG+ +H
Sbjct: 65 KEAFLDGNK----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HRDLKS N+L+ A+ +KI D G++++ + T + GT +MAP
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT-QIGTPHYMAP 170
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 7e-19
Identities = 59/191 (30%), Positives = 87/191 (45%), Gaps = 37/191 (19%)
Query: 143 FAQGAFGKLYRGTYNG----ED---VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195
+GAFGK++ + +D VA+K L+ E ++ Q FQ+E +L L+H
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK------EASESARQDFQREAELLTVLQH 66
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR--------QNRAVPL-KLAVKQAL- 245
+IVRF G C + +V EY + G + +FL V +L + Q L
Sbjct: 67 QHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 246 ---DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEGMT 295
+A GM Y+ L F+HRDL + N L+ +KI DFG++R V M
Sbjct: 127 IASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 296 PETGTYRWMAP 306
P RWM P
Sbjct: 187 P----IRWMPP 193
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 8e-19
Identities = 49/177 (27%), Positives = 86/177 (48%), Gaps = 15/177 (8%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G +Y+ GE VAIK ++ + + + +E+ +L L H NI++ +
Sbjct: 9 EGTYGVVYKARDKLTGEIVAIKKIKLRFESE----GIPKTALREIKLLKELNHPNIIKLL 64
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
R + +V E+ + + + + + R +P L + +G+A+ H G +HR
Sbjct: 65 DVFRHKGDLYLVFEFMDT-DLYKLI-KDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHR 122
Query: 263 DLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWM-AP----GNSFFSP 313
DLK +NLLI+ + +K+ADFG+AR T T RW AP G+ +S
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT-RWYRAPELLLGDKGYST 178
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 8e-19
Identities = 40/151 (26%), Positives = 70/151 (46%), Gaps = 18/151 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM----LATLK-HLN 197
+G+F + ++ AIKIL+ K Q+++++ + V + L L H
Sbjct: 11 EGSFSTVVLAKEKETNKEYAIKILD-------KRQLIKEKKVKYVKIEKEVLTRLNGHPG 63
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP-LKLAVKQALDVARGMAYVHG 256
I++ + V EYA G + Q++ + + + + L + Y+H
Sbjct: 64 IIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILL---ALEYLHS 120
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287
G IHRDLK +N+L+ D IKI DFG A++
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKV 151
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 9e-19
Identities = 50/161 (31%), Positives = 79/161 (49%), Gaps = 25/161 (15%)
Query: 161 VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220
VA+K+L N + F +E+ +++ LK NI+R + C C++TEY +
Sbjct: 49 VAVKMLREDANKNAR-----NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMEN 103
Query: 221 GSVRQFLTRRQNRAVPLKLAVK---------QALDVARGMAYVHGLGFIHRDLKSDNLLI 271
G + QFL+R + + K V A +A GM Y+ L F+HRDL + N L+
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163
Query: 272 SADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMA 305
+ +IKIADFG++R +Q + P RWM+
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLP----IRWMS 200
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-18
Identities = 51/167 (30%), Positives = 83/167 (49%), Gaps = 11/167 (6%)
Query: 145 QGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204
+G FG+++ G ++ + + E P ++ +F QE +L H NIVR IG
Sbjct: 5 RGNFGEVFSGRLRADNTPVAVKSCRETLPPD---LKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDL 264
C ++ IV E +GG FL R + + +K ++ + A GM Y+ IHRDL
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 265 KSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR-----WMAP 306
+ N L++ +KI+DFG++R E +G+ TG + W AP
Sbjct: 121 AARNCLVTEKNVLKISDFGMSREE--EDGVYASTGGMKQIPVKWTAP 165
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 2e-18
Identities = 54/167 (32%), Positives = 84/167 (50%), Gaps = 22/167 (13%)
Query: 146 GAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFI 202
G FG +Y GE VAIK +++ + E+ + +EV L L H NIV+
Sbjct: 10 GTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-----REVKSLRKLNEHPNIVKLK 64
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP---LKLAVKQALDVARGMAYVHGLGF 259
R+ V EY +G ++ Q + R+ + ++ + Q + +G+A++H GF
Sbjct: 65 EVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQ---ILQGLAHIHKHGF 120
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY---RW 303
HRDLK +NLL+S + +KIADFG+AR + P T Y RW
Sbjct: 121 FHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYT-DYVSTRW 163
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 38/219 (17%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQVME 180
W KL +G +G FG++ G D VA+K+L+ ++ EK +
Sbjct: 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK--DDATEKD--LS 65
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL------------- 227
+ MM KH NI+ +GAC + ++ EYA G++R++L
Sbjct: 66 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125
Query: 228 -TRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
R + + K V VARGM Y+ IHRDL + N+L++ + +KIADFG+AR
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
Query: 287 -------IEVQTEGMTPETGTYRWMAPGNSFFSPLPHPS 318
+ T G P +WMAP F H S
Sbjct: 186 DVNNIDYYKKTTNGRLP----VKWMAPEALFDRVYTHQS 220
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 46/147 (31%), Positives = 72/147 (48%), Gaps = 14/147 (9%)
Query: 145 QGAFGKLY--RGTYNGEDVAIK-ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GA+G + R GE VAIK E ++ K + +EV +L L+H NIV
Sbjct: 11 EGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL-----REVKVLRQLRHENIVNL 65
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLGF 259
A R++ +V EY ++ + L P ++ + Q L + +AY H
Sbjct: 66 KEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLL---QAIAYCHSHNI 121
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR 286
IHRD+K +N+L+S +K+ DFG AR
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-18
Identities = 53/176 (30%), Positives = 87/176 (49%), Gaps = 12/176 (6%)
Query: 140 GTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN 197
G GAF Y R G +A+K + N + + + + ++E+ ++A L H +
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
I+R +GA + + + E+ GGSV L++ A + + + RG++Y+H
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN 122
Query: 258 GFIHRDLKSDNLLI-SADKSIKIADFGVA-RIEVQTEGMTPE-----TGTYRWMAP 306
IHRD+K NLLI S + ++IADFG A R+ + G E GT +MAP
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG-AGEFQGQLLGTIAFMAP 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 7e-18
Identities = 53/212 (25%), Positives = 98/212 (46%), Gaps = 47/212 (22%)
Query: 136 KLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVM 188
L +G +G FGK+ + T VA+K+L+ ++ E ++ E
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLL-----SEFN 55
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---------------- 232
+L + H ++++ GAC + ++ EYAK GS+R FL +
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 233 ------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
RA+ + + A ++RGM Y+ + +HRDL + N+L++ + +KI+DFG++R
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 287 IEV--------QTEGMTPETGTYRWMAPGNSF 310
+V +++G P +WMA + F
Sbjct: 176 -DVYEEDSYVKRSKGRIP----VKWMAIESLF 202
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-17
Identities = 51/162 (31%), Positives = 87/162 (53%), Gaps = 15/162 (9%)
Query: 143 FAQGAFGKLY------RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
+G FGK+ G GE VA+K L +PE+ ++E+ +L L H
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIA----DLKKEIEILRNLYHE 66
Query: 197 NIVRFIGACRKRMVWCI--VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
NIV++ G C + I + E+ GS++++L R +N+ + LK +K A+ + +GM Y+
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYL 125
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMT 295
++HRDL + N+L+ ++ +KI DFG+ + IE E T
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT 167
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-17
Identities = 43/167 (25%), Positives = 83/167 (49%), Gaps = 9/167 (5%)
Query: 144 AQGAFGKLYRGTY--NGEDVAIKILE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G+FG +++ + A+K ++ N E+ + ++ E +LA L I+R
Sbjct: 9 GKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-----EARVLAKLDSSYIIR 63
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ + + IV EYA+ G + + L ++ R +P + + + G+A++H +
Sbjct: 64 YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKIL 123
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI-EVQTEGMTPETGTYRWMAP 306
HRD+KS NL + A ++KI D GVA++ T GT +++P
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSP 170
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 1e-17
Identities = 53/175 (30%), Positives = 88/175 (50%), Gaps = 11/175 (6%)
Query: 140 GTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN 197
G QGAFG++Y G ++A K ++ +PE ++ + + E+ +L L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEV-SALECEIQLLKNLQHER 65
Query: 198 IVRFIGACRKR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
IV++ G R R I EY GGSV+ L + A+ + K + GM+Y+H
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMSYLH 123
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVAR----IEVQTEGMTPETGTYRWMAP 306
+HRD+K N+L + ++K+ DFG ++ I + G+ TGT WM+P
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 15/170 (8%)
Query: 146 GAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G FG+++RG VAIK L+ P + Q F E ++ H NI+R
Sbjct: 16 GEFGEVFRGILKMPGRKEVAVAIKTLK-----PGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
G K I+TEY + G++ ++L +L V +A GM Y+ + ++
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKYLSDMNYV 129
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI-EVQTEGMTPETG---TYRWMAP 306
HRDL + N+L++++ K++DFG++R+ E EG +G RW AP
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-17
Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 19/187 (10%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
E+ + + +G +G +Y V I I E PE + Q + +E+
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPL----HEEIA 57
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQA 244
+ + LKH NIV+++G+ + + I E GGS+ L + ++ + KQ
Sbjct: 58 LHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI 117
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSI-KIADFG----VARIEVQTEGMTPETG 299
L+ G+ Y+H +HRD+K DN+L++ + KI+DFG +A I TE TG
Sbjct: 118 LE---GLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF---TG 171
Query: 300 TYRWMAP 306
T ++MAP
Sbjct: 172 TLQYMAP 178
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 22/178 (12%)
Query: 139 MGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
+ +GA G +++ GE VA+K + + Q +E+ L +H
Sbjct: 4 ILGRIGEGAHGIVFKAKDRETGETVALKKV----ALRRLEGGIPNQALREIKALQACQHP 59
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARG 250
+V+ + + +V EY + L Q ++ L +G
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLL--------KG 111
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG--MTPETGTYRWMAP 306
+AY+H G +HRDLK NLLISAD +KIADFG+AR+ + E + + T + AP
Sbjct: 112 VAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAP 169
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 45/167 (26%), Positives = 86/167 (51%), Gaps = 11/167 (6%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPE-NNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GAFG+ LYR T + V K + + E+ + E+++L+ L+H NI+ +
Sbjct: 10 KGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL-----NEIVILSLLQHPNIIAY 64
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
I EYA GG++ + R++ + ++ + + ++Y+H G +H
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILH 124
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
RD+K+ N+ ++ IK+ DFG+++I + +E ET GT +M+P
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKI-LGSEYSMAETVVGTPYYMSP 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-17
Identities = 51/172 (29%), Positives = 80/172 (46%), Gaps = 17/172 (9%)
Query: 145 QGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G FG +Y GT D A+K L R + E Q F +E +++ H N++
Sbjct: 5 KGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-----FLKEGIIMKDFSHPNVL 59
Query: 200 RFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
+G C +V Y K G +R F+ R + +K + L VA+GM Y+
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFI-RSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT-----YRWMA 305
F+HRDL + N ++ ++K+ADFG+AR E + T +WMA
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-17
Identities = 59/192 (30%), Positives = 90/192 (46%), Gaps = 37/192 (19%)
Query: 143 FAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
+ AFGK+Y+G + + VAIK L + NNP++ +FQQE ++A L H
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTL-KDINNPQQWG----EFQQEASLMAELHHP 67
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA-----VPLKLAVKQALD----- 246
NIV +G + C++ EY G + +FL R + VK +LD
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 247 -----VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEGM 294
+A GM Y+ F+H+DL + N+LI +KI+D G++R VQ + +
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 295 TPETGTYRWMAP 306
P RWM P
Sbjct: 188 LP----IRWMPP 195
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 5e-17
Identities = 49/156 (31%), Positives = 74/156 (47%), Gaps = 30/156 (19%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G++Y+ GE VA+K + R EN E +E+ +L L+H NIVR
Sbjct: 9 EGTYGQVYKARNKKTGELVALKKI-RMENEKEG---FPITAIREIKLLQKLRHPNIVRLK 64
Query: 203 GACRKRMVWCIVTEYAKGG----------SVRQFLTRRQNR--AVPLKLAVKQALDVARG 250
IVT KG + L + + +K +KQ L G
Sbjct: 65 ---------EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLL---EG 112
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ Y+H G +HRD+K N+LI+ D +K+ADFG+AR
Sbjct: 113 LQYLHSNGILHRDIKGSNILINNDGVLKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-17
Identities = 56/168 (33%), Positives = 87/168 (51%), Gaps = 15/168 (8%)
Query: 144 AQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G+FG++Y+G N E VAIKI++ E+A+ + QQE+ +L+ I R+
Sbjct: 13 GKGSFGEVYKGIDNRTKEVVAIKIIDL-----EEAEDEIEDIQQEITVLSQCDSPYITRY 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL--DVARGMAYVHGLGF 259
G+ K I+ EY GGS L + PL+ + ++ +G+ Y+H
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHSERK 122
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTE-GMTPETGTYRWMAP 306
IHRD+K+ N+L+S +K+ADFGVA T+ GT WMAP
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-17
Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 33/200 (16%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQ- 181
W + K+ M QG+FG +Y G G VAIK + E A + E+
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN------EAASMRERI 54
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL----TRRQNRAV-- 235
+F E ++ ++VR +G + ++ E G ++ +L +N V
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114
Query: 236 --PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292
LK ++ A ++A GMAY++ F+HRDL + N +++ D ++KI DFG+ R +T+
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 174
Query: 293 ------GMTPETGTYRWMAP 306
G+ P RWM+P
Sbjct: 175 YRKGGKGLLP----VRWMSP 190
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 9e-17
Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 11/176 (6%)
Query: 139 MGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
+G QGAFG++Y G ++A+K ++ +PE ++ + + E+ +L L H
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEV-NALECEIQLLKNLLHE 64
Query: 197 NIVRFIGACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
IV++ G R M I E+ GGS++ L + A+ + K + G++Y+
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVSYL 122
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVAR----IEVQTEGMTPETGTYRWMAP 306
H +HRD+K N+L + ++K+ DFG ++ I + GM TGT WM+P
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-16
Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 11/178 (6%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVMML 190
I+ +L G FG ++ G + + VAIK + + + E+ F +E ++
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAIN-------EGAMSEEDFIEEAKVM 53
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L H +V+ G C ++ IVTE+ + G + +L +RQ + + + DV G
Sbjct: 54 MKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK-DMLLSMCQDVCEG 112
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
M Y+ FIHRDL + N L+S+ +K++DFG+ R + E + + +W P
Sbjct: 113 MEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPP 170
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 1e-16
Identities = 58/175 (33%), Positives = 87/175 (49%), Gaps = 29/175 (16%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQ----EVMMLATLKHLNI 198
+G +G +Y+ GE VA+K + R +N E+ E+ +L LKH NI
Sbjct: 9 EGTYGVVYKARDKKTGEIVALKKI-RLDNE-------EEGIPSTALREISLLKELKHPNI 60
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHG 256
V+ + +V EY ++++L +R P +K + Q L RG+AY H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLL---RGLAYCHS 116
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 306
+HRDLK N+LI+ D +K+ADFG+AR I ++T T E T YR AP
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVTLWYR--AP 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 2e-16
Identities = 56/170 (32%), Positives = 85/170 (50%), Gaps = 23/170 (13%)
Query: 146 GAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G +G +Y R + GE A+KI++ + QQE+ M+ KH NIV + G
Sbjct: 20 GTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL------IQQEIFMVKECKHCNIVAYFG 73
Query: 204 A--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGL 257
+ R+++ C+ EY GGS++ V L+ Q V R G+AY+H
Sbjct: 74 SYLSREKLWICM--EYCGGGSLQDIY------HVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 306
G +HRD+K N+L++ + +K+ADFGV A+I GT WMAP
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAP 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 38/203 (18%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRG-------TYNGEDVAIKILERPENNPEKAQVMEQQFQ 184
I R + + +GAFGK++ T + VA+K L+ P K FQ
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK------DFQ 55
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL--------------TRR 230
+E +L L+H +IV+F G C +V EY K G + +FL R+
Sbjct: 56 REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 115
Query: 231 QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR---- 286
+ L + A +A GM Y+ F+HRDL + N L+ A+ +KI DFG++R
Sbjct: 116 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 175
Query: 287 ---IEVQTEGMTPETGTYRWMAP 306
V M P RWM P
Sbjct: 176 TDYYRVGGHTMLP----IRWMPP 194
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 61/189 (32%), Positives = 89/189 (47%), Gaps = 35/189 (18%)
Query: 143 FAQGAFGKLYRGT-YN---GED---VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195
+GAFGK++ YN +D VA+K L+ +N K F +E +L L+H
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARK------DFHREAELLTNLQH 66
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV-------PLKLAVKQALDVA 248
+IV+F G C + +V EY K G + +FL AV P +L Q L +A
Sbjct: 67 EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126
Query: 249 R----GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-------GMTPE 297
+ GM Y+ F+HRDL + N L+ + +KI DFG++R T+ M P
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP- 185
Query: 298 TGTYRWMAP 306
RWM P
Sbjct: 186 ---IRWMPP 191
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-16
Identities = 54/166 (32%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 146 GAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
GAFGK+Y+ G A K++E K++ + + E+ +LAT H IV+ +G
Sbjct: 23 GAFGKVYKAKNKETGALAAAKVIE------TKSEEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
A I+ E+ GG+V + R +++ +Q L+ + Y+H + IH
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE---ALQYLHSMKIIH 133
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 306
RDLK+ N+L++ D IK+ADFGV+ V+T + GT WMAP
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAP 179
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-16
Identities = 50/153 (32%), Positives = 76/153 (49%), Gaps = 16/153 (10%)
Query: 161 VAIKILERPENNPEKAQVMEQQ---FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
VAIK L KA E+Q F E ++ H NI+ G K IVTEY
Sbjct: 35 VAIKTL--------KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEY 86
Query: 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
+ GS+ FL + + ++L V +A GM Y+ +G++HRDL + N+L++++
Sbjct: 87 MENGSLDAFLRKHDGQFTVIQL-VGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVC 145
Query: 278 KIADFGVARI-EVQTEGMTPETG---TYRWMAP 306
K++DFG++R+ E E G RW AP
Sbjct: 146 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP 178
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 4e-16
Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 33/200 (16%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGT----YNGE---DVAIKILERPENNPEKAQVMEQ- 181
W + K+ + QG+FG +Y G GE VA+K + E A + E+
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERI 54
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL-------TRRQNRA 234
+F E ++ ++VR +G K +V E G ++ +L R
Sbjct: 55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114
Query: 235 VP-LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292
P L+ ++ A ++A GMAY++ F+HRDL + N +++ D ++KI DFG+ R +T+
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 174
Query: 293 ------GMTPETGTYRWMAP 306
G+ P RWMAP
Sbjct: 175 YRKGGKGLLP----VRWMAP 190
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 5e-16
Identities = 49/154 (31%), Positives = 81/154 (52%), Gaps = 17/154 (11%)
Query: 142 AFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQF-QQEVMMLATLKHLNI 198
+G+FGK+Y + + E IK E + K V E++ ++EV++LA +KH NI
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIK-----EIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL----DVARGMAYV 254
V F + ++ IV EY GG L +R NR + + Q L ++ G+ ++
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGD----LMKRINRQRGVLFSEDQILSWFVQISLGLKHI 117
Query: 255 HGLGFIHRDLKSDNLLISADKSI-KIADFGVARI 287
H +HRD+KS N+ +S + + K+ DFG+AR
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 5e-16
Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 10/148 (6%)
Query: 161 VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAK 219
+A+K + N + Q++ +E+ +L IV F GA + I EY
Sbjct: 29 MAVKTIRLEINEAIQKQIL-----RELDILHKCNSPYIVGFYGAFYNNGDIS-ICMEYMD 82
Query: 220 GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIHRDLKSDNLLISADKSIK 278
GGS+ + L Q R +P ++ K A+ V +G+ Y+H IHRD+K N+L+++ IK
Sbjct: 83 GGSLDKILKEVQGR-IPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIK 141
Query: 279 IADFGVARIEVQTEGMTPETGTYRWMAP 306
+ DFGV+ V + T GT +MAP
Sbjct: 142 LCDFGVSGQLVNSLAKT-FVGTSSYMAP 168
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 7e-16
Identities = 50/165 (30%), Positives = 83/165 (50%), Gaps = 12/165 (7%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QGA G +Y G++VAIK + + P+K ++ E++++ KH NIV ++
Sbjct: 29 QGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELII-----NEILVMRENKHPNIVNYL 82
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ +V EY GGS+ +T + ++ L + + ++H IHR
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSNQVIHR 139
Query: 263 DLKSDNLLISADKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 306
D+KSDN+L+ D S+K+ DFG A+I + + GT WMAP
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 7e-16
Identities = 52/172 (30%), Positives = 90/172 (52%), Gaps = 16/172 (9%)
Query: 143 FAQGAFGKLYRGTY--NGEDV----AIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
GAFG +Y+G + GE V AIKIL E KA V +F E +++A++ H
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILN--ETTGPKANV---EFMDEALIMASMDHP 69
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
++VR +G C + +VT+ G + ++ ++ + +L + + +A+GM Y+
Sbjct: 70 HLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIAKGMMYLEE 127
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTY--RWMA 305
+HRDL + N+L+ + +KI DFG+AR +E + + G +WMA
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 8e-16
Identities = 57/168 (33%), Positives = 85/168 (50%), Gaps = 19/168 (11%)
Query: 146 GAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G +G +Y R GE AIK++ + E + A V QQE++M+ KH NIV + G
Sbjct: 20 GTYGDVYKARNVNTGELAAIKVI-KLEPGEDFAVV-----QQEIIMMKDCKHSNIVAYFG 73
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLGF 259
+ +R I E+ GGS++ V L+ Q V+R G+ Y+H G
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIY------HVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 260 IHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 306
+HRD+K N+L++ + +K+ADFGV A+I GT WMAP
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAP 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 8e-16
Identities = 57/183 (31%), Positives = 89/183 (48%), Gaps = 30/183 (16%)
Query: 133 DLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
DLR++ G+FG +Y R E VAIK + + +++ Q +EV L
Sbjct: 19 DLREI------GHGSFGAVYFARDVRTNEVVAIKKMSY---SGKQSNEKWQDIIKEVRFL 69
Query: 191 ATLKHLNIVRFIGAC--RKRMVWCIVTEYAKGGSVRQFLT--RRQNRAVPLKLAVKQALD 246
L+H N + + G C R+ W +V EY G S L ++ + V + AL
Sbjct: 70 QQLRHPNTIEYKG-CYLREHTAW-LVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQ 126
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET---GTYRW 303
G+AY+H IHRD+K+ N+L++ ++K+ADFG A + ++P GT W
Sbjct: 127 ---GLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL------VSPANSFVGTPYW 177
Query: 304 MAP 306
MAP
Sbjct: 178 MAP 180
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 49/172 (28%), Positives = 86/172 (50%), Gaps = 19/172 (11%)
Query: 146 GAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRFI 202
G +G++Y+G + G+ AIK+++ E+ E++ + E+ ML H NI +
Sbjct: 27 GTYGQVYKGRHVKTGQLAAIKVMDVTEDE-------EEEIKLEINMLKKYSHHRNIATYY 79
Query: 203 GACRKR-------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
GA K+ +W +V E+ GSV + + A+ ++ RG+A++H
Sbjct: 80 GAFIKKSPPGHDDQLW-LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH 138
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 306
IHRD+K N+L++ + +K+ DFGV A+++ GT WMAP
Sbjct: 139 AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 190
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 52/178 (29%), Positives = 86/178 (48%), Gaps = 23/178 (12%)
Query: 141 TAFAQGAFGKLYRGTYN----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
G FG + +G Y + VA+KIL+ N+P ++ + +E ++ L +
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP----ALKDELLREANVMQQLDNP 56
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
IVR IG C W +V E A+ G + +FL ++N+ V K + V+ GM Y+
Sbjct: 57 YIVRMIGICEAE-SWMLVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKYLEE 113
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI--------EVQTEGMTPETGTYRWMAP 306
F+HRDL + N+L+ KI+DFG+++ + +T G P +W AP
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWP----VKWYAP 167
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 25/159 (15%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNI 198
+GA+G +Y+ G VA+K + P + + + +E+ +L L+ H NI
Sbjct: 8 GEGAYGTVYKARDLNTGRFVALKKVRVPLS----EEGIPLSTLREIALLKQLESFEHPNI 63
Query: 199 VRFIGAC------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA---- 248
VR + C R+ + +V E+ V Q L ++ L + D+
Sbjct: 64 VRLLDVCHGPRTDRELKLT-LVFEH-----VDQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
RG+ ++H +HRDLK N+L+++D +KIADFG+ARI
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 38/143 (26%), Positives = 73/143 (51%), Gaps = 7/143 (4%)
Query: 143 FAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
++GA+G+++ + G+ AIK++++ + K QV Q E +L+ + +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKK-ADMIRKNQV--DQVLTERDILSQAQSPYVVK 57
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ + + +V EY GG + L ++ +A ++ + Y+H G I
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLL--ENVGSLDEDVARIYIAEIVLALEYLHSNGII 115
Query: 261 HRDLKSDNLLISADKSIKIADFG 283
HRDLK DN+LI ++ +K+ DFG
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFG 138
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 55/169 (32%), Positives = 89/169 (52%), Gaps = 17/169 (10%)
Query: 144 AQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G+FG++++G N VAIKI++ E+A+ + QQE+ +L+ + ++
Sbjct: 13 GKGSFGEVFKGIDNRTQQVVAIKIIDL-----EEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-KLAVKQAL-DVARGMAYVHGLGF 259
G+ K I+ EY GGS L RA P + + L ++ +G+ Y+H
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEILKGLDYLHSEKK 122
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
IHRD+K+ N+L+S +K+ADFGVA T+ + T GT WMAP
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAP 170
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-15
Identities = 45/168 (26%), Positives = 79/168 (47%), Gaps = 25/168 (14%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQFQQEVMMLA 191
L +G +G FG + G + +D VA+K ++ + +++ E F E +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKL--DIHTYSEIEE--FLSEAACMK 56
Query: 192 TLKHLNIVRFIGAC---------RKRMVWCIVTEYAKGGSVRQFL----TRRQNRAVPLK 238
H N+++ IG C K MV + + K G + FL +PL+
Sbjct: 57 DFDHPNVMKLIGVCFEASSLQKIPKPMV---ILPFMKHGDLHSFLLYSRLGGLPEKLPLQ 113
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+K +D+A GM Y+ FIHRDL + N ++ D ++ +ADFG+++
Sbjct: 114 TLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 55/173 (31%), Positives = 84/173 (48%), Gaps = 28/173 (16%)
Query: 146 GAFGKLYRGTYNGEDV--AIKILE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFGK+Y+ + + A KI++ E E F E+ +L+ KH NIV
Sbjct: 16 GAFGKVYKAQHKETGLFAAAKIIQIESEEELE-------DFMVEIDILSECKHPNIVGLY 68
Query: 203 GA-CRKRMVWCIVTEYAKGGSVRQF-------LTRRQNRAVPLKLAVKQALDVARGMAYV 254
A + +W I+ E+ GG++ LT Q R V +Q L+ + ++
Sbjct: 69 EAYFYENKLW-ILIEFCDGGALDSIMLELERGLTEPQIRYV-----CRQMLE---ALNFL 119
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 306
H IHRDLK+ N+L++ D +K+ADFGV A+ + + GT WMAP
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAP 172
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-15
Identities = 49/145 (33%), Positives = 78/145 (53%), Gaps = 11/145 (7%)
Query: 146 GAFGKLYRGTYNGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
G FG + +G Y DVAIK+L+ N EK+ E + E+M L + IVR
Sbjct: 6 GNFGCVKKGVYKMRKKQIDVAIKVLK---NENEKSVRDEMMREAEIMH--QLDNPYIVRM 60
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
IG C + +V E A GG + +FL+ +++ + + V+ V+ GM Y+ G F+H
Sbjct: 61 IGVCEAEALM-LVMEMASGGPLNKFLSGKKDE-ITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 262 RDLKSDNLLISADKSIKIADFGVAR 286
RDL + N+L+ KI+DFG+++
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSK 143
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-15
Identities = 42/146 (28%), Positives = 79/146 (54%), Gaps = 8/146 (5%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVME-QQFQQEVMMLATLKHLNIVRF 201
+G+FGK L + +G+ IK E N K E ++ ++EV +L+ +KH NIV++
Sbjct: 10 EGSFGKAILVKSKEDGKQYVIK-----EINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ + IV +Y +GG + + + ++ P + + + + +VH +H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILH 124
Query: 262 RDLKSDNLLISADKSIKIADFGVARI 287
RD+KS N+ ++ D +IK+ DFG+AR+
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARV 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 5e-15
Identities = 51/189 (26%), Positives = 87/189 (46%), Gaps = 23/189 (12%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYN--GED---VAIKILERPENNPEKAQVMEQQ---F 183
ID+ + + G FG++ RG G+ VAIK L K+ E+Q F
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL--------KSGYTEKQRRDF 52
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
E ++ H NI+ G K I+TE+ + G++ FL + + ++L V
Sbjct: 53 LSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-VGM 111
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY-- 301
+A GM Y+ + ++HRDL + N+L++++ K++DFG++R T +
Sbjct: 112 LRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG 171
Query: 302 ----RWMAP 306
RW AP
Sbjct: 172 KIPIRWTAP 180
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-15
Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 10/164 (6%)
Query: 146 GAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205
GAFGK+Y+ ++ +L + K++ + + E+ +LA+ H NIV+ + A
Sbjct: 16 GAFGKVYKA----QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 206 RKRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
I+ E+ GG+V + R +++ KQ L+ + Y+H IHRD
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE---ALNYLHENKIIHRD 128
Query: 264 LKSDNLLISADKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 306
LK+ N+L + D IK+ADFGV+ +T + GT WMAP
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 172
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (180), Expect = 8e-15
Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 34/178 (19%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQV----MEQQFQQEVMMLATLKHLNI 198
+G+FGK+ R G+ A+K+L+ K ++ + E +L+ + H I
Sbjct: 3 KGSFGKVLLVRKKDTGKLYAMKVLK-------KKKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 199 VRFIGACRKRMVWCI--------VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
V+ + + V EYA GG + L + + A A ++
Sbjct: 56 VK--------LHYAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAEIVLA 105
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+ Y+H LG I+RDLK +N+L+ AD IK+ DFG+A+ EG T GT ++AP
Sbjct: 106 LEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNTFCGTPEYLAP 162
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 9e-15
Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 23/175 (13%)
Query: 146 GAFGKLYRG-TYNGEDVAIKILERPENNPEKAQVMEQ-QFQQEVMMLATLKHLNIVRFIG 203
G FGK+ G + G A +++ + A EQ F QEV L H N+++ +G
Sbjct: 6 GWFGKVLLGEAHRGMSKARVVVKELRAS---ATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-----AVPLKLAVKQALDVARGMAYVHGLG 258
C + + + +V E+ G ++ +L R NR + + A +VA G+ ++H
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYL--RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMAP 306
FIH DL N ++AD S+KI D+G+A + P RW+AP
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVP----LRWLAP 171
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 61/189 (32%), Positives = 88/189 (46%), Gaps = 40/189 (21%)
Query: 144 AQGAFGKLYRGTY----NGEDVAIKILER--PENNPEKAQVMEQQFQQEVMMLATL-KHL 196
+G FG++ R + AIK+L+ EN+ + F E+ +L L H
Sbjct: 11 GEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEND-------HRDFAGELEVLCKLGHHP 63
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ------------- 243
NI+ +GAC R I EYA G++ FL R++R + A +
Sbjct: 64 NIINLLGACENRGYLYIAIEYAPYGNLLDFL--RKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 244 ---ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE----VQTEGMTP 296
A DVA GM Y+ FIHRDL + N+L+ + + KIADFG++R E +T G P
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP 181
Query: 297 ETGTYRWMA 305
RWMA
Sbjct: 182 ----VRWMA 186
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 47/173 (27%), Positives = 85/173 (49%), Gaps = 17/173 (9%)
Query: 145 QGAFGKLYRGT----YNGEDVAIKILERPENNPEKAQVMEQ-QFQQEVMMLATLKHLNIV 199
G FGK+ G Y V +K L A V EQ +F +E +L+H N++
Sbjct: 5 NGWFGKVILGEVNSGYTPAQVVVKELR------VSASVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFL--TRRQNRAVPLKLAVKQ-ALDVARGMAYVHG 256
+ +G C + + +V E+ G ++ +L R+ P +++ A ++A G+ ++H
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY---RWMAP 306
FIH DL N L++AD ++KI D+G++ + + + + RW+AP
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAP 171
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 41/130 (31%), Positives = 64/130 (49%), Gaps = 8/130 (6%)
Query: 158 GEDVAIKI-LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216
G+ VAIK LE ++ K M +E+ ML L+H N+V I R++ +V E
Sbjct: 26 GQIVAIKKFLESEDDKMVKKIAM-----REIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80
Query: 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276
+ +V L + N + K + RG+ + H IHRD+K +N+L+S
Sbjct: 81 FVDH-TVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV 138
Query: 277 IKIADFGVAR 286
+K+ DFG AR
Sbjct: 139 VKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 40/160 (25%), Positives = 76/160 (47%), Gaps = 10/160 (6%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
L +G +G FG + G N +D +K+ + + + F E + + H
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 197 NIVRFIGACRKRM------VWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALD 246
N++R IG C + + ++ + K G + FL + +P ++ VK D
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+A GM Y+ FIHRDL + N +++ + ++ +ADFG+++
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 48/177 (27%), Positives = 91/177 (51%), Gaps = 13/177 (7%)
Query: 139 MGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
+G +GAFG++Y G ++A+K + ++ E ++ + + E+ +L L+H
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEV-NALECEIQLLKNLRHD 64
Query: 197 NIVRFIGACR--KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
IV++ G R + I EY GGS++ L + A+ + + + +G++Y+
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGVSYL 122
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-----EGMTPETGTYRWMAP 306
H +HRD+K N+L + ++K+ DFG ++ +QT G+ TGT WM+P
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASK-RIQTICMSGTGIKSVTGTPYWMSP 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 12/166 (7%)
Query: 144 AQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
QGA G ++ G++VAIK + + P+K ++ E++++ LK+ NIV F
Sbjct: 28 GQGASGTVFTAIDVATGQEVAIKQINL-QKQPKKELII-----NEILVMKELKNPNIVNF 81
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ + +V EY GGS+ +T + ++ L + + ++H IH
Sbjct: 82 LDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL---QALEFLHANQVIH 138
Query: 262 RDLKSDNLLISADKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 306
RD+KSDN+L+ D S+K+ DFG A+I + + GT WMAP
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 8/167 (4%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F +Y+ +G VA+K ++ E KA+ Q +E+ +L L H N+++++
Sbjct: 12 KGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR---QDCLKEIDLLKQLDHPNVIKYL 68
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFL--TRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ + IV E A G + + + ++Q R +P + K + + + ++H +
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIM 128
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI-EVQTEGMTPETGTYRWMAP 306
HRD+K N+ I+A +K+ D G+ R +T GT +M+P
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 51/166 (30%), Positives = 84/166 (50%), Gaps = 11/166 (6%)
Query: 144 AQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G+FG++++G N VAIKI++ E+A+ + QQE+ +L+ + ++
Sbjct: 13 GKGSFGEVFKGIDNRTQKVVAIKIIDL-----EEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
G+ K I+ EY GGS L + +++ L +G+ Y+H IH
Sbjct: 68 YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSEKKIH 124
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTE-GMTPETGTYRWMAP 306
RD+K+ N+L+S +K+ADFGVA T+ GT WMAP
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 20/176 (11%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G+FG + R +G+ + K ++ EK QQ EV +L LKH NIVR+
Sbjct: 10 KGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-----QQLVSEVNILRELKHPNIVRY 64
Query: 202 IGAC--RKRMVWCIVTEYAKGGSVRQFL--TRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
R IV EY +GG + Q + +++ + + + + + + H
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 258 G-----FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+HRDLK N+ + A+ ++K+ DFG+A+I + + +T GT +M+P
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-LGHDSSFAKTYVGTPYYMSP 179
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 31/203 (15%)
Query: 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVME-----QQFQQ 185
+LRKL + G FG +++G + E +IKI P + ++ Q FQ+
Sbjct: 6 ETELRKLKL---LGSGVFGTVHKGIWIPEGDSIKI-------PVAIKTIQDRSGRQTFQE 55
Query: 186 ---EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
++ + +L H IVR +G C + +VT+ + GS+ + + ++ P +L +
Sbjct: 56 ITDHMLAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRL-LN 113
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-------EVQTEGMT 295
+ +A+GM Y+ +HR+L + N+L+ +D ++IADFGVA + +E T
Sbjct: 114 WCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173
Query: 296 PETGTYRWMAPGNSFFSPLPHPS 318
P +WMA + F H S
Sbjct: 174 P----IKWMALESILFGRYTHQS 192
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 50/161 (31%), Positives = 78/161 (48%), Gaps = 8/161 (4%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G++G ++ R G+ VAIK E++P V+++ +E+ ML LKH N+V I
Sbjct: 11 EGSYGVVFKCRNRETGQIVAIKKFVESEDDP----VIKKIALREIRMLKQLKHPNLVNLI 66
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
R++ +V EY +V L + R VP L K + + + H IHR
Sbjct: 67 EVFRRKRKLHLVFEYCDH-TVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHR 124
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
D+K +N+LI+ IK+ DFG ARI + RW
Sbjct: 125 DVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW 165
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 3e-14
Identities = 47/165 (28%), Positives = 84/165 (50%), Gaps = 13/165 (7%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQV-MEQQFQQEVMMLATLKHLNIVRF 201
+G + +Y+ G VAIK ++ ++A+ + +E+ +L LKH NI+
Sbjct: 10 EGTYAVVYKARDKETGRIVAIKKIK--LGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA-VKQ-ALDVARGMAYVHGLGF 259
+ + +V E+ + + + +++++ L A +K L RG+ Y+H
Sbjct: 68 LDVFGHKSNINLVFEFM-ETDLEKVI---KDKSIVLTPADIKSYMLMTLRGLEYLHSNWI 123
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPETGTYRW 303
+HRDLK +NLLI++D +K+ADFG+AR MT + T RW
Sbjct: 124 LHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVT-RW 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 3e-14
Identities = 53/173 (30%), Positives = 90/173 (52%), Gaps = 27/173 (15%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLNI 198
G+FG+ L R +G+ A+KIL KA++++ + + V+ +L +++H +
Sbjct: 11 TGSFGRVMLVRHKGSGKYYALKILS-------KAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 199 VRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
V G+ + +V EY GG + L R++ P +A A V + Y+H
Sbjct: 64 VNLYGSFQDDSNLY--LVMEYVPGGELFSHL--RKSGRFPEPVARFYAAQVVLALEYLHS 119
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVA-RIEVQTEGM--TPETGTYRWMAP 306
L ++RDLK +NLL+ +D IKI DFG A R++ +T + TPE ++AP
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPE-----YLAP 167
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 5e-14
Identities = 62/183 (33%), Positives = 91/183 (49%), Gaps = 29/183 (15%)
Query: 132 IDLRKLNMGTAFAQGAFGKL--YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
+DL+ + MG AFG + R G++VAIK + +P + P V+ ++ +E+ +
Sbjct: 13 VDLQPVGMG------AFGLVCSARDQLTGQNVAIKKIMKPFSTP----VLAKRTYRELKL 62
Query: 190 LATLKHLNIVR----FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ-- 243
L L+H NI+ FI VTE G + + LT R PL+ Q
Sbjct: 63 LKHLRHENIISLSDIFISPLEDIY---FVTELL-GTDLHRLLTSR-----PLEKQFIQYF 113
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
+ RG+ YVH G +HRDLK N+LI+ + +KI DFG+ARI Q MT T +
Sbjct: 114 LYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI--QDPQMTGYVSTRYY 171
Query: 304 MAP 306
AP
Sbjct: 172 RAP 174
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 55/175 (31%), Positives = 81/175 (46%), Gaps = 38/175 (21%)
Query: 134 LRKLNMGTAFAQGAFGKLYRGTYN--GEDVAIK-ILERPENN--PEKAQVMEQQFQQEVM 188
LR + +G FG++Y+ G VA+K IL E + P A +E+
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL-------REIK 59
Query: 189 MLATLKHLNIVRFI--------GACRKRMVWCIVTEYA--------KGGSVRQFLTRRQN 232
+L LKH N+V I + RKR +VT Y + SV+ LT Q
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LTESQ- 116
Query: 233 RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
+K + Q L+ G+ Y+H +HRD+K+ N+LI +KIADFG+AR
Sbjct: 117 ----IKCYMLQLLE---GINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 5e-14
Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 7/165 (4%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GAFG ++ R + + V IK + + ++ Q E +L L H NI+ +
Sbjct: 10 RGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE----RLAAQNECQVLKLLSHPNIIEYY 65
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ IV EYA GG++ +++ +R N + + + + + +VH +HR
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHR 125
Query: 263 DLKSDNLLISADKSI-KIADFGVARIEVQTEGMTPETGTYRWMAP 306
DLK+ N+L+ K + KI DFG+++I GT +++P
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISP 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 7e-14
Identities = 56/187 (29%), Positives = 88/187 (47%), Gaps = 36/187 (19%)
Query: 144 AQGAFGKLYRGTYNGE----DVAIKILER--PENNPEKAQVMEQQFQQEVMMLATL-KHL 196
+G FG++ + + D AIK ++ +++ + F E+ +L L H
Sbjct: 4 GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-------HRDFAGELEVLCKLGHHP 56
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ----------NRAVPLKLAVKQAL- 245
NI+ +GAC R + EYA G++ FL + + + L+ +Q L
Sbjct: 57 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 246 ---DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE----VQTEGMTPET 298
DVARGM Y+ FIHRDL + N+L+ + KIADFG++R + +T G P
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP-- 174
Query: 299 GTYRWMA 305
RWMA
Sbjct: 175 --VRWMA 179
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 7e-14
Identities = 47/174 (27%), Positives = 86/174 (49%), Gaps = 19/174 (10%)
Query: 144 AQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVR 200
G +G++Y+G + G+ AIK+++ + E++ +QE+ ML H NI
Sbjct: 15 GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-------EEEIKQEINMLKKYSHHRNIAT 67
Query: 201 FIGACRKR-------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
+ GA K+ +W +V E+ GSV + + + + ++ RG+++
Sbjct: 68 YYGAFIKKNPPGMDDQLW-LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 306
+H IHRD+K N+L++ + +K+ DFGV A+++ GT WMAP
Sbjct: 127 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 180
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 8e-14
Identities = 51/159 (32%), Positives = 80/159 (50%), Gaps = 29/159 (18%)
Query: 164 KILERPENNPEKAQVM--------EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215
K++ RP +V+ +Q +E+ +L + H N+V+ ++
Sbjct: 92 KVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151
Query: 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQAL-DVAR----GMAYVHGLGFIHRDLKSDNLL 270
E+ GGS+ + +A +Q L DVAR G+AY+H +HRD+K NLL
Sbjct: 152 EFMDGGSL-------EGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLL 200
Query: 271 ISADKSIKIADFGVARIEVQTEGMTP---ETGTYRWMAP 306
I++ K++KIADFGV+RI QT M P GT +M+P
Sbjct: 201 INSAKNVKIADFGVSRILAQT--MDPCNSSVGTIAYMSP 237
|
Length = 353 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 8e-14
Identities = 45/154 (29%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 157 NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC--RKRMVWCIV 214
G A+K + + NP+ +++Q +E+ + + K IV++ GA I
Sbjct: 25 TGMIFALKTITT-DPNPD----LQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79
Query: 215 TEYAKGGSVRQFL--TRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
EY +GGS+ +++ + K+ K A V +G++Y+H IHRD+K N+L++
Sbjct: 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT 139
Query: 273 ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+K+ DFGV+ V + T TGT +MAP
Sbjct: 140 RKGQVKLCDFGVSGELVNSLAGT-FTGTSFYMAP 172
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 9e-14
Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 31/176 (17%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
GA+G + G VAIK + ++ A+ + +E+ +L L+H NI+
Sbjct: 10 SGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAK----RILREIKLLRHLRHENIIGLL 65
Query: 201 --FIGACRKRM--VWCIVTEYAKG--GSV---RQFLTRRQNRAVPLKLAVKQALDVARGM 251
+ V+ IVTE + V Q LT ++ + Q L RG+
Sbjct: 66 DILRPPSPEDFNDVY-IVTELMETDLHKVIKSPQPLTDDH-----IQYFLYQIL---RGL 116
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYRW 303
Y+H IHRDLK N+L++++ +KI DFG+AR E + +T T RW
Sbjct: 117 KYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVT-RW 171
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 36/199 (18%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGE----DVAIKILERPENNPEKAQVMEQQFQQEV 187
++ + +G FG++ + + D AIK ++ + + + F E+
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-----HRDFAGEL 58
Query: 188 MMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL--------- 237
+L L H NI+ +GAC R + EYA G++ FL R++R +
Sbjct: 59 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL--RKSRVLETDPAFAIANS 116
Query: 238 ---KLAVKQAL----DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEV 289
L+ +Q L DVARGM Y+ FIHRDL + N+L+ + KIADFG++R EV
Sbjct: 117 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 176
Query: 290 ---QTEGMTPETGTYRWMA 305
+T G P RWMA
Sbjct: 177 YVKKTMGRLP----VRWMA 191
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 30/211 (14%)
Query: 101 VTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGK--LYRGTYNG 158
VTH AL + ++D P LENY +G+ G + R ++G
Sbjct: 1 VTHEQFKAAL-RMVVDQGDPRSLLENY-------------IKIGEGSTGIVCIAREKHSG 46
Query: 159 EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-FIGACRKRMVWCIVTEY 217
VA+K+++ K Q E F EV+++ +H N+V + +W ++ E+
Sbjct: 47 RQVAVKMMDL-----RKQQRRELLFN-EVVIMRDYQHQNVVEMYKSYLVGEELW-VLMEF 99
Query: 218 AKGGSVRQFLTRRQNRAVPLKLA-VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276
+GG++ ++ Q R ++A V ++ V + + Y+H G IHRD+KSD++L++ D
Sbjct: 100 LQGGALTDIVS--QTRLNEEQIATVCES--VLQALCYLHSQGVIHRDIKSDSILLTLDGR 155
Query: 277 IKIADFG-VARIEVQTEGMTPETGTYRWMAP 306
+K++DFG A+I GT WMAP
Sbjct: 156 VKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 27/204 (13%)
Query: 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGED----VAIKILERPENNPEKAQVMEQQFQQE 186
+L+K+ + GAFG +Y+G + +GE+ VAIK+L EN KA ++ E
Sbjct: 8 ELKKVKV---LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR--ENTSPKAN---KEILDE 59
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
++A + + R +G C V +VT+ G + ++ ++R L + +
Sbjct: 60 AYVMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDL-LNWCVQ 117
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTY--RW 303
+A+GM+Y+ + +HRDL + N+L+ + +KI DFG+AR +++ + G +W
Sbjct: 118 IAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177
Query: 304 MAPGNSFFSPLPHPSFEHK---WS 324
MA + H F H+ WS
Sbjct: 178 MA-----LESILHRRFTHQSDVWS 196
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 144 AQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
++GAFG +Y + G+ AIK+L + + K QV + ++ +MM+ + +
Sbjct: 5 SKGAFGSVYLAKKRSTGDYFAIKVL-KKSDMIAKNQVTNVKAERAIMMIQGESP-YVAKL 62
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ + + +V EY GG + + +P A + +V G+ +H G IH
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE--TGTYRWMAP 306
RD+K +NLLI +K+ DFG++R G+ + GT ++AP
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAP 162
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 64/229 (27%), Positives = 109/229 (47%), Gaps = 30/229 (13%)
Query: 100 KVTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGT--YN 157
+V+H AL Q ++ P E L+++ + +G +G+ G + T +
Sbjct: 1 RVSHEQFRAAL-QLVVSPGDPREYLDSF---------IKIG----EGSTGIVCIATEKHT 46
Query: 158 GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
G+ VA+K ++ K Q E F EV+++ H N+V + +V E+
Sbjct: 47 GKQVAVKKMDL-----RKQQRRELLFN-EVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100
Query: 218 AKGGSVRQFLTR-RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276
+GG++ +T R N + L V R ++Y+H G IHRD+KSD++L+++D
Sbjct: 101 LEGGALTDIVTHTRMNE----EQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR 156
Query: 277 IKIADFG-VARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWS 324
IK++DFG A++ + GT WMAP S LP+ + WS
Sbjct: 157 IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAP--EVISRLPYGTEVDIWS 203
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRG----TYNGED---VAIKILERPENNPEKAQV-MEQQF 183
I+L + + FGK+Y+G T GE VAIK L+ +KA+ + ++F
Sbjct: 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK------DKAEGPLREEF 55
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR----AVPLKL 239
+ E MM + L+H NIV +G K ++ Y + +FL R +
Sbjct: 56 KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115
Query: 240 AVKQALD----------VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289
VK L+ +A GM ++ +H+DL + N+L+ ++KI+D G+ R EV
Sbjct: 116 TVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFR-EV 174
Query: 290 QTEGMTPETGT----YRWMAP 306
G RWM+P
Sbjct: 175 YAADYYKLMGNSLLPIRWMSP 195
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 53/173 (30%), Positives = 89/173 (51%), Gaps = 22/173 (12%)
Query: 158 GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV----WCI 213
G VA+K + + K Q E F EV+++ +H NIV + +V W +
Sbjct: 44 GRQVAVKKM-----DLRKQQRRELLFN-EVVIMRDYQHPNIVEMYSS---YLVGDELW-V 93
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLA-VKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
V E+ +GG++ +T R ++A V A V + ++++H G IHRD+KSD++L++
Sbjct: 94 VMEFLEGGALTDIVT--HTRMNEEQIATVCLA--VLKALSFLHAQGVIHRDIKSDSILLT 149
Query: 273 ADKSIKIADFG-VARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWS 324
+D +K++DFG A++ + GT WMAP S LP+ + WS
Sbjct: 150 SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP--EVISRLPYGTEVDIWS 200
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 44/146 (30%), Positives = 66/146 (45%), Gaps = 11/146 (7%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G + +Y+G GE VA+K L+ E P A +E+ ++ LKH NIVR
Sbjct: 10 EGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-------REISLMKELKHENIVR 62
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+V EY + T A+ + +G+A+ H +
Sbjct: 63 LHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVL 122
Query: 261 HRDLKSDNLLISADKSIKIADFGVAR 286
HRDLK NLLI+ +K+ADFG+AR
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 52/154 (33%), Positives = 78/154 (50%), Gaps = 13/154 (8%)
Query: 144 AQGAFGKLY--RGTYNGEDVAIKILERPE---NNPEKAQVMEQQFQQEVMMLATLKHLNI 198
++GAFGK+Y R N + A+K++++ + N M Q Q E LA K I
Sbjct: 13 SRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKN------MVHQVQAERDALALSKSPFI 66
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
V + + +V EY GG V+ L + AVK +VA + Y+H G
Sbjct: 67 VHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEM--AVKYISEVALALDYLHRHG 124
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292
IHRDLK DN+LIS + IK+ DFG++++ + E
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 3e-13
Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 12/166 (7%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
QGA G +Y G++VAIK + + P+K ++ E++++ K+ NIV +
Sbjct: 28 GQGASGTVYTAIDIATGQEVAIKQMNL-QQQPKKELII-----NEILVMRENKNPNIVNY 81
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ + +V EY GGS+ +T + ++ L + + ++H IH
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALDFLHSNQVIH 138
Query: 262 RDLKSDNLLISADKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 306
RD+KSDN+L+ D S+K+ DFG A+I + + GT WMAP
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 5e-13
Identities = 48/166 (28%), Positives = 83/166 (50%), Gaps = 12/166 (7%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
QGA G +Y G++VAI+ + + P+K ++ E++++ K+ NIV +
Sbjct: 29 GQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELII-----NEILVMRENKNPNIVNY 82
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ + +V EY GGS+ +T + ++ L + + ++H IH
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSNQVIH 139
Query: 262 RDLKSDNLLISADKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 306
RD+KSDN+L+ D S+K+ DFG A+I + + GT WMAP
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 6e-13
Identities = 49/176 (27%), Positives = 80/176 (45%), Gaps = 32/176 (18%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QG FG+++ R + VA+K + EN E + + E+ +L LKH N+V I
Sbjct: 22 QGTFGEVFKARHKKTKQIVALKKV-LMENEKEGFPITALR---EIKILQLLKHENVVNLI 77
Query: 203 GACRKR--------------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL--D 246
CR + +C E+ G L N+ V L+ + +
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFC---EHDLAG----LL---SNKNVKFTLSEIKKVMKM 127
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR 302
+ G+ Y+H +HRD+K+ N+LI+ D +K+ADFG+AR ++ P T R
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-13
Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 26/178 (14%)
Query: 144 AQGAFGKLYR--GTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVR 200
+G +GK+++ NG A+KIL+ + ++++ + E +L L H N+V+
Sbjct: 27 GKGTYGKVFKVLNKKNGSKAAVKILDPIHD-------IDEEIEAEYNILKALSDHPNVVK 79
Query: 201 FIGACRKRMV------WCIVTEYAKGGSV----RQFLTRRQNRAVPL-KLAVKQALDVAR 249
F G K+ V W +V E GGSV + FL R + P+ + +AL
Sbjct: 80 FYGMYYKKDVKNGDQLW-LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL---M 135
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 306
G+ ++H IHRD+K +N+L++ + +K+ DFGV A++ GT WMAP
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 8e-13
Identities = 53/178 (29%), Positives = 83/178 (46%), Gaps = 18/178 (10%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILE---RPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G +Y R GE VA+K + E P A +E+ +L L H NIV
Sbjct: 10 EGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-------REISLLKELNHPNIV 62
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + +V E+ +++F+ +PL L + +G+A+ H
Sbjct: 63 KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV 121
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP----GNSFFS 312
+HRDLK NLLI+ + +IK+ADFG+AR V T E T + AP G ++S
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 179
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 9e-13
Identities = 41/160 (25%), Positives = 79/160 (49%), Gaps = 23/160 (14%)
Query: 144 AQGAFGKLY---RGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G++Y R G++ AIK + E+ + Q +E+ +L LKH N+V
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGD---KEQYTGISQSACREIALLRELKHENVV 65
Query: 200 RFIGACRKRM---VWCIVTEYAKG--GSVRQFLTRRQNRAVP---LKLAVKQALDVARGM 251
+ + V+ ++ +YA+ + +F + + ++P +K + Q L+ G+
Sbjct: 66 SLVEVFLEHADKSVY-LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN---GV 121
Query: 252 AYVHGLGFIHRDLKSDNLLISADKS----IKIADFGVARI 287
Y+H +HRDLK N+L+ + +KI D G+AR+
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 25/201 (12%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKI--LERPENNPEKAQVMEQQFQQEV 187
++L KL +G++ +Y+G NG+ VA+K+ ++ E P A +E
Sbjct: 8 LNLEKL------GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-------REA 54
Query: 188 MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQAL 245
+L LKH NIV + V EY + Q++ + P ++L + Q L
Sbjct: 55 SLLKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLL 113
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEGMTPETGTYRWM 304
RG+AY+HG +HRDLK NLLIS +K+ADFG+AR + + ++ + E T W
Sbjct: 114 ---RGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTL-WY 169
Query: 305 APGNSFFSPLPHPSFEHKWSA 325
P + + S W A
Sbjct: 170 RPPDVLLGATDYSSALDIWGA 190
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 51/195 (26%), Positives = 92/195 (47%), Gaps = 32/195 (16%)
Query: 146 GAFGKLYRGTYN--GED----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
GAFG +Y+G + GE VAIK L R +P+ ++ E ++A++ + ++
Sbjct: 18 GAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPK----ANKEILDEAYVMASVDNPHVC 72
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
R +G C V ++T+ G + ++ ++ L + + +A+GM Y+
Sbjct: 73 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-LNWCVQIAKGMNYLEERRL 130
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARI------EVQTE-GMTPETGTYRWMAPGNSFFS 312
+HRDL + N+L+ + +KI DFG+A++ E E G P +WMA
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP----IKWMA-----LE 181
Query: 313 PLPHPSFEHK---WS 324
+ H + H+ WS
Sbjct: 182 SILHRIYTHQSDVWS 196
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-12
Identities = 54/194 (27%), Positives = 92/194 (47%), Gaps = 24/194 (12%)
Query: 142 AFAQGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQF-QQEVMMLATLKHLNI 198
+G++G+ L R +G+ IK L N A E++ +QE +L+ LKH NI
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKL-----NLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 199 VRFIGACRKRMVW-------CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
V + R W IV + +GG + L ++ + +P V+ + +A +
Sbjct: 62 VAY------RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-EVQTEGMTPETGTYRWMAPGNSF 310
Y+H +HRDLK+ N+ ++ IK+ D G+AR+ E Q + + GT +M+P
Sbjct: 116 QYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSP--EL 173
Query: 311 FSPLPHPSFEHKWS 324
FS P+ W+
Sbjct: 174 FSNKPYNYKSDVWA 187
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-12
Identities = 42/169 (24%), Positives = 85/169 (50%), Gaps = 11/169 (6%)
Query: 143 FAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
F + ++Y T V +K L+ ++ E + +F Q+ L+H NI++ +
Sbjct: 8 FGKVLLSEIYTDT-GVARVVVKELKANASSKE-----QNEFLQQGDPYRILQHPNILQCL 61
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQN--RAVPLKLAVKQALDVARGMAYVHGLGFI 260
G C + + + +V EY + G ++ +L++ Q R L L + A ++A G+ ++H F+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFL 121
Query: 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY---RWMAP 306
H DL N +++D ++K+ D+G+ + + + E RW+AP
Sbjct: 122 HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP 170
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 36/186 (19%)
Query: 133 DLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
DLR++ G+FG +Y R N E VAIK + + +++ Q +EV L
Sbjct: 19 DLREI------GHGSFGAVYFARDVRNSEVVAIKKMSY---SGKQSNEKWQDIIKEVRFL 69
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA-- 248
L+H N +++ G + +V EY G + ++ PL Q +++A
Sbjct: 70 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PL-----QEVEIAAV 120
Query: 249 -----RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET---GT 300
+G+AY+H IHRD+K+ N+L+S +K+ DFG A I M P GT
Sbjct: 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGT 174
Query: 301 YRWMAP 306
WMAP
Sbjct: 175 PYWMAP 180
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 48/175 (27%), Positives = 84/175 (48%), Gaps = 20/175 (11%)
Query: 144 AQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVR 200
+G +GK+Y+ T +G A+KIL+ + ++++ + E +L +L H N+V+
Sbjct: 31 GKGTYGKVYKVTNKKDGSLAAVKILDPISD-------VDEEIEAEYNILQSLPNHPNVVK 83
Query: 201 FIGA------CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL--DVARGMA 252
F G +W +V E GGSV + + L A+ + G+
Sbjct: 84 FYGMFYKADKLVGGQLW-LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ 142
Query: 253 YVHGLGFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 306
++H IHRD+K +N+L++ + +K+ DFGV A++ GT WMAP
Sbjct: 143 HLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 197
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 18/169 (10%)
Query: 144 AQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQ---QEVMMLATLKHLNI 198
G+FG +Y T + E VA+K + + +++Q +EV L LKH N
Sbjct: 30 GHGSFGAVYFATNSHTNEVVAVKKMSY------SGKQTNEKWQDIIKEVKFLQQLKHPNT 83
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQF-LTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ + G K +V EY G + + ++ + V + AL +G+AY+H
Sbjct: 84 IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL---QGLAYLHSH 140
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
IHRD+K+ N+L++ +K+ADFG A GT WMAP
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF---VGTPYWMAP 186
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 47/145 (32%), Positives = 73/145 (50%), Gaps = 8/145 (5%)
Query: 144 AQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GA+G + R E VAIK + E N E +++ +E+ ML TLK NIV
Sbjct: 10 GEGAYGVVLKCRHKETKEIVAIKKFKDSEENEE----VKETTLRELKMLRTLKQENIVEL 65
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
A R+R +V EY + ++ + L N P K+ + + + + H +H
Sbjct: 66 KEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVR-SYIYQLIKAIHWCHKNDIVH 123
Query: 262 RDLKSDNLLISADKSIKIADFGVAR 286
RD+K +NLLIS + +K+ DFG AR
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 53/177 (29%), Positives = 82/177 (46%), Gaps = 18/177 (10%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGED---VAIKILERPENNPEKAQVMEQQFQQEVM----M 189
N G+FG++ TY ED VAIK E K+++++Q+ V +
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFE-------KSKIIKQKQVDHVFSERKI 84
Query: 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
L + H V G+ + +V E+ GG FL R+N+ P + A +
Sbjct: 85 LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL--RRNKRFPNDVGCFYAAQIVL 142
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
Y+ L ++RDLK +NLL+ D IK+ DFG A++ V T T GT ++AP
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYT-LCGTPEYIAP 197
|
Length = 340 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 44/168 (26%), Positives = 84/168 (50%), Gaps = 8/168 (4%)
Query: 144 AQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G F ++YR T + + VA+K ++ E KA+ Q +E+ +L L H N++++
Sbjct: 11 GRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR---QDCVKEIDLLKQLNHPNVIKY 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLT--RRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + IV E A G + Q + ++Q R +P + K + + + ++H
Sbjct: 68 LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV 127
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
+HRD+K N+ I+A +K+ D G+ R +T GT +M+P
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 4e-12
Identities = 50/150 (33%), Positives = 76/150 (50%), Gaps = 17/150 (11%)
Query: 143 FAQGAFGKLYRGT--YNGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G++ +Y+G NG+ VA+K+ L+ E P A +E +L LKH NI
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-------REASLLKGLKHANI 65
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHG 256
V + +V EY + Q++ + P +KL + Q L RG++Y+H
Sbjct: 66 VLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLL---RGLSYIHQ 121
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+HRDLK NLLIS +K+ADFG+AR
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 43/168 (25%), Positives = 82/168 (48%), Gaps = 8/168 (4%)
Query: 144 AQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G F ++YR T +G VA+K ++ + KA+ +E+ +L L H N++++
Sbjct: 11 GRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR---ADCIKEIDLLKQLNHPNVIKY 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLT--RRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + IV E A G + + + ++Q R +P K K + + + ++H
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV 127
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
+HRD+K N+ I+A +K+ D G+ R +T GT +M+P
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-12
Identities = 54/193 (27%), Positives = 95/193 (49%), Gaps = 25/193 (12%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKIL-ERP--ENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G+FG +Y + + +K+L E P E NP + Q QE +L+ L H IV
Sbjct: 10 KGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV----QANQEAQLLSKLDHPAIV 65
Query: 200 RFIGACRKRMVWCIVTEYAKGG----SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
+F + +R +CI+TEY +G + + + + + + + + G+ Y+H
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEEL--KHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM-TPETGTYRWMAPGNSFFSPL 314
+HRDLK+ N+ + + +KI DFGV+R+ + + + T TGT +M+P L
Sbjct: 124 QRRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSP-----EAL 177
Query: 315 PHPSFEHK---WS 324
H ++ K WS
Sbjct: 178 KHQGYDSKSDIWS 190
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 6e-12
Identities = 44/169 (26%), Positives = 82/169 (48%), Gaps = 27/169 (15%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVME----QQFQQEV 187
+G +G FG + ED VA+K+L KA + ++F +E
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML--------KADIFSSSDIEEFLREA 52
Query: 188 MMLATLKHLNIVRFIG-ACRKRM-----VWCIVTEYAKGGSVRQFL--TR--RQNRAVPL 237
+ H N+++ IG + R R + ++ + K G + FL +R + +PL
Sbjct: 53 ACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPL 112
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ V+ +D+A GM Y+ FIHRDL + N +++ + ++ +ADFG+++
Sbjct: 113 QTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 49/148 (33%), Positives = 72/148 (48%), Gaps = 17/148 (11%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G++ +Y+G G+ VA+K LE E P A +E +L LKH NIV
Sbjct: 15 EGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-------REASLLKDLKHANIVT 67
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLG 258
+ +V EY ++Q++ ++L + Q L RG+AY H
Sbjct: 68 LHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL---RGLAYCHQRR 123
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVAR 286
+HRDLK NLLIS +K+ADFG+AR
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 32/121 (26%), Positives = 57/121 (47%), Gaps = 2/121 (1%)
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
E M+L + H +++R + C+V + + +LT+R +R +P+ A+
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKR-SRPLPIDQALIIEK 164
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMA 305
+ G+ Y+H IHRD+K++N+ I+ + I D G A+ V GT A
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNA 224
Query: 306 P 306
P
Sbjct: 225 P 225
|
Length = 357 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 54/178 (30%), Positives = 83/178 (46%), Gaps = 15/178 (8%)
Query: 134 LRKLNMGTAFAQGAFGKL----YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
L MG G+FG++ ++GT GE AIK L++ E K QV Q QE +
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGT--GEYYAIKCLKKREILKMK-QV--QHVAQEKSI 71
Query: 190 LATLKHLNIVRFI-GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
L L H IV + + V+ + E+ GG + F R+ P +A ++
Sbjct: 72 LMELSHPFIVNMMCSFQDENRVY-FLLEFVVGGEL--FTHLRKAGRFPNDVAKFYHAELV 128
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
Y+H I+RDLK +NLL+ +K+ DFG A+ +V + GT ++AP
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KV-PDRTFTLCGTPEYLAP 184
|
Length = 329 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 2e-11
Identities = 54/179 (30%), Positives = 84/179 (46%), Gaps = 22/179 (12%)
Query: 133 DLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
DLR++ G+FG +Y R E VAIK + + +++ Q +EV L
Sbjct: 29 DLREI------GHGSFGAVYFARDVRTNEVVAIKKMSY---SGKQSNEKWQDIIKEVKFL 79
Query: 191 ATLKHLNIVRFIGA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD--V 247
+KH N + + G R+ W +V EY G + ++ PL+ A+
Sbjct: 80 QRIKHPNSIEYKGCYLREHTAW-LVMEYCLGSASDLLEVHKK----PLQEVEIAAITHGA 134
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+G+AY+H IHRD+K+ N+L++ +K+ADFG A I GT WMAP
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF---VGTPYWMAP 190
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 53/175 (30%), Positives = 89/175 (50%), Gaps = 23/175 (13%)
Query: 146 GAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL---NIVR 200
GA+G +Y R ++G VA+K + R + N + + +EV +L L+ NIVR
Sbjct: 11 GAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPL---STVREVALLKRLEAFDHPNIVR 66
Query: 201 FIGAC------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL---KLAVKQALDVARGM 251
+ C R+ V +V E+ +R +L + +P K ++Q L RG+
Sbjct: 67 LMDVCATSRTDRETKV-TLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFL---RGL 121
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
++H +HRDLK +N+L+++ +K+ADFG+ARI +TP T + AP
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAP 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271
V EY GG + F +R R A A ++ G+ ++H G I+RDLK DN+L+
Sbjct: 72 FFVMEYVNGGDL-MFHIQRSGR-FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL 129
Query: 272 SADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
++ IKIADFG+ + E G+T T GT ++AP
Sbjct: 130 DSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 39/145 (26%), Positives = 76/145 (52%), Gaps = 7/145 (4%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG+ L + + + A+K + P K+ + ++E ++LA +KH NIV F
Sbjct: 10 EGSFGRALLVQHVNSDQKYAMKEIRLP-----KSSSAVEDSRKEAVLLAKMKHPNIVAFK 64
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ IV EY GG + Q + ++ + P ++ + + G+ ++H +HR
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHR 124
Query: 263 DLKSDNLLISADKSIKIADFGVARI 287
D+KS N+ ++ + +K+ DFG AR+
Sbjct: 125 DIKSKNIFLTQNGKVKLGDFGSARL 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 25/59 (42%), Positives = 35/59 (59%), Gaps = 1/59 (1%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-MTPETGTYRWMAP 306
RG+ Y+H +HRDLK NLL++A+ +KI DFG+AR + MT T + AP
Sbjct: 119 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAP 177
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 51/171 (29%), Positives = 87/171 (50%), Gaps = 18/171 (10%)
Query: 146 GAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
GAFG ++ T +G+ VA+K + N V ++ +E+ ML KH N++ +
Sbjct: 11 GAFGVVWSVTDPRDGKRVALKKMPNVFQN----LVSCKRVFRELKMLCFFKHDNVLSALD 66
Query: 204 ACRKRMVWC-----IVTEYAKGGSVRQFLTRRQNRAVP-LKLAVKQALDVARGMAYVHGL 257
+ + +VTE + + + + Q + +K+ + Q L RG+ Y+H
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQIL---RGLKYLHSA 122
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG--MTPETGTYRWMAP 306
G +HRD+K NLL++++ +KI DFG+AR+E E MT E T + AP
Sbjct: 123 GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 143 FAQGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G FGK L R G A+KIL R E K +V + V+ L ++
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKIL-RKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ R+ C V EYA GG + L+R R + A ++ + Y+H +
Sbjct: 62 YAFQTHDRL--CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVV 117
Query: 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+RD+K +NL++ D IKI DFG+ + E ++G T +T GT ++AP
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-11
Identities = 39/130 (30%), Positives = 66/130 (50%), Gaps = 11/130 (8%)
Query: 179 MEQQFQQEVMMLATLKHLNIVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP 236
+++Q E+ +L I+ F GA R+ C TE+ GGS+ + R +P
Sbjct: 42 LQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC--TEFMDGGSLDVY------RKIP 93
Query: 237 LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTP 296
+ + A+ V +G+ Y+ L +HRD+K N+L++ +K+ DFGV+ V + T
Sbjct: 94 EHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT- 152
Query: 297 ETGTYRWMAP 306
GT +MAP
Sbjct: 153 YVGTNAYMAP 162
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 51/172 (29%), Positives = 85/172 (49%), Gaps = 18/172 (10%)
Query: 157 NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216
+G+ VA+K ++ K Q E F EV+++ +H N+V + +V E
Sbjct: 44 SGKLVAVKKMDL-----RKQQRRELLFN-EVVIMRDYQHENVVEMYNSYLVGDELWVVME 97
Query: 217 YAKGGSVRQFLTR---RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
+ +GG++ +T + + + LAV +AL V +H G IHRD+KSD++L++
Sbjct: 98 FLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSV------LHAQGVIHRDIKSDSILLTH 151
Query: 274 DKSIKIADFG-VARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWS 324
D +K++DFG A++ + GT WMAP S LP+ WS
Sbjct: 152 DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP--ELISRLPYGPEVDIWS 201
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 5e-11
Identities = 35/101 (34%), Positives = 48/101 (47%), Gaps = 14/101 (13%)
Query: 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271
C V EYA GG + + AV A V G+ Y+H ++RDLK DNLL+
Sbjct: 78 CFVMEYAAGGDL---MMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL 134
Query: 272 SADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
+ +KIADFG+ + EGM GT ++AP
Sbjct: 135 DTEGFVKIADFGLCK-----EGMGFGDRTSTFCGTPEFLAP 170
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 5e-11
Identities = 60/179 (33%), Positives = 88/179 (49%), Gaps = 20/179 (11%)
Query: 136 KLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL 193
KLN +G +G +YR T +GE VA+K + R +N + + + E+ +L L
Sbjct: 11 KLNR---IGEGTYGIVYRARDTTSGEIVALKKV-RMDNERDGIPISSLR---EITLLLNL 63
Query: 194 KHLNIVRFIGACRKRMVWCI--VTEYAKGGSVRQFLTRR-QNRAVPLKLA-VKQ-ALDVA 248
+H NIV + + I V EY + Q L N P + VK L +
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCE-----QDLASLLDNMPTPFSESQVKCLMLQLL 118
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
RG+ Y+H IHRDLK NLL++ +KIADFG+AR + + MTP+ T + AP
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAP 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 6e-11
Identities = 40/158 (25%), Positives = 74/158 (46%), Gaps = 24/158 (15%)
Query: 145 QGAFGKLYRGTYNGE------DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G FG+++ G E +V +K ++ ++ + QV QE +L L H NI
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVK---DHASEIQV--TLLLQESCLLYGLSHQNI 70
Query: 199 VRFIGAC----RKRMVWCIVTEYAKGGSVRQFLTR------RQNRAVPLKLAVKQALDVA 248
+ + C V + Y G+++ FL + +A+ + V A+ +A
Sbjct: 71 LPILHVCIEDGEPPFV---LYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
GM+Y+H G IH+D+ + N +I + +KI D ++R
Sbjct: 128 CGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 6e-11
Identities = 36/150 (24%), Positives = 66/150 (44%), Gaps = 16/150 (10%)
Query: 139 MGTAFAQGAFGKLYRGTYNGEDVAIKI--LERPENNPEKAQVME--QQFQQEVMMLATLK 194
+G F L + VA+K L+ + E + QQE++ L+
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLD--------SCSKEDLKLLQQEIITSRQLQ 57
Query: 195 HLNIVRFIGA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL-DVARGMA 252
H NI+ ++ + ++ +V+ GS L +P +LA+ L DV +
Sbjct: 58 HPNILPYVTSFIVDSELY-VVSPLMAYGSCEDLLKTHFPEGLP-ELAIAFILKDVLNALD 115
Query: 253 YVHGLGFIHRDLKSDNLLISADKSIKIADF 282
Y+H GFIHR +K+ ++L+S D + ++
Sbjct: 116 YIHSKGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 7e-11
Identities = 65/257 (25%), Positives = 100/257 (38%), Gaps = 84/257 (32%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQ 181
+W +L +G +GAFGK+ + + G VA+K+L+ E +M
Sbjct: 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALM-- 58
Query: 182 QFQQEVMMLATL-KHLNIVRFIGACRKR----MVWCIVTEYAKGG-------SVRQFLTR 229
E+ +L + HLN+V +GAC K MV + EY K G S R+ +
Sbjct: 59 ---TELKILIHIGHHLNVVNLLGACTKPGGPLMV---IVEYCKFGNLSNYLRSKRECFSP 112
Query: 230 RQNRAVPLKLAV-----KQALD-------------------------------------- 246
+N++ + KQ LD
Sbjct: 113 YRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTL 172
Query: 247 ---------VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE 297
VARGM ++ IHRDL + N+L+S + +KI DFG+AR ++ +
Sbjct: 173 EDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVR 231
Query: 298 TGTYR----WMAPGNSF 310
G R WMAP + F
Sbjct: 232 KGDARLPLKWMAPESIF 248
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 41/132 (31%), Positives = 66/132 (50%), Gaps = 11/132 (8%)
Query: 158 GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI--GACRKRMVWCIVT 215
G +VAIK+L + PE+ +F++E + A L H NIV + G +++ V
Sbjct: 3 GHEVAIKLLR--TDAPEEEH-QRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VF 58
Query: 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-- 273
EY G ++R+ L + A+P + L V +A H G +HRDLK N+++S
Sbjct: 59 EYVPGRTLREVLA--ADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTG 116
Query: 274 -DKSIKIADFGV 284
K+ DFG+
Sbjct: 117 VRPHAKVLDFGI 128
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 47/148 (31%), Positives = 72/148 (48%), Gaps = 15/148 (10%)
Query: 144 AQGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLN 197
+GAFG+ L R G+ A+K+L K+ ++++ V +LA
Sbjct: 10 GRGAFGEVWLVRDKDTGQVYAMKVLR-------KSDMIKRNQIAHVRAERDILADADSPW 62
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
IV+ + + +V EY GG + L R+ P + A ++ + VH L
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKL 120
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVA 285
GFIHRD+K DN+LI AD IK+ADFG+
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 9e-11
Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 18/149 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIK---ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G +++ E VA+K + + E P A +E+ +L LKH NIV
Sbjct: 10 EGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-------REICLLKELKHKNIV 62
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGL 257
R +V EY ++++ P +K + Q L +G+A+ H
Sbjct: 63 RLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLL---KGLAFCHSH 118
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVAR 286
+HRDLK NLLI+ + +K+ADFG+AR
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+V + + C+V EY +GG L + A+P+ +A + + Y+H
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARI 287
G +HRDLK DNLLI++ IK+ DFG+++I
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 41/153 (26%), Positives = 75/153 (49%), Gaps = 11/153 (7%)
Query: 158 GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
G +VA+K L RP N Q ++ +E+++L + H NI+ + + + E+
Sbjct: 46 GINVAVKKLSRPFQN----QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKS---LEEF 98
Query: 218 AKGGSVRQFLTRRQNRAVPLKLAVKQA----LDVARGMAYVHGLGFIHRDLKSDNLLISA 273
V + + + + ++L ++ + G+ ++H G IHRDLK N+++ +
Sbjct: 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 158
Query: 274 DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
D ++KI DFG+AR MTP T + AP
Sbjct: 159 DCTLKILDFGLARTACTNFMMTPYVVTRYYRAP 191
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 53/179 (29%), Positives = 81/179 (45%), Gaps = 26/179 (14%)
Query: 145 QGAFGKLY--RGTYNGEDVAIK--ILERPENN-PEKAQVMEQQFQQEVMMLATLKHLN-I 198
+G +GK+Y R G+ VA+K LE E P A +E+ +L L I
Sbjct: 11 EGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL-------REISLLQMLSESIYI 63
Query: 199 VRFIGA------CRKRMVWCIVTEYAKGGSVRQFLT---RRQNRAVPLKLAVKQALDVAR 249
VR + K ++ +V EY +++F+ R R +P K + +
Sbjct: 64 VRLLDVEHVEEKNGKPSLY-LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKS-IKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
G+A+ H G +HRDLK NLL+ K +KIAD G+ R + + T E T + AP
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 9/163 (5%)
Query: 146 GAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G FG+++ R + A+K++ PE K EQ E +L + H I+R
Sbjct: 12 GTFGRVHLVRDRISEHYYALKVMAIPEVIRLK---QEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
+ ++ EY GG + +L R + + A ++ + Y+H ++RD
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRD 126
Query: 264 LKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
LK +N+L+ + IK+ DFG A+ +++ T GT ++AP
Sbjct: 127 LKPENILLDKEGHIKLTDFGFAK-KLRDRTWT-LCGTPEYLAP 167
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 27/184 (14%)
Query: 133 DLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT 192
+L+ + G AQG Y T G++VAIK L RP N A+ + +++ V+M
Sbjct: 20 NLKPIGSG---AQGIVCAAY-DTVTGQNVAIKKLSRPFQNVTHAK---RAYRELVLMK-L 71
Query: 193 LKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR--- 249
+ H NI+ + + + E+ V + + L ++ LD R
Sbjct: 72 VNHKNIIGLLNVFTPQKS---LEEFQDVYLVMELMDAN------LCQVIQMDLDHERMSY 122
Query: 250 -------GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR 302
G+ ++H G IHRDLK N+++ +D ++KI DFG+AR + MTP T
Sbjct: 123 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 182
Query: 303 WMAP 306
+ AP
Sbjct: 183 YRAP 186
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 53/195 (27%), Positives = 86/195 (44%), Gaps = 19/195 (9%)
Query: 124 LENYDEWTIDLRKLNMGT-------AFAQGAFG--KLYRGTYNGEDVAIKILERPENNPE 174
L Y + +R L M +GAFG +L R + A+K+L + E
Sbjct: 25 LNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR 84
Query: 175 KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA 234
F +E ++A +V+ A + +V EY GG + ++ N
Sbjct: 85 SDSAF---FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS---NYD 138
Query: 235 VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294
VP K A +V + +H +GFIHRD+K DN+L+ +K+ADFG +++ EGM
Sbjct: 139 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGM 197
Query: 295 T---PETGTYRWMAP 306
GT +++P
Sbjct: 198 VRCDTAVGTPDYISP 212
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 52/170 (30%), Positives = 83/170 (48%), Gaps = 18/170 (10%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FGK L R G+ A+KIL++ E K +V + V+ L +++
Sbjct: 5 KGTFGKVILVREKATGKYYAMKILKK-EVIIAKDEVAHTLTESRVLQNTRHPFLTALKYS 63
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALDVARGMAYVHGLG 258
R+ C V EYA GG + L+R ++RA + AL Y+H
Sbjct: 64 FQTHDRL--CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG------YLHSCD 115
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
++RDLK +NL++ D IKI DFG+ + + ++G T +T GT ++AP
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKTFCGTPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 64/190 (33%), Positives = 86/190 (45%), Gaps = 29/190 (15%)
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED--VAIK--ILERPENNPEKAQVM 179
LE Y I L KL GT + +Y+G D VA+K LE E P A
Sbjct: 5 LETY----IKLDKLGEGT------YATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-- 52
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--RAVPL 237
+EV +L LKH NIV +V EY ++Q+L N +
Sbjct: 53 -----REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNV 106
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEGMTP 296
KL + Q L RG+ Y H +HRDLK NLLI+ +K+ADFG+AR + + T+ +
Sbjct: 107 KLFLFQLL---RGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN 163
Query: 297 ETGTYRWMAP 306
E T W P
Sbjct: 164 EVVTL-WYRP 172
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 47/170 (27%), Positives = 83/170 (48%), Gaps = 17/170 (10%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM-----MLATLKHLN 197
+G+FGK L + +G A+K+L+ K +++++ Q +M +L LKH
Sbjct: 5 KGSFGKVLLAKRKSDGSFYAVKVLQ-------KKTILKKKEQNHIMAERNVLLKNLKHPF 57
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+V + + V +Y GG + F ++ R A A +VA + Y+H L
Sbjct: 58 LVGLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVASAIGYLHSL 115
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
I+RDLK +N+L+ + + + DFG+ + V+ E T GT ++AP
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 56/255 (21%), Positives = 91/255 (35%), Gaps = 79/255 (30%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQ 181
+W +L +G GAFGK+ + G VA+K+L+ E +M
Sbjct: 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALM-- 58
Query: 182 QFQQEVMMLATL-KHLNIVRFIGAC-RKRMVWCIVTEYAK-------------------- 219
E+ +L + HLN+V +GAC + ++ E+ K
Sbjct: 59 ---SELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYRE 115
Query: 220 -----------------------GGSVR----QFLTRRQNRAVPLKLA------------ 240
G +F P +
Sbjct: 116 KSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMED 175
Query: 241 -VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
+ + VARGM ++ IHRDL + N+L+S + +KI DFG+AR ++ + G
Sbjct: 176 LICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKG 234
Query: 300 TYR----WMAPGNSF 310
+ R WMAP + F
Sbjct: 235 SARLPLKWMAPESIF 249
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 41/147 (27%), Positives = 67/147 (45%), Gaps = 19/147 (12%)
Query: 146 GAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G FG+L RG VAI L ++ ++ + F E + L H NIVR
Sbjct: 16 GRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR-----RGFLAEALTLGQFDHSNIVR 70
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD----VARGMAYVHG 256
G + IVTEY G++ FL + + +L Q + +A GM Y+
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHEG-----QLVAGQLMGMLPGLASGMKYLSE 125
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFG 283
+G++H+ L + +L+++D KI+ F
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 46/150 (30%), Positives = 73/150 (48%), Gaps = 17/150 (11%)
Query: 145 QGAFGKLY--RGTYNGEDVAIK-I-LE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G +Y R GE VA+K I LE E P A +E+ +L L H NIV
Sbjct: 9 EGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI-------REISLLKELNHPNIV 61
Query: 200 RF--IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
R + ++ +V E+ +++++ + L + +G+AY H
Sbjct: 62 RLLDVVHSENKLY--LVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARI 287
+HRDLK NLLI + ++K+ADFG+AR
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 52/178 (29%), Positives = 81/178 (45%), Gaps = 34/178 (19%)
Query: 145 QGAFGKL--YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA+G++ T G VAIK L RP + A+ + +E+ +L + H N++ +
Sbjct: 25 SGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAK----RTYRELRLLKHMDHENVIGLL 80
Query: 203 GACRKRMVWC------------IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
V+ +VT G + + ++ ++ V Q L RG
Sbjct: 81 D------VFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQIL---RG 130
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-MTPETGTYRW-MAP 306
+ Y+H G IHRDLK N+ ++ D +KI DFG+AR T+ MT T RW AP
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR---HTDDEMTGYVAT-RWYRAP 184
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 48/172 (27%), Positives = 86/172 (50%), Gaps = 20/172 (11%)
Query: 145 QGAFGKLY-----RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM---MLATLKHL 196
QG+FGK++ G G+ A+K+L+ KA + + + M +LA + H
Sbjct: 6 QGSFGKVFLVRKITGPDAGQLYAMKVLK-------KATLKVRDRVRTKMERDILAEVNHP 58
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL-DVARGMAYVH 255
IV+ A + ++ ++ +GG + TR + + VK L ++A + ++H
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAELALALDHLH 115
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
LG I+RDLK +N+L+ + IK+ DFG+++ + E GT +MAP
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAP 167
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 144 AQGAFGKLYRG---TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+GA+GK+++ G VA+K + R + E + + + L T +H N+VR
Sbjct: 10 GEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 201 FIGACR-----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
C + +V E+ + +L + VP + + RG+ ++H
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
+HRDLK N+L+++ IK+ADFG+ARI
Sbjct: 128 SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 57/179 (31%), Positives = 82/179 (45%), Gaps = 21/179 (11%)
Query: 138 NMGTAFAQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMM-----L 190
N +G+FGK+ G D AIKIL K V+ Q E M L
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKIL--------KKDVIIQDDDVECTMVEKRVL 54
Query: 191 ATLKHLNIVRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
A + + +C + M V EY GG + + + P AV A ++A
Sbjct: 55 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPH--AVFYAAEIAI 112
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
G+ ++H G I+RDLK DN+++ A+ IKIADFG+ + E G T T GT ++AP
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRTFCGTPDYIAP 170
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-10
Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 12/167 (7%)
Query: 144 AQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
AQG Y + +VAIK L RP N Q ++ +E++++ + H NI+ +
Sbjct: 29 AQGIVCAAYDAVLD-RNVAIKKLSRPFQN----QTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA----LDVARGMAYVHGLGF 259
+ + E+ V + + + + ++L ++ + G+ ++H G
Sbjct: 84 VFTPQKS---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI 140
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
IHRDLK N+++ +D ++KI DFG+AR + MTP T + AP
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 46/166 (27%), Positives = 76/166 (45%), Gaps = 26/166 (15%)
Query: 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIK-ILERPENNPEKAQVMEQQFQQEVMMLA 191
+ +G G+FG +Y E VAIK +L+ P Q +E++++
Sbjct: 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----------QYKNRELLIMK 114
Query: 192 TLKHLNIVRF--------IGACRKRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAV 241
L H+NI+ K + +V E+ +V +++ R N A+PL L
Sbjct: 115 NLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVK 173
Query: 242 KQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVAR 286
+ + R +AY+H HRDLK NLLI + ++K+ DFG A+
Sbjct: 174 LYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219
|
Length = 440 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 6e-10
Identities = 40/142 (28%), Positives = 75/142 (52%), Gaps = 9/142 (6%)
Query: 145 QGAFGKLY----RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G G+++ +GT G+ A+K+L++ E +V +QE+ LATL H +
Sbjct: 11 KGDVGRVFLVRLKGT--GKLFALKVLDKKEMIKRN-KVKRVLTEQEI--LATLDHPFLPT 65
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ + C+V +Y GG + + L R+ + + ++A A +V + Y+H LG +
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIV 125
Query: 261 HRDLKSDNLLISADKSIKIADF 282
+RDLK +N+L+ I ++DF
Sbjct: 126 YRDLKPENILLHESGHIMLSDF 147
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 6e-10
Identities = 57/174 (32%), Positives = 77/174 (44%), Gaps = 27/174 (15%)
Query: 148 FGKLYRGTY----------NGEDVAIK--ILERPENNPEKAQVMEQQFQQEVMMLATLKH 195
KL GTY VA+K LE E P A +EV +L LKH
Sbjct: 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-------REVSLLKNLKH 62
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV--PLKLAVKQALDVARGMAY 253
NIV +V EY ++Q+L N +K+ + Q L RG++Y
Sbjct: 63 ANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLL---RGLSY 118
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEGMTPETGTYRWMAP 306
H +HRDLK NLLI+ +K+ADFG+AR + V T+ + E T W P
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTL-WYRP 171
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 6e-10
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 104 ALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTA-------FAQGAFG--KLYRG 154
AL D AL ++ L Y++ + KL M +GAFG +L R
Sbjct: 5 ALVYDCDIPALRKNKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRH 64
Query: 155 TYNGEDVAIKILERPE--NNPEKAQVMEQQFQQEVMMLATLKHLN---IVRFIGACRKRM 209
+ + A+K+L + E + A E++ ++M H N IV+ A +
Sbjct: 65 KSSKQVYAMKLLSKFEMIKRSDSAFFWEER---DIM-----AHANSEWIVQLHYAFQDDK 116
Query: 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNL 269
+V EY GG + ++ N +P K A +V + +H +GFIHRD+K DN+
Sbjct: 117 YLYMVMEYMPGGDLVNLMS---NYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM 173
Query: 270 LISADKSIKIADFGVARIEVQTEGM 294
L+ +K+ADFG +++ GM
Sbjct: 174 LLDKSGHLKLADFGTC-MKMDANGM 197
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 7e-10
Identities = 27/63 (42%), Positives = 36/63 (57%), Gaps = 6/63 (9%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYRWM 304
RG+ Y+H +HRDLK NLL++ + +KI DFG+ARI T +T T RW
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT-RWY 175
Query: 305 -AP 306
AP
Sbjct: 176 RAP 178
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 27/64 (42%), Positives = 34/64 (53%), Gaps = 7/64 (10%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-----EVQTEGMTPETGTYRW 303
RG+ Y+H IHRDLK NLL++ D ++I DFG+AR MT T RW
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT-RW 176
Query: 304 M-AP 306
AP
Sbjct: 177 YRAP 180
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 7e-10
Identities = 57/187 (30%), Positives = 87/187 (46%), Gaps = 21/187 (11%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMM----- 189
N +G+FGK+ G D AIKIL K V+ Q E M
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKIL--------KKDVVIQDDDVECTMVEKRV 53
Query: 190 LATLKHLNIVRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
LA + + +C + M V EY GG + + + P AV A ++A
Sbjct: 54 LALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPH--AVFYAAEIA 111
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
G+ ++H G I+RDLK DN+++ ++ IKIADFG+ + E +G+T +T GT ++AP
Sbjct: 112 IGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAP 170
Query: 307 GNSFFSP 313
+ P
Sbjct: 171 EIIAYQP 177
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 8e-10
Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 46/164 (28%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQ-------QEVMMLATLKH 195
+G +G +YR GE VA+K L+ ME++ + +E+ +L L+H
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKLK-----------MEKEKEGFPITSLREINILLKLQH 63
Query: 196 LNIVRFIGACRKRMVW-------CIVTEYAKGGSVRQFL-----TRRQNRAVP-LKLAVK 242
NIV K +V +V EY V L T +Q +K +
Sbjct: 64 PNIVTV-----KEVVVGSNLDKIYMVMEY-----VEHDLKSLMETMKQPFLQSEVKCLML 113
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
Q L G+A++H +HRDLK+ NLL++ +KI DFG+AR
Sbjct: 114 QLL---SGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 8e-10
Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 37/164 (22%)
Query: 160 DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAK 219
+VAIK L RP N Q ++ +E++++ + H NI+ + +
Sbjct: 51 NVAIKKLSRPFQN----QTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTP 94
Query: 220 GGSVRQFLTRRQNRAVPLKL-------AVKQALDVAR----------GMAYVHGLGFIHR 262
S+ +F Q+ + ++L ++ LD R G+ ++H G IHR
Sbjct: 95 QKSLEEF----QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 150
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
DLK N+++ +D ++KI DFG+AR + MTP T + AP
Sbjct: 151 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 5/95 (5%)
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
V EY GG + + + P AV A +++ G+ ++H G I+RDLK DN+++ +
Sbjct: 79 VMEYVNGGDLMYHIQQVGKFKEPQ--AVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136
Query: 274 DKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+ IKIADFG+ + E +G+T T GT ++AP
Sbjct: 137 EGHIKIADFGMCK-EHMVDGVTTRTFCGTPDYIAP 170
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 43/174 (24%), Positives = 83/174 (47%), Gaps = 17/174 (9%)
Query: 141 TAFAQGAFGKLYRGTYNGEDV--AIKILERPENNPEKAQVMEQQFQQEVM-----MLATL 193
+G+FGK+ + + A+K+L+ K +++++ Q+ +M +L +
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQ-------KKAILKKKEQKHIMAERNVLLKNV 53
Query: 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
KH +V + + V +Y GG + L R R+ P A A ++A + Y
Sbjct: 54 KHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGY 111
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
+H L I+RDLK +N+L+ + + + DFG+ + ++ T GT ++AP
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 23/173 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVA---IKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G +Y+ E +A I++ + E P A +E+ +L ++H NIV
Sbjct: 12 EGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-------REISLLKEMQHGNIV 64
Query: 200 RF--IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
R + KR+ +V EY +++ + + A +L + RG+AY H
Sbjct: 65 RLQDVVHSEKRLY--LVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 258 GFIHRDLKSDNLLIS-ADKSIKIADFGVAR---IEVQTEGMTPETGTYRWMAP 306
+HRDLK NLLI ++K+ADFG+AR I V+T T E T + AP
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVVTLWYRAP 172
|
Length = 294 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 42/168 (25%), Positives = 87/168 (51%), Gaps = 11/168 (6%)
Query: 144 AQGAFGK--LYRGTYNGEDVAIKILERPE--NNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G+FGK L + +G+ A+K+L++ N E+ +M ++ ++L +KH +V
Sbjct: 4 GKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAER----NVLLKNVKHPFLV 59
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + V ++ GG + F ++ R+ P A A ++A + Y+H +
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLHSINI 117
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEV-QTEGMTPETGTYRWMAP 306
++RDLK +N+L+ + + + DFG+ + + Q++ T GT ++AP
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 52/172 (30%), Positives = 83/172 (48%), Gaps = 18/172 (10%)
Query: 143 FAQGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G FGK L R +G+ A+KIL++ E K +V + V+ L ++
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKK-EVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALDVARGMAYVHG 256
+ + R+ C V EY GG + L+R ++R + ALD Y+H
Sbjct: 62 YSFQTKDRL--CFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALD------YLHS 113
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
++RDLK +NL++ D IKI DFG+ + E T+ T +T GT ++AP
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 62/195 (31%), Positives = 90/195 (46%), Gaps = 28/195 (14%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED--VAIK--ILERPENNPEKAQVMEQQFQ 184
E I L KL GT + +++G + VA+K LE E P A
Sbjct: 6 ETYIKLEKLGEGT------YATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI------- 52
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--RAVPLKLAVK 242
+EV +L LKH NIV +V EY ++Q++ N +K+ +
Sbjct: 53 REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLY 111
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEGMTPETGTY 301
Q L RG+AY H +HRDLK NLLI+ +K+ADFG+AR + V T+ + E T
Sbjct: 112 QIL---RGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL 168
Query: 302 RWMAP----GNSFFS 312
+ P G+S +S
Sbjct: 169 WYRPPDVLLGSSEYS 183
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 43/171 (25%), Positives = 84/171 (49%), Gaps = 17/171 (9%)
Query: 144 AQGAFGKLYRGTYNGEDV--AIKILERPENNPEKAQVMEQQFQQEVM-----MLATLKHL 196
+G+FGK+ + E+ A+K+L+ K +++++ ++ +M +L +KH
Sbjct: 4 GKGSFGKVLLARHKAEEKFYAVKVLQ-------KKAILKKKEEKHIMSERNVLLKNVKHP 56
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+V + + V +Y GG + L R + P A A ++A + Y+H
Sbjct: 57 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR--ARFYAAEIASALGYLHS 114
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
L ++RDLK +N+L+ + I + DFG+ + ++ G T GT ++AP
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 52/195 (26%), Positives = 87/195 (44%), Gaps = 19/195 (9%)
Query: 124 LENYDEWTIDLRKLNMGT-------AFAQGAFG--KLYRGTYNGEDVAIKILERPENNPE 174
L Y++ +RKL M +GAFG +L R + + A+K+L + E
Sbjct: 25 LNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKR 84
Query: 175 KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA 234
F +E ++A +V+ A + +V EY GG + ++ N
Sbjct: 85 SDSAF---FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS---NYD 138
Query: 235 VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294
VP K A +V + +H +G IHRD+K DN+L+ +K+ADFG +++ GM
Sbjct: 139 VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGM 197
Query: 295 T---PETGTYRWMAP 306
GT +++P
Sbjct: 198 VRCDTAVGTPDYISP 212
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 18/38 (47%), Positives = 28/38 (73%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ + Y+H IHRDLK N+L+++D +K+ADFG+AR
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 39/144 (27%), Positives = 69/144 (47%), Gaps = 6/144 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G +Y+G G+ VA+K + R E+ E + +E+ +L L+H NIV
Sbjct: 10 EGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEG---VPSTAIREISLLKELQHPNIVCLQ 65
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ ++ E+ + + + + + +L + +G+ + H +HR
Sbjct: 66 DVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHR 125
Query: 263 DLKSDNLLISADKSIKIADFGVAR 286
DLK NLLI IK+ADFG+AR
Sbjct: 126 DLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-09
Identities = 40/146 (27%), Positives = 75/146 (51%), Gaps = 13/146 (8%)
Query: 144 AQGAFG--KLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GAFG +L + G A+KIL R + EK QV + ++++++ A L +V+
Sbjct: 10 GRGAFGEVRLVQKKDTGHVYAMKIL-RKADMLEKEQVGHIRAERDILVEA--DSLWVVKM 66
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---RAVPLKLAVKQALDVARGMAYVHGLG 258
+ + ++ ++ E+ GG + L ++ +A + + +H LG
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-----ETVLAIDSIHQLG 121
Query: 259 FIHRDLKSDNLLISADKSIKIADFGV 284
FIHRD+K DNLL+ + +K++DFG+
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 17/152 (11%)
Query: 141 TAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQ-----QFQQEVMMLATL 193
T QG +G+++ + GE VA+K + K ++ + E +L T
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRM--------KKSLLFKLNEVRHVLTERDILTTT 58
Query: 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
K +V+ + A + + EY GG R L + A ++ +
Sbjct: 59 KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDA 116
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
+H LG+IHRDLK +N LI A IK+ DFG++
Sbjct: 117 LHELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 34/125 (27%), Positives = 57/125 (45%), Gaps = 8/125 (6%)
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ- 243
E +L L H +V + + +V + GG +R L+++ V +
Sbjct: 49 NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK----VKFSEEQVKF 104
Query: 244 -ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-GTY 301
++ + Y+H G IHRD+K DN+L+ + I DF +A V + +T T GT
Sbjct: 105 WICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATK-VTPDTLTTSTSGTP 163
Query: 302 RWMAP 306
+MAP
Sbjct: 164 GYMAP 168
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 43/145 (29%), Positives = 65/145 (44%), Gaps = 15/145 (10%)
Query: 146 GAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQ----FQQEVMMLATLKHLNIV 199
GAFG+ L R A+K L KA V+ + + E +LA + +V
Sbjct: 12 GAFGEVCLVRKVDTNALYAMKTLR-------KADVLMRNQAAHVKAERDILAEADNEWVV 64
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + + V +Y GG + L R LA ++ + VH +GF
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGF 122
Query: 260 IHRDLKSDNLLISADKSIKIADFGV 284
IHRD+K DN+LI D IK+ DFG+
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
V EY GG + + + + A A ++ G+ ++H G I+RDLK DN+L+
Sbjct: 74 VMEYLNGGDLMFHI--QSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK 131
Query: 274 DKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
D IKIADFG+ + + EG GT ++AP
Sbjct: 132 DGHIKIADFGMCKENMNGEGKASTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 42/141 (29%), Positives = 69/141 (48%), Gaps = 7/141 (4%)
Query: 146 GAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
GAFG+ L A+K L R ++ + QV + ++++ LA + +V+
Sbjct: 12 GAFGEVCLACKVDTHALYAMKTL-RKKDVLNRNQVAHVKAERDI--LAEADNEWVVKLYY 68
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
+ + + V +Y GG + L R + P LA ++ + VH +GFIHRD
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 264 LKSDNLLISADKSIKIADFGV 284
+K DN+LI D IK+ DFG+
Sbjct: 127 IKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 5e-09
Identities = 26/63 (41%), Positives = 34/63 (53%), Gaps = 5/63 (7%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR----IEVQTEGMTPETGTYRWM 304
G+ Y+H +HRDLK NLL++AD +KI DFG+AR + G E RW
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 305 -AP 306
AP
Sbjct: 176 RAP 178
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 47/184 (25%), Positives = 83/184 (45%), Gaps = 17/184 (9%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEV 187
W + R N+ + GA+G + T G VA+K L RP ++ + ++ +E+
Sbjct: 13 WEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 67
Query: 188 MMLATLKHLNIVRFI-----GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
+L +KH N++ + + + + G + + ++ ++ +
Sbjct: 68 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 127
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR 302
Q L RG+ Y+H IHRDLK NL ++ D +KI DFG+AR + MT T
Sbjct: 128 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 182
Query: 303 WMAP 306
+ AP
Sbjct: 183 YRAP 186
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-09
Identities = 45/170 (26%), Positives = 77/170 (45%), Gaps = 20/170 (11%)
Query: 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQF 183
N W + R ++ GA+G + GE VAIK L RP ++++ ++
Sbjct: 7 NKTVWELPERYTSL-KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF----QSEIFAKRA 61
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA--- 240
+E+ +L ++H N++ + + E+ V ++ + + L+
Sbjct: 62 YRELTLLKHMQHENVIGLLDVFTSAV---SGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK 118
Query: 241 ----VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
V Q L G+ Y+H G IHRDLK NL ++ D +KI DFG+AR
Sbjct: 119 VQYLVYQML---CGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 7e-09
Identities = 52/191 (27%), Positives = 84/191 (43%), Gaps = 26/191 (13%)
Query: 146 GAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
GAFG+ L R A+K L R ++ + QV + ++++ LA + +VR
Sbjct: 12 GAFGEVCLARKVDTKALYAMKTL-RKKDVLLRNQVAHVKAERDI--LAEADNEWVVRLYY 68
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
+ + + V +Y GG + L R P LA ++ + VH +GFIHRD
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 264 LKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHP-----S 318
+K DN+LI D IK+ DFG+ TG +RW + ++ H
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLC------------TG-FRW-THDSKYYQSGDHVRQDSMD 172
Query: 319 FEHKWSAKESC 329
F ++W +C
Sbjct: 173 FSNEWGDPANC 183
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 8e-09
Identities = 45/163 (27%), Positives = 76/163 (46%), Gaps = 34/163 (20%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF- 201
+G +G++Y R GE VA+K + R +N E + + E+ +L L H NIV
Sbjct: 17 EGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIR---EIKILRQLNHRNIVNLK 72
Query: 202 ---------IGACRKRMVWCIVTEYA--------KGGSVRQFLTRRQNRAVPLKLAVKQA 244
+ + + + +V EY + G V + ++ +KQ
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH--FSEDHIKSF-----MKQL 125
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
L+ G+ Y H F+HRD+K N+L++ IK+ADFG+AR+
Sbjct: 126 LE---GLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 11/169 (6%)
Query: 143 FAQGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G FGK L + G A+KIL++ E K +V + V+ + L ++
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGF 259
+ R+ C V EYA GG + L+R R A ++ + Y+H
Sbjct: 62 YSFQTHDRL--CFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNV 117
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
++RDLK +NL++ D IKI DFG+ + E +G T +T GT ++AP
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 9/166 (5%)
Query: 145 QGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FGK+ G D AIK+L++ + + V ++ ++ LA KH +
Sbjct: 5 KGSFGKVMLAELKGTDEVYAIKVLKK-DVILQDDDVDCTMTEKRILALAA-KHPFLTALH 62
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ + V EY GG + F +R +R + A +V + ++H G I+R
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDL-MFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
DLK DN+L+ A+ K+ADFG+ + E G+T T GT ++AP
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 31/195 (15%)
Query: 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQF 183
N W + R N+ T GA+G + T + VA+K L RP ++ + ++
Sbjct: 7 NKTVWEVPERYQNL-TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF----QSLIHARRT 61
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK- 242
+E+ +L +KH N++ + + T + + L VK
Sbjct: 62 YRELRLLKHMKHENVIGLLD---------VFTPATSIENFNEVYLVTNLMGADLNNIVKC 112
Query: 243 QAL----------DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291
Q L + RG+ Y+H G IHRDLK N+ ++ D ++I DFG+AR Q
Sbjct: 113 QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QAD 169
Query: 292 EGMTPETGTYRWMAP 306
+ MT T + AP
Sbjct: 170 DEMTGYVATRWYRAP 184
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 37/137 (27%), Positives = 60/137 (43%), Gaps = 22/137 (16%)
Query: 185 QEVMMLATLKHLNIVRF--------------IGACRKRMVWCIVTEYAKGGSVRQFLTRR 230
+E+ ++ L H NIV+ +G+ + IV EY + + L +
Sbjct: 51 REIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQG 109
Query: 231 QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI-KIADFGVARI-- 287
+L + Q L RG+ Y+H +HRDLK N+ I+ + + KI DFG+ARI
Sbjct: 110 PLSEEHARLFMYQLL---RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD 166
Query: 288 -EVQTEGMTPETGTYRW 303
+G E +W
Sbjct: 167 PHYSHKGYLSEGLVTKW 183
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 42/145 (28%), Positives = 74/145 (51%), Gaps = 8/145 (5%)
Query: 165 ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVR 224
I+ R + E + Q +E+ +L IV F GA I E+ GGS+
Sbjct: 32 IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 91
Query: 225 QFLTRRQNRAVPLKLAVKQALDVARGMAYV---HGLGFIHRDLKSDNLLISADKSIKIAD 281
Q L ++ + +P ++ K ++ V RG+AY+ H + +HRD+K N+L+++ IK+ D
Sbjct: 92 QVL--KEAKRIPEEILGKVSIAVLRGLAYLREKHQI--MHRDVKPSNILVNSRGEIKLCD 147
Query: 282 FGVARIEVQTEGMTPETGTYRWMAP 306
FGV+ + + + GT +M+P
Sbjct: 148 FGVSGQLIDSMANS-FVGTRSYMSP 171
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 18/173 (10%)
Query: 142 AFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
GA+G + G VAIK L RP ++++ ++ +E+ +L +KH N++
Sbjct: 22 QVGSGAYGTVCSALDRRTGAKVAIKKLYRPF----QSELFAKRAYRELRLLKHMKHENVI 77
Query: 200 RFIGACRKRMVWCIVTEYA-----KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
+ + ++ G + + + + ++ V Q L +G+ Y+
Sbjct: 78 GLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQML---KGLKYI 134
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-MTPETGTYRWMAP 306
H G IHRDLK NL ++ D +KI DFG+AR QT+ MT T + AP
Sbjct: 135 HAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTRWYRAP 184
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 13/100 (13%)
Query: 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
+V EY GG + F +RQ R +P + A A ++ + ++H G I+RDLK DN+L+
Sbjct: 73 LVIEYVNGGDL-MFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130
Query: 273 ADKSIKIADFGVARIEVQTEGMTPE------TGTYRWMAP 306
AD IK+ D+G+ + EG+ P GT ++AP
Sbjct: 131 ADGHIKLTDYGMCK-----EGLGPGDTTSTFCGTPNYIAP 165
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 39/133 (29%), Positives = 62/133 (46%), Gaps = 19/133 (14%)
Query: 184 QQEVMMLATLKHLN---IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA 240
Q + L L N IV F GA I E+ GGS+ Q L ++ +P +
Sbjct: 44 NQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPENIL 101
Query: 241 VKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET- 298
K ++ V RG+ Y+ +HRD+K N+L+++ IK+ DFGV+ G ++
Sbjct: 102 GKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS-------GQLIDSM 154
Query: 299 -----GTYRWMAP 306
GT +M+P
Sbjct: 155 ANSFVGTRSYMSP 167
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-08
Identities = 25/134 (18%), Positives = 61/134 (45%), Gaps = 10/134 (7%)
Query: 151 LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR----FIGACR 206
+Y+G +N ++V I+ ++ +V+ + E+ L + NI++ I
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKG---HKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92
Query: 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLK 265
++ EY G +R+ L + + + K + A+D +G+ ++ +++L
Sbjct: 93 DLPRLSLILEYCTRGYLREVL--DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLT 150
Query: 266 SDNLLISADKSIKI 279
S + L++ + +KI
Sbjct: 151 SVSFLVTENYKLKI 164
|
Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 42/168 (25%), Positives = 74/168 (44%), Gaps = 9/168 (5%)
Query: 143 FAQGAFGKL----YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G FG++ R T G+ A K LE+ K + M +Q +L + +
Sbjct: 8 LGKGGFGEVCACQVRAT--GKMYACKRLEKKRIKKRKGESMALNEKQ---ILEKVNSQFV 62
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
V A + C+V GG ++ + N + A+ A ++ G+ +H
Sbjct: 63 VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
++RDLK +N+L+ I+I+D G+A + E + GT +MAP
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 6e-08
Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 145 QGAFGKLYR-----GTYNGEDVAIKILERPENNPEKAQVMEQQ-----FQQEVMMLATLK 194
+G +GK+++ G G+ A+K+L+ KA ++ Q + E +L +K
Sbjct: 6 KGGYGKVFQVRKVTGADTGKIFAMKVLK-------KATIVRNQKDTAHTKAERNILEAVK 58
Query: 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL-DVARGMAY 253
H IV I A + ++ EY GG + L R + ++ L +++ + +
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE---GIFMEDTACFYLSEISLALEH 115
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+H G I+RDLK +N+L+ A +K+ DFG+ + + EG T GT +MAP
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-EGTVTHTFCGTIEYMAP 169
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 18/30 (60%), Positives = 24/30 (80%)
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFG 283
+H LG+IHRD+K DNLL+ A IK++DFG
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFG 146
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 44/146 (30%), Positives = 75/146 (51%), Gaps = 13/146 (8%)
Query: 144 AQGAFG--KLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GAFG +L + G A+KIL R + EK QV + ++++++ A + + F
Sbjct: 10 GRGAFGEVRLVQKKDTGHIYAMKIL-RKADMLEKEQVAHIRAERDILVEADGAWV-VKMF 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---RAVPLKLAVKQALDVARGMAYVHGLG 258
KR ++ I+ E+ GG + L ++ A +A + + +H LG
Sbjct: 68 YSFQDKRNLYLIM-EFLPGGDMMTLLMKKDTLSEEATQFYIA-----ETVLAIDAIHQLG 121
Query: 259 FIHRDLKSDNLLISADKSIKIADFGV 284
FIHRD+K DNLL+ A +K++DFG+
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 33/95 (34%), Positives = 55/95 (57%), Gaps = 5/95 (5%)
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
V E+ GG + F +RQ R +P + A + +++ + ++H G I+RDLK DN+L+ A
Sbjct: 74 VIEFVSGGDL-MFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA 131
Query: 274 DKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+ IK+ D+G+ + E G T T GT ++AP
Sbjct: 132 EGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAP 165
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 13/99 (13%)
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
V EY GG + F +RQ R +P + A + +++ + Y+H G I+RDLK DN+L+ +
Sbjct: 74 VIEYVNGGDL-MFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 131
Query: 274 DKSIKIADFGVARIEVQTEGMTPE------TGTYRWMAP 306
+ IK+ D+G+ + EG+ P GT ++AP
Sbjct: 132 EGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAP 165
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 15/171 (8%)
Query: 143 FAQGAFGKLYRGTYNGED--VAIKILERP----ENNPEKAQVMEQQFQQEVMMLATLKHL 196
+G+FGK++ G + AIK L++ +++ E V ++ V+ LA +H
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMV-----EKRVLSLA-WEHP 56
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + + V EY GG + F + ++ L A A ++ G+ ++H
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDL-MFHIQSCHK-FDLPRATFYAAEIICGLQFLHS 114
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
G ++RDLK DN+L+ D IKIADFG+ + + + T GT ++AP
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 41/167 (24%), Positives = 73/167 (43%), Gaps = 11/167 (6%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG++ + G+ A K L++ K EQ E +L + IV
Sbjct: 3 KGGFGEVCACQVKATGKMYACKKLDKKRLKKRKG---EQMALNEKKILEKVSSRFIVSLA 59
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A + C+V GG ++ + P A+ A + G+ ++H ++R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET---GTYRWMAP 306
DLK +N+L+ +++I+D G+A V+ +G GT +MAP
Sbjct: 120 DLKPENVLLDDHGNVRISDLGLA---VELKGGKKIKGRAGTPGYMAP 163
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 36/115 (31%), Positives = 59/115 (51%), Gaps = 11/115 (9%)
Query: 175 KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA 234
KA + +E+ +L T+ H I+ I A R + C+V K L +R+
Sbjct: 125 KAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD-----LFTYVDRS 179
Query: 235 VPLKLAVKQALDVARGM----AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
PL L +QA+ + R + AY+HG G IHRD+K++N+ + ++ + DFG A
Sbjct: 180 GPLPL--EQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 36/115 (31%), Positives = 57/115 (49%), Gaps = 14/115 (12%)
Query: 127 YD-EWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQV 178
YD W + L +G GAFG++ T +G VA+K+L+ + EK +
Sbjct: 28 YDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQAL 87
Query: 179 MEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN 232
M E+ +++ L HLNIV +GAC K I+TEY + G + +L R ++
Sbjct: 88 M-----SELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKH 137
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 40/140 (28%), Positives = 70/140 (50%), Gaps = 10/140 (7%)
Query: 175 KAQVMEQQFQQEVMML----ATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTR 229
+A V Q+ ++ +M L ++ V F GA R+ VW I E S+ +F +
Sbjct: 35 RATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW-ICMEVMDT-SLDKFYKK 92
Query: 230 --RQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ +P + K A+ + + + Y+H L IHRD+K N+LI+ + +K+ DFG++
Sbjct: 93 VYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG 152
Query: 287 IEVQTEGMTPETGTYRWMAP 306
V + T + G +MAP
Sbjct: 153 YLVDSVAKTIDAGCKPYMAP 172
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 19/32 (59%), Positives = 25/32 (78%)
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
VH LGFIHRD+K DN+LI IK++DFG++
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 27/93 (29%), Positives = 46/93 (49%), Gaps = 3/93 (3%)
Query: 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280
V+ L+ + + + VARGM ++ +HRDL + N+L++ K +KI
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKIC 279
Query: 281 DFGVARIEVQTEGMTPETGTY---RWMAPGNSF 310
DFG+AR + + T+ +WMAP + F
Sbjct: 280 DFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF 312
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 14/135 (10%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG---ED----VAIKILERPENN 172
PT+ L ++W L G GAFGK+ T G ED VA+K+L+ +
Sbjct: 24 PTQ-LPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT 82
Query: 173 PEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ 231
E+ +M E+ +L+ L +H NIV +GAC ++TEY G + FL ++
Sbjct: 83 DEREALM-----SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKA 137
Query: 232 NRAVPLKLAVKQALD 246
+ +A+ + +
Sbjct: 138 ETFLNFVMALPEISE 152
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 41/168 (24%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 143 FAQGAFGKL----YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G FG++ R T G+ A K LE+ K + M +Q +L + +
Sbjct: 8 LGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGESMALNEKQ---ILEKVNSRFV 62
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
V A + C+V GG ++ + AV A ++ G+ +H
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
++RDLK +N+L+ I+I+D G+A + + + GT +MAP
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 42/169 (24%), Positives = 75/169 (44%), Gaps = 19/169 (11%)
Query: 146 GAFGKLYRGTYNGEDV--AIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLNIV 199
G FG++ ++ A+K ++ K ++E Q+ + +L H IV
Sbjct: 4 GGFGRVELVKVKSKNRTFALKCVK-------KRHIVETGQQEHIFSEKEILEECNHPFIV 56
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + ++ EY GG + L R A V Y+H G
Sbjct: 57 KLYRTFKDKKYIYMLMEYCLGGELWTIL--RDRGLFDEYTARFYIACVVLAFEYLHNRGI 114
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
I+RDLK +NLL+ ++ +K+ DFG A+ ++++ T T GT ++AP
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAK-KLKSGQKT-WTFCGTPEYVAP 161
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 49/204 (24%), Positives = 89/204 (43%), Gaps = 30/204 (14%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRG--TYNGEDVAIK---ILERPENNPEKAQVMEQ-- 181
++I R + G +G +GK+ + T G+ VAIK I+E + + Q++
Sbjct: 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62
Query: 182 -QFQ--QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP-L 237
F +E+ ++ +KH NI+ + + +V + +++ + R+ +
Sbjct: 63 IHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQV 121
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-------- 289
K + Q L G+ +H F+HRDL N+ I++ KIADFG+AR
Sbjct: 122 KCILLQIL---NGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178
Query: 290 -------QTEGMTPETGTYRWMAP 306
+ E MT + T + AP
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAP 202
|
Length = 335 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 28/70 (40%), Positives = 35/70 (50%), Gaps = 6/70 (8%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY---RWM- 304
R + Y+H HRDLK N+L +AD +KI DFG+AR+ Y RW
Sbjct: 114 RALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 305 APG--NSFFS 312
AP SFFS
Sbjct: 174 APELCGSFFS 183
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 32/119 (26%), Positives = 56/119 (47%), Gaps = 14/119 (11%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVMEQ 181
+W +L +G +GAFG++ G D VA+K+L+ + E +M
Sbjct: 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM-- 58
Query: 182 QFQQEVMMLATL-KHLNIVRFIGACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
E+ +L + HLN+V +GAC K ++ E+ K G++ +L ++ VP K
Sbjct: 59 ---SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYK 114
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 5e-07
Identities = 28/133 (21%), Positives = 63/133 (47%), Gaps = 6/133 (4%)
Query: 174 EKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR 233
EK ++E++ +L + IV A + C+V GG ++ + R
Sbjct: 37 EKMALLEKE------ILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGER 90
Query: 234 AVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293
+ ++ + + + G+ ++H + ++RD+K +N+L+ + +++D G+A +
Sbjct: 91 GLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT 150
Query: 294 MTPETGTYRWMAP 306
+T GT +MAP
Sbjct: 151 ITQRAGTNGYMAP 163
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 30/123 (24%), Positives = 52/123 (42%), Gaps = 13/123 (10%)
Query: 173 PEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN 232
F + +++ L H ++V+ G C R +V EY K G + FL R+
Sbjct: 38 LGSDHRDSLAFFETASLMSQLSHKHLVKLYGVC-VRDENIMVEEYVKFGPLDVFL-HREK 95
Query: 233 RAVPL--KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS-------IKIADFG 283
V L KL V + L A + Y+ +H ++ N+L++ IK++D G
Sbjct: 96 NNVSLHWKLDVAKQL--ASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153
Query: 284 VAR 286
+
Sbjct: 154 IPI 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 17/164 (10%)
Query: 154 GTYNGEDVAIKILERPEN--------NPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205
G NG V K+ +P + E + Q +E+ +L IV F GA
Sbjct: 14 GAGNG-GVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV---HGLGFIHR 262
I E+ GGS+ Q L ++ +P ++ K ++ V +G+ Y+ H + +HR
Sbjct: 73 YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHKI--MHR 128
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
D+K N+L+++ IK+ DFGV+ + + + GT +M+P
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSP 171
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 42/131 (32%), Positives = 59/131 (45%), Gaps = 15/131 (11%)
Query: 127 YD-EWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQV 178
YD W L +G GAFGK+ GT G VA+K+L+ + EK +
Sbjct: 28 YDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQAL 87
Query: 179 MEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTR-RQNRAVP 236
M E+ ++ L HLNIV +GAC K I+TEY G + +L + R N
Sbjct: 88 M-----SELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSR 142
Query: 237 LKLAVKQALDV 247
K+ LD+
Sbjct: 143 HPEKPKKDLDI 153
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 9e-07
Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 5/81 (6%)
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY---RW 303
VA GM ++ +HRDL + N+LI K +KI DFG+AR ++ + T+ +W
Sbjct: 248 VANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKW 307
Query: 304 MAPGNSFFSPLPHPSFEHKWS 324
MAP S F+ L + + WS
Sbjct: 308 MAP-ESIFNNL-YTTLSDVWS 326
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 9e-07
Identities = 36/115 (31%), Positives = 57/115 (49%), Gaps = 14/115 (12%)
Query: 127 YD-EWTIDLRKLNMGTAFAQGAFGKLYRGTYNG---ED----VAIKILERPENNPEKAQV 178
YD +W +L+ G GAFGK+ T G D VA+K+L+ + E+ +
Sbjct: 26 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREAL 85
Query: 179 MEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN 232
M E+ +L+ L H+NIV +GAC ++TEY G + FL R+++
Sbjct: 86 M-----SELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRD 135
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 3/94 (3%)
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
V E+ GG + F + + R L A A ++ G+ ++H G I+RDLK DN+++
Sbjct: 74 VMEFLNGGDL-MFHIQDKGR-FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR 131
Query: 274 DKSIKIADFGVARIEVQTEG-MTPETGTYRWMAP 306
D IKIADFG+ + V + + GT ++AP
Sbjct: 132 DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 26/71 (36%), Positives = 39/71 (54%), Gaps = 5/71 (7%)
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR- 302
+ VA+GM ++ IHRDL + N+L+S + +KI DFG+AR ++ + G R
Sbjct: 185 SFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL 243
Query: 303 ---WMAPGNSF 310
WMAP F
Sbjct: 244 PLKWMAPETIF 254
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 25/68 (36%), Positives = 40/68 (58%), Gaps = 5/68 (7%)
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR---- 302
VA+GM+++ IHRDL + N+L++ + KI DFG+AR +++ + G R
Sbjct: 223 VAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLAR-DIRNDSNYVVKGNARLPVK 281
Query: 303 WMAPGNSF 310
WMAP + F
Sbjct: 282 WMAPESIF 289
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 43/177 (24%), Positives = 86/177 (48%), Gaps = 28/177 (15%)
Query: 146 GAFGKLY-----RGTYNGEDVAIKILERP---------ENNPEKAQVMEQQFQQEVMMLA 191
GA+GK++ G +G+ A+K+L++ E+ + QV+E Q L
Sbjct: 11 GAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP--FLV 68
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
TL + A + ++ +Y GG + L++R+ R ++ + ++ +
Sbjct: 69 TLHY--------AFQTDTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSG-EIVLAL 118
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR--IEVQTEGMTPETGTYRWMAP 306
++H LG I+RD+K +N+L+ ++ + + DFG+++ E + E GT +MAP
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 25/57 (43%), Positives = 35/57 (61%), Gaps = 6/57 (10%)
Query: 233 RAVPLKLAVKQALDVAR----GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
R PL LA Q VAR + Y+HG G IHRD+K++N+L++ + I + DFG A
Sbjct: 253 RLRPLGLA--QVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAA 307
|
Length = 461 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 44/177 (24%), Positives = 85/177 (48%), Gaps = 16/177 (9%)
Query: 138 NMGTAFAQGAFG--KLYRGTYNGEDVAIKILERPENNPEKAQVMEQ----QFQQEVMMLA 191
++ + +G FG ++ R G+ A+K+++ K+ ++ Q F++E +L+
Sbjct: 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMK-------KSVLLAQETVSFFEEERDILS 56
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
I + A + + +V EY GG + L R +++ +A ++ +
Sbjct: 57 ISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYLAELVLAI 115
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFG-VARIEV-QTEGMTPETGTYRWMAP 306
VH +G++HRD+K +N+LI IK+ADFG AR+ + GT ++AP
Sbjct: 116 HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAP 172
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 36/131 (27%), Positives = 65/131 (49%), Gaps = 8/131 (6%)
Query: 179 MEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
+ +Q +E+ ++ + IV F GA C+ E+ GS L R + P+
Sbjct: 46 VRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGS----LDRIYKKGGPIP 101
Query: 239 LAV--KQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMT 295
+ + K A+ V G+ Y++ +HRD+K N+L+++ IK+ DFGV+ + + T
Sbjct: 102 VEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT 161
Query: 296 PETGTYRWMAP 306
GT +M+P
Sbjct: 162 -FVGTSTYMSP 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 28/100 (28%), Positives = 55/100 (55%), Gaps = 12/100 (12%)
Query: 213 IVTEYAKGGSVRQFLTRRQN---RAVPLKLA-VKQALDVARGMAYVHGLGFIHRDLKSDN 268
++ +Y GG + L +R++ V + +A + ALD ++H LG I+RD+K +N
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD------HLHQLGIIYRDIKLEN 135
Query: 269 LLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+L+ ++ + + DFG+++ + E + GT +MAP
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 18/154 (11%)
Query: 145 QGAFGKLYRGTYN---GEDVAIK-ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G G++Y Y+ VA+K I E NP +++++F +E + A L H IV
Sbjct: 12 KGGMGEVYLA-YDPVCSRRVALKKIREDLSENP----LLKKRFLREAKIAADLIHPGIVP 66
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFL-TRRQNRAVPLKLAVKQAL--------DVARGM 251
C Y +G +++ L + Q ++ +LA K ++ + +
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
YVH G +HRDLK DN+L+ + I D+G A
Sbjct: 127 EYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160
|
Length = 932 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 4e-06
Identities = 28/96 (29%), Positives = 54/96 (56%), Gaps = 3/96 (3%)
Query: 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
+V +Y GG + L++ ++R +P +A ++ + VH L ++HRD+K DN+L+
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 136
Query: 273 ADKSIKIADFG--VARIEVQTEGMTPETGTYRWMAP 306
+ I++ADFG + +E T + GT +++P
Sbjct: 137 MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 172
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 27/100 (27%), Positives = 52/100 (52%), Gaps = 3/100 (3%)
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
E +L + H +I++ G C++ K + +L ++N A+ LA++++
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERS- 190
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
V R + Y+H IHRD+K++N+ I+ + + DFG A
Sbjct: 191 -VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-06
Identities = 49/176 (27%), Positives = 72/176 (40%), Gaps = 30/176 (17%)
Query: 149 GKLYRGTYNGEDVAIKILERPEN-----NPEKAQVMEQQFQQEVMMLATLKHLN---IVR 200
+L +G Y K+L RP + ++ E +F Q +M L L IV
Sbjct: 7 DELGKGNYG---SVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVD 63
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLT-RRQNRAVPLKLAVKQALDVARGMAY--VHGL 257
F GA + EY GS+ + +P DV R + Y V GL
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPE--------DVLRRITYAVVKGL 115
Query: 258 GF-------IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
F IHRD+K N+L++ + +K+ DFGV+ V + T G +MAP
Sbjct: 116 KFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT-NIGCQSYMAP 170
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 5e-06
Identities = 23/65 (35%), Positives = 38/65 (58%), Gaps = 3/65 (4%)
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTY 301
A ++ + ++H G I+RDLK DN+L+ + K+ADFG+ + + G T T GT
Sbjct: 102 AAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF-NGKTTSTFCGTP 160
Query: 302 RWMAP 306
++AP
Sbjct: 161 DYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 7e-06
Identities = 24/71 (33%), Positives = 44/71 (61%), Gaps = 1/71 (1%)
Query: 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
+V +Y GG + L++ ++R +P +A ++ + VH LG++HRD+K DN+L+
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD 136
Query: 273 ADKSIKIADFG 283
+ I++ADFG
Sbjct: 137 KNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 41/174 (23%), Positives = 78/174 (44%), Gaps = 15/174 (8%)
Query: 146 GAFGKLY--RGTYNGED-VAIKILERPENNP-------EKAQVMEQQFQQEVMMLATLKH 195
GAFG +Y R NG++ +A+K E +NP E+ + + + ++ L+H
Sbjct: 11 GAFGCVYKVRKKNNGQNLLALK--EINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRH 68
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLT--RRQNRAVPLKLAVKQALDVARGMAY 253
NIVR+ + IV + +G + + + + + + + + + Y
Sbjct: 69 PNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRY 128
Query: 254 VHGLGFI-HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+H I HRDL +N+++ D + I DFG+A+ + +T GT + P
Sbjct: 129 LHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCP 182
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 24/71 (33%), Positives = 39/71 (54%), Gaps = 5/71 (7%)
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR- 302
+ VA+GM ++ IHRD+ + N+L++ + KI DFG+AR ++ + G R
Sbjct: 218 SSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-DIMNDSNYVVKGNARL 276
Query: 303 ---WMAPGNSF 310
WMAP + F
Sbjct: 277 PVKWMAPESIF 287
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 44/179 (24%), Positives = 82/179 (45%), Gaps = 27/179 (15%)
Query: 145 QGAFGKLYRGTYN-----GE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195
QG F K+++G GE +V +K+L++ N E F+ MM + L H
Sbjct: 5 QGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRN-----YSESFFEAASMM-SQLSH 58
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
++V G C +V EY K GS+ +L + +N + + ++ A +A + ++
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLE 117
Query: 256 GLGFIHRDLKSDNLLIS---ADKS-----IKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G H ++ + N+L+ K+ IK++D G++ I V + + E W+ P
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS-ITVLPKEILLE--RIPWVPP 173
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 41/160 (25%), Positives = 69/160 (43%), Gaps = 12/160 (7%)
Query: 147 AFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206
A GK+Y A K LE+ K + M +Q +L + +V A
Sbjct: 23 ATGKMY---------ACKKLEKKRIKKRKGEAMALNEKQ---ILEKVNSRFVVSLAYAYE 70
Query: 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKS 266
+ C+V GG ++ + N + AV A ++ G+ +H ++RDLK
Sbjct: 71 TKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKP 130
Query: 267 DNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+N+L+ I+I+D G+A + E + GT +MAP
Sbjct: 131 ENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 18/39 (46%), Positives = 27/39 (69%)
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
V G+ +H +G +HRD+K +NLL++ D +KI DFG A
Sbjct: 318 VLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 22/71 (30%), Positives = 43/71 (60%), Gaps = 1/71 (1%)
Query: 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
+V +Y GG + L++ ++R +P +A ++ + +H L ++HRD+K DN+L+
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD 136
Query: 273 ADKSIKIADFG 283
+ I++ADFG
Sbjct: 137 MNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 25/83 (30%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 227 LTRRQNRAVPLKLAVKQALDVARGMAYV---HGLGFIHRDLKSDNLLISADKSIKIADFG 283
L +R +P + K + + + + Y+ HG+ IHRD+K N+L+ A ++K+ DFG
Sbjct: 103 LLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGV--IHRDVKPSNILLDASGNVKLCDFG 160
Query: 284 VARIEVQTEGMTPETGTYRWMAP 306
++ V ++ T G +MAP
Sbjct: 161 ISGRLVDSKAKTRSAGCAAYMAP 183
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 37/153 (24%), Positives = 66/153 (43%), Gaps = 22/153 (14%)
Query: 153 RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW- 211
+ +GE A+K+++ + + + Q EV L +IV+ C +
Sbjct: 52 KRVSDGEPFAVKVVDMEGMSEAD----KNRAQAEVCCLLNCDFFSIVK----CHEDFAKK 103
Query: 212 -----------CIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLG 258
+V +YA G +RQ + R NR A + V + +VH
Sbjct: 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH 163
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291
IHRD+KS N+L+ ++ +K+ DFG +++ T
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT 196
|
Length = 496 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 24/97 (24%), Positives = 54/97 (55%), Gaps = 6/97 (6%)
Query: 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVK-QALDVARGMAYVHGLGFIHRDLKSDNLLI 271
++ +Y GG + L +R N + + V+ + ++ + ++H LG ++RD+K +N+L+
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFS---EDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL 138
Query: 272 SADKSIKIADFGVAR--IEVQTEGMTPETGTYRWMAP 306
++ + + DFG+++ + + E GT +MAP
Sbjct: 139 DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 27/105 (25%), Positives = 47/105 (44%), Gaps = 2/105 (1%)
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
+ E+ LA H IV+ + ++ EY GG + + + +R +P +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 244 AL--DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
L + + VH +HRDLKS N+ + IK+ DFG ++
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK 217
|
Length = 478 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 41/168 (24%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 143 FAQGAFGKL----YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G FG++ R T G+ A K LE+ K + M E +L + +
Sbjct: 8 LGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGEAMALN---EKRILEKVNSRFV 62
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
V A + C+V GG ++ + N + A+ A ++ G+ +
Sbjct: 63 VSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER 122
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
++RDLK +N+L+ I+I+D G+A + E + GT +MAP
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 8e-05
Identities = 36/128 (28%), Positives = 62/128 (48%), Gaps = 11/128 (8%)
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL--TRRQNRAVPLKLAVKQ 243
E +LA + IV A + + C+V GG +R + +N P A
Sbjct: 43 EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY 102
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-----QTEGMTPET 298
+ G+ ++H I+RDLK +N+L+ D +++I+D G+A +E+ +T+G
Sbjct: 103 TAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGY---A 158
Query: 299 GTYRWMAP 306
GT +MAP
Sbjct: 159 GTPGFMAP 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 1e-04
Identities = 29/149 (19%), Positives = 49/149 (32%), Gaps = 26/149 (17%)
Query: 146 GAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI----VRF 201
G ++Y ED +KI + ++EV +L L + V
Sbjct: 9 GLTNRVYLLGTKDEDYVLKINPS--------REKGADREREVAILQLLARKGLPVPKVLA 60
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL---G 258
G ++ E+ +G + L A +A +A +H L
Sbjct: 61 SGESDGWSY--LLMEWIEG----ETLDEVSEEEKE-----DIAEQLAELLAKLHQLPLLV 109
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARI 287
H DL N+L+ K + I D+ A
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 32/129 (24%), Positives = 56/129 (43%), Gaps = 14/129 (10%)
Query: 151 LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF-----IGAC 205
L R T G V ++I + E + + Q EV++ +H NI+ G+
Sbjct: 18 LARHTPTGTLVTVRITDLENCTEEHLKAL----QNEVVLSHFFRHPNIMTSWTVFTTGS- 72
Query: 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265
+W +++ + GS L + L RG+ Y+H G+IHR++K
Sbjct: 73 ---WLW-VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIK 128
Query: 266 SDNLLISAD 274
+ ++LIS D
Sbjct: 129 ASHILISGD 137
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 42/162 (25%), Positives = 76/162 (46%), Gaps = 20/162 (12%)
Query: 140 GTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
G +G +G +Y+ +G+D L++ E + +E+ +L LKH N+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNV 60
Query: 199 V---RFIGACRKRMVWCIVTEYAKGG--SVRQFLTRRQNRAVPLKLA---VKQAL-DVAR 249
+ + + R VW ++ +YA+ + +F + P++L VK L +
Sbjct: 61 IALQKVFLSHSDRKVW-LLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 250 GMAYVHGLGFIHRDLKSDNLLISAD----KSIKIADFGVARI 287
G+ Y+H +HRDLK N+L+ + +KIAD G AR+
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 39/166 (23%), Positives = 74/166 (44%), Gaps = 9/166 (5%)
Query: 146 GAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRFIGA 204
GAFG + + + + + EK Q ++ ++ +++ + IV+F GA
Sbjct: 15 GAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ---KRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 205 CRKRMVWCIVTEYAKGGSVRQFLTR---RQNRAVPLKLAVKQALDVARGMAYV-HGLGFI 260
+ I E S+ +F +P ++ K A+ + + Y+ L I
Sbjct: 72 LFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKII 130
Query: 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
HRD+K N+L+ + +IK+ DFG++ V + T + G +MAP
Sbjct: 131 HRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 176
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 42/165 (25%), Positives = 75/165 (45%), Gaps = 26/165 (15%)
Query: 140 GTAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195
G +G +G +Y+ + D A+K +E + +E+ +L LKH
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIE--------GTGISMSACREIALLRELKH 57
Query: 196 LNIV---RFIGACRKRMVWCIVTEYAKGG--SVRQFLTRRQNRAVPLKLA---VKQAL-D 246
N++ + + R VW ++ +YA+ + +F + P++L VK L
Sbjct: 58 PNVISLQKVFLSHADRKVW-LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISAD----KSIKIADFGVARI 287
+ G+ Y+H +HRDLK N+L+ + +KIAD G AR+
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 16/38 (42%), Positives = 25/38 (65%), Gaps = 1/38 (2%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ + ++H G HRD+K +N+LI D +K+ADFG R
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 24/95 (25%), Positives = 46/95 (48%), Gaps = 3/95 (3%)
Query: 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
+VT+Y GG + F ++ A ++ + ++H ++RDLK +N+L+
Sbjct: 73 LVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD 130
Query: 273 ADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
A I + DFG+++ + T GT ++AP
Sbjct: 131 ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAP 165
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 5e-04
Identities = 36/158 (22%), Positives = 67/158 (42%), Gaps = 31/158 (19%)
Query: 143 FAQGAFGKLYRGTYNGEDVAIKI-LERPENNPE------------KAQVMEQQFQQEVMM 189
+GA ++Y G + G IK + + +PE +A++M + + V +
Sbjct: 4 IKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNV 63
Query: 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
A ++ FI IV EY +G ++ + + L + ++ R
Sbjct: 64 PAVY-FVDPENFI----------IVMEYIEGEPLKDLINSNGMEELEL------SREIGR 106
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
+ +H G IH DL + N+++S K I + DFG+A
Sbjct: 107 LVGKLHSAGIIHGDLTTSNMILSGGK-IYLIDFGLAEF 143
|
Length = 211 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 5e-04
Identities = 31/150 (20%), Positives = 60/150 (40%), Gaps = 20/150 (13%)
Query: 144 AQGAFGKLYRGTYNGEDVAIKI-LERPENNPEKAQ-VMEQQFQQEVMMLATLKHLNI--- 198
QGA +Y + G +K + + +PE + + ++ ++E +LA + +
Sbjct: 5 KQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVP 64
Query: 199 -VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
V + IV EY +G ++ L L + V + +H
Sbjct: 65 IVYDVDPDNGL----IVMEYIEGELLKDALEEA-----RPDLLREVGRLVGK----LHKA 111
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARI 287
G +H DL + N+++S + I DFG+
Sbjct: 112 GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 6e-04
Identities = 37/165 (22%), Positives = 75/165 (45%), Gaps = 5/165 (3%)
Query: 144 AQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G FG++Y R G+ A+K L++ ++ + + + + +++T IV
Sbjct: 3 GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM 62
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
A C + + GG + L+ Q+ K A ++ G+ ++H ++
Sbjct: 63 TYAFHTPDKLCFILDLMNGGDLHYHLS--QHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
RDLK N+L+ ++I+D G+A + + GT+ +MAP
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAP 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 343 | |||
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.98 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.98 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.98 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.98 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.98 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.98 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.98 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.98 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.98 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.98 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.94 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.84 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.75 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.74 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.64 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.63 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.62 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.61 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.54 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.53 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.52 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.5 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.45 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.44 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.44 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.43 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.35 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.28 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.24 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.2 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.11 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.03 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.02 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 99.0 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.99 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.97 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.89 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.88 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.78 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.74 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.73 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.72 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.68 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.61 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.5 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.49 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.48 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.36 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.31 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.29 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.19 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.18 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.18 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.09 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.99 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.9 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.85 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.84 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.8 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.79 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.74 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.72 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.69 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.4 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.25 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.23 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.14 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 97.13 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.06 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.0 | |
| PLN02236 | 344 | choline kinase | 96.87 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.85 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.82 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.8 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.69 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.54 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.45 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.3 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.3 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.24 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.89 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.89 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.87 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.52 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.45 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.4 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.34 |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=373.56 Aligned_cols=277 Identities=28% Similarity=0.469 Sum_probs=232.6
Q ss_pred cCCCCCCcccccccCCCCeEEEEeecCCCCCCCcccccccCCCCCcCC-Ccce--eecceeeec--CCccc-cccCchHH
Q 019304 37 GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYS--VSVGQSVFR--PGKVT-HALNDDAL 110 (343)
Q Consensus 37 ~~~~~~~~~~~~~s~~~g~~s~s~~~ss~~s~~~~~~~~~~~~~~~~~-~~~s--~~~~~~~~~--~~~~~-~~~~~d~l 110 (343)
.+|+|++++|.+ ..|++++++.+...+.. ...+.||.++... +.+. ++ ....|. +..+. +..+.+++
T Consensus 103 ~~G~flvR~se~---~~g~yslsv~~~~~~~~---~~~v~hyri~~~~~~~~~~~~~-~~~~F~~l~~lv~~~~~~~~gl 175 (468)
T KOG0197|consen 103 KEGAFLVRESES---DKGDYSLSVREGDSGGL---GAKVKHYRIRQLDGGGLYPYID-ERELFSSLQQLVNYYSKNADGL 175 (468)
T ss_pred CccceeeecccC---CcCCeeEEEEeccccCC---ccceeeeeeeEcCCCCeecCCC-HHHhhhhHHHHHhhhhccCcch
Confidence 458899998865 78999999998887663 3367899999887 4354 54 334443 44554 48899999
Q ss_pred HHHHhcCCCC-----CCCCCC-CccceecccccccccccccccceEEEEEEECCc-eEEEEEeeCCCCChhHHHHHHHHH
Q 019304 111 AQALMDHRYP-----TEGLEN-YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQF 183 (343)
Q Consensus 111 ~~~l~~~~~~-----~~~~~~-~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~ 183 (343)
+..+..++.. +..... .+.|+++.+.+++++.||+|.||.||.|.|++. +||+|.++.....+ +.|
T Consensus 176 ~~~l~~p~~~~~~~~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~-------~~f 248 (468)
T KOG0197|consen 176 CTRLRDPCSKQGHTKPQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP-------EAF 248 (468)
T ss_pred hhcccCchhccCCCCCCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh-------hHH
Confidence 9999998863 122222 789999999999999999999999999999776 99999998765554 578
Q ss_pred HHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCC
Q 019304 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (343)
Q Consensus 184 ~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrD 263 (343)
.+|+.+|++|+|++||+++++|..+..+|||||||+.|+|.+||+...+..+.....+.++.|||+||+||+++++||||
T Consensus 249 ~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRD 328 (468)
T KOG0197|consen 249 LREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRD 328 (468)
T ss_pred HHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchh
Confidence 99999999999999999999999999999999999999999999986677799999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEeccccccccccCCCccCCCC---CcceecCCCCCCCCCCCCCCceeeeeeeccccccc
Q 019304 264 LKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG---TYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTW 334 (343)
Q Consensus 264 lkp~NILv~~~~~vkl~DFg~a~~~~~~~~~~~~~g---t~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~~~ 334 (343)
|.++||||+++..+||+|||+||...++ .++...| ...|.|||.+ .+.+|+.|||||+ +++++|
T Consensus 329 LAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~~~~kfPIkWtAPEa~-----~~~~FS~kSDVWS-FGVlL~ 395 (468)
T KOG0197|consen 329 LAARNILVDEDLVVKISDFGLARLIGDD-EYTASEGGKFPIKWTAPEAL-----NYGKFSSKSDVWS-FGVLLW 395 (468)
T ss_pred hhhhheeeccCceEEEcccccccccCCC-ceeecCCCCCCceecCHHHH-----hhCCcccccceee-hhhhHH
Confidence 9999999999999999999999955443 3333333 4899999999 9999999999995 444444
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=332.26 Aligned_cols=196 Identities=28% Similarity=0.426 Sum_probs=174.5
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
.+|.+.+.||.|+||+||+|++ ++..||||.+.+.....+. .+.+..|+.+|+.++|||||++++++..++.+|
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~----~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKL----VELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHH----HHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 5677888899999999999988 7789999999876654432 356789999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC------CcEEEecccccc
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD------KSIKIADFGVAR 286 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~------~~vkl~DFg~a~ 286 (343)
+|||||.||+|.+|+++++ .+++.++..++.|++.||++||+++||||||||.|||++.. -.+||+|||+||
T Consensus 86 lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999999998764 59999999999999999999999999999999999999864 468999999999
Q ss_pred ccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCccC
Q 019304 287 IEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRHI 341 (343)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~~ 341 (343)
.........+.||+|.|||||++ ..+.|+.|+|+|+.+. +++.+||-+.+
T Consensus 164 ~L~~~~~a~tlcGSplYMAPEV~-----~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 164 FLQPGSMAETLCGSPLYMAPEVI-----MSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hCCchhHHHHhhCCccccCHHHH-----HhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 98887777888999999999999 8999999999996333 55888886544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=332.05 Aligned_cols=204 Identities=41% Similarity=0.730 Sum_probs=181.0
Q ss_pred CCccceecccccccccccccccceEEEEEEECCce-EEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEE
Q 019304 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (343)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 204 (343)
...+|.++..++.+.+.||+|+||+||+|.|.|+. ||||++.......+. .+.|.+|+.+|.+++|||||+++|+
T Consensus 32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~----~~~f~~E~~il~~l~HpNIV~f~G~ 107 (362)
T KOG0192|consen 32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES----RKAFRREASLLSRLRHPNIVQFYGA 107 (362)
T ss_pred cccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH----HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 45678899999999999999999999999999998 999999877666543 5789999999999999999999999
Q ss_pred EEeCC-eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeCCCCCCcEEEcCCC-cEEEec
Q 019304 205 CRKRM-VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG-FIHRDLKSDNLLISADK-SIKIAD 281 (343)
Q Consensus 205 ~~~~~-~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~g-iiHrDlkp~NILv~~~~-~vkl~D 281 (343)
|.++. ..+||||||++|+|.+++.+.....+++..+++++.||++||+|||+++ ||||||||+||||+.+. ++||+|
T Consensus 108 ~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~D 187 (362)
T KOG0192|consen 108 CTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIAD 187 (362)
T ss_pred EcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECC
Confidence 99988 7899999999999999998754567999999999999999999999999 99999999999999997 999999
Q ss_pred cccccccccC-CCccCCCCCcceecCCCCCCCCCC--CCCCceeeeeeecccccccCCCCc
Q 019304 282 FGVARIEVQT-EGMTPETGTYRWMAPGNSFFSPLP--HPSFEHKWSAKESCLKTTWPPPWR 339 (343)
Q Consensus 282 Fg~a~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~--~~~~~~~sDi~~~~~~~~~~p~~~ 339 (343)
||+++..... ..++...||+.|||||++ . ...|+.|+||| ++++++|-...+
T Consensus 188 FGlsr~~~~~~~~~~~~~GT~~wMAPEv~-----~~~~~~~~~K~Dvy-SFgIvlWEl~t~ 242 (362)
T KOG0192|consen 188 FGLSREKVISKTSMTSVAGTYRWMAPEVL-----RGEKSPYTEKSDVY-SFGIVLWELLTG 242 (362)
T ss_pred CccceeeccccccccCCCCCccccChhhh-----cCCCCcCCccchhh-hHHHHHHHHHHC
Confidence 9999976654 345557899999999999 6 67999999999 666665543333
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=320.35 Aligned_cols=203 Identities=25% Similarity=0.330 Sum_probs=170.9
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHH-HHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKA-QVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 210 (343)
.+.|.+.+.||+|+||.|-+|.. +++.||||++++......+. ..-.....+|+++|++|+|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 45677889999999999999976 88999999998765443221 1112346799999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC---CcEEEeccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD---KSIKIADFGVARI 287 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~---~~vkl~DFg~a~~ 287 (343)
.|+||||++||.|.+++... ..+.+.....++.|++.|+.|||++||+||||||+|||+..+ ..+||+|||+|++
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred eEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999999999765 347788889999999999999999999999999999999866 6799999999999
Q ss_pred cccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc-----cccccCCCCcc
Q 019304 288 EVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC-----LKTTWPPPWRH 340 (343)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~-----~~~~~~p~~~~ 340 (343)
......+.+.||||.|.|||++... ....+..++|+|++. .+++||||-..
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~k--g~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~ 384 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASK--GVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE 384 (475)
T ss_pred cccceehhhhcCCccccChhheecC--CeecccchheeeeccceEEEEeccCCCcccc
Confidence 8877788999999999999999432 233344689999633 35589998654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=310.81 Aligned_cols=199 Identities=23% Similarity=0.369 Sum_probs=173.8
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
+..++|++++.||+|+||+||.++. +++.+|+|++++......+ ..+...+|..+|..++||.||+++..|++..
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~---e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~ 98 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKK---EVRHTKAERNILSKIKHPFIVKLIYSFQTEE 98 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhh---hHHHHHHHHHHHHhCCCCcEeeeEEecccCC
Confidence 3457889999999999999999976 7889999999875543321 1356789999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
.+|+|+||+.||.|..+|++. ..+++..+.-++++|+.||.|||++|||||||||+|||++.+|+++|+|||+|+...
T Consensus 99 kLylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred eEEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999999999764 459999999999999999999999999999999999999999999999999999644
Q ss_pred c-CCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 290 Q-TEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 290 ~-~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
. .....+.|||+.|||||++ ....|+..+|+|++.+ +++||||.+.
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil-----~~~gy~~~vDWWsLGillYeML~G~pPF~~~ 228 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEIL-----LGKGYDKAVDWWSLGILLYEMLTGKPPFYAE 228 (357)
T ss_pred cCCCccccccCCccccChHHH-----hcCCCCcccchHhHHHHHHHHhhCCCCCcCc
Confidence 3 3445567999999999999 8889999999996433 5699999654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=309.42 Aligned_cols=187 Identities=30% Similarity=0.414 Sum_probs=166.6
Q ss_pred eecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
.+...+++.++.||+|..|+||++.+ +++.+|+|++...... ...+++.+|+++++.++||+||++||+|..+
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~-----~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDP-----ALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCH-----HHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 35567788889999999999999998 6889999999443322 2347899999999999999999999999999
Q ss_pred C-eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 209 M-VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 209 ~-~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
. .++|+||||++|+|.+++... +.+++..+.+++.+|++||.|||+ ++||||||||+||||+..|.|||||||.++
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSG 227 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccH
Confidence 9 599999999999999999865 459999999999999999999995 899999999999999999999999999999
Q ss_pred ccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 287 IEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
....+ ...+.+||..|||||.+ ....|+.++|||++.+
T Consensus 228 ~lvnS-~a~tfvGT~~YMsPERi-----~g~~Ys~~sDIWSLGL 265 (364)
T KOG0581|consen 228 ILVNS-IANTFVGTSAYMSPERI-----SGESYSVKSDIWSLGL 265 (364)
T ss_pred Hhhhh-hcccccccccccChhhh-----cCCcCCcccceecccH
Confidence 87665 55778999999999999 8999999999996444
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=318.85 Aligned_cols=189 Identities=27% Similarity=0.394 Sum_probs=168.7
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|..++.||+|+|+.||+++. +|+.||+|++.+....... ..+.+.+|+++.++|+|||||++|++|++.+.+|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~---~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVY 94 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPK---QREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVY 94 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcc---hHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceE
Confidence 6799999999999999999987 8899999999875443322 2367889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~- 291 (343)
||+|+|+.++|..+++++ .++.+.+++.++.||+.||.|||+++|||||||..|++++++.+|||+|||+|......
T Consensus 95 ivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999999999999854 56999999999999999999999999999999999999999999999999999877644
Q ss_pred CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccccccc
Q 019304 292 EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTW 334 (343)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~~~ 334 (343)
+...+.||||.|+|||++ .....+..+|||+ .++++|
T Consensus 173 Erk~TlCGTPNYIAPEVl-----~k~gHsfEvDiWS-lGcvmY 209 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVL-----NKSGHSFEVDIWS-LGCVMY 209 (592)
T ss_pred cccceecCCCcccChhHh-----ccCCCCCchhhhh-hhhHHH
Confidence 666788999999999999 8999999999994 444433
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=293.23 Aligned_cols=200 Identities=24% Similarity=0.353 Sum_probs=176.3
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
....+|+..+.||.|+||+|.+++. +|.-+|+|++.+...-..+ ..+...+|..+|+.+.||.++++++.+.+..
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklK---QveH~~nEk~vL~~v~~PFlv~l~~t~~d~~ 117 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLK---QVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS 117 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHH---HHHHHhhHHHHHhhccCceeEEEEEeeccCC
Confidence 3457888999999999999999987 7788999999765443322 2356789999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
.+|+||||++||.|..++++.+ .+++..++-+|+||+.||+|||+.+|++|||||+|||+|.+|.+||+|||+|+...
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 9999999999999999998753 59999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCccCCC
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRHILI 343 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~~~~ 343 (343)
.. ..+.||||.|+|||.+ ..+.|..++|+|++.. +.+||||..+.+|
T Consensus 196 ~r--T~TlCGTPeYLAPEii-----~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~ 247 (355)
T KOG0616|consen 196 GR--TWTLCGTPEYLAPEII-----QSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI 247 (355)
T ss_pred Cc--EEEecCCccccChHHh-----hcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH
Confidence 43 5667999999999999 8999999999997444 5599999877653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=298.80 Aligned_cols=199 Identities=24% Similarity=0.387 Sum_probs=169.5
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEE-EEEeCC
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG-ACRKRM 209 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~-~~~~~~ 209 (343)
++.+|++.++||.|+||.||++.. +|..||.|.++-...+... .+.+..|+.+|++|+|||||++|+ .+.++.
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~----rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKA----RQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHH----HHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 457899999999999999999976 8999999999744444332 367899999999999999999998 454444
Q ss_pred -eEEEEEEecCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeCCCCCCcEEEcCCCcEEEecc
Q 019304 210 -VWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHG--LG--FIHRDLKSDNLLISADKSIKIADF 282 (343)
Q Consensus 210 -~~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~--~g--iiHrDlkp~NILv~~~~~vkl~DF 282 (343)
.++||||+++.|+|..+++. .+...+++..+|+++.|+|.||..+|+ .. |+||||||.||+++.+|.|||.||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 48999999999999999984 345679999999999999999999999 45 999999999999999999999999
Q ss_pred ccccccccCCC-ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 283 GVARIEVQTEG-MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 283 g~a~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
|+++....... ..+.+|||+||+||.+ ...+|+.|||||+..+ +...+||.++
T Consensus 173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i-----~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 173 GLGRFLSSKTTFAHSLVGTPYYMSPERI-----HESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred hhHhHhcchhHHHHhhcCCCcccCHHHH-----hcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 99998765433 4567999999999999 8999999999996333 3366777654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=303.59 Aligned_cols=192 Identities=26% Similarity=0.448 Sum_probs=166.9
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCC
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRM 209 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~ 209 (343)
..+.|.+++.||+|+||+|+.|.. +++.||+|++.+....... ....+.+.+|+.+++.++ ||||++++.++....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS-QKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc-cccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 457889999999999999999987 7899999988765322122 223356779999999998 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-CcEEEecccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARIE 288 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~-~~vkl~DFg~a~~~ 288 (343)
.+|+||||+.||.|.+++.. ...+.+..+.+++.|++.|++|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 99999999999999999987 3458889999999999999999999999999999999999998 99999999999987
Q ss_pred -ccCCCccCCCCCcceecCCCCCCCCCCCCC-Cc-eeeeeeecccccc
Q 019304 289 -VQTEGMTPETGTYRWMAPGNSFFSPLPHPS-FE-HKWSAKESCLKTT 333 (343)
Q Consensus 289 -~~~~~~~~~~gt~~y~APE~~~~~~~~~~~-~~-~~sDi~~~~~~~~ 333 (343)
.........|||+.|+|||++ .... |+ .++||| +|+++.
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl-----~~~~~Y~g~~aDvW-S~GViL 213 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVL-----SGKGTYSGKAADVW-SLGVIL 213 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHh-----CCCCCcCCchhhhh-hhHHHH
Confidence 456678888999999999999 5655 76 899999 565443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=301.41 Aligned_cols=202 Identities=24% Similarity=0.355 Sum_probs=173.7
Q ss_pred eecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
.+..++|++++.||+|+||.||+|+- +|..+|+|++++........ ...+..|-.+|....+|.||++|..|++.
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Q---v~hV~aERdiL~~~ds~~vVKLyYsFQD~ 213 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQ---VEHVRAERDILAEVDSPWVVKLYYSFQDK 213 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhh---HHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence 45678999999999999999999976 88999999998866544322 35678899999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
+.+||||||++||++..+|.+. ..+++.++..++.+++.|++-||+.|+|||||||+|+|||..|++||+|||+|.-.
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999999999865 46999999999999999999999999999999999999999999999999998521
Q ss_pred cc----------------------C--C-----C-------------------ccCCCCCcceecCCCCCCCCCCCCCCc
Q 019304 289 VQ----------------------T--E-----G-------------------MTPETGTYRWMAPGNSFFSPLPHPSFE 320 (343)
Q Consensus 289 ~~----------------------~--~-----~-------------------~~~~~gt~~y~APE~~~~~~~~~~~~~ 320 (343)
.. . . . ..+.+|||.|||||++ ....|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl-----l~kgY~ 366 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL-----LGKGYG 366 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH-----hcCCCC
Confidence 10 0 0 0 0124599999999999 788899
Q ss_pred eeeeeeeccc-----ccccCCCCccCC
Q 019304 321 HKWSAKESCL-----KTTWPPPWRHIL 342 (343)
Q Consensus 321 ~~sDi~~~~~-----~~~~~p~~~~~~ 342 (343)
..+|+|++.+ ++|||||.+++|
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp 393 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSETP 393 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999997444 459999988876
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=310.58 Aligned_cols=270 Identities=25% Similarity=0.437 Sum_probs=219.4
Q ss_pred CCCCCCcccccccCCCCeEEEEeecCCCCCCCcccccccCCCCCcCC-Ccceeecceeeec--CCccc-cccCchHHHHH
Q 019304 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVT-HALNDDALAQA 113 (343)
Q Consensus 38 ~~~~~~~~~~~~s~~~g~~s~s~~~ss~~s~~~~~~~~~~~~~~~~~-~~~s~~~~~~~~~--~~~~~-~~~~~d~l~~~ 113 (343)
.|+|++++|++ ..|-+|+|++..- -+.||+|.... +..+++ ..+.|+ .+.|. |+.-.|+|...
T Consensus 173 nGSFLVRESEs---SpgQ~sISlRyeG---------RVyHYRINt~~dgK~yvt-~EsrF~TLaELVHHHStvADGLitt 239 (1157)
T KOG4278|consen 173 NGSFLVRESES---SPGQYSISLRYEG---------RVYHYRINTDNDGKMYVT-QESRFRTLAELVHHHSTVADGLITT 239 (1157)
T ss_pred ccceEEeeccC---CCcceeEEEEecc---------eEEEEEeeccCCccEEEe-ehhhhhHHHHHHhhccccccceeEe
Confidence 45666666654 4566677766421 35789988776 556665 445554 44554 47788899888
Q ss_pred HhcCCCCCC------CCCCCccceecccccccccccccccceEEEEEEEC--CceEEEEEeeCCCCChhHHHHHHHHHHH
Q 019304 114 LMDHRYPTE------GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQ 185 (343)
Q Consensus 114 l~~~~~~~~------~~~~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~ 185 (343)
|..+..... -....|+|+++..++.+..+||-|.||.||.|.|. ...||||.++...+. .++|+.
T Consensus 240 LhYPApK~nKptvygvSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-------veEFLk 312 (1157)
T KOG4278|consen 240 LHYPAPKKNKPTVYGVSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLK 312 (1157)
T ss_pred eeccCccCCCCceeeecCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-------HHHHHH
Confidence 876543211 22356999999999999999999999999999994 457999999765543 368999
Q ss_pred HHHHHhcCCCCCcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Q 019304 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (343)
Q Consensus 186 E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlk 265 (343)
|+.+|+.++|||+|+|+|+|..+..+|||+|||..|+|.+||++.....++.-.++.|+.||..||+||..+++|||||.
T Consensus 313 EAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLA 392 (1157)
T KOG4278|consen 313 EAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLA 392 (1157)
T ss_pred HHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhh
Confidence 99999999999999999999999999999999999999999998777778888999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeccccccccccCCCccCCCCC---cceecCCCCCCCCCCCCCCceeeeeeeccccccc
Q 019304 266 SDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTW 334 (343)
Q Consensus 266 p~NILv~~~~~vkl~DFg~a~~~~~~~~~~~~~gt---~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~~~ 334 (343)
++|+||.++..|||+|||++|++..+ .++...|. ..|.|||-+ .+..|+.|+|||. +++..|
T Consensus 393 ARNCLVgEnhiVKvADFGLsRlMtgD-TYTAHAGAKFPIKWTAPEsL-----AyNtFSiKSDVWA-FGVLLW 457 (1157)
T KOG4278|consen 393 ARNCLVGENHIVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESL-----AYNTFSIKSDVWA-FGVLLW 457 (1157)
T ss_pred hhhccccccceEEeeccchhhhhcCC-ceecccCccCcccccCcccc-----cccccccchhhHH-HHHHHH
Confidence 99999999999999999999987543 45555554 799999999 9999999999994 444433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=299.08 Aligned_cols=197 Identities=24% Similarity=0.336 Sum_probs=170.9
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM 209 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 209 (343)
...+|.+++.||+|+|.+|++|+. +++.+|||++.+...-.++. .+-+.+|-..|.+| .||.|++||..|++..
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~K---vkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~ 147 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKK---VKYVTREKEALTQLSGHPGIVKLYFTFQDEE 147 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcc---cchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence 457899999999999999999987 78899999997655444333 24567889999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
.+|+|+||+++|.|.+++++. +.+++..++.++++|+.||+|||++|||||||||+|||++.++++||+|||.|+++.
T Consensus 148 sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999999999876 459999999999999999999999999999999999999999999999999998764
Q ss_pred cCCCc--------------cCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 290 QTEGM--------------TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 290 ~~~~~--------------~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
..... .+++||..|++||++ ..+..+..+|+|++.+ +.|-|||.+
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL-----~~~~~~~~sDiWAlGCilyQmlaG~PPFra 289 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELL-----NDSPAGPSSDLWALGCILYQMLAGQPPFRA 289 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHh-----cCCCCCcccchHHHHHHHHHHhcCCCCCcc
Confidence 32211 457899999999999 8899999999997544 336777754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=280.21 Aligned_cols=184 Identities=27% Similarity=0.394 Sum_probs=162.8
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
+.|+.+.++|+|++|+||+|++ +|+.||||++...+.++. ..+-.++|+++|++++|||+|.++++|.....++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~----VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklh 77 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPV----VKKIALREIRMLKQLKHENLVNLIEVFRRKRKLH 77 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHH----HHHHHHHHHHHHHhcccchHHHHHHHHHhcceeE
Confidence 3566778899999999999987 889999999977665443 3466789999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc-cC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QT 291 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~-~~ 291 (343)
+|+||++. ++.+-|.+.. ..++.+.+.+++.|++.|+.|+|++++|||||||+||||+.+|.+||||||+||... ++
T Consensus 78 LVFE~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 78 LVFEYCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred EEeeecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 99999987 6666666543 458999999999999999999999999999999999999999999999999999877 66
Q ss_pred CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeec
Q 019304 292 EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES 328 (343)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~ 328 (343)
+.++..+.|..|.|||.+. ....|...+|||+.
T Consensus 156 d~YTDYVATRWYRaPELLv----GDtqYG~pVDiWAi 188 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLV----GDTQYGKPVDIWAI 188 (396)
T ss_pred chhhhhhhhhhccChhhhc----ccCcCCCcccchhh
Confidence 6788889999999999995 45889999999963
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=293.13 Aligned_cols=187 Identities=29% Similarity=0.530 Sum_probs=160.2
Q ss_pred cccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-eEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-VWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~ 212 (343)
++|.-...||+|+||.||+|.. +++.||||.+....... .++|.+|+.++.+++|||+|+++|+|.+.. ..+
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~------~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~ 148 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG------EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRL 148 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc------hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEE
Confidence 5666667899999999999999 55899999876544321 246999999999999999999999999988 599
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG---FIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~g---iiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
+|+|||++|+|.++|......+++|..+++||.++|+||+|||... ||||||||+|||+|++.++||+|||+|+...
T Consensus 149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP 228 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence 9999999999999998654327899999999999999999999853 9999999999999999999999999997655
Q ss_pred c-CCCccCC-CCCcceecCCCCCCCCCCCCCCceeeeeeeccccc
Q 019304 290 Q-TEGMTPE-TGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKT 332 (343)
Q Consensus 290 ~-~~~~~~~-~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~ 332 (343)
. ....... .||..|+|||++ ..+..+.|+|||++..+.
T Consensus 229 ~~~~~~~~~~~gt~gY~~PEy~-----~~g~lt~KsDVySFGVvl 268 (361)
T KOG1187|consen 229 EGDTSVSTTVMGTFGYLAPEYA-----STGKLTEKSDVYSFGVVL 268 (361)
T ss_pred ccccceeeecCCCCccCChhhh-----ccCCcCcccccccchHHH
Confidence 4 3222223 899999999999 789999999999766543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=296.01 Aligned_cols=195 Identities=26% Similarity=0.407 Sum_probs=171.5
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
...|..-++||+|+.|.||.+.. +++.||||.+........ +-+.+|+.+|+..+|+|||.+++.+...+.+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k------eLilnEi~Vm~~~~H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK------ELLLNEILVMRDLHHPNIVNFLDSYLVGDEL 345 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch------hhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence 45677778999999999999976 778899999987665543 5689999999999999999999999988999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++|||||+||+|.+.+... .+++..+..|+++++.||+|||.+||||||||.+|||++.+|.+||+|||+|......
T Consensus 346 WVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred EEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 9999999999999999764 3899999999999999999999999999999999999999999999999998865544
Q ss_pred C-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecccc-----cccCCCCccCC
Q 019304 292 E-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLK-----TTWPPPWRHIL 342 (343)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~-----~~~~p~~~~~~ 342 (343)
. ...+.+|||+|||||++ ....|..|+|||++.++ .+-||++..-|
T Consensus 423 ~~KR~TmVGTPYWMAPEVv-----trk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P 474 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVV-----TRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP 474 (550)
T ss_pred cCccccccCCCCccchhhh-----hhcccCccccchhhhhHHHHHhcCCCCccCCCh
Confidence 3 44567899999999999 99999999999975553 37888876544
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=299.06 Aligned_cols=196 Identities=30% Similarity=0.469 Sum_probs=177.0
Q ss_pred CCccceecccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
.-+.|+|+++.+.-++-||+|+.|.||+|++.++.||||.++. .-..++.-|++|+|||||.+.|+|
T Consensus 115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~e-------------lkETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRE-------------LKETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred hhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhh-------------hhhhhHHHHHhccCcceeeEeeee
Confidence 4578999999999999999999999999999999999998742 223678889999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
.....+|||||||..|.|...|+.. ..+.......+..+||.||.|||.+.|||||||.-||||..+..|||+|||.+
T Consensus 182 tqsPcyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 182 TQSPCYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred cCCceeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccch
Confidence 9999999999999999999999764 45888999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecccccccCCCCccCC
Q 019304 286 RIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTWPPPWRHIL 342 (343)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~~~~p~~~~~~ 342 (343)
+....-..+-+++||..|||||++ ...+.+.|+||| +++++.|-.-.+.||
T Consensus 260 ~e~~~~STkMSFaGTVaWMAPEvI-----rnePcsEKVDIw-SfGVVLWEmLT~EiP 310 (904)
T KOG4721|consen 260 KELSDKSTKMSFAGTVAWMAPEVI-----RNEPCSEKVDIW-SFGVVLWEMLTGEIP 310 (904)
T ss_pred HhhhhhhhhhhhhhhHhhhCHHHh-----hcCCccccccee-hhHHHHHHHHhcCCC
Confidence 876655555678999999999999 999999999999 788888876666665
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=292.89 Aligned_cols=202 Identities=27% Similarity=0.468 Sum_probs=169.6
Q ss_pred CCccceecccccccccccccccceEEEEEEE--C-C--ce-EEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcc
Q 019304 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--N-G--ED-VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199 (343)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~-~--~~-vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv 199 (343)
....|++.-++..+.++||+|+||.||+|+. . + .. ||||..+..... ......+|.+|+++|++++|||||
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~---~~~~~~e~m~EArvMr~l~H~NVV 224 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSEL---TKEQIKEFMKEARVMRQLNHPNVV 224 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccc---cHHHHHHHHHHHHHHHhCCCCCEE
Confidence 3467999999999999999999999999987 2 2 23 899988752211 223357899999999999999999
Q ss_pred eEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEE
Q 019304 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (343)
Q Consensus 200 ~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl 279 (343)
++||++....++++|||+|.||+|.++|++... .++..+.+.++.+.+.||+|||++++|||||.++|+|++.++.+||
T Consensus 225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEe
Confidence 999999999999999999999999999987653 6999999999999999999999999999999999999999999999
Q ss_pred eccccccccccCCCccCC-CCCcceecCCCCCCCCCCCCCCceeeeeeecccccccCCC
Q 019304 280 ADFGVARIEVQTEGMTPE-TGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTWPPP 337 (343)
Q Consensus 280 ~DFg~a~~~~~~~~~~~~-~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~~~~p~ 337 (343)
+|||+++........... .-...|+|||.+ ....|+.++||| +++++.|--|
T Consensus 304 SDFGLs~~~~~~~~~~~~~klPirWLAPEtl-----~~~~~s~kTDV~-sfGV~~~Eif 356 (474)
T KOG0194|consen 304 SDFGLSRAGSQYVMKKFLKKLPIRWLAPETL-----NTGIFSFKTDVW-SFGVLLWEIF 356 (474)
T ss_pred CccccccCCcceeeccccccCcceecChhhh-----ccCccccccchh-heeeeEEeee
Confidence 999999865422222212 245899999999 788999999999 5565555433
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=281.11 Aligned_cols=195 Identities=24% Similarity=0.366 Sum_probs=170.6
Q ss_pred ccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
.+|-++.+.|++.+.||.|..+.||+|+. .++.||||++....-+. ....+.+|+..|+.++||||++++.+|
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~-----~ld~l~kE~~~msl~~HPNIv~~~~sF 93 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN-----DLDALRKEVQTMSLIDHPNIVTYHCSF 93 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh-----hHHHHHHHHHHhhhcCCCCcceEEEEE
Confidence 45777889999999999999999999987 77899999997644333 246789999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
..+..+|+||.||.+|++.++++..-...+++..+..|++++++||.|||++|.||||||+.||||+.+|.|||+|||.+
T Consensus 94 vv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvs 173 (516)
T KOG0582|consen 94 VVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVS 173 (516)
T ss_pred EecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceee
Confidence 99999999999999999999999877777999999999999999999999999999999999999999999999999987
Q ss_pred cccccCC-C----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 286 RIEVQTE-G----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 286 ~~~~~~~-~----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
..+.... . ....+|||+|||||++.. ....|+.|+|||++.+
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q---~~~GYdfKaDIwSfGI 220 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQ---QLHGYDFKADIWSFGI 220 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhhh---cccCccchhhhhhhhH
Confidence 6443322 1 145589999999999632 6788999999996443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=292.21 Aligned_cols=186 Identities=28% Similarity=0.372 Sum_probs=168.4
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCC-
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRM- 209 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~- 209 (343)
.++|++.++||.|.||.||+|+. ++..||||.+++....-+.. .-+||+..|++|. |||||++.+++.+.+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-----~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-----MNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-----HHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 47899999999999999999987 78899999998776654322 3469999999998 999999999999988
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
.+|+|||||+. +|+++++.+ +..+++..+..|+.||++||+|+|.+|+.||||||+||||.....+||+|||+||...
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 99999999964 999999887 7889999999999999999999999999999999999999999999999999999888
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
....++..+.|..|.|||+++ ....|+.+.|+|++.+
T Consensus 162 SkpPYTeYVSTRWYRAPEvLL----rs~~Ys~pvD~wA~Gc 198 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLL----RSGYYSSPVDMWAVGC 198 (538)
T ss_pred cCCCcchhhhcccccchHHhh----hccccCCchHHHHHHH
Confidence 878888899999999999996 7788999999996443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=296.31 Aligned_cols=192 Identities=25% Similarity=0.444 Sum_probs=171.0
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
.-|++++.||.|+-|.|-+|++ +|+.+|||++.+.....+.. ...+.+|+-+|+.+.|||++++|++|.....+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~---~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQ---PAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeecccccccccc---ccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence 4466789999999999999998 89999999997764332222 256889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+|.||+++|.|.+++-++ +++++.++.+++.||+.|+.|||..+|+||||||+|+|++..+.+||+|||+|.+...+.
T Consensus 89 lvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred EEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 999999999999999765 459999999999999999999999999999999999999999999999999999888887
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCc-eeeeeeeccccc------ccCCC
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFE-HKWSAKESCLKT------TWPPP 337 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~-~~sDi~~~~~~~------~~~p~ 337 (343)
...+.||+|.|.|||++ .+.+|. .++||| +|+++ +.+||
T Consensus 167 lLeTSCGSPHYA~PEIV-----~G~pYdG~~sDVW-SCGVILfALLtG~LPF 212 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIV-----SGRPYDGRPSDVW-SCGVILFALLTGKLPF 212 (786)
T ss_pred cccccCCCcccCCchhh-----cCCCCCCCccccc-hhHHHHHHHHhCCCCC
Confidence 88888999999999999 788887 899999 66654 55665
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=276.28 Aligned_cols=194 Identities=28% Similarity=0.516 Sum_probs=159.7
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--e
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--V 210 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~ 210 (343)
.++..++.||+|+||.||++.. +|+..|||.+....... .+.+.+|+.+|.+++|||||+++|...... .
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~------~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT------SESLEREIRILSRLNHPNIVQYYGSSSSRENDE 90 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh------HHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence 4567789999999999999988 47899999987652111 356889999999999999999999754444 6
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-CCcEEEeccccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFGVARIEV 289 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~-~~~vkl~DFg~a~~~~ 289 (343)
++++|||+++|+|.+++.+.++ .+++..+..+++||++||+|||++|+|||||||+||||+. ++.+||+|||+++...
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 8999999999999999988765 7999999999999999999999999999999999999999 7999999999998655
Q ss_pred c----CCCccCCCCCcceecCCCCCCCCCCCCC-Cceeeeeeeccccc--ccC--CCCcc
Q 019304 290 Q----TEGMTPETGTYRWMAPGNSFFSPLPHPS-FEHKWSAKESCLKT--TWP--PPWRH 340 (343)
Q Consensus 290 ~----~~~~~~~~gt~~y~APE~~~~~~~~~~~-~~~~sDi~~~~~~~--~~~--p~~~~ 340 (343)
. ........||+.|||||++ ..+. ...++|||+++.++ +++ |||..
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi-----~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVI-----RNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred cccccccccccccCCccccCchhh-----cCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 2 1223456899999999999 5432 23599999754422 333 66654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=285.11 Aligned_cols=189 Identities=22% Similarity=0.301 Sum_probs=164.0
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR-- 208 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-- 208 (343)
....|+.+++||+|.||.||+|+. +|+.||+|.+.......+. ..-..+|+.+|++|.||||++|.+...+.
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~----~~t~~REI~ILr~l~HpNIikL~eivt~~~~ 190 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGF----PITAIREIKILRRLDHPNIIKLEEIVTSKLS 190 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcc----hHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence 456788899999999999999988 8889999999866544432 23467999999999999999999999887
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
..+|+|+|||+. +|.-++... .-.+++..+..++.|++.||+|||.+||+|||||.+|||||.+|.+||+|||+|++.
T Consensus 191 ~siYlVFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 191 GSIYLVFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred ceEEEEEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 689999999987 888888653 345899999999999999999999999999999999999999999999999999976
Q ss_pred ccCC--CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccccc
Q 019304 289 VQTE--GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKT 332 (343)
Q Consensus 289 ~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~ 332 (343)
.... .++..+-|..|.|||.++ ....|+.++|+| +++++
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLL----G~t~Yg~aVDlW-S~GCI 309 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLL----GATSYGTAVDLW-SVGCI 309 (560)
T ss_pred cCCCCcccccceEEeeccChHHhc----CCcccccceeeh-hhhHH
Confidence 5433 477888999999999996 678899999999 55544
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=281.36 Aligned_cols=198 Identities=21% Similarity=0.370 Sum_probs=177.6
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
..+|++.+.||+|.||+|-++.. .|+.||||.+++.....++. .-.+.+|+++|..|+||||+++|.+|...+.+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqD---lvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQD---LVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHH---HHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 46889999999999999999975 78999999998776655433 24678999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
.|||||..+|.|++|+.+++ .+++.++..+++||++|+.|||.++++|||||.+|||+|.++.+||+|||++-+..+.
T Consensus 129 vivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 99999999999999998764 4999999999999999999999999999999999999999999999999999988888
Q ss_pred CCccCCCCCcceecCCCCCCCCCCCCCCc-eeeeeeecccccccCCCCccCC
Q 019304 292 EGMTPETGTYRWMAPGNSFFSPLPHPSFE-HKWSAKESCLKTTWPPPWRHIL 342 (343)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~-~~sDi~~~~~~~~~~p~~~~~~ 342 (343)
....++||+|.|.+||++ ++.+|. +.+|.| ++++..|+...+.+|
T Consensus 207 kfLqTFCGSPLYASPEIv-----NG~PY~GPEVDsW-sLGvLLYtLVyGtMP 252 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIV-----NGTPYKGPEVDSW-SLGVLLYTLVYGTMP 252 (668)
T ss_pred cHHHHhcCCcccCCcccc-----CCCCCCCCccchh-hHHHHHHHHhhcccc
Confidence 888899999999999999 666666 789999 777777777666665
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=290.37 Aligned_cols=193 Identities=27% Similarity=0.466 Sum_probs=170.0
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|.+.+.||+|+||.||+|+. +.+.||+|.+.+....... .+.+.+|+++++.++|||||.++++|+....++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~----l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~ 77 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKE----LKNLRQEVRILRSLKHPNIVEMLESFETSAHLW 77 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHH----HHHHHHHHHHHHhcCCcchhhHHHhhcccceEE
Confidence 5677889999999999999987 6678999999876655432 367899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+|+||+.| +|..++.. .+.++++.+..++.+++.||.|||+.+|+|||+||.|||++..+++|+||||+||.+....
T Consensus 78 vVte~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 78 VVTEYAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred EEehhhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 99999987 99999975 4569999999999999999999999999999999999999999999999999999876544
Q ss_pred C-ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 293 G-MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 293 ~-~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
. .++..|||.|||||.. ..+.|+..+|+|+... .++.|||..
T Consensus 155 ~vltsikGtPlYmAPElv-----~e~pyd~~sDlWslGcilYE~~~G~PPF~a 202 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELV-----EEQPYDHTSDLWSLGCILYELYVGQPPFYA 202 (808)
T ss_pred eeeeeccCcccccCHHHH-----cCCCccchhhHHHHHHHHHHHhcCCCCchH
Confidence 3 4566899999999999 8999999999996332 447788864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=265.03 Aligned_cols=201 Identities=24% Similarity=0.358 Sum_probs=176.4
Q ss_pred ccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
..|.+ ++|++++.||+|-||.||.|+. ++..||+|++.+..... ...++++.+|+++...|+||||+++|++|
T Consensus 17 ~~~~l--~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~---~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 17 KTWTL--DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK---TQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred cccch--hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH---hcchhhhhheeEeecccCCccHHhhhhhe
Confidence 45554 7899999999999999999987 56689999997654322 23457899999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
.+...+|+++||..+|+|+..|.......+++.....+..|+|.||.|+|.+++|||||||+|+|++..+.+||+|||-+
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGws 171 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWS 171 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCce
Confidence 99999999999999999999999777778999999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 286 RIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
...+ .....+.|||..|.|||.. .....+.++|+|+... +++.|||=+
T Consensus 172 V~~p-~~kR~tlcgt~dyl~pEmv-----~~~~hd~~Vd~w~lgvl~yeflvg~ppFes 224 (281)
T KOG0580|consen 172 VHAP-SNKRKTLCGTLDYLPPEMV-----EGRGHDKFVDLWSLGVLCYEFLVGLPPFES 224 (281)
T ss_pred eecC-CCCceeeecccccCCHhhc-----CCCCccchhhHHHHHHHHHHHHhcCCchhh
Confidence 7654 3455677999999999999 8999999999996333 557888743
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=281.47 Aligned_cols=206 Identities=27% Similarity=0.374 Sum_probs=165.0
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHH--------HHHHHHHHHHHHHHhcCCCCCcceE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKA--------QVMEQQFQQEVMMLATLKHLNIVRF 201 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~l 201 (343)
...++|++++.||+|.||.|-+|.. +++.||||++.+........ ..-.++..+|+.+|++|+|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 4568999999999999999999988 78899999997654332111 0113578999999999999999999
Q ss_pred EEEEEeC--CeEEEEEEecCCCCHHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEE
Q 019304 202 IGACRKR--MVWCIVTEYAKGGSVRQFLTRRQNRA-VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278 (343)
Q Consensus 202 ~~~~~~~--~~~~iv~E~~~~gsL~~~l~~~~~~~-~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vk 278 (343)
+++..+. +.+|||+|||..|.+... ....+ +.+.++++++++++.||+|||.+|||||||||+|+||+.+|+||
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence 9999775 479999999998877543 23344 88999999999999999999999999999999999999999999
Q ss_pred EeccccccccccC------CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeee-----cccccccCCCCccC
Q 019304 279 IADFGVARIEVQT------EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKE-----SCLKTTWPPPWRHI 341 (343)
Q Consensus 279 l~DFg~a~~~~~~------~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~-----~~~~~~~~p~~~~~ 341 (343)
|+|||.+....++ ......+|||.|+|||...... .......+.|||+ +|++.+-.||+++.
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~-~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGN-SFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCC-CccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 9999998755222 1233468999999999984320 1233447889996 67777888887754
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=280.97 Aligned_cols=197 Identities=26% Similarity=0.434 Sum_probs=175.0
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCe
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMV 210 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~ 210 (343)
...|++++.||+|.||.||+++. +|+.+|+|++.+....... ....+.+|+.+|+++. |||||.+++++.+...
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~---~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE---DREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc---cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 35788889999999999999988 6889999999876654432 2357889999999998 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC----CcEEEecccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD----KSIKIADFGVAR 286 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~----~~vkl~DFg~a~ 286 (343)
+++|||+++||.|.+.+.+. .+++..+..++.|++.+++|||+.|++||||||+|+|+... +.+|++|||++.
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999999876 29999999999999999999999999999999999999633 479999999999
Q ss_pred ccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeee-----cccccccCCCCccC
Q 019304 287 IEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKE-----SCLKTTWPPPWRHI 341 (343)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~-----~~~~~~~~p~~~~~ 341 (343)
...........+||+.|+|||++ ....|+..+|+|+ +.++++++|||+..
T Consensus 188 ~~~~~~~~~~~~Gtp~y~APEvl-----~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 188 FIKPGERLHTIVGTPEYVAPEVL-----GGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred EccCCceEeeecCCccccCchhh-----cCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 87775567788999999999999 7799999999996 44467999999875
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=292.41 Aligned_cols=199 Identities=23% Similarity=0.324 Sum_probs=168.6
Q ss_pred ceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 206 (343)
..+...+|.+.+.||+|+||+|+++.. +++.+|||++++...-..+. .+....|.+++... +||.+++++.+|+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~---Ve~~~~EkrI~~la~~HPFL~~L~~~fQ 439 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDE---VESLMCEKRIFELANRHPFLVNLFSCFQ 439 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecccc---HHHHHHHHHHHHHhccCCeEeecccccc
Confidence 356678999999999999999999988 66789999998765433222 24567888887777 5999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
.++++|+||||+.||++..+.+ ...+++..+.-+++.|+.||.|||++||||||||.+|||+|.+|++||+|||+++
T Consensus 440 T~~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 440 TKEHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred cCCeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999999999554443 3459999999999999999999999999999999999999999999999999999
Q ss_pred ccc-cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 287 IEV-QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 287 ~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
... .+...++.||||.|||||++ ....|+..+|+|++.. +++-.||-+
T Consensus 517 e~m~~g~~TsTfCGTpey~aPEil-----~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g 570 (694)
T KOG0694|consen 517 EGMGQGDRTSTFCGTPEFLAPEVL-----TEQSYTRAVDWWGLGVLLYEMLVGESPFPG 570 (694)
T ss_pred ccCCCCCccccccCChhhcChhhh-----ccCcccchhhHHHHHHHHHHHHcCCCCCCC
Confidence 644 44566788999999999999 8999999999995333 345666643
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=270.97 Aligned_cols=195 Identities=20% Similarity=0.242 Sum_probs=163.9
Q ss_pred cccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 019304 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv 214 (343)
|+..+.||+|+||.||++.. +++.||||.+........ .....+.+|+.+++.++|++|+++++++.+.+.+++|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhh---hhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence 56678999999999999987 688999999865432211 1234678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCc
Q 019304 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (343)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~ 294 (343)
|||+++++|.+++.......+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++........
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV 158 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence 99999999998887654456899999999999999999999999999999999999999999999999999865444344
Q ss_pred cCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 295 TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 295 ~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
....||+.|+|||++ ....++.++|||++.. +++.+||.+
T Consensus 159 ~~~~g~~~y~aPE~~-----~~~~~~~~~DvwslGvil~el~~g~~pf~~ 203 (285)
T cd05631 159 RGRVGTVGYMAPEVI-----NNEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203 (285)
T ss_pred cCCCCCCCccCHhhh-----cCCCCCcccCchhHHHHHHHHHhCCCCCCC
Confidence 556899999999999 7888999999996333 335566543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=287.79 Aligned_cols=195 Identities=32% Similarity=0.630 Sum_probs=171.7
Q ss_pred CccceecccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 127 ~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
.++|+|+.+++.+++.||+|.||+||+|.|.| +||||+++.....+++ .+.|.+|+.++++-+|.||+-+.|+|.
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~q----lqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQ----LQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHH----HHHHHHHHHHHhhcchhhheeeehhhc
Confidence 37899999999999999999999999999976 5799999988777764 478999999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
.+.. .||+-||+|.+|+.+++-.. ..+.....++||+||++||.|||.++|||||||..||++.++++|||.|||++.
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred CCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEeccccee
Confidence 8876 89999999999999998543 458999999999999999999999999999999999999999999999999987
Q ss_pred cccc---CCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 287 IEVQ---TEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 287 ~~~~---~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.... ........|...|||||++.-+ ...+|+..+|||++..
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmq--d~nPfS~qSDVYaFGi 581 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQ--DDNPFSFQSDVYAFGI 581 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhc--ccCCCCcccchhhhhH
Confidence 5432 2234555788999999999433 5788999999995443
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=282.03 Aligned_cols=196 Identities=20% Similarity=0.327 Sum_probs=163.4
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||++.. +++.||||++.+..... ......+.+|+.++..++||+|+++++.+.+...+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~ 77 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLE---KEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLY 77 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH---hhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEE
Confidence 3677889999999999999987 67899999997532211 122356888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+||||+++|+|.+++.+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 78 lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999999999764 458999999999999999999999999999999999999999999999999987532210
Q ss_pred ------------------------------------CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----c
Q 019304 293 ------------------------------------GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----K 331 (343)
Q Consensus 293 ------------------------------------~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~ 331 (343)
.....+||+.|+|||++ ....++.++|+|++++ +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~-----~~~~~~~~~DvwSlGvil~ell 230 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVF-----MQTGYNKLCDWWSLGVIMYEML 230 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHH-----cCCCCCCchhhhhhHHHHHHHH
Confidence 01235799999999999 7788999999996433 3
Q ss_pred cccCCCCcc
Q 019304 332 TTWPPPWRH 340 (343)
Q Consensus 332 ~~~~p~~~~ 340 (343)
++.+||.+.
T Consensus 231 ~G~~Pf~~~ 239 (363)
T cd05628 231 IGYPPFCSE 239 (363)
T ss_pred hCCCCCCCC
Confidence 466776543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=257.71 Aligned_cols=183 Identities=26% Similarity=0.375 Sum_probs=159.5
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
.+|...+.||+|.||.||+|++ +|+.||||.++......- ......+|+..|+.++|+||+.++++|.....+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG----i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~ 77 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG----INRTALREIKLLQELKHPNIIELIDVFPHKSNLS 77 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC----ccHHHHHHHHHHHHccCcchhhhhhhccCCCceE
Confidence 4677788999999999999988 789999999987643321 1135689999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+|+|||+. +|...++.. ...+....+..++.++++|++|||++.|+||||||.|+||+++|.+||+|||+|+......
T Consensus 78 lVfEfm~t-dLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 78 LVFEFMPT-DLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred EEEEeccc-cHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 99999976 899888754 4568889999999999999999999999999999999999999999999999999876443
Q ss_pred -CccCCCCCcceecCCCCCCCCCCCCCCceeeeeee
Q 019304 293 -GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKE 327 (343)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~ 327 (343)
..+..+-|..|.|||.+. ..+.|...+|+|+
T Consensus 156 ~~~~~~V~TRWYRAPELLf----Gsr~Yg~~VDmWa 187 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLF----GSRQYGTGVDMWA 187 (318)
T ss_pred cccccceeeeeccChHHhc----cchhcCCcchhhh
Confidence 344457899999999985 6788999999996
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=296.58 Aligned_cols=201 Identities=29% Similarity=0.474 Sum_probs=171.6
Q ss_pred CCccceecccccccccccccccceEEEEEEEC-------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCc
Q 019304 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198 (343)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI 198 (343)
.....+++..+..+.+.||+|+||+||+|... .+-||||.++...... ..++|.+|++++..++||||
T Consensus 477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~-----~~~dF~REaeLla~l~H~nI 551 (774)
T KOG1026|consen 477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQ-----ARQDFRREAELLAELQHPNI 551 (774)
T ss_pred ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHH-----HHHHHHHHHHHHHhccCCCe
Confidence 34567888999999999999999999999762 2469999997644332 34789999999999999999
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhC--------CCC----CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCC
Q 019304 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------NRA----VPLKLAVKQALDVARGMAYVHGLGFIHRDLKS 266 (343)
Q Consensus 199 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------~~~----~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp 266 (343)
|+++|+|.+.+++|+|+|||..|+|.+||.... +.+ ++..+.+.||.|||.||.||-++.++||||.+
T Consensus 552 VrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLAT 631 (774)
T KOG1026|consen 552 VRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLAT 631 (774)
T ss_pred EEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhh
Confidence 999999999999999999999999999998642 122 77889999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeccccccccccCCCccCC---CCCcceecCCCCCCCCCCCCCCceeeeeeecccccccCCC
Q 019304 267 DNLLISADKSIKIADFGVARIEVQTEGMTPE---TGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTWPPP 337 (343)
Q Consensus 267 ~NILv~~~~~vkl~DFg~a~~~~~~~~~~~~---~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~~~~p~ 337 (343)
+|+||.++-.|||+|||++|-.-..+-+... .-..+|||||.| .+++|+.+|||| ++++++|--|
T Consensus 632 RNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsI-----ly~kFTteSDVW-s~GVvLWEIF 699 (774)
T KOG1026|consen 632 RNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESI-----LYGKFTTESDVW-SFGVVLWEIF 699 (774)
T ss_pred hhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHh-----hcCcccchhhhh-hhhhhhhhhh
Confidence 9999999999999999999964443333322 234899999999 899999999999 7888888655
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=276.80 Aligned_cols=201 Identities=24% Similarity=0.336 Sum_probs=168.5
Q ss_pred ccceecccccccccccccccceEEEEEEEC---CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 204 (343)
..+.+..++|++.+.||+|+||.||+|.+. +..||+|++....... ....+.+.+|+.+++.++||||++++++
T Consensus 23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~Iv~~~~~ 99 (340)
T PTZ00426 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK---QKQVDHVFSERKILNYINHPFCVNLYGS 99 (340)
T ss_pred cCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhh---hhhHHHHHHHHHHHHhCCCCCCcceEEE
Confidence 445667789999999999999999999862 2579999986432211 1123568899999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccc
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~ 284 (343)
+.+...+++||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~~~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~ 177 (340)
T PTZ00426 100 FKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGF 177 (340)
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCC
Confidence 99999999999999999999999764 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 285 ARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
++.... .....+||+.|+|||++ ....++.++|+|+++. +++.+||++.
T Consensus 178 a~~~~~--~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 231 (340)
T PTZ00426 178 AKVVDT--RTYTLCGTPEYIAPEIL-----LNVGHGKAADWWTLGIFIYEILVGCPPFYAN 231 (340)
T ss_pred CeecCC--CcceecCChhhcCHHHH-----hCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence 986533 23445899999999999 6778899999996443 3366677654
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=279.85 Aligned_cols=194 Identities=22% Similarity=0.298 Sum_probs=161.1
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||+|+||.||++.. +++.||||++.+..... ....+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l 78 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFK---KDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL 78 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHH---hHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence 577889999999999999987 77899999986532211 1223568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~- 292 (343)
||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 79 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 79 IMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999999999999754 458899999999999999999999999999999999999999999999999986321100
Q ss_pred -----------------------------------------------CccCCCCCcceecCCCCCCCCCCCCCCceeeee
Q 019304 293 -----------------------------------------------GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSA 325 (343)
Q Consensus 293 -----------------------------------------------~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi 325 (343)
.....+||+.|+|||++ .+..++.++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di 231 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF-----LQQGYGQECDW 231 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHH-----ccCCCCCceee
Confidence 00124699999999999 77889999999
Q ss_pred eeccc-----ccccCCCCc
Q 019304 326 KESCL-----KTTWPPPWR 339 (343)
Q Consensus 326 ~~~~~-----~~~~~p~~~ 339 (343)
|++++ +++++||.+
T Consensus 232 wSlGvil~elltG~~Pf~~ 250 (377)
T cd05629 232 WSLGAIMFECLIGWPPFCS 250 (377)
T ss_pred EecchhhhhhhcCCCCCCC
Confidence 96443 346677644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=275.92 Aligned_cols=195 Identities=25% Similarity=0.349 Sum_probs=165.3
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 210 (343)
...+|++.+.||+|+||.||+|++ +++.||||++....... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK---MKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR 92 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence 347889999999999999999988 67899999997532211 1123568899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~ 290 (343)
+|+||||+++++|.+++.+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999999999764 3588999999999999999999999999999999999999999999999999986533
Q ss_pred CCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 291 TEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 291 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
. ....+||+.|+|||++ ....++.++|+|+++. +++.+||.+
T Consensus 171 ~--~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~elltg~~pf~~ 217 (329)
T PTZ00263 171 R--TFTLCGTPEYLAPEVI-----QSKGHGKAVDWWTMGVLLYEFIAGYPPFFD 217 (329)
T ss_pred C--cceecCChhhcCHHHH-----cCCCCCCcceeechHHHHHHHHcCCCCCCC
Confidence 2 2345799999999999 7788899999996433 346666654
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=278.38 Aligned_cols=195 Identities=22% Similarity=0.308 Sum_probs=162.0
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||+|.. +++.||||++....... ......+.+|+.+++.++||||+++++++.+...+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 77 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLE---KEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLY 77 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEE
Confidence 3678889999999999999988 67899999997532211 112356789999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 78 lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999999999999764 358999999999999999999999999999999999999999999999999986432110
Q ss_pred ---------------------------------------CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc---
Q 019304 293 ---------------------------------------GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL--- 330 (343)
Q Consensus 293 ---------------------------------------~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~--- 330 (343)
.....+||+.|+|||++ ....++.++|+|++++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG~il~ 230 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVF-----LQTGYNKECDWWSLGVIMY 230 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHH-----cCCCCCCeeeeecchhHHH
Confidence 01124699999999999 7788999999996443
Q ss_pred --ccccCCCCc
Q 019304 331 --KTTWPPPWR 339 (343)
Q Consensus 331 --~~~~~p~~~ 339 (343)
+++.+||.+
T Consensus 231 el~~G~~Pf~~ 241 (364)
T cd05599 231 EMLVGYPPFCS 241 (364)
T ss_pred HhhcCCCCCCC
Confidence 335666543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=273.31 Aligned_cols=184 Identities=24% Similarity=0.337 Sum_probs=158.9
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||+|.+ +++.||||++....... ....+.+.+|+.+++.++||||+++++++......|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~ 77 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK---LNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLY 77 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhh---hhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEE
Confidence 3678889999999999999988 57899999997532211 112356889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 78 lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999999999754 3588999999999999999999999999999999999999999999999999975433
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.....+||+.|+|||++ ....++.++|||+++.
T Consensus 154 ~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~ 186 (333)
T cd05600 154 YANSVVGSPDYMAPEVL-----RGKGYDFTVDYWSLGC 186 (333)
T ss_pred ccCCcccCccccChhHh-----cCCCCCCccceecchH
Confidence 33456799999999999 7778999999996443
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=271.70 Aligned_cols=179 Identities=24% Similarity=0.332 Sum_probs=152.9
Q ss_pred cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEec
Q 019304 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~ 218 (343)
+.||+|+||.||++.. +++.||||++.+..... ......+.+|+.+++.++||||+++++++.....+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIA---KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCC
Confidence 3689999999999987 67899999997532211 112356789999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc-CCCccCC
Q 019304 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPE 297 (343)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~-~~~~~~~ 297 (343)
++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......
T Consensus 78 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 155 (323)
T cd05571 78 NGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence 999999998754 4589999999999999999999999999999999999999999999999999875322 2233446
Q ss_pred CCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 298 TGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 298 ~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+||+.|+|||++ ....++.++|+|+++
T Consensus 156 ~gt~~y~aPE~~-----~~~~~~~~~DiwSlG 182 (323)
T cd05571 156 CGTPEYLAPEVL-----EDNDYGRAVDWWGLG 182 (323)
T ss_pred ecCccccChhhh-----cCCCCCccccCcccc
Confidence 799999999999 778899999999543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=276.04 Aligned_cols=191 Identities=27% Similarity=0.503 Sum_probs=157.5
Q ss_pred cceecccccccccccccccceEEEEEEE-------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcce
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVR 200 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~ 200 (343)
.|+++.++|++.+.||+|+||.||+|.+ .++.||||++....... ..+.+.+|+.+++.+ +||||++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~niv~ 75 (338)
T cd05102 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATAS-----EHKALMSELKILIHIGNHLNVVN 75 (338)
T ss_pred CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchH-----HHHHHHHHHHHHHHhccCcceee
Confidence 4889999999999999999999999974 23579999986533221 125688999999999 8999999
Q ss_pred EEEEEEeC-CeEEEEEEecCCCCHHHHHHhhC------------------------------------------------
Q 019304 201 FIGACRKR-MVWCIVTEYAKGGSVRQFLTRRQ------------------------------------------------ 231 (343)
Q Consensus 201 l~~~~~~~-~~~~iv~E~~~~gsL~~~l~~~~------------------------------------------------ 231 (343)
+++++... ..+++||||+++|+|.+++....
T Consensus 76 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (338)
T cd05102 76 LLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSG 155 (338)
T ss_pred EEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCc
Confidence 99988764 45899999999999999997532
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCC---ccC
Q 019304 232 ------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTP 296 (343)
Q Consensus 232 ------------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~ 296 (343)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....... ...
T Consensus 156 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 235 (338)
T cd05102 156 STNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235 (338)
T ss_pred ccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccC
Confidence 12367788899999999999999999999999999999999999999999999985432211 122
Q ss_pred CCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 297 ETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 297 ~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
..+++.|+|||++ ....++.++|||++.
T Consensus 236 ~~~~~~y~aPE~~-----~~~~~~~~sDiwslG 263 (338)
T cd05102 236 ARLPLKWMAPESI-----FDKVYTTQSDVWSFG 263 (338)
T ss_pred CCCCccccCcHHh-----hcCCCCcccCHHHHH
Confidence 3456889999999 778899999999643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=277.73 Aligned_cols=185 Identities=23% Similarity=0.271 Sum_probs=155.3
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||+|+||.||+++. +++.||||++....... ....+.+.+|+.+++.++||||+++++.+.+.+.+|+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLM---RNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHh---hhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence 578889999999999999987 67899999986432111 1123568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC--
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-- 291 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~-- 291 (343)
||||+++|+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 79 v~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 79 VMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999999999764 35888999999999999999999999999999999999999999999999997422100
Q ss_pred ------------------------------------------CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 292 ------------------------------------------EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 292 ------------------------------------------~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
......+||+.|+|||++ ....++.++|||+++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG 231 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL-----LRTGYTQLCDWWSVG 231 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHH-----cCCCCCcceeeeecc
Confidence 001134799999999999 778899999999643
Q ss_pred c
Q 019304 330 L 330 (343)
Q Consensus 330 ~ 330 (343)
+
T Consensus 232 v 232 (376)
T cd05598 232 V 232 (376)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=278.40 Aligned_cols=194 Identities=24% Similarity=0.285 Sum_probs=160.8
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
.|++.+.||+|+||.||+|.. +++.||+|++...... .....+.+.+|+.+++.++||||+++++.+.+...+|+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~---~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~l 78 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL---LRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 78 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh---hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEE
Confidence 477889999999999999987 6788999998653221 11223578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC--
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-- 291 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~-- 291 (343)
||||+++|+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 v~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 79 VMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999999999764 35889999999999999999999999999999999999999999999999997522100
Q ss_pred ----------------------------------------------CCccCCCCCcceecCCCCCCCCCCCCCCceeeee
Q 019304 292 ----------------------------------------------EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSA 325 (343)
Q Consensus 292 ----------------------------------------------~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi 325 (343)
......+||+.|+|||++ ....++.++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-----~~~~~~~~~Di 231 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL-----LRTGYTQLCDW 231 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHh-----cCCCCCCeeeE
Confidence 001234799999999999 77889999999
Q ss_pred eeccc-----ccccCCCCc
Q 019304 326 KESCL-----KTTWPPPWR 339 (343)
Q Consensus 326 ~~~~~-----~~~~~p~~~ 339 (343)
|++++ +++.+||.+
T Consensus 232 wSlGvil~elltG~~Pf~~ 250 (382)
T cd05625 232 WSVGVILYEMLVGQPPFLA 250 (382)
T ss_pred EechHHHHHHHhCCCCCCC
Confidence 96443 336677654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=277.89 Aligned_cols=194 Identities=24% Similarity=0.285 Sum_probs=161.4
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
.|++++.||+|+||+||+|+. +++.||||++........ ...+.+.+|+.+++.++||||+++++++.+...+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~---~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 78 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNR---NQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhh---HHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEE
Confidence 477889999999999999987 678999999975332211 223578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~- 292 (343)
||||+++|+|.+++.+. ..+++..+..++.|++.||+|||+.||+||||||+||||+.++++||+|||+++......
T Consensus 79 v~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 79 VMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999999999764 358899999999999999999999999999999999999999999999999875321000
Q ss_pred -----------------------------------------------CccCCCCCcceecCCCCCCCCCCCCCCceeeee
Q 019304 293 -----------------------------------------------GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSA 325 (343)
Q Consensus 293 -----------------------------------------------~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi 325 (343)
.....+||+.|+|||++ ....++.++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-----~~~~~~~~~Di 231 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL-----LRKGYTQLCDW 231 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHH-----cCCCCCCccce
Confidence 01234799999999999 77889999999
Q ss_pred eeccc-----ccccCCCCc
Q 019304 326 KESCL-----KTTWPPPWR 339 (343)
Q Consensus 326 ~~~~~-----~~~~~p~~~ 339 (343)
|++++ +++.+||..
T Consensus 232 wSlG~il~elltG~~Pf~~ 250 (381)
T cd05626 232 WSVGVILFEMLVGQPPFLA 250 (381)
T ss_pred eehhhHHHHHHhCCCCCcC
Confidence 96443 346677754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=273.36 Aligned_cols=194 Identities=21% Similarity=0.316 Sum_probs=161.3
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||+|+||.||++.. +++.||||++....... ......+.+|+.++..++||+|+++++.+.+...+|+
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 78 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLE---KEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL 78 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhh---hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 577889999999999999987 67899999997432111 1223568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~- 292 (343)
||||+++++|.+++.+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 79 v~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 79 IMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999999999999754 358999999999999999999999999999999999999999999999999986432110
Q ss_pred -----------------------------------CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----cc
Q 019304 293 -----------------------------------GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KT 332 (343)
Q Consensus 293 -----------------------------------~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~ 332 (343)
.....+||+.|+|||++ ....++.++|+|++++ ++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~-----~~~~~~~~~DiwSlGvilyel~t 231 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVF-----MQTGYNKLCDWWSLGVIMYEMLI 231 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHH-----cCCCCCCcceeccccceeeeccc
Confidence 01234799999999999 7888999999996433 33
Q ss_pred ccCCCCc
Q 019304 333 TWPPPWR 339 (343)
Q Consensus 333 ~~~p~~~ 339 (343)
+.+||.+
T Consensus 232 G~~Pf~~ 238 (360)
T cd05627 232 GYPPFCS 238 (360)
T ss_pred CCCCCCC
Confidence 6666644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=266.78 Aligned_cols=188 Identities=26% Similarity=0.361 Sum_probs=156.5
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM---- 209 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---- 209 (343)
.|.-.+.+|.|+||.||+|.. +++.||||..-....-. .+|+.+|+.+.|||||++.-+|....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----------NRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----------cHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 455668899999999999987 66899999886544322 38999999999999999988885432
Q ss_pred -eEEEEEEecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-CcEEEeccccc
Q 019304 210 -VWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVA 285 (343)
Q Consensus 210 -~~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~-~~vkl~DFg~a 285 (343)
...+|||||+. +|+++++.. .+..++...+.-+..|+++||.|||+.||+||||||.|+|||.+ |.+||||||.|
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 45789999975 999999742 34558888889999999999999999999999999999999965 99999999999
Q ss_pred cccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccccc------ccCCCCc
Q 019304 286 RIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKT------TWPPPWR 339 (343)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~------~~~p~~~ 339 (343)
+.....+...+..-|..|.|||.+. ....|+.+.|||+ ++++ +.|.|-|
T Consensus 174 K~L~~~epniSYicSRyYRaPELif----ga~~Yt~~IDiWS-aGCV~aELl~g~plFpG 228 (364)
T KOG0658|consen 174 KVLVKGEPNISYICSRYYRAPELIF----GATEYTTSIDIWS-AGCVMAELLKGQPLFPG 228 (364)
T ss_pred eeeccCCCceeEEEeccccCHHHHc----CccccCceeEEhh-hhHHHHHHhcCCcccCC
Confidence 9988877777777899999999996 6788999999995 4433 5555543
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=276.58 Aligned_cols=204 Identities=21% Similarity=0.272 Sum_probs=165.2
Q ss_pred ceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 207 (343)
..+..++|++.+.||+|+||.||++.. +++.+|+|++.+...... ...+.+.+|+.+++.++||||+++++++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKR---SDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 345567899999999999999999988 578899999864322111 123467899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
...+|+||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 99999999999999999998643 488899999999999999999999999999999999999999999999999986
Q ss_pred cccCCC--ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 288 EVQTEG--MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 288 ~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
...... ....+||+.|+|||++...+ ....++.++|+|+++. +++.+||.+.
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQG-GDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccC-CCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 543222 23457999999999983210 1134789999996443 3466777543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=269.86 Aligned_cols=192 Identities=21% Similarity=0.309 Sum_probs=162.2
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||+|+||.||+|.. +++.||+|++........ ...+.+.+|+.+++.++||||+++++++.+...+++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 78 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRL---KQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM 78 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhh---HHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence 577889999999999999988 588999999975332211 123568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCC
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~ 293 (343)
||||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++.... .
T Consensus 79 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~--~ 154 (291)
T cd05612 79 LMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--R 154 (291)
T ss_pred EEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC--C
Confidence 99999999999999764 3588999999999999999999999999999999999999999999999999986533 2
Q ss_pred ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 294 MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 294 ~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
....+||+.|+|||++ ....++.++|||+++. +++.+||.+
T Consensus 155 ~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG~il~~l~~g~~pf~~ 200 (291)
T cd05612 155 TWTLCGTPEYLAPEVI-----QSKGHNKAVDWWALGILIYEMLVGYPPFFD 200 (291)
T ss_pred cccccCChhhcCHHHH-----cCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2345799999999999 7778899999996433 335556543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=287.13 Aligned_cols=193 Identities=27% Similarity=0.473 Sum_probs=168.8
Q ss_pred ceecccccccccccccccceEEEEEEE--CC---ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEE
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NG---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 204 (343)
.+||...+++.+.||.|.||+|++|+. .+ ..||||.++....... ..+|+.|+.||.++.||||++|.|+
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytekq-----rrdFL~EAsIMGQFdHPNIIrLEGV 698 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQ-----RRDFLSEASIMGQFDHPNIIRLEGV 698 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHH-----HhhhhhhhhhcccCCCCcEEEEEEE
Confidence 368888999999999999999999987 34 4699999976443322 3689999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccc
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~ 284 (343)
.....++.||+|||++|+|+.||+.+.+ .+...++..|++.|+.||+||-+.|++||||.++||||+.+-.+|++|||+
T Consensus 699 VTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 699 VTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred EecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccc
Confidence 9999999999999999999999998764 488899999999999999999999999999999999999999999999999
Q ss_pred ccccccCC--CccCCCC--CcceecCCCCCCCCCCCCCCceeeeeeeccccccc
Q 019304 285 ARIEVQTE--GMTPETG--TYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTW 334 (343)
Q Consensus 285 a~~~~~~~--~~~~~~g--t~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~~~ 334 (343)
+|+..++. .+++.-| ..+|.|||.+ .+.+|+.+|||| ++++++|
T Consensus 778 SRvledd~~~~ytt~GGKIPiRWTAPEAI-----a~RKFTsASDVW-SyGIVmW 825 (996)
T KOG0196|consen 778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAI-----AYRKFTSASDVW-SYGIVMW 825 (996)
T ss_pred eeecccCCCccccccCCccceeecChhHh-----hhcccCchhhcc-ccceEEE
Confidence 99875543 2333333 3799999999 999999999999 6666665
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=268.78 Aligned_cols=189 Identities=22% Similarity=0.312 Sum_probs=158.0
Q ss_pred cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEec
Q 019304 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~ 218 (343)
+.||+|+||.||++.. +++.||||++.+...... .....+.+|+.+++.++||||+++++++...+.+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAK---DEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCC
Confidence 3689999999999987 678999999975432211 12356789999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc-CCCccCC
Q 019304 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPE 297 (343)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~-~~~~~~~ 297 (343)
++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......
T Consensus 78 ~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 155 (328)
T cd05593 78 NGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF 155 (328)
T ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence 999999888653 3589999999999999999999999999999999999999999999999999875322 2233445
Q ss_pred CCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 298 TGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 298 ~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
+||+.|+|||++ ....++.++|+|+++. +++.+||+.
T Consensus 156 ~gt~~y~aPE~~-----~~~~~~~~~DiwslGvil~elltG~~Pf~~ 197 (328)
T cd05593 156 CGTPEYLAPEVL-----EDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (328)
T ss_pred cCCcCccChhhh-----cCCCCCccCCccccchHHHHHhhCCCCCCC
Confidence 799999999999 7788999999996433 335566643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=279.00 Aligned_cols=188 Identities=27% Similarity=0.389 Sum_probs=162.0
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
+.|..++.||.|+||.||-+++ +.+.||||.+.-........+ ++++.|+.+|++++|||+|.+-||+......|
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKW---qDIlKEVrFL~~l~HPntieYkgCyLre~TaW 102 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW---QDILKEVRFLRQLRHPNTIEYKGCYLREHTAW 102 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHH---HHHHHHHHHHHhccCCCcccccceeeccchHH
Confidence 4466678999999999999987 778999999976554443222 68999999999999999999999999988889
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+|||||- |+-.+++.-. ..++.+.++..|+.+.+.||+|||+.+.||||||+.|||+++.|.|||+|||.|.+..+
T Consensus 103 LVMEYCl-GSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 103 LVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHHHHHh-ccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 9999995 5888888643 35689999999999999999999999999999999999999999999999999987544
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccccc
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKT 332 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~ 332 (343)
..+++|||+|||||+++.. ..+.|+.|+|||++.+.+
T Consensus 179 -AnsFvGTPywMAPEVILAM--DEGqYdgkvDvWSLGITC 215 (948)
T KOG0577|consen 179 -ANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITC 215 (948)
T ss_pred -hhcccCCccccchhHheec--cccccCCccceeeccchh
Confidence 4568999999999999654 789999999999655543
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=269.35 Aligned_cols=188 Identities=23% Similarity=0.317 Sum_probs=156.8
Q ss_pred cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEec
Q 019304 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~ 218 (343)
+.||+|+||.||++.. +++.||+|++....... ......+.+|+.+++.++||||+++++++.....+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA---KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCC
Confidence 3689999999999987 67899999997532211 112356778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc-CCCccCC
Q 019304 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPE 297 (343)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~-~~~~~~~ 297 (343)
++++|..++... ..+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.... .......
T Consensus 78 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 155 (323)
T cd05595 78 NGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence 999999888654 3589999999999999999999999999999999999999999999999999875322 2233445
Q ss_pred CCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 298 TGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 298 ~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
+||+.|+|||++ ....++.++|+|+++. +++.+||.
T Consensus 156 ~gt~~y~aPE~~-----~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 196 (323)
T cd05595 156 CGTPEYLAPEVL-----EDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred cCCcCcCCcccc-----cCCCCCchhchhhhHHHHHHHHhCCCCCC
Confidence 799999999999 7788999999996433 23555654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=272.45 Aligned_cols=184 Identities=26% Similarity=0.382 Sum_probs=158.9
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||+|+||.||+|.. +++.||||++....... ......+.+|+.++..++||||+++++++.+...+++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK---RNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL 78 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh---ccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence 678889999999999999998 58899999997532211 1123568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~- 292 (343)
||||+++++|.+++.+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 79 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 79 VMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 99999999999999765 458999999999999999999999999999999999999999999999999997654332
Q ss_pred -----------------------------CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 293 -----------------------------GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 293 -----------------------------~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
......||+.|+|||++ ....++.++|||+++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG 217 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL-----RGTPYGLECDWWSLG 217 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHH-----cCCCCCCceeeEecc
Confidence 12345799999999999 777899999999543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=260.00 Aligned_cols=195 Identities=24% Similarity=0.381 Sum_probs=168.2
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|.|+.|+++.. +|+.+|+|++......... .+.+.+|+++-+.|+||||+++.+...+....|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~----~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcccc----HHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 5788889999999999999977 8899999998765544432 367889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc---CCCcEEEeccccccccc
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS---ADKSIKIADFGVARIEV 289 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~---~~~~vkl~DFg~a~~~~ 289 (343)
+|+|+|+|+.|..-+-.+ ..+++..+-..++||+.+|.|+|.+||||||+||.|+|+- ...-+||+|||+|....
T Consensus 87 lvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999999997766554 4478888889999999999999999999999999999995 34569999999998777
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeee-----cccccccCCCCcc
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKE-----SCLKTTWPPPWRH 340 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~-----~~~~~~~~p~~~~ 340 (343)
.........|||.|||||++ ...+|+..+|||+ +.++.+|||||+.
T Consensus 165 ~g~~~~G~~GtP~fmaPEvv-----rkdpy~kpvDiW~cGViLfiLL~G~~PF~~~ 215 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVL-----KKDPYSKPVDIWACGVILYILLVGYPPFWDE 215 (355)
T ss_pred CccccccccCCCcccCHHHh-----hcCCCCCcchhhhhhHHHHHHHhCCCCCCCc
Confidence 55555667899999999999 8999999999994 3335599999983
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=273.85 Aligned_cols=206 Identities=21% Similarity=0.269 Sum_probs=167.2
Q ss_pred ccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
.++.+..++|++.+.||+|+||.||++.. +++.||+|++.+...... .....+.+|+.+++.++||||+++++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~il~~~~h~~iv~~~~~~ 112 (370)
T cd05596 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKR---SDSAFFWEERDIMAHANSEWIVQLHYAF 112 (370)
T ss_pred ccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh---hhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 34556778999999999999999999987 678999999964322111 1124577899999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
.+...+++||||+++|+|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~ 189 (370)
T cd05596 113 QDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (370)
T ss_pred ecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccce
Confidence 9999999999999999999998653 4788999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC--ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 286 RIEVQTEG--MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 286 ~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
+....... ....+||+.|+|||++...+ ....++.++|+|+++. +++.+||.+.
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 190 MKMDANGMVRCDTAVGTPDYISPEVLKSQG-GDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred eeccCCCcccCCCCCCCcCeECHHHhccCC-CCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 76543221 23457999999999983211 1345889999996433 3466777654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=273.93 Aligned_cols=206 Identities=21% Similarity=0.275 Sum_probs=166.8
Q ss_pred ccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
.++.+..++|++.+.||+|+||.||++.+ +++.+|+|++.+...... ...+.+.+|+.+++.++||||+++++++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~---~~~~~~~~e~~i~~~~~hp~iv~~~~~~ 112 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR---SDSAFFWEERDIMAFANSPWVVQLFYAF 112 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhh---HHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34556678999999999999999999988 678899999864322111 1234578899999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
.....+++||||+++++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 113 QDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 9999999999999999999998653 3888999999999999999999999999999999999999999999999999
Q ss_pred cccccCC--CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 286 RIEVQTE--GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 286 ~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
+...... .....+||+.|+|||++.... ....++.++|+|+++. +++.+||.+.
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQG-GDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccC-CCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 8654322 123457999999999983210 1234889999996443 3366777543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=266.16 Aligned_cols=179 Identities=24% Similarity=0.327 Sum_probs=151.9
Q ss_pred cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEec
Q 019304 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~ 218 (343)
+.||+|+||.||++.. +++.||+|++........ .....+.+|+.+++.++||||+++++++.....+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK---DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 3689999999999987 778999999975332211 12346778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEEEeccccccccc-cCCCccC
Q 019304 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QTEGMTP 296 (343)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~-~~~~~~~ 296 (343)
++++|..++... ..+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++... .......
T Consensus 78 ~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 78 NGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence 999999988654 358999999999999999999997 799999999999999999999999999987532 2223344
Q ss_pred CCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 297 ETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 297 ~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.+||+.|+|||++ ....++.++|+|+++
T Consensus 156 ~~gt~~y~aPE~~-----~~~~~~~~~DiwslG 183 (325)
T cd05594 156 FCGTPEYLAPEVL-----EDNDYGRAVDWWGLG 183 (325)
T ss_pred ccCCcccCCHHHH-----ccCCCCCcccccccc
Confidence 5799999999999 778899999999543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=259.51 Aligned_cols=185 Identities=26% Similarity=0.418 Sum_probs=158.2
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCC-cceEEEEEEeCC-
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN-IVRFIGACRKRM- 209 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~- 209 (343)
...|+..++||+|.||+||+|+. +|+.||+|.+....... - ......+|+.+++.++|+| |+++++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E-G---~P~taiREisllk~L~~~~~iv~L~dv~~~~~~ 85 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE-G---VPSTAIREISLLKRLSHANHIVRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc-C---CCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence 45677788899999999999987 88999999997654420 0 1134579999999999999 999999998877
Q ss_pred -----eEEEEEEecCCCCHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 019304 210 -----VWCIVTEYAKGGSVRQFLTRRQN--RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (343)
Q Consensus 210 -----~~~iv~E~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DF 282 (343)
.+++|+||++. +|..++..... ..++...+..++.|++.||+|||+++|+||||||.||||+++|.+||+||
T Consensus 86 ~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeecc
Confidence 89999999965 99999986543 35777899999999999999999999999999999999999999999999
Q ss_pred ccccccc-cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeee
Q 019304 283 GVARIEV-QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKE 327 (343)
Q Consensus 283 g~a~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~ 327 (343)
|+|+... +...++..++|..|.|||+++ ....|+..+|||+
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaPEvLl----Gs~~Ys~~vDiWs 206 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAPEVLL----GSTSYSTSVDIWS 206 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCHHHhc----CCCcCCCCcchHh
Confidence 9999655 334577889999999999995 3456999999995
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=265.83 Aligned_cols=187 Identities=20% Similarity=0.273 Sum_probs=156.7
Q ss_pred cccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEecCC
Q 019304 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (343)
Q Consensus 143 lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~~~ 220 (343)
||+|+||.||++.. +++.||+|++.+..... ......+.+|+.+++.++||||+++++++......++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVS---RSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCC
Confidence 69999999999988 57789999987532211 11235678999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc-CCCccCCCC
Q 019304 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPETG 299 (343)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~-~~~~~~~~g 299 (343)
++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+|
T Consensus 78 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 155 (312)
T cd05585 78 GELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG 155 (312)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence 9999999764 3589999999999999999999999999999999999999999999999999985332 222344579
Q ss_pred CcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 300 TYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 300 t~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
|+.|+|||++ ....++.++|+|+++. +++.+||.+
T Consensus 156 t~~y~aPE~~-----~~~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 156 TPEYLAPELL-----LGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred CcccCCHHHH-----cCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence 9999999999 7788999999996443 335666643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=255.84 Aligned_cols=201 Identities=23% Similarity=0.374 Sum_probs=173.5
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCC--CChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCe
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPE--NNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMV 210 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 210 (343)
.|.-.+.||.|..+.|-++.. +++++|+|++.... ...+....+.+.-.+|+.+|+++ -||+|+++.++++.+..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 344456799999999999976 78899999986433 23334556667889999999998 69999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~ 290 (343)
+++|+|.|+.|.|.++|... -.++++...+|++|++.|++|||.++|+||||||+|||++++.++||+|||+|....+
T Consensus 98 ~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 99999999999999999764 4589999999999999999999999999999999999999999999999999998888
Q ss_pred CCCccCCCCCcceecCCCCCC-CCCCCCCCceeeeeeeccccc------ccCCCCc
Q 019304 291 TEGMTPETGTYRWMAPGNSFF-SPLPHPSFEHKWSAKESCLKT------TWPPPWR 339 (343)
Q Consensus 291 ~~~~~~~~gt~~y~APE~~~~-~~~~~~~~~~~sDi~~~~~~~------~~~p~~~ 339 (343)
++.....||||.|+|||.+.. --..+..|+..+|+| .|+++ +-||||-
T Consensus 176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~W-a~GVImyTLLaGcpPFwH 230 (411)
T KOG0599|consen 176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEW-ACGVIMYTLLAGCPPFWH 230 (411)
T ss_pred chhHHHhcCCCcccChhheeeecccCCCCccchhhHH-HHHHHHHHHHcCCCchhH
Confidence 888888999999999999833 233788999999999 67665 4567774
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=262.85 Aligned_cols=201 Identities=20% Similarity=0.278 Sum_probs=171.6
Q ss_pred eecccccccccccccccceEEEEEEECC--ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNG--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
.+.++.|++++.||+|.-|.||++...+ ..+|+|++.+...... ....+...|.+||+.+.||.++.||..++.+
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~r---kKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASR---KKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhh---hHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 4677899999999999999999999854 7899999987655432 2346788999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
...|+|||||+||+|...++++....+++..+.-++++|+.||+|||-.|||+|||||+||||.++|++.|+||+++...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999986321
Q ss_pred c----------------------------------c-C----------------------CCccCCCCCcceecCCCCCC
Q 019304 289 V----------------------------------Q-T----------------------EGMTPETGTYRWMAPGNSFF 311 (343)
Q Consensus 289 ~----------------------------------~-~----------------------~~~~~~~gt~~y~APE~~~~ 311 (343)
. . . ....+.+||..|+|||++
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI-- 307 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI-- 307 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee--
Confidence 0 0 0 011235699999999999
Q ss_pred CCCCCCCCceeeeeeeccccc-----ccCCCCc
Q 019304 312 SPLPHPSFEHKWSAKESCLKT-----TWPPPWR 339 (343)
Q Consensus 312 ~~~~~~~~~~~sDi~~~~~~~-----~~~p~~~ 339 (343)
.+..-+.++|+|.+.+.+ +-+||-+
T Consensus 308 ---~G~GHgsAVDWWtfGIflYEmLyG~TPFKG 337 (459)
T KOG0610|consen 308 ---RGEGHGSAVDWWTFGIFLYEMLYGTTPFKG 337 (459)
T ss_pred ---ecCCCCchhhHHHHHHHHHHHHhCCCCcCC
Confidence 899999999999644432 5566644
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=275.74 Aligned_cols=195 Identities=30% Similarity=0.479 Sum_probs=167.4
Q ss_pred eecccccccccccccccceEEEEEEECC-ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNG-EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
+++...+.+.++||+|.||.|.+|...+ ..||||.++....... .++|.+|+.+|.+|+||||++++|+|..++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~-----r~~F~kEIkiLsqLkhPNIveLvGVC~~De 608 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNA-----RNDFLKEIKILSRLKHPNIVELLGVCVQDD 608 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhH-----HHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence 5677888999999999999999998866 8999999976544332 478999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
++++|+|||++|+|.+|+.+............+||.||++||+||.+.+++||||.++|+|++.++++||+|||++|-.-
T Consensus 609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccc
Confidence 99999999999999999987644334556678899999999999999999999999999999999999999999999543
Q ss_pred cCCCccC---CCCCcceecCCCCCCCCCCCCCCceeeeeeecccccccCC
Q 019304 290 QTEGMTP---ETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTWPP 336 (343)
Q Consensus 290 ~~~~~~~---~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~~~~p 336 (343)
..+.+.. .+-..+|||||.+ ..++|+.+||+| ..++++|--
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsi-----llgkFttaSDvW-afgvTlwE~ 732 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESI-----LLGKFTTASDVW-AFGVTLWEV 732 (807)
T ss_pred cCCceeeecceeeeeeehhHHHH-----Hhccccchhhhh-hhHHHHHHH
Confidence 3332222 2446899999999 899999999999 666776643
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=272.33 Aligned_cols=187 Identities=24% Similarity=0.362 Sum_probs=167.8
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe-E
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV-W 211 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~ 211 (343)
++|..++.+|+|+||.++.+++ +++.+++|.+.......... +...+|+.++++++|||||.+++.|.+++. .
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r----~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l 79 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER----RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLL 79 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh----HHHHHHHHHHHhccCCCeeeeccchhcCCceE
Confidence 5788899999999999998876 66789999997665544322 367899999999999999999999999988 9
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
+|||+|++||+|.+.+.+.++..++++.+++++.|++.|+.|||+..|+|||||+.||+++.++.|||.|||+|+.....
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999999999887788999999999999999999999999999999999999999999999999999988776
Q ss_pred C-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 292 E-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
. ...+.+|||.||.||.+ ...+|..|+|||++.+
T Consensus 160 ~~~a~tvvGTp~YmcPEil-----~d~pYn~KSDiWsLGC 194 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEIL-----SDIPYNEKSDIWSLGC 194 (426)
T ss_pred hhhhheecCCCcccCHHHh-----CCCCCCccCcchhhcc
Confidence 5 55677999999999999 9999999999996433
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=266.75 Aligned_cols=200 Identities=21% Similarity=0.270 Sum_probs=161.4
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||++.. +++.||||++.+.... .....+.+.+|+.+++.++|+||+++++++.+...+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 77 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML---KRAETACFREERDVLVNGDRRWITNLHYAFQDENNLY 77 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh---hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEE
Confidence 3678899999999999999987 6789999999642211 1112356889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+||||+++++|.+++.+. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 78 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999999753 3458899999999999999999999999999999999999999999999999987543322
Q ss_pred C--ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 293 G--MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 293 ~--~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
. ....+||+.|+|||++.........++.++|+|++++ +++.+||.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 2 2234699999999998321112456889999996433 23555653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=260.40 Aligned_cols=185 Identities=22% Similarity=0.272 Sum_probs=158.9
Q ss_pred cccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 019304 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv 214 (343)
|++.+.||+|+||.||++.. +++.||||++....... ......+.+|+.+++.++||||+++++.+...+.+++|
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh---hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 66778999999999999987 67899999986533221 11234678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCc
Q 019304 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (343)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~ 294 (343)
|||+++++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||+++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI 158 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence 99999999999887654556899999999999999999999999999999999999999999999999999865443333
Q ss_pred cCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 295 TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 295 ~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
...+|++.|+|||++ .+..++.++|+|+++
T Consensus 159 ~~~~~~~~y~aPE~~-----~~~~~~~~~Diws~G 188 (285)
T cd05605 159 RGRVGTVGYMAPEVV-----KNERYTFSPDWWGLG 188 (285)
T ss_pred ccccCCCCccCcHHh-----cCCCCCccccchhHH
Confidence 455899999999999 778899999999643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=264.92 Aligned_cols=191 Identities=21% Similarity=0.279 Sum_probs=159.1
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||++.. +++.||||+++...... ....+.+.+|+.+++.++||||+++++++.+...++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~ 77 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLA---QETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLY 77 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEE
Confidence 3578889999999999999987 67899999997533211 123457889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+||||+++++|.+++.+. ...+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 78 lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred EEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999999999999764 2458999999999999999999999999999999999999999999999999998654332
Q ss_pred C--ccCCCCCcceecCCCCCCCCCC-CCCCceeeeeeecc
Q 019304 293 G--MTPETGTYRWMAPGNSFFSPLP-HPSFEHKWSAKESC 329 (343)
Q Consensus 293 ~--~~~~~gt~~y~APE~~~~~~~~-~~~~~~~sDi~~~~ 329 (343)
. .....||+.|+|||++...... ...++.++|||+++
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG 196 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLG 196 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeeccc
Confidence 2 2234799999999998322111 56788999999543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=265.55 Aligned_cols=191 Identities=20% Similarity=0.256 Sum_probs=157.3
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||+++. +++.||+|++.+.... .......+.+|..++..++|++|+++++++.+.+..|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~ 77 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML---KRAETACFREERNVLVNGDCQWITTLHYAFQDENYLY 77 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH---hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 3678889999999999999987 6678999998642211 1122356788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+||||+++|+|.+++.+.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 78 lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999999997632 458899999999999999999999999999999999999999999999999997654332
Q ss_pred Cc--cCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 293 GM--TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 293 ~~--~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.. ...+||+.|+|||++.........++.++|+|+++
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlG 195 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLG 195 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeee
Confidence 21 23579999999999832211225788999999643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=265.83 Aligned_cols=187 Identities=20% Similarity=0.294 Sum_probs=156.1
Q ss_pred cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeEEEEEEe
Q 019304 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
+.||+|+||.||++.+ +++.||||++++...... ...+.+.+|..+++.+ +||||+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~---~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD---EDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeC
Confidence 3689999999999987 678999999975432221 1235678899999888 799999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc-ccCCCccC
Q 019304 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEGMTP 296 (343)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~-~~~~~~~~ 296 (343)
+++++|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.. ........
T Consensus 78 ~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (329)
T cd05588 78 VSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST 155 (329)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence 9999999988654 45899999999999999999999999999999999999999999999999998742 22223345
Q ss_pred CCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCC
Q 019304 297 ETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPP 337 (343)
Q Consensus 297 ~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~ 337 (343)
.+||+.|+|||++ ....++.++|+|+++. +++.+||
T Consensus 156 ~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~~l~el~~g~~Pf 196 (329)
T cd05588 156 FCGTPNYIAPEIL-----RGEDYGFSVDWWALGVLMFEMMAGRSPF 196 (329)
T ss_pred ccCCccccCHHHH-----cCCCCCCccceechHHHHHHHHHCCCCc
Confidence 6899999999999 7788999999996433 3355555
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=261.95 Aligned_cols=189 Identities=30% Similarity=0.449 Sum_probs=155.9
Q ss_pred ecccccccccccccccceEEEEEEEC------------------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTYN------------------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL 193 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 193 (343)
++..+|++.+.||+|+||.||+|.+. +..||+|++...... .....|.+|+.+++.+
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l 76 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK-----NARNDFLKEVKILSRL 76 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH-----HHHHHHHHHHHHHhhc
Confidence 45578889999999999999999752 236999998654321 1235789999999999
Q ss_pred CCCCcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCC-----------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 019304 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN-----------------RAVPLKLAVKQALDVARGMAYVHG 256 (343)
Q Consensus 194 ~h~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~-----------------~~~~~~~~~~i~~qi~~gL~yLH~ 256 (343)
+||||+++++++.+....++||||+++++|.+++..... ..+++..+++++.|++.||.|||+
T Consensus 77 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 77 KDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred CCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999865321 235677889999999999999999
Q ss_pred CCceeCCCCCCcEEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 257 ~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.||+||||||+|||++.++.+||+|||+++....... .....+++.|+|||++ ....++.++|+|+++.
T Consensus 157 ~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slG~ 228 (304)
T cd05096 157 LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI-----LMGKFTTASDVWAFGV 228 (304)
T ss_pred CCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHH-----hcCCCCchhhhHHHHH
Confidence 9999999999999999999999999999975433221 1223457899999998 6778999999996443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=270.65 Aligned_cols=193 Identities=29% Similarity=0.403 Sum_probs=164.7
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
..|+..+.||+|+||.||+|.+ .++.||||++.......+ ...+.+|+.++.+++++||.++|+.+.....++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de-----Iediqqei~~Ls~~~~~~it~yygsyl~g~~Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE-----IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchh-----hHHHHHHHHHHHhcCcchHHhhhhheeecccHH
Confidence 4566668999999999999988 678999999976554433 367889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
++||||.||++.+.++.. ..+.+..+.-++++++.||.|||.++.||||||+.|||+..+|.+||+|||++.......
T Consensus 88 iiMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999999999999753 334788888899999999999999999999999999999999999999999987655443
Q ss_pred C-ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 293 G-MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 293 ~-~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
. ...++|||.|||||++ ....|+.|+|||++.+ +.+-||+..
T Consensus 166 ~rr~tfvGTPfwMAPEVI-----~~~~Y~~KADIWSLGITaiEla~GePP~s~ 213 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVI-----KQSGYDTKADIWSLGITAIELAKGEPPHSK 213 (467)
T ss_pred hccccccccccccchhhh-----ccccccchhhhhhhhHHHHHHhcCCCCCcc
Confidence 2 3677999999999999 8889999999995443 335555543
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=262.79 Aligned_cols=178 Identities=22% Similarity=0.322 Sum_probs=152.0
Q ss_pred cccccccceEEEEEEE-----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEE
Q 019304 141 TAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~ 215 (343)
+.||+|+||.||++.. +++.+|+|++........ ....+.+|+.++++++||||+++++++.....+|+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR----DRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhh----hHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEE
Confidence 5799999999999864 568899999975332111 1245778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-CCc
Q 019304 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EGM 294 (343)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~-~~~ 294 (343)
||+++++|.+++.+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 78 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 78 DFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence 999999999999654 35899999999999999999999999999999999999999999999999998764433 223
Q ss_pred cCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 295 TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 295 ~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
...+||+.|+|||.+ ....++.++|+|+++
T Consensus 156 ~~~~g~~~y~aPE~~-----~~~~~~~~~DiwslG 185 (318)
T cd05582 156 YSFCGTVEYMAPEVV-----NRRGHTQSADWWSFG 185 (318)
T ss_pred ecccCChhhcCHHHH-----cCCCCCCccceeccc
Confidence 445799999999999 778889999999543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=264.42 Aligned_cols=194 Identities=24% Similarity=0.254 Sum_probs=159.0
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 212 (343)
+|++.+.||+|+||.||+|.. +++.||||++.+...... ...+.+..|..++..+ +|++|+++++++...+.++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD---DDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLY 77 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEE
Confidence 467789999999999999988 567899999975432111 1224567788888777 5899999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc-C
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-T 291 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~-~ 291 (343)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus 78 lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 78 FVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999999999998754 3588999999999999999999999999999999999999999999999999875332 2
Q ss_pred CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 292 EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
......+||+.|+|||++ ....++.++|+|++++ +++.+||.+
T Consensus 156 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlGvil~elltg~~Pf~~ 203 (323)
T cd05616 156 VTTKTFCGTPDYIAPEII-----AYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203 (323)
T ss_pred CccccCCCChhhcCHHHh-----cCCCCCCccchhchhHHHHHHHhCCCCCCC
Confidence 233456799999999999 7788999999996443 335666543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=262.90 Aligned_cols=189 Identities=22% Similarity=0.361 Sum_probs=153.3
Q ss_pred cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCeEEEEEEe
Q 019304 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVM-MLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
+.||+|+||+||+|.. +++.+|+|++.+...... .....+.+|.. +++.++||||+++++.+...+..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR---KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcC
Confidence 3689999999999987 688999999975322111 11234555554 57789999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc-cCCCccC
Q 019304 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QTEGMTP 296 (343)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~-~~~~~~~ 296 (343)
+++++|..++.+. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++... .......
T Consensus 78 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (325)
T cd05604 78 VNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT 155 (325)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence 9999999888653 458999999999999999999999999999999999999999999999999987532 2223345
Q ss_pred CCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 297 ETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 297 ~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.+||+.|+|||++ ....++.++|+|+++. +++.+||..
T Consensus 156 ~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~el~~G~~pf~~ 198 (325)
T cd05604 156 FCGTPEYLAPEVI-----RKQPYDNTVDWWCLGAVLYEMLYGLPPFYC 198 (325)
T ss_pred ccCChhhCCHHHH-----cCCCCCCcCccccccceehhhhcCCCCCCC
Confidence 5799999999999 7788999999995433 235555543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=265.01 Aligned_cols=192 Identities=25% Similarity=0.325 Sum_probs=156.2
Q ss_pred cccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHH---hcCCCCCcceEEEEEEeCCeE
Q 019304 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML---ATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~nIv~l~~~~~~~~~~ 211 (343)
|++.+.||+|+||.||+|.+ +++.||||++.+....... ..+.+.+|+.++ +.++||||+++++++......
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARD---EVESLMCEKRIFETANSERHPFLVNLFACFQTEDHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhh---HHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEE
Confidence 45678999999999999987 6789999999754321111 124566666554 567899999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc-
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ- 290 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~- 290 (343)
|+||||+++++|..++.. ..+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 78 ~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999999988754 3589999999999999999999999999999999999999999999999999875322
Q ss_pred CCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 291 TEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 291 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.......+|++.|+|||.+ ....++.++|+|+++. +++.+||.+
T Consensus 155 ~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~DiwslG~il~el~~G~~pf~~ 203 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVL-----TETSYTRAVDWWGLGVLIYEMLVGESPFPG 203 (324)
T ss_pred CCcccccccCccccCHhHh-----cCCCCCcccchhhHHHHHHHHHhCCCCCCC
Confidence 2223446799999999999 7788999999996433 335566654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=262.55 Aligned_cols=190 Identities=24% Similarity=0.306 Sum_probs=156.0
Q ss_pred cccccccceEEEEEEE-----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEE
Q 019304 141 TAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~ 215 (343)
+.||+|+||.||++.. .++.||||++.+..... .......+.+|+.+++.++||||+++++++.....+|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR--NQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHh--hhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence 5799999999999975 46789999997532211 1112346789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-CCc
Q 019304 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EGM 294 (343)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~-~~~ 294 (343)
||+++++|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 80 EYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred eCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence 999999999999764 34788889999999999999999999999999999999999999999999998743222 223
Q ss_pred cCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 295 TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 295 ~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
...+||+.|+|||++ ....++.++|||+++. +++.+||..
T Consensus 158 ~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~G~~pf~~ 202 (323)
T cd05584 158 HTFCGTIEYMAPEIL-----MRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202 (323)
T ss_pred cccCCCccccChhhc-----cCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence 345799999999999 6778899999996333 346666543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=262.53 Aligned_cols=189 Identities=24% Similarity=0.351 Sum_probs=152.8
Q ss_pred cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCeEEEEEEe
Q 019304 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVM-MLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
+.||+|+||.||+|+. +++.||+|++.+...... ...+.+.+|.. +++.++||||+++++.+...+.+|+||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKK---KEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHh---hHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcC
Confidence 3689999999999988 678999999975322111 11234555554 67889999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc-CCCccC
Q 019304 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (343)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~-~~~~~~ 296 (343)
+++++|..++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05603 78 VNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST 155 (321)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence 9999999888653 4588899999999999999999999999999999999999999999999999875322 223344
Q ss_pred CCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 297 ETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 297 ~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.+||+.|+|||.+ ....++.++|+|+++. +++.+||.+
T Consensus 156 ~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (321)
T cd05603 156 FCGTPEYLAPEVL-----RKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (321)
T ss_pred ccCCcccCCHHHh-----cCCCCCCcCcccccchhhhhhhcCCCCCCC
Confidence 5799999999999 7788999999995333 335556543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=263.63 Aligned_cols=187 Identities=20% Similarity=0.306 Sum_probs=155.3
Q ss_pred cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeEEEEEEe
Q 019304 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
+.||+|+||.||++.. +++.||+|++++...... ...+.+.+|+.++.++ +||||+++++++.....+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD---EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcch---hHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeC
Confidence 3689999999999987 677899999976432221 1234577888888776 899999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc-CCCccC
Q 019304 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (343)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~-~~~~~~ 296 (343)
+++++|..++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (329)
T cd05618 78 VNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 155 (329)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence 9999999888654 4589999999999999999999999999999999999999999999999999875322 222344
Q ss_pred CCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCC
Q 019304 297 ETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPP 337 (343)
Q Consensus 297 ~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~ 337 (343)
.+||+.|+|||++ .+..++.++|+|+++. +++.+||
T Consensus 156 ~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~el~~g~~Pf 196 (329)
T cd05618 156 FCGTPNYIAPEIL-----RGEDYGFSVDWWALGVLMFEMMAGRSPF 196 (329)
T ss_pred ccCCccccCHHHH-----cCCCCCCccceecccHHHHHHhhCCCCC
Confidence 5799999999999 7788999999996433 3355555
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=261.88 Aligned_cols=189 Identities=23% Similarity=0.365 Sum_probs=153.3
Q ss_pred cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCeEEEEEEe
Q 019304 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVM-MLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
+.||+|+||+||+|.. +++.||||++.+...... ...+.+.+|.. +++.++||||+++++.+.....+++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK---KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh---hHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcC
Confidence 3689999999999988 688999999975322111 11234445544 56889999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc-CCCccC
Q 019304 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (343)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~-~~~~~~ 296 (343)
+++++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (323)
T cd05575 78 VNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST 155 (323)
T ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence 9999999998754 4588999999999999999999999999999999999999999999999999875322 223344
Q ss_pred CCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 297 ETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 297 ~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.+||+.|+|||++ ....++.++|+|+++. +++.+||..
T Consensus 156 ~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~ell~g~~pf~~ 198 (323)
T cd05575 156 FCGTPEYLAPEVL-----RKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (323)
T ss_pred ccCChhhcChhhh-----cCCCCCccccccccchhhhhhhcCCCCCCC
Confidence 5799999999999 7788999999996433 335556543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=263.55 Aligned_cols=193 Identities=24% Similarity=0.277 Sum_probs=157.9
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCC-CcceEEEEEEeCCeEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL-NIVRFIGACRKRMVWC 212 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~ 212 (343)
+|++.+.||+|+||.||+|.. +++.||||++.+..... ....+.+..|..++..+.|+ +|+++++++...+.+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ---DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 77 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEE
Confidence 467889999999999999988 56789999997532211 11235678899999999765 5888999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc-cC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QT 291 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~-~~ 291 (343)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++... ..
T Consensus 78 lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 78 FVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999999999998754 348899999999999999999999999999999999999999999999999987432 22
Q ss_pred CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 292 EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
......+||+.|+|||++ ....++.++|+|++++ +++.+||.
T Consensus 156 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslGvil~elltG~~pf~ 202 (324)
T cd05587 156 KTTRTFCGTPDYIAPEII-----AYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202 (324)
T ss_pred CceeeecCCccccChhhh-----cCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 233445799999999999 7788999999996333 33556653
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=268.20 Aligned_cols=195 Identities=28% Similarity=0.462 Sum_probs=161.7
Q ss_pred CCccceecccccccccccccccceEEEEEEE-------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCC
Q 019304 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (343)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 197 (343)
....|.++.++|++++.||+|+||.||+|++ ++..||||+++....... .+.+.+|+.+++.+ +|||
T Consensus 26 ~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~-----~~~~~~Ei~il~~l~~Hpn 100 (375)
T cd05104 26 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTE-----REALMSELKVLSYLGNHIN 100 (375)
T ss_pred CccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHH-----HHHHHHHHHHHHHhcCCcc
Confidence 3457889999999999999999999999974 345799999975433221 25788999999999 8999
Q ss_pred cceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCC---------------------------------------------
Q 019304 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------------------------------------------- 232 (343)
Q Consensus 198 Iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------------------------------------------- 232 (343)
|++++++|......++||||+++|+|.+++.....
T Consensus 101 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 180 (375)
T cd05104 101 IVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVP 180 (375)
T ss_pred eeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccc
Confidence 99999999999999999999999999999975321
Q ss_pred ----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccc
Q 019304 233 ----------------------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (343)
Q Consensus 233 ----------------------------~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~ 284 (343)
..+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 260 (375)
T cd05104 181 TKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGL 260 (375)
T ss_pred cccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCcc
Confidence 2467788899999999999999999999999999999999999999999999
Q ss_pred ccccccCCCc---cCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 285 ARIEVQTEGM---TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 285 a~~~~~~~~~---~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
++........ ....+++.|+|||.+ ....++.++|+|++..
T Consensus 261 a~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~sDi~slG~ 304 (375)
T cd05104 261 ARDIRNDSNYVVKGNARLPVKWMAPESI-----FNCVYTFESDVWSYGI 304 (375)
T ss_pred ceeccCcccccccCCCCCCcceeChhHh-----cCCCCCCCCCHHHHHH
Confidence 9754332211 122345789999999 7788999999996443
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=258.29 Aligned_cols=198 Identities=27% Similarity=0.334 Sum_probs=165.3
Q ss_pred ceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 207 (343)
|+++ +.|...+.||+|++|.|..+.. +|+.||||.+..+...... .++..+|+.+|+.++|+||+.+++++..
T Consensus 18 ~~i~-~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~----akRtlRElklLr~~~HeNIi~l~di~~p 92 (359)
T KOG0660|consen 18 FEIP-RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQID----AKRTLRELKLLRHLRHENIIGLLDIFRP 92 (359)
T ss_pred Eecc-ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHH----HHHHHHHHHHHHHhcCCCcceEEeeccc
Confidence 3443 3444578999999999999987 7899999999766655433 3788999999999999999999999876
Q ss_pred -----CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 019304 208 -----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (343)
Q Consensus 208 -----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DF 282 (343)
-..+|+|+|+|+ .+|...++.. ..++.+.+..++.|+++||+|+|+.+++||||||+|+|++.+..+|||||
T Consensus 93 ~~~~~f~DvYiV~elMe-tDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 93 PSRDKFNDVYLVFELME-TDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred ccccccceeEEehhHHh-hHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccc
Confidence 246899999995 5999999764 34899999999999999999999999999999999999999999999999
Q ss_pred cccccccc---CCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 283 GVARIEVQ---TEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 283 g~a~~~~~---~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
|+||.... ...++..+.|..|.|||.+. ....|+...|||+..+ +++.|.|-+
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll----~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG 230 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLL----NSSEYTKAIDIWSVGCILAEMLTGKPLFPG 230 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHh----ccccccchhhhhhhhHHHHHHHcCCCCCCC
Confidence 99998753 44567778899999999995 7899999999995222 335555533
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=269.05 Aligned_cols=196 Identities=28% Similarity=0.461 Sum_probs=162.7
Q ss_pred CCCCccceecccccccccccccccceEEEEEEE-------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CC
Q 019304 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KH 195 (343)
Q Consensus 124 ~~~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 195 (343)
++..+.|.++.++|++++.||+|+||.||+|.+ +++.||||++........ ...+.+|+.+++.+ +|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~il~~l~~h 101 (374)
T cd05106 27 LPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDE-----REALMSELKILSHLGQH 101 (374)
T ss_pred ccccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHH-----HHHHHHHHHHHHhhccC
Confidence 445678999999999999999999999999975 224799999975433221 25688999999999 89
Q ss_pred CCcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhC--------------------------------------------
Q 019304 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ-------------------------------------------- 231 (343)
Q Consensus 196 ~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~-------------------------------------------- 231 (343)
|||++++++|.....+++||||+++|+|.+++....
T Consensus 102 ~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (374)
T cd05106 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTY 181 (374)
T ss_pred CceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccc
Confidence 999999999999999999999999999999986431
Q ss_pred ------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 232 ------------------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 232 ------------------------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
...+++..+++++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~ 261 (374)
T cd05106 182 VEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARD 261 (374)
T ss_pred cccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeee
Confidence 12367788899999999999999999999999999999999999999999999875
Q ss_pred cccCCCc---cCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 288 EVQTEGM---TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 288 ~~~~~~~---~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
....... ....+++.|+|||++ ....++.++|||++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DvwSlG 301 (374)
T cd05106 262 IMNDSNYVVKGNARLPVKWMAPESI-----FDCVYTVQSDVWSYG 301 (374)
T ss_pred ccCCcceeeccCCCCccceeCHHHh-----cCCCCCccccHHHHH
Confidence 4332211 112345789999999 778899999999643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=262.27 Aligned_cols=188 Identities=24% Similarity=0.278 Sum_probs=154.5
Q ss_pred cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeEEEEEEe
Q 019304 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
+.||+|+||.||+|.. +++.||||++.+..... ....+.+..|..++..+ +||+|+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ---DDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhh---hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeC
Confidence 3689999999999988 56789999997532211 11234577888888866 799999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc-CCCccC
Q 019304 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (343)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~-~~~~~~ 296 (343)
+++++|..++.+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05591 78 VNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT 155 (321)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence 9999999988754 3588999999999999999999999999999999999999999999999999875322 223344
Q ss_pred CCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 297 ETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 297 ~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.+||+.|+|||++ ....++.++|+|+++. +++.+||.
T Consensus 156 ~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~el~tg~~Pf~ 197 (321)
T cd05591 156 FCGTPDYIAPEIL-----QELEYGPSVDWWALGVLMYEMMAGQPPFE 197 (321)
T ss_pred cccCccccCHHHH-----cCCCCCCccceechhHHHHHHhcCCCCCC
Confidence 5799999999999 7788999999996443 23555553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=257.39 Aligned_cols=195 Identities=24% Similarity=0.362 Sum_probs=156.7
Q ss_pred cccccccccccccceEEEEEEE---CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC---CCCCcceEEEEEEe-
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACRK- 207 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~- 207 (343)
++|++.+.||+|+||.||+|.. .++.||||+++......... ..+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~ 76 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP----LSTIREVAVLRHLETFEHPNVVRLFDVCTVS 76 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCch----HHHHHHHHHHHhhcccCCCCcceEEEEEecc
Confidence 3678889999999999999986 35789999987544332211 2455676666655 69999999999852
Q ss_pred ----CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 208 ----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 208 ----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
...+++||||++ ++|.+++.......+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||
T Consensus 77 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 77 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred cCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346899999996 599999987655668999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 284 VARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
+++............||+.|+|||.+ ....++.++|+|+++. +++.+||.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DiwslG~il~el~~g~~~f~~ 211 (290)
T cd07862 156 LARIYSFQMALTSVVVTLWYRAPEVL-----LQSSYATPVDLWSVGCIFAEMFRRKPLFRG 211 (290)
T ss_pred ceEeccCCcccccccccccccChHHH-----hCCCCCCccchHHHHHHHHHHHcCCCCcCC
Confidence 99865544344456799999999999 6778999999996433 335555543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=269.86 Aligned_cols=194 Identities=26% Similarity=0.534 Sum_probs=168.9
Q ss_pred ccceecccccccccccccccceEEEEEEEC----Cc--eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN----GE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~----~~--~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l 201 (343)
..+++..+.+.+.+.||.|.||.||+|++. |+ .||||..+....... .+.|++|+.+|+.+.|||||++
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-----tekflqEa~iMrnfdHphIikL 456 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-----TEKFLQEASIMRNFDHPHIIKL 456 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-----HHHHHHHHHHHHhCCCcchhhe
Confidence 467788888999999999999999999882 32 588998876544332 2689999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEec
Q 019304 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (343)
Q Consensus 202 ~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~D 281 (343)
+|+|.+.. .+||||+++-|.|.+||+.++ ..++......++.||+.+|.|||+..++||||.++||||.....|||+|
T Consensus 457 IGv~~e~P-~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 457 IGVCVEQP-MWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred eeeeeccc-eeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecc
Confidence 99999865 589999999999999998764 4689999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccCCCC--CcceecCCCCCCCCCCCCCCceeeeeeeccccccc
Q 019304 282 FGVARIEVQTEGMTPETG--TYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTW 334 (343)
Q Consensus 282 Fg~a~~~~~~~~~~~~~g--t~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~~~ 334 (343)
||++|.......++...| ...|||||-+ +..+|+.+|||| .+++++|
T Consensus 535 FGLSR~~ed~~yYkaS~~kLPIKWmaPESI-----NfRrFTtASDVW-MFgVCmW 583 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKASRGKLPIKWMAPESI-----NFRRFTTASDVW-MFGVCMW 583 (974)
T ss_pred cchhhhccccchhhccccccceeecCcccc-----chhcccchhhHH-HHHHHHH
Confidence 999998877666655555 4799999999 999999999999 5666655
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=262.75 Aligned_cols=201 Identities=20% Similarity=0.253 Sum_probs=161.9
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||++.. +++.+|+|++.+.... .....+.+.+|+.++..++|++|+++++++.+...++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 77 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML---KRAETACFREERDVLVNGDNQWITTLHYAFQDENNLY 77 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH---HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEE
Confidence 3678889999999999999988 5678999998642211 1122345888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+||||+++|+|.+++.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 78 lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999999997632 358899999999999999999999999999999999999999999999999987543222
Q ss_pred C--ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 293 G--MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 293 ~--~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
. ....+||+.|+|||++.........++.++|+|+++. +++.+||.+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 2 2235799999999998322222467899999996433 335666644
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=261.29 Aligned_cols=185 Identities=18% Similarity=0.265 Sum_probs=153.6
Q ss_pred ccccccccccccceEEEEEEE-----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM 209 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 209 (343)
+|++.+.||+|+||.||++.. +++.||+|++.+..... .....+.+.+|+.+++.+ +||+|+++++++....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ--KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh--hhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC
Confidence 467889999999999999875 56789999997532211 112235678899999999 5899999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
.+++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 999999999999999999764 358899999999999999999999999999999999999999999999999987543
Q ss_pred cCC--CccCCCCCcceecCCCCCCCCCCC-CCCceeeeeeecc
Q 019304 290 QTE--GMTPETGTYRWMAPGNSFFSPLPH-PSFEHKWSAKESC 329 (343)
Q Consensus 290 ~~~--~~~~~~gt~~y~APE~~~~~~~~~-~~~~~~sDi~~~~ 329 (343)
... .....+||+.|+|||++ .. ..++.++|||+++
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~~DiwslG 194 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEII-----RGKGGHGKAVDWWSLG 194 (332)
T ss_pred ccCCCccccccCCccccCHHHh-----cCCCCCCCccccccch
Confidence 222 22345799999999998 44 3478899999543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=263.32 Aligned_cols=178 Identities=23% Similarity=0.398 Sum_probs=157.9
Q ss_pred ccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEe
Q 019304 140 GTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 140 ~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
.+.||+|.||+||-|++ +|+.||||++.+-...+.+. .++.+|+.+|+++.||.||.+-..|+..+.+++|||-
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe----sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEK 644 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE----SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEK 644 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchH----HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehh
Confidence 47899999999999977 89999999998776665442 5788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC---CcEEEeccccccccccCCCc
Q 019304 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD---KSIKIADFGVARIEVQTEGM 294 (343)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~---~~vkl~DFg~a~~~~~~~~~ 294 (343)
+.| +..+.+-....+.+++.....+..||+.||.|||-++|+|+||||+|||+.+. -.+||||||+||++....-.
T Consensus 645 l~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 645 LHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 965 66666655555679999999999999999999999999999999999999743 47999999999998876666
Q ss_pred cCCCCCcceecCCCCCCCCCCCCCCceeeeeee
Q 019304 295 TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKE 327 (343)
Q Consensus 295 ~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~ 327 (343)
.+.+|||.|+|||++ ..+.|+...|+|+
T Consensus 724 rsVVGTPAYLaPEVL-----rnkGyNrSLDMWS 751 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVL-----RNKGYNRSLDMWS 751 (888)
T ss_pred hhhcCCccccCHHHH-----hhcccccccccee
Confidence 778999999999999 8999999999995
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=261.85 Aligned_cols=188 Identities=21% Similarity=0.288 Sum_probs=156.5
Q ss_pred cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeEEEEEEe
Q 019304 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
+.||+|+||.||++.. +++.||+|++.+..... ....+.+.+|+.++..+ +||+|+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD---DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeC
Confidence 3699999999999987 66889999997643221 12235678899999888 699999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc-cCCCccC
Q 019304 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QTEGMTP 296 (343)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~-~~~~~~~ 296 (343)
+++++|..++... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++... .......
T Consensus 78 ~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (327)
T cd05617 78 VNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST 155 (327)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence 9999999988654 358999999999999999999999999999999999999999999999999987532 2223345
Q ss_pred CCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 297 ETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 297 ~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.+||+.|+|||++ ....++.++|+|+++. +++.+||.
T Consensus 156 ~~gt~~y~aPE~~-----~~~~~~~~~DiwslGvil~ell~g~~pf~ 197 (327)
T cd05617 156 FCGTPNYIAPEIL-----RGEEYGFSVDWWALGVLMFEMMAGRSPFD 197 (327)
T ss_pred ccCCcccCCHHHH-----CCCCCCchheeehhHHHHHHHHhCCCCCC
Confidence 6899999999999 7788999999996443 33555653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=253.97 Aligned_cols=187 Identities=24% Similarity=0.306 Sum_probs=158.9
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--C
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--R 208 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~ 208 (343)
..++|+.+..|++|.||.||+|++ +++.||+|.++......- .----++|+.+|.+++|||||.+-.+..- -
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G----FPItsLREIniLl~~~H~NIV~vkEVVvG~~~ 149 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG----FPITSLREINILLKARHPNIVEVKEVVVGSNM 149 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCC----CcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence 346788889999999999999988 778999999975442110 00124799999999999999999887753 3
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
+.+|+|||||+. +|...+.... .++...++..+..|+++|++|||.+.|+||||||+|+|++..|.+||+|||+||..
T Consensus 150 d~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 150 DKIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred ceeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhh
Confidence 579999999987 8999998654 67999999999999999999999999999999999999999999999999999976
Q ss_pred ccC-CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 289 VQT-EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 289 ~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
... ..+++.+-|..|.|||.++ ....|+...|+|+..
T Consensus 228 gsp~k~~T~lVVTLWYRaPELLL----G~~tyst~iDMWSvG 265 (419)
T KOG0663|consen 228 GSPLKPYTPLVVTLWYRAPELLL----GAKTYSTAVDMWSVG 265 (419)
T ss_pred cCCcccCcceEEEeeecCHHHhc----CCcccCcchhhhhHH
Confidence 543 4577888999999999996 567899999999633
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=266.46 Aligned_cols=195 Identities=26% Similarity=0.381 Sum_probs=171.3
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
...|.+.+.||+|.|++|.++++ ++..||||++++...+.... +.+.+|+.+|+.+.|||||+++.+...+..+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~----~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKR----QKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHH----HHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 35677889999999999999987 88999999999988877543 4588999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
|+||||+.+|.+.+++.+... ..+..+..++.|++++++|||+++|+|||||++|||++.+..+||+|||++.+....
T Consensus 131 ylV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence 999999999999999987543 666889999999999999999999999999999999999999999999999988877
Q ss_pred CCccCCCCCcceecCCCCCCCCCCCCCCc-eeeeeee-----cccccccCCCCc
Q 019304 292 EGMTPETGTYRWMAPGNSFFSPLPHPSFE-HKWSAKE-----SCLKTTWPPPWR 339 (343)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~-~~sDi~~-----~~~~~~~~p~~~ 339 (343)
....+.||++.|.|||++ ...+|. +.+|+|+ +.++.+-+||=+
T Consensus 209 ~~lqt~cgsppyAaPEl~-----~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG 257 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELF-----NGKKYDGPEVDIWSLGVVLYALVEGSLPFDG 257 (596)
T ss_pred ccccccCCCCCccChHhh-----cCcccCCcceehhhhhhhheeeeecccccCC
Confidence 777888999999999999 555565 8999995 333445556543
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=262.37 Aligned_cols=188 Identities=20% Similarity=0.264 Sum_probs=154.6
Q ss_pred cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeEEEEEEe
Q 019304 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
+.||+|+||.||+|.. +++.||||++.+..... ....+.+.+|..++..+ +||||+++++++.....+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQ---DDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh---ccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcC
Confidence 3689999999999987 57889999987532111 11234667888888776 699999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc-cCCCccC
Q 019304 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QTEGMTP 296 (343)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~-~~~~~~~ 296 (343)
+++++|.+++.+. ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++... .......
T Consensus 78 ~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (320)
T cd05590 78 VNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST 155 (320)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence 9999999988754 358999999999999999999999999999999999999999999999999987532 2223345
Q ss_pred CCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 297 ETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 297 ~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.+||+.|+|||++ ....++.++|+|+++. +++.+||.
T Consensus 156 ~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (320)
T cd05590 156 FCGTPDYIAPEIL-----QEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197 (320)
T ss_pred cccCccccCHHHH-----cCCCCCCccchhhhHHHHHHHhhCCCCCC
Confidence 5799999999999 7788999999996433 33555654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=261.37 Aligned_cols=185 Identities=23% Similarity=0.327 Sum_probs=159.7
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
+..++|++.+.||+|+||.||++++ ++..+|+|++..... ....+++.+|+.+++.++||||+++++++....
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-----PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-----HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 3457889999999999999999998 577899999875322 122367899999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 154 (331)
T cd06649 77 EISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (331)
T ss_pred EEEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence 999999999999999999764 3488999999999999999999986 6999999999999999999999999998755
Q ss_pred ccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 289 VQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
... ......||+.|+|||++ ....++.++|+|+++
T Consensus 155 ~~~-~~~~~~g~~~y~aPE~~-----~~~~~~~~~DiwslG 189 (331)
T cd06649 155 IDS-MANSFVGTRSYMSPERL-----QGTHYSVQSDIWSMG 189 (331)
T ss_pred ccc-ccccCCCCcCcCCHhHh-----cCCCCCchHhHHHHH
Confidence 332 23445799999999999 777899999999543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=287.93 Aligned_cols=195 Identities=31% Similarity=0.523 Sum_probs=163.4
Q ss_pred ecccccccccccccccceEEEEEEE---CCc----eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY---NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~---~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 204 (343)
++....++.+.||+|+||.||+|.. ++. .||||.+.+..... .+.+|++|..+|+.++|||||+++|+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~-----~~~~Fl~Ea~~m~~f~HpNiv~liGv 763 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQ-----EVSDFLKEALLMSKFDHPNIVSLIGV 763 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHH-----HHHHHHHHHHHHhcCCCcceeeEEEe
Confidence 4567888899999999999999987 333 48899887644332 24689999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEE
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQ-----NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl 279 (343)
|.+....+|++|||++|+|..||++.+ ...+....++.++.|||+|++||+++++|||||.++|+|++...+|||
T Consensus 764 ~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 764 CLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred ecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEE
Confidence 999999999999999999999998752 345788999999999999999999999999999999999999999999
Q ss_pred eccccccccccCCCcc--CC-CCCcceecCCCCCCCCCCCCCCceeeeeeecccccccCCC
Q 019304 280 ADFGVARIEVQTEGMT--PE-TGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTWPPP 337 (343)
Q Consensus 280 ~DFg~a~~~~~~~~~~--~~-~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~~~~p~ 337 (343)
+|||+||.+.....+. .. .-..+|||||.+ ..+.|+.|+||| ++++++|-.|
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl-----~d~iFtskSDvW-sFGVllWEif 898 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESL-----KDGIFTSKSDVW-SFGVLLWEIF 898 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHH-----hhcccccccchh-hhHHHHHHHH
Confidence 9999999443322221 11 223799999999 789999999999 6666666443
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=260.56 Aligned_cols=189 Identities=22% Similarity=0.337 Sum_probs=152.8
Q ss_pred cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHH-HHHhcCCCCCcceEEEEEEeCCeEEEEEEe
Q 019304 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
+.||+|+||.||+|.+ +++.||+|++.+...... .....+..|. .+++.++||||+++++++...+.+|+||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK---KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh---hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeC
Confidence 3689999999999988 567899999975322111 1123344444 457889999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc-CCCccC
Q 019304 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (343)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~-~~~~~~ 296 (343)
+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 78 INGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence 9999999999754 3478888899999999999999999999999999999999999999999999875322 223345
Q ss_pred CCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 297 ETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 297 ~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.+||+.|+|||++ ....++.++|||++++ +++.+||++
T Consensus 156 ~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (325)
T cd05602 156 FCGTPEYLAPEVL-----HKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (325)
T ss_pred ccCCccccCHHHH-----cCCCCCCccccccccHHHHHHhcCCCCCCC
Confidence 5799999999999 7788999999996433 346666654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=257.03 Aligned_cols=194 Identities=23% Similarity=0.330 Sum_probs=159.0
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++.+.||.|+||.||+|.. +++.||+|+++....... ...+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-----PCTAIREVSLLKNLKHANIVTLHDIIHTERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCc-----chhHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 46788899999999999999987 678999999865432211 13567899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||+++ +|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred EEEEeCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 999999975 999988654 345788999999999999999999999999999999999999999999999998754322
Q ss_pred -CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 292 -EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 292 -~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.......+++.|+|||.+. ....++.++|+|+++. +++.+||-
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~~l~~l~~g~~pf~ 205 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLL----GSTEYSTPIDMWGVGCILYEMATGRPMFP 205 (288)
T ss_pred CccccCceecccccChHHhc----CCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 2233457899999999883 3466899999996333 33555553
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=260.77 Aligned_cols=188 Identities=23% Similarity=0.281 Sum_probs=152.3
Q ss_pred cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhc-CCCCCcceEEEEEEeCCeEEEEEEe
Q 019304 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT-LKHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
+.||+|+||.||+|.. +++.||||+++....... ...+.+..|..++.. .+||||+++++++.....+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED---DDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 3689999999999988 567899999975322111 112345566666664 4899999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-CCccC
Q 019304 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EGMTP 296 (343)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~-~~~~~ 296 (343)
+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 78 ~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 155 (316)
T cd05592 78 LNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155 (316)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence 9999999998754 35899999999999999999999999999999999999999999999999999754322 23344
Q ss_pred CCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 297 ETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 297 ~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.+||+.|+|||.+ ....++.++|+|+++. +++.+||.
T Consensus 156 ~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~ell~G~~Pf~ 197 (316)
T cd05592 156 FCGTPDYIAPEIL-----KGQKYNESVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred ccCCccccCHHHH-----cCCCCCCcccchhHHHHHHHHHhCCCCCC
Confidence 5799999999999 7778999999996443 23555654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=258.39 Aligned_cols=193 Identities=23% Similarity=0.328 Sum_probs=158.3
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||+|.. +++.||||++........ ...+.+|+.+++.++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-----PFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc-----chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEE
Confidence 5788899999999999999988 678999999875433221 135678999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~- 291 (343)
+||||++ ++|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 80 LVFEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred EEEECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 9999995 5888888654 345888999999999999999999999999999999999999999999999998753321
Q ss_pred CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 292 EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.......||+.|+|||++. ....++.++|+|++.+ +++.+||.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~ 205 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLL----GSTEYSTCLDMWGVGCIFVEMIQGVAAFP 205 (303)
T ss_pred ccCCCCcccCCCCChHHHc----CCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 2234457899999999873 3456889999996432 23555653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=253.86 Aligned_cols=194 Identities=20% Similarity=0.248 Sum_probs=163.1
Q ss_pred cccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 019304 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv 214 (343)
|+..+.||+|+||.||++.. +++.+|||.+........ .....+.+|+.+++.++|++|+.+++.+.+.+.+++|
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccch---HHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEE
Confidence 45667899999999999988 678999999875433221 1224577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCc
Q 019304 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (343)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~ 294 (343)
|||+++++|.+++.......+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++.........
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence 99999999999987655556899999999999999999999999999999999999999999999999998765443344
Q ss_pred cCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 295 TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 295 ~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
....|++.|+|||.+ .+..++.++|+|+++. +++.+||.
T Consensus 159 ~~~~g~~~y~aPE~~-----~~~~~~~~~DiwslG~~l~~l~~g~~Pf~ 202 (285)
T cd05630 159 KGRVGTVGYMAPEVV-----KNERYTFSPDWWALGCLLYEMIAGQSPFQ 202 (285)
T ss_pred cCCCCCccccChHHH-----cCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 455799999999999 7788999999996333 33566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=255.07 Aligned_cols=187 Identities=16% Similarity=0.253 Sum_probs=156.6
Q ss_pred eecccccccc--cccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-
Q 019304 131 TIDLRKLNMG--TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK- 207 (343)
Q Consensus 131 ~i~~~~~~~~--~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~- 207 (343)
.++.++++.. ..|++|++|.||+|.++|+.||||.+....... ....+.|.+|+.++++++||||+++++++.+
T Consensus 14 ~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~ 90 (283)
T PHA02988 14 CIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGH---KVLIDITENEIKNLRRIDSNNILKIYGFIIDI 90 (283)
T ss_pred ecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEecccccccc---HHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec
Confidence 4445555554 679999999999999999999999997653322 2234678899999999999999999999876
Q ss_pred ---CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 208 ---RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 208 ---~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
...+++||||+++|+|.+++.+. ..+++...+.++.|++.||.|||+. +++||||||+|||++.++.+||+|||
T Consensus 91 ~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg 168 (283)
T PHA02988 91 VDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHG 168 (283)
T ss_pred ccCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccc
Confidence 34689999999999999999764 3588899999999999999999985 99999999999999999999999999
Q ss_pred cccccccCCCccCCCCCcceecCCCCCCCCCCC--CCCceeeeeeecc
Q 019304 284 VARIEVQTEGMTPETGTYRWMAPGNSFFSPLPH--PSFEHKWSAKESC 329 (343)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~--~~~~~~sDi~~~~ 329 (343)
+++..... .....|++.|+|||.+ .+ ..++.++|||+++
T Consensus 169 ~~~~~~~~--~~~~~~~~~y~aPE~~-----~~~~~~~~~k~Di~SlG 209 (283)
T PHA02988 169 LEKILSSP--PFKNVNFMVYFSYKML-----NDIFSEYTIKDDIYSLG 209 (283)
T ss_pred hHhhhccc--cccccCcccccCHHHh-----hhccccccchhhhhHHH
Confidence 99865432 2345789999999998 44 7899999999543
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=264.96 Aligned_cols=193 Identities=28% Similarity=0.464 Sum_probs=161.0
Q ss_pred ccceecccccccccccccccceEEEEEEEC-------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcc
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIV 199 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv 199 (343)
..|+++.++|++++.||+|+||.||+|++. +..||||++....... ..+.+.+|+.+++.+. ||||+
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~-----~~~~~~~Ei~~l~~l~~HpnIv 104 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSS-----EKQALMSELKIMTHLGPHLNIV 104 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChH-----HHHHHHHHHHHHHhcCCCCCee
Confidence 578899999999999999999999999862 2369999996543221 1257899999999996 99999
Q ss_pred eEEEEEEeCCeEEEEEEecCCCCHHHHHHhhC------------------------------------------------
Q 019304 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ------------------------------------------------ 231 (343)
Q Consensus 200 ~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~------------------------------------------------ 231 (343)
+++++|.+...+|+||||+++|+|.+++.+..
T Consensus 105 ~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (400)
T cd05105 105 NLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQAD 184 (400)
T ss_pred eEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccc
Confidence 99999999999999999999999999987532
Q ss_pred ----------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Q 019304 232 ----------------------------------------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (343)
Q Consensus 232 ----------------------------------------------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlk 265 (343)
...+++..+..++.|++.||+|||+.+++|||||
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dik 264 (400)
T cd05105 185 TTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLA 264 (400)
T ss_pred ccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence 1236777888999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 266 SDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 266 p~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|+|||++.++.+||+|||+++....... .....+++.|+|||.+ ....++.++|||+++.
T Consensus 265 p~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DiwSlGv 327 (400)
T cd05105 265 ARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI-----FDNLYTTLSDVWSYGI 327 (400)
T ss_pred hHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhh-----cCCCCCchhhHHHHHH
Confidence 9999999999999999999985433221 1223567889999999 6778899999996443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=260.80 Aligned_cols=193 Identities=23% Similarity=0.263 Sum_probs=157.9
Q ss_pred cccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeEEE
Q 019304 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~i 213 (343)
|+..+.||+|+||.||+|.. +++.||||++.+..... ....+.+..|..+++.+. |++|+++++++...+.+|+
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ---DDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF 78 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence 56778999999999999987 67899999997532211 112346778888888885 5778889999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-C
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-E 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~-~ 292 (343)
||||+++++|.+++.+. ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++..... .
T Consensus 79 v~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 79 VMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred EEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 99999999999998754 35899999999999999999999999999999999999999999999999998753322 2
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.....+||+.|+|||++ ....++.++|+|+++. +++.+||.+
T Consensus 157 ~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslGvil~elltG~~pf~~ 203 (323)
T cd05615 157 TTRTFCGTPDYIAPEII-----AYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203 (323)
T ss_pred cccCccCCccccCHHHH-----cCCCCCCccchhhhHHHHHHHHhCCCCCCC
Confidence 23345799999999999 7788999999996433 336666644
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=250.40 Aligned_cols=189 Identities=31% Similarity=0.485 Sum_probs=162.8
Q ss_pred ceecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
|.|+.++|++.++||+|+||.||+|.. +++.||+|.+...... .+.+.+|+.+++.++|+||+++++.+...
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-------VQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchh-------HHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 788999999999999999999999987 5678999988643321 25788999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
...+++|||+++++|.+++.+.....+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++..
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVI 153 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceec
Confidence 99999999999999999998765566888999999999999999999999999999999999999999999999999865
Q ss_pred ccCCC--ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 289 VQTEG--MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 289 ~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
..... .....++..|+|||.+ ....++.++|+|+++.
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 192 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAI-----NFGSFTIKSDVWSFGI 192 (261)
T ss_pred CCCceeccCCCccceecCCHHHh-----ccCCCChhhhhhhhHH
Confidence 43221 1223456789999998 7778899999996443
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=255.85 Aligned_cols=183 Identities=26% Similarity=0.349 Sum_probs=154.0
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||+|+||.||++++ +++.||||++........ ..+.+.+|+.+++.++||||+++++++.....+++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEE----VKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL 77 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccccc----chhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence 578889999999999999998 567899999976543322 23567899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~- 292 (343)
||||++++.+..+... ...+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||+++......
T Consensus 78 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 78 VFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9999998766544322 3458999999999999999999999999999999999999999999999999998654322
Q ss_pred -CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 293 -GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
......||+.|+|||++ .+..++.++|+|+++
T Consensus 156 ~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DiwslG 188 (287)
T cd07848 156 ANYTEYVATRWYRSPELL-----LGAPYGKAVDMWSVG 188 (287)
T ss_pred ccccccccccccCCcHHH-----cCCCCCCchhHHhHH
Confidence 22345789999999999 677899999999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=267.30 Aligned_cols=190 Identities=27% Similarity=0.356 Sum_probs=164.3
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-C-----CCcceEEEEEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-H-----LNIVRFIGACR 206 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~l~~~~~ 206 (343)
.+|.+.+.||+|.||+|.+|.+ +++.||||+++.... ..++-..|+.+|..|+ | -|+|+++++|.
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-------f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-------FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-------HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 3788999999999999999987 788999999975332 2356678999999996 4 38999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC--CCcEEEecccc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA--DKSIKIADFGV 284 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~--~~~vkl~DFg~ 284 (343)
..+++|||+|.++ .+|+++++.++...++...++.++.||+.||..||+.+|||+||||+|||+.+ ...|||+|||.
T Consensus 259 fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 259 FRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred cccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccc
Confidence 9999999999995 59999999988888999999999999999999999999999999999999974 34799999999
Q ss_pred ccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 285 ARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
|....+.- . +.+-+..|.|||++ .+.+|+.+.|+|++.+ .+|||.|-+
T Consensus 338 Sc~~~q~v-y-tYiQSRfYRAPEVI-----LGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 338 SCFESQRV-Y-TYIQSRFYRAPEVI-----LGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred ccccCCcc-e-eeeeccccccchhh-----ccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 98755432 2 56788999999999 8999999999997444 348888854
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=266.06 Aligned_cols=188 Identities=21% Similarity=0.296 Sum_probs=158.4
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
+....|++.+.||+|+||.||++.. +++.||+|.... +.+.+|+.+++.++||||+++++++....
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------------~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 156 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------------GGTATEAHILRAINHPSIIQLKGTFTYNK 156 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------------hhhHHHHHHHHhCCCCCCCCEeEEEEECC
Confidence 3456799999999999999999987 678999996532 34678999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
..++|+|++. ++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 157 ~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 157 FTCLILPRYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred eeEEEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 9999999995 6898888654 348899999999999999999999999999999999999999999999999997532
Q ss_pred cC--CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 290 QT--EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 290 ~~--~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.. ......+||+.|+|||++ ....++.++|+|+++. +++.+|++.
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELL-----ARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccccccccccCccCCCChhhh-----cCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 21 223345799999999999 7788999999996443 335556553
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=252.56 Aligned_cols=185 Identities=21% Similarity=0.263 Sum_probs=158.0
Q ss_pred cccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 019304 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv 214 (343)
|+..+.||+|+||+||++.+ +++.+|+|.+........ .....+.+|+.+++.++|++|+.+++.+...+..++|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKR---KGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhh---hHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence 45567899999999999988 678999999865432211 1224578899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCc
Q 019304 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (343)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~ 294 (343)
|||+++++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence 99999999999887655556999999999999999999999999999999999999999999999999998764433333
Q ss_pred cCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 295 TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 295 ~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
....|++.|+|||.+ .+..++.++|+|+++
T Consensus 159 ~~~~g~~~~~aPE~~-----~~~~~~~~~Di~slG 188 (285)
T cd05632 159 RGRVGTVGYMAPEVL-----NNQRYTLSPDYWGLG 188 (285)
T ss_pred cCCCCCcCccChHHh-----cCCCCCcccchHHHH
Confidence 455799999999999 778899999999644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=252.90 Aligned_cols=179 Identities=19% Similarity=0.309 Sum_probs=152.6
Q ss_pred cccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEecCC
Q 019304 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (343)
Q Consensus 143 lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~~~ 220 (343)
||+|+||.||++.. +++.+|+|.+........ ...+.+..|+++++.++||||+++++.+.....+++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK---SGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc---hhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCC
Confidence 69999999999987 688999999864322111 1124556799999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCccCCCCC
Q 019304 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300 (343)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~~~~~gt 300 (343)
++|.+++.......+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.............|+
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGT 157 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCC
Confidence 99999887655556889999999999999999999999999999999999999999999999998765443334456799
Q ss_pred cceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 301 YRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 301 ~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+.|+|||++ ....++.++|+|+++
T Consensus 158 ~~y~aPE~~-----~~~~~~~~~DvwslG 181 (277)
T cd05607 158 NGYMAPEIL-----KEEPYSYPVDWFAMG 181 (277)
T ss_pred CCccCHHHH-----ccCCCCCchhHHHHH
Confidence 999999999 677799999999643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=262.20 Aligned_cols=182 Identities=24% Similarity=0.324 Sum_probs=153.3
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-- 209 (343)
.++|++.+.||+|+||.||++.. +++.||||++........ ....+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQT----HAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchh----HHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 36788999999999999999987 678999999976543322 2356789999999999999999999986543
Q ss_pred ----eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 210 ----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 210 ----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
.+|+||||+++ +|.+.+.. .++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 47999999975 67666643 3788889999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 286 RIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+............||+.|+|||.+ ....++.++|+|+++
T Consensus 171 ~~~~~~~~~~~~~~t~~y~aPE~~-----~~~~~~~~~DiwSlG 209 (359)
T cd07876 171 RTACTNFMMTPYVVTRYYRAPEVI-----LGMGYKENVDIWSVG 209 (359)
T ss_pred cccccCccCCCCcccCCCCCchhc-----cCCCCCcchhhHHHH
Confidence 865444444556899999999999 778899999999543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=271.38 Aligned_cols=200 Identities=26% Similarity=0.402 Sum_probs=173.6
Q ss_pred CCccceecccccccccccccccceEEEEEEE---CCc--eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcce
Q 019304 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY---NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (343)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~ 200 (343)
.-++--|+.+++++.++||+|.||.|++|.| .|+ .||||.++....... ...|++|+.+|.+|+|||+|+
T Consensus 101 ~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~-----mddflrEas~M~~L~H~hliR 175 (1039)
T KOG0199|consen 101 IDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAI-----MDDFLREASHMLKLQHPHLIR 175 (1039)
T ss_pred CCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchh-----HHHHHHHHHHHHhccCcceeE
Confidence 3345567888999999999999999999999 343 689999987665542 368999999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEe
Q 019304 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (343)
Q Consensus 201 l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~ 280 (343)
|||+..+ ..+.+|+|+++.|+|.+.|++.....+....+..++.||+.||.||.++++|||||.++|+|+-...+|||+
T Consensus 176 LyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~ 254 (1039)
T KOG0199|consen 176 LYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKIC 254 (1039)
T ss_pred Eeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeee
Confidence 9999988 567899999999999999998666778899999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCccCC----CCCcceecCCCCCCCCCCCCCCceeeeeeecccccccCCC
Q 019304 281 DFGVARIEVQTEGMTPE----TGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTWPPP 337 (343)
Q Consensus 281 DFg~a~~~~~~~~~~~~----~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~~~~p~ 337 (343)
|||++|-....+.+-.. .-...|.|||.+ .+.+|+.+||+| ++++++|--|
T Consensus 255 DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsL-----rh~kFShaSDvW-myGVTiWEMF 309 (1039)
T KOG0199|consen 255 DFGLMRALGENEDMYVMAPQRKVPFAWCAPESL-----RHRKFSHASDVW-MYGVTIWEMF 309 (1039)
T ss_pred cccceeccCCCCcceEecCCCcCcccccCHhHh-----ccccccccchhh-hhhhhHHhhh
Confidence 99999977655443322 234789999999 999999999999 8888888765
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=271.06 Aligned_cols=194 Identities=19% Similarity=0.235 Sum_probs=160.7
Q ss_pred ccccccccccccccceEEEEEEE--C-CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--N-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~-~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 210 (343)
...|.+.+.||+|+||.||+|.. + ++.||+|.+..... . ....+.+|+.+++.++||||+++++.+...+.
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~---~---~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE---R---QAAYARSELHCLAACDHFGIVKHFDDFKSDDK 139 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH---H---HHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence 44588999999999999999976 3 56788887643221 1 12457789999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
+|+||||+++|+|.+++... ...++++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 99999999999999988643 2345889999999999999999999999999999999999999999999999999865
Q ss_pred ccCC---CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 289 VQTE---GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 289 ~~~~---~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.... .....+||+.|+|||++ ....++.++|||++++ +++.+||.
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~slG~~l~el~tg~~Pf~ 272 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELW-----ERKRYSKKADMWSLGVILYELLTLHRPFK 272 (478)
T ss_pred CCccccccccccCCCccccCHhHh-----CCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 4322 13345799999999999 7788999999996433 33555653
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=251.22 Aligned_cols=197 Identities=24% Similarity=0.390 Sum_probs=162.0
Q ss_pred ecccccccccccccccceEEEEEEE-----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
++.++|++.+.||+|+||.||+|.+ .+..||+|.++...... ....+.+|+.+++.++||||+++++++.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 76 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK-----QRRGFLAEALTLGQFDHSNIVRLEGVIT 76 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHH-----HHHHHHHHHHHHhcCCCCCcCeEEEEEe
Confidence 5667899999999999999999975 24589999987543221 1257889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
.....++||||+++++|.+++.+.. ..+++..++.++.|++.||+|||++|++||||||+|||++.++.+|++|||.+.
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 77 RGNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred cCCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 9999999999999999999997642 458899999999999999999999999999999999999999999999999876
Q ss_pred ccccCCCcc--CCCCCcceecCCCCCCCCCCCCCCceeeeeeecccc------cccCCCCc
Q 019304 287 IEVQTEGMT--PETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLK------TTWPPPWR 339 (343)
Q Consensus 287 ~~~~~~~~~--~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~------~~~~p~~~ 339 (343)
......... ...+++.|+|||.+ ....++.++|||+++.+ .+.+|||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~~l~ell~~g~~p~~~ 211 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAI-----QYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred cccccchhcccCCCCceeecCHHHH-----hhCCccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 532221111 22356789999998 77889999999964332 25556654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=252.51 Aligned_cols=188 Identities=22% Similarity=0.271 Sum_probs=155.5
Q ss_pred cccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEecCC
Q 019304 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (343)
Q Consensus 143 lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~~~ 220 (343)
||+|+||+||++.. +++.||+|.+........ ...+.+..|+.+++.++||||+++++++.....+++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR---KGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhh---HHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCC
Confidence 69999999999987 678999999865432221 1235678899999999999999999999999999999999999
Q ss_pred CCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-CccCC
Q 019304 221 GSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-GMTPE 297 (343)
Q Consensus 221 gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~-~~~~~ 297 (343)
++|.+++... ....+++..++.++.|++.||+|||+++|+||||||+||+++.++.+||+|||++....... .....
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 9999887542 23458999999999999999999999999999999999999999999999999987543322 22345
Q ss_pred CCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 298 TGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 298 ~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.||+.|+|||.+ ....++.++|+|+++. +++.+||.
T Consensus 158 ~g~~~y~aPE~~-----~~~~~~~~~DvwslG~il~el~~g~~pf~ 198 (280)
T cd05608 158 AGTPGFMAPELL-----QGEEYDFSVDYFALGVTLYEMIAARGPFR 198 (280)
T ss_pred CCCcCccCHHHh-----cCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 789999999999 7788999999996443 23555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=271.96 Aligned_cols=189 Identities=26% Similarity=0.413 Sum_probs=160.4
Q ss_pred cccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC------e
Q 019304 139 MGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM------V 210 (343)
Q Consensus 139 ~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~ 210 (343)
..+.||+|+||.||+|++ +|+.||||.+++...... .++..+|+++|++++|||||++.++=.+.. .
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~-----~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRP-----RERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccch-----HHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 347799999999999986 899999999976443222 256889999999999999999998765433 4
Q ss_pred EEEEEEecCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc--CCC--cEEEeccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS--ADK--SIKIADFGVA 285 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~--~~~--~vkl~DFg~a 285 (343)
..+|||||.||+|...+.+..+ ..+++.+.+.++.+++.||.|||++||+||||||.||++- .+| .-||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 5899999999999999986433 4599999999999999999999999999999999999984 334 4799999999
Q ss_pred cccccCCCccCCCCCcceecCCCCCCCCCC-CCCCceeeeeeec-----ccccccCCC
Q 019304 286 RIEVQTEGMTPETGTYRWMAPGNSFFSPLP-HPSFEHKWSAKES-----CLKTTWPPP 337 (343)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~-~~~~~~~sDi~~~-----~~~~~~~p~ 337 (343)
|-..+.....+..||+.|.|||.+ . .+.|+..+|.|++ -+++|+.||
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~-----E~q~~y~~tVDLWS~GvtlY~caTG~lPF 224 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELY-----ERQKKYTATVDLWSFGVTLYECATGELPF 224 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHH-----hhccCcCceeehhhhhhHHHHHhccCCCC
Confidence 998888888899999999999999 5 4889999999963 336677776
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=262.43 Aligned_cols=188 Identities=26% Similarity=0.337 Sum_probs=153.2
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
....+|+..+.||+|+||.||+|++ +++.||||++...... ...+.+.+|+.+++.++|+||+++++++....
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 145 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED-----TVRRQICREIEILRDVNHPNVVKCHDMFDHNG 145 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcH-----HHHHHHHHHHHHHHhCCCCCcceeeeEeccCC
Confidence 3457788889999999999999987 6789999998653321 22357889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
.+++||||+++++|.+.. ..++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 146 ~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 146 EIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA 219 (353)
T ss_pred eEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence 999999999999986432 25677788999999999999999999999999999999999999999999998654
Q ss_pred cCC-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 290 QTE-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 290 ~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
... ......||+.|+|||.+..........+.++|||++++
T Consensus 220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGv 261 (353)
T PLN00034 220 QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGV 261 (353)
T ss_pred cccccccccccCccccCccccccccccCcCCCcchhHHHHHH
Confidence 322 23445799999999987322222333457899995443
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=258.22 Aligned_cols=185 Identities=22% Similarity=0.334 Sum_probs=158.9
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
+..++|++.+.||+|+||.||++.+ +++.+|+|++...... .....+.+|+++++.++||||+++++++.+..
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP-----AIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH-----HHHHHHHHHHHHHHHCCCCcccceeEEEEECC
Confidence 4457899999999999999999988 5778999988654321 12356889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++...
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 77 EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (333)
T ss_pred EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence 999999999999999999764 3488999999999999999999985 7999999999999999999999999998754
Q ss_pred ccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 289 VQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
... ......||+.|+|||++ .+..++.++|+|+++
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~-----~~~~~~~~~DvwslG 189 (333)
T cd06650 155 IDS-MANSFVGTRSYMSPERL-----QGTHYSVQSDIWSMG 189 (333)
T ss_pred hhh-ccccCCCCccccCHHHh-----cCCCCCcHHHHHHHH
Confidence 332 23345799999999999 777899999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=257.75 Aligned_cols=189 Identities=23% Similarity=0.287 Sum_probs=154.0
Q ss_pred cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhc-CCCCCcceEEEEEEeCCeEEEEEEe
Q 019304 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT-LKHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
+.||+|+||.||+|.+ +++.||+|++++...... ...+.+..|..++.. ++||+|+++++++...+.+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLID---DDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhc---chHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECC
Confidence 4699999999999988 678999999975322111 112456677777765 4899999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc-CCCccC
Q 019304 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (343)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~-~~~~~~ 296 (343)
+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05620 78 LNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST 155 (316)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence 9999999998754 3588999999999999999999999999999999999999999999999999874321 222345
Q ss_pred CCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 297 ETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 297 ~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.+||+.|+|||++ ....++.++|+|+++. +++.+||++
T Consensus 156 ~~gt~~y~aPE~~-----~~~~~~~~~DiwslGvil~el~~g~~Pf~~ 198 (316)
T cd05620 156 FCGTPDYIAPEIL-----QGLKYTFSVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred cCCCcCccCHHHH-----cCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 6799999999999 7788999999996433 335566654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=259.86 Aligned_cols=193 Identities=22% Similarity=0.359 Sum_probs=171.3
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
.-|.+.+.||+|.|++|-++++ +|..||||++.+...+.... ..+.+|++.|+.++|||||++|++......+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st----~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLST----GHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhh----hHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence 3466778999999999999976 99999999999887765433 46779999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc-CCCcEEEeccccccccccC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~-~~~~vkl~DFg~a~~~~~~ 291 (343)
+|+|+=++|+|++|+.+.. ..++++.+.++++||+.|+.|||+..++||||||+|+.+. .-|-|||.|||++-.+.++
T Consensus 94 LiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999999998754 4599999999999999999999999999999999999865 6789999999999888888
Q ss_pred CCccCCCCCcceecCCCCCCCCCCCCCCc-eeeeeee-----cccccccCCC
Q 019304 292 EGMTPETGTYRWMAPGNSFFSPLPHPSFE-HKWSAKE-----SCLKTTWPPP 337 (343)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~-~~sDi~~-----~~~~~~~~p~ 337 (343)
...++.||+..|-|||++ .+..|+ +++|||+ +.++++.+||
T Consensus 173 ~kL~TsCGSLAYSAPEIL-----LGDsYDAPAVDiWSLGVILyMLVCGq~PF 219 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEIL-----LGDSYDAPAVDIWSLGVILYMLVCGQPPF 219 (864)
T ss_pred chhhcccchhhccCchhh-----hcCccCCcchhhhHHHHHHHHHHhCCCcc
Confidence 888999999999999999 667777 8889996 4446677777
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=247.39 Aligned_cols=188 Identities=29% Similarity=0.515 Sum_probs=161.6
Q ss_pred ceecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
|+++.++|++.+.||+|++|.||+|.+ +++.||+|.++..... .+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-------PKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc-------HHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence 678889999999999999999999987 5578999998754332 24688999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
...++||||+++++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++..
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 74 EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVI 153 (261)
T ss_pred CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence 99999999999999999997655456899999999999999999999999999999999999999999999999999865
Q ss_pred ccCCCccCCCC---CcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 289 VQTEGMTPETG---TYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 289 ~~~~~~~~~~g---t~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.... .....| +..|+|||.+ ....++.++|+|+++.
T Consensus 154 ~~~~-~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 192 (261)
T cd05068 154 KEDI-YEAREGAKFPIKWTAPEAA-----LYNRFSIKSDVWSFGI 192 (261)
T ss_pred cCCc-ccccCCCcCceeccCcccc-----ccCCCCchhhHHHHHH
Confidence 4321 112223 4589999999 7788999999996443
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=259.35 Aligned_cols=193 Identities=22% Similarity=0.260 Sum_probs=154.5
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR----- 208 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----- 208 (343)
+|++.+.||+|+||.||+|.. +++.||||.+......... ..++.+|+.+++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 76 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSD----ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 76 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchh----HHHHHHHHHHHHhCCCCCEeeecceEeccCCCCC
Confidence 477889999999999999987 6789999998643322211 24688999999999999999999988543
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
..+|+||||++ ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 77 KDIYVVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred ceEEEEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 24799999995 6899988654 35899999999999999999999999999999999999999999999999999754
Q ss_pred ccCC----CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 289 VQTE----GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 289 ~~~~----~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.... .....+||+.|+|||++.. ....++.++|||++++ +++.+||.
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~~DvwSlGvvl~el~tg~~pf~ 209 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFP 209 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhc---cccccCchhHHHHHHHHHHHHHcCCCCCC
Confidence 2211 1234579999999999821 1267899999996433 33555553
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=256.88 Aligned_cols=188 Identities=22% Similarity=0.288 Sum_probs=152.7
Q ss_pred cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhc-CCCCCcceEEEEEEeCCeEEEEEEe
Q 019304 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT-LKHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
+.||+|+||.||+|.+ +++.||||+++....... ...+.+..|..++.. ++||||+++++++.+...+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD---DDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhc---chHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeC
Confidence 3689999999999988 567899999975322111 112345667777775 5999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc-CCCccC
Q 019304 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (343)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~-~~~~~~ 296 (343)
+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05619 78 LNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT 155 (316)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence 9999999999753 3488899999999999999999999999999999999999999999999999874322 122344
Q ss_pred CCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 297 ETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 297 ~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.+||+.|+|||++ ....++.++|+|+++. +++.+||.
T Consensus 156 ~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~el~~G~~pf~ 197 (316)
T cd05619 156 FCGTPDYIAPEIL-----LGQKYNTSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred ecCCccccCHHHH-----cCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 5799999999999 7788999999996433 33555553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=255.22 Aligned_cols=188 Identities=20% Similarity=0.293 Sum_probs=150.6
Q ss_pred cccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC---CCCCcceEEEEEEeCCeEEEEEEe
Q 019304 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 143 lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
||+|+||.||+|.. +++.||||++........ .....+..|..++..+ .||+|+++++++.....+|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAK---KEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhh---hHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence 69999999999987 678999999864322111 1123445666666655 699999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc-CCCccC
Q 019304 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (343)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~-~~~~~~ 296 (343)
+++++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~ 155 (330)
T cd05586 78 MSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT 155 (330)
T ss_pred CCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence 9999999998754 4589999999999999999999999999999999999999999999999999875322 223345
Q ss_pred CCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 297 ETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 297 ~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.+||+.|+|||++. ....++.++|+|+++. +++++||.+
T Consensus 156 ~~gt~~y~aPE~~~----~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 156 FCGTTEYLAPEVLL----DEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred ccCCccccCHHHHc----CCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 67999999999982 2345889999996433 346677654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=256.89 Aligned_cols=179 Identities=24% Similarity=0.305 Sum_probs=150.6
Q ss_pred cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeEEEEEEe
Q 019304 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
+.||+|+||.||++.+ +++.||||++.+...... .....+.+|..+++.+ +||||+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQD---DDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh---hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 3689999999999988 567899999975322111 1234567888888887 799999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc-CCCccC
Q 019304 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (343)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~-~~~~~~ 296 (343)
+++++|..++.+. ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (318)
T cd05570 78 VNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST 155 (318)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence 9999999988754 3589999999999999999999999999999999999999999999999999875322 222334
Q ss_pred CCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 297 ETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 297 ~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.+||+.|+|||++ ....++.++|+|+++
T Consensus 156 ~~g~~~y~aPE~~-----~~~~~~~~~DiwslG 183 (318)
T cd05570 156 FCGTPDYIAPEIL-----SYQPYGPAVDWWALG 183 (318)
T ss_pred eecCccccCHHHh-----cCCCCCcchhhhhHH
Confidence 5799999999999 778899999999643
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=249.32 Aligned_cols=184 Identities=26% Similarity=0.404 Sum_probs=151.0
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC---CCCCcceEEEEEEe---
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACRK--- 207 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~--- 207 (343)
+|++.+.||+|+||.||+|.. +++.||+|.+.......... ..+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~----~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~ 76 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLP----LSTVREVALLKRLEAFDHPNIVRLMDVCATSRT 76 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCc----hHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC
Confidence 467789999999999999987 67899999987543322111 2345666666554 79999999998864
Q ss_pred --CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 208 --RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 208 --~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
...++++|||+.+ +|.+++.......+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++
T Consensus 77 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 77 DRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred CCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcc
Confidence 2457999999975 8999987655556899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 286 RIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+............||+.|+|||++ ....++.++|+|+++
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DiwslG 194 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVL-----LQSTYATPVDMWSVG 194 (288)
T ss_pred ccccCcccCCCccccccccCchHh-----hCCCCCCcchhhhHH
Confidence 866544444556789999999999 677899999999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=246.87 Aligned_cols=188 Identities=24% Similarity=0.482 Sum_probs=161.3
Q ss_pred ceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 207 (343)
|+++..+|.+.+.||+|++|.||+|.+ .++.||+|++...... ...+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLLGVCTR 73 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchH-------HHHHHHHHHHHHhCCCCChhheEEEEcC
Confidence 778889999999999999999999987 5788999998643221 2468899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
...++++|||+++++|.+++.......+++..++.++.|++.||+|||+.|++||||||+||++++++.+||+|||+++.
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~ 153 (263)
T cd05052 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 153 (263)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence 99999999999999999999765555689999999999999999999999999999999999999999999999999886
Q ss_pred cccCCCc--cCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 288 EVQTEGM--TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 288 ~~~~~~~--~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
....... ....+++.|+|||.+ ....++.++|+|+++
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slG 192 (263)
T cd05052 154 MTGDTYTAHAGAKFPIKWTAPESL-----AYNKFSIKSDVWAFG 192 (263)
T ss_pred cccceeeccCCCCCccccCCHHHh-----ccCCCCchhHHHHHH
Confidence 5432211 112345789999998 778889999999644
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=245.53 Aligned_cols=185 Identities=26% Similarity=0.458 Sum_probs=156.3
Q ss_pred cccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
+.++|++.+.||+|+||.||++.+ ++..+|+|.+...... ...+.+|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-------EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPL 74 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc-------HHHHHHHHHHHHHCCCCCceeEEEEEccCCCE
Confidence 557788899999999999999988 4568999988644332 24688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||.++.....
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 99999999999999987543 35889999999999999999999999999999999999999999999999998754322
Q ss_pred CCc--cCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 292 EGM--TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 292 ~~~--~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
... ....++..|+|||.+ ....++.++|+|+++.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~s~G~ 189 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVF-----NFSKYSSKSDVWSFGV 189 (256)
T ss_pred ceeccCCCCCchhhCChhhc-----ccCccchhhhhHHHHH
Confidence 211 122355789999999 7778999999996443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=264.58 Aligned_cols=193 Identities=24% Similarity=0.383 Sum_probs=155.0
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR-- 208 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-- 208 (343)
..++|++++.||+|+||.||+|.. +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~ 133 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----------QYKNRELLIMKNLNHINIIFLKDYYYTECF 133 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----------chHHHHHHHHHhcCCCCCcceeeeEeeccc
Confidence 346789999999999999999987 67899999885432 1234799999999999999998876432
Q ss_pred ------CeEEEEEEecCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC-cEEE
Q 019304 209 ------MVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKI 279 (343)
Q Consensus 209 ------~~~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~-~vkl 279 (343)
..+++||||+++ +|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 134 ~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 134 KKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred ccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceee
Confidence 246799999975 78777753 2345689999999999999999999999999999999999998654 7999
Q ss_pred eccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 280 ADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 280 ~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
+|||+|+............||+.|+|||++. ....++.++|||++++ +++++||.+.
T Consensus 213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 274 (440)
T PTZ00036 213 CDFGSAKNLLAGQRSVSYICSRFYRAPELML----GATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274 (440)
T ss_pred eccccchhccCCCCcccCCCCcCccCHHHhc----CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999998665444444567899999999873 3356899999996433 3467777553
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=259.97 Aligned_cols=183 Identities=23% Similarity=0.308 Sum_probs=154.4
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC---
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--- 208 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--- 208 (343)
.++|++.+.||+|+||.||++.. .++.||||++........ ..+.+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT----HAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChH----HHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 47889999999999999999987 678999999976543322 235678999999999999999999988643
Q ss_pred ---CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 209 ---MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 209 ---~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
...++||||+++ +|.+.+.. .++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 347999999965 77777643 3788889999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 286 RIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+............||+.|+|||++ ....++.++|+|+++.
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~-----~~~~~~~~~DiwslG~ 206 (355)
T cd07874 167 RTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENVDIWSVGC 206 (355)
T ss_pred ccCCCccccCCccccCCccCHHHH-----cCCCCCchhhHHHHHH
Confidence 865544444556899999999999 7778999999996443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=259.99 Aligned_cols=194 Identities=29% Similarity=0.480 Sum_probs=161.6
Q ss_pred CCccceecccccccccccccccceEEEEEEEC-------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCC
Q 019304 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLN 197 (343)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n 197 (343)
....|+++.++|.+++.||+|+||.||+|++. ++.||||+++....... .+.+.+|+.++..+. |||
T Consensus 28 ~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~-----~~~~~~E~~~l~~l~~H~n 102 (401)
T cd05107 28 YDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSE-----KQALMSELKIMSHLGPHLN 102 (401)
T ss_pred CCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhH-----HHHHHHHHHHHHhcCCCCC
Confidence 34569999999999999999999999999863 25799999976433221 246889999999997 999
Q ss_pred cceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCC---------------------------------------------
Q 019304 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------------------------------------------- 232 (343)
Q Consensus 198 Iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------------------------------------------- 232 (343)
|+++++++.....+++||||+++|+|.+++.+...
T Consensus 103 iv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (401)
T cd05107 103 IVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMS 182 (401)
T ss_pred eEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccC
Confidence 99999999999999999999999999999975321
Q ss_pred ---------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 019304 233 ---------------------------------------------------RAVPLKLAVKQALDVARGMAYVHGLGFIH 261 (343)
Q Consensus 233 ---------------------------------------------------~~~~~~~~~~i~~qi~~gL~yLH~~giiH 261 (343)
..+++..++.++.|++.||+|||+.+++|
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH 262 (401)
T cd05107 183 KDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVH 262 (401)
T ss_pred CccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCc
Confidence 12566678889999999999999999999
Q ss_pred CCCCCCcEEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 262 rDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
|||||+|||++.++.+||+|||+++....... .....+++.|+|||.+ ....++.++|+|+++
T Consensus 263 rdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DvwslG 328 (401)
T cd05107 263 RDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI-----FNNLYTTLSDVWSFG 328 (401)
T ss_pred ccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHh-----cCCCCCcHhHHHHHH
Confidence 99999999999999999999999986432221 1233577899999999 677789999999643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=255.83 Aligned_cols=191 Identities=27% Similarity=0.506 Sum_probs=157.9
Q ss_pred cceecccccccccccccccceEEEEEEE-------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcce
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVR 200 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~ 200 (343)
+|.++.++|++.+.||+|+||.||+|.. +++.||+|++....... ..+.+.+|+.+++.+ +||||++
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~-----~~~~~~~E~~~~~~l~~h~niv~ 75 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATAS-----EYKALMTELKILIHIGHHLNVVN 75 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHH-----HHHHHHHHHHHHHhhccCcchhh
Confidence 5889999999999999999999999964 23679999986543221 125678899999999 8999999
Q ss_pred EEEEEEeC-CeEEEEEEecCCCCHHHHHHhhCC-----------------------------------------------
Q 019304 201 FIGACRKR-MVWCIVTEYAKGGSVRQFLTRRQN----------------------------------------------- 232 (343)
Q Consensus 201 l~~~~~~~-~~~~iv~E~~~~gsL~~~l~~~~~----------------------------------------------- 232 (343)
++++|... ..+++++||+++++|.+++.....
T Consensus 76 ~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (337)
T cd05054 76 LLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD 155 (337)
T ss_pred eeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhh
Confidence 99988654 568899999999999999864321
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCC---ccCC
Q 019304 233 ------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPE 297 (343)
Q Consensus 233 ------------~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~ 297 (343)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ....
T Consensus 156 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~ 235 (337)
T cd05054 156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235 (337)
T ss_pred cccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCC
Confidence 2578889999999999999999999999999999999999999999999999986433221 1223
Q ss_pred CCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 298 TGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 298 ~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.++..|+|||++ ....++.++|||++.
T Consensus 236 ~~~~~y~aPE~~-----~~~~~~~~~Di~SlG 262 (337)
T cd05054 236 RLPLKWMAPESI-----FDKVYTTQSDVWSFG 262 (337)
T ss_pred CCCccccCcHHh-----cCCCCCccccHHHHH
Confidence 456789999999 788899999999643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=268.24 Aligned_cols=198 Identities=24% Similarity=0.305 Sum_probs=163.0
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
...++|++.+.||+|+||.||++.. +++.||||++......... ...+.+|+.++..++|+||++++..+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~----~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEAD----KNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHH----HHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 3457899999999999999999987 7889999999765543322 356789999999999999999988775432
Q ss_pred --------eEEEEEEecCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEE
Q 019304 210 --------VWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (343)
Q Consensus 210 --------~~~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl 279 (343)
.+++||||+++|+|.+++..+. ...+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEE
Confidence 3689999999999999997532 346889999999999999999999999999999999999999999999
Q ss_pred eccccccccccC---CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecccc-----cccCCCC
Q 019304 280 ADFGVARIEVQT---EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLK-----TTWPPPW 338 (343)
Q Consensus 280 ~DFg~a~~~~~~---~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~-----~~~~p~~ 338 (343)
+|||+++..... ......+||+.|+|||++ ....++.++|||+++.+ ++.+||.
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~-----~~~~~s~k~DVwSlGvilyeLltG~~Pf~ 246 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIW-----RRKPYSKKADMFSLGVLLYELLTLKRPFD 246 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHh-----CCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 999999864322 123345799999999999 77889999999964432 3455554
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=247.88 Aligned_cols=189 Identities=30% Similarity=0.525 Sum_probs=157.9
Q ss_pred ecccccccccccccccceEEEEEEECC-------ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 204 (343)
++..+|++.+.||+|+||.||+|...+ ..||+|.+...... .....|.+|+.+++.++||||++++++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~-----~~~~~~~~ei~~l~~l~h~~i~~~~~~ 76 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-----KVQQEFRQEAELMSDLQHPNIVCLLGV 76 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH-----HHHHHHHHHHHHHHhcCCcccceEEEE
Confidence 456789999999999999999998632 46999988643321 123578999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEE
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQN--------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NIL 270 (343)
+......+++|||+++++|.+++..... ..+++..++.++.|++.||+|||++|++|+||||+||+
T Consensus 77 ~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil 156 (283)
T cd05048 77 CTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCL 156 (283)
T ss_pred EcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEE
Confidence 9998899999999999999999976421 34788889999999999999999999999999999999
Q ss_pred EcCCCcEEEeccccccccccCC---CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 271 ISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 271 v~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+++++.+||+|||+++...... ......+++.|+|||.+ ....++.++|+|+++.
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~sDv~slG~ 214 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAI-----LYGKFTTESDIWSFGV 214 (283)
T ss_pred EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHh-----ccCcCchhhhHHHHHH
Confidence 9999999999999987543222 12234568899999998 6778999999996443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=242.78 Aligned_cols=186 Identities=32% Similarity=0.561 Sum_probs=163.0
Q ss_pred ceecccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
|.++.++|++.+.||+|++|.||+|...++.||||.+..... ..+++.+|+.+++.++|+||+++++.+....
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 73 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGN 73 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCC
Confidence 567788999999999999999999999999999999975432 2367899999999999999999999999888
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
..++||||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||.++...
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccc
Confidence 99999999999999999987655568999999999999999999999999999999999999999999999999998653
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.. ......+..|+|||.+ ....++.++|+|+++
T Consensus 154 ~~--~~~~~~~~~~~ape~~-----~~~~~~~~~Di~slG 186 (256)
T cd05039 154 QG--QDSGKLPVKWTAPEAL-----REKKFSTKSDVWSFG 186 (256)
T ss_pred cc--cccCCCcccccCchhh-----cCCcCCcHHHHHHHH
Confidence 22 1233456789999998 677889999999644
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=243.94 Aligned_cols=186 Identities=28% Similarity=0.524 Sum_probs=160.0
Q ss_pred ceecccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE-eC
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR-KR 208 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~ 208 (343)
|.++.++|++.+.||+|+||.||++...++.+|+|.+..... .+.+.+|+.+++.++|++++++++++. ..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~--------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCch--------HHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence 677889999999999999999999999999999999854221 246889999999999999999999764 44
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
...++++||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++..
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 73 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152 (256)
T ss_pred CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceec
Confidence 57899999999999999998765556889999999999999999999999999999999999999999999999998754
Q ss_pred ccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 289 VQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
... .....++..|+|||++ ....++.++|+|+++.
T Consensus 153 ~~~--~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slG~ 187 (256)
T cd05082 153 SST--QDTGKLPVKWTAPEAL-----REKKFSTKSDVWSFGI 187 (256)
T ss_pred ccc--CCCCccceeecCHHHH-----ccCCCCchhhhHHHHH
Confidence 322 2233456789999998 7788999999996443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=258.73 Aligned_cols=182 Identities=24% Similarity=0.315 Sum_probs=153.9
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC---
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--- 208 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--- 208 (343)
.++|++.+.||+|+||.||++.. .++.||||++......... .+.+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH----AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchh----HHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence 46788999999999999999987 6788999999765433222 25678999999999999999999987543
Q ss_pred ---CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 209 ---MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 209 ---~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
..+|+||||+++ +|.+++.. .++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 99 EEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred cccCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 357999999965 78777753 3788889999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 286 RIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+............||+.|+|||++ .+..++.++|+|+++
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~-----~~~~~~~~~DiwSlG 212 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENVDIWSVG 212 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHH-----hCCCCCchhhHHhHH
Confidence 875544444556899999999999 778899999999543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=276.63 Aligned_cols=197 Identities=21% Similarity=0.275 Sum_probs=161.5
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
.+|++.+.||+|+||.||+|.+ +++.||||++........ ...+++.+|+.+++.++||||+++++++.+.+..+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e---~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~ly 78 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENP---LLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVY 78 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCH---HHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEE
Confidence 5688899999999999999987 678999999975433222 23467999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 213 IVTEYAKGGSVRQFLTRRQ---------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
+||||++|++|.+++.... ....+...++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999999986421 1234566788999999999999999999999999999999999999999999
Q ss_pred cccccccCC-------------------CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 284 VARIEVQTE-------------------GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 284 ~a~~~~~~~-------------------~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
+++...... .....+||+.|+|||.+ .+..++.++|+|+++. +++.+||.+
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l-----~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL-----LGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHh-----cCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 997641100 01124699999999999 7788999999996433 346666643
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=251.87 Aligned_cols=185 Identities=23% Similarity=0.439 Sum_probs=153.2
Q ss_pred cccccccccccccccceEEEEEEE--CCc----eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
...+|+..+.||+|+||.||+|.+ +++ .||+|+++..... ...+++.+|+.+++.++||||++++++|.
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~g~~~ 79 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-----KANKEILDEAYVMASVDNPHVCRLLGICL 79 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEc
Confidence 446788999999999999999986 344 3899998643221 12357889999999999999999999998
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
.. ..++++||+++|+|.+++.... ..++...++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+++
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 80 TS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred CC-CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccc
Confidence 75 4679999999999999997643 357888999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCc---cCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 287 IEVQTEGM---TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 287 ~~~~~~~~---~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
........ ....++..|+|||.+ ....++.++|+|+++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~-----~~~~~~~~~Di~slG 198 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESI-----LHRIYTHQSDVWSYG 198 (316)
T ss_pred cccCCCcceeccCCccceeecChHHh-----ccCCCCchhhhHHHH
Confidence 65433221 122346789999999 788899999999644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=246.61 Aligned_cols=191 Identities=25% Similarity=0.432 Sum_probs=158.1
Q ss_pred ceecccccccccccccccceEEEEEEEC-------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEE
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~ 202 (343)
|.+..++|++.+.||+|+||.||+|.+. ++.||||.+....... ...++.+|+.+++.++||||++++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~iv~~~ 75 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR-----ERIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHH-----HHHHHHHHHHHHHhCCCCCeeeEE
Confidence 7788899999999999999999999763 3579999885432211 125688999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCCHHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC
Q 019304 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274 (343)
Q Consensus 203 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~ 274 (343)
+++......++||||+++++|.+++.+... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 76 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 155 (277)
T ss_pred EEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC
Confidence 999998999999999999999999975321 235677889999999999999999999999999999999999
Q ss_pred CcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 275 KSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 275 ~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+.+||+|||+++....... .....+++.|+|||.+ ....++.++|+|+++.
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 209 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL-----KDGVFTTYSDVWSFGV 209 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHh-----hcCCcCchhHHHHHHH
Confidence 9999999999875432211 1123457889999999 7788999999996444
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=245.58 Aligned_cols=191 Identities=26% Similarity=0.436 Sum_probs=160.4
Q ss_pred ceecccccccccccccccceEEEEEEEC-------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEE
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~ 202 (343)
|+++.++|++.+.||+|+||.||+|... +..||+|.+....... ....+.+|+.+++.+.||||++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~ 75 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR-----ERIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHH-----HHHHHHHHHHHHHhCCCCceeEEE
Confidence 7788899999999999999999999863 2579999986443221 124688999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCCHHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC
Q 019304 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274 (343)
Q Consensus 203 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~ 274 (343)
+++......++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+++||||||+|||++.+
T Consensus 76 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~ 155 (277)
T cd05032 76 GVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED 155 (277)
T ss_pred EEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC
Confidence 999999999999999999999999975321 236788899999999999999999999999999999999999
Q ss_pred CcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 275 KSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 275 ~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+.+||+|||+++....... .....++..|+|||.+ ....++.++|+|++++
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 209 (277)
T cd05032 156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL-----KDGVFTTKSDVWSFGV 209 (277)
T ss_pred CCEEECCcccchhhccCcccccCCCCCccccccCHHHH-----hcCCCCcccchHHHHH
Confidence 9999999999876443321 2234567899999998 7788999999996443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=239.82 Aligned_cols=184 Identities=23% Similarity=0.373 Sum_probs=158.4
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||+|+||.||++.+ +++.+|+|.++...... ..+.+.+|+.+++.++||||+++++.+.....+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSS-----AVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchH-----HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEE
Confidence 467789999999999999987 67899999986543222 13567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCC
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~ 293 (343)
+|||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||++++++.++|+|||.++.......
T Consensus 76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999999999998765556688999999999999999999999999999999999999999999999999876543222
Q ss_pred -ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 294 -MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 294 -~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.....|++.|+|||++ ....++.++|+|+++
T Consensus 156 ~~~~~~~~~~~~aPE~~-----~~~~~~~~~Dv~slG 187 (255)
T cd08219 156 YACTYVGTPYYVPPEIW-----ENMPYNNKSDIWSLG 187 (255)
T ss_pred ccccccCCccccCHHHH-----ccCCcCchhhhhhhc
Confidence 2335689999999998 777899999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=244.30 Aligned_cols=188 Identities=31% Similarity=0.509 Sum_probs=158.6
Q ss_pred ceecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
|.++..+|++.++||+|+||.||+|++ +...||+|++....... +.+.+|+.+++.++||||+++++.+..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~-------~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-------EAFLQEAQVMKKLRHEKLVQLYAVVSE- 72 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCH-------HHHHHHHHHHHhCCCCCcceEEEEECC-
Confidence 678888999999999999999999988 44579999987533321 468899999999999999999998754
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
...++||||+++++|.+++.+.....+++..+..++.|++.||+|||+.+++|+||||+||+++.++.+||+|||.++..
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~ 152 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 152 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeec
Confidence 45789999999999999998654456789999999999999999999999999999999999999999999999999765
Q ss_pred ccCCCc--cCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 289 VQTEGM--TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 289 ~~~~~~--~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
...... ....++..|+|||.. ....++.++|+|+++.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~-----~~~~~~~~~DvwslG~ 191 (262)
T cd05071 153 EDNEYTARQGAKFPIKWTAPEAA-----LYGRFTIKSDVWSFGI 191 (262)
T ss_pred cccccccccCCcccceecCHhHh-----ccCCCCchhhHHHHHH
Confidence 433221 123456789999998 7788999999996443
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=257.10 Aligned_cols=177 Identities=22% Similarity=0.363 Sum_probs=152.3
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
...|++.+.||+|+||.||+|.. +++.||+|+.... ....|+.+++.++||||+++++++......
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 132 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------------TTLIEAMLLQNVNHPSVIRMKDTLVSGAIT 132 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------------ccHHHHHHHHhCCCCCCcChhheEEeCCee
Confidence 35688999999999999999998 5568999975321 234689999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++|+|++. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 133 ~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 133 CMVLPHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EEEEEccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 99999995 5899988753 346899999999999999999999999999999999999999999999999999754433
Q ss_pred CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 292 EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.......||+.|+|||++ ....++.++|+|++.
T Consensus 211 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG 243 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVL-----ARDKYNSKADIWSAG 243 (357)
T ss_pred cccccccccccccCCeec-----CCCCCCchhhHHHHH
Confidence 333455799999999999 778899999999643
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=240.58 Aligned_cols=185 Identities=23% Similarity=0.370 Sum_probs=159.6
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|.+.+.||+|++|.||+++. +++.|++|.+........ ..+.+.+|+.+++.++||||+++++.+.....+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR----EREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNI 76 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHH----HHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEE
Confidence 366778999999999999988 678999999875443322 23578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCC
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~ 293 (343)
||||+++++|.+++.......++...++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||+++.......
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999999999876556789999999999999999999999999999999999999999999999999886543322
Q ss_pred -ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 294 -MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 294 -~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.....|++.|+|||++ ....++.++|+|+++
T Consensus 157 ~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG 188 (256)
T cd08529 157 FANTIVGTPYYLSPELC-----EDKPYNEKSDVWALG 188 (256)
T ss_pred hhhccccCccccCHHHh-----cCCCCCCccchHHHH
Confidence 2344788999999999 777889999999643
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-33 Score=243.33 Aligned_cols=184 Identities=23% Similarity=0.352 Sum_probs=159.6
Q ss_pred cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe----CCeEEE
Q 019304 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK----RMVWCI 213 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~~~i 213 (343)
+.||-|-.|+|..+.. +++.+|+|++... ....+|+++--.. .|||||++++++.. ...+.+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi 136 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI 136 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence 5799999999999977 7889999998532 2345788765444 69999999998843 457899
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc---CCCcEEEecccccccccc
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS---ADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~---~~~~vkl~DFg~a~~~~~ 290 (343)
|||.|+||.|.+.++.++...+.+.++..|..||+.|+.|||+.+|.||||||+|+|.. .+..+||+|||+|+....
T Consensus 137 VmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 137 VMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred eeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 99999999999999998888899999999999999999999999999999999999996 456899999999997665
Q ss_pred CCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeee-----cccccccCCCCcc
Q 019304 291 TEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKE-----SCLKTTWPPPWRH 340 (343)
Q Consensus 291 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~-----~~~~~~~~p~~~~ 340 (343)
.....+.|-||+|.|||++ ...+|+..+|+|+ +.++++||||.++
T Consensus 217 ~~~L~TPc~TPyYvaPevl-----g~eKydkscdmwSlgVimYIlLCGyPPFYS~ 266 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVL-----GPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_pred CccccCCcccccccCHHHh-----CchhcCCCCCccchhHHHHHhhcCCCccccc
Confidence 5667778999999999999 9999999999997 3446799999764
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=248.26 Aligned_cols=193 Identities=29% Similarity=0.502 Sum_probs=160.2
Q ss_pred ccceecccccccccccccccceEEEEEEE---------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCC
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY---------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 197 (343)
..|++...+|.+.+.||+|+||.||++++ ++..||+|.+....... ..+.+.+|+.+++.+ +|||
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~ 82 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK-----DLSDLVSEMEMMKMIGKHKN 82 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchH-----HHHHHHHHHHHHHhhccCCC
Confidence 45788899999999999999999999974 22468999886432221 135788999999999 8999
Q ss_pred cceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCC
Q 019304 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (343)
Q Consensus 198 Iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~gL~yLH~~giiHrD 263 (343)
|+++++.+......++||||+++++|.+++..... ..+++..++.++.|++.||.|||++|++|||
T Consensus 83 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~d 162 (304)
T cd05101 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRD 162 (304)
T ss_pred chheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 99999999999999999999999999999976421 2467788899999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 264 LKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 264 lkp~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|||+|||++.++.+||+|||+++....... .....+++.|+|||++ ....++.++|+|+++.
T Consensus 163 lkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 227 (304)
T cd05101 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGV 227 (304)
T ss_pred cccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhh-----ccCCCCchhhHHHHHH
Confidence 999999999999999999999986533211 1223456889999999 6788999999996444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=243.42 Aligned_cols=189 Identities=31% Similarity=0.516 Sum_probs=162.4
Q ss_pred ceecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
|+++.++|++.+.||+|+||.||++.. +++.||||.+....... +++.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP-------EAFLQEAQIMKKLRHDKLVQLYAVCSEE 73 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCH-------HHHHHHHHHHhhCCCCCEeeeeeeeecC
Confidence 778899999999999999999999987 45789999987544332 4688999999999999999999999988
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
..+++||||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||+++..
T Consensus 74 ~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 74 EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLI 153 (261)
T ss_pred CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceec
Confidence 88999999999999999998755556899999999999999999999999999999999999999999999999998765
Q ss_pred ccCCC--ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 289 VQTEG--MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 289 ~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
..... .....++..|+|||.+ ....++.++|+|+++.
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~-----~~~~~~~~~Di~slG~ 192 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAA-----NYGRFTIKSDVWSFGI 192 (261)
T ss_pred cchhhhhhhccCCCccccCHHHh-----ccCCcCchhHHHHHHH
Confidence 43211 1122345789999999 7778899999996543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-32 Score=242.35 Aligned_cols=184 Identities=28% Similarity=0.471 Sum_probs=155.4
Q ss_pred cccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
+..+|++.+.||+|+||.||++.+ .+..+|+|++....... ..+.+|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-------DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPI 74 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH-------HHHHHHHHHHHhCCCCCEEEEEEEEcCCCce
Confidence 456788999999999999999988 45579999986544322 3578899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++.....
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred EEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 99999999999999997643 35889999999999999999999999999999999999999999999999998764332
Q ss_pred CCcc--CCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 292 EGMT--PETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 292 ~~~~--~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.... ...++..|+|||.+ ....++.++|+|+++
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~-----~~~~~~~~~Di~slG 188 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVF-----DYSRFSSKSDVWSFG 188 (256)
T ss_pred cccccCCCCCCccccCHHHh-----ccCCCCchhhHHHHH
Confidence 2111 11234579999999 778899999999644
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=242.86 Aligned_cols=188 Identities=32% Similarity=0.513 Sum_probs=159.3
Q ss_pred ceecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
|+++.++|++.+.||+|+||.||+|.. .+..+|+|.+....... +.+.+|+.+++.++|++++++++.+..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-------ESFLEEAQIMKKLRHDKLVQLYAVVSE- 72 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH-------HHHHHHHHHHHhcCCCceEEEEeEECC-
Confidence 778889999999999999999999987 56789999987644432 468899999999999999999998854
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
...+++|||+++++|.+++.......+++..++.++.|++.||.|||+.+++||||||+||++++++.+||+|||++...
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLI 152 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeec
Confidence 45789999999999999997655556899999999999999999999999999999999999999999999999999765
Q ss_pred ccCCCc--cCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 289 VQTEGM--TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 289 ~~~~~~--~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
...... ....++..|+|||.+ ....++.++|+|+++.
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 191 (260)
T cd05070 153 EDNEYTARQGAKFPIKWTAPEAA-----LYGRFTIKSDVWSFGI 191 (260)
T ss_pred cCcccccccCCCCCccccChHHH-----hcCCCcchhhhHHHHH
Confidence 432211 122355689999998 6788999999996443
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=269.92 Aligned_cols=203 Identities=24% Similarity=0.368 Sum_probs=163.4
Q ss_pred ceecccccccccccccccceEEEEEEE-CC-ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEE-
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NG-EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGAC- 205 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~- 205 (343)
.+|...++++.+.|.+|||+.||.|.. .+ .++|+|++-.... ...+.+.+|+++|+.|+ |+|||.+++..
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de------~~L~~v~~EI~~MK~L~gh~nIV~yidss~ 105 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDE------EALNAVKREIDIMKLLSGHKNIVSYIDSSA 105 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCH------HHHHHHHHHHHHHHHhcCCCceeeEecccc
Confidence 456667888899999999999999998 44 8999998865421 12467899999999997 99999999943
Q ss_pred Ee------CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCcEEEcCCCcE
Q 019304 206 RK------RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSI 277 (343)
Q Consensus 206 ~~------~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~g--iiHrDlkp~NILv~~~~~v 277 (343)
.. .-.++|+||||.||.|.+++..+....+.+.++++|+.|+|+|+.+||... |||||||.+||||+.+|..
T Consensus 106 ~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~ 185 (738)
T KOG1989|consen 106 INRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNY 185 (738)
T ss_pred ccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCE
Confidence 11 124789999999999999999776666999999999999999999999997 9999999999999999999
Q ss_pred EEeccccccccccCCCccC----------CCCCcceecCCCCCCCCCCCCCCceeeeeeeccc----ccccCCCCcc
Q 019304 278 KIADFGVARIEVQTEGMTP----------ETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL----KTTWPPPWRH 340 (343)
Q Consensus 278 kl~DFg~a~~~~~~~~~~~----------~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~----~~~~~p~~~~ 340 (343)
||||||.|........... ..-|+.|.|||.+ .-+.+..++.|+|||++.+ +++|+.|+..
T Consensus 186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMI--Dlysg~pI~eKsDIWALGclLYkLCy~t~PFe~ 260 (738)
T KOG1989|consen 186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMI--DLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE 260 (738)
T ss_pred EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHH--hhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc
Confidence 9999999864322211111 1258999999998 2237888999999996333 5567666654
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=246.76 Aligned_cols=192 Identities=26% Similarity=0.430 Sum_probs=158.3
Q ss_pred ceecccccccccccccccceEEEEEEEC-------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEE
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~ 202 (343)
|+++..+|++.+.||+|+||.||+|... +..||+|.+........ ...+.+|+.+++.++||||++++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~ 75 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE-----RIEFLNEASVMKGFTCHHVVRLL 75 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHH-----HHHHHHHHHHHHhCCCCCeeeEE
Confidence 7889999999999999999999999652 34799998864432211 24678999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCCHHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC
Q 019304 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274 (343)
Q Consensus 203 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~ 274 (343)
+++.+....++||||+++|+|.+++.+... .......+..++.|++.||.|||+++++||||||+|||++.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~ 155 (288)
T cd05061 76 GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD 155 (288)
T ss_pred EEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC
Confidence 999999999999999999999999975321 234567788999999999999999999999999999999999
Q ss_pred CcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecccc
Q 019304 275 KSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLK 331 (343)
Q Consensus 275 ~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~ 331 (343)
+.+||+|||+++....... .....++..|+|||.+ ....++.++|+|+++.+
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~-----~~~~~~~~~DvwslG~~ 210 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL-----KDGVFTTSSDMWSFGVV 210 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHh-----ccCCCChHhHHHHHHHH
Confidence 9999999999885433221 1222456789999998 77889999999965443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=244.41 Aligned_cols=190 Identities=31% Similarity=0.519 Sum_probs=162.6
Q ss_pred ceecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
|+....+|++.+.||.|+||.||+|.+ .++.+|+|++....... ...+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (261)
T cd05148 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK------QQDFQKEVQALKRLRHKHLISLFAVCSVG 74 (261)
T ss_pred CcCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhh------HHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence 556678899999999999999999988 56789999986543211 24688999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
..+++||||+++++|.+++.+.....+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||.+...
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 75 EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhc
Confidence 99999999999999999998765667899999999999999999999999999999999999999999999999998764
Q ss_pred ccCC-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 289 VQTE-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 289 ~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.... ......+++.|+|||.+ ....++.++|+|+++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~-----~~~~~~~~~DiwslG~ 192 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAA-----SHGTFSTKSDVWSFGI 192 (261)
T ss_pred CCccccccCCCCceEecCHHHH-----ccCCCCchhhHHHHHH
Confidence 3321 12233456889999998 7788999999996443
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=242.55 Aligned_cols=185 Identities=29% Similarity=0.480 Sum_probs=156.2
Q ss_pred cccccccccccccccceEEEEEEECC-ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTYNG-EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
+.++|++.+.||+|+||.||++.+.+ ..+|||.+...... ...+.+|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-------EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPI 74 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc-------HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCc
Confidence 45778889999999999999998844 46999998654332 24688999999999999999999999988889
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||.++.....
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 99999999999999997643 35899999999999999999999999999999999999999999999999998754332
Q ss_pred CCc--cCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 292 EGM--TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 292 ~~~--~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
... ....++..|+|||.+ ....++.++|+|+++.
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~-----~~~~~~~~~Di~slG~ 189 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVL-----LYSKFSSKSDVWAFGV 189 (256)
T ss_pred ceeecCCCccChhhCCHHHH-----hcCcccchhHHHHHHH
Confidence 211 122356789999999 7778999999996443
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=248.20 Aligned_cols=194 Identities=29% Similarity=0.487 Sum_probs=160.5
Q ss_pred CccceecccccccccccccccceEEEEEEEC---------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCC
Q 019304 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHL 196 (343)
Q Consensus 127 ~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 196 (343)
...|++..++|.+++.||+|+||.||++.+. ...+|+|.+....... ..+.+.+|+.+++.+ +||
T Consensus 10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~h~ 84 (307)
T cd05098 10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK-----DLSDLISEMEMMKMIGKHK 84 (307)
T ss_pred CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChH-----HHHHHHHHHHHHHHhcCCC
Confidence 4578899999999999999999999999752 2469999987532211 125688899999999 799
Q ss_pred CcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeC
Q 019304 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------------RAVPLKLAVKQALDVARGMAYVHGLGFIHR 262 (343)
Q Consensus 197 nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~gL~yLH~~giiHr 262 (343)
||+++++++......++||||+++++|.+++..... ..+++..+++++.|++.||+|||+.|++||
T Consensus 85 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 164 (307)
T cd05098 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHR 164 (307)
T ss_pred CEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 999999999999999999999999999999976432 247888999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 263 DLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 263 Dlkp~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
||||+|||++.++.+||+|||.++....... .....+++.|+|||.+ ....++.++|+|+++.
T Consensus 165 dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DvwslG~ 230 (307)
T cd05098 165 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-----FDRIYTHQSDVWSFGV 230 (307)
T ss_pred cccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHh-----ccCCCCcHHHHHHHHH
Confidence 9999999999999999999999875432211 1112345789999998 6778899999996443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=241.97 Aligned_cols=188 Identities=29% Similarity=0.491 Sum_probs=160.7
Q ss_pred ceecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
|+|..++|++.++||+|+||.||+|.. +++.||+|.+....... .++.+|+.+++.++||||+++++.+..
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~- 72 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP-------EAFLAEANLMKQLQHPRLVRLYAVVTQ- 72 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcH-------HHHHHHHHHHHhcCCcCeeeEEEEEcc-
Confidence 778889999999999999999999987 67889999987554432 468899999999999999999998754
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
...+++|||+++++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++...
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 73 EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLI 152 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeec
Confidence 56799999999999999997655567899999999999999999999999999999999999999999999999998765
Q ss_pred ccCCC--ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 289 VQTEG--MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 289 ~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
..... .....++..|+|||.+ ....++.++|+|+++.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~-----~~~~~~~~~Di~slG~ 191 (260)
T cd05067 153 EDNEYTAREGAKFPIKWTAPEAI-----NYGTFTIKSDVWSFGI 191 (260)
T ss_pred CCCCcccccCCcccccccCHHHh-----ccCCcCcccchHHHHH
Confidence 42221 1223456789999999 7788999999996443
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=241.14 Aligned_cols=188 Identities=29% Similarity=0.470 Sum_probs=159.8
Q ss_pred ceecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
|+++.++|++.+.||+|+||.||++.. .+..+|+|.+..... ..+.+.+|+.+++.++|+||+++++.+..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-------SVEAFLAEANVMKTLQHDKLVKLHAVVTK- 72 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh-------HHHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence 788899999999999999999999987 556799998864321 12568899999999999999999999887
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
...+++|||+++++|.+++.+.....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||.+...
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 152 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeec
Confidence 67799999999999999998755556788899999999999999999999999999999999999999999999998754
Q ss_pred ccCCC--ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 289 VQTEG--MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 289 ~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
..... .....++..|+|||++ ....++.++|+|+++.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~-----~~~~~~~~~Di~slG~ 191 (260)
T cd05073 153 EDNEYTAREGAKFPIKWTAPEAI-----NFGSFTIKSDVWSFGI 191 (260)
T ss_pred cCCCcccccCCcccccccCHhHh-----ccCCcCccccchHHHH
Confidence 33221 1122456789999999 7778999999997543
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=252.54 Aligned_cols=191 Identities=26% Similarity=0.501 Sum_probs=156.2
Q ss_pred cceecccccccccccccccceEEEEEEE-------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcce
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVR 200 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~ 200 (343)
+|.++.++|++++.||+|+||.||+|.+ +++.||||+++....... ...+.+|+.++..+ +||||++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~h~niv~ 75 (343)
T cd05103 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLNVVN 75 (343)
T ss_pred CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHH-----HHHHHHHHHHHHhccCCccHhh
Confidence 4888899999999999999999999974 457899999965432221 25688999999999 6899999
Q ss_pred EEEEEEeC-CeEEEEEEecCCCCHHHHHHhhCC-----------------------------------------------
Q 019304 201 FIGACRKR-MVWCIVTEYAKGGSVRQFLTRRQN----------------------------------------------- 232 (343)
Q Consensus 201 l~~~~~~~-~~~~iv~E~~~~gsL~~~l~~~~~----------------------------------------------- 232 (343)
+++++... ..+++||||+++|+|.+++.....
T Consensus 76 ~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (343)
T cd05103 76 LLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEE 155 (343)
T ss_pred hcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCC
Confidence 99988654 467899999999999999875321
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCC-
Q 019304 233 ------------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG- 293 (343)
Q Consensus 233 ------------------~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~- 293 (343)
..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 235 (343)
T cd05103 156 KSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235 (343)
T ss_pred CccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch
Confidence 2357778889999999999999999999999999999999999999999999875432211
Q ss_pred --ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 294 --MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 294 --~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.....+++.|+|||.+ ....++.++|+|+++
T Consensus 236 ~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG 268 (343)
T cd05103 236 VRKGDARLPLKWMAPETI-----FDRVYTIQSDVWSFG 268 (343)
T ss_pred hhcCCCCCCcceECcHHh-----cCCCCCchhhHHHHH
Confidence 1122356789999998 778899999999644
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=244.23 Aligned_cols=194 Identities=30% Similarity=0.503 Sum_probs=161.5
Q ss_pred ccceecccccccccccccccceEEEEEEEC-------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcc
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIV 199 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv 199 (343)
..|+++.++|++.+.||+|+||.||++.+. ...+|+|.+....... ....+.+|+.+++.+ +||||+
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~i~ 79 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-----DLSDLVSEMEMMKMIGKHKNII 79 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHH-----HHHHHHHHHHHHHhhcCCCCee
Confidence 468888999999999999999999999863 2578999986533221 124688999999999 899999
Q ss_pred eEEEEEEeCCeEEEEEEecCCCCHHHHHHhh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Q 019304 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRR--------------QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (343)
Q Consensus 200 ~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlk 265 (343)
++++++.....++++|||+++++|.+++... ....+++..++.++.|++.||+|||+.+++|||||
T Consensus 80 ~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlk 159 (293)
T cd05053 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLA 159 (293)
T ss_pred eEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 9999999999999999999999999999753 23457888999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecccc
Q 019304 266 SDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLK 331 (343)
Q Consensus 266 p~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~ 331 (343)
|+|||++.++.+||+|||+++....... .....+++.|+|||.+ ....++.++|+|+++.+
T Consensus 160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~i 223 (293)
T cd05053 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVL 223 (293)
T ss_pred eeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHh-----ccCCcCcccceeehhhH
Confidence 9999999999999999999986543221 1122345789999998 77889999999975443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-33 Score=266.27 Aligned_cols=186 Identities=25% Similarity=0.388 Sum_probs=158.2
Q ss_pred ccccccccccceEEEEEEEC--CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEE
Q 019304 138 NMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (343)
Q Consensus 138 ~~~~~lg~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~ 215 (343)
.++..||.|+||+||++... +-..|-|++..... .-.+.++-|+.||..+.||+||++++.|...+.++|+.
T Consensus 35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkse------EELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSE------EELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHhhhcCccchhhhhhhcccchhhhhhhhhcccch------hHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 34567999999999999874 33457787754322 22367899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc-CCCc
Q 019304 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGM 294 (343)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~-~~~~ 294 (343)
|||.||-+..++-.. +..+.+..+..+|.|+|.||.|||+++|||||||+.|||+.-+|.++|+|||++..... ....
T Consensus 109 EFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred eecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 999999988877654 45699999999999999999999999999999999999999999999999998754322 2334
Q ss_pred cCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 295 TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 295 ~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.++.|||+|||||+.....+...+|+.++|||++.+
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGI 223 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGI 223 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhh
Confidence 577999999999999888889999999999996544
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-33 Score=245.78 Aligned_cols=199 Identities=23% Similarity=0.328 Sum_probs=170.2
Q ss_pred eecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
.+..++|..++.||+|.||+|-+++- +++.+|+|++++...-... + ...-+.|-++|+..+||.+..+-..|+..
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakd-E--VAHTlTE~RVL~~~~HPFLt~LKYsFQt~ 240 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKD-E--VAHTLTENRVLQNCRHPFLTSLKYSFQTQ 240 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehH-H--hhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence 45678899999999999999999976 7889999999765433221 1 12456889999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
+++|+||||+.||.|.-+|.+. ..+++.....+-..|+.||.|||+++||+||||.+|+|+|.+|++||+|||+++..
T Consensus 241 drlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred ceEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999999998888653 45899999999999999999999999999999999999999999999999999853
Q ss_pred -ccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 289 -VQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 289 -~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.....++++||||.|+|||++ ....|..++|+|.... +++.+||..
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVl-----eDnDYgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVL-----EDNDYGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred ccccceeccccCChhhcCchhh-----ccccccceeehhhhhHHHHHHHhccCcccc
Confidence 344567889999999999999 8999999999995333 457777743
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=241.10 Aligned_cols=186 Identities=23% Similarity=0.375 Sum_probs=157.5
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||+|+. +++.||||.+........+ ....+.+|+.+++.++||||+++++.+...+..+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAK---ARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELN 78 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHH---HHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEE
Confidence 5688889999999999999987 7889999988653332221 2356889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc
Q 019304 213 IVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~ 290 (343)
+|+||+++++|.+++... ....+++..+..++.|++.||+|||+++++|+||||+||+++.++.++|+|||++.....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999999988642 234578899999999999999999999999999999999999999999999999876543
Q ss_pred CC-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeec
Q 019304 291 TE-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES 328 (343)
Q Consensus 291 ~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~ 328 (343)
.. ......|++.|+|||.+ ....++.++|+|++
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~-----~~~~~~~~~Di~sl 192 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERI-----HENGYNFKSDIWSL 192 (267)
T ss_pred hhHHHhcCCCCccccChhhh-----ccCCCCchhhHHHH
Confidence 22 12334688999999999 67788999999954
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=255.55 Aligned_cols=189 Identities=22% Similarity=0.309 Sum_probs=157.5
Q ss_pred cccccccccccccccceEEEEEEE----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
-..+|.+.+.||+|+||.||++.. .++.||+|.+... +...+|+.+++.++||||+++++++...
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----------~~~~~E~~il~~l~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----------KTPGREIDILKTISHRAIINLIHAYRWK 158 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----------ccHHHHHHHHHhcCCCCccceeeeEeeC
Confidence 346799999999999999999976 3467999987542 1345899999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
..+|+|||++. ++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 159 ~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred CEEEEEehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 99999999995 589988843 345899999999999999999999999999999999999999999999999998754
Q ss_pred ccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 289 VQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 289 ~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
..... .....||+.|+|||++ ....++.++|+|+++. +++.+||++.
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELL-----ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred CcccccccccccccccCccCHhHh-----cCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 33221 2234799999999999 7788999999996443 3356677653
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=243.52 Aligned_cols=182 Identities=28% Similarity=0.523 Sum_probs=156.4
Q ss_pred cccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 019304 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv 214 (343)
|++++.||+|+||.||++.. +++.+|+|++......... .....+|+.+++.++||||+++++++......++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE----REENIREIKILRRLRHPNIVQILDVFQDDNYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH----HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc----cchhhhhhhcccccccccccccccccccccccccc
Confidence 56789999999999999999 5568999999875433222 12345699999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc-ccCCC
Q 019304 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEG 293 (343)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~-~~~~~ 293 (343)
||++++++|.+++... ..++...++.++.|++.||++||+.+++|+||||+||+++.++.++|+|||.+... .....
T Consensus 77 ~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp EEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred cccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999843 34899999999999999999999999999999999999999999999999998753 22334
Q ss_pred ccCCCCCcceecCCCCCCCCCC-CCCCceeeeeeecc
Q 019304 294 MTPETGTYRWMAPGNSFFSPLP-HPSFEHKWSAKESC 329 (343)
Q Consensus 294 ~~~~~gt~~y~APE~~~~~~~~-~~~~~~~sDi~~~~ 329 (343)
.....+++.|+|||++ . ...++.++|+|+++
T Consensus 155 ~~~~~~~~~y~aPE~~-----~~~~~~~~~~Di~slG 186 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVL-----QQGKKYTRKSDIWSLG 186 (260)
T ss_dssp BSSSSSSGGGSCHHHH-----TTTSSBSTHHHHHHHH
T ss_pred cccccccccccccccc-----cccccccccccccccc
Confidence 4556899999999998 6 88999999999533
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-32 Score=275.21 Aligned_cols=205 Identities=22% Similarity=0.285 Sum_probs=163.5
Q ss_pred CccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEE
Q 019304 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (343)
Q Consensus 127 ~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 204 (343)
+...+....+|++++.||+|+||.||++.+ .+..||+|++........ ....|.+|+.+++.|+|||||+++++
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~----~~~~~~~EI~IL~~L~HPNIVrl~d~ 80 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKER----EKSQLVIEVNVMRELKHKNIVRYIDR 80 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHH----HHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence 344555668999999999999999999988 567899999876544332 23578899999999999999999998
Q ss_pred EEe--CCeEEEEEEecCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeCCCCCCcEEEcC
Q 019304 205 CRK--RMVWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGL-------GFIHRDLKSDNLLISA 273 (343)
Q Consensus 205 ~~~--~~~~~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~-------giiHrDlkp~NILv~~ 273 (343)
+.. ...+||||||+++++|.+++.... ...+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 854 356899999999999999997532 34689999999999999999999984 4999999999999964
Q ss_pred -----------------CCcEEEeccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----c
Q 019304 274 -----------------DKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----K 331 (343)
Q Consensus 274 -----------------~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~ 331 (343)
.+.+||+|||+++...........+||+.|+|||++.. ....++.++|||++++ +
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~g---e~~~~s~KSDVWSLG~ILYELL 237 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLH---ETKSYDDKSDMWALGCIIYELC 237 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhc---cCCCCCchhHHHHHHHHHHHHH
Confidence 23589999999986544433445579999999999832 2345889999996433 3
Q ss_pred cccCCCC
Q 019304 332 TTWPPPW 338 (343)
Q Consensus 332 ~~~~p~~ 338 (343)
++.+||.
T Consensus 238 TGk~PF~ 244 (1021)
T PTZ00266 238 SGKTPFH 244 (1021)
T ss_pred HCCCCCC
Confidence 3556653
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=240.18 Aligned_cols=186 Identities=27% Similarity=0.440 Sum_probs=156.5
Q ss_pred cccccccccccccccceEEEEEEEC-----CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 207 (343)
+.++|++.+.||+|+||.||+|.+. ...||||.+....... ....|.+|+.+++.++||||+++++.+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDK-----QRLDFLTEASIMGQFDHPNIIRLEGVVTK 76 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChH-----HHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence 4577889999999999999999872 3479999886543222 23578899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
....++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+++|+||||+|||++.++.+||+|||+++.
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 999999999999999999997643 3689999999999999999999999999999999999999999999999999986
Q ss_pred cccC-CCcc--CCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 288 EVQT-EGMT--PETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 288 ~~~~-~~~~--~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.... .... ...+++.|+|||.+ ....++.++|+|+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~-----~~~~~~~~~Dv~slG 195 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAI-----AYRKFTSASDVWSFG 195 (266)
T ss_pred ccccccceeccCCCCCccccChhhh-----ccCCCccccchHHHH
Confidence 5421 1111 12345789999999 778899999999643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=248.06 Aligned_cols=194 Identities=22% Similarity=0.318 Sum_probs=158.2
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|.+.+.||+|+||.||+|+. +++.||+|.++....... ...+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 79 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIVHTDKSL 79 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc-----chhHHHHHHHHHhCCCCCcceEEEEEeeCCeE
Confidence 36788899999999999999987 677899999875433221 13567899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||+++ +|.+++... ...++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 80 TLVFEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred EEEEeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 999999975 898888654 345788999999999999999999999999999999999999999999999998754322
Q ss_pred C-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 292 E-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
. ......+|+.|+|||.+. ....++.++|+|+++. +++.+||-
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~el~tg~~pf~ 206 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLL----GSSEYSTQIDMWGVGCIFFEMASGRPLFP 206 (309)
T ss_pred ccccccccccccccCCHHHh----CCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 2 223456899999999883 3456889999996433 33555553
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=244.59 Aligned_cols=184 Identities=24% Similarity=0.355 Sum_probs=158.8
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|++|.||++.+ +++.||+|++....... ......+.+|+.+++.+.||||+++++++.....++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK---LKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLY 77 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEE
Confidence 3678889999999999999988 67899999986533211 112357889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+||||+++++|.+++.+. ..+++..+..++.|++.||+|||+.|++|+||+|+|||++.++.+||+|||+++.....
T Consensus 78 ~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 78 LVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999999999765 45899999999999999999999999999999999999999999999999999865443
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
....++++.|+|||.+ ....++.++|+|+++.
T Consensus 155 -~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 186 (290)
T cd05580 155 -TYTLCGTPEYLAPEII-----LSKGYGKAVDWWALGI 186 (290)
T ss_pred -CCCCCCCccccChhhh-----cCCCCCccccHHHHHH
Confidence 3345789999999998 6678889999996443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=243.51 Aligned_cols=188 Identities=28% Similarity=0.452 Sum_probs=155.9
Q ss_pred ecccccccccccccccceEEEEEEE------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
++.++|++.+.||+|+||.||+|.+ .+..||+|.+...... . ....+.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~-~----~~~~~~~E~~~l~~l~h~niv~~~~~~ 76 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP-Q----QWGEFQQEASLMAELHHPNIVCLLGVV 76 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH-H----HHHHHHHHHHHHhhCCCCCeeeEEEEE
Confidence 4567888999999999999999975 3467999998643221 1 235688999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEE
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQ---------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NIL 270 (343)
......++||||+++++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+|||
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nil 156 (283)
T cd05090 77 TQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNIL 156 (283)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEE
Confidence 99999999999999999999986432 124678888999999999999999999999999999999
Q ss_pred EcCCCcEEEeccccccccccCC---CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 271 ISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 271 v~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
++.++.+||+|||+++...... ......++..|+|||.+ ....++.++|+|++.
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slG 213 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAI-----MYGKFSSDSDIWSFG 213 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHh-----ccCCCCchhhhHHHH
Confidence 9999999999999997543221 12233467789999998 677899999999644
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=238.62 Aligned_cols=188 Identities=27% Similarity=0.440 Sum_probs=158.3
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
+.|++.+.||+|++|.||++.. +++.+|+|.+......... ....+.+.+|+.+++.++||||+++++++.....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPET-KKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhh-HHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE
Confidence 4577889999999999999986 6789999998755433221 122357889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+|+||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++......
T Consensus 81 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 999999999999998764 348889999999999999999999999999999999999999999999999987543211
Q ss_pred C----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 293 G----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 293 ~----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
. .....|+..|+|||.+ ....++.++|+|+++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 195 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVI-----SGEGYGRKADVWSVGC 195 (263)
T ss_pred cccccccCCCcCccccCccee-----ccCCCCchhhhHHHHH
Confidence 1 1334688999999999 6777999999996433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=239.24 Aligned_cols=196 Identities=30% Similarity=0.488 Sum_probs=162.8
Q ss_pred ccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv 214 (343)
+|+.++.||+|+||.||+|.. +++.+|+|.+................+.+|+.+++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467788999999999999987 7788999998765443333333446789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc----
Q 019304 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ---- 290 (343)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~---- 290 (343)
+||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 9999999999999754 3478999999999999999999999999999999999999999999999999875321
Q ss_pred ---CCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 291 ---TEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 291 ---~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
........|++.|+|||.+ ....++.++|+|+++. +++.+||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~-----~~~~~~~~~Dv~slG~~~~~l~~g~~p~~ 209 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVI-----NESGYGRKSDIWSIGCTVFEMATGKPPLA 209 (265)
T ss_pred ccccccccccCCCccccChhhh-----cCCCCcchhhHHHHHHHHHHHHhCCCccc
Confidence 1112334689999999999 7778899999996433 33555553
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=255.41 Aligned_cols=192 Identities=24% Similarity=0.320 Sum_probs=155.8
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM---- 209 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---- 209 (343)
+|++.+.||+|+||.||++.. +++.||||.+........ ..+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 76 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV----SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPF 76 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchH----HHHHHHHHHHHHHhCCCCCcCCHhheecCCCcccc
Confidence 467789999999999999986 788999999865433222 2356889999999999999999999998776
Q ss_pred -eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 210 -VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 210 -~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
.+|+|+||+. ++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 77 EEIYVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred ceEEEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 7899999996 5888887543 45899999999999999999999999999999999999999999999999999864
Q ss_pred ccCC--CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 289 VQTE--GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 289 ~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.... ......+|+.|+|||.+. ....++.++|+|+++. +++.+||.
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~el~~g~~pf~ 206 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILM----GSRHYTSAVDIWSVGCIFAELLGRRILFQ 206 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHc----CCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence 3321 233456899999999983 2245789999996433 33555553
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=241.98 Aligned_cols=193 Identities=21% Similarity=0.358 Sum_probs=159.9
Q ss_pred ccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeEEEEEE
Q 019304 140 GTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTE 216 (343)
Q Consensus 140 ~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~iv~E 216 (343)
.+.||+|+++.|-.++. ++.++|||++.+..... ..++.+|++++.+++ |+||++++++|.++..+|+|||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHs------R~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfE 156 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHS------RSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFE 156 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchH------HHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEe
Confidence 36799999999998876 89999999998875543 257889999999995 9999999999999999999999
Q ss_pred ecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC---cEEEecccccccccc---
Q 019304 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SIKIADFGVARIEVQ--- 290 (343)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~---~vkl~DFg~a~~~~~--- 290 (343)
-|.||+|..++.++. .+++.++.++..+|+.||.+||.+||.||||||+|||...-. -||||||.+..-+..
T Consensus 157 Km~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 157 KMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred cccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 999999999998754 599999999999999999999999999999999999986433 489999998653211
Q ss_pred -----CCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeec-----ccccccCCCCcc
Q 019304 291 -----TEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES-----CLKTTWPPPWRH 340 (343)
Q Consensus 291 -----~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~-----~~~~~~~p~~~~ 340 (343)
.....+.+|+..|||||+..--.-.-..|+.++|.|++ .++.+||||.++
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 12234568999999999873222245679999999963 335599999664
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=245.87 Aligned_cols=193 Identities=28% Similarity=0.465 Sum_probs=162.1
Q ss_pred ccceecccccccccccccccceEEEEEEE-------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcc
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIV 199 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv 199 (343)
.+|.+..++|.+.+.||+|+||.||++.. .+..||||.++...... ..+.+.+|+.+++++ +||||+
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~iv 102 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS-----EREALMSELKIMSHLGNHENIV 102 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChH-----HHHHHHHHHHHHHhccCCCCcc
Confidence 35778889999999999999999999975 23479999886543221 125788999999999 799999
Q ss_pred eEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEE
Q 019304 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (343)
Q Consensus 200 ~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl 279 (343)
++++.+......++||||+.+++|.+++.......+++..+..++.|++.||+|||+++++|+||||+|||++.++.+||
T Consensus 103 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l 182 (302)
T cd05055 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKI 182 (302)
T ss_pred eEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEE
Confidence 99999999999999999999999999997654445899999999999999999999999999999999999999999999
Q ss_pred eccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 280 ADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 280 ~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+|||+++....... .....+++.|+|||.+ ....++.++|+|+++.
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DiwslGv 231 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESI-----FNCVYTFESDVWSYGI 231 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhh-----ccCCCCcHhHHHHHHH
Confidence 99999875433221 1123457889999999 7788999999996443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=241.00 Aligned_cols=178 Identities=23% Similarity=0.377 Sum_probs=153.1
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||+|.. +++.||+|++....... ..+.+.+|+.+++++.||||+++++.+...+..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE-----LQKQIMSELEILYKCDSPYIIGFYGAFFVENRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChH-----HHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEE
Confidence 3577889999999999999987 67889999986543211 2357889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+||||+++++|..+. .+++..+..++.|++.||.|||+.|++|+||||+|||++.++.+||+|||++......
T Consensus 76 lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 76 ICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred EEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 999999999996552 3678889999999999999999999999999999999999999999999998754332
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
......||+.|+|||.+ ....++.++|+|+++
T Consensus 149 ~~~~~~~~~~y~aPE~~-----~~~~~~~~~DvwslG 180 (279)
T cd06619 149 IAKTYVGTNAYMAPERI-----SGEQYGIHSDVWSLG 180 (279)
T ss_pred cccCCCCChhhcCceee-----cCCCCCCcchHHHHH
Confidence 23445899999999999 777899999999643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-33 Score=248.02 Aligned_cols=188 Identities=26% Similarity=0.399 Sum_probs=162.8
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
-|.++.+||+|++|.||++.+ .|+.+|||.+.... -.+++..|+.+|++++.|++|++||.+.....++|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--------DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--------DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--------hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence 356778999999999999977 88999999875322 13689999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~- 292 (343)
|||||-.|++.++++.+ +.++.+.++..++++.++||+|||...-||||||+.|||++.+|+.||+|||.|....+.-
T Consensus 106 VMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred ehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 99999999999999864 4679999999999999999999999999999999999999999999999999997544332
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCC
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPP 337 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~ 337 (343)
...+..|||.|||||++ ..-.|+.++|||++.+ +.+.||.
T Consensus 185 KRNTVIGTPFWMAPEVI-----~EIGY~~~ADIWSLGITaIEMAEG~PPY 229 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVI-----EEIGYDTKADIWSLGITAIEMAEGRPPY 229 (502)
T ss_pred hhCccccCcccccHHHH-----HHhccchhhhHhhhcchhhhhhcCCCCc
Confidence 23556899999999999 8889999999996443 3366654
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=239.82 Aligned_cols=186 Identities=25% Similarity=0.422 Sum_probs=156.8
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++.+.||+|+||.||+|.. +++.||+|+++...... ...+.+|+.+++.++||||+++++.+.....+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED------FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKL 81 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhH------HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Confidence 46788899999999999999987 67899999987543221 13577899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred EEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 9999999999999998754 35899999999999999999999999999999999999999999999999998754322
Q ss_pred -CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 292 -EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 292 -~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.......|++.|+|||++... ....++.++|+|+++
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~~DvwSlG 196 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVE--RKGGYNQLCDIWAVG 196 (267)
T ss_pred ccccccccCcccccChhhhccc--cCCCCCchhhhHHHH
Confidence 122345799999999987211 245688999999643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=243.97 Aligned_cols=188 Identities=25% Similarity=0.410 Sum_probs=156.4
Q ss_pred ecccccccccccccccceEEEEEEEC-------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 204 (343)
++..+|.+.+.||+|+||.||+|.+. ++.||||++...... ...+.+.+|+.+++.++||||++++++
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~h~~iv~~~~~ 76 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG-----PLREEFKHEAMMRSRLQHPNIVCLLGV 76 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH-----HHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 45677889999999999999999862 367999998754322 123568899999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEE
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NIL 270 (343)
+......++++||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+|||
T Consensus 77 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil 156 (283)
T cd05091 77 VTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL 156 (283)
T ss_pred EcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheE
Confidence 999999999999999999999986321 234788889999999999999999999999999999999
Q ss_pred EcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 271 ISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 271 v~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+++++.+||+|||+++....... .....+++.|+|||.+ ....++.++|+|++.
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slG 213 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAI-----MYGKFSIDSDIWSYG 213 (283)
T ss_pred ecCCCceEecccccccccccchheeeccCccCCccccCHHHH-----hcCCCCcchhHHHHH
Confidence 99999999999999875433221 1233467899999999 677899999999643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=244.47 Aligned_cols=188 Identities=28% Similarity=0.458 Sum_probs=152.7
Q ss_pred ecccccccccccccccceEEEEEEE--CCc--eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 206 (343)
+.+++|++.+.||+|+||.||+|.+ ++. .+|+|.+..... ......+.+|+.++.++ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~ 78 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-----KDDHRDFAGELEVLCKLGHHPNIINLLGACE 78 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCC-----HHHHHHHHHHHHHHHHhcCCCCcceEEEEEC
Confidence 3457888999999999999999987 444 357776643221 11235788999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~ 272 (343)
....+++||||+++++|.+++.+.. ...+++..++.++.|++.||+|||++|++||||||+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~ 158 (303)
T cd05088 79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 158 (303)
T ss_pred CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec
Confidence 9999999999999999999997542 12478899999999999999999999999999999999999
Q ss_pred CCCcEEEeccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 273 ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 273 ~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.++.+||+|||+++............++..|+|||.+ ....++.++|+|++.
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG 210 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL-----NYSVYTTNSDVWSYG 210 (303)
T ss_pred CCCcEEeCccccCcccchhhhcccCCCcccccCHHHH-----hccCCcccccchhhh
Confidence 9999999999998643221111222346789999998 677789999999644
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=238.26 Aligned_cols=187 Identities=27% Similarity=0.443 Sum_probs=155.0
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--Ce
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--MV 210 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~ 210 (343)
++|++.+.||+|+||.||++.. +++.||||.+.......... ...+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETS-KEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccH-HHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 4677889999999999999987 67899999986443222111 1235788999999999999999999998764 46
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~ 290 (343)
++++|||+++++|.+++... ..+++..+..++.|++.||+|||+++++|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 78999999999999998754 3478888999999999999999999999999999999999999999999999875432
Q ss_pred C----CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 291 T----EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 291 ~----~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
. .......|+..|+|||.+ ....++.++|+|+++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slG 196 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVI-----SGEGYGRKADIWSVG 196 (265)
T ss_pred ccccccccccCCCCccccChhhh-----cCCCCCcchhHHHHH
Confidence 1 123345689999999999 677889999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=225.68 Aligned_cols=194 Identities=23% Similarity=0.337 Sum_probs=160.8
Q ss_pred ceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 206 (343)
++++.+.+.-+..||+|++|.|-+.++ +|+..|+|.+...-.+.+. ++.++|+.+..+. .+|.+|.+||...
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q-----~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQ-----KRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHH-----HHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 556667777788999999998877766 8999999999766554433 5677888876554 7999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~-giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
....++|.||.|+ .||..+.++ .++..+++..+-+|+..|..||.|||++ .+||||+||+||||+.+|+||+||||
T Consensus 116 regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 116 REGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred ccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccc
Confidence 9999999999995 488877664 2466799999999999999999999987 89999999999999999999999999
Q ss_pred cccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 284 VARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.+....++-..+...|...|||||.+..+ .....|+.+||||++.+
T Consensus 195 IsG~L~dSiAkt~daGCkpYmaPEri~~e-~n~~gY~vksDvWSLGI 240 (282)
T KOG0984|consen 195 ISGYLVDSIAKTMDAGCKPYMAPERINPE-LNQKGYSVKSDVWSLGI 240 (282)
T ss_pred cceeehhhhHHHHhcCCCccCChhhcCcc-cCcccceeehhhhhhhh
Confidence 99887665555556788999999998543 23448999999995433
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=260.82 Aligned_cols=183 Identities=26% Similarity=0.434 Sum_probs=152.2
Q ss_pred cccccccccccccceEEEEEEE--CCceEE---EEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVA---IKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~va---vK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
+..++...||+|+|-+||+|.+ .|-.|| ||+-+. .+.....++|..|+.+|+.|+||||+++|..|.+..
T Consensus 40 Ry~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~-----~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~ 114 (632)
T KOG0584|consen 40 RYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDV-----TQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD 114 (632)
T ss_pred ceeehhhhcccccceeeeeccccccchhhHHHHHhHHHh-----hcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC
Confidence 4556778999999999999987 455554 222111 111223478999999999999999999999998765
Q ss_pred e--EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeCCCCCCcEEEc-CCCcEEEecccc
Q 019304 210 V--WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL--GFIHRDLKSDNLLIS-ADKSIKIADFGV 284 (343)
Q Consensus 210 ~--~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~--giiHrDlkp~NILv~-~~~~vkl~DFg~ 284 (343)
. +.+|+|.+..|+|..|+++.+. ++.+.+..||+||++||.|||++ .|||||||.+||+|+ ..|.|||.|+|+
T Consensus 115 n~~in~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGL 192 (632)
T KOG0584|consen 115 NKTINFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGL 192 (632)
T ss_pred CceeeeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhH
Confidence 4 8899999999999999987644 88899999999999999999998 499999999999997 678999999999
Q ss_pred ccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecccc
Q 019304 285 ARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLK 331 (343)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~ 331 (343)
|.+...... ....|||.|||||.+ ...|+..+|||+|..+
T Consensus 193 Atl~r~s~a-ksvIGTPEFMAPEmY------EE~YnE~VDVYaFGMC 232 (632)
T KOG0584|consen 193 ATLLRKSHA-KSVIGTPEFMAPEMY------EENYNELVDVYAFGMC 232 (632)
T ss_pred HHHhhcccc-ceeccCccccChHHH------hhhcchhhhhhhhhHH
Confidence 998776544 347899999999988 5889999999975543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-33 Score=279.17 Aligned_cols=200 Identities=21% Similarity=0.265 Sum_probs=169.2
Q ss_pred cceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
+..+..++|.+++.||+|+||.|..++. +++.+|+|++.+..+-.... ...|..|-.+|..-..+-|++++-+|+
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~---tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAE---TACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchh---HHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 3455678999999999999999999987 67889999997633221111 135888999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
++.++|+|||||+||+|..++.+.. .+|++++..++..|+.||.-||+.|+|||||||+|||+|..|++||+|||.|-
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHH
Confidence 9999999999999999999998754 69999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCC--ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccccccc
Q 019304 287 IEVQTEG--MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTW 334 (343)
Q Consensus 287 ~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~~~ 334 (343)
.+..++. ....+|||.|++||++.......+.|...+|+| +.++.+|
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwW-SlGV~~Y 272 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWW-SLGVFMY 272 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchh-hhHHHHH
Confidence 6654433 345589999999999965544558899999999 5555444
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=241.49 Aligned_cols=187 Identities=29% Similarity=0.464 Sum_probs=156.7
Q ss_pred cccccccccccccccceEEEEEEEC-------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
..++|.+.+.||+|+||.||+|... ++.||||++....... ..+.+.+|+++++.++||||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~ 77 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND-----ARKDFEREAELLTNFQHENIVKFYGVC 77 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHH-----HHHHHHHHHHHHHhcCCCCchheeeEE
Confidence 4567889999999999999999762 3679999986543321 236789999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQ------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~ 273 (343)
......++||||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 78 TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157 (280)
T ss_pred ecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence 99999999999999999999997542 234778889999999999999999999999999999999999
Q ss_pred CCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 274 DKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 274 ~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
++.+||+|||+++....... .....+++.|+|||.+ ....++.++|+|+++
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG 211 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESI-----MYRKFTTESDVWSFG 211 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhh-----ccCCcchhhhHHHHH
Confidence 99999999999875432211 1233457899999999 778899999999644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=246.58 Aligned_cols=183 Identities=26% Similarity=0.522 Sum_probs=150.5
Q ss_pred ccccccccccceEEEEEEEC------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 138 NMGTAFAQGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 138 ~~~~~lg~G~fg~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
++.+.||.|.||.||+|.+. +..|+||.+... ...+ ..+.|.+|++.+++++||||++++|++......
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~----~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEE----EEEEFLNEIQILRKLRHPNIVKLYGFCIENEPL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHH----HHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccc----cceeeeecccccccccccccccccccccccccc
Confidence 35678999999999999986 568999999542 2221 136889999999999999999999999988889
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++|+||+++|+|.+++.......+++..++.++.|++.||.|||+++++|+||+++|||++.++.+||+|||+++.....
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999875567999999999999999999999999999999999999999999999999999865222
Q ss_pred CC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 292 EG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 292 ~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.. .........|+|||.+ ....++.++|||+++.
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~-----~~~~~~~ksDVysfG~ 193 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVL-----KDGEYTKKSDVYSFGM 193 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHH-----HHSEESHHHHHHHHHH
T ss_pred ccccccccccccccccccccc-----cccccccccccccccc
Confidence 11 1223467899999999 6777999999995443
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=245.25 Aligned_cols=192 Identities=29% Similarity=0.510 Sum_probs=159.1
Q ss_pred ccceecccccccccccccccceEEEEEEE---------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCC
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY---------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 197 (343)
.+|.++..+|.+++.||+|+||.||+++. ....+|+|.+....... ....+.+|+.+++.+ .|||
T Consensus 5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~ 79 (314)
T cd05099 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDK-----DLADLISEMELMKLIGKHKN 79 (314)
T ss_pred ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChH-----HHHHHHHHHHHHHhccCCCC
Confidence 46888899999999999999999999975 23468999886433221 135688999999999 6999
Q ss_pred cceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCC
Q 019304 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (343)
Q Consensus 198 Iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrD 263 (343)
|+++++++.....++++|||+++++|.+++.... ...+++..+..++.|++.||.|||++|++|||
T Consensus 80 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~d 159 (314)
T cd05099 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRD 159 (314)
T ss_pred eeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 9999999999889999999999999999997642 13478888999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 264 LKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 264 lkp~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
|||+|||++.++.+||+|||+++....... .....+++.|+|||.+ ....++.++|+|+++
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DiwslG 223 (314)
T cd05099 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFG 223 (314)
T ss_pred ccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHH-----ccCCcCccchhhHHH
Confidence 999999999999999999999986533211 1122345689999998 678899999999644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=243.36 Aligned_cols=189 Identities=29% Similarity=0.476 Sum_probs=155.2
Q ss_pred ecccccccccccccccceEEEEEEECC----------------ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTYNG----------------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 195 (343)
++.++|++.+.||+|+||.||++...+ ..||+|.+...... . ....|.+|+++++.++|
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~----~~~~~~~ei~~l~~l~h 76 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK-T----ARNDFLKEIKIMSRLKN 76 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH-H----HHHHHHHHHHHHHhCCC
Confidence 456789999999999999999987522 24899998653221 1 23578999999999999
Q ss_pred CCcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Q 019304 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN----------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (343)
Q Consensus 196 ~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~----------~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlk 265 (343)
|||+++++++......++||||+++++|.+++..... ..+++..++.++.|++.||.|||++|++|+|||
T Consensus 77 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlk 156 (295)
T cd05097 77 PNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLA 156 (295)
T ss_pred CCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccC
Confidence 9999999999999999999999999999999865321 136788899999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 266 SDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 266 p~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|+||+++.++.+||+|||+++....... .....+++.|+|||.+ ....++.++|+|+++.
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DvwSlG~ 219 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESI-----LLGKFTTASDVWAFGV 219 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhh-----ccCCcCchhhHHHHHH
Confidence 9999999999999999999875432221 1223456799999998 7788999999996443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=244.23 Aligned_cols=181 Identities=24% Similarity=0.335 Sum_probs=155.8
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||+|+||.||++.+ ++..+|+|.+..... . ....++.+|+++++.++||||+++++++...+.+++
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-P----AIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI 76 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-H----HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence 578889999999999999987 567899998865322 1 123568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
||||+++++|.+++.+. ..+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.+||+|||++......
T Consensus 77 v~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 77 CMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred EeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 99999999999999764 458899999999999999999997 59999999999999999999999999998754332
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
......|++.|+|||.+ .+..++.++|+|+++
T Consensus 154 ~~~~~~~~~~~~aPE~~-----~~~~~~~~~DiwslG 185 (308)
T cd06615 154 MANSFVGTRSYMSPERL-----QGTHYTVQSDIWSLG 185 (308)
T ss_pred ccccCCCCcCccChhHh-----cCCCCCccchHHHHH
Confidence 23445789999999998 677789999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=238.85 Aligned_cols=185 Identities=31% Similarity=0.561 Sum_probs=158.4
Q ss_pred ceecccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
|-++.++|++.+.||+|+||.||++...++.||+|.+..... .+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~--------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVT--------AQAFLEETAVMTKLHHKNLVRLLGVILHNG 72 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcch--------HHHHHHHHHHHHhCCCCCcCeEEEEEcCCC
Confidence 556778899999999999999999999999999999864321 246889999999999999999999987654
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
.++||||+++++|.+++.......+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++...
T Consensus 73 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 73 -LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred -cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecc
Confidence 6899999999999999987655568999999999999999999999999999999999999999999999999987533
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.. ......+..|+|||.+ ....++.++|+|+++.
T Consensus 152 ~~--~~~~~~~~~y~~pe~~-----~~~~~~~~~Dv~slG~ 185 (254)
T cd05083 152 MG--VDNSKLPVKWTAPEAL-----KHKKFSSKSDVWSYGV 185 (254)
T ss_pred cc--CCCCCCCceecCHHHh-----ccCCcCchhhHHHHHH
Confidence 21 2223446789999998 7788999999996443
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=235.84 Aligned_cols=185 Identities=21% Similarity=0.316 Sum_probs=159.4
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|+..+.||.|+||.||.++. +++.+++|.+......... .+++.+|+.++++++|+||+++++++.+...+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~----~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 76 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKE----RRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLI 76 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhH----HHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEE
Confidence 477889999999999988876 6789999998765443322 2568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~- 292 (343)
+|||+++++|.+++.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||+++......
T Consensus 77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999999999987655568999999999999999999999999999999999999999999999999988654332
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
......+++.|+|||.+ ....++.++|+|+++
T Consensus 157 ~~~~~~~~~~y~ape~~-----~~~~~~~~~Dv~slG 188 (256)
T cd08221 157 MAETVVGTPYYMSPELC-----QGVKYNFKSDIWALG 188 (256)
T ss_pred cccccCCCccccCHhhc-----CCCCCCCcchhHHHH
Confidence 23345789999999998 677788999999644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=239.29 Aligned_cols=188 Identities=30% Similarity=0.486 Sum_probs=157.6
Q ss_pred ceecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
|+++.++|.+.+.||+|++|.||++.+ .+..+|+|.+...... .+.+.+|+.+++.++|||++++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 72 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-------PEAFLQEAQIMKKLRHDKLVPLYAVVSE- 72 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc-------HHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence 677778899999999999999999988 4457999988653322 2468899999999999999999998764
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
...+++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||++++++.+||+|||+++..
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~ 152 (260)
T cd05069 73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLI 152 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEc
Confidence 45789999999999999998655556889999999999999999999999999999999999999999999999999765
Q ss_pred ccCCCc--cCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 289 VQTEGM--TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 289 ~~~~~~--~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
...... ....++..|+|||.. ....++.++|+|+++.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~Pe~~-----~~~~~~~~~Di~slG~ 191 (260)
T cd05069 153 EDNEYTARQGAKFPIKWTAPEAA-----LYGRFTIKSDVWSFGI 191 (260)
T ss_pred cCCcccccCCCccchhhCCHHHh-----ccCCcChHHHHHHHHH
Confidence 332211 122456789999998 7788999999996443
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=236.87 Aligned_cols=187 Identities=27% Similarity=0.421 Sum_probs=157.2
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 210 (343)
+.++|++.+.||+|+||.||+|+. +++.||+|++....... ...+.+|+.+++.++||||+++++.+.....
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~------~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~ 80 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD------FSLIQQEIFMVKECKHCNIVAYFGSYLSREK 80 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch------HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Confidence 346789999999999999999987 67889999997543222 1357789999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~ 290 (343)
+++||||+++++|.+++... ..+++..+..++.|++.||+|||+.|++||||+|+||+++.++.+||+|||+++....
T Consensus 81 ~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 99999999999999998653 3588999999999999999999999999999999999999999999999999886533
Q ss_pred CC-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 291 TE-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 291 ~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.. ......|++.|+|||.+... ....++.++|+|+++
T Consensus 159 ~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~~~Dvws~G 196 (267)
T cd06646 159 TIAKRKSFIGTPYWMAPEVAAVE--KNGGYNQLCDIWAVG 196 (267)
T ss_pred cccccCccccCccccCHhHcccc--cCCCCcchhhHHHHH
Confidence 21 22345789999999987321 245578899999643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=241.12 Aligned_cols=188 Identities=29% Similarity=0.478 Sum_probs=156.8
Q ss_pred cccccccccccccccceEEEEEEECC------------------ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTYNG------------------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~~~------------------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 194 (343)
...+|++.+.||+|+||.||++.... ..||+|.+...... ...+.+.+|+.+++.++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-----~~~~~~~~e~~~l~~l~ 77 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-----NAREDFLKEVKILSRLS 77 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-----HHHHHHHHHHHHHHhcC
Confidence 45678899999999999999987622 45899998754322 22367889999999999
Q ss_pred CCCcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Q 019304 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ---------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (343)
Q Consensus 195 h~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlk 265 (343)
||||+++++++.....++++||++++++|.+++.... ...+++..++.++.|++.||+|||++|++|||||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 78 DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred CCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 9999999999999899999999999999999997643 1258899999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 266 SDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 266 p~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|+||+++.++.++|+|||+++....... .....+++.|+|||.+ ....++.++|||++..
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slG~ 220 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV-----LLGKFTTKSDVWAFGV 220 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHh-----hcCCCCccchhhhhHH
Confidence 9999999999999999999875432221 2233567899999998 6778999999996443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=239.30 Aligned_cols=196 Identities=21% Similarity=0.345 Sum_probs=162.8
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
.+|++.+.||+|+||.||++.. +++.+|||.+........ ....++.+|+.+++.++||||+++++.+......+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 78 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDA---KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 78 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhH---HHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEE
Confidence 4678889999999999999986 788999998865433222 12357889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc
Q 019304 213 IVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~ 290 (343)
++|||+++++|.+++... ....+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999999998742 234578999999999999999999999999999999999999999999999999876543
Q ss_pred CC-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecccc-----cccCCCC
Q 019304 291 TE-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLK-----TTWPPPW 338 (343)
Q Consensus 291 ~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~-----~~~~p~~ 338 (343)
.. ......|++.|+|||.+ ....++.++|+|+++.+ ++.+|++
T Consensus 159 ~~~~~~~~~~~~~~~ape~~-----~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 207 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERI-----HENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred CCcccccccCCcCccCHHHh-----cCCCccchhhHHHHHHHHHHHHhCCCCcc
Confidence 22 22345789999999999 77889999999964332 3555554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=250.84 Aligned_cols=185 Identities=23% Similarity=0.369 Sum_probs=152.5
Q ss_pred ceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 207 (343)
|++ .++|++.+.||+|+||.||+|.. +++.||||++....... ...+.+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07878 11 WEV-PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL----IHARRTYRELRLLKHMKHENVIGLLDVFTP 85 (343)
T ss_pred hhh-hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh----HHHHHHHHHHHHHHhcCCCchhhhhhhhcc
Confidence 444 36789999999999999999987 67789999987543221 123567799999999999999999998754
Q ss_pred C------CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEec
Q 019304 208 R------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (343)
Q Consensus 208 ~------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~D 281 (343)
. ...|+++|++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 86 ATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcC
Confidence 3 3468999998 7799888753 3489999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 282 FGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 282 Fg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
||+++.... ......||+.|+|||++. ....++.++|||+++
T Consensus 162 fg~~~~~~~--~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG 203 (343)
T cd07878 162 FGLARQADD--EMTGYVATRWYRAPEIML----NWMHYNQTVDIWSVG 203 (343)
T ss_pred CccceecCC--CcCCccccccccCchHhc----CCccCCchhhhHhHH
Confidence 999986433 234457999999999982 235789999999643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=238.52 Aligned_cols=186 Identities=26% Similarity=0.445 Sum_probs=155.3
Q ss_pred cccccccccccccccceEEEEEEE--CC---ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NG---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 207 (343)
+..+|++.+.||+|+||.||+|.+ ++ ..+|+|.++...... ..+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK-----QRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHH-----HHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 457788899999999999999976 22 368999886533221 23578899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
.+..++||||+++++|.+++.+.. ..+++..++.++.|++.||.|||+.+++||||||+|||++.++.+||+|||+++.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 999999999999999999997643 4578999999999999999999999999999999999999999999999999986
Q ss_pred cccCCC--c--cCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 288 EVQTEG--M--TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 288 ~~~~~~--~--~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
...... . ....++..|+|||.+ ....++.++|+|++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~-----~~~~~~~~~Dv~slG 196 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAI-----AYRKFTSASDVWSYG 196 (267)
T ss_pred cccccceeeecCCCccceeecCHhHh-----ccCccCchhhhHHHH
Confidence 543211 1 112235789999999 778899999999644
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=240.07 Aligned_cols=205 Identities=26% Similarity=0.392 Sum_probs=165.8
Q ss_pred ccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
++|-.+.+.|++.+.||.|+||.||+|.. +++.+|+|.+..... ...+.+.+|+.+++.++||||+++++.+
T Consensus 5 ~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (292)
T cd06644 5 RRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE------EELEDYMVEIEILATCNHPYIVKLLGAF 78 (292)
T ss_pred hcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH------HHHHHHHHHHHHHHhCCCCcEeeeEEEE
Confidence 44555667899999999999999999987 578999999865321 1235688999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
.....+++||||+++++|..++.+.. ..+++..+..++.|++.+|.|||+.+++||||||+||+++.++.+||+|||++
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~ 157 (292)
T cd06644 79 YWDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVS 157 (292)
T ss_pred EeCCeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccc
Confidence 99999999999999999988876533 45899999999999999999999999999999999999999999999999998
Q ss_pred cccccC-CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecccc-----cccCCCCc
Q 019304 286 RIEVQT-EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLK-----TTWPPPWR 339 (343)
Q Consensus 286 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~-----~~~~p~~~ 339 (343)
...... .......+++.|+|||.+.........++.++|+|+++.+ ++.+|++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 217 (292)
T cd06644 158 AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217 (292)
T ss_pred eeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence 753222 1223446889999999984333335668899999954332 24466543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=239.86 Aligned_cols=186 Identities=25% Similarity=0.457 Sum_probs=153.6
Q ss_pred cccccccccccccccceEEEEEEE--CCc----eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
..++|++.+.||+|+||.||+|.+ +++ .||+|++....... ..+.+.+|+.+++.+.||||+++++.+.
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-----ANKEILDEAYVMAGVGSPYVCRLLGICL 79 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHH-----HHHHHHHHHHHHHhcCCCCCceEEEEEc
Confidence 457788899999999999999986 444 48999986533221 2357889999999999999999999997
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
.. ..++++||+++|+|.+++.... ..+++..++.++.|++.||+|||+++++||||||+|||+++++.+||+|||+++
T Consensus 80 ~~-~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 80 TS-TVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred CC-CcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCcee
Confidence 65 4679999999999999997543 458999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCc---cCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 287 IEVQTEGM---TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 287 ~~~~~~~~---~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
........ ....+++.|+|||.. ....++.++|+|+++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~-----~~~~~~~~~Di~slG~ 199 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESI-----LHRRFTHQSDVWSYGV 199 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHh-----ccCCCCchhHHHHHHH
Confidence 65432221 112346789999999 7788999999996544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=239.02 Aligned_cols=189 Identities=26% Similarity=0.449 Sum_probs=156.3
Q ss_pred cccccccccccccccceEEEEEEE------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
+.+.|++.+.||+|+||.||++.+ ++..||+|.+...... .....+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (284)
T cd05079 2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-----NHIADLKKEIEILRNLYHENIVKYKGICT 76 (284)
T ss_pred chhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH-----HHHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 346678899999999999999974 4678999998643321 12357899999999999999999999987
Q ss_pred eC--CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccc
Q 019304 207 KR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (343)
Q Consensus 207 ~~--~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~ 284 (343)
.. ..+++||||+++++|.+++.+.. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus 77 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 77 EDGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred cCCCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcc
Confidence 75 56899999999999999986542 3578999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccccc
Q 019304 285 ARIEVQTEG----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKT 332 (343)
Q Consensus 285 a~~~~~~~~----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~ 332 (343)
++....... .....++..|+|||.+ .+..++.++|+|++..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~-----~~~~~~~~~Di~slG~il 202 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECL-----IQSKFYIASDVWSFGVTL 202 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHh-----ccCCCCccccchhhhhhh
Confidence 886543221 1234567889999998 677899999999654433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=244.88 Aligned_cols=186 Identities=22% Similarity=0.336 Sum_probs=146.9
Q ss_pred ccccccccceEEEEEEE----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCeEEE
Q 019304 140 GTAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RMVWCI 213 (343)
Q Consensus 140 ~~~lg~G~fg~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~i 213 (343)
+++||+|+||.||+|.. +++.+|+|.+...... ..+.+|+.+++.++||||+++++++.. ...+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--------MSACREIALLRELKHPNVISLQKVFLSHADRKVWL 77 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc--------HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEE
Confidence 46899999999999986 3468999998654322 346789999999999999999999854 456899
Q ss_pred EEEecCCCCHHHHHHhhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE----cCCCcEEEecc
Q 019304 214 VTEYAKGGSVRQFLTRRQ-------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI----SADKSIKIADF 282 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~-------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv----~~~~~vkl~DF 282 (343)
++||+. ++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 78 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 999996 48888876321 2348889999999999999999999999999999999999 45678999999
Q ss_pred ccccccccCC----CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 283 GVARIEVQTE----GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 283 g~a~~~~~~~----~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
|+++...... ......||+.|+|||++. ....++.++|+|+++. +++.+||.
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLL----GARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHc----CCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9998654321 223457899999999983 2356899999996333 33555553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=257.49 Aligned_cols=177 Identities=21% Similarity=0.287 Sum_probs=151.2
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
..|.+.+.||+|+||.||++.+ .++.||||.... ..+.+|+.++++++|+||+++++++......+
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC 236 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 4688889999999999999998 567899995421 23568999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+|||++. ++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 237 lv~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEEEccC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 9999995 68998886532 368999999999999999999999999999999999999999999999999997643321
Q ss_pred C---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 293 G---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 293 ~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
. .....||+.|+|||++ ....++.++|||++++
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~-----~~~~~~~~sDvwSlGv 350 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVL-----AGDPYTPSVDIWSAGL 350 (461)
T ss_pred ccccccccCCCcCCcCHHHH-----cCCCCCchHHHHHHHH
Confidence 1 1234699999999999 7778999999995443
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=234.21 Aligned_cols=184 Identities=23% Similarity=0.336 Sum_probs=158.5
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|+..+.||+|++|.||++.. +++.+|||.+......... .+.+.+|+.+++.++||||+++++.+......++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE----RLAAQNECQVLKLLSHPNIIEYYENFLEDKALMI 76 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHH----HHHHHHHHHHHhhCCCCchhheeeeEecCCEEEE
Confidence 467788999999999999987 6788999999765443322 3578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-CcEEEeccccccccccCC
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTE 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~-~~vkl~DFg~a~~~~~~~ 292 (343)
||||+++++|.+++.......+++..+..++.+++.||+|||++|++|+||+|+||+++.+ +.+||+|||++.......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999999999987655668999999999999999999999999999999999999854 468999999998655443
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeec
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES 328 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~ 328 (343)
......+++.|+|||.+ ....++.++|+|++
T Consensus 157 ~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~sl 187 (256)
T cd08220 157 KAYTVVGTPCYISPELC-----EGKPYNQKSDIWAL 187 (256)
T ss_pred cccccccCCcccCchhc-----cCCCCCcccchHHH
Confidence 33445789999999999 67788999999954
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=229.03 Aligned_cols=195 Identities=22% Similarity=0.382 Sum_probs=164.0
Q ss_pred ccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGA 204 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~ 204 (343)
+....|.++++.+..||.|..|.|+++++ +|...|||.+.+.....+. ++++..+.++.... .|.||+.+|+
T Consensus 85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~-----kRILmDldvv~~s~dcpyIV~c~Gy 159 (391)
T KOG0983|consen 85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEEN-----KRILMDLDVVLKSHDCPYIVQCFGY 159 (391)
T ss_pred cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHH-----HHHHHhhhHHhhccCCCeeeeeeeE
Confidence 34566788999999999999999999988 6689999999876654432 57778888776664 8999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
|..+..++|.||.|. ..+..++++ -.+++++..+-++...+.+||.||.++ +|||||+||+|||+|..|.+||||||
T Consensus 160 Fi~n~dV~IcMelMs-~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFG 237 (391)
T KOG0983|consen 160 FITNTDVFICMELMS-TCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFG 237 (391)
T ss_pred EeeCchHHHHHHHHH-HHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccc
Confidence 999988999999994 356666654 446799999999999999999999865 89999999999999999999999999
Q ss_pred cccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccccc
Q 019304 284 VARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKT 332 (343)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~ 332 (343)
.+....+....+...|.+.|||||.+ .|....+|+..+|||+ ++++
T Consensus 238 IsGrlvdSkAhtrsAGC~~YMaPERi--dp~~~~kYDiRaDVWS-lGIT 283 (391)
T KOG0983|consen 238 ISGRLVDSKAHTRSAGCAAYMAPERI--DPPDKPKYDIRADVWS-LGIT 283 (391)
T ss_pred ccceeecccccccccCCccccCcccc--CCCCCCccchhhhhhh-hccc
Confidence 99877766666666899999999999 3446889999999995 4433
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=235.80 Aligned_cols=185 Identities=30% Similarity=0.499 Sum_probs=156.7
Q ss_pred cccccccccccceEEEEEEE--CCceEEEEEeeCCCCChh---HHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPE---KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
|.+++.||+|++|.||+|.. +++.+|+|.+........ ......+.+.+|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 56778999999999999987 678999998876544322 2233446789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.|++||||+|+||++++++.+||+|||.++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred EEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 9999999999999999764 45888899999999999999999999999999999999999999999999998765421
Q ss_pred C-------CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeec
Q 019304 292 E-------GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES 328 (343)
Q Consensus 292 ~-------~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~ 328 (343)
. ......|++.|+|||.+ ....++.++|+|++
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~-----~~~~~~~~~Dv~sl 198 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVV-----KQTSYTRKADIWSL 198 (267)
T ss_pred cccCCccccccccCCCcCccChhHh-----ccCCCCchhhhHHH
Confidence 1 11223588999999999 77788999999953
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=238.41 Aligned_cols=183 Identities=30% Similarity=0.464 Sum_probs=151.0
Q ss_pred cccccccccccccceEEEEEEE------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
+.|++.+.||+|+||+||++.+ +++.||+|.+....... ....+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ-----NTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4458889999999999988753 46689999986543211 225688999999999999999999988653
Q ss_pred --CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 209 --MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 209 --~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
..+++||||+++++|.+++... .+++..++.++.|++.||.|||+++++||||||+|||++.++.+||+|||+++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccc
Confidence 4578999999999999999653 48999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCC----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 287 IEVQTEG----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 287 ~~~~~~~----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
....... .....++..|+|||.+ ....++.++|+|+++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~-----~~~~~~~~~Di~slG~ 198 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECL-----KENKFSYASDVWSFGV 198 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHh-----cccCCCcccccHHHHH
Confidence 6543221 1223456789999998 6778999999996443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=245.96 Aligned_cols=193 Identities=30% Similarity=0.507 Sum_probs=159.7
Q ss_pred ccceecccccccccccccccceEEEEEEEC---------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCC
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 197 (343)
.+|++...+|++++.||+|+||.||++.+. ...||+|.+....... ..+.+.+|+.+++++ +|||
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~ 79 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK-----DLSDLVSEMEMMKMIGKHKN 79 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHH-----HHHHHHHHHHHHHhhcCCCC
Confidence 578899999999999999999999999751 1368999886432221 135788999999999 7999
Q ss_pred cceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCC
Q 019304 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (343)
Q Consensus 198 Iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrD 263 (343)
|+++++++.....+++++||+++++|.+++.+.. ...+++..+..++.|++.||+|||++|++|||
T Consensus 80 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~d 159 (334)
T cd05100 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRD 159 (334)
T ss_pred eeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 9999999999999999999999999999997642 12467788899999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 264 LKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 264 lkp~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|||+|||++.++.+||+|||+++....... .....++..|+|||++ ....++.++|+|+++.
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 224 (334)
T cd05100 160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGV 224 (334)
T ss_pred cccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHh-----ccCCcCchhhhHHHHH
Confidence 999999999999999999999976433221 1122345789999999 7788999999996443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=237.38 Aligned_cols=197 Identities=25% Similarity=0.439 Sum_probs=160.1
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC---
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR--- 208 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~--- 208 (343)
..|++.+.||+|+||.||+|.. .++.||+|++...... ...+.+|+.+++.+ +||||+++++.+...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-------EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc-------HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 5677888999999999999987 6788999998754322 14577899999998 699999999998753
Q ss_pred ---CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 209 ---MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 209 ---~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
..++++|||+.+++|.+++.......+++..+..++.|++.||+|||+++|+|+||||+||++++++.+||+|||++
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 45899999999999999998755566899999999999999999999999999999999999999999999999998
Q ss_pred cccccC-CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 286 RIEVQT-EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 286 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
+..... .......|++.|+|||++.........++.++|+|++.. +++.+||.
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~ 217 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 217 (272)
T ss_pred eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 764332 223345789999999998433223567889999995432 23555553
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=243.27 Aligned_cols=186 Identities=22% Similarity=0.344 Sum_probs=158.2
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|++|.||+|.. +++.+|+|.+........ ...+.+.+|+.+++.++||||+++++.+......+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKR---NKVKRVLTEQEILATLDHPFLPTLYASFQTETYLC 77 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchH---HHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEE
Confidence 3577889999999999999988 578999999976543321 12357889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+||||+++++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 99999999999999986555678999999999999999999999999999999999999999999999999886432211
Q ss_pred C------------------------------ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeec
Q 019304 293 G------------------------------MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES 328 (343)
Q Consensus 293 ~------------------------------~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~ 328 (343)
. .....||..|+|||.+ ....++.++|+|++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~Di~sl 218 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVI-----SGDGHGSAVDWWTL 218 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHH-----cCCCCCchHHHHHH
Confidence 0 1123688999999999 67778999999953
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=235.76 Aligned_cols=187 Identities=22% Similarity=0.369 Sum_probs=159.0
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|++|.||+|.. +++.||+|.++........ ..+.+.+|+.+++.++|++|+++++.+...+..+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~ 78 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAK---ARQDCLKEIDLLKQLDHPNVIKYLASFIENNELN 78 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchh---hHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 4688889999999999999988 6889999998754332221 1357889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc
Q 019304 213 IVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~ 290 (343)
+||||+++++|.+++... ....++...++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||+++....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999999998753 234578999999999999999999999999999999999999999999999999876433
Q ss_pred CC-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 291 TE-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 291 ~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.. ......+++.|+|||.+ .+..++.++|+|+++
T Consensus 159 ~~~~~~~~~~~~~y~apE~~-----~~~~~~~~~Di~slG 193 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERI-----HENGYNFKSDIWSLG 193 (267)
T ss_pred CCcccceecCCccccCHHHh-----ccCCCCchhcHHHHH
Confidence 22 22335789999999998 778899999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=239.71 Aligned_cols=193 Identities=24% Similarity=0.378 Sum_probs=163.3
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
..+|++.+.||+|++|.||+|.. +++.||+|.+....... .+.+.+|+.+++.+.||||+++++.+......
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~------~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch------HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence 36788889999999999999986 67899999987544322 24688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++.....
T Consensus 93 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred EEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 999999999999999864 24788999999999999999999999999999999999999999999999998754332
Q ss_pred C-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 292 E-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
. ......|++.|+|||.+ ....++.++|+|+++. +++.+||+..
T Consensus 170 ~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~ 219 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVV-----TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (296)
T ss_pred ccccCcccCCccccCHHHH-----cCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 2 22335789999999998 7778899999996433 4477777554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=241.02 Aligned_cols=185 Identities=30% Similarity=0.457 Sum_probs=150.5
Q ss_pred cccccccccccccceEEEEEEE--CCc--eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM 209 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 209 (343)
++|++.+.||+|+||.||+|.. ++. .+++|.++..... ...+.+.+|+.++.++ +||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE-----NDHRDFAGELEVLCKLGHHPNIINLLGACENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH-----HHHHHHHHHHHHHHhhcCCCchhheEEEEccCC
Confidence 5788899999999999999987 333 4688887632211 1235788999999999 7999999999999988
Q ss_pred eEEEEEEecCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQN--------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK 275 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~ 275 (343)
.+++|+||+++++|.+++.+... ..+++..++.++.|++.||+|||++|++||||||+|||++.++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL 156 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC
Confidence 99999999999999999975321 2478889999999999999999999999999999999999999
Q ss_pred cEEEeccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 276 SIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 276 ~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.+||+|||++..............+..|+|||.+ ....++.++|||+++
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DvwSlG 205 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESL-----NYSVYTTKSDVWSFG 205 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhh-----ccCCCCchhhHHHHH
Confidence 9999999998643221111112335679999998 777899999999644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=233.72 Aligned_cols=179 Identities=27% Similarity=0.444 Sum_probs=148.8
Q ss_pred cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEec
Q 019304 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~ 218 (343)
+.||+|+||.||+|++ +++.+|+|.+...... .....+.+|+.+++.++||||+++++++......++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP-----DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCH-----HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeec
Confidence 3689999999999987 7889999988643221 12357889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCcc---
Q 019304 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMT--- 295 (343)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~~--- 295 (343)
++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.........
T Consensus 76 ~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 76 QGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred cCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999999998753 3458899999999999999999999999999999999999999999999999987543221111
Q ss_pred CCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 296 PETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 296 ~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
....+..|+|||.+ ....++.++|+|+++.
T Consensus 155 ~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slG~ 184 (252)
T cd05084 155 MKQIPVKWTAPEAL-----NYGRYSSESDVWSFGI 184 (252)
T ss_pred CCCCceeecCchhh-----cCCCCChHHHHHHHHH
Confidence 11224579999999 7778999999996443
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=233.69 Aligned_cols=185 Identities=23% Similarity=0.356 Sum_probs=156.5
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CCeEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-RMVWC 212 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~ 212 (343)
.|++.+.||.|++|.||++.. +++.||+|.+........ ..+.+.+|+.+++.++|+|++++++.+.. ...++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRR----ERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHH----HHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEE
Confidence 367889999999999999987 668899999875443322 23568899999999999999999998764 44679
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
++|||+++++|.+++.......+++..++.++.|++.|+.+||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999999999987555668999999999999999999999999999999999999999999999999987653322
Q ss_pred -CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 293 -GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
......+++.|+|||.+ ....++.++|+|+++
T Consensus 157 ~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slG 189 (257)
T cd08223 157 DMASTLIGTPYYMSPELF-----SNKPYNYKSDVWALG 189 (257)
T ss_pred CccccccCCcCccChhHh-----cCCCCCchhhhHHHH
Confidence 22344689999999999 778899999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=244.35 Aligned_cols=182 Identities=18% Similarity=0.274 Sum_probs=149.9
Q ss_pred cccccccc--cceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 019304 139 MGTAFAQG--AFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (343)
Q Consensus 139 ~~~~lg~G--~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv 214 (343)
++++||+| +|++||++.. +++.||+|.+........ ..+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNE----MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHH----HHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEE
Confidence 45789999 7889999987 778999999865433222 235677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC--
Q 019304 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-- 292 (343)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~-- 292 (343)
|||+++++|.+++.......+++..++.++.|++.||+|||+++|+||||||+|||++.++.++++||+.+.......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999999999976544568999999999999999999999999999999999999999999999998654321110
Q ss_pred ------CccCCCCCcceecCCCCCCCCCCC--CCCceeeeeeecc
Q 019304 293 ------GMTPETGTYRWMAPGNSFFSPLPH--PSFEHKWSAKESC 329 (343)
Q Consensus 293 ------~~~~~~gt~~y~APE~~~~~~~~~--~~~~~~sDi~~~~ 329 (343)
......++..|+|||++ .. ..++.++|+|+++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~~~DiwslG 197 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVL-----QQNLQGYDAKSDIYSVG 197 (327)
T ss_pred ccccccccccccceecccChHHh-----hcccCCCCchhhHHHHH
Confidence 01123567889999998 43 4689999999643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=249.84 Aligned_cols=190 Identities=19% Similarity=0.271 Sum_probs=168.6
Q ss_pred ceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 207 (343)
+-+..+.|..-+.||+|+||.|+-++- +|+-+|+|.+.+..... ..-+...++|..+|.+++.+.||.+-.++.+
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk---r~ge~maLnEk~iL~kV~s~FiVslaYAfeT 256 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK---RKGETMALNEKQILEKVSSPFIVSLAYAFET 256 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH---hhhhHHhhHHHHHHHHhccCcEEEEeeeecC
Confidence 345667777888999999999998865 88899999886533322 2234567899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
.+.+|+|+..|.||+|.-++....+..+++..++-++++|+.||++||+.+|++|||||+|||+|+.|+++|+|+|+|..
T Consensus 257 kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 257 KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEe
Confidence 99999999999999999998877767799999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeee
Q 019304 288 EVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKE 327 (343)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~ 327 (343)
+.........+||.+|||||++ ....|+...|+|+
T Consensus 337 i~~g~~~~~rvGT~GYMAPEvl-----~ne~Y~~s~Dwf~ 371 (591)
T KOG0986|consen 337 IPEGKPIRGRVGTVGYMAPEVL-----QNEVYDFSPDWFS 371 (591)
T ss_pred cCCCCccccccCcccccCHHHH-----cCCcccCCccHHH
Confidence 8877777778999999999999 7888999999995
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=236.40 Aligned_cols=196 Identities=25% Similarity=0.422 Sum_probs=158.8
Q ss_pred cccccccccccccccceEEEEEEE--CC---ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NG---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 207 (343)
+..+|++.+.||+|+||.||+|.+ ++ ..||||.+..... . ...+.|..|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~-~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 76 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT-E----KQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC-H----HHHHHHHHHHHHHHhCCCcCcceEEEEECC
Confidence 345678899999999999999987 33 3599999865322 1 123578999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
....++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||+++.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccc
Confidence 999999999999999999997543 4588999999999999999999999999999999999999999999999999875
Q ss_pred cccCCCc---cCCC---CCcceecCCCCCCCCCCCCCCceeeeeeecccc------cccCCCCc
Q 019304 288 EVQTEGM---TPET---GTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLK------TTWPPPWR 339 (343)
Q Consensus 288 ~~~~~~~---~~~~---gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~------~~~~p~~~ 339 (343)
....... .... .+..|+|||.+ ....++.++|+|+++.+ .+.+|||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~-----~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~ 214 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAI-----AYRKFTSASDVWSYGIVMWEVMSYGERPYWD 214 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHh-----ccCcccchhhhhhhHHHHHHHhcCCCCCCCC
Confidence 4332211 1111 24579999999 77889999999964432 24556654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=239.14 Aligned_cols=184 Identities=23% Similarity=0.353 Sum_probs=152.6
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||+|++|.||+|+. +++.||||.+........ ..+.+.+|+.+++.++||||+++++++..+..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEG----VPSTAIREISLLKELQHPNIVCLQDVLMQESRLYL 76 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCC----chHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEE
Confidence 467788999999999999987 678999999865432221 12467789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-
Q 019304 214 VTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~- 291 (343)
||||++ ++|.+++.... ...+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||++......
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 77 IFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred EEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 999997 58988886543 256899999999999999999999999999999999999999999999999998754322
Q ss_pred CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeec
Q 019304 292 EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES 328 (343)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~ 328 (343)
.......+++.|+|||.+. ....++.++|+|++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~----~~~~~~~~~Dv~sl 188 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLL----GSPRYSTPVDIWSI 188 (285)
T ss_pred ccccCCcccccccChHHhc----CCCCcCcHHHHHHH
Confidence 1223346789999999873 23457899999954
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=238.76 Aligned_cols=199 Identities=25% Similarity=0.352 Sum_probs=163.8
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++.+.||.|++|.||++.+ +++.+|+|++..... ...+.+.+|+.+++.++||||+++++.+......
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE------EELEDFMVEIDILSECKHPNIVGLYEAYFYENKL 77 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH------HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeE
Confidence 46788999999999999999987 578899999864321 1235788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||+++++|.+++.+.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 78 WILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99999999999999987643 45899999999999999999999999999999999999999999999999988654322
Q ss_pred C-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 292 E-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
. ......+++.|+|||.+.........++.++|+|+++. +++.+||..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~ 210 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE 210 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCccc
Confidence 1 22334689999999998433334566889999996433 335666643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=233.09 Aligned_cols=194 Identities=29% Similarity=0.454 Sum_probs=162.7
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++.+.||+|+||.||+|.. +++.+++|++...... ..+.+.+|+.+++.++||||+++++.+.....+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 75 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD------DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKL 75 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh------hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEE
Confidence 36788889999999999999987 5678999999754332 235788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
+++|||+++++|.+++... ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++.+||+|||.+......
T Consensus 76 ~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 76 WIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 9999999999999998764 245899999999999999999999999999999999999999999999999998764432
Q ss_pred C-CccCCCCCcceecCCCCCCCCCCCC---CCceeeeeeeccc-----ccccCCCCc
Q 019304 292 E-GMTPETGTYRWMAPGNSFFSPLPHP---SFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~~~~~~~~---~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
. ......++..|+|||.+ ... .++.++|+|+++. +++.+|++.
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~-----~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~ 206 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVA-----AVERKGGYDGKCDIWALGITAIELAELQPPMFD 206 (262)
T ss_pred hhccccccCCccccCchhh-----cccccCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 2 23345788999999998 444 8899999996433 235666543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=238.98 Aligned_cols=187 Identities=27% Similarity=0.440 Sum_probs=155.8
Q ss_pred ecccccccccccccccceEEEEEEE-------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 204 (343)
|...+|.+.+.||+|+||.||++.. ++..+|+|.+..... ...+.+.+|+.+++.++||||++++++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 75 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD------NARKDFHREAELLTNLQHEHIVKFYGV 75 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH------HHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 4557888999999999999999974 234589998864321 123578999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQ-----------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~ 273 (343)
+.....+++||||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+|||+++
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~ 155 (288)
T cd05093 76 CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 155 (288)
T ss_pred EecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 999999999999999999999997532 124899999999999999999999999999999999999999
Q ss_pred CCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 274 DKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 274 ~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
++.+||+|||+++....... .....+++.|+|||.+ ....++.++|+|+++
T Consensus 156 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~sDiwslG 209 (288)
T cd05093 156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI-----MYRKFTTESDVWSLG 209 (288)
T ss_pred CCcEEeccCCccccccCCceeecCCCCCccccccCHHHh-----ccCCCCchhhHHHHH
Confidence 99999999999875432211 1223457889999999 778899999999643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=236.87 Aligned_cols=186 Identities=23% Similarity=0.435 Sum_probs=151.4
Q ss_pred cccccccccccccccceEEEEEEE--CCc----eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
...+|++.+.||+|+||.||+|.+ +++ .+++|.+..... .....++..|+..++.+.||||+++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~ 79 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG-----RQTFQEITDHMLAMGSLDHAYIVRLLGICP 79 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc-----hHHHHHHHHHHHHHhcCCCCCcceEEEEEC
Confidence 346788889999999999999988 454 467777643221 122356788999999999999999999876
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
. ...++++||+++|+|.+++.... ..+++..+..++.|++.||+|||+++++||||||+|||++.++.+||+|||+++
T Consensus 80 ~-~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 80 G-ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred C-CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccce
Confidence 4 45689999999999999997543 458999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 287 IEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 287 ~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
....... .....++..|+|||.+ ....++.++|+|+++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~-----~~~~~~~~~Dv~slG~ 199 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESI-----LFGRYTHQSDVWSYGV 199 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHh-----ccCCcCchhhHHHHHH
Confidence 6433221 2233567889999999 7788999999996543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=233.62 Aligned_cols=185 Identities=23% Similarity=0.426 Sum_probs=151.2
Q ss_pred cccccccccccceEEEEEEEC-----CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe-
Q 019304 137 LNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV- 210 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~- 210 (343)
|++++.||+|+||.||+|... +..||+|.++....... ....+.+|+.+++.++||||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 76 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS----EIEEFLSEAACMKDFDHPNVMKLIGVCFEASSL 76 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHH----HHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcc
Confidence 467889999999999999862 25799999875433322 13578999999999999999999998866543
Q ss_pred -----EEEEEEecCCCCHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEec
Q 019304 211 -----WCIVTEYAKGGSVRQFLTRRQ----NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (343)
Q Consensus 211 -----~~iv~E~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~D 281 (343)
.++++||+++++|..++.... ...+++..++.++.|++.||.|||+.+++||||||+||++++++.+||+|
T Consensus 77 ~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 77 QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECC
Confidence 799999999999999986432 23588899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCc---cCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 282 FGVARIEVQTEGM---TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 282 Fg~a~~~~~~~~~---~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
||+++........ ....++..|+|||.+ ....++.++|+|+++.
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~-----~~~~~~~~~Dv~SlG~ 203 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESL-----ADRVYTSKSDVWAFGV 203 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhc-----ccCCCCcccchHHHHH
Confidence 9999865432211 112356789999998 7788999999996443
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=236.96 Aligned_cols=195 Identities=23% Similarity=0.379 Sum_probs=156.8
Q ss_pred ccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGA 204 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 204 (343)
+.+....++|++.+.||+|+||.||++.. +++.+|+|++...... ...+.+|+.+++.+ +||||++++++
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~e~~~l~~l~~h~~i~~~~~~ 83 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI-------DEEIEAEYNILKALSDHPNVVKFYGM 83 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch-------HHHHHHHHHHHHHHhcCCCeeeeeee
Confidence 44445667889999999999999999987 6789999987542211 14577899999999 69999999998
Q ss_pred EE-----eCCeEEEEEEecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcE
Q 019304 205 CR-----KRMVWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277 (343)
Q Consensus 205 ~~-----~~~~~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~v 277 (343)
+. ....+++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+++||||||+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCE
Confidence 84 345689999999999999988642 23457888999999999999999999999999999999999999999
Q ss_pred EEeccccccccccCC-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 278 KIADFGVARIEVQTE-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 278 kl~DFg~a~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
||+|||+++...... ......|++.|+|||++.........++.++|+|+++
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG 216 (286)
T cd06638 164 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLG 216 (286)
T ss_pred EEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHH
Confidence 999999987643322 2233468999999999832222346689999999643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=236.15 Aligned_cols=186 Identities=25% Similarity=0.467 Sum_probs=154.2
Q ss_pred cccccccccccccccceEEEEEEE--CCc----eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
...+|++.+.||+|+||.||+|.+ +++ .+|+|.+...... .....+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP-----KANKEILDEAYVMASVDHPHVVRLLGICL 79 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCH-----HHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 457788999999999999999986 333 5899988654431 12357889999999999999999999998
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
. ...++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++++||||||+|||++.++.+||+|||+++
T Consensus 80 ~-~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 80 S-SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred c-CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 7 67899999999999999997643 348999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCcc---CCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 287 IEVQTEGMT---PETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 287 ~~~~~~~~~---~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
......... ...++..|+|||.+ ....++.++|+|+++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~-----~~~~~~~~~Di~slG~ 199 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESI-----LHRIYTHKSDVWSYGV 199 (279)
T ss_pred cccCcccceecCCCcccccccCHHHh-----hcCCcCchhhHHHHHH
Confidence 654322111 12235789999998 7788999999996443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=236.71 Aligned_cols=188 Identities=21% Similarity=0.267 Sum_probs=157.6
Q ss_pred cccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEecCC
Q 019304 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (343)
Q Consensus 143 lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~~~ 220 (343)
||+|+||.||++.. +++.||+|++....... ....+.+.+|+.+++.++||||+++++.+...+..|+||||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK---RKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh---hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCC
Confidence 68999999999976 67899999987533221 11235677899999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCccCCCCC
Q 019304 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300 (343)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~~~~~gt 300 (343)
++|.+++.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+.............++
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGT 157 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCC
Confidence 99999998765556899999999999999999999999999999999999999999999999998865443334445688
Q ss_pred cceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 301 YRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 301 ~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
..|+|||.+ ....++.++|+|+++. +++.+||.
T Consensus 158 ~~y~~PE~~-----~~~~~~~~~Di~slG~il~~l~~g~~p~~ 195 (277)
T cd05577 158 PGYMAPEVL-----QGEVYDFSVDWFALGCTLYEMIAGRSPFR 195 (277)
T ss_pred CCcCCHHHh-----cCCCCCchhhhHHHHHHHHHHhhCCCCCC
Confidence 999999998 6677999999996433 33555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=235.20 Aligned_cols=187 Identities=26% Similarity=0.394 Sum_probs=155.4
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
+.|++.+.||+|+||.||++.. ++..+++|.+..... ...+.+.+|+.+++.++||||+++++.+......+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~ 78 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE------EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 78 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH------HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEE
Confidence 3457788999999999999988 567889998854321 12356889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~- 291 (343)
+|+||+++++|..++.+. ...+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++......
T Consensus 79 ~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 79 ILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 999999999998887653 346899999999999999999999999999999999999999999999999998754322
Q ss_pred CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeec
Q 019304 292 EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES 328 (343)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~ 328 (343)
.......+++.|+|||++.........++.++|+|++
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 194 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL 194 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhH
Confidence 1233457899999999984333345678899999954
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=244.37 Aligned_cols=187 Identities=33% Similarity=0.512 Sum_probs=153.0
Q ss_pred ccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhc--CCCCCcceEEEEEEeCC--
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT--LKHLNIVRFIGACRKRM-- 209 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~-- 209 (343)
.+++++.+.||+|.||.||+|.|.|+.||||++...+. +.+.+|.++.+. |+|+||+.+++.-..+.
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE---------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE---------RSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEecccch---------hhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 46788999999999999999999999999999965332 457788888876 49999999998865443
Q ss_pred --eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-----C---CceeCCCCCCcEEEcCCCcEEE
Q 019304 210 --VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-----L---GFIHRDLKSDNLLISADKSIKI 279 (343)
Q Consensus 210 --~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-----~---giiHrDlkp~NILv~~~~~vkl 279 (343)
++++|++|-+.|||+|||.+ ..++.+..++++..++.||++||- + .|.|||||..||||.+++++-|
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 68999999999999999976 458999999999999999999994 2 4999999999999999999999
Q ss_pred eccccccccccC-----CCccCCCCCcceecCCCCCCCCCCCCCCc--eeeeeeeccccccc
Q 019304 280 ADFGVARIEVQT-----EGMTPETGTYRWMAPGNSFFSPLPHPSFE--HKWSAKESCLKTTW 334 (343)
Q Consensus 280 ~DFg~a~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~~~~~--~~sDi~~~~~~~~~ 334 (343)
+|+|+|...... ...+..+||.+|||||++ ....+..-|. ..+||| ++++++|
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvL-detin~~~Fesyk~ADIY-afgLVlW 417 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVL-DETINMKHFESYKRADIY-AFGLVLW 417 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHh-hhhcChhhhhhhhHHHHH-HHHHHHH
Confidence 999999754433 234567999999999998 2223333343 567999 5555555
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=232.49 Aligned_cols=186 Identities=26% Similarity=0.459 Sum_probs=157.6
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|+..+.||+|++|.||+|.. +++.|++|.+........ .....+.+.+|+.+++.++|+||+++++.+.....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQT-GQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccccc-chHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEE
Confidence 356678899999999999987 678999999875443221 11224678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCC
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~ 293 (343)
++||+++++|.+++.+. ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~ 157 (258)
T cd06632 80 FLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF 157 (258)
T ss_pred EEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccc
Confidence 99999999999999754 3478899999999999999999999999999999999999999999999999886544333
Q ss_pred ccCCCCCcceecCCCCCCCCCCCCC-Cceeeeeeecc
Q 019304 294 MTPETGTYRWMAPGNSFFSPLPHPS-FEHKWSAKESC 329 (343)
Q Consensus 294 ~~~~~gt~~y~APE~~~~~~~~~~~-~~~~sDi~~~~ 329 (343)
.....|++.|+|||.+ .... ++.++|+|+++
T Consensus 158 ~~~~~~~~~y~~pe~~-----~~~~~~~~~~D~~slG 189 (258)
T cd06632 158 AKSFKGSPYWMAPEVI-----AQQGGYGLAADIWSLG 189 (258)
T ss_pred ccccCCCcceeCHHHh-----cCCCCCCchhhhHHHH
Confidence 4456789999999998 5555 89999999644
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=239.04 Aligned_cols=186 Identities=30% Similarity=0.466 Sum_probs=154.7
Q ss_pred cccccccccccccccceEEEEEEE-------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
..++|.+.+.||+|+||.||+|.+ ++..+++|.+..... ...+.+.+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL------AARKDFQREAELLTNLQHEHIVKFYGVC 76 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH------HHHHHHHHHHHHHhcCCCCCcceEEEEE
Confidence 456788889999999999999975 234588888754322 1225688999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv 271 (343)
......++||||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+|||+
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~ 156 (291)
T cd05094 77 GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV 156 (291)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE
Confidence 99999999999999999999997532 1347889999999999999999999999999999999999
Q ss_pred cCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 272 SADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 272 ~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+.++.+||+|||++........ .....+++.|+|||.+ ....++.++|+|+++
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG 212 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI-----MYRKFTTESDVWSFG 212 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHh-----ccCCCCchhhHHHHH
Confidence 9999999999999875433211 1233567899999998 778899999999643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=236.72 Aligned_cols=185 Identities=21% Similarity=0.288 Sum_probs=159.7
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||.|+||.||++.. +++.||+|++.+...... ...+.+.+|+.++++++||||+++++.+......++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEK---GSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYL 77 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcch---hHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEE
Confidence 477889999999999999988 578999999975443221 124678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCC
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~ 293 (343)
|+||+++++|.+++... ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 78 VVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred EEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 99999999999999764 4588999999999999999999999999999999999999999999999999876544333
Q ss_pred ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 294 MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 294 ~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.....|+..|+|||.+ ....++.++|+|+++.
T Consensus 156 ~~~~~~~~~y~~PE~~-----~~~~~~~~~Di~slG~ 187 (258)
T cd05578 156 TTSTSGTPGYMAPEVL-----CRQGYSVAVDWWSLGV 187 (258)
T ss_pred ccccCCChhhcCHHHH-----cccCCCCcccchhhHH
Confidence 3455789999999999 6777999999996443
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=238.79 Aligned_cols=189 Identities=27% Similarity=0.452 Sum_probs=154.2
Q ss_pred ecccccccccccccccceEEEEEEEC------------------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTYN------------------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL 193 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 193 (343)
++.++|++.+.||+|+||.||++.+. ...+|+|++...... ...+.+.+|+.+++.+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~E~~~l~~l 76 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK-----NARNDFLKEIKIMSRL 76 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH-----HHHHHHHHHHHHHHhC
Confidence 34577999999999999999998542 236899998654321 1235788999999999
Q ss_pred CCCCcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC
Q 019304 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDL 264 (343)
Q Consensus 194 ~h~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~---------~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDl 264 (343)
+|+||+++++++......++||||+++++|.+++..... ..+++..+..++.|++.||+|||+.|++|+||
T Consensus 77 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl 156 (296)
T cd05095 77 KDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDL 156 (296)
T ss_pred CCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccC
Confidence 999999999999999999999999999999999976431 23667789999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 265 KSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 265 kp~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
||+|||++.++.++|+|||+++....... .....+++.|+|||.. ....++.++|+|+++.
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~-----~~~~~~~~~DiwSlG~ 220 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESI-----LLGKFTTASDVWAFGV 220 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHH-----hcCCccchhhhhHHHH
Confidence 99999999999999999999875433221 1122346789999988 6678999999996443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=237.94 Aligned_cols=192 Identities=25% Similarity=0.383 Sum_probs=162.5
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++.+.||+|++|.||++.. +++.||+|.+....... .+.+.+|+.+++.++||||+++++.+......
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch------HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 36788899999999999999986 68899999987543322 24678999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred EEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 999999999999999864 34788999999999999999999999999999999999999999999999998754332
Q ss_pred CC-ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 292 EG-MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 292 ~~-~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.. .....+++.|+|||.+ ....++.++|+|+++. +++.+||+.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slGvil~~l~tg~~pf~~ 217 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVV-----TRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (297)
T ss_pred ccCcCcccCCccccCHHHH-----cCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 22 2334788999999999 7788899999996432 346666654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=235.39 Aligned_cols=183 Identities=25% Similarity=0.380 Sum_probs=144.1
Q ss_pred ccccccceEEEEEEE-C---CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEe
Q 019304 142 AFAQGAFGKLYRGTY-N---GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 142 ~lg~G~fg~Vy~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
.||+|+||.||+|.. + ...+|+|.+...... .....+.+|+.+++.++||||+++++.+......++||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATP-----DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCCh-----HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence 589999999999975 3 246788876543221 1235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCC-
Q 019304 218 AKGGSVRQFLTRRQN---RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG- 293 (343)
Q Consensus 218 ~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~- 293 (343)
+++++|.+++..... ...++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999999999976432 2346778889999999999999999999999999999999999999999999875322211
Q ss_pred --ccCCCCCcceecCCCCCCC--CCCCCCCceeeeeeecc
Q 019304 294 --MTPETGTYRWMAPGNSFFS--PLPHPSFEHKWSAKESC 329 (343)
Q Consensus 294 --~~~~~gt~~y~APE~~~~~--~~~~~~~~~~sDi~~~~ 329 (343)
.....+++.|+|||++... ......++.++|+|+++
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG 196 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLG 196 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHH
Confidence 1223456789999987321 11245678899999643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=234.88 Aligned_cols=190 Identities=27% Similarity=0.421 Sum_probs=161.9
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||.|++|.||+|.. +++.||+|++....... ....+.+|+.+++.++||||+++++.+.....+++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED-----EIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI 76 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccch-----HHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence 577889999999999999987 67899999987543211 12467899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-C
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-E 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~-~ 292 (343)
|+||+++++|.+++... .+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||+++..... .
T Consensus 77 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 77 IMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 99999999999998753 5899999999999999999999999999999999999999999999999999865543 2
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
......+++.|+|||.+ ....++.++|+|+++. +++.+|+.
T Consensus 154 ~~~~~~~~~~y~~PE~~-----~~~~~~~~sDv~slG~il~~l~tg~~p~~ 199 (274)
T cd06609 154 KRNTFVGTPFWMAPEVI-----KQSGYDEKADIWSLGITAIELAKGEPPLS 199 (274)
T ss_pred ccccccCCccccChhhh-----ccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 23445788999999999 6777999999996433 34566654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=231.34 Aligned_cols=180 Identities=30% Similarity=0.552 Sum_probs=154.9
Q ss_pred cccccccceEEEEEEEC-----CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEE
Q 019304 141 TAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~ 215 (343)
+.||+|+||.||+|... +..||+|++....... ..+.+.+|+.+++.++|+||+++++++.....+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-----ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-----HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEE
Confidence 46899999999999884 7789999997654432 2367889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 216 EYAKGGSVRQFLTRRQ-------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 216 E~~~~gsL~~~l~~~~-------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
||+++++|.+++.... ...+++..++.++.|++.||+|||+++++|+||+|+||+++.++.+||+|||.++..
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccc
Confidence 9999999999998642 356899999999999999999999999999999999999999999999999999865
Q ss_pred ccCC---CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 289 VQTE---GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 289 ~~~~---~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.... ......+++.|+|||.+ ....++.++|+|+++.
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 195 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESL-----KDGIFTSKSDVWSFGV 195 (262)
T ss_pred ccccccccccCCCcCccccCHHHh-----ccCCcchhhccHHHHH
Confidence 4432 12334678999999998 6678999999996443
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=239.62 Aligned_cols=193 Identities=24% Similarity=0.339 Sum_probs=157.8
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++.+.||+|+||.||+|.. +++.||+|.+........ ...+.+|+.+++.++||||+++++++.....+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIIHTEKSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc-----hhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence 46788899999999999999987 578899999865433221 13567899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||++ ++|.+++.+. ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred EEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 99999997 5999988754 345889999999999999999999999999999999999999999999999998754322
Q ss_pred C-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCC
Q 019304 292 E-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPP 337 (343)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~ 337 (343)
. ......+++.|+|||.+. ....++.++|+|+++. +++.+||
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~----~~~~~~~~~Dv~slG~~l~el~tg~~~f 205 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILL----GSTDYSTQIDMWGVGCIFYEMSTGRPLF 205 (301)
T ss_pred CCcccccceeecccCcHHHh----CCCCCccHHHHHHHHHHHHHHHhCCCCC
Confidence 1 223446789999999873 2345889999996433 3355555
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=237.02 Aligned_cols=193 Identities=26% Similarity=0.362 Sum_probs=158.0
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||+|++|.||+|.. +++.||+|++........ ..+.+.+|+.+++.++||||+++++++......++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 77 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV----IKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL 77 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCcc----ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence 577889999999999999988 578999999865432221 12457899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~- 292 (343)
||||++++.|..+... ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 78 VFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EEeccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 9999999877776643 2358999999999999999999999999999999999999999999999999998654332
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
......++..|+|||.+. ....++.++|+|+++. +++.+||.
T Consensus 156 ~~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~i~~~l~~g~~p~~ 202 (286)
T cd07847 156 DYTDYVATRWYRAPELLV----GDTQYGPPVDVWAIGCVFAELLTGQPLWP 202 (286)
T ss_pred cccCcccccccCCHHHHh----CCCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 223446889999999882 2356889999996443 33555553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=233.56 Aligned_cols=188 Identities=26% Similarity=0.412 Sum_probs=157.6
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|+.++.||+|++|.||++.. +++.+|+|++..............+.+.+|+.+++.++|+||+++++.+.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 366778999999999999986 778999999975544333333345789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC-cEEEeccccccccccCC
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTE 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~-~vkl~DFg~a~~~~~~~ 292 (343)
|+||+++++|.+++.+. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .+||+|||.+.......
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999999754 3588999999999999999999999999999999999998765 69999999987654321
Q ss_pred C-----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 293 G-----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 293 ~-----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
. .....++..|+|||.+ ....++.++|+|+++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~-----~~~~~~~~~Dv~slG~ 196 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVL-----RGEQYGRSCDVWSVGC 196 (268)
T ss_pred ccCCccccccccccceeCHhHh-----ccCCCCcccchHHHHH
Confidence 1 1234678999999998 6778899999996433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=234.06 Aligned_cols=184 Identities=23% Similarity=0.343 Sum_probs=145.9
Q ss_pred cccccccceEEEEEEEC----CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEE
Q 019304 141 TAFAQGAFGKLYRGTYN----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E 216 (343)
+.||+|+||.||+|.+. +..+|+|.++....... ...+.+|+.+++.++||||+++++.+.+....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE-----QMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEE
Confidence 36899999999999862 34689998865443221 2468899999999999999999999999888999999
Q ss_pred ecCCCCHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCC
Q 019304 217 YAKGGSVRQFLTRRQN---RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (343)
Q Consensus 217 ~~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~ 293 (343)
|+++++|.+++..... ...++..+..++.|++.||+|||+.+++||||||+||+++.++++||+|||+++.......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 9999999999975321 2356677889999999999999999999999999999999999999999999875432221
Q ss_pred ---ccCCCCCcceecCCCCCCC--CCCCCCCceeeeeeecc
Q 019304 294 ---MTPETGTYRWMAPGNSFFS--PLPHPSFEHKWSAKESC 329 (343)
Q Consensus 294 ---~~~~~gt~~y~APE~~~~~--~~~~~~~~~~sDi~~~~ 329 (343)
.....+++.|+|||++... ......++.++|+|++.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG 196 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLG 196 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHH
Confidence 1234578899999998321 01123568899999644
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=237.51 Aligned_cols=191 Identities=26% Similarity=0.397 Sum_probs=161.5
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++.+.||.|++|.||+|.. +++.||+|.+....... .+.+.+|+.+++.++||||+++++.+.....+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK------KELIINEILVMKELKNPNIVNFLDSFLVGDEL 91 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch------HHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence 46788999999999999999986 78899999986543221 24678999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++|+||+++++|.+++... .+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred EEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 9999999999999988643 4889999999999999999999999999999999999999999999999998754332
Q ss_pred CC-ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 292 EG-MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 292 ~~-~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.. .....+++.|+|||.+ ....++.++|+|+++. +++.+||.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slGvil~~lltg~~pf~ 216 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVV-----TRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (296)
T ss_pred cccCCCcCCCccccCcchh-----cCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 22 2334788999999999 7788999999996433 33555654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=236.63 Aligned_cols=187 Identities=30% Similarity=0.466 Sum_probs=155.6
Q ss_pred ecccccccccccccccceEEEEEEE-------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 204 (343)
+..+++.+.++||+|+||.||++.. ++..+|+|.+..... ...+.+.+|+++++.++|+||++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 75 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE------SARQDFQREAELLTVLQHQHIVRFYGV 75 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH------HHHHHHHHHHHHHhcCCCCCCceEEEE
Confidence 4567889999999999999999964 345789998764321 123578999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQN-------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~-------------~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv 271 (343)
+......+++|||+++++|.+++..... ..+++..++.++.|++.||+|||++|++||||||+|||+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~ 155 (280)
T cd05092 76 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV 155 (280)
T ss_pred EecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE
Confidence 9999999999999999999999975432 247889999999999999999999999999999999999
Q ss_pred cCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 272 SADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 272 ~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
++++.+||+|||+++....... .....+++.|+|||.+ ....++.++|+|+++
T Consensus 156 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG 211 (280)
T cd05092 156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI-----LYRKFTTESDIWSFG 211 (280)
T ss_pred cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHh-----ccCCcCchhhHHHHH
Confidence 9999999999999875432211 1122356889999998 778899999999644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=232.26 Aligned_cols=177 Identities=29% Similarity=0.518 Sum_probs=147.2
Q ss_pred ccccccceEEEEEEE----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEe
Q 019304 142 AFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 142 ~lg~G~fg~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
.||+|+||.||+|.+ +++.+|+|+++...... ...+.+.+|+.+++.+.||||+++++.+.. +.+++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP----ALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcH----HHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEec
Confidence 589999999999975 46789999987544332 234678999999999999999999998864 457899999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCC----
Q 019304 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---- 293 (343)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~---- 293 (343)
+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.......
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 77 AELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999999999754 3588999999999999999999999999999999999999999999999999976543221
Q ss_pred ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 294 MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 294 ~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.....+++.|+|||.+ ....++.++|+|+++.
T Consensus 155 ~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 186 (257)
T cd05116 155 KTHGKWPVKWYAPECM-----NYYKFSSKSDVWSFGV 186 (257)
T ss_pred cCCCCCCccccCHhHh-----ccCCcCchhHHHHHHH
Confidence 1122345799999998 7778999999996443
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=238.14 Aligned_cols=185 Identities=26% Similarity=0.477 Sum_probs=152.1
Q ss_pred ccccccccccccceEEEEEEECC-------ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 136 KLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
+|++.+.||+|+||.||+|.... ..+|+|.+....... ..+++.+|+.+++.++||||+++++.+...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSS-----ELRDLLSEFNLLKQVNHPHVIKLYGACSQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHH-----HHHHHHHHHHHHhhCCCCCEeeEEEEEecC
Confidence 36778999999999999998622 468888886433211 125788999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCC
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQ----------------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKS 266 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp 266 (343)
...++++||+.+++|.+++.... ...+++..++.++.|++.||+|||+.+++||||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp 155 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA 155 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhh
Confidence 99999999999999999987531 12477888999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 267 DNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 267 ~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+|||+++++.+||+|||+++....... .....++..|+|||.+ ....++.++|+|++..
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~-----~~~~~~~~~Di~slG~ 217 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL-----FDHIYTTQSDVWSFGV 217 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHH-----ccCCcchHhHHHHHHH
Confidence 999999999999999999875432211 1223456789999998 6778999999996443
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=232.33 Aligned_cols=176 Identities=27% Similarity=0.507 Sum_probs=144.7
Q ss_pred ccccccceEEEEEEE----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEe
Q 019304 142 AFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 142 ~lg~G~fg~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
.||+|+||.||+|.+ .+..||+|++...... ...+.+.+|+.+++.++||||+++++++.. ...++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK-----SVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccCh-----HHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEe
Confidence 489999999999976 2346999998654321 123578999999999999999999998864 467899999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCC----
Q 019304 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---- 293 (343)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~---- 293 (343)
+++++|.+++... ...+++..+++++.|++.||+|||++|++||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 76 ASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999999998753 34689999999999999999999999999999999999999999999999999875433221
Q ss_pred ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 294 MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 294 ~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.....+++.|+|||.+ ....++.++|+|+++
T Consensus 155 ~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG 185 (257)
T cd05115 155 RSAGKWPLKWYAPECI-----NFRKFSSRSDVWSYG 185 (257)
T ss_pred cCCCCCCcccCCHHHH-----ccCCCCchhhHHHHH
Confidence 1112235789999998 677889999999644
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=235.70 Aligned_cols=185 Identities=27% Similarity=0.495 Sum_probs=151.9
Q ss_pred cccccccccccccceEEEEEEE------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
.+|++.+.||+|+||.||++.+ +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 77 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA------EHLRDFEREIEILKSLQHDNIVKYKGVCYSA 77 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH------HHHHHHHHHHHHHHhCCCCCeeEEEEEEccC
Confidence 5678889999999999999974 467899999865321 1235788999999999999999999987543
Q ss_pred --CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 209 --MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 209 --~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
..+++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 78 GRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred CCCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccc
Confidence 46799999999999999997542 358899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCc----cCCCCCcceecCCCCCCCCCCCCCCceeeeeeecccc
Q 019304 287 IEVQTEGM----TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLK 331 (343)
Q Consensus 287 ~~~~~~~~----~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~ 331 (343)
........ ....++..|+|||.+ ....++.++|+|+++.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~~ 200 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESL-----TESKFSVASDVWSFGVV 200 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHh-----ccCCcChHHHHHHHHHH
Confidence 65432221 112234569999998 67789999999964443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=234.85 Aligned_cols=184 Identities=26% Similarity=0.392 Sum_probs=156.7
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||+|++|.||+|.+ +++.||+|++........ ....+.+|+.+++.++||||+++++++......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 76 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGG----IPNQALREIKALQACQHPYVVKLLDVFPHGSGFVL 76 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccch----hhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEE
Confidence 477889999999999999987 678999999976543221 23578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~- 292 (343)
|+||+ +++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 77 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 77 VMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred Eeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 99999 999999987543 568999999999999999999999999999999999999999999999999988654432
Q ss_pred -CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 293 -GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
......|+..|+|||.+. ....++.++|+|+++
T Consensus 155 ~~~~~~~~~~~y~aPE~~~----~~~~~~~~~Di~slG 188 (286)
T cd07832 155 RLYSHQVATRWYRAPELLY----GARKYDPGVDLWAVG 188 (286)
T ss_pred CccccccCcccccCceeee----ccccCCchhHHHHHH
Confidence 234457899999999983 234578999999643
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=231.86 Aligned_cols=186 Identities=28% Similarity=0.458 Sum_probs=154.8
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCeE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RMVW 211 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~ 211 (343)
+|+..+.||+|+||.||++.. +++.||+|.+......... ....+.+.+|+.+++.++||||+++++.+.. ...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPET-SKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchh-HHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 577889999999999999987 6789999998755433321 1223578899999999999999999998875 3578
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++++||+++++|.+++... ..+++...+.++.|++.||+|||+++++||||+|+||+++.++.+||+|||+++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 8999999999999999754 34788999999999999999999999999999999999999999999999998754321
Q ss_pred ----CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 292 ----EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 292 ----~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.......++..|+|||.+ ....++.++|+|+++
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slG 196 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVI-----SGEGYGRKADVWSLG 196 (266)
T ss_pred cccCCccccCCccccccCHHHh-----CCCCCCchhhhHHHH
Confidence 112234688999999999 778899999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=231.69 Aligned_cols=185 Identities=24% Similarity=0.393 Sum_probs=157.9
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||+|+||.||++.. +++.||+|.+......... .+++.+|+.+++.++||||+++++++......++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKE----REESRKEVAVLSNMKHPNIVQYQESFEENGNLYI 76 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHH----HHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEE
Confidence 477889999999999999987 6789999998754332221 2578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCC
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~ 293 (343)
|+||+++++|.+++.......+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++........
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999999999999765555688999999999999999999999999999999999999999999999999875433221
Q ss_pred -ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 294 -MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 294 -~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.....|++.|+|||++ ....++.++|+|+++
T Consensus 157 ~~~~~~~~~~~~~pe~~-----~~~~~~~~~Dv~slG 188 (256)
T cd08218 157 LARTCIGTPYYLSPEIC-----ENRPYNNKSDIWALG 188 (256)
T ss_pred hhhhccCCccccCHHHh-----CCCCCCCccchhHHH
Confidence 2234688999999998 778889999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=255.16 Aligned_cols=190 Identities=16% Similarity=0.242 Sum_probs=149.1
Q ss_pred eecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC------CCCcceEE
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK------HLNIVRFI 202 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~l~ 202 (343)
.+..++|++.+.||+|+||.||+|.+ .++.||||+++..... .+.+..|+.+++.++ |++++.++
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-------~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY-------TRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhh-------HHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 34457899999999999999999987 6778999999642211 123445555555554 45688898
Q ss_pred EEEEeC-CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCC-----
Q 019304 203 GACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADK----- 275 (343)
Q Consensus 203 ~~~~~~-~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~giiHrDlkp~NILv~~~~----- 275 (343)
+++... ..+|+|||++ +++|.+++.+. ..+++..+..++.||+.||.|||+ .|||||||||+|||++.++
T Consensus 198 ~~~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 198 RYFQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EEEEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccc
Confidence 888764 4789999998 77999988764 458999999999999999999998 5999999999999998665
Q ss_pred -----------cEEEeccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCC
Q 019304 276 -----------SIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPP 337 (343)
Q Consensus 276 -----------~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~ 337 (343)
.+||+|||.+.... ......+||+.|+|||++ ....|+.++|||++++ +++.+||
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~-----~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVV-----LGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred ccccccCCCCceEEECCCCccccCc--cccccccCCccccCcHHh-----hcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 49999999886422 234456899999999999 7788999999996333 3355665
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=233.69 Aligned_cols=197 Identities=26% Similarity=0.441 Sum_probs=159.6
Q ss_pred ecccccccccccccccceEEEEEEE--CCc---eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGE---DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~---~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
|...+|+..+.||+|+||.||+|.. +++ .+|+|.+....... ..+.+.+|+.+++.++||||+++++++.
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK-----QRQDFLSEASIMGQFSHHNIIRLEGVVT 76 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHH-----HHHHHHHHHHHHhcCCCCCeeEEEEEEc
Confidence 3456778889999999999999987 333 68999886543222 1356889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
.....++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||+++
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 77 KFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccce
Confidence 9999999999999999999987533 458899999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCc--c--CCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----cc-ccCCCCc
Q 019304 287 IEVQTEGM--T--PETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KT-TWPPPWR 339 (343)
Q Consensus 287 ~~~~~~~~--~--~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~-~~~p~~~ 339 (343)
........ . ....++.|+|||.+ ....++.++|+|+++. ++ +..|+|.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~-----~~~~~~~~~Dv~slG~il~ell~~g~~p~~~ 213 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAI-----AYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHh-----hcCCcChHhHHHHHHHHHHHHHhCCCCCCCc
Confidence 54332111 1 11234679999999 7788999999996432 22 5666654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=234.29 Aligned_cols=195 Identities=23% Similarity=0.349 Sum_probs=154.7
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHH-HhcCCCCCcceEEEEEEeCCeEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-LATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
+|++.+.||+|+||.||+++. +++.||||.+........ ..++..|+.+ ++.+.||||+++++++......+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~ 76 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-----QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW 76 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-----HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence 577889999999999999988 688999999876543322 1345556654 66779999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 213 IVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~-giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
++|||++ ++|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9999996 5898888653 234689999999999999999999997 99999999999999999999999999998654
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCC
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPP 337 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~ 337 (343)
.....+...++..|+|||.+... .....++.++|+|++.. +++..|+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 207 (283)
T cd06617 156 DSVAKTIDAGCKPYMAPERINPE-LNQKGYDVKSDVWSLGITMIELATGRFPY 207 (283)
T ss_pred cccccccccCCccccChhhcCCc-ccccccCccccchhhHHHHHHHHhCCCCC
Confidence 43333445789999999987321 12256789999995333 3355555
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=231.32 Aligned_cols=188 Identities=25% Similarity=0.444 Sum_probs=155.1
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--Ce
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--MV 210 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~ 210 (343)
.+|.+.+.||+|+||.||+|.. +++.||+|.+........ .......+.+|+.+++.++||||+++++.+.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQE-TSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccch-hhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence 4677889999999999999987 678999998854322211 112336788999999999999999999998764 46
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~ 290 (343)
+++++||+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 889999999999999987543 478899999999999999999999999999999999999999999999999875432
Q ss_pred C----CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 291 T----EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 291 ~----~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
. .......++..|+|||.+ ....++.++|+|+++.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 197 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVI-----SGEGYGRKADVWSVAC 197 (264)
T ss_pred ccccCccccccCCcccccCHhhh-----cCCCCCccccHHHHHH
Confidence 1 112334689999999999 6778899999996443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=233.35 Aligned_cols=175 Identities=19% Similarity=0.340 Sum_probs=143.8
Q ss_pred cccccccceEEEEEEEC--------------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 141 TAFAQGAFGKLYRGTYN--------------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
+.||+|+||.||+|++. ...||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~------~~~~~~~~~~~~l~~l~hp~iv~~~~~~~ 74 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR------DISLAFFETASMMRQVSHKHIVLLYGVCV 74 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh------hHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 36899999999999752 12588888754321 12357889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc-------EEE
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS-------IKI 279 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~-------vkl 279 (343)
.....++||||+++++|..++... ...+++..++.++.|++.||+|||+++++||||||+|||++.++. +|+
T Consensus 75 ~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 75 RDVENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred cCCCCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 988899999999999999888653 345899999999999999999999999999999999999987664 899
Q ss_pred eccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 280 ADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 280 ~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+|||++..... .....++..|+|||.+. ....++.++|||+++
T Consensus 154 ~d~g~~~~~~~---~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG 196 (262)
T cd05077 154 SDPGIPITVLS---RQECVERIPWIAPECVE----DSKNLSIAADKWSFG 196 (262)
T ss_pred CCCCCCccccC---cccccccccccChhhhc----CCCCCCchhHHHHHH
Confidence 99999865322 22346888999999882 256789999999643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=232.06 Aligned_cols=177 Identities=21% Similarity=0.284 Sum_probs=153.0
Q ss_pred cccccceEEEEEEEC--CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEecCC
Q 019304 143 FAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (343)
Q Consensus 143 lg~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~~~ 220 (343)
||.|++|.||+++.. ++.+|+|++.+...... ...+.+.+|+.+++.++||||+++++.+.+...+++++||+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVET---GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhh---hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCC
Confidence 689999999999984 88999999976443221 2236789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCccCCCCC
Q 019304 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300 (343)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~~~~~gt 300 (343)
++|.+++.+. ..++...+..++.|++.||+|||+++++|+||+|+||+++.++.+||+|||+++............++
T Consensus 78 ~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 155 (262)
T cd05572 78 GELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGT 155 (262)
T ss_pred CcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCC
Confidence 9999999764 34889999999999999999999999999999999999999999999999999865543333345789
Q ss_pred cceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 301 YRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 301 ~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+.|+|||.+ ....++.++|+|+++
T Consensus 156 ~~~~~PE~~-----~~~~~~~~~Di~slG 179 (262)
T cd05572 156 PEYVAPEII-----LNKGYDFSVDYWSLG 179 (262)
T ss_pred cCccChhHh-----cCCCCCChhhhhhhH
Confidence 999999998 677889999999643
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=237.23 Aligned_cols=195 Identities=23% Similarity=0.340 Sum_probs=160.2
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||+|+||.||++.. .++.||+|.+....... ....+.+.+|+.+++.++||||+++++.+.....+++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLIL---RNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM 78 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhh---HHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence 577889999999999999987 56789999986543211 1223578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~- 292 (343)
||||+++++|.+++... ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++......
T Consensus 79 v~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 79 VMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99999999999999754 358899999999999999999999999999999999999999999999999986421100
Q ss_pred ---------------CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 293 ---------------GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 293 ---------------~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
......+++.|+|||.+ ....++.++|+|+++. +++.+||++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~vl~el~~g~~pf~~~ 219 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI-----LRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 219 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhc-----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 01123578899999998 6788999999996433 3366676654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=230.02 Aligned_cols=178 Identities=30% Similarity=0.482 Sum_probs=149.1
Q ss_pred cccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEecC
Q 019304 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAK 219 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~~ 219 (343)
+.||+|+||.||+|.. +++.+|+|++...... .....+.+|+.+++.++||||+++++.+......++||||++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ-----ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP 75 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCH-----HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence 3689999999999987 6678999998654321 122468899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCc--cCC
Q 019304 220 GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM--TPE 297 (343)
Q Consensus 220 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~--~~~ 297 (343)
+++|.+++.... ..+++..++.++.|++.+|.|||++|++|+||||+||+++.++.+||+|||+++........ ...
T Consensus 76 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 76 GGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 999999987543 45789999999999999999999999999999999999999999999999998754322111 112
Q ss_pred CCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 298 TGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 298 ~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.+++.|+|||++ ....++.++|+|+++
T Consensus 155 ~~~~~y~aPE~~-----~~~~~~~~~Di~slG 181 (250)
T cd05085 155 QIPIKWTAPEAL-----NYGRYSSESDVWSYG 181 (250)
T ss_pred CCcccccCHHHh-----ccCCCCchhHHHHHH
Confidence 345789999999 777899999999644
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=235.72 Aligned_cols=189 Identities=21% Similarity=0.331 Sum_probs=156.0
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||++.+ +++.||+|.+...... . ....+.+|+.+++.++||||+++++.+.....++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~-~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE-S----KFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCH-H----HHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEE
Confidence 3678889999999999999988 5789999988643221 1 1257889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEEEecccccccccc
Q 019304 213 IVTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~-~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~ 290 (343)
+||||+++++|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 9999999999999887532 2358999999999999999999996 5999999999999999999999999999875433
Q ss_pred CCCccCCCCCcceecCCCCCCCCC-CCCCCceeeeeeecc
Q 019304 291 TEGMTPETGTYRWMAPGNSFFSPL-PHPSFEHKWSAKESC 329 (343)
Q Consensus 291 ~~~~~~~~gt~~y~APE~~~~~~~-~~~~~~~~sDi~~~~ 329 (343)
. ......+++.|+|||.+..... ....++.++|+|+++
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG 194 (286)
T cd06622 156 S-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLG 194 (286)
T ss_pred C-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHH
Confidence 2 2334568899999999833222 334578999999643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=232.73 Aligned_cols=184 Identities=23% Similarity=0.433 Sum_probs=148.7
Q ss_pred ccccccccccceEEEEEEEC--Cc--eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----
Q 019304 138 NMGTAFAQGAFGKLYRGTYN--GE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR----- 208 (343)
Q Consensus 138 ~~~~~lg~G~fg~Vy~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----- 208 (343)
.+++.||+|+||.||+|.+. +. .+|+|.++........ .+.+.+|+.+++.++||||+++++.+...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE----MEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHH----HHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence 46788999999999999873 32 5899988764333222 35788999999999999999999987432
Q ss_pred -CeEEEEEEecCCCCHHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 209 -MVWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 209 -~~~~iv~E~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
...+++|||+++++|.+++... ....+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCC
Confidence 2468999999999999988532 22347899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 284 VARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 284 ~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+++....... .....+++.|+|||.+ ....++.++|+|+++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~-----~~~~~~~~~Di~slG~ 202 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESL-----ADRVYTTKSDVWSFGV 202 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHc-----cCCCcChHHHHHHHHH
Confidence 9986543221 1122456789999999 7888999999996443
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=239.57 Aligned_cols=177 Identities=21% Similarity=0.357 Sum_probs=141.9
Q ss_pred ccccccccceEEEEEEE----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCeEEE
Q 019304 140 GTAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RMVWCI 213 (343)
Q Consensus 140 ~~~lg~G~fg~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~i 213 (343)
+.+||+|+||.||+|+. ++..||+|.+...... ..+.+|+.+++.++||||+++++++.. ...+++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--------MSACREIALLRELKHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc--------HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence 36799999999999986 3468999998654322 246789999999999999999999854 457899
Q ss_pred EEEecCCCCHHHHHHhh-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE----cCCCcEEEecc
Q 019304 214 VTEYAKGGSVRQFLTRR-------QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI----SADKSIKIADF 282 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv----~~~~~vkl~DF 282 (343)
|+||+++ +|.+++... ....+++..+..++.|++.||.|||+.+++||||||+|||+ +.++++||+||
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 78 LFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9999965 888877532 12347888999999999999999999999999999999999 45679999999
Q ss_pred ccccccccCC----CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 283 GVARIEVQTE----GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 283 g~a~~~~~~~----~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
|+++...... ......||+.|+|||.+. ....++.++|+|+++
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwSlG 203 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLL----GARHYTKAIDIWAIG 203 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhc----CCCccCcHHHHHhHH
Confidence 9998654321 123457899999999982 235689999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=230.75 Aligned_cols=185 Identities=25% Similarity=0.381 Sum_probs=157.5
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++++.||.|+||.||+|.. ++..+|+|++....... ..+.+.+|+.+++.++|+||+++++.+......+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-----SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-----HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEE
Confidence 3678899999999999999987 67789999986544332 2357889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 213 IVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
+|+|++++++|.+++..... ..+++..+..++.|++.||+|||+.|++|+||+|+||++++++.+||+|||++......
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 99999999999999976433 46889999999999999999999999999999999999999999999999998754432
Q ss_pred CC-----ccCCCCCcceecCCCCCCCCCCCC-CCceeeeeeecc
Q 019304 292 EG-----MTPETGTYRWMAPGNSFFSPLPHP-SFEHKWSAKESC 329 (343)
Q Consensus 292 ~~-----~~~~~gt~~y~APE~~~~~~~~~~-~~~~~sDi~~~~ 329 (343)
.. .....|++.|+|||.+ ... .++.++|+|+++
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~-----~~~~~~~~~~Dv~slG 194 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVM-----EQVHGYDFKADIWSFG 194 (267)
T ss_pred ccccccccccccCChhhcChHHH-----ccccCcCcccchHhHh
Confidence 21 1234689999999998 444 789999999643
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=236.46 Aligned_cols=184 Identities=24% Similarity=0.382 Sum_probs=152.8
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++.+.||+|++|.||+|.. +++.||||.+......... ..+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP-----FTAIREASLLKDLKHANIVTLHDIIHTKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCc-----hhHHHHHHHHhhCCCcceeeEEEEEecCCeE
Confidence 36788899999999999999987 6789999998754332211 3467899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||+++.....
T Consensus 79 ~lv~e~~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred EEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 999999975 9999887543 36889999999999999999999999999999999999999999999999998753221
Q ss_pred -CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeec
Q 019304 292 -EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES 328 (343)
Q Consensus 292 -~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~ 328 (343)
.......+++.|+|||.+. ....++.++|+|++
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~Dv~sl 190 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLL----GSTEYSTSLDMWGV 190 (291)
T ss_pred CccccccccccccCCcHHhh----cCcccCcHHHHHHH
Confidence 1122335788999999883 23558899999954
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=254.10 Aligned_cols=199 Identities=23% Similarity=0.256 Sum_probs=176.2
Q ss_pred ecccccccccccccccceEEEEEEECCce--EEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
+.+.+++....||-|+||.|-+++.+++. +|+|++++......+. ++.+..|-++|..++.|.||++|..|.+..
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQ---qeHv~sEr~Im~~~~s~fIvrLYrTfrd~k 493 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQ---QEHVFSERNIMMECRSDFIVRLYRTFRDSK 493 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhH---HHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence 45678888899999999999999886655 8999987765544333 256789999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
.+|++||-|-||.|+..++++ +.++..++..++.-+++|++|||++|||+|||||+|++++.+|-+||.|||+|+...
T Consensus 494 yvYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 999999999999999999775 459999999999999999999999999999999999999999999999999999998
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
......++||||.|+|||++ .++.-+.++|.|++.+ +++-|||.+-
T Consensus 572 ~g~KTwTFcGTpEYVAPEII-----LnKGHD~avDyWaLGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 572 SGRKTWTFCGTPEYVAPEII-----LNKGHDRAVDYWALGILIYELLTGSPPFSGV 622 (732)
T ss_pred cCCceeeecCCcccccchhh-----hccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 88888999999999999999 7888999999996443 5578888654
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=235.38 Aligned_cols=187 Identities=30% Similarity=0.453 Sum_probs=153.0
Q ss_pred cccccccccccccccceEEEEEEEC-------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
..++|++.+.||+|++|.||+|.+. +..||+|.+....... .+..|.+|+.+++.++|+||+++++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ-----DESDFLMEALIMSKFNHQNIVRLIGVS 78 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 4577888999999999999999883 3578888875432211 125688999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC---cE
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQN-----RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SI 277 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~---~v 277 (343)
.+....++||||+++++|.+++..... ..+++..++.++.||+.||+|||+++++||||||+||+++.++ .+
T Consensus 79 ~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 79 FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred ccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence 998889999999999999999976432 2478899999999999999999999999999999999998654 69
Q ss_pred EEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 278 KIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 278 kl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
||+|||+++....... ......++.|+|||++ ....++.++|||+++
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DiwslG 208 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAF-----LDGIFTSKTDVWSFG 208 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHH-----hcCCcCchhHHHHHH
Confidence 9999999986532211 1122335689999999 778899999999644
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=233.30 Aligned_cols=187 Identities=25% Similarity=0.447 Sum_probs=153.7
Q ss_pred eecccccccccccccccceEEEEEEECC-----ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNG-----EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
++...+|.+.+.||+|+||.||+|.+.. ..||||........ ...+.+.+|+.+++.+.||||+++++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 76 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP-----SVREKFLQEAYIMRQFDHPHIVKLIGVI 76 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH-----HHHHHHHHHHHHHHhCCCCchhceeEEE
Confidence 4566788899999999999999998722 36899988643321 1235788999999999999999999998
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
.+. ..++||||+++++|.+++.+.. ..+++..++.++.|++.||+|||+.+++|+||||+||+++.++.+||+|||++
T Consensus 77 ~~~-~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 77 TEN-PVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred cCC-CcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCcee
Confidence 764 4689999999999999997643 35899999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCc--cCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 286 RIEVQTEGM--TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 286 ~~~~~~~~~--~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+........ ....+++.|+|||.+ ....++.++|+|+++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG 195 (270)
T cd05056 155 RYLEDESYYKASKGKLPIKWMAPESI-----NFRRFTSASDVWMFG 195 (270)
T ss_pred eecccccceecCCCCccccccChhhh-----ccCCCCchhhhHHHH
Confidence 865433221 122345689999998 777899999999644
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=230.64 Aligned_cols=185 Identities=24% Similarity=0.469 Sum_probs=156.1
Q ss_pred cccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
+..+|++.+.||+|+||.||++.+ +++.+|+|.+....... ..+.+|+++++.+.||+|+++++++......
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-------EDFIEEAQVMMKLSHPKLVQLYGVCTERSPI 74 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH-------HHHHHHHHHHHhCCCCCeeeEEEEEccCCce
Confidence 456788889999999999999988 47889999986544332 4688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+++|+||||+||+++.++.+||+|||.++.....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 75 CLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 99999999999999987533 35789999999999999999999999999999999999999999999999998754332
Q ss_pred CC--ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 292 EG--MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 292 ~~--~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.. .....++..|+|||.+ ....++.++|+|+++.
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~-----~~~~~~~~~Dv~slG~ 189 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVF-----SFSKYSSKSDVWSFGV 189 (256)
T ss_pred cccccCCCccchhhcCHhHh-----ccCCcChHHHHHHHHH
Confidence 11 1122345789999998 6778999999996443
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=231.86 Aligned_cols=173 Identities=22% Similarity=0.386 Sum_probs=144.1
Q ss_pred cccccccceEEEEEEECCc------------eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 141 TAFAQGAFGKLYRGTYNGE------------DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~~~------------~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
+.||+|+||.||+|.+... .+++|.+...... ...+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-------SLAFFETASLMSQLSHKHLVKLYGVCVR- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-------HHHHHHHHHHHHcCCCcchhheeeEEec-
Confidence 3689999999999988332 3777876543221 3578899999999999999999999987
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC-------cEEEec
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-------SIKIAD 281 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~-------~vkl~D 281 (343)
...++||||+++++|.+++.+.. ..++...++.++.|++.||+|||++|++||||||+|||++.++ .+||+|
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 66799999999999999998643 2588999999999999999999999999999999999999887 799999
Q ss_pred cccccccccCCCccCCCCCcceecCCCCCCCCCCCC--CCceeeeeeeccc
Q 019304 282 FGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHP--SFEHKWSAKESCL 330 (343)
Q Consensus 282 Fg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~--~~~~~sDi~~~~~ 330 (343)
||+++.... .....++..|+|||++ ... .++.++|+|+++.
T Consensus 152 fg~a~~~~~---~~~~~~~~~y~aPE~~-----~~~~~~~~~~~Di~slG~ 194 (259)
T cd05037 152 PGIPITVLS---REERVERIPWIAPECI-----RNGQASLTIAADKWSFGT 194 (259)
T ss_pred CCccccccc---ccccccCCCccChhhh-----cCCCCCcchhhHHHHHHH
Confidence 999886433 2234577889999998 444 7899999996443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=231.91 Aligned_cols=198 Identities=28% Similarity=0.440 Sum_probs=162.1
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC-
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM- 209 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~- 209 (343)
.++|++.+.||+|++|.||+|.. +++.+++|++...... .+.+.+|+.+++++ .|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-------EEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh-------HHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 47888999999999999999988 5678999998754321 24688999999999 7999999999997654
Q ss_pred -----eEEEEEEecCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 019304 210 -----VWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (343)
Q Consensus 210 -----~~~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DF 282 (343)
.+++||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.+||+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCC
Confidence 4899999999999999987543 456899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCC-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 283 GVARIEVQTE-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 283 g~a~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
|++....... ......|++.|+|||.+.........++.++|+|+++. +++.+||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 219 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcc
Confidence 9987543321 22345689999999988443334567889999996443 33666654
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=236.56 Aligned_cols=189 Identities=28% Similarity=0.455 Sum_probs=156.0
Q ss_pred ecccccccccccccccceEEEEEEE-------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 204 (343)
++.++|++.+.||+|+||.||++.. ++..||+|++...... ...+.+.+|+.+++.+.||||++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~ei~~l~~l~h~~iv~~~~~ 76 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-----DMQADFQREAALMAEFDHPNIVKLLGV 76 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH-----HHHHHHHHHHHHHHhcCCCchheEEEE
Confidence 4567888999999999999999986 3468999998643321 123578899999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQN--------------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDL 264 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------------------~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDl 264 (343)
+......++++||+++++|.+++..... ..+++..++.++.|++.||.|||+++++||||
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl 156 (288)
T cd05050 77 CAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL 156 (288)
T ss_pred EcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 9998899999999999999999975321 23677888999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 265 KSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 265 kp~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
||+||+++.++.+||+|||+++....... ......++.|+|||.+ ....++.++|+|+++.
T Consensus 157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slG~ 220 (288)
T cd05050 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESI-----FYNRYTTESDVWAYGV 220 (288)
T ss_pred cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHH-----hcCCCCchhHHHHHHH
Confidence 99999999999999999999875432211 1122346789999998 7788999999996443
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=243.36 Aligned_cols=182 Identities=24% Similarity=0.330 Sum_probs=153.3
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC---
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--- 208 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--- 208 (343)
.++|+..+.||+|+||.||+|.. +++.||||++.+....... ...+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTH----AKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhH----HHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence 36788899999999999999987 7889999998654433222 24577899999999999999999998644
Q ss_pred ---CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 209 ---MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 209 ---~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
...|+||||+.+ +|.+.+... ++...+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus 91 ~~~~~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 91 EEFQDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cccCcEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 346999999964 888887542 788899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 286 RIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+............+++.|+|||.+ .+..++.++|+|+++
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DvwslG 204 (353)
T cd07850 166 RTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENVDIWSVG 204 (353)
T ss_pred eeCCCCCCCCCCcccccccCHHHH-----hCCCCCCchhhHhHH
Confidence 865444334455789999999999 778899999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=230.75 Aligned_cols=181 Identities=27% Similarity=0.419 Sum_probs=157.8
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||+|.+ +++.+++|.+..... .+++.+|+.+++.++||||+++++.+......|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 74 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--------LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLW 74 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--------HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEE
Confidence 6788899999999999999988 468899999864321 367899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+++||+++++|.+++... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++.......
T Consensus 75 l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 75 IVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred EEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 999999999999998753 3468999999999999999999999999999999999999999999999999988654432
Q ss_pred -CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 293 -GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
......++..|+|||.+ .+..++.++|+|+++
T Consensus 154 ~~~~~~~~~~~y~~PE~~-----~~~~~~~~~Di~s~G 186 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVI-----QEIGYNNKADIWSLG 186 (256)
T ss_pred cccccccCCccccCHHHH-----hcCCCCchhhHHHHH
Confidence 22334688999999998 677899999999643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=230.35 Aligned_cols=179 Identities=28% Similarity=0.461 Sum_probs=151.4
Q ss_pred cccccccceEEEEEEEC---Cc--eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEE
Q 019304 141 TAFAQGAFGKLYRGTYN---GE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~---~~--~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~ 215 (343)
+.||+|++|.||+|.+. ++ .||||.+...... ...+.+.+|+.++++++||||+++++.+.. ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-----DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-----HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEE
Confidence 36899999999999872 22 6899998765443 234689999999999999999999999988 8889999
Q ss_pred EecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCC--
Q 019304 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-- 293 (343)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~-- 293 (343)
||+++++|.+++.......+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||+++.......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999999999875435689999999999999999999999999999999999999999999999999986543211
Q ss_pred --ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 294 --MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 294 --~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.....++..|+|||.+ ....++.++|+|+++.
T Consensus 155 ~~~~~~~~~~~y~~pE~~-----~~~~~~~~~Di~slG~ 188 (257)
T cd05040 155 VMEEHLKVPFAWCAPESL-----RTRTFSHASDVWMFGV 188 (257)
T ss_pred ecccCCCCCceecCHHHh-----cccCcCchhhhHHHHH
Confidence 1123567899999999 7788999999996444
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=234.92 Aligned_cols=184 Identities=22% Similarity=0.351 Sum_probs=157.8
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 210 (343)
..++|++.+.||+|+||.||++.. +++.||+|++...... ...+.+.+|+.+++.++||||+++++.+.....
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS-----SVRKQILRELQIMHECRSPYIVSFYGAFLNENN 77 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcc-----hHHHHHHHHHHHHHHcCCCCcceEeeeEecCCE
Confidence 346788999999999999999988 5889999988653321 123578899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
+++||||+++++|.+++.+. ..+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred EEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 99999999999999998763 358999999999999999999997 599999999999999999999999999987543
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.. ......|+..|+|||++ ....++.++|+|+++
T Consensus 156 ~~-~~~~~~~~~~~~aPE~~-----~~~~~~~~~Di~slG 189 (284)
T cd06620 156 NS-IADTFVGTSTYMSPERI-----QGGKYTVKSDVWSLG 189 (284)
T ss_pred hh-ccCccccCcccCCHHHH-----ccCCCCccchHHHHH
Confidence 22 22345789999999998 677899999999644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=243.85 Aligned_cols=193 Identities=29% Similarity=0.411 Sum_probs=156.9
Q ss_pred ecccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhc--CCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT--LKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~ 209 (343)
.+...+++.+.||+|.||.||+|.++++.||||++.... .+.|.+|-++.+. ++|+||++++++-....
T Consensus 207 ~~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~---------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t 277 (534)
T KOG3653|consen 207 LELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQE---------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGT 277 (534)
T ss_pred ccCCchhhHHHhhcCccceeehhhccCceeEEEecCHHH---------HHHHHhHHHHHhccCccchhHHHhhchhccCC
Confidence 346778899999999999999999999999999995311 2568888888765 58999999998865444
Q ss_pred ----eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeCCCCCCcEEEcCCCc
Q 019304 210 ----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL---------GFIHRDLKSDNLLISADKS 276 (343)
Q Consensus 210 ----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---------giiHrDlkp~NILv~~~~~ 276 (343)
.++||+||.+.|+|.+||+.. .+++....+++..+++||+|||+- .|+|||||..||||..|++
T Consensus 278 ~~~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT 354 (534)
T KOG3653|consen 278 ADRMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT 354 (534)
T ss_pred ccccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc
Confidence 789999999999999999864 489999999999999999999962 5999999999999999999
Q ss_pred EEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCC-CCCceeeeeeecccccccCCC
Q 019304 277 IKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPH-PSFEHKWSAKESCLKTTWPPP 337 (343)
Q Consensus 277 vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~-~~~~~~sDi~~~~~~~~~~p~ 337 (343)
+-|+|||+|.....+.. ....+||.+|||||++.+..... ..--...||| ++++++|--.
T Consensus 355 ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvY-amgLVLWEi~ 418 (534)
T KOG3653|consen 355 CCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVY-AMGLVLWEIA 418 (534)
T ss_pred EEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHH-HHHHHHHHHH
Confidence 99999999987654432 23368999999999995432222 2333567999 6666666443
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=228.82 Aligned_cols=182 Identities=32% Similarity=0.581 Sum_probs=154.9
Q ss_pred ccccccccccceEEEEEEECC------ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 138 NMGTAFAQGAFGKLYRGTYNG------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 138 ~~~~~lg~G~fg~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
++.+.||.|+||.||++.+.. ..||+|.+....... ..+.+.+|+.+++.+.|+||+++++.+.+....
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ-----QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH-----HHHHHHHHHHHHHhcCCCchheEEEEEcCCCee
Confidence 567889999999999998843 789999996543321 235788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
+++|||+++++|.+++.......+++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||+++.....
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999999997654333899999999999999999999999999999999999999999999999999865443
Q ss_pred CCcc--CCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 292 EGMT--PETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 292 ~~~~--~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.... ...+++.|+|||.+ ....++.++|+|+++
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~-----~~~~~~~~~Di~slG 191 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESL-----KDGKFTSKSDVWSFG 191 (258)
T ss_pred cccccccCCCcccccChHHh-----ccCCCCcchhHHHHH
Confidence 2222 12367899999998 778899999999644
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=233.39 Aligned_cols=188 Identities=22% Similarity=0.374 Sum_probs=155.4
Q ss_pred ecccccccccccccccceEEEEEEEC------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
++.++|++.+.||+|+||.||+|.+. +..|++|.+..... . ...+.+.+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~-~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~ 77 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS-E----IQVTLLLQESCLLYGLSHQNILPILHVC 77 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCC-H----HHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 56688999999999999999999873 47899998864321 1 1236788999999999999999999987
Q ss_pred Ee-CCeEEEEEEecCCCCHHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEE
Q 019304 206 RK-RMVWCIVTEYAKGGSVRQFLTRRQN------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278 (343)
Q Consensus 206 ~~-~~~~~iv~E~~~~gsL~~~l~~~~~------~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vk 278 (343)
.. ....++++||+++++|.+++..... ..+++..++.++.|++.||+|||+.+++||||||+||+++.++.+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 78 IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred ecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEE
Confidence 66 4667899999999999999976432 3588999999999999999999999999999999999999999999
Q ss_pred EeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 279 IADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 279 l~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
|+|||+++....... .....++..|+|||.+ ....++.++|||+++
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~-----~~~~~~~~~Di~slG 206 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESL-----VNKEYSSASDVWSFG 206 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHH-----hcCCCCchhhHHHhH
Confidence 999999985432211 1223456789999999 777899999999543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=233.37 Aligned_cols=182 Identities=27% Similarity=0.388 Sum_probs=157.3
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||+|++|.||++.. +++.+|+|.+...... ...+++.+|+.+++.++||||+++++.+.....+++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-----AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-----HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEE
Confidence 567788999999999999988 5789999998764432 223578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
++||+++++|.+++.... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.+||+|||.+.......
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 999999999999997643 568999999999999999999999 999999999999999999999999999987654322
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
. ....++..|+|||.+ ....++.++|+|+++
T Consensus 156 ~-~~~~~~~~y~~PE~~-----~~~~~~~~~Dv~slG 186 (265)
T cd06605 156 A-KTFVGTSSYMAPERI-----QGNDYSVKSDIWSLG 186 (265)
T ss_pred h-hcccCChhccCHHHH-----cCCCCCchhhHHHHH
Confidence 2 226789999999999 667899999999643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=247.42 Aligned_cols=205 Identities=22% Similarity=0.280 Sum_probs=168.2
Q ss_pred ccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
..-..|+.-|..++.||-|+||+|.+++. +...+|+|.+++...-.... .-....|-.||..-..+-||+||..|
T Consensus 622 kRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQ---vaHVKAERDILAEADn~WVVrLyySF 698 (1034)
T KOG0608|consen 622 KRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQ---VAHVKAERDILAEADNEWVVRLYYSF 698 (1034)
T ss_pred HHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhh---hhhhhhhhhhHhhcCCcceEEEEEEe
Confidence 34456788888899999999999999975 55578999887544322111 12466788999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
++.+.+|+||||++||++..+|.+. +-++++.+..+++++.+|+++.|..|+|||||||+|||||.+|++||+|||+|
T Consensus 699 QDkdnLYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLC 776 (1034)
T KOG0608|consen 699 QDKDNLYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC 776 (1034)
T ss_pred ccCCceEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccc
Confidence 9999999999999999999999875 45899999999999999999999999999999999999999999999999998
Q ss_pred ccc---------ccCC-----C-----------------------------ccCCCCCcceecCCCCCCCCCCCCCCcee
Q 019304 286 RIE---------VQTE-----G-----------------------------MTPETGTYRWMAPGNSFFSPLPHPSFEHK 322 (343)
Q Consensus 286 ~~~---------~~~~-----~-----------------------------~~~~~gt~~y~APE~~~~~~~~~~~~~~~ 322 (343)
.-+ .... . ....+||+.|+|||++ ....|+..
T Consensus 777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl-----~r~g~~q~ 851 (1034)
T KOG0608|consen 777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVL-----ARTGYTQL 851 (1034)
T ss_pred ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHh-----cccCcccc
Confidence 511 0000 0 0123599999999999 89999999
Q ss_pred eeeeecc-----cccccCCCCccCC
Q 019304 323 WSAKESC-----LKTTWPPPWRHIL 342 (343)
Q Consensus 323 sDi~~~~-----~~~~~~p~~~~~~ 342 (343)
+|+|+.. .+.+.+||..++|
T Consensus 852 cdwws~gvil~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 852 CDWWSVGVILYEMLVGQPPFLADTP 876 (1034)
T ss_pred chhhHhhHHHHHHhhCCCCccCCCC
Confidence 9999622 2558899977765
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=235.55 Aligned_cols=185 Identities=23% Similarity=0.296 Sum_probs=153.8
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--C
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--M 209 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~ 209 (343)
.++|+..+.||+|+||.||+|.+ +++.+|+|.++....... ....+.+|+.++++++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 79 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG----FPITSLREINILLKLQHPNIVTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccccc----chhhHHHHHHHHHhcCCCCEEEEEEEEEecCCC
Confidence 35788889999999999999998 578899999975443311 224567899999999999999999998877 7
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
..|+||||+++ +|.+++.... ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||+++...
T Consensus 80 ~~~lv~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 80 KIYMVMEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred cEEEEehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 89999999975 9999887543 358999999999999999999999999999999999999999999999999988654
Q ss_pred cC-CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeec
Q 019304 290 QT-EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES 328 (343)
Q Consensus 290 ~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~ 328 (343)
.. .......+++.|+|||.+. ....++.++|+|++
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~sl 193 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLL----GAKEYSTAIDMWSV 193 (293)
T ss_pred CCccccccccccccccCchhhc----CCccccchhhHHHH
Confidence 43 2233456789999999883 23347899999953
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=232.68 Aligned_cols=188 Identities=24% Similarity=0.444 Sum_probs=156.2
Q ss_pred cccccccccccccccceEEEEEEE-------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
+.++|+..+.||+|+||.||+|+. ..+.|++|.+...... ...+.+.+|+.++++++||||+++++.+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 77 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE-----NLQSEFRRELDMFRKLSHKNVVRLLGLC 77 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch-----HHHHHHHHHHHHHHhcCCcceeeeEEEE
Confidence 457788899999999999999986 2357899988643321 1235788999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEE
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQN-------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~-------~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vk 278 (343)
.+....++||||+++++|.+++..... ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.++
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 78 REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred CCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEE
Confidence 998899999999999999999976541 1589999999999999999999999999999999999999999999
Q ss_pred EeccccccccccCC--CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 279 IADFGVARIEVQTE--GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 279 l~DFg~a~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|+|||+++...... ......+++.|+|||.+ ....++.++|+|+++.
T Consensus 158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~-----~~~~~~~~~Di~slG~ 206 (275)
T cd05046 158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAV-----QEDDFSTKSDVWSFGV 206 (275)
T ss_pred EcccccccccCcccccccCCceeEEeecChhhh-----ccCCCCchhhHHHHHH
Confidence 99999987432211 22334567889999998 6677889999996443
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=231.39 Aligned_cols=186 Identities=31% Similarity=0.468 Sum_probs=154.4
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChh----HHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPE----KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
+|...+.||+|+||.||+|.. +++.+|+|.++....... ......+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 356778999999999999976 678999998864332211 12223467889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
.+++||||+++++|.+++.+. ..++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999999999999764 458889999999999999999999999999999999999999999999999987543
Q ss_pred cCC---CccCCCCCcceecCCCCCCCCCCCC--CCceeeeeeec
Q 019304 290 QTE---GMTPETGTYRWMAPGNSFFSPLPHP--SFEHKWSAKES 328 (343)
Q Consensus 290 ~~~---~~~~~~gt~~y~APE~~~~~~~~~~--~~~~~sDi~~~ 328 (343)
... ......|+..|+|||.+ ... .++.++|+|++
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~-----~~~~~~~~~~~Dv~sl 198 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVI-----HSYSQGYSAKVDIWSL 198 (272)
T ss_pred ccccccccccccCCccccCHHHh-----ccccCCCCccchhHHH
Confidence 211 12234688999999998 443 48899999954
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=232.24 Aligned_cols=187 Identities=20% Similarity=0.247 Sum_probs=147.8
Q ss_pred ccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHH---HHhcCCCCCcceEEEEEEeCCeEEEEEE
Q 019304 142 AFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVM---MLATLKHLNIVRFIGACRKRMVWCIVTE 216 (343)
Q Consensus 142 ~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~nIv~l~~~~~~~~~~~iv~E 216 (343)
.||+|+||.||++.. +++.+|+|.+.+......... ..+.+|.. ++....||+|+.+++.+...+..++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---TLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHH---HHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence 389999999999987 578999999976543322211 22334443 3444579999999999999999999999
Q ss_pred ecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCccC
Q 019304 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTP 296 (343)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~~~ 296 (343)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+++||||||+|||++.++.+||+|||++...... ....
T Consensus 78 ~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~ 154 (279)
T cd05633 78 LMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHA 154 (279)
T ss_pred cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-CccC
Confidence 99999999998754 35899999999999999999999999999999999999999999999999998754332 2233
Q ss_pred CCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 297 ETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 297 ~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
..|++.|+|||.+. ....++.++|+|+++. +++..||.
T Consensus 155 ~~~~~~y~aPE~~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 197 (279)
T cd05633 155 SVGTHGYMAPEVLQ----KGTAYDSSADWFSLGCMLFKLLRGHSPFR 197 (279)
T ss_pred cCCCcCccCHHHhc----CCCCCCchhhhHHHHHHHHHHHhCCCCcC
Confidence 47999999999882 2456889999996433 33555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=228.70 Aligned_cols=183 Identities=27% Similarity=0.436 Sum_probs=156.0
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|+..+.||+|+||.||+|.. +++.||+|.+...... ....+.+.+|+.+++.++|+||+++++.+.....+++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND----PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYI 76 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc----hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEE
Confidence 477889999999999999987 6789999999766543 1234678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCC
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~ 293 (343)
|+||+++++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++........
T Consensus 77 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 77 FMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred EEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999999999764 3478889999999999999999999999999999999999999999999999876543222
Q ss_pred c-----cCCCCCcceecCCCCCCCCCCCCC---Cceeeeeeecc
Q 019304 294 M-----TPETGTYRWMAPGNSFFSPLPHPS---FEHKWSAKESC 329 (343)
Q Consensus 294 ~-----~~~~gt~~y~APE~~~~~~~~~~~---~~~~sDi~~~~ 329 (343)
. ....+++.|+|||++ .... ++.++|+|+++
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~-----~~~~~~~~~~~~Dv~s~G 193 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVI-----TGGKGKGHGRAADIWSLG 193 (264)
T ss_pred cccccccCCcCCcCccChhhc-----cCCCCCCCCcccchHHHH
Confidence 1 124678999999998 4444 88999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=232.86 Aligned_cols=175 Identities=18% Similarity=0.326 Sum_probs=142.5
Q ss_pred ccccccceEEEEEEEC--------------------------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCC
Q 019304 142 AFAQGAFGKLYRGTYN--------------------------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195 (343)
Q Consensus 142 ~lg~G~fg~Vy~~~~~--------------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 195 (343)
.||+|+||.||+|.+. ...||+|++.... ......+.+|+.+++.++|
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~------~~~~~~~~~~~~~~~~l~h 75 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH------RDIALAFFETASLMSQVSH 75 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH------HHHHHHHHHHHHHHhcCCC
Confidence 6999999999999741 1258888885321 1223578899999999999
Q ss_pred CCcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC
Q 019304 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK 275 (343)
Q Consensus 196 ~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~ 275 (343)
|||+++++++......++||||+++++|..++.+. ...+++..+..++.|++.||+|||+++|+||||||+|||++..+
T Consensus 76 ~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 76 IHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred CCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 99999999999999999999999999999998653 34588999999999999999999999999999999999997543
Q ss_pred -------cEEEeccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 276 -------SIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 276 -------~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.+|++|||++..... .....+++.|+|||.+. ....++.++|+|+++.
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~----~~~~~~~~~Dv~slG~ 209 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALS---REERVERIPWIAPECVP----GGNSLSTAADKWSFGT 209 (274)
T ss_pred cccCccceeeecCCcccccccc---ccccccCCcccCchhhc----CCCCCCcHHHHHHHHH
Confidence 489999998764322 22346788999999882 2366899999996443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=232.59 Aligned_cols=189 Identities=26% Similarity=0.437 Sum_probs=155.1
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe---
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK--- 207 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~--- 207 (343)
.+.|++.+.||+|+||.||+|.+ +++.+|+|++...... ...+..|+.+++.+ .||||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~-------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-------EEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHH-------HHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 46778889999999999999988 6788999998653211 24577899999988 69999999999853
Q ss_pred ---CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccc
Q 019304 208 ---RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (343)
Q Consensus 208 ---~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~ 284 (343)
...++++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~ 167 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV 167 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcc
Confidence 45789999999999999999876556688888999999999999999999999999999999999999999999999
Q ss_pred ccccccC-CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 285 ARIEVQT-EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 285 a~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+...... .......|++.|+|||.+.........++.++|+|+++
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG 213 (282)
T cd06636 168 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLG 213 (282)
T ss_pred hhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHH
Confidence 8754322 12334578999999999832222356788999999643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=231.01 Aligned_cols=179 Identities=30% Similarity=0.465 Sum_probs=145.0
Q ss_pred ccccccceEEEEEEE--CCc--eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeEEEEEE
Q 019304 142 AFAQGAFGKLYRGTY--NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTE 216 (343)
Q Consensus 142 ~lg~G~fg~Vy~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~iv~E 216 (343)
.||+|+||.||+|.. ++. .+|+|.+...... ...+.+.+|+.+++.+ +||||+++++++.....+++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-----DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCH-----HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence 589999999999987 333 4688877632211 1225688999999999 89999999999999999999999
Q ss_pred ecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 019304 217 YAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (343)
Q Consensus 217 ~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DF 282 (343)
|+++++|.+++.... ...+++..++.++.|++.||+|||+.|++||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence 999999999997542 124788899999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 283 GVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 283 g~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|+++.............++.|+|||++ ....++.++|+|+++.
T Consensus 157 gl~~~~~~~~~~~~~~~~~~y~apE~~-----~~~~~~~~~Di~slG~ 199 (270)
T cd05047 157 GLSRGQEVYVKKTMGRLPVRWMAIESL-----NYSVYTTNSDVWSYGV 199 (270)
T ss_pred CCccccchhhhccCCCCccccCChHHH-----ccCCCCchhhHHHHHH
Confidence 998632221111122345679999998 7788999999996443
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=229.47 Aligned_cols=183 Identities=23% Similarity=0.381 Sum_probs=143.7
Q ss_pred ccccccceEEEEEEE-CCc---eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEe
Q 019304 142 AFAQGAFGKLYRGTY-NGE---DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 142 ~lg~G~fg~Vy~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
.||+|+||.||++.. ++. .+++|.+....... ..+.+.+|+.+++.++||||+++++.+......++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSK-----EQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChH-----HHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEec
Confidence 589999999999975 333 45666664432211 236789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC---C
Q 019304 218 AKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT---E 292 (343)
Q Consensus 218 ~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~---~ 292 (343)
+++++|.+++.+.. ....+...+..++.|++.||+|||+.+++||||||+|||++.++.+||+|||++...... .
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 99999999997542 234567778899999999999999999999999999999999999999999998642211 1
Q ss_pred CccCCCCCcceecCCCCCCC--CCCCCCCceeeeeeecc
Q 019304 293 GMTPETGTYRWMAPGNSFFS--PLPHPSFEHKWSAKESC 329 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~--~~~~~~~~~~sDi~~~~ 329 (343)
.....++++.|+|||++... ......++.++|+|+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG 195 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALG 195 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHH
Confidence 12344688999999987321 11234568899999643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=232.07 Aligned_cols=200 Identities=21% Similarity=0.267 Sum_probs=161.6
Q ss_pred ccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHH-HhcCCCCCcceEEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-LATLKHLNIVRFIGA 204 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~nIv~l~~~ 204 (343)
..|++...+++-+..||.|+||+|++..+ .|+..|||.++......++ ++++.|.+. ++.-+.||||++||+
T Consensus 57 ~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq-----~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 57 HLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQ-----KRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred cccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHH-----HHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 34566667777888999999999999988 7889999999765543332 577788875 455579999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHH---hhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEe
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLT---RRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIA 280 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~---~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-giiHrDlkp~NILv~~~~~vkl~ 280 (343)
+..+..-+|.||+|+ .||..+.+ ..+...+++..+..|+.-.+.||.||... .|||||+||+|||++..|.+|||
T Consensus 132 ~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLC 210 (361)
T KOG1006|consen 132 LFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLC 210 (361)
T ss_pred hhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeee
Confidence 988888899999995 47755443 34556689999999999999999999865 89999999999999999999999
Q ss_pred ccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecccccccCCC
Q 019304 281 DFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTWPPP 337 (343)
Q Consensus 281 DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~~~~p~ 337 (343)
|||.+.....+-..+...|...|||||.+.. ....|+.+||+| ++++++|-..
T Consensus 211 DFGIcGqLv~SiAkT~daGCrpYmAPERi~p---~~~gyDiRSDvW-SLGITL~EvA 263 (361)
T KOG1006|consen 211 DFGICGQLVDSIAKTVDAGCRPYMAPERIDP---SDKGYDIRSDVW-SLGITLYEVA 263 (361)
T ss_pred cccchHhHHHHHHhhhccCCccccChhccCC---ccCCcchhhhhh-hhcceEeeee
Confidence 9999987666555666689999999999953 334699999999 5665555443
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=230.74 Aligned_cols=187 Identities=19% Similarity=0.215 Sum_probs=147.8
Q ss_pred ccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHH---HHHHhcCCCCCcceEEEEEEeCCeEEEEEE
Q 019304 142 AFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQE---VMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (343)
Q Consensus 142 ~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E---~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E 216 (343)
.||+|+||.||++.. +++.||+|.+.+......... ..+..| +.+++...||+|+.+++.+...+..++|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhH---HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEe
Confidence 379999999999987 678999999876543322111 123333 344555689999999999999999999999
Q ss_pred ecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCccC
Q 019304 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTP 296 (343)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~~~ 296 (343)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++...... ....
T Consensus 78 ~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~ 154 (278)
T cd05606 78 LMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHA 154 (278)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcC
Confidence 99999999988653 45899999999999999999999999999999999999999999999999998754332 2234
Q ss_pred CCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 297 ETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 297 ~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
..|++.|+|||.+. ....++.++|+|+++. +++.+||.
T Consensus 155 ~~~~~~y~aPE~~~----~~~~~~~~~Di~s~G~~l~~l~~g~~p~~ 197 (278)
T cd05606 155 SVGTHGYMAPEVLQ----KGVAYDSSADWFSLGCMLFKLLRGHSPFR 197 (278)
T ss_pred cCCCcCCcCcHHhc----CCCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 57999999999982 2346889999996433 23555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=232.64 Aligned_cols=182 Identities=25% Similarity=0.365 Sum_probs=150.9
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||+|.. +++.||+|++........ ...+.+|+.+++.++|+||+++++++......+
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 79 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-----PFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCC-----cHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence 5788889999999999999986 678999999865433221 135678999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+|+||+. ++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+|||++.++.+||+|||+++......
T Consensus 80 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 80 FVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred EEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9999995 68888776432 457788889999999999999999999999999999999999999999999987533221
Q ss_pred -CccCCCCCcceecCCCCCCCCCCC-CCCceeeeeeec
Q 019304 293 -GMTPETGTYRWMAPGNSFFSPLPH-PSFEHKWSAKES 328 (343)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~~~~~~-~~~~~~sDi~~~ 328 (343)
......+++.|+|||.+ .+ ..++.++|+|++
T Consensus 158 ~~~~~~~~~~~y~aPE~~-----~~~~~~~~~~Dv~sl 190 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVL-----LGATDYSSALDIWGA 190 (291)
T ss_pred CCCCCccccccccCCcee-----ecCCCCCcHHHHHHH
Confidence 22334678999999998 43 457889999964
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=233.97 Aligned_cols=183 Identities=25% Similarity=0.360 Sum_probs=153.5
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||+|+||.||+|.+ +++.||+|+++....... ..+.+.+|+++++.++|+||+++++++...+.+++
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 77 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDED----VKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL 77 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccccc----chhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence 578889999999999999988 578999999865433221 23578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~- 292 (343)
||||++++.+..+..+ ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 78 VFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9999988666555433 3458899999999999999999999999999999999999999999999999988654432
Q ss_pred -CccCCCCCcceecCCCCCCCCCCCC-CCceeeeeeecc
Q 019304 293 -GMTPETGTYRWMAPGNSFFSPLPHP-SFEHKWSAKESC 329 (343)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~~~~~~~-~~~~~sDi~~~~ 329 (343)
......++..|+|||++ ... .++.++|+|+++
T Consensus 156 ~~~~~~~~~~~~~~PE~~-----~~~~~~~~~~Dv~slG 189 (288)
T cd07833 156 SPLTDYVATRWYRAPELL-----VGDTNYGKPVDVWAIG 189 (288)
T ss_pred ccccCcccccCCcCCchh-----cCCCCcCchhhHHHHH
Confidence 23345788999999999 455 788999999644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=229.19 Aligned_cols=188 Identities=22% Similarity=0.356 Sum_probs=151.7
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
++.........||+|+||.||+|.+ ++..||+|.+...... ..+.+.+|+.+++.++|+||+++++++....
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR------YVQPLHEEIALHSYLKHRNIVQYLGSDSENG 78 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH------HHHHHHHHHHHHHhcCCCCeeeeeeeeccCC
Confidence 3344444556899999999999987 5678999988653321 1357889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-CCcEEEecccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAV--PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFGVAR 286 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~--~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~-~~~vkl~DFg~a~ 286 (343)
.+++|+||+++++|.+++.... ..+ +...+..++.|++.||+|||+.|++||||||+||+++. ++.+||+|||++.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 9999999999999999997542 224 77888899999999999999999999999999999986 6799999999987
Q ss_pred ccccCC-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 287 IEVQTE-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 287 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
...... ......|++.|+|||.+.. ....++.++|+|+++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~~Dv~slG 198 (268)
T cd06624 158 RLAGINPCTETFTGTLQYMAPEVIDK---GPRGYGAPADIWSLG 198 (268)
T ss_pred ecccCCCccccCCCCccccChhhhcc---ccccCCchhhhHHHH
Confidence 543222 2233468999999999821 123478999999644
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=254.44 Aligned_cols=191 Identities=20% Similarity=0.243 Sum_probs=146.2
Q ss_pred ccccccccccccccceEEEEEEEC---CceEEEEEeeCCCCCh-----------hHHHHHHHHHHHHHHHHhcCCCCCcc
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTYN---GEDVAIKILERPENNP-----------EKAQVMEQQFQQEVMMLATLKHLNIV 199 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~~---~~~vavK~~~~~~~~~-----------~~~~~~~~~~~~E~~~l~~l~h~nIv 199 (343)
..+|++++.||+|+||+||+|... +...++|.+....... .........+.+|+.+++.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998752 2222333111000000 00111235688999999999999999
Q ss_pred eEEEEEEeCCeEEEEEEecCCCCHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc
Q 019304 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ---NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276 (343)
Q Consensus 200 ~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~ 276 (343)
++++++...+..|+|+|++. ++|.+++.... ........+..++.||+.||+|||++|||||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 99999999999999999995 58888875432 112335667889999999999999999999999999999999999
Q ss_pred EEEeccccccccccCCC--ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 277 IKIADFGVARIEVQTEG--MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 277 vkl~DFg~a~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+||+|||+++....... ....+||+.|+|||++ .+..++.++|||+++.
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlGv 356 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEIL-----AGDGYCEITDIWSCGL 356 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhh-----cCCCCCcHHHHHHHHH
Confidence 99999999986543222 2235799999999999 7788999999995443
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=229.51 Aligned_cols=185 Identities=30% Similarity=0.541 Sum_probs=154.9
Q ss_pred ccccccccccccccceEEEEEEEC------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 207 (343)
.++|++.+.||+|+||.||+++++ ++.+|||++...... ...+.|.+|+.+++.+.||||+++++++..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~ 77 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-----QHRSDFEREIEILRTLDHENIVKYKGVCEK 77 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-----HHHHHHHHHHHHHHhCCCCChheEEeeeec
Confidence 467888899999999999999863 578999999755433 223679999999999999999999999877
Q ss_pred --CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 208 --RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 208 --~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
....+++|||+++++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||.+
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 78 PGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred CCCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 557899999999999999997643 35889999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCc----cCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 286 RIEVQTEGM----TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 286 ~~~~~~~~~----~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
......... ....++..|+|||.+ ....++.++|+|++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~-----~~~~~~~~~Di~slG 199 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECL-----RTSKFSSASDVWSFG 199 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHH-----ccCCCCcccchHHHh
Confidence 865422111 122445679999998 667889999999533
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=228.12 Aligned_cols=185 Identities=25% Similarity=0.404 Sum_probs=156.2
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCeE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RMVW 211 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~ 211 (343)
+|++.+.||.|+||.||++.. +++.||+|.+......... .+++.+|+.+++.++||||+++++.+.. ....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE----KQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTL 76 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHH----HHHHHHHHHHHHhcCCCccceeeeeeecCCCCEE
Confidence 467788999999999999987 6788999998765443322 2578899999999999999999998754 4567
Q ss_pred EEEEEecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeCCCCCCcEEEcCCCcEEEecccc
Q 019304 212 CIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVH-----GLGFIHRDLKSDNLLISADKSIKIADFGV 284 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH-----~~giiHrDlkp~NILv~~~~~vkl~DFg~ 284 (343)
+++|||+++++|.+++... ....+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||+
T Consensus 77 ~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 77 YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred EEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccc
Confidence 9999999999999999753 2356899999999999999999999 88999999999999999999999999999
Q ss_pred ccccccCCC-ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 285 ARIEVQTEG-MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 285 a~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+........ .....+++.|+|||.+ ....++.++|+|+++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~-----~~~~~~~~~Dv~slG 197 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQL-----NHMSYDEKSDIWSLG 197 (265)
T ss_pred cccccCCcccccccccCCCccChhhh-----cCCCCCchhHHHHHH
Confidence 986554332 3345789999999999 777799999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=234.52 Aligned_cols=187 Identities=25% Similarity=0.349 Sum_probs=155.9
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||+|++|.||+|.. +++.||||.+........ .......+.+|+.+++.++|+||+++++++......++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA-KDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccc-cchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence 366778999999999999987 578999999976543311 11233567789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-C
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-E 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~-~ 292 (343)
||||+ +++|.+++.... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||+++..... .
T Consensus 80 v~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred EEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 99999 889999997543 36899999999999999999999999999999999999999999999999999865433 2
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
......+++.|+|||.+. ....++.++|+|++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~----~~~~~~~~~Dv~slG 190 (298)
T cd07841 158 KMTHQVVTRWYRAPELLF----GARHYGVGVDMWSVG 190 (298)
T ss_pred cccccccceeeeCHHHHh----CCCCCCcHHHHHHHH
Confidence 233446788999999872 335678999999644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=236.11 Aligned_cols=185 Identities=23% Similarity=0.384 Sum_probs=152.9
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||+|+||.||+|++ +|+.||+|.+........ ....+.+|+.+++.++||||+++++++.+...+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~----~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALREICLLKELKHKNIVRLYDVLHSDKKLTL 76 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccccc----CccchhHHHHHHHhcCCCCeeeHHHHhccCCceEE
Confidence 367788999999999999988 688999999875432221 12457789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-C
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-E 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~-~ 292 (343)
|+||++ ++|.+++... ...+++..++.++.||+.||.|||+++++||||||+||+++.++.+||+|||+++..... .
T Consensus 77 v~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 77 VFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred EEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 999997 5888887653 345899999999999999999999999999999999999999999999999998754322 1
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
......+++.|+|||.+. ....++.++|+|+++.
T Consensus 155 ~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~ 188 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLF----GAKLYSTSIDMWSAGC 188 (284)
T ss_pred CcCCCccccCCcChHHHh----CCcccCcHHHHHHHHH
Confidence 223456789999999883 2345789999996443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=226.62 Aligned_cols=176 Identities=30% Similarity=0.490 Sum_probs=146.5
Q ss_pred cccccccceEEEEEEE--CC---ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEE
Q 019304 141 TAFAQGAFGKLYRGTY--NG---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~--~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~ 215 (343)
+.||+|+||.||+|.+ .+ ..+|+|.+...... ...+++.+|+.+++.+.||||+++++++.. ...++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-----AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEE
Confidence 4699999999999987 22 57999998755443 223678999999999999999999998764 4578999
Q ss_pred EecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCc-
Q 019304 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM- 294 (343)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~- 294 (343)
||+++++|.+++.... .+++..++.++.|++.||+|||..+++|+||||+|||++.++.+||+|||+++........
T Consensus 75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 75 ELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred EeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999999997643 5899999999999999999999999999999999999999999999999999865432221
Q ss_pred c---CCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 295 T---PETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 295 ~---~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
. ...++..|+|||.+ ....++.++|+|+++
T Consensus 153 ~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG 185 (257)
T cd05060 153 RATTAGRWPLKWYAPECI-----NYGKFSSKSDVWSYG 185 (257)
T ss_pred ccccCccccccccCHHHh-----cCCCCCccchHHHHH
Confidence 1 11234689999999 778899999999643
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=230.70 Aligned_cols=191 Identities=27% Similarity=0.403 Sum_probs=160.0
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
..|+..+.||.|+||.||+|.+ +++.||||++...... ...+.+.+|+.+++.+.||||+++++++.+....+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 4567788999999999999987 5789999998754322 12367889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 79 IIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 99999999999999864 348888999999999999999999999999999999999999999999999987643322
Q ss_pred -CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 293 -GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
......++..|+|||.+ ....++.++|+|+++. +++.+|+.
T Consensus 156 ~~~~~~~~~~~y~apE~~-----~~~~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVI-----QQSAYDSKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred cccccccCcccccCHhHh-----ccCCCccHHHHHHHHHHHHHHHHCCCCCC
Confidence 22334688999999998 7778999999996433 33555554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=233.99 Aligned_cols=182 Identities=29% Similarity=0.436 Sum_probs=155.3
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
+.|+..+.||+|+||.||+|.+ +++.||+|.+....... ..+.+.+|+.+++.++||||+++++.+.....++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED-----EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLW 78 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH-----HHHHHHHHHHHHHcCCCCccHhhhcccccCCceE
Confidence 3566778899999999999987 57789999986443222 2357889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 79 IIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 99999999999998854 358899999999999999999999999999999999999999999999999987644322
Q ss_pred -CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 293 -GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
......|+..|+|||.+ ....++.++|+|+++
T Consensus 156 ~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slG 188 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVI-----KQSAYDFKADIWSLG 188 (277)
T ss_pred hhhhcccCcccccCHHHh-----CcCCCchhhhHHHHH
Confidence 12234688999999999 777899999999643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=229.07 Aligned_cols=199 Identities=25% Similarity=0.395 Sum_probs=158.3
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC--
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR-- 208 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-- 208 (343)
.++|++.+.||+|+||.||++.. +++.+|+|++...... ...+.+|+.+++.+ +|||++++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~-------~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-------DEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH-------HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 46788889999999999999987 6789999998643221 24577899999998 899999999998754
Q ss_pred ---CeEEEEEEecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 209 ---MVWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 209 ---~~~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
..+++||||+++++|.+++... ....+++..++.++.|++.||+|||+.+++|+||||+||+++.++.+||+|||
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg 173 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG 173 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecc
Confidence 3579999999999999988642 23468899999999999999999999999999999999999999999999999
Q ss_pred cccccccCC-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecccc-----cccCCCCc
Q 019304 284 VARIEVQTE-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLK-----TTWPPPWR 339 (343)
Q Consensus 284 ~a~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~-----~~~~p~~~ 339 (343)
+++...... ......|++.|+|||.+.........++.++|+|+++.+ ++.+|+..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~ 235 (291)
T cd06639 174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235 (291)
T ss_pred cchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCC
Confidence 987644322 223346889999999984322223457899999954332 35566543
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-30 Score=233.13 Aligned_cols=188 Identities=21% Similarity=0.306 Sum_probs=151.4
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCe
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMV 210 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~ 210 (343)
.++|+..+.||+|+||.||++.. +++.+|+|.+....... ....+.+|+.++.++. ||||+++++++.....
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~ 77 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEK-----EQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD 77 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChH-----HHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc
Confidence 35667778999999999999988 67899999987543321 2357889999999996 9999999999998888
Q ss_pred EEEEEEecCCCCHHHHHH---hhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 211 WCIVTEYAKGGSVRQFLT---RRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~---~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
.+++|||+.. ++.++.. ......+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 78 ~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 156 (288)
T cd06616 78 CWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISG 156 (288)
T ss_pred EEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhH
Confidence 9999999864 6655432 23345689999999999999999999975 99999999999999999999999999997
Q ss_pred ccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 287 IEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
............|++.|+|||.+... ....++.++|+|+++
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~~Di~slG 197 (288)
T cd06616 157 QLVDSIAKTRDAGCRPYMAPERIDPS--ARDGYDVRSDVWSLG 197 (288)
T ss_pred HhccCCccccccCccCccCHHHhccc--cccCCcchhhhhHHH
Confidence 65443333445789999999998211 023789999999643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-30 Score=255.84 Aligned_cols=197 Identities=32% Similarity=0.554 Sum_probs=166.9
Q ss_pred ccceecccccccccccccccceEEEEEEEC---------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCC
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 197 (343)
+.|+++.+++++.+.||+|.||+|++|... ...||||.++......+ .+.+..|+.+|+.+ +|||
T Consensus 289 ~~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~-----~~~~~~El~~m~~~g~H~n 363 (609)
T KOG0200|consen 289 PKWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSE-----KKDLMSELNVLKELGKHPN 363 (609)
T ss_pred CceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHH-----HHHHHHHHHHHHHhcCCcc
Confidence 389999999999999999999999999742 34799999976665533 26799999999998 6999
Q ss_pred cceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhC------------C--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCC
Q 019304 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ------------N--RAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (343)
Q Consensus 198 Iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~------------~--~~~~~~~~~~i~~qi~~gL~yLH~~giiHrD 263 (343)
|+.++|+|.....+++|+||++.|+|.++++..+ . ..++....+.++.|||.||+||++..+||||
T Consensus 364 iv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRD 443 (609)
T KOG0200|consen 364 IVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRD 443 (609)
T ss_pred hhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchh
Confidence 9999999999999999999999999999998755 0 1378889999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEeccccccccccCCCccC--CCC--CcceecCCCCCCCCCCCCCCceeeeeeecccccccC
Q 019304 264 LKSDNLLISADKSIKIADFGVARIEVQTEGMTP--ETG--TYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTWP 335 (343)
Q Consensus 264 lkp~NILv~~~~~vkl~DFg~a~~~~~~~~~~~--~~g--t~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~~~~ 335 (343)
|.++|||+..+..+||+|||+||.......+.. ..| ...|||||.+ ....|+.|+||| +++++.|.
T Consensus 444 LAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl-----~~~~ft~kSDVW-SfGI~L~E 513 (609)
T KOG0200|consen 444 LAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESL-----FDRVFTSKSDVW-SFGILLWE 513 (609)
T ss_pred hhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHh-----ccCcccccchhh-HHHHHHHH
Confidence 999999999999999999999996544333321 223 3569999999 889999999999 45545553
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=229.09 Aligned_cols=181 Identities=30% Similarity=0.484 Sum_probs=152.6
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCe
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMV 210 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~ 210 (343)
.|+..+.||+|+||.||+|.+ +++.||+|.+........ ..++.+|+.+++.++ |||++++++++.....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-----VSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchh-----HHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCE
Confidence 466778999999999999987 678999999865432221 246778999999886 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~ 290 (343)
.++||||+++++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred EEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999999999998642 588999999999999999999999999999999999999999999999999876543
Q ss_pred CC-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeec
Q 019304 291 TE-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES 328 (343)
Q Consensus 291 ~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~ 328 (343)
.. ......|++.|+|||.+. ....++.++|+|++
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~Dv~sl 188 (277)
T cd06917 154 NSSKRSTFVGTPYWMAPEVIT----EGKYYDTKADIWSL 188 (277)
T ss_pred CccccccccCCcceeCHHHhc----cCCccccchhHHHH
Confidence 32 223447899999999882 23557899999964
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=212.14 Aligned_cols=193 Identities=23% Similarity=0.338 Sum_probs=160.9
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|...++||+|.+|+||+|+. +++.||+|.++....+.-- ....++|+.+++.++|.|||+++++...+..+-+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegv----pssalreicllkelkhknivrl~dvlhsdkkltl 78 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV----PSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC----cHHHHHHHHHHHHhhhcceeehhhhhccCceeEE
Confidence 345567899999999999987 6789999998765443211 1356799999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-C
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-E 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~-~ 292 (343)
|+|||+ ..|..+.... ++.++...+..++.|+++||.++|++++.||||||.|+||+.+|.+|++|||+++-..-. .
T Consensus 79 vfe~cd-qdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 79 VFEFCD-QDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred eHHHhh-HHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 999995 4898888764 456899999999999999999999999999999999999999999999999999965432 2
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccccc-------ccCCCCc
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKT-------TWPPPWR 339 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~-------~~~p~~~ 339 (343)
.++..+-|..|.+|.++. .-+-|+...|+|+ ++++ +||.|-+
T Consensus 157 cysaevvtlwyrppdvlf----gakly~tsidmws-agcifaelanagrplfpg 205 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLF----GAKLYSTSIDMWS-AGCIFAELANAGRPLFPG 205 (292)
T ss_pred eeeceeeeeeccCcceee----eeehhccchHhhh-cchHHHHHhhcCCCCCCC
Confidence 456668899999999995 4566889999995 3322 7887744
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=234.17 Aligned_cols=186 Identities=27% Similarity=0.500 Sum_probs=151.8
Q ss_pred cccccccccccccccceEEEEEEE--CCc----eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
..++|+..+.||+|+||.||+|.+ ++. .||+|.+....... ....+.+|+.+++.++||||+++++.+.
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~~~~l~h~niv~~~~~~~ 79 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPK-----ANVEFMDEALIMASMDHPHLVRLLGVCL 79 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHH-----HHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 346778889999999999999987 444 47888886433221 1246889999999999999999999987
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
... .++++||+++|+|.+++.... ..+++..++.++.|++.||.|||+++++||||||+|||++.++.+||+|||+++
T Consensus 80 ~~~-~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 80 SPT-IQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred CCC-ceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccc
Confidence 654 579999999999999987542 357889999999999999999999999999999999999999999999999998
Q ss_pred ccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 287 IEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 287 ~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
....... .....++..|+|||.+ ....++.++|+|+++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~-----~~~~~~~~~DiwslG~ 199 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECI-----HYRKFTHQSDVWSYGV 199 (303)
T ss_pred cccCcccccccCCCccccccCCHHHh-----ccCCCChHHHHHHHHH
Confidence 6543221 1122456789999998 7788999999996443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=233.72 Aligned_cols=184 Identities=23% Similarity=0.349 Sum_probs=153.9
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||+|+||.||+|.+ +++.||+|++....... ...+.+.+|+.+++.++||||+++++++......++
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK----MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL 77 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc----hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence 577889999999999999998 57899999986544332 123567899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-C
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-E 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~-~ 292 (343)
|+||+++++|..+.... ..+++..+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|||++...... .
T Consensus 78 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 78 VFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred EEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 99999998888776542 34899999999999999999999999999999999999999999999999998764332 2
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
......++..|+|||++. ....++.++|+|+++
T Consensus 156 ~~~~~~~~~~y~aPE~~~----~~~~~~~~~Dv~slG 188 (286)
T cd07846 156 VYTDYVATRWYRAPELLV----GDTKYGRAVDIWAVG 188 (286)
T ss_pred ccCcccceeeccCcHHhc----cccccCchHhHHHHH
Confidence 233456889999999983 235578899999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=232.35 Aligned_cols=190 Identities=26% Similarity=0.394 Sum_probs=159.3
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
..+|.+.+.||+|+||.||++.. +++.||+|.+....... .+.+.+|+.+++.++||||+++++.+......
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 91 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK------KELIINEILVMRENKHPNIVNYLDSYLVGDEL 91 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchH------HHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence 36788889999999999999986 67889999985432221 25688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++|+||+++++|.+++.+. .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred EEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 9999999999999998653 3788899999999999999999999999999999999999999999999988754332
Q ss_pred C-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCC
Q 019304 292 E-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPP 337 (343)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~ 337 (343)
. ......|++.|+|||.+ ....++.++|+|+++. +++.+||
T Consensus 169 ~~~~~~~~~~~~y~~PE~~-----~~~~~~~~~Dv~slG~ll~~ll~g~~pf 215 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVV-----TRKAYGPKVDIWSLGIMAIEMVEGEPPY 215 (293)
T ss_pred ccccccccCChhhcCchhh-----ccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 2 22334688999999998 6778899999996433 2355555
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=224.20 Aligned_cols=185 Identities=22% Similarity=0.434 Sum_probs=159.2
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||.|++|.||++.. +++.+|+|++......... .+.+.+|+++++.++|||++++++.+......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~l 76 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKE----REDALNEVKILKKLNHPNIIKYYESFEEKGKLCI 76 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHH----HHHHHHHHHHHHhcCCCChhheEEEEecCCEEEE
Confidence 467788999999999999998 4789999999765543222 2568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 214 VTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
|+||+++++|.+++.... ...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred EEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999999998653 356899999999999999999999999999999999999999999999999998765443
Q ss_pred C-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 292 E-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
. ......|++.|+|||.+ ....++.++|+|+++
T Consensus 157 ~~~~~~~~~~~~y~~pe~~-----~~~~~~~~~Dv~slG 190 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELC-----QNKPYNYKSDIWSLG 190 (258)
T ss_pred cceecceeeeecccChhHh-----ccCCCCccccHHHHH
Confidence 2 22334789999999998 677799999999644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=225.83 Aligned_cols=182 Identities=27% Similarity=0.398 Sum_probs=158.3
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||+|++|.||+++. +++.|+||++...... ...+.+.+|+..++.++|+||+++++.+......++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-----EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEE
Confidence 567789999999999999988 5789999998765432 223678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
|+||+++++|.+++... ..+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 77 VLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999999999764 458999999999999999999999 999999999999999999999999999988654433
Q ss_pred Cc-cCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 293 GM-TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 293 ~~-~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.. ....++..|+|||.+ ....++.++|+|+++
T Consensus 155 ~~~~~~~~~~~y~~pE~~-----~~~~~~~~~Dv~slG 187 (264)
T cd06623 155 DQCNTFVGTVTYMSPERI-----QGESYSYAADIWSLG 187 (264)
T ss_pred CcccceeecccccCHhhh-----CCCCCCchhhHHHHH
Confidence 22 244688999999998 677899999999643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-30 Score=235.16 Aligned_cols=189 Identities=21% Similarity=0.372 Sum_probs=157.2
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
.|.....||+|+||.||++.. +++.||+|.+....... .+.+.+|+.+++.+.||||+++++.+......++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~i 95 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR------RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWV 95 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch------HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEE
Confidence 344456799999999999987 67899999986533221 2467899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~- 292 (343)
|+||+++++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.......
T Consensus 96 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 96 LMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred EEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 9999999999998754 348899999999999999999999999999999999999999999999999987543321
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
......|++.|+|||.+ ....++.++|+|+++. +++.+||.
T Consensus 173 ~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slG~il~el~~g~~p~~ 218 (297)
T cd06659 173 KRKSLVGTPYWMAPEVI-----SRTPYGTEVDIWSLGIMVIEMVDGEPPYF 218 (297)
T ss_pred cccceecCccccCHHHH-----ccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 22345789999999999 6778899999996443 33566654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=229.33 Aligned_cols=182 Identities=26% Similarity=0.356 Sum_probs=152.8
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CeE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--MVW 211 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 211 (343)
+|...+.||.|++|.||++.. +++.+|+|.+...... ....++.+|+++++.++||||+++++++... ..+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-----DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-----HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence 456778999999999999988 6789999998754332 1235788999999999999999999998654 368
Q ss_pred EEEEEecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 212 CIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
++||||+++++|.+++... ....++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 9999999999999987642 23457889999999999999999999999999999999999999999999999987543
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeec
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES 328 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~ 328 (343)
.. ......++..|+|||.+ ....++.++|+|++
T Consensus 157 ~~-~~~~~~~~~~y~~pE~~-----~~~~~~~~~Dv~sl 189 (287)
T cd06621 157 NS-LAGTFTGTSFYMAPERI-----QGKPYSITSDVWSL 189 (287)
T ss_pred cc-ccccccCCccccCHHHh-----cCCCCCchhhHHHH
Confidence 32 22344678999999999 77889999999953
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=228.33 Aligned_cols=181 Identities=27% Similarity=0.420 Sum_probs=154.4
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
-|+..+.||+|+||.||+|.. +++.||||++....... ..+.+.+|+.+++.++||||+++++.+......++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-----EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchH-----HHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEE
Confidence 466778999999999999986 67899999886433221 23578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~- 292 (343)
||||+++++|.+++.. ..+++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 80 IMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 9999999999999864 348899999999999999999999999999999999999999999999999987543321
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
......++..|+|||.+ ....++.++|+|+++
T Consensus 157 ~~~~~~~~~~y~~PE~~-----~~~~~~~~~Dv~slG 188 (277)
T cd06641 157 KRNTFVGTPFWMAPEVI-----KQSAYDSKADIWSLG 188 (277)
T ss_pred hhccccCCccccChhhh-----ccCCCCchhhHHHHH
Confidence 22345688999999998 677889999999643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=226.27 Aligned_cols=179 Identities=28% Similarity=0.448 Sum_probs=143.9
Q ss_pred cccccccceEEEEEEE-----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CCeEEEE
Q 019304 141 TAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-RMVWCIV 214 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~iv 214 (343)
+.||+|+||.||+|.+ ....||||.+....... ..+.+.+|+.+++.++||||+++++.+.. +...+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE-----EVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHH-----HHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEE
Confidence 3689999999999986 12469999875422111 13578899999999999999999998753 4567899
Q ss_pred EEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC--
Q 019304 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-- 292 (343)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~-- 292 (343)
|||+.+++|.+++.+.. ...++..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||+++......
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 76 LPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred EecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999999997543 346777788999999999999999999999999999999999999999999987543211
Q ss_pred ---CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 293 ---GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 293 ---~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
......+++.|+|||.+ ....++.++|||++..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 190 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESL-----QTQKFTTKSDVWSFGV 190 (262)
T ss_pred eecccccCcCCccccChhHh-----ccCccchHHHHHHHHH
Confidence 11123457789999998 7788999999996443
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-31 Score=240.31 Aligned_cols=198 Identities=25% Similarity=0.312 Sum_probs=163.8
Q ss_pred eecccccccccccccccceEEEEEEECC--ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNG--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK 207 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 207 (343)
.|...+|.++..||+|+||+|.++...| +.+|||++++...-..+. .+--..|-++|... +-|.+++++.+++.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDD---vectm~EKrvLAL~~kppFL~qlHScFQT 421 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDD---VECTMVEKRVLALPGKPPFLVQLHSCFQT 421 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCc---ccceehhhhheecCCCCchHHHHHHHhhh
Confidence 5667889999999999999999998854 569999997654322111 12335677777766 67899999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
.+++|+||||+.||+|.-.++..+ .+.+..+.-+|.+|+-||-+||++|||+||||.+|||++.+|++||+|||+++.
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc
Confidence 999999999999999998887654 488888999999999999999999999999999999999999999999999985
Q ss_pred cc-cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 288 EV-QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 288 ~~-~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.- ......+.||||.|+|||++ .+++|...+|+|++.. +.+-|||=
T Consensus 500 ni~~~~TTkTFCGTPdYiAPEIi-----~YqPYgksvDWWa~GVLLyEmlaGQpPFd 551 (683)
T KOG0696|consen 500 NIFDGVTTKTFCGTPDYIAPEII-----AYQPYGKSVDWWAFGVLLYEMLAGQPPFD 551 (683)
T ss_pred cccCCcceeeecCCCcccccceE-----EecccccchhHHHHHHHHHHHHcCCCCCC
Confidence 32 23345678999999999999 8999999999996443 33667763
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=230.01 Aligned_cols=187 Identities=19% Similarity=0.274 Sum_probs=152.9
Q ss_pred ccccccccccccceEEEEEEE-----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM 209 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 209 (343)
.|++.+.||+|+||.||++.. +|+.||+|++....... .....+.+.+|+.+++.+ +|++|+.+++++....
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ--KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhh--cchHHHHHHHHHHHHHhcccCCChhceeeEeecCC
Confidence 367788999999999999976 57889999986532211 111235678899999999 5899999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+|||++.++.+||+|||+++...
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 999999999999999999764 358889999999999999999999999999999999999999999999999987643
Q ss_pred cCC--CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 290 QTE--GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 290 ~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
... ......|+..|+|||.+.. ....++.++|+|+++
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~~Dv~slG 195 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRG---GDGGHDKAVDWWSMG 195 (290)
T ss_pred cccccccccccCCcccCChhhccC---CCCCCCccccHHHHH
Confidence 321 2234568999999999821 124577899999543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=231.27 Aligned_cols=186 Identities=24% Similarity=0.357 Sum_probs=152.2
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|++|.||+|.. +++.||+|.+........ ....+.+|+.+++.++||||+++++++.....++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEG----VPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLY 77 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccccc----chHHHHHHHHHHHhccCCCEeeEEEEEecCCeEE
Confidence 4678889999999999999987 678999999865433221 1246788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-CCcEEEeccccccccccC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFGVARIEVQT 291 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~-~~~vkl~DFg~a~~~~~~ 291 (343)
+||||++ ++|.+++.......+++..+..++.||+.||+|||+++++|+||+|+||+++. ++.+||+|||++......
T Consensus 78 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 78 LVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9999996 58888887655555688888999999999999999999999999999999985 567999999999754322
Q ss_pred -CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 292 -EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 292 -~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.......+++.|+|||.+. ....++.++|+|+++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~----~~~~~~~~~Dv~slG 191 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILL----GSRHYSTPVDIWSVG 191 (294)
T ss_pred ccccccCceeecccCHHHHh----CCCCCCcHHHHHHHH
Confidence 2223446789999999882 234578999999643
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-30 Score=244.96 Aligned_cols=190 Identities=24% Similarity=0.355 Sum_probs=157.1
Q ss_pred ccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEe
Q 019304 140 GTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 140 ~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
.-.||+|.+|+||-|++ +....|||.+..... ...+.+..|+.+-+.|+|.|||+++|.+.++..+-|.||-
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds------r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEq 653 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS------REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQ 653 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeecccccc------hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeec
Confidence 34699999999999988 445678898754322 2236788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc-CCCcEEEeccccccccccC-CCc
Q 019304 218 AKGGSVRQFLTRR-QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIADFGVARIEVQT-EGM 294 (343)
Q Consensus 218 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~-~~~~vkl~DFg~a~~~~~~-~~~ 294 (343)
++||+|.++|+.. +.-.-.+.+.-.+..||++||+|||+..|+|||||-+|+||+ -.|.+||+|||.++....- ...
T Consensus 654 VPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T 733 (1226)
T KOG4279|consen 654 VPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT 733 (1226)
T ss_pred CCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence 9999999999853 322237788889999999999999999999999999999997 5799999999998765433 334
Q ss_pred cCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 295 TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 295 ~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.++.||..|||||++-. ....|..++|||++.+ +++.|||.
T Consensus 734 ETFTGTLQYMAPEvIDq---G~RGYG~aADIWS~GCT~vEMATGrPPF~ 779 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQ---GPRGYGKAADIWSFGCTMVEMATGRPPFV 779 (1226)
T ss_pred cccccchhhhChHhhcc---CCcCCCchhhhhhccceeEeeccCCCCee
Confidence 56789999999999932 4567999999996544 56899984
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-30 Score=234.99 Aligned_cols=189 Identities=24% Similarity=0.385 Sum_probs=156.5
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
.|.....||+|+||.||++.. ++..||||.+..... ...+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l 96 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ------QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV 96 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH------HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence 344456799999999999987 678999999854221 123568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~- 292 (343)
||||+++++|.+++.. ..+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|||++.......
T Consensus 97 v~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 97 VMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred EEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 9999999999998854 247889999999999999999999999999999999999999999999999987543222
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
......|++.|+|||.+ ....++.++|+|+++. +++..|++
T Consensus 174 ~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slGvil~el~~g~~p~~ 219 (292)
T cd06658 174 KRKSLVGTPYWMAPEVI-----SRLPYGTEVDIWSLGIMVIEMIDGEPPYF 219 (292)
T ss_pred cCceeecCccccCHHHH-----ccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 22334689999999998 7778899999996443 23555554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=221.01 Aligned_cols=198 Identities=18% Similarity=0.183 Sum_probs=161.7
Q ss_pred ccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
+...|+.++|.+.+.||+|||+-||+++. +++.+|+|.+....... .+..++|++..++++|||++++++..
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~------~e~~~rEid~~rkf~s~~vl~l~dh~ 87 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQED------IEEALREIDNHRKFNSPNVLRLVDHQ 87 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHH------HHHHHHHHHHHHhhCCcchHHHHHHH
Confidence 34567889999999999999999999985 78899999987654221 35678999999999999999998876
Q ss_pred EeC-----CeEEEEEEecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCcEEEcCCCc
Q 019304 206 RKR-----MVWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKS 276 (343)
Q Consensus 206 ~~~-----~~~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~g--iiHrDlkp~NILv~~~~~ 276 (343)
..+ ...||+++|...|+|.+.+... ++..+++..++.++.+||+||++||+.. ++||||||+|||+++.+.
T Consensus 88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~ 167 (302)
T KOG2345|consen 88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL 167 (302)
T ss_pred HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc
Confidence 433 3489999999999999999854 3456899999999999999999999998 999999999999999999
Q ss_pred EEEeccccccccccCCC----------ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccccccc
Q 019304 277 IKIADFGVARIEVQTEG----------MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTW 334 (343)
Q Consensus 277 vkl~DFg~a~~~~~~~~----------~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~~~ 334 (343)
++|.|||.+....-.-. ......|..|.|||.+.-. .+...+.++||| +++++.|
T Consensus 168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk--~~~ti~ertDIW-SLGCtLY 232 (302)
T KOG2345|consen 168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVK--SHCTITERTDIW-SLGCTLY 232 (302)
T ss_pred eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecc--cCcccccccchh-hhhHHHH
Confidence 99999998864221100 1123468999999998433 678899999999 5555443
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=239.91 Aligned_cols=199 Identities=18% Similarity=0.213 Sum_probs=161.4
Q ss_pred ccceecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGAC 205 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~ 205 (343)
+-..+.-+.|+++++||+||...||++.. +.+.+|+|.+.....+.. ..+.|.+|+.+|.+|+ |.+||++|++-
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~q----tl~gy~nEI~lL~KLkg~~~IIqL~DYE 429 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQ----TLDGYRNEIALLNKLKGHDKIIQLYDYE 429 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHH----HHHHHHHHHHHHHHhcCCceEEEEeeee
Confidence 34567889999999999999999999988 556788887765444433 3478999999999995 89999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
..+..+|+||||=+ .+|..+|.++... .+.-.+..+..|++.++.++|++||||.||||.|+|+- .|.+||+|||.|
T Consensus 430 v~d~~lYmvmE~Gd-~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA 506 (677)
T KOG0596|consen 430 VTDGYLYMVMECGD-IDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIA 506 (677)
T ss_pred ccCceEEEEeeccc-ccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechh
Confidence 99999999999885 5999999876543 34347888999999999999999999999999999986 799999999999
Q ss_pred cccccCCC---ccCCCCCcceecCCCCCCCCCC------CCCCceeeeeeeccccccc
Q 019304 286 RIEVQTEG---MTPETGTYRWMAPGNSFFSPLP------HPSFEHKWSAKESCLKTTW 334 (343)
Q Consensus 286 ~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~------~~~~~~~sDi~~~~~~~~~ 334 (343)
..+..... ..+.+||+.||+||++...... .-+.+.+|||| +|++++|
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvW-SLGCILY 563 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVW-SLGCILY 563 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchh-hhhhHHH
Confidence 87654332 3456899999999999442111 23477999999 5555533
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=243.35 Aligned_cols=198 Identities=26% Similarity=0.429 Sum_probs=166.7
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe----
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK---- 207 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~---- 207 (343)
.-+.+.+.||.|.+|.||+++. +++.+|+|++....... +++..|.++++.. .|||++.+||++..
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-------eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-------EEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-------HHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 3445568899999999999876 88999999997655443 4577889999887 69999999999964
Q ss_pred -CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 208 -~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
.+.++||||||.+|+..++++...+..+.+..+..|++.++.||.+||...+||||||-.|||++.++.|||+|||++.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 4579999999999999999998778889999999999999999999999999999999999999999999999999987
Q ss_pred ccccC-CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecccc-----cccCCCCc
Q 019304 287 IEVQT-EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLK-----TTWPPPWR 339 (343)
Q Consensus 287 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~-----~~~~p~~~ 339 (343)
....+ ....+.+|||.|||||++-..+.....|+..+|+|++.+. .+-||++.
T Consensus 172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D 230 (953)
T KOG0587|consen 172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD 230 (953)
T ss_pred eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC
Confidence 54433 3345668999999999997666678889999999964442 25555543
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=226.66 Aligned_cols=185 Identities=24% Similarity=0.406 Sum_probs=156.3
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||+|+||.||++.. ++..+|+|.+......... .+.+.+|+.+++.++|+||+++++.+......++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~l 76 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKE----KEASKKEVILLAKMKHPNIVTFFASFQENGRLFI 76 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchh----hHHHHHHHHHHHhCCCCChhhhhheeccCCeEEE
Confidence 367788999999999999988 6788999998764332211 2467899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC-cEEEeccccccccccCC
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTE 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~-~vkl~DFg~a~~~~~~~ 292 (343)
|+||+++++|.+++.+.....+++..+..++.|++.||.|||+.+++|+||||+||++++++ .+||+|||.+.......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 77 VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999999999875555688999999999999999999999999999999999999775 56999999987654322
Q ss_pred C-ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 293 G-MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 293 ~-~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
. .....|++.|+|||.+ ....++.++|+|+++
T Consensus 157 ~~~~~~~~~~~~~ape~~-----~~~~~~~~~Dv~slG 189 (257)
T cd08225 157 ELAYTCVGTPYYLSPEIC-----QNRPYNNKTDIWSLG 189 (257)
T ss_pred ccccccCCCccccCHHHH-----cCCCCCchhhHHHHH
Confidence 2 2234689999999998 677899999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=229.23 Aligned_cols=174 Identities=20% Similarity=0.367 Sum_probs=143.6
Q ss_pred cccccccceEEEEEEEC---------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 141 TAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
+.||+|+||.||+|... ...+|+|.+.... ....+.+.+|+.+++.+.||||+++++.+......
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH------RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh------HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCc
Confidence 36899999999999762 2348888774322 12235788999999999999999999999998889
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc--------EEEeccc
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--------IKIADFG 283 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~--------vkl~DFg 283 (343)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.++. ++++|||
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred EEEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 99999999999999997643 35889999999999999999999999999999999999987664 6999999
Q ss_pred cccccccCCCccCCCCCcceecCCCCCCCCCCC-CCCceeeeeeecc
Q 019304 284 VARIEVQTEGMTPETGTYRWMAPGNSFFSPLPH-PSFEHKWSAKESC 329 (343)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~-~~~~~~sDi~~~~ 329 (343)
++..... .....+++.|+|||++ .. ..++.++|+|++.
T Consensus 154 ~~~~~~~---~~~~~~~~~y~aPE~~-----~~~~~~~~~~DiwslG 192 (258)
T cd05078 154 ISITVLP---KEILLERIPWVPPECI-----ENPQNLSLAADKWSFG 192 (258)
T ss_pred cccccCC---chhccccCCccCchhc-----cCCCCCCchhhHHHHH
Confidence 9865432 2234688999999998 44 5588999999643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=231.59 Aligned_cols=186 Identities=26% Similarity=0.360 Sum_probs=152.2
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR-- 208 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-- 208 (343)
+.++|++.+.||+|+||.||+|.. +++.||+|++......... ...+.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGI----PISSLREITLLLNLRHPNIVELKEVVVGKHL 80 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCC----cchhhHHHHHHHhCCCCCCcceEEEEecCCC
Confidence 346788999999999999999988 6889999998754322211 12456899999999999999999998755
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
..+++||||+++ +|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++..
T Consensus 81 ~~~~lv~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 81 DSIFLVMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred CeEEEEEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 468999999965 8988887532 45899999999999999999999999999999999999999999999999999865
Q ss_pred ccC-CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeec
Q 019304 289 VQT-EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES 328 (343)
Q Consensus 289 ~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~ 328 (343)
... .......+++.|+|||.+. ....++.++|+|++
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~Dvwsl 195 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLL----GCTTYTTAIDMWAV 195 (309)
T ss_pred CCccCCCCcccccccccChhhhc----CCCCcCchHHHHHH
Confidence 432 2233345688999999883 23568899999963
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=229.83 Aligned_cols=203 Identities=23% Similarity=0.369 Sum_probs=160.9
Q ss_pred ccceecccccccccccccccceEEEEEEEC--CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGA 204 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 204 (343)
.+|.++.++|++.+.||+|++|.||+|.+. ++.||||.++....... ...+.+|+.++... .||||++++++
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~e~~~~~~~~~~~~i~~~~~~ 82 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE-----NKRILMDLDVVLKSHDCPYIVKCYGY 82 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHH-----HHHHHHHHHHHHhccCCCchHhhhee
Confidence 456778889999999999999999999984 88999999975433221 23566677766666 59999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
+.+....+++|||+. ++|.+++.... ..+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~v~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg 160 (296)
T cd06618 83 FITDSDVFICMELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFG 160 (296)
T ss_pred eecCCeEEEEeeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccc
Confidence 999999999999995 47877776533 468999999999999999999997 599999999999999999999999999
Q ss_pred cccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 284 VARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
++.............+++.|+|||.+.... .+..++.++|+|+++. +++.+||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~~~Di~slG~il~el~~g~~p~~ 219 (296)
T cd06618 161 ISGRLVDSKAKTRSAGCAAYMAPERIDPPD-PNPKYDIRADVWSLGISLVELATGQFPYK 219 (296)
T ss_pred cchhccCCCcccCCCCCccccCHhhcCCCC-CccccccchhHHHHHHHHHHHHhCCCCCC
Confidence 987654433344456889999999983211 1355889999996433 33555553
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=230.29 Aligned_cols=184 Identities=25% Similarity=0.391 Sum_probs=153.4
Q ss_pred cccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 019304 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv 214 (343)
|+..+.||.|++|.||+|+. +++.||||.+........ ....+.+|++++++++||||+++++++.+....++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG----VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 77 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccc----cchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence 66788999999999999987 678999998865432221 124688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-C
Q 019304 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-G 293 (343)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~-~ 293 (343)
|||+. ++|.+++.......+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||+++...... .
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 99996 589999876555678999999999999999999999999999999999999999999999999987543322 2
Q ss_pred ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 294 MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 294 ~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.....+++.|+|||.+. ....++.++|+|+++
T Consensus 157 ~~~~~~~~~y~aPE~~~----~~~~~~~~~Dv~slG 188 (284)
T cd07860 157 YTHEVVTLWYRAPEILL----GCKYYSTAVDIWSLG 188 (284)
T ss_pred cccccccccccCCeEEe----cCCCCCcHHHHHHHH
Confidence 23346789999999882 234468899999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=228.42 Aligned_cols=194 Identities=25% Similarity=0.380 Sum_probs=158.7
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
+.|+..+.||+|+||.||+|.. +++.||+|.+........ ...+.+.+|+.+++.++||||+++++++......+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcH---HHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 5688889999999999999987 678999999865433222 12356889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+|+||++ ++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 92 lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 92 LVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred EEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 9999997 5787777643 24589999999999999999999999999999999999999999999999999875432
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.....+++.|+|||.+... ....++.++|+|+++. +++.+|++
T Consensus 168 -~~~~~~~~~y~aPE~~~~~--~~~~~~~~sDv~s~G~il~el~tg~~p~~ 215 (307)
T cd06607 168 -ANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKPPLF 215 (307)
T ss_pred -CCCccCCccccCceeeecc--CCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence 2345688999999987321 2466889999996543 33556654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=227.74 Aligned_cols=184 Identities=23% Similarity=0.363 Sum_probs=153.1
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|+..+.||.|++|.||+|+. +++.||||.+........ ...+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT-----PSTAIREISLMKELKHENIVRLHDVIHTENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccc-----hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEE
Confidence 467789999999999999998 678999999875443221 1356789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 214 VTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
||||+++ +|.+++.... ...+++..+..++.|++.||.|||+.|++|+||||+||++++++.+||+|||+++......
T Consensus 76 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 76 VFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred EEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 9999985 8988886543 2458999999999999999999999999999999999999999999999999987543321
Q ss_pred -CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 293 -GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
......+++.|+|||.+. ....++.++|+|+++
T Consensus 155 ~~~~~~~~~~~y~~PE~~~----~~~~~~~~~Dv~slG 188 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLL----GSRTYSTSIDIWSVG 188 (284)
T ss_pred cccccccccccccChHHhc----CCCCCCcHHHHHHHH
Confidence 223446789999999873 234578999999643
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=225.86 Aligned_cols=180 Identities=23% Similarity=0.323 Sum_probs=148.7
Q ss_pred cccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeC--CeE
Q 019304 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKR--MVW 211 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~ 211 (343)
|++.+.||+|+||.||+|.. +++.+|+|.++........ ....+|+.++.++. |+||+++++++.+. ..+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-----~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-----VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-----hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcE
Confidence 45678899999999999987 6789999998754332221 23457888888885 99999999999987 889
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||++ ++|.+++.... ..+++..++.++.|++.||+|||+.|++||||+|+||+++. +.+||+|||+++.....
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 76 ALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 99999997 58888886533 45899999999999999999999999999999999999999 99999999999865444
Q ss_pred CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeec
Q 019304 292 EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES 328 (343)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~ 328 (343)
.......+++.|+|||.+. ....++.++|+|++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~----~~~~~~~~~Di~sl 185 (282)
T cd07831 153 PPYTEYISTRWYRAPECLL----TDGYYGPKMDIWAV 185 (282)
T ss_pred CCcCCCCCCcccCChhHhh----cCCCCCcchhHHHH
Confidence 3444456899999999762 34567899999953
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=225.78 Aligned_cols=188 Identities=19% Similarity=0.303 Sum_probs=155.4
Q ss_pred cccccccccccceEEEEEEEC---CceEEEEEeeCCCCChh----HHHHHHHHHHHHHHHHhc-CCCCCcceEEEEEEeC
Q 019304 137 LNMGTAFAQGAFGKLYRGTYN---GEDVAIKILERPENNPE----KAQVMEQQFQQEVMMLAT-LKHLNIVRFIGACRKR 208 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~~---~~~vavK~~~~~~~~~~----~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~ 208 (343)
|++.+.||+|+||.||++.+. ++.+|+|.+........ .......++.+|+.++.. ++||||+++++.+...
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 677889999999999999983 47899998864332111 112234567789988865 7999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~-~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
...+++|||+++++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||.+
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccce
Confidence 9999999999999999988542 34468899999999999999999996 68999999999999999999999999999
Q ss_pred cccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 286 RIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.............|+..|+|||.+ ....++.++|+|+++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~Pe~~-----~~~~~~~~~Dv~slG 200 (269)
T cd08528 162 KQKQPESKLTSVVGTILYSCPEIV-----KNEPYGEKADVWAFG 200 (269)
T ss_pred eecccccccccccCcccCcChhhh-----cCCCCchHHHHHHHH
Confidence 865544344456789999999999 777899999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=222.15 Aligned_cols=178 Identities=29% Similarity=0.484 Sum_probs=149.5
Q ss_pred cccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEecC
Q 019304 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAK 219 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~~ 219 (343)
++||+|+||.||++.. +++.||+|.+...... .....+.+|+.+++.+.||||+++++++......++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 75 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-----DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVP 75 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-----HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCC
Confidence 4689999999999988 4789999998754433 123578999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCc---cC
Q 019304 220 GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM---TP 296 (343)
Q Consensus 220 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~---~~ 296 (343)
+++|.+++.... ..++...+..++.+++.+|.|||+++++||||+|+||+++.++.+||+|||+++........ ..
T Consensus 76 ~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 76 GGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 999999997543 35788999999999999999999999999999999999999999999999998754321111 11
Q ss_pred CCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 297 ETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 297 ~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
..++..|+|||.+ ....++.++|+|+++
T Consensus 155 ~~~~~~y~~PE~~-----~~~~~~~~~Di~slG 182 (251)
T cd05041 155 KQIPIKWTAPEAL-----NYGRYTSESDVWSYG 182 (251)
T ss_pred CcceeccCChHhh-----ccCCCCcchhHHHHH
Confidence 2335679999998 677889999999644
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=220.92 Aligned_cols=184 Identities=29% Similarity=0.481 Sum_probs=159.3
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CeE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--MVW 211 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 211 (343)
+|+..+.||+|++|.||+|.. +++.|++|++....... ...+.+.+|+.++++++||||+++++.+... ..+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSE----EELEALEREIRILSSLQHPNIVRYYGSERDEEKNTL 76 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccch----HHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeE
Confidence 356678999999999999998 48899999997655431 2236789999999999999999999999988 889
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++++||+++++|.+++.... .+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||.+......
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 77 NIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999999999997653 6899999999999999999999999999999999999999999999999998876554
Q ss_pred CC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 292 EG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 292 ~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.. .....++..|+|||.+ ....++.++|+|+++.
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~-----~~~~~~~~~Dv~slG~ 191 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVI-----RGEEYGRAADIWSLGC 191 (260)
T ss_pred cccccccCCCCCccccCHhhh-----cCCCCCchhhHHHHHH
Confidence 32 3445789999999999 6777999999996443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=250.71 Aligned_cols=187 Identities=27% Similarity=0.509 Sum_probs=160.8
Q ss_pred ccccccccccccceEEEEEEE--CCc----eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
+.+..++||+|+||.||+|.| .++ +||||++......... ++++.|+.+|.++.|||+++++++|....
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s-----~e~LdeAl~masldHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKAS-----IELLDEALRMASLDHPNLLRLLGVCMLST 771 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhh-----HHHHHHHHHHhcCCCchHHHHhhhcccch
Confidence 556678999999999999998 443 7999998765544322 57899999999999999999999998776
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
+-||++||+.|+|.+|++..+ ..+.....+.++.||++||+|||+++++||||.++|+||.+-..+||.|||+|+...
T Consensus 772 -~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 679999999999999998743 568889999999999999999999999999999999999999999999999999876
Q ss_pred cCC-CccCCCC--CcceecCCCCCCCCCCCCCCceeeeeeecccccccC
Q 019304 290 QTE-GMTPETG--TYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTWP 335 (343)
Q Consensus 290 ~~~-~~~~~~g--t~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~~~~ 335 (343)
... .++...| .+.|||=|.+ ....|+.++||| +++++.|-
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i-----~~~~~thqSDVW-sfGVtiWE 892 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESI-----RIRKYTHQSDVW-SFGVTIWE 892 (1177)
T ss_pred cccccccccccccCcHHHHHHHh-----hccCCCchhhhh-hhhhhHHH
Confidence 543 3344344 4899999999 999999999999 77777763
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=228.96 Aligned_cols=185 Identities=24% Similarity=0.355 Sum_probs=150.0
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCe--
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMV-- 210 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~-- 210 (343)
+|++.+.||+|+||.||+|.+ +++.||||.+........ ....+.+|+.+++.+. ||||+++++++.....
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 77 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG----IPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG 77 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccC----CchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence 577889999999999999987 678999998865432211 1246788999999995 6999999999987665
Q ss_pred ---EEEEEEecCCCCHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-CCcEEEeccc
Q 019304 211 ---WCIVTEYAKGGSVRQFLTRRQ---NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFG 283 (343)
Q Consensus 211 ---~~iv~E~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~-~~~vkl~DFg 283 (343)
+|+||||+++ +|.+++.... ...+++..++.++.||+.||.|||++|++||||||+||+++. ++.+||+|||
T Consensus 78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 8988887543 235799999999999999999999999999999999999998 8899999999
Q ss_pred cccccccC-CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 284 VARIEVQT-EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 284 ~a~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+++..... .......+++.|+|||.+. ....++.++|+|+++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG 199 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLL----GSTHYSTPVDIWSVG 199 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhh----CCCCCCchHHHHHHH
Confidence 98754322 2223346789999999872 235678999999643
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=224.72 Aligned_cols=184 Identities=21% Similarity=0.412 Sum_probs=148.7
Q ss_pred cccccccccccceEEEEEEE-----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--
Q 019304 137 LNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-- 209 (343)
|++.+.||+|+||.||+|.+ +++.||||++......... .+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD----IEEFLREAACMKEFDHPNVIKLIGVSLRSRAK 76 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHH----HHHHHHHHHHHhcCCCCCcceEEEEEccCCCC
Confidence 45678899999999999975 3578999999765433322 356889999999999999999999886532
Q ss_pred ----eEEEEEEecCCCCHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEec
Q 019304 210 ----VWCIVTEYAKGGSVRQFLTRRQ----NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (343)
Q Consensus 210 ----~~~iv~E~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~D 281 (343)
.+++++||+++++|.+++.... ...++...++.++.|++.||+|||+.|++||||||+||+++.++.+||+|
T Consensus 77 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 77 GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred CcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECc
Confidence 3478999999999998875321 12478889999999999999999999999999999999999999999999
Q ss_pred cccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 282 FGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 282 Fg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
||+++....... .....+++.|++||.+ ....++.++|+|+++
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~-----~~~~~~~~sDi~slG 202 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESL-----ADNVYTTHSDVWAFG 202 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHH-----hcCccchhhhhHHHH
Confidence 999885432221 1223456789999998 777889999999643
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=231.19 Aligned_cols=184 Identities=19% Similarity=0.266 Sum_probs=151.3
Q ss_pred ccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEe
Q 019304 138 NMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 138 ~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
.+++.+|.|+++.|+++..+++.||||++.......+ ..+.+.+|+.+++.++||||+++++++......+++|||
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 80 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKE----DLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL 80 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchh----HHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEec
Confidence 4556677777777778777899999999976533322 235789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCC----
Q 019304 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---- 293 (343)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~---- 293 (343)
+++++|.+++.......+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999999999876555689999999999999999999999999999999999999999999999998864322111
Q ss_pred ----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeec
Q 019304 294 ----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES 328 (343)
Q Consensus 294 ----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~ 328 (343)
.....++..|+|||++.. ....++.++|+|++
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~~Diws~ 196 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQ---NLQGYNEKSDIYSV 196 (314)
T ss_pred cccccccccccccccCHHHhcC---CCCCCCcchhHHHH
Confidence 123357789999999831 12458899999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-30 Score=258.22 Aligned_cols=195 Identities=25% Similarity=0.389 Sum_probs=152.0
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-----
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----- 207 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----- 207 (343)
.+|+..+.||+||||.||+++. +|+.+|||++.... . ......+.+|+.++.+|+|||||++|..|.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s----~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-S----DKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-H----HHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 4566778899999999999987 99999999997654 1 1223678899999999999999999865500
Q ss_pred --------------------------------------------------------------------------------
Q 019304 208 -------------------------------------------------------------------------------- 207 (343)
Q Consensus 208 -------------------------------------------------------------------------------- 207 (343)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred --------------------------C--------CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q 019304 208 --------------------------R--------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253 (343)
Q Consensus 208 --------------------------~--------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~y 253 (343)
+ ..+||-||||+...|.+++.++... -.....|+++++|+.||.|
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHH
Confidence 0 1368999999997777777654321 1477899999999999999
Q ss_pred HHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc-------------------cCCCccCCCCCcceecCCCCCCCCC
Q 019304 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-------------------QTEGMTPETGTYRWMAPGNSFFSPL 314 (343)
Q Consensus 254 LH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~-------------------~~~~~~~~~gt~~y~APE~~~~~~~ 314 (343)
+|++|+|||||||.||++++++.|||.|||+|.... .....+..+||..|+|||++.+.
T Consensus 713 IH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~-- 790 (1351)
T KOG1035|consen 713 IHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT-- 790 (1351)
T ss_pred HHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc--
Confidence 999999999999999999999999999999997511 01123456899999999999421
Q ss_pred CCCCCceeeeeeeccccc--ccCCC
Q 019304 315 PHPSFEHKWSAKESCLKT--TWPPP 337 (343)
Q Consensus 315 ~~~~~~~~sDi~~~~~~~--~~~p~ 337 (343)
...+|+.|+|+|++.++. +|-||
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~yPF 815 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLYPF 815 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhccC
Confidence 113699999999544432 45555
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=229.69 Aligned_cols=187 Identities=24% Similarity=0.380 Sum_probs=150.3
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM- 209 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~- 209 (343)
+.++|++.+.||+|+||.||+|.. +++.||||.+........ ....+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG----FPITALREIKILQLLKHENVVNLIEICRTKAT 85 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC----chhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence 456788899999999999999987 678999999865432221 1134568999999999999999999987654
Q ss_pred -------eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 019304 210 -------VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (343)
Q Consensus 210 -------~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DF 282 (343)
..++||||+.+ +|.+++... ...+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 86 PYNRYKGSFYLVFEFCEH-DLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred cccCCCceEEEEEcCCCc-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcC
Confidence 45999999964 888888653 345899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCC-----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 283 GVARIEVQTEG-----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 283 g~a~~~~~~~~-----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
|++........ .....++..|+|||.+. ....++.++|+|+++
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~Di~slG 211 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLL----GERDYGPPIDMWGAG 211 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhc----CCcccCchhhhHHHH
Confidence 99875433221 12345788999999872 224478899999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=226.43 Aligned_cols=179 Identities=30% Similarity=0.500 Sum_probs=147.1
Q ss_pred ccccccceEEEEEEECC--------ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 142 AFAQGAFGKLYRGTYNG--------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 142 ~lg~G~fg~Vy~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
.||+|+||.||+|+... +.+|||.+....... ....+.+|+.+++.++||||+++++++......++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ-----EKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI 76 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchh-----hHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence 58999999999998632 568999886432211 12568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC-----cEEEeccc
Q 019304 214 VTEYAKGGSVRQFLTRRQ-----NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-----SIKIADFG 283 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~-----~vkl~DFg 283 (343)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+++|+||||+||+++.++ .+||+|||
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 999999999999997532 23378889999999999999999999999999999999999877 89999999
Q ss_pred cccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 284 VARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 284 ~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+++....... .....++..|+|||.+ ....++.++|+|+++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slG~ 201 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESL-----LDGKFTTQSDVWSFGV 201 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHH-----ccCCcccchhHHHHHH
Confidence 9875432211 1123456889999999 7788999999996443
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=226.96 Aligned_cols=183 Identities=30% Similarity=0.389 Sum_probs=154.1
Q ss_pred cccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeEEE
Q 019304 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~i 213 (343)
|++.+.||+|++|.||+|.. +++.||||.+........ .....+|+..++.++ ||||+++++++.+....++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-----ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-----HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEE
Confidence 45678999999999999998 567899999865443221 123457899999999 9999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCC
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~ 293 (343)
||||+ +++|.+++.......+++..++.++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 99999 77999998765545689999999999999999999999999999999999999999999999999986554434
Q ss_pred ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 294 MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 294 ~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.....++..|+|||.+. ....++.++|+|+++
T Consensus 155 ~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~s~G 186 (283)
T cd07830 155 YTDYVSTRWYRAPEILL----RSTSYSSPVDIWALG 186 (283)
T ss_pred cCCCCCcccccCceeee----cCcCcCCccchhhHH
Confidence 44557899999999873 345678999999643
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=227.96 Aligned_cols=191 Identities=16% Similarity=0.228 Sum_probs=141.8
Q ss_pred ecccccccccccccccceEEEEEEEC-----CceEEEEEeeCCCCChhHHH-----HHHHHHHHHHHHHhcCCCCCcceE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQ-----VMEQQFQQEVMMLATLKHLNIVRF 201 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l 201 (343)
+..++|++.+.||+|+||.||+|.+. +..+|+|+............ ........+...+..+.|++++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 44578999999999999999999873 34667776433222111100 011223344556677899999999
Q ss_pred EEEEEeCC----eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcE
Q 019304 202 IGACRKRM----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277 (343)
Q Consensus 202 ~~~~~~~~----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~v 277 (343)
++++.... ..++++|++. .++.+.+... ...++..+..++.|++.||+|||+.+++||||||+|||++.++.+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 99876543 3467888874 4777776543 236788889999999999999999999999999999999999999
Q ss_pred EEeccccccccccCC--------CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 278 KIADFGVARIEVQTE--------GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 278 kl~DFg~a~~~~~~~--------~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
||+|||+|+...... ......||+.|+|||++ ....++.++|||+++.
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~-----~~~~~~~~~DiwSlG~ 221 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAH-----NGACVTRRGDLESLGY 221 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHh-----CCCCCCcHHHHHHHHH
Confidence 999999997643211 11234699999999999 7888999999996433
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=223.63 Aligned_cols=185 Identities=23% Similarity=0.397 Sum_probs=158.0
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||+|++|.||+++. +++.+|+|.+......... ...+.+|+.+++.++|+||+++++++......++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKE----REDAVNEIRILASVNHPNIISYKEAFLDGNKLCI 76 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHH----HHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEE
Confidence 366788999999999999987 6788999998754433221 2567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 214 VTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
|+||+++++|.+++.+.. ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 999999999999987632 345888999999999999999999999999999999999999999999999999876544
Q ss_pred CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 292 EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
......+++.|+|||.+ ....++.++|+|+++.
T Consensus 157 -~~~~~~~~~~~~~Pe~~-----~~~~~~~~~D~~slG~ 189 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVW-----KGRPYSYKSDIWSLGC 189 (256)
T ss_pred -CcccccCCccccCHHHH-----CCCCCCchhhHHHHHH
Confidence 33345688999999999 7788899999996443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=224.18 Aligned_cols=183 Identities=26% Similarity=0.415 Sum_probs=151.7
Q ss_pred cccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC---CCCCcceEEEEEEeCCe-
Q 019304 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACRKRMV- 210 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~- 210 (343)
|++.+.||+|+||.||+|.+ +++.+|+|.+........ ....+.+|+.+++.+ .||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 76 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG----IPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD 76 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccch----hhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC
Confidence 45678899999999999998 478999999975443221 123456777776655 69999999999988776
Q ss_pred ----EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 211 ----WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 211 ----~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
++++|||+.+ +|.+++.......+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++.
T Consensus 77 ~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 77 RELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred CCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 89998876544568999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 287 IEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
............+++.|+|||.+ ....++.++|+|+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~-----~~~~~~~~~Di~s~G 193 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVL-----LQSSYATPVDMWSVG 193 (287)
T ss_pred eccCCcccccccccccccChHHh-----ccCCCCCcchhhhHH
Confidence 65444333444688999999999 677889999999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=230.67 Aligned_cols=186 Identities=22% Similarity=0.372 Sum_probs=150.0
Q ss_pred ccccccccccccceEEEEEEE----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--C
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--M 209 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~ 209 (343)
+|++.+.||+|+||.||+|.. .++.||+|.+......... ..+.+.+|+.+++.++||||+++++++... .
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTG---ISQSACREIALLRELKHENVVSLVEVFLEHADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccC---ccHHHHHHHHHHHhcCCCCccceEEEEeCCCCc
Confidence 366778999999999999988 4689999999764321111 124577899999999999999999999988 7
Q ss_pred eEEEEEEecCCCCHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC----CCcEEEecc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQ---NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA----DKSIKIADF 282 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~----~~~vkl~DF 282 (343)
.+++||||+++ +|.+++.... ...+++..++.++.|++.||.|||+.+++||||||+||+++. ++.+||+||
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 78 SVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred eEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 89999999975 7777765322 235889999999999999999999999999999999999999 899999999
Q ss_pred ccccccccCCC----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 283 GVARIEVQTEG----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 283 g~a~~~~~~~~----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
|+++....... .....+++.|+|||.+. ....++.++|+|+++
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~Dv~slG 203 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLL----GARHYTKAIDIWAIG 203 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHh----CCCCCCcHHHHHHHH
Confidence 99886433211 22346789999999872 234688999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=219.08 Aligned_cols=182 Identities=27% Similarity=0.497 Sum_probs=157.7
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|...+.||+|++|.||++.. +++.+++|++..... ...+.+.+|+.+++.++||+++++++.+......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 74 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK------EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWI 74 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 366778999999999999998 578899999976443 123578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCC
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~ 293 (343)
++||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 75 ~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 75 VMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 999999999999987643 4689999999999999999999999999999999999999999999999999886554332
Q ss_pred ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 294 MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 294 ~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.....++..|+|||.+ ....++.++|+|+++
T Consensus 154 ~~~~~~~~~~~~PE~~-----~~~~~~~~~Dv~slG 184 (253)
T cd05122 154 RNTMVGTPYWMAPEVI-----NGKPYDYKADIWSLG 184 (253)
T ss_pred ccceecCCcccCHHHH-----cCCCCCccccHHHHH
Confidence 3455789999999998 667789999999643
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=219.11 Aligned_cols=192 Identities=33% Similarity=0.491 Sum_probs=161.6
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|++.+.||+|++|.||++.. +++.+|+|.+....... .....+.+|+++++.++|||++++++++......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE----EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYI 76 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH----HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Confidence 467789999999999999987 56789999997654331 123578999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCC
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~ 293 (343)
++||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 77 v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 77 ILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred EEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999999999999764 4589999999999999999999999999999999999999999999999999986544322
Q ss_pred -ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 294 -MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 294 -~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.....++..|+|||.. ....++.++|+|+++. +++.+|++
T Consensus 155 ~~~~~~~~~~y~~pe~~-----~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~ 200 (254)
T cd06627 155 DDASVVGTPYWMAPEVI-----EMSGASTASDIWSLGCTVIELLTGNPPYY 200 (254)
T ss_pred cccccccchhhcCHhhh-----cCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 2345689999999998 5666889999996433 33555554
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=234.42 Aligned_cols=182 Identities=25% Similarity=0.360 Sum_probs=149.1
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC---
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--- 209 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--- 209 (343)
++|++.+.||+|+||.||+|.+ +++.||||.+...... ....++.+|+.+++.++||||+++++++....
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ-----TFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc-----hhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 5788899999999999999987 6789999998642221 12356788999999999999999999876543
Q ss_pred --eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 210 --VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 210 --~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
.+++|+||+++ +|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++.
T Consensus 80 ~~~~~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 80 FNDVYIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred cceEEEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 57999999965 88877753 3589999999999999999999999999999999999999999999999999875
Q ss_pred cccCCC----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 288 EVQTEG----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 288 ~~~~~~----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
...... .....||+.|+|||.+. ....++.++|+|+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwslG 197 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIML----NSKGYTKAIDIWSVG 197 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhh----CCCCCCcHHHHHHHH
Confidence 432211 12346899999999862 345689999999643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=221.50 Aligned_cols=176 Identities=23% Similarity=0.361 Sum_probs=145.1
Q ss_pred cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHH-HhcCCCCCcceEEEEEEeCCeEEEEEEe
Q 019304 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-LATLKHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
+.||+|+||.||+|.. +++.||||++.+....... ....+..|..+ .....|+|++++++++...+.+++|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKN---QVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHH---HHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEec
Confidence 5799999999999987 6789999998654322111 12234455444 4456899999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCccCC
Q 019304 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE 297 (343)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~~~~ 297 (343)
+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||+++.... ....
T Consensus 79 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~ 153 (260)
T cd05611 79 LNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKF 153 (260)
T ss_pred cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccC
Confidence 9999999999754 3588999999999999999999999999999999999999999999999999875332 2334
Q ss_pred CCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 298 TGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 298 ~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.+++.|+|||.+ ....++.++|+|++.
T Consensus 154 ~~~~~y~~pe~~-----~~~~~~~~~Dv~slG 180 (260)
T cd05611 154 VGTPDYLAPETI-----LGVGDDKMSDWWSLG 180 (260)
T ss_pred CCCcCccChhhh-----cCCCCcchhhhHHHH
Confidence 688999999998 566689999999633
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=224.38 Aligned_cols=182 Identities=29% Similarity=0.423 Sum_probs=157.1
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
+.|+..+.||+|++|.||++.+ +++.|++|++..... ..+.+.+|+.+++.++|+||+++++.+......+
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-------NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 5577888999999999999988 478999999975433 2356889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+++||+++++|.+++.... ..++...+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999999999998754 368999999999999999999999999999999999999999999999999886543221
Q ss_pred -CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 293 -GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
......+++.|+|||.+ ....++.++|+|+++
T Consensus 171 ~~~~~~~~~~~y~~PE~~-----~~~~~~~~~Dv~slG 203 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVI-----KRKDYGPKVDIWSLG 203 (286)
T ss_pred hhhccccCCcccCCHhHh-----cCCCCCCccccHHHH
Confidence 22334688999999998 677789999999533
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=230.06 Aligned_cols=183 Identities=19% Similarity=0.277 Sum_probs=147.8
Q ss_pred cccccc--cceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEE
Q 019304 141 TAFAQG--AFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (343)
Q Consensus 141 ~~lg~G--~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E 216 (343)
..||+| +||+||++.+ +++.||+|++........ ..+.+.+|+.+++.++||||+++++++......++|+|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEE----HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISP 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHH----HHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEe
Confidence 456666 8999999988 789999999876543332 23678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCc--
Q 019304 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM-- 294 (343)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~-- 294 (343)
|+.+++|.+++.......+++..+..++.|++.||+|||++|++||||||+|||++.++.+|++||+.+.........
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999999999998765556899999999999999999999999999999999999999999999999865432111110
Q ss_pred ------cCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 295 ------TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 295 ------~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
....++..|+|||++.. ....++.++|+|+++.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~~DiwslG~ 198 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQ---DLYGYNVKSDIYSVGI 198 (328)
T ss_pred ccccccccccCccCccChhhhcC---CCCCCCchhhHHHHHH
Confidence 11234677999999832 1245789999996443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=224.94 Aligned_cols=190 Identities=23% Similarity=0.380 Sum_probs=157.0
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
.|...+.||+|++|.||++.. +++.+++|.+...... ..+.+.+|+.+++.+.||||+++++.+...+..++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~ 93 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ------RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWV 93 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh------HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEE
Confidence 344457899999999999986 6788999988643221 12468899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~- 292 (343)
++||+++++|.+++.. ..++...+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+.......
T Consensus 94 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 94 VMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 9999999999999876 348889999999999999999999999999999999999999999999999887543322
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
......|++.|+|||.+ ....++.++|+|+++. +++.+|+..
T Consensus 171 ~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 171 RRKSLVGTPYWMAPEVI-----SRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred ccccccCCccccCHHHh-----cCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence 22334689999999998 6778899999996433 335555543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=226.02 Aligned_cols=193 Identities=23% Similarity=0.326 Sum_probs=156.5
Q ss_pred cccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 019304 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv 214 (343)
|++.+.||.|++|.||+|.+ +++.||+|++........ ....+.+|+.+++.++|||++++++++.+....+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv 76 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG----VPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLV 76 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccccc----chhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEE
Confidence 45678899999999999987 688999999875432221 124577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-C
Q 019304 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-G 293 (343)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~-~ 293 (343)
|||++ ++|.+++.......+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||+++...... .
T Consensus 77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 77 FEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred EeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 99995 699999876554568999999999999999999999999999999999999999999999999987543221 2
Q ss_pred ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 294 MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 294 ~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.....+++.|+|||++. ....++.++|+|+++. +++.+||.
T Consensus 156 ~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 201 (283)
T cd07835 156 YTHEVVTLWYRAPEILL----GSRQYSTPVDIWSIGCIFAEMVNRRPLFP 201 (283)
T ss_pred cCccccccCCCCCceee----cCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 23346789999999872 2345788999996432 33555553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=223.43 Aligned_cols=177 Identities=22% Similarity=0.368 Sum_probs=150.8
Q ss_pred cccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEecCC
Q 019304 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (343)
Q Consensus 143 lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~~~ 220 (343)
||.|+||.||++.+ +++.+++|++....... ....+.+.+|+.+++.++||||+++++.+......|+++||+++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR---KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhh---hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCC
Confidence 68899999999998 48899999986543322 22346788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC--------
Q 019304 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-------- 292 (343)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~-------- 292 (343)
++|.+++.+.. .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++.......
T Consensus 78 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 78 GDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99999997643 58999999999999999999999999999999999999999999999999987543221
Q ss_pred -CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 293 -GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
......+++.|+|||.. ....++.++|+|+++
T Consensus 156 ~~~~~~~~~~~~~~Pe~~-----~~~~~~~~~Dv~slG 188 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVI-----LGQGHSKTVDWWSLG 188 (265)
T ss_pred ccccCcccCccccCHHHh-----cCCCCCcchhhHHHH
Confidence 12234678999999998 667789999999643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=224.65 Aligned_cols=183 Identities=23% Similarity=0.348 Sum_probs=151.9
Q ss_pred cccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CeEE
Q 019304 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--MVWC 212 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~ 212 (343)
|++.+.||+|++|.||+|.. +++.+|+|.+........ ..+.+.+|+.+++.++|||++++++++... ...+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 76 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEG----FPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIY 76 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccccccc----chHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEE
Confidence 45678899999999999988 568999999986542211 124678999999999999999999999888 7899
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+|+||+++ +|.+++.... ..+++..++.++.|++.||+|||+.|++|+||+|+||++++++.+||+|||++.......
T Consensus 77 lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 77 MVFEYMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred EEeccccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 99999975 8988886542 468999999999999999999999999999999999999999999999999988654432
Q ss_pred --CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 293 --GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 293 --~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
......++..|+|||.+. ....++.++|+|+++
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~----~~~~~~~~~Dv~slG 189 (287)
T cd07840 155 SADYTNRVITLWYRPPELLL----GATRYGPEVDMWSVG 189 (287)
T ss_pred cccccccccccccCCceeeE----ccccCChHHHHHHHH
Confidence 123346788999999872 234678999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=226.87 Aligned_cols=185 Identities=24% Similarity=0.367 Sum_probs=156.9
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVW 211 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~ 211 (343)
++|++.+.||+|++|.||++.. +++.||+|++......... ..+.+.+|+.+++++. ||||+++++++......
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 77 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEK---KVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENL 77 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchH---HHHHHHHHHHHHHhcccCCCchhHHHHhcCCceE
Confidence 3678889999999999999987 7889999998764332221 2357889999999998 99999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++|||++++++|.+++.+. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 78 YFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999999999999764 35899999999999999999999999999999999999999999999999998754332
Q ss_pred C---------------------CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 292 E---------------------GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 292 ~---------------------~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
. ......++..|+|||.. ....++.++|+|+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~-----~~~~~~~~~Di~slG 209 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL-----NEKPAGKSSDLWALG 209 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHh-----CCCCCChhhhHHHHH
Confidence 1 11233578999999998 667789999999643
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=227.23 Aligned_cols=186 Identities=23% Similarity=0.349 Sum_probs=151.8
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM- 209 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~- 209 (343)
...+|++.+.||+|+||.||+|.. +++.||+|+++....... ....+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~----~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG----FPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC----chHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 346788899999999999999998 578999999975432221 1245678999999999999999999987654
Q ss_pred ---------eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEe
Q 019304 210 ---------VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (343)
Q Consensus 210 ---------~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~ 280 (343)
.+++|+||+++ ++..++... ...+++..++.++.|++.||.|||+.||+|+||||+||+++.++.+||+
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeC
Confidence 78999999976 788877653 3458999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCC--CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeec
Q 019304 281 DFGVARIEVQTE--GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES 328 (343)
Q Consensus 281 DFg~a~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~ 328 (343)
|||++....... ......+++.|+|||.+. ....++.++|+|++
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~----~~~~~~~~~Di~sl 204 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLL----GEERYGPAIDVWSC 204 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhc----CCCCCCchhHHHHH
Confidence 999988654322 122335678999999873 23457889999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=226.29 Aligned_cols=177 Identities=23% Similarity=0.347 Sum_probs=150.5
Q ss_pred cccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEE
Q 019304 139 MGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (343)
Q Consensus 139 ~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E 216 (343)
....||+|+||.||++.. +++.||||.+..... .....+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ------QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 97 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch------hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEe
Confidence 346799999999999987 678999998754221 123568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-Ccc
Q 019304 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-GMT 295 (343)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~-~~~ 295 (343)
|+++++|.+++.. ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 98 ~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~ 174 (292)
T cd06657 98 FLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174 (292)
T ss_pred cCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence 9999999998754 247889999999999999999999999999999999999999999999999887543321 223
Q ss_pred CCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 296 PETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 296 ~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
...|++.|+|||.+ ....++.++|+|+++
T Consensus 175 ~~~~~~~y~~pE~~-----~~~~~~~~~Dv~slG 203 (292)
T cd06657 175 SLVGTPYWMAPELI-----SRLPYGPEVDIWSLG 203 (292)
T ss_pred ccccCccccCHHHh-----cCCCCCchhhHHHHH
Confidence 45689999999998 677889999999644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=230.03 Aligned_cols=188 Identities=22% Similarity=0.309 Sum_probs=150.9
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHH--------HHHHHHHHHHHHHhcCCCCCcceEEEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQ--------VMEQQFQQEVMMLATLKHLNIVRFIGA 204 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~ 204 (343)
+...+.+.||+|+||.||+|.. .++.||||++........... .....+.+|+.+++.++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 3445667899999999999986 678999999875443321100 011257799999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccc
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~ 284 (343)
+......++||||++ ++|.+++... ..+++.....++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||.
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence 999999999999996 5899998653 3488999999999999999999999999999999999999999999999999
Q ss_pred cccccc---------------CCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 285 ARIEVQ---------------TEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 285 a~~~~~---------------~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
++.... ........+++.|+|||.+. ....++.++|+|+++
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~Dv~slG 221 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLM----GAEKYHFAVDMWSVG 221 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcc----cCCCCCcHHHHHHHH
Confidence 875431 11122335688999999983 224578999999643
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=221.90 Aligned_cols=182 Identities=18% Similarity=0.245 Sum_probs=146.2
Q ss_pred ccccccc--cccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCe
Q 019304 136 KLNMGTA--FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMV 210 (343)
Q Consensus 136 ~~~~~~~--lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 210 (343)
+|.+.+. ||+|+||.||++.. ++..+|+|++....... .|+.....+ +||||+++++.+...+.
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----------~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----------IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 3444444 59999999999987 67889999986533221 122222212 79999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC-cEEEeccccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEV 289 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~-~vkl~DFg~a~~~~ 289 (343)
+++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||+++...
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 999999999999999997643 689999999999999999999999999999999999999888 99999999987543
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.. ....+++.|+|||++ ....++.++|+|+++. +++.+|+.
T Consensus 162 ~~---~~~~~~~~y~aPE~~-----~~~~~~~~~DvwslG~il~~l~~g~~p~~ 207 (267)
T PHA03390 162 TP---SCYDGTLDYFSPEKI-----KGHNYDVSFDWWAVGVLTYELLTGKHPFK 207 (267)
T ss_pred CC---ccCCCCCcccChhhh-----cCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 22 234689999999999 7778899999996433 33555553
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-30 Score=258.04 Aligned_cols=187 Identities=26% Similarity=0.368 Sum_probs=155.9
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+++-+.+||.|.||.||.|.. +|...|+|.++-...... ....+.+|..++..++|||+|++||+=...+..+|
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k----~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHK----TFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccc----cCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 455677899999999999987 788899998865444321 23567899999999999999999999998888999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~- 292 (343)
.||||++|+|.+.+...+ -.++.....+..|++.|+.|||++|||||||||+||+++.+|.+|+.|||.|..+....
T Consensus 1312 FMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 999999999999997643 36777778889999999999999999999999999999999999999999998655432
Q ss_pred ----CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 293 ----GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 293 ----~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
......|||-|||||++.+. ....-..+.|||+..+
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t--~~kG~~~A~DiWslGC 1429 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGT--KGKGHGGAADIWSLGC 1429 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhccc--ccCCCCcchhhhcccc
Confidence 12345799999999999553 3455668899997544
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=229.69 Aligned_cols=183 Identities=25% Similarity=0.352 Sum_probs=149.8
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC--C
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR--M 209 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~--~ 209 (343)
.+|++.+.||+|+||.||+|.+ +++.+|||.+......... ...+.+|+.+++++ +||||+++++++... .
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~----~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD----AQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchh----hhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 6788889999999999999987 5789999988654332221 24577899999999 999999999998654 3
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
.+++||||++ ++|.+++... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 6899999997 5999888653 57888889999999999999999999999999999999999999999999987543
Q ss_pred cCC------CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 290 QTE------GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 290 ~~~------~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
... ......|++.|+|||.+. ....++.++|+|+++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~sDi~slG 200 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILL----GSTRYTKGVDMWSVG 200 (337)
T ss_pred cccccccCcchhcccccccccCceeee----ccccccccchHHHHH
Confidence 321 122346889999999873 345678999999643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=231.16 Aligned_cols=183 Identities=23% Similarity=0.333 Sum_probs=154.1
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM---- 209 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---- 209 (343)
+|++.+.||+|++|.||+|.. +++.||||.+....... ...+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL----IDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDF 76 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccc----hhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccc
Confidence 477889999999999999997 57899999987644322 12357889999999999999999999998775
Q ss_pred -eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 210 -VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 210 -~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
.+|++|||++ ++|.+++... ..+++..++.++.|++.||+|||+.|++|+||||+|||++.++.++|+|||++...
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 77 NDVYIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred cceEEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 7899999997 4898888653 36899999999999999999999999999999999999999999999999999865
Q ss_pred ccCC----CccCCCCCcceecCCCCCCCCCCCC-CCceeeeeeeccc
Q 019304 289 VQTE----GMTPETGTYRWMAPGNSFFSPLPHP-SFEHKWSAKESCL 330 (343)
Q Consensus 289 ~~~~----~~~~~~gt~~y~APE~~~~~~~~~~-~~~~~sDi~~~~~ 330 (343)
.... ......+++.|+|||.+ ... .++.++|+|+++.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~sDi~slG~ 195 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELL-----LSSSRYTKAIDIWSVGC 195 (330)
T ss_pred cccccccccccccccccCcCCceee-----ecccCCCcchhHHHHHH
Confidence 4432 23345688999999999 445 7899999996443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=231.60 Aligned_cols=184 Identities=23% Similarity=0.346 Sum_probs=150.6
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe----C
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----R 208 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~ 208 (343)
++|++.+.||+|++|.||+|.. +++.||+|++........ ..+.+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPT----LAKRTLRELKILRHFKHDNIIAIRDILRPPGADF 80 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccccc----chHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence 5778889999999999999987 688999999875432221 12567789999999999999999988753 3
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
..+++||||+. ++|.+++... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+++..
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 81 KDVYVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred ceEEEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 46899999996 5899888653 34899999999999999999999999999999999999999999999999998754
Q ss_pred ccCCC-----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 289 VQTEG-----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 289 ~~~~~-----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
..... .....|+..|+|||.+. ....++.++|+|+++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~----~~~~~~~~~Di~slG 199 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLL----SLPEYTTAIDMWSVG 199 (334)
T ss_pred cccCcCCCcccccccccccccChHHhc----CCcccccccchHHHH
Confidence 33211 12347889999999982 235689999999643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-28 Score=223.27 Aligned_cols=195 Identities=26% Similarity=0.392 Sum_probs=158.7
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
+.|...+.||+|+||.||+++. ++..+|+|.+........ .....+.+|+.+++.++|||++++++++......+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN---EKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW 101 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCch---HHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence 4466778999999999999987 678999999875433322 22357889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+||||+.+ +|.+++... ...+++..+..++.|++.||.|||+.+++||||+|+||+++.++.+||+|||++.....
T Consensus 102 lv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 102 LVMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred EEEeCCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 99999975 888877643 34588999999999999999999999999999999999999999999999999875332
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecccc-----cccCCCCc
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLK-----TTWPPPWR 339 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~-----~~~~p~~~ 339 (343)
.....|++.|+|||.+... ..+.++.++|+|+++.+ ++.+||+.
T Consensus 178 -~~~~~~~~~y~aPE~~~~~--~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 226 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKPPLFN 226 (317)
T ss_pred -cccccCCccccChhhhhcC--CCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 2345789999999997321 24568899999964432 46666643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-31 Score=229.86 Aligned_cols=180 Identities=23% Similarity=0.358 Sum_probs=152.7
Q ss_pred cccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-----
Q 019304 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM----- 209 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----- 209 (343)
++-.+.||-|+||.||.+++ +|+.||+|.+..-.. .....+++.+|+.+|..++|.|++..++..+...
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq----~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQ----NLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHH----HHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence 34457899999999999988 899999998854332 2333478899999999999999999998887653
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
.+|+++|.|.. +|..++-. ...++.+.+.-++.||++||+|||+.+|.||||||.|+||+.+..+||||||+||...
T Consensus 131 EiYV~TELmQS-DLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 131 ELYVLTELMQS-DLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHHHHh-hhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccc
Confidence 46889999965 88888865 4568889999999999999999999999999999999999999999999999999865
Q ss_pred cCC--CccCCCCCcceecCCCCCCCCCCCCCCceeeeeee
Q 019304 290 QTE--GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKE 327 (343)
Q Consensus 290 ~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~ 327 (343)
... .++..+-|.+|.|||.++ ....|+.+.|||+
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLM----GaRhYs~AvDiWS 243 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLM----GARRYTGAVDIWS 243 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhh----cchhhcCccceeh
Confidence 443 456678899999999996 5678999999995
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-30 Score=224.69 Aligned_cols=186 Identities=22% Similarity=0.360 Sum_probs=152.9
Q ss_pred cccccccccccccccceEEEEEEE----C--CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY----N--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~----~--~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
++..|+....||+|.+|.||+|.. + .+.+|||.++......-- .....+|+.+++.++||||+.+..++.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi----S~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI----SMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc----CHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 346788889999999999999965 2 237899998755221110 134679999999999999999999987
Q ss_pred e-CCeEEEEEEecCCCCHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC----CcEE
Q 019304 207 K-RMVWCIVTEYAKGGSVRQFLTRR---QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD----KSIK 278 (343)
Q Consensus 207 ~-~~~~~iv~E~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~----~~vk 278 (343)
. +..+++++||.+. +|.++++-. ....++...+..++-||+.|+.|||+.-|+||||||+||||..+ |.||
T Consensus 98 ~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence 7 7789999999987 899888732 23468999999999999999999999999999999999999877 8999
Q ss_pred EeccccccccccCC----CccCCCCCcceecCCCCCCCCCCCCCCceeeeeee
Q 019304 279 IADFGVARIEVQTE----GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKE 327 (343)
Q Consensus 279 l~DFg~a~~~~~~~----~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~ 327 (343)
|+|||++|+....- .....+-|..|.|||.++ .-.-|+.+.|+|+
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLL----Ga~hYT~AiDvWA 225 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLL----GARHYTKAIDVWA 225 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhc----ccccccchhhhHH
Confidence 99999999765431 223446789999999996 5677999999996
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-27 Score=242.78 Aligned_cols=185 Identities=30% Similarity=0.404 Sum_probs=154.9
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++.++||+|+||.||+|.+ +++.||||++........ ...+.+.+|+.+++.++||||+++++++.....+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~---~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 79 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINK---NMVHQVQAERDALALSKSPFIVHLYYSLQSANNV 79 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCH---HHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEE
Confidence 36788899999999999999998 488999999976443222 2235788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
|+||||+++++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus 80 ~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~ 157 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR 157 (669)
T ss_pred EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCC
Confidence 9999999999999999754 34888999999999999999999999999999999999999999999999999865433
Q ss_pred C-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeee
Q 019304 292 E-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKE 327 (343)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~ 327 (343)
. ......+|+.|+|||... ....-...+++|.
T Consensus 158 ~~~~~~~~~t~~~~~pe~~~----~~~~~~~~s~~~s 190 (669)
T cd05610 158 ELNMMDILTTPSMAKPKNDY----SRTPGQVLSLISS 190 (669)
T ss_pred cccccccccCccccCccccc----cCCCCceeeeeee
Confidence 2 234457899999999873 3333445566663
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=230.21 Aligned_cols=184 Identities=24% Similarity=0.315 Sum_probs=151.1
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC----
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~---- 208 (343)
++|++.+.||+|+||.||++.. +++.||||.+......... ...+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID----AKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccch----hHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 4688889999999999999987 6789999998754322211 24567899999999999999999987654
Q ss_pred -CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 209 -MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 209 -~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
...++|+||+. ++|.+++... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 81 FNDVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred cCcEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 24799999995 6898888653 4589999999999999999999999999999999999999999999999999986
Q ss_pred cccC-CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 288 EVQT-EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 288 ~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.... .......++..|+|||.+. ....++.++|+|+++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG 196 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELLL----NCSEYTTAIDVWSVG 196 (337)
T ss_pred cCCCcccccccccccCccChHHHh----cCCCCCCcccHHHHH
Confidence 5432 2233456889999999872 234588999999643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-29 Score=233.39 Aligned_cols=193 Identities=21% Similarity=0.274 Sum_probs=158.8
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHH---HHHHHHHHHHHhcCC---CCCcceEEEEE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVM---EQQFQQEVMMLATLK---HLNIVRFIGAC 205 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~---~~~~~~E~~~l~~l~---h~nIv~l~~~~ 205 (343)
+.+|...+.+|+|+||.|+.|.+ +...|+||.+.+...-.. .++. .-.+--|+.+|..++ |+||++++++|
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~D-tWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVD-TWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhh-hhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 45688999999999999999998 556899998865332111 1111 112456999999997 99999999999
Q ss_pred EeCCeEEEEEEec-CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccc
Q 019304 206 RKRMVWCIVTEYA-KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (343)
Q Consensus 206 ~~~~~~~iv~E~~-~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~ 284 (343)
++++.+||+||-- ++.+|.+++.... .+.+.++..|+.||+.|+++||++||||||||-+|+.++.+|-+||+|||.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 9999999999985 6788999997643 489999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccCCCCCcceecCCCCCCCCCCCCCCc-eeeeeeecccccccCC
Q 019304 285 ARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFE-HKWSAKESCLKTTWPP 336 (343)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~-~~sDi~~~~~~~~~~p 336 (343)
|..... .....++||..|.|||++ .+.+|- ..-||| ..++..|+-
T Consensus 717 aa~~ks-gpfd~f~gtv~~aapevl-----~g~~y~gk~qdiw-algillyti 762 (772)
T KOG1152|consen 717 AAYTKS-GPFDVFVGTVDYAAPEVL-----GGEKYLGKPQDIW-ALGILLYTI 762 (772)
T ss_pred hhhhcC-CCcceeeeeccccchhhh-----CCCccCCCcchhh-hhhheeeEE
Confidence 986544 456778999999999999 677776 556999 555555543
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=229.86 Aligned_cols=191 Identities=24% Similarity=0.339 Sum_probs=154.5
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-- 209 (343)
.++|++.+.||+|+||.||++.. +++.||||++....... ...+.+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSE----LFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccch----HHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 46688999999999999999987 67899999986543221 12356789999999999999999999987553
Q ss_pred ----eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 210 ----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 210 ----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
.+++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 458999999 7799888753 35899999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 286 RIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
+.... ......+++.|+|||.+. ....++.++|+|+++. +++.+||.
T Consensus 166 ~~~~~--~~~~~~~~~~y~aPE~~~----~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 217 (343)
T cd07880 166 RQTDS--EMTGYVVTRWYRAPEVIL----NWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217 (343)
T ss_pred ccccc--CccccccCCcccCHHHHh----CCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 75432 223446789999999982 2245889999996432 23555553
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=222.85 Aligned_cols=185 Identities=19% Similarity=0.291 Sum_probs=152.1
Q ss_pred ccccccccccccceEEEEEEE-----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM 209 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 209 (343)
+|++.+.||+|++|.||++.. +++.||||++...... ......+.+.+|+.+++.+ .||+|+++++.+....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~--~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV--QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH--hhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC
Confidence 367788999999999999875 4578999998753221 1122335688999999999 5999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+++...
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 999999999999999998753 358889999999999999999999999999999999999999999999999987643
Q ss_pred cCCC--ccCCCCCcceecCCCCCCCCCCCCC--Cceeeeeeecc
Q 019304 290 QTEG--MTPETGTYRWMAPGNSFFSPLPHPS--FEHKWSAKESC 329 (343)
Q Consensus 290 ~~~~--~~~~~gt~~y~APE~~~~~~~~~~~--~~~~sDi~~~~ 329 (343)
.... .....|++.|+|||.+ .... .+.++|+|++.
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~~~Dv~slG 195 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVI-----RGGSGGHDKAVDWWSLG 195 (288)
T ss_pred cccccccccccCCccccCHHHh-----cCCCCCCcchhhhHHHH
Confidence 3221 1234689999999998 4443 78899999543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=228.95 Aligned_cols=181 Identities=24% Similarity=0.336 Sum_probs=149.5
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC----
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~---- 208 (343)
++|++.+.||+|+||.||++.. +++.||+|++........ ..+.+.+|+.+++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII----HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhH----HHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 6788999999999999999986 678999999875432221 235678899999999999999999988643
Q ss_pred --CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 209 --MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 209 --~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence 3468888887 7799888754 248899999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 287 IEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.... ......+++.|+|||.+. ....++.++|+|+++
T Consensus 169 ~~~~--~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwslG 205 (345)
T cd07877 169 HTDD--EMTGYVATRWYRAPEIML----NWMHYNQTVDIWSVG 205 (345)
T ss_pred cccc--cccccccCCCccCHHHHh----CccCCCchhhHHHHH
Confidence 5432 233457889999999872 235688999999644
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=220.24 Aligned_cols=193 Identities=26% Similarity=0.392 Sum_probs=156.1
Q ss_pred cccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 019304 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv 214 (343)
|...+.||+|+||.||+|+. +++.||+|++......... ..+.+.+|+.+++.++|||++++++++.+....++|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 99 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE---KWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV 99 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 45567899999999999987 6789999998754433221 235688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCc
Q 019304 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (343)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~ 294 (343)
|||+. ++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.... ..
T Consensus 100 ~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~ 174 (313)
T cd06633 100 MEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PA 174 (313)
T ss_pred EecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CC
Confidence 99996 5888887653 3458899999999999999999999999999999999999999999999999986422 23
Q ss_pred cCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 295 TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 295 ~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
....|+..|+|||.+... ....++.++|+|+++. +++.+|++.
T Consensus 175 ~~~~~~~~y~aPE~~~~~--~~~~~~~~sDv~slGvil~el~~g~~p~~~ 222 (313)
T cd06633 175 NSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKPPLFN 222 (313)
T ss_pred CCccccccccChhhcccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 345789999999998321 2456889999996433 235566543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=221.77 Aligned_cols=182 Identities=26% Similarity=0.387 Sum_probs=153.7
Q ss_pred cccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 019304 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv 214 (343)
|+..+.||+|++|.||++.. +++.+++|.+........ ....+.+|+.+++.++|+||+++++.+.....+++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 76 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEG----IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLV 76 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccch----hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEE
Confidence 45667899999999999987 678899999876544321 235788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-C
Q 019304 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-G 293 (343)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~-~ 293 (343)
+||+++ +|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||.+....... .
T Consensus 77 ~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 77 FEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred EeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 999975 8988887643 468999999999999999999999999999999999999999999999999987654432 2
Q ss_pred ccCCCCCcceecCCCCCCCCCCCC-CCceeeeeeecc
Q 019304 294 MTPETGTYRWMAPGNSFFSPLPHP-SFEHKWSAKESC 329 (343)
Q Consensus 294 ~~~~~gt~~y~APE~~~~~~~~~~-~~~~~sDi~~~~ 329 (343)
.....++..|+|||.+ ... .++.++|+|+++
T Consensus 155 ~~~~~~~~~~~~PE~~-----~~~~~~~~~~Di~slG 186 (283)
T cd05118 155 YTHYVVTRWYRAPELL-----LGDKGYSTPVDIWSVG 186 (283)
T ss_pred ccCccCcccccCcHHH-----hcCCCCCchhHHHHHH
Confidence 3344688999999998 444 789999999643
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=225.72 Aligned_cols=183 Identities=23% Similarity=0.301 Sum_probs=146.6
Q ss_pred ccccccccccccceEEEEEEE--C--CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC--
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--N--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR-- 208 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-- 208 (343)
+|++.+.||+|+||.||++.. . ++.||+|.+....... ...+.+.+|+.+++.+ .||||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 76 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK----ILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG 76 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccc----hhHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence 366788999999999999998 3 6689999986433222 1235678899999999 599999999875432
Q ss_pred --CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 209 --MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 209 --~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
..+++++|++. ++|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++
T Consensus 77 ~~~~~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 77 NFNELYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred cCCcEEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 45789999996 5899988643 458999999999999999999999999999999999999999999999999997
Q ss_pred ccccCC-----CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 287 IEVQTE-----GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 287 ~~~~~~-----~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
...... ......||+.|+|||.+. ....++.++|+|+++
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~~Di~slG 197 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIML----SFQSYTKAIDVWSVG 197 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHh----CCCCCCcHHHHHHHH
Confidence 543211 122346899999999872 335688999999643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=223.74 Aligned_cols=198 Identities=22% Similarity=0.329 Sum_probs=162.4
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCC-CChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE-e
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPE-NNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR-K 207 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~ 207 (343)
.--++|-++.+||+|+|..||++.+ ..+-||||+-.... +..++...+.+...+|.++-+.|.||.||++|+++. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3446788899999999999999976 66789999875433 344566667788899999999999999999999995 4
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeCCCCCCcEEEc---CCCcEEEecc
Q 019304 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL--GFIHRDLKSDNLLIS---ADKSIKIADF 282 (343)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~--giiHrDlkp~NILv~---~~~~vkl~DF 282 (343)
.+.+|-|+|||+|.+|.-||+.. ..++++++..|+.||+.||.||.+. .|||-||||.|||+. ..|.+||+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 56789999999999999999754 4589999999999999999999987 599999999999985 4578999999
Q ss_pred ccccccccCCC--------ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecccccc
Q 019304 283 GVARIEVQTEG--------MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTT 333 (343)
Q Consensus 283 g~a~~~~~~~~--------~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~~ 333 (343)
|+++++..... .+...||..|++||.+.- +...++.+.|+|||+ .++++
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvV-gkePPKIsnKVDVWS-vGVIF 674 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVV-GKEPPKISNKVDVWS-VGVIF 674 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeec-CCCCCccccceeeEe-eehhh
Confidence 99998754321 234579999999999831 224678999999994 44443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-29 Score=221.34 Aligned_cols=191 Identities=19% Similarity=0.296 Sum_probs=162.9
Q ss_pred ccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGA 204 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 204 (343)
..|.+.+.+|.+++.||+|++++|..+++ +.+.+|+|++++.-.+.... ..=.+.|..+..+- +||.+|.++.+
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndded---idwvqtek~vfe~asn~pflvglhsc 319 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDED---IDWVQTEKHVFEQASNNPFLVGLHSC 319 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCccc---chhHHhhHHHHHhccCCCeEEehhhh
Confidence 46778889999999999999999999987 66789999997654433211 12244666666655 79999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccc
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~ 284 (343)
|+.+..+++|.||+.||+|.-+.++. ..+|++.+..+...|+.||.|||++|||+||||.+|+|++..|++||+|+|+
T Consensus 320 fqtesrlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygm 397 (593)
T KOG0695|consen 320 FQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGM 397 (593)
T ss_pred hcccceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccch
Confidence 99999999999999999998777653 4599999999999999999999999999999999999999999999999999
Q ss_pred cccc-ccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeec
Q 019304 285 ARIE-VQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES 328 (343)
Q Consensus 285 a~~~-~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~ 328 (343)
++.. .+....+++||||.|+|||.+ .+..|...+|+|++
T Consensus 398 cke~l~~gd~tstfcgtpnyiapeil-----rgeeygfsvdwwal 437 (593)
T KOG0695|consen 398 CKEGLGPGDTTSTFCGTPNYIAPEIL-----RGEEYGFSVDWWAL 437 (593)
T ss_pred hhcCCCCCcccccccCCCcccchhhh-----cccccCceehHHHH
Confidence 9863 344556778999999999999 99999999999953
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=224.12 Aligned_cols=190 Identities=27% Similarity=0.387 Sum_probs=153.9
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CCe
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-RMV 210 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~ 210 (343)
.++|++.+.||.|+||.||++.. +++.||||++.+...... ..+.+.+|+.+++.++||||+++++++.. ...
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPV----LAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccc----hhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 35688999999999999999986 678999998865433221 12567799999999999999999999865 457
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~ 290 (343)
.++++||+ +++|.+++.. ..++...+..++.|++.||.|||+.+++||||+|+||+++.++.+||+|||.++....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred EEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 88999999 5689888753 3478888899999999999999999999999999999999999999999999875322
Q ss_pred CCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCC
Q 019304 291 TEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPP 337 (343)
Q Consensus 291 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~ 337 (343)
......+++.|+|||.+. ....++.++|+|+++. +++.+||
T Consensus 161 --~~~~~~~~~~y~aPE~~~----~~~~~~~~~Dv~slG~il~el~tg~~~f 206 (328)
T cd07856 161 --QMTGYVSTRYYRAPEIML----TWQKYDVEVDIWSAGCIFAEMLEGKPLF 206 (328)
T ss_pred --CcCCCcccccccCceeee----ccCCcCcHHHHHHHHHHHHHHHhCCCCC
Confidence 223446789999999872 2357899999996443 3355555
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=214.11 Aligned_cols=177 Identities=26% Similarity=0.350 Sum_probs=152.0
Q ss_pred cccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEecCC
Q 019304 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (343)
Q Consensus 143 lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~~~ 220 (343)
||+|+||.||++.. +++.+|+|++........ .....+.+|+.+++.++||||+++++.+.....+++||||+++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR---KEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcch---HHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCC
Confidence 68999999999988 578999999876543221 1235788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-CCccCCCC
Q 019304 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EGMTPETG 299 (343)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~-~~~~~~~g 299 (343)
++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+...... .......+
T Consensus 78 ~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (250)
T cd05123 78 GELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG 155 (250)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence 99999997643 5889999999999999999999999999999999999999999999999998765432 22344578
Q ss_pred CcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 300 TYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 300 t~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+..|+|||.+ .....+.++|+|+++
T Consensus 156 ~~~~~~Pe~~-----~~~~~~~~~D~~slG 180 (250)
T cd05123 156 TPEYLAPEVL-----LGKGYGKAVDWWSLG 180 (250)
T ss_pred CccccChHHh-----CCCCCCchhhHHHHH
Confidence 8999999999 677789999999644
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=227.24 Aligned_cols=184 Identities=24% Similarity=0.398 Sum_probs=149.4
Q ss_pred ceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 207 (343)
|++. .+|...+.||+|+||.||+|.+ +++.||||++.+...... ....+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 85 (342)
T cd07879 11 WELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI----FAKRAYRELTLLKHMQHENVIGLLDVFTS 85 (342)
T ss_pred hccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccccc----chhHHHHHHHHHHhcCCCCccchhheecc
Confidence 5553 4688889999999999999987 678999999876432221 22467899999999999999999999865
Q ss_pred CC------eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEec
Q 019304 208 RM------VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (343)
Q Consensus 208 ~~------~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~D 281 (343)
.. .+++|+||+.. +|..+.. ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~d 160 (342)
T cd07879 86 AVSGDEFQDFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILD 160 (342)
T ss_pred cccCCCCceEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEee
Confidence 43 46899999964 7766642 3488999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 282 FGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 282 Fg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
||+++.... ......+++.|+|||.+. ....++.++|+|+++
T Consensus 161 fg~~~~~~~--~~~~~~~~~~y~aPE~~~----~~~~~~~~~Dv~slG 202 (342)
T cd07879 161 FGLARHADA--EMTGYVVTRWYRAPEVIL----NWMHYNQTVDIWSVG 202 (342)
T ss_pred CCCCcCCCC--CCCCceeeecccChhhhc----CccccCchHHHHHHH
Confidence 999875432 233456789999999982 235688999999643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=219.25 Aligned_cols=182 Identities=26% Similarity=0.396 Sum_probs=152.3
Q ss_pred cccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 019304 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv 214 (343)
|+..+.||+|.+|.||+|+. +++.+|+|++........ ..+.+.+|+.+++.++|+||+++++++.....+++|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 76 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG----IPSTALREISLLKELKHPNIVKLLDVIHTERKLYLV 76 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccccccc----ccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEE
Confidence 44567899999999999988 578999999976542211 124677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-C
Q 019304 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-G 293 (343)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~-~ 293 (343)
+||++ ++|.+++.+.. ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.+||+|||+++...... .
T Consensus 77 ~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 77 FEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred ecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 99997 59999997643 358999999999999999999999999999999999999999999999999987654322 2
Q ss_pred ccCCCCCcceecCCCCCCCCCCCC-CCceeeeeeecc
Q 019304 294 MTPETGTYRWMAPGNSFFSPLPHP-SFEHKWSAKESC 329 (343)
Q Consensus 294 ~~~~~gt~~y~APE~~~~~~~~~~-~~~~~sDi~~~~ 329 (343)
.....++..|+|||.+ ... .++.++|+|+++
T Consensus 155 ~~~~~~~~~~~aPE~~-----~~~~~~~~~~Dv~slG 186 (282)
T cd07829 155 YTHEVVTLWYRAPEIL-----LGSKHYSTAVDIWSVG 186 (282)
T ss_pred cCccccCcCcCChHHh-----cCCcCCCccccHHHHH
Confidence 3344567899999998 444 789999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=222.17 Aligned_cols=186 Identities=24% Similarity=0.316 Sum_probs=149.0
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC---
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--- 208 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--- 208 (343)
.++|++.+.||+|++|.||+|.+ +++.+|||++......... ...+.+|+.+++.++||||+++++.+.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF----PITALREIKILKKLKHPNVVPLIDMAVERPDK 82 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc----chhHHHHHHHHHhcCCCCccchhhheeccccc
Confidence 47888999999999999999987 6788999998654332211 13467899999999999999999987543
Q ss_pred -----CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 209 -----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 209 -----~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
..+++|+||+++ +|...+... ...+++..+..++.|+++||+|||++|++|+||||+||++++++.+||+|||
T Consensus 83 ~~~~~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 83 SKRKRGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred ccccCceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCc
Confidence 346999999965 787777643 3468999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC------------ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 284 VARIEVQTEG------------MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 284 ~a~~~~~~~~------------~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+++....... .+...+++.|+|||.+. ....++.++|+|+++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~Dv~slG 214 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLL----GERRYTTAVDIWGIG 214 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhh----CCCccCchhHhHHHH
Confidence 9875432211 12235688899999872 335688999999644
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=219.82 Aligned_cols=194 Identities=26% Similarity=0.396 Sum_probs=156.4
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
+.|+..+.||+|+||.||+|+. +++.+|+|.+........ ...+++.+|+.+++.++|+|++++++++......+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccCh---HHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 4577778999999999999987 677899999864322221 12356889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+|+||+. ++|.+++... ...+++..+..++.|++.||.|||+.+++||||+|+||+++.++.+||+|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-- 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (308)
T ss_pred EEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence 9999996 5888877643 34588999999999999999999999999999999999999999999999999875432
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.....+++.|+|||.+... ....++.++|+|+++. +++.+|++
T Consensus 168 -~~~~~~~~~y~aPE~~~~~--~~~~~~~~~Di~slG~il~el~~g~~p~~ 215 (308)
T cd06634 168 -ANXFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKPPLF 215 (308)
T ss_pred -cccccCCccccCHHHHhhc--ccCCCCcccchHHHHHHHHHHHcCCCCCc
Confidence 2345688999999987211 2356788999996433 33555554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=217.14 Aligned_cols=187 Identities=25% Similarity=0.395 Sum_probs=150.0
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
+|.+.+.||+|+||.||++.+ .+..+++|+++......... ....++.+|+.+++.++||||+++++.+.+....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNP-NETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCc-chHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEE
Confidence 477889999999999999987 34456777765432211110 112356789999999999999999999998888999
Q ss_pred EEEecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 214 VTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
|+||+++++|.+++... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.+||+|||+++.....
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 99999999999988642 2346899999999999999999999999999999999999974 67999999998764332
Q ss_pred C-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 292 E-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
. ......|++.|+|||.+ ....++.++|+|+++
T Consensus 159 ~~~~~~~~~~~~~~~pe~~-----~~~~~~~~~Dv~slG 192 (260)
T cd08222 159 CDLATTFTGTPYYMSPEAL-----KHQGYDSKSDIWSLG 192 (260)
T ss_pred cccccCCCCCcCccCHHHH-----ccCCCCchhhHHHHH
Confidence 2 22345688999999998 677788999999543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=250.67 Aligned_cols=171 Identities=19% Similarity=0.336 Sum_probs=143.1
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
.+...+.||+|+||.||+|.. ++..||||.+...... ...|+..+++++|||||+++++|.+....++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence 455667899999999999986 6789999998643321 1246888999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCCCcEEEcCCCcEEEecccccccccc
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH---GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~ 290 (343)
||||+++|+|.++++. +++..+.+++.|++.||+||| +.+++||||||+||+++.++.+++. |+.......
T Consensus 761 v~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 761 IHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 9999999999999953 788999999999999999999 6699999999999999998888876 665543221
Q ss_pred CCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 291 TEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 291 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.....+|+.|+|||++ ....++.++|||+++.
T Consensus 835 ---~~~~~~t~~y~aPE~~-----~~~~~~~~sDv~S~Gv 866 (968)
T PLN00113 835 ---DTKCFISSAYVAPETR-----ETKDITEKSDIYGFGL 866 (968)
T ss_pred ---CCCccccccccCcccc-----cCCCCCcccchhhHHH
Confidence 1233688999999999 7888999999996433
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=224.46 Aligned_cols=181 Identities=22% Similarity=0.292 Sum_probs=146.8
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC----
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~---- 208 (343)
.+|++.+.||.|+||.||+|.. +++.||+|.+....... .+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~------~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS------VKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCch------HHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 6788899999999999999987 67899999986654321 24678899999999999999999776543
Q ss_pred ----------CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc-CCCcE
Q 019304 209 ----------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKSI 277 (343)
Q Consensus 209 ----------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~-~~~~v 277 (343)
...++|+||++ ++|.+++.. ..+++..++.++.|++.||.|||+.|++||||||+||+++ .++.+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceE
Confidence 35789999997 589888753 3488999999999999999999999999999999999997 45678
Q ss_pred EEeccccccccccCC----CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 278 KIADFGVARIEVQTE----GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 278 kl~DFg~a~~~~~~~----~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
||+|||.++...... ......++..|+|||.+. ....++.++|+|+++
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwSlG 206 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLL----SPNNYTKAIDMWAAG 206 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHh----CccccCchhhHHHHH
Confidence 999999987543211 112336789999999862 345688999999643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=210.46 Aligned_cols=164 Identities=15% Similarity=0.164 Sum_probs=138.8
Q ss_pred ccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEecCCCCH
Q 019304 146 GAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSV 223 (343)
Q Consensus 146 G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~~~gsL 223 (343)
|.+|.||++.+ +++.+|+|.+.... .+.+|...+....||||+++++.+.....+++||||+++++|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCH
Confidence 88999999988 77899999986532 123455555566799999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCccCCCCCcce
Q 019304 224 RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303 (343)
Q Consensus 224 ~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y 303 (343)
.+++.+.. .+++..+..++.|++.||+|||+.|++||||||+||+++.++.++++|||.+...... .....++..|
T Consensus 73 ~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y 148 (237)
T cd05576 73 WSHISKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMY 148 (237)
T ss_pred HHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccc
Confidence 99997643 4889999999999999999999999999999999999999999999999987654332 2334567889
Q ss_pred ecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 304 MAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 304 ~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+|||.+ ....++.++|+|+++
T Consensus 149 ~aPE~~-----~~~~~~~~~DvwslG 169 (237)
T cd05576 149 CAPEVG-----GISEETEACDWWSLG 169 (237)
T ss_pred cCCccc-----CCCCCCchhhHHHHH
Confidence 999998 777889999999643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=224.09 Aligned_cols=193 Identities=23% Similarity=0.346 Sum_probs=155.9
Q ss_pred ceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 207 (343)
|++ .++|++.+.||+|++|.||+|.. +++.||||++........ ..+.+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~-~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07851 11 WEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI----HAKRTYRELRLLKHMDHENVIGLLDVFTP 85 (343)
T ss_pred ecc-cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhh----HHHHHHHHHHHHHhccCCCHHHHHHHhhc
Confidence 444 35688999999999999999988 578899999865432222 22567789999999999999999988766
Q ss_pred CCe------EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEec
Q 019304 208 RMV------WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (343)
Q Consensus 208 ~~~------~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~D 281 (343)
... .++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|
T Consensus 86 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 86 ASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred cccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcc
Confidence 554 89999999 6699998864 3589999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCC
Q 019304 282 FGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPP 337 (343)
Q Consensus 282 Fg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~ 337 (343)
||++..... ......+++.|+|||.+. ....++.++|+|+++. +++.+||
T Consensus 162 fg~~~~~~~--~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwslGv~l~elltg~~pf 216 (343)
T cd07851 162 FGLARHTDD--EMTGYVATRWYRAPEIML----NWMHYNQTVDIWSVGCIMAELLTGKTLF 216 (343)
T ss_pred ccccccccc--cccCCcccccccCHHHHh----CCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 999876433 234457889999999872 2246789999996432 3355555
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=216.90 Aligned_cols=180 Identities=15% Similarity=0.127 Sum_probs=131.7
Q ss_pred ccccccccccccccceEEEEEEE---CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcce-EEEEEEeCC
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-FIGACRKRM 209 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~~~~~ 209 (343)
...|.+.+.||+|+||+||+|.+ +++.||||++........ .....+.|.+|+++|+.++|+|++. +++. .
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~-~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWS-KPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccc-cHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 46788999999999999999987 466789998753211000 1122356999999999999999985 5442 3
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC-CCCcEEEcCCCcEEEecccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDL-KSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDl-kp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
..|+||||++|++|... . . .. ...++.+++.+|.|||++||+|||| ||+|||++.++.+||+|||+|+..
T Consensus 92 ~~~LVmE~~~G~~L~~~-~--~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-R--P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred CcEEEEEccCCCCHHHh-C--c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 46999999999999632 1 1 11 1467889999999999999999999 999999999999999999999865
Q ss_pred ccCCC---------ccCCCCCcceecCCCCCCC-CCCCCCCceeeeeee
Q 019304 289 VQTEG---------MTPETGTYRWMAPGNSFFS-PLPHPSFEHKWSAKE 327 (343)
Q Consensus 289 ~~~~~---------~~~~~gt~~y~APE~~~~~-~~~~~~~~~~sDi~~ 327 (343)
..... .+...+++.|+|||.+... .......+...|.|.
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW~ 211 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIWL 211 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcEE
Confidence 43221 1334688999999998321 111222334467774
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-27 Score=213.04 Aligned_cols=180 Identities=22% Similarity=0.325 Sum_probs=153.9
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCC--C----CcceEEEEE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--L----NIVRFIGAC 205 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~----nIv~l~~~~ 205 (343)
..+|.+...+|+|.||+|-++.+ .+..||||+++. ...+.++..-|+++++++.+ | .+|++.++|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-------V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-------VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-------HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 57899999999999999999977 557899999964 22334567789999999942 3 367888889
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC------------
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA------------ 273 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~------------ 273 (343)
.-.+++|||+|.+ |-|+.+++..+...+++...+..|+.|++.++++||+.+++|-||||+|||+.+
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999999 669999999888888999999999999999999999999999999999999842
Q ss_pred --------CCcEEEeccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeec
Q 019304 274 --------DKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES 328 (343)
Q Consensus 274 --------~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~ 328 (343)
+..|||+|||.|+...+.+ +..+.|..|.|||++ .+-.++..+|||+.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEVi-----LgLGwS~pCDvWSi 295 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVI-----LGLGWSQPCDVWSI 295 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchhe-----eccCcCCccCceee
Confidence 1248999999998755433 566889999999999 88999999999953
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-29 Score=215.94 Aligned_cols=184 Identities=26% Similarity=0.421 Sum_probs=151.4
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeC---CCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILER---PENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~---~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
.+...|.-..+||+|.||.||+|+. .++.||+|++-. ...-+ ...++|+.+|..++|+|++.+++.|.
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfp-------italreikiL~~lkHenv~nliEic~ 86 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFP-------ITALREIKILQLLKHENVVNLIEICR 86 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCc-------HHHHHHHHHHHHhcchhHHHHHHHHh
Confidence 3456677778999999999999976 677889886532 22222 23579999999999999999998884
Q ss_pred e--------CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEE
Q 019304 207 K--------RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278 (343)
Q Consensus 207 ~--------~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vk 278 (343)
. ...+|+|+.+|+. +|.-+|... ...++..++.+++.++..||.|+|...|+|||+||+|+||+.+|++|
T Consensus 87 tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilk 164 (376)
T KOG0669|consen 87 TKATPTNRDRATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILK 164 (376)
T ss_pred hccCCcccccceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEE
Confidence 3 2358999999987 888888653 24589999999999999999999999999999999999999999999
Q ss_pred EeccccccccccCC-----CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeec
Q 019304 279 IADFGVARIEVQTE-----GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES 328 (343)
Q Consensus 279 l~DFg~a~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~ 328 (343)
|+|||++|...... .++..+-|..|.+||.++ ....|..+.|+|..
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllL----G~r~yg~~iDiWgA 215 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLL----GDREYGPPIDIWGA 215 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhh----cccccCCcchhHhH
Confidence 99999998654332 245556799999999996 67889999999963
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=223.06 Aligned_cols=180 Identities=19% Similarity=0.305 Sum_probs=133.0
Q ss_pred eecccccccccccccccceEEEEEEE------------------CCceEEEEEeeCCCCChhHH--------HHHHHHHH
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTY------------------NGEDVAIKILERPENNPEKA--------QVMEQQFQ 184 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~------------------~~~~vavK~~~~~~~~~~~~--------~~~~~~~~ 184 (343)
.+..++|.+.++||+|+||.||+|.. .++.||||.+.......... ....+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 34678999999999999999999963 34579999986433211100 00112344
Q ss_pred HHHHHHhcCCCCCc-----ceEEEEEEe--------CCeEEEEEEecCCCCHHHHHHhhCC-------------------
Q 019304 185 QEVMMLATLKHLNI-----VRFIGACRK--------RMVWCIVTEYAKGGSVRQFLTRRQN------------------- 232 (343)
Q Consensus 185 ~E~~~l~~l~h~nI-----v~l~~~~~~--------~~~~~iv~E~~~~gsL~~~l~~~~~------------------- 232 (343)
.|+.++.+++|.++ ++++++|.. ....++||||+++++|.+++.....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57777777766654 566776643 3457999999999999999864211
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCccCC--CCCcceecCC
Q 019304 233 ---RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE--TGTYRWMAPG 307 (343)
Q Consensus 233 ---~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~~~~--~gt~~y~APE 307 (343)
..+++..+..++.|++.+|.|||+.+|+||||||+|||++.++.+||+|||+++........... .+|+.|+|||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 12356678889999999999999999999999999999999999999999999754433222222 3479999999
Q ss_pred CCC
Q 019304 308 NSF 310 (343)
Q Consensus 308 ~~~ 310 (343)
.+.
T Consensus 381 ~l~ 383 (507)
T PLN03224 381 ELV 383 (507)
T ss_pred hhc
Confidence 983
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-27 Score=224.67 Aligned_cols=179 Identities=18% Similarity=0.267 Sum_probs=149.3
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCe
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMV 210 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 210 (343)
...|.+...+|.|+|+.|-.+.. +++..++|++.+...+. .+|+.++... +||||+++.+++.+...
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~----------~~e~~~~~~~~~h~niv~~~~v~~~~~~ 390 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDN----------QDEIPISLLVRDHPNIVKSHDVYEDGKE 390 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccccc----------ccccchhhhhcCCCcceeecceecCCce
Confidence 45677778899999999999987 77889999998763332 3566555444 79999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE-cCCCcEEEeccccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI-SADKSIKIADFGVARIEV 289 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv-~~~~~vkl~DFg~a~~~~ 289 (343)
.|+|||.+.|+-|.+.+.... .....+..|+++|+.++.|||++|++||||||+|||+ +..++++|+|||.++...
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred eeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 999999999998888876533 2226777899999999999999999999999999999 689999999999998655
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecccccc
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTT 333 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~~ 333 (343)
.. ....+-|..|.|||+. ....|+..+|+| +++++.
T Consensus 468 ~~--~~tp~~t~~y~APEvl-----~~~~yt~acD~W-SLGvlL 503 (612)
T KOG0603|consen 468 RS--CDTPALTLQYVAPEVL-----AIQEYTEACDWW-SLGVLL 503 (612)
T ss_pred hh--hcccchhhcccChhhh-----ccCCCCcchhhH-HHHHHH
Confidence 44 3345778999999999 899999999999 444443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=226.63 Aligned_cols=188 Identities=24% Similarity=0.333 Sum_probs=149.0
Q ss_pred ccccccccccccce-EEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFG-KLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg-~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~i 213 (343)
-+.-.+.+|.|+.| .||+|.+.+++||||.+.... .....+|+..|+.- .|||||++|+.-.+....||
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~---------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YI 580 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF---------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYI 580 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh---------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEE
Confidence 34445678999988 589999999999999885422 23467999999888 79999999999999999999
Q ss_pred EEEecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC---C--CcEEEecccccc
Q 019304 214 VTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---D--KSIKIADFGVAR 286 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~---~--~~vkl~DFg~a~ 286 (343)
+.|.|. .+|.+++... ..........+....|+++||++||+.+||||||||.||||+. + .+++|+|||+++
T Consensus 581 alELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 581 ALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred EehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 999995 4999999863 1111111345778899999999999999999999999999975 3 468999999999
Q ss_pred ccccCCC----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecccccccCCCC
Q 019304 287 IEVQTEG----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTWPPPW 338 (343)
Q Consensus 287 ~~~~~~~----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~~~~p~~ 338 (343)
....+.. .....||-+|+|||++ ....-+.++|||++.++.+|...=
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L-----~~~~~~~avDiFslGCvfyYvltg 710 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQL-----REDRKTQAVDIFSLGCVFYYVLTG 710 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHH-----hccccCcccchhhcCceEEEEecC
Confidence 7654332 2334699999999999 677777899999766666665443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=229.20 Aligned_cols=171 Identities=18% Similarity=0.234 Sum_probs=120.7
Q ss_pred cceecccccccccccccccceEEEEEEE--C----CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEE
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--N----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~ 202 (343)
.+....++|++.+.||+|+||.||+|++ + +..||||.+...... + .+..| .+....+.++..+.
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e-------~~~~e--~l~~~~~~~~~~~~ 195 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-E-------IWMNE--RVRRACPNSCADFV 195 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-H-------HHHHH--HHHhhchhhHHHHH
Confidence 4455778999999999999999999988 4 678999987542211 0 11111 11111122222111
Q ss_pred EE------EEeCCeEEEEEEecCCCCHHHHHHhhCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 019304 203 GA------CRKRMVWCIVTEYAKGGSVRQFLTRRQNR------------------AVPLKLAVKQALDVARGMAYVHGLG 258 (343)
Q Consensus 203 ~~------~~~~~~~~iv~E~~~~gsL~~~l~~~~~~------------------~~~~~~~~~i~~qi~~gL~yLH~~g 258 (343)
.. +.....+++|+||+.+++|.+++...... ......+..++.|++.||.|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g 275 (566)
T PLN03225 196 YGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG 275 (566)
T ss_pred HhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC
Confidence 11 24456789999999999999998753210 0112345678999999999999999
Q ss_pred ceeCCCCCCcEEEcC-CCcEEEeccccccccccC--CCccCCCCCcceecCCCC
Q 019304 259 FIHRDLKSDNLLISA-DKSIKIADFGVARIEVQT--EGMTPETGTYRWMAPGNS 309 (343)
Q Consensus 259 iiHrDlkp~NILv~~-~~~vkl~DFg~a~~~~~~--~~~~~~~gt~~y~APE~~ 309 (343)
|+||||||+|||++. ++.+||+|||+|+..... ......++|+.|+|||.+
T Consensus 276 IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~ 329 (566)
T PLN03225 276 IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQY 329 (566)
T ss_pred EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHh
Confidence 999999999999985 589999999999854322 223456789999999976
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-28 Score=229.84 Aligned_cols=185 Identities=26% Similarity=0.422 Sum_probs=160.8
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 210 (343)
+..+|.+...+|+|.+|.||++++ +++..|+|+++....+.. +-+.+|+-+++.++|||||.++|.+...+.
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~------~~iqqei~~~~dc~h~nivay~gsylr~dk 86 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDF------SGIQQEIGMLRDCRHPNIVAYFGSYLRRDK 86 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccc------cccccceeeeecCCCcChHHHHhhhhhhcC
Confidence 346788889999999999999987 788999999987665543 356799999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~ 290 (343)
.+|+||||.+|+|.+..+- ..++++..+..+++..+.||+|||+.|-+|||||-.|||+++.|.+|++|||.+..+..
T Consensus 87 lwicMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred cEEEEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh
Confidence 9999999999999998754 45689999999999999999999999999999999999999999999999998764433
Q ss_pred C-CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeee
Q 019304 291 T-EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKE 327 (343)
Q Consensus 291 ~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~ 327 (343)
. ....++.|||+|||||+..=. ..+.|...+|+|+
T Consensus 165 ti~KrksfiGtpywmapEvaave--rkggynqlcdiwa 200 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVE--RKGGYNQLCDIWA 200 (829)
T ss_pred hhhhhhcccCCccccchhHHHHH--hcccccccccccc
Confidence 2 345677999999999987211 5788999999995
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=196.09 Aligned_cols=182 Identities=29% Similarity=0.505 Sum_probs=154.1
Q ss_pred cccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 019304 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv 214 (343)
|.+.+.||+|++|.||++.. +++.+|+|.+...... ...+.+.+|+..++.++|+|++++++.+......+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEE
Confidence 34668899999999999988 3689999999765433 1236788999999999999999999999998899999
Q ss_pred EEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC--
Q 019304 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-- 292 (343)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~-- 292 (343)
+|++++++|.+++..... .+++..+..++.+++.++.+||+++++|+||+|.||+++.++.++|+|||.+.......
T Consensus 76 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred EeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999999999999976432 17889999999999999999999999999999999999999999999999988654432
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeec
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES 328 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~ 328 (343)
......++..|++||.+. ....++.++|+|++
T Consensus 155 ~~~~~~~~~~~~~pe~~~----~~~~~~~~~Dv~~l 186 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLL----GGKGYGEAVDIWSL 186 (225)
T ss_pred cccceeccCCcCCHhHhc----CCCCCCchhhHHHH
Confidence 234457889999999873 45667789999963
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-27 Score=199.11 Aligned_cols=180 Identities=16% Similarity=0.333 Sum_probs=156.3
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeC-
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKR- 208 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~- 208 (343)
..++|++.+++|+|-++.||.|.. +++.++||++++.. .+.+.+|+.+|+.|. ||||++++++..++
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~ 106 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---------KKKIKREIKILQNLRGGPNIIKLLDIVKDPE 106 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---------HHHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence 356899999999999999999985 78899999996522 357899999999997 99999999999765
Q ss_pred -CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-CCcEEEecccccc
Q 019304 209 -MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFGVAR 286 (343)
Q Consensus 209 -~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~-~~~vkl~DFg~a~ 286 (343)
..+.+|+||+.+.+...+... ++...+..++.++++||.|||+.||.|||+||.|++|+. ...++|+|.|+|.
T Consensus 107 SktpaLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 107 SKTPSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred ccCchhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHh
Confidence 457899999998777666543 777788999999999999999999999999999999995 4579999999999
Q ss_pred ccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 287 IEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+..+....+..+.+.+|--||.+. ..+.|+...|+|++.+
T Consensus 182 FYHp~~eYnVRVASRyfKGPELLV----dy~~YDYSLD~WS~Gc 221 (338)
T KOG0668|consen 182 FYHPGKEYNVRVASRYFKGPELLV----DYQMYDYSLDMWSLGC 221 (338)
T ss_pred hcCCCceeeeeeehhhcCCchhee----echhccccHHHHHHHH
Confidence 988887888888999999999996 7888999999996433
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=204.98 Aligned_cols=182 Identities=24% Similarity=0.294 Sum_probs=151.6
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-- 209 (343)
..+|.-++.+|.|.- .|--+.+ .+++||+|.+..+..+...+ ++..+|..++..++|+||++++.++....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~a----kra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHA----KRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccc----hhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 356677788898887 5555544 78899999988775443222 56789999999999999999999996543
Q ss_pred ----eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 210 ----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 210 ----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
..|+|||+|. .+|.+.+.. .++-+++..+..|++.|++|||+.||+||||||+||++..++.+||+|||+|
T Consensus 91 ~~~~e~y~v~e~m~-~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 91 EEFQEVYLVMELMD-ANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHhHHHHHHhhh-hHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhh
Confidence 4699999995 589888863 2677888999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 286 RIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+.....-.++..+.|..|.|||++ .+-.|..++|||+..+
T Consensus 166 r~e~~~~~mtpyVvtRyyrapevi-----l~~~~ke~vdiwSvGc 205 (369)
T KOG0665|consen 166 RTEDTDFMMTPYVVTRYYRAPEVI-----LGMGYKENVDIWSVGC 205 (369)
T ss_pred cccCcccccCchhheeeccCchhe-----eccCCcccchhhhhhh
Confidence 976665567788999999999999 4555999999996433
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=197.13 Aligned_cols=171 Identities=30% Similarity=0.460 Sum_probs=148.9
Q ss_pred cceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEecCCCCHH
Q 019304 147 AFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVR 224 (343)
Q Consensus 147 ~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~~~gsL~ 224 (343)
+||.||+|.+ +++.+|+|++........ .+.+.+|+..++.++|++|+++++.+......++++||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-----RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-----HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHH
Confidence 5899999998 468999999976544321 367899999999999999999999999989999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCccCCCCCccee
Q 019304 225 QFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWM 304 (343)
Q Consensus 225 ~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~ 304 (343)
+++..... ++...++.++.+++.++.|||+.+++|+||+|+||+++.++.++|+|||.+.............+++.|+
T Consensus 76 ~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 153 (244)
T smart00220 76 DLLKKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYM 153 (244)
T ss_pred HHHHhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCC
Confidence 99876432 8889999999999999999999999999999999999999999999999998765544455567899999
Q ss_pred cCCCCCCCCCCCCCCceeeeeeecc
Q 019304 305 APGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 305 APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
|||.+ ....++.++|+|+++
T Consensus 154 ~pE~~-----~~~~~~~~~Di~slG 173 (244)
T smart00220 154 APEVL-----LGKGYGKAVDVWSLG 173 (244)
T ss_pred CHHHH-----ccCCCCchhhHHHHH
Confidence 99999 678889999999543
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-26 Score=211.52 Aligned_cols=196 Identities=22% Similarity=0.314 Sum_probs=165.8
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCC------CCcceEEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH------LNIVRFIG 203 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~nIv~l~~ 203 (343)
+-..+|.+....|+|-|+.|.+|.+ .|..||||++.... .+.+.=+.|+++|++|.. -|+++++-
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-------~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-------VMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-------HHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 4456778888899999999999987 67799999997533 333556799999999962 37899999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-CcEEEec
Q 019304 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIAD 281 (343)
Q Consensus 204 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~-~~vkl~D 281 (343)
.|...+++|+|+|-+ ..+|.+.|++.+ +-.+....+..++.|++.||..|..+||+|.||||+||||++. ..+||||
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeecc
Confidence 999999999999998 469999999764 3457888999999999999999999999999999999999854 5789999
Q ss_pred cccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecccccccCCCCccCC
Q 019304 282 FGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTWPPPWRHIL 342 (343)
Q Consensus 282 Fg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~~~~p~~~~~~ 342 (343)
||.|...... ..++..-+.-|.|||++ .+-+|+...|+| +.+|++|-...+.||
T Consensus 581 fGSA~~~~en-eitPYLVSRFYRaPEIi-----LG~~yd~~iD~W-SvgctLYElYtGkIl 634 (752)
T KOG0670|consen 581 FGSASFASEN-EITPYLVSRFYRAPEII-----LGLPYDYPIDTW-SVGCTLYELYTGKIL 634 (752)
T ss_pred Cccccccccc-cccHHHHHHhccCccee-----ecCcccCCccce-eeceeeEEeecccee
Confidence 9999876554 34555667789999999 789999999999 888998888888776
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=184.77 Aligned_cols=176 Identities=28% Similarity=0.530 Sum_probs=150.9
Q ss_pred cccccceEEEEEEEC--CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEecCC
Q 019304 143 FAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (343)
Q Consensus 143 lg~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~~~ 220 (343)
||+|++|.||++... ++.+++|++....... ..+.+.+|+..++.++|++++++++++......++++|++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCC
Confidence 689999999999985 8899999997654432 235788999999999999999999999998899999999998
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-CCcEEEeccccccccccCC-CccCCC
Q 019304 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFGVARIEVQTE-GMTPET 298 (343)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~-~~~vkl~DFg~a~~~~~~~-~~~~~~ 298 (343)
++|.+++.... ..++...++.++.+++.++++||+.|++|+||+|.||+++. ++.++|+|||.+....... ......
T Consensus 76 ~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 76 GSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence 99999987642 35889999999999999999999999999999999999998 8999999999998654332 133356
Q ss_pred CCcceecCCCCCCCCCCCC-CCceeeeeeecc
Q 019304 299 GTYRWMAPGNSFFSPLPHP-SFEHKWSAKESC 329 (343)
Q Consensus 299 gt~~y~APE~~~~~~~~~~-~~~~~sDi~~~~ 329 (343)
+...|++||.+ ... .++.+.|+|+++
T Consensus 155 ~~~~~~~pe~~-----~~~~~~~~~~D~~~lg 181 (215)
T cd00180 155 GTPAYMAPEVL-----LGKGYYSEKSDIWSLG 181 (215)
T ss_pred CCCCccChhHh-----cccCCCCchhhhHHHH
Confidence 78999999998 555 888999999544
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-24 Score=189.28 Aligned_cols=185 Identities=19% Similarity=0.262 Sum_probs=146.3
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEE-EEeCCe
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGA-CRKRMV 210 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~-~~~~~~ 210 (343)
+.|.+.+.||+|.||.+-++.+ ..+.+++|.+.++... ..+|.+|..---.| .|.||+..|++ |+..+.
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt-------~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT-------QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh-------HHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 5678889999999999999988 5578999998765433 35789998766566 58999998875 567778
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc--CCCcEEEecccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS--ADKSIKIADFGVARIE 288 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~--~~~~vkl~DFg~a~~~ 288 (343)
+.+++||++.|+|.+-+.. ..+.+....+++.|+++|+.|+|+++++|||||.+||||- +..+|||||||..+..
T Consensus 97 YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred EEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 8899999999999888754 3478888899999999999999999999999999999995 4458999999998753
Q ss_pred ccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecccc
Q 019304 289 VQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLK 331 (343)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~ 331 (343)
+.. ....--+..|.|||....-+...-...+.+|+|.+.++
T Consensus 174 g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi 214 (378)
T KOG1345|consen 174 GTT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGII 214 (378)
T ss_pred Cce--ehhhhhhcccCCcHHHhhccccceEecccccchheeee
Confidence 321 12223456789999875444444556688999975543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=180.31 Aligned_cols=144 Identities=21% Similarity=0.186 Sum_probs=109.4
Q ss_pred ccccccccceEEEEEEE-CCceEEEEEeeCCCCChhH--------------------HHHHHHHHHHHHHHHhcCCCCCc
Q 019304 140 GTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEK--------------------AQVMEQQFQQEVMMLATLKHLNI 198 (343)
Q Consensus 140 ~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~--------------------~~~~~~~~~~E~~~l~~l~h~nI 198 (343)
...||+|+||.||+|.. +|+.||||+++........ .........+|+.+++.+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999987 7899999999765321111 01112334569999999988776
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeCCCCCCcEEEcCCCcE
Q 019304 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV-HGLGFIHRDLKSDNLLISADKSI 277 (343)
Q Consensus 199 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yL-H~~giiHrDlkp~NILv~~~~~v 277 (343)
......... . .+|||||++++++...... ...++...+..++.|++.+|.|| |+.||+||||||+|||++ ++.+
T Consensus 82 ~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 82 PCPEPILLK-S-HVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCcEEEec-C-CEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence 443332222 2 3799999998777654322 24588899999999999999999 799999999999999998 5789
Q ss_pred EEecccccccc
Q 019304 278 KIADFGVARIE 288 (343)
Q Consensus 278 kl~DFg~a~~~ 288 (343)
+|+|||+|...
T Consensus 157 ~LiDFG~a~~~ 167 (190)
T cd05147 157 YIIDVSQSVEH 167 (190)
T ss_pred EEEEccccccC
Confidence 99999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=175.53 Aligned_cols=145 Identities=18% Similarity=0.146 Sum_probs=111.7
Q ss_pred ccccccccceEEEEEEE-CCceEEEEEeeCCCCChhH--------------------HHHHHHHHHHHHHHHhcCCCCCc
Q 019304 140 GTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEK--------------------AQVMEQQFQQEVMMLATLKHLNI 198 (343)
Q Consensus 140 ~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~--------------------~~~~~~~~~~E~~~l~~l~h~nI 198 (343)
...||+|++|.||+|.. +|+.||||+++........ .......+.+|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999987 6999999999875322110 11112345689999999999987
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcE
Q 019304 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSI 277 (343)
Q Consensus 199 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~giiHrDlkp~NILv~~~~~v 277 (343)
.....+.... .++||||++|+++....... ..++......++.|++.++.+||+ .||+||||||+|||++ ++.+
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 5444433333 37999999987554432222 347788899999999999999999 9999999999999998 8999
Q ss_pred EEeccccccccc
Q 019304 278 KIADFGVARIEV 289 (343)
Q Consensus 278 kl~DFg~a~~~~ 289 (343)
+|+|||+|+...
T Consensus 157 ~liDFG~a~~~~ 168 (190)
T cd05145 157 YIIDVSQAVELD 168 (190)
T ss_pred EEEEcccceecC
Confidence 999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-23 Score=190.63 Aligned_cols=188 Identities=23% Similarity=0.319 Sum_probs=152.9
Q ss_pred cccccccccccccceEEEEEEE-----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 208 (343)
+.|....+||+|.|+.||+++. ..+.||+|.+...... .++.+|+++|..+ -+.||+++.+++..+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--------~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--------SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--------hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 5677889999999999999975 3468999998765443 4688999999999 589999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc-CCCcEEEeccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIADFGVARI 287 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~-~~~~vkl~DFg~a~~ 287 (343)
+...+|+||++.....++... ++...+..++..++.||+++|.+|||||||||+|+|.+ ..+.-.|+|||+|..
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 999999999999999998864 67888999999999999999999999999999999998 567889999999861
Q ss_pred cc-----------------c----------------CCCc------------cCCCCCcceecCCCCCCCCCCCCCCcee
Q 019304 288 EV-----------------Q----------------TEGM------------TPETGTYRWMAPGNSFFSPLPHPSFEHK 322 (343)
Q Consensus 288 ~~-----------------~----------------~~~~------------~~~~gt~~y~APE~~~~~~~~~~~~~~~ 322 (343)
.. + .... -...||++|.|||++. ..+.-+.+
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~----k~~~Qtta 258 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLF----RCPRQTTA 258 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHh----hccCcCCc
Confidence 00 0 0000 0123899999999995 78889999
Q ss_pred eeeee-----cccccccCCCCc
Q 019304 323 WSAKE-----SCLKTTWPPPWR 339 (343)
Q Consensus 323 sDi~~-----~~~~~~~~p~~~ 339 (343)
+|||+ +.++....||+.
T Consensus 259 iDiws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred cceeeccceeehhhcccccccc
Confidence 99995 222335555543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=189.01 Aligned_cols=131 Identities=23% Similarity=0.408 Sum_probs=114.5
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-----C---CCcceEEE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-----H---LNIVRFIG 203 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~nIv~l~~ 203 (343)
-.+|.+.++||-|.|.+||+|.+ ..+.||+|+.+. ++++.+..+.|+.+|++++ | .+||+|++
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-------AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD 149 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-------AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD 149 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-------hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence 37899999999999999999987 567899999974 4455567789999999884 2 37999999
Q ss_pred EEEeC----CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEc
Q 019304 204 ACRKR----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLIS 272 (343)
Q Consensus 204 ~~~~~----~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-giiHrDlkp~NILv~ 272 (343)
.|... .++|+|+|++ |.+|..++++..-+.++...+..|++||+.||.|||.. ||||-||||+|||+.
T Consensus 150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 99653 4799999999 77999999988778899999999999999999999965 999999999999984
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-22 Score=185.31 Aligned_cols=180 Identities=19% Similarity=0.311 Sum_probs=145.4
Q ss_pred ccccccccccccceEEEEEEECC---ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC----CCCcceEEEEE-Ee
Q 019304 136 KLNMGTAFAQGAFGKLYRGTYNG---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK----HLNIVRFIGAC-RK 207 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----h~nIv~l~~~~-~~ 207 (343)
+|++.+.||+|+||.||.+.... ..+|+|+-........ ..+..|..++..+. -+++..+++.. ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~------~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP------SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC------ccchhHHHHHHHHhhhcCCCCCCEEEEeccCC
Confidence 78899999999999999999733 4688888765432221 13567777777776 26899999999 47
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-----CcEEEecc
Q 019304 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-----KSIKIADF 282 (343)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~-----~~vkl~DF 282 (343)
...-++||+.+ |.+|.++........++..++..++.|++.+|++||+.|++||||||+|+++... ..+.|.||
T Consensus 93 ~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 93 EDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred CceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 77789999998 7899998876656779999999999999999999999999999999999999854 46999999
Q ss_pred cccc--ccccCC--------C-ccCCCCCcceecCCCCCCCCCCCCCCceeeeeee
Q 019304 283 GVAR--IEVQTE--------G-MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKE 327 (343)
Q Consensus 283 g~a~--~~~~~~--------~-~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~ 327 (343)
|+|+ ...... . .....||..|+++.+. .....+.+.|+|+
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H-----~~~e~~r~DDles 222 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVH-----LGIEQGRRDDLES 222 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHh-----CCCccCCchhhhh
Confidence 9998 321111 1 1234599999999999 8889999999987
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.1e-22 Score=174.27 Aligned_cols=168 Identities=11% Similarity=0.134 Sum_probs=127.6
Q ss_pred ccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHH---HHHHHHHHHHHhcCCCCCcceEEEEEEeC--
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM---EQQFQQEVMMLATLKHLNIVRFIGACRKR-- 208 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-- 208 (343)
..+|+..+.||.|+||.||+...++..+|||++.+.....+..... ...+.+|+..+.++.||+|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 4688899999999999999987778899999997655443322111 12268999999999999999998876543
Q ss_pred ------CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 019304 209 ------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (343)
Q Consensus 209 ------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DF 282 (343)
...+++|||++|.+|.++.. ++. ....+++.+|..||+.|++|||++|+||++++++ ++|+||
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 35789999999999988732 232 2456899999999999999999999999999888 999999
Q ss_pred ccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeec
Q 019304 283 GVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES 328 (343)
Q Consensus 283 g~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~ 328 (343)
|..+......... .+. ....|..++|+|++
T Consensus 179 g~~~~~~e~~a~d-----------~~v-----ler~y~~~~di~~l 208 (232)
T PRK10359 179 SGKRCTAQRKAKD-----------RID-----LERHYGIKNEIKDL 208 (232)
T ss_pred CCcccccchhhHH-----------HHH-----HHhHhcccccccce
Confidence 9876432211111 023 44556678999953
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.7e-22 Score=169.57 Aligned_cols=181 Identities=24% Similarity=0.325 Sum_probs=145.7
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCC-CCcceEEEEEEeC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRFIGACRKR 208 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~ 208 (343)
|-...|.+.++||+|+||.+|.|.. +|+.||||+=......+ ++..|..+...|++ ..|..+..+..+.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp--------qL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP--------QLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc--------chhHHHHHHHHhccCCCCchhhhhcccc
Confidence 4457899999999999999999987 89999999876555544 46788999999975 6777788888888
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC---CCcEEEeccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVA 285 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~---~~~vkl~DFg~a 285 (343)
..-.+|||.+ |-+|.+++.- ....++.++++-++-|++.-++|+|.+++|||||||+|+|+.- ...+.++|||+|
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred ccceeeeecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccch
Confidence 8889999999 7799888763 2345899999999999999999999999999999999999973 456889999999
Q ss_pred cccccCCC--------ccCCCCCcceecCCCCCCCCCCCCCCceeeeeee
Q 019304 286 RIEVQTEG--------MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKE 327 (343)
Q Consensus 286 ~~~~~~~~--------~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~ 327 (343)
+..-+... -....||.+|.+-.+. .+..-+..-|+-+
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh-----~g~eqSRRDDmeS 206 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAH-----LGIEQSRRDDMES 206 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhh-----hhhhhhhhhhhhh
Confidence 85433211 2345799999998877 5555566666654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.7e-22 Score=175.49 Aligned_cols=185 Identities=24% Similarity=0.316 Sum_probs=149.8
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVW 211 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~ 211 (343)
-.|+++++||+|+||+++.|+. +++.||||.=.+....+ ++..|.+..+.|. .+.|...|-+..+..+-
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP--------QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP--------QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCcc--------hHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 3688999999999999999986 99999999765444333 4567888888884 68999999988888888
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-----CcEEEecccccc
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-----KSIKIADFGVAR 286 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~-----~~vkl~DFg~a~ 286 (343)
.+|+|++ |-||.+++. ..+..++.+++..+|.|++.-++|+|++.+|.|||||+|+||..- ..+.|+|||+|+
T Consensus 100 iLVidLL-GPSLEDLFD-~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFD-LCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhhhh-CcCHHHHHH-HhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 8999999 779988875 445679999999999999999999999999999999999999743 458999999998
Q ss_pred ccccCC--------CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccccccc
Q 019304 287 IEVQTE--------GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTW 334 (343)
Q Consensus 287 ~~~~~~--------~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~~~ 334 (343)
...+.. ...+..||.+||+-... .+..-+..-|+=++.-+.+|
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTH-----lGrEQSRRDDLEaLGHvFmY 228 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTH-----LGREQSRRDDLEALGHVFMY 228 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeecc-----ccchhhhhhhHHHhhhhhhh
Confidence 654322 13456899999998887 56677777776544434333
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=164.77 Aligned_cols=136 Identities=16% Similarity=0.302 Sum_probs=104.0
Q ss_pred ccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-----CCCCcceEEEEEEeCC---e-
Q 019304 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-----KHLNIVRFIGACRKRM---V- 210 (343)
Q Consensus 140 ~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~---~- 210 (343)
.+.||+|+||.||.-..++.. +||++....... .+.+.+|+.+++.+ .||||++++|++.++. .
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~~------~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDGG------DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cceecCCCceEEEECCCCcCe-EEEEEeccccch------HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 467999999999962223334 799886543221 25689999999999 5799999999998874 3
Q ss_pred EEEEEEe--cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHH-HHHHhCCceeCCCCCCcEEEcC----CCcEEEec-c
Q 019304 211 WCIVTEY--AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM-AYVHGLGFIHRDLKSDNLLISA----DKSIKIAD-F 282 (343)
Q Consensus 211 ~~iv~E~--~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL-~yLH~~giiHrDlkp~NILv~~----~~~vkl~D-F 282 (343)
+.+|+|| +.+++|.+++.+. .+++. ..++.+++.++ +|||+++|+||||||+|||++. +..++|+| |
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 3378999 5579999999652 25554 35677888777 9999999999999999999974 33799999 5
Q ss_pred ccccc
Q 019304 283 GVARI 287 (343)
Q Consensus 283 g~a~~ 287 (343)
|....
T Consensus 155 G~~~~ 159 (210)
T PRK10345 155 GESTF 159 (210)
T ss_pred CCcce
Confidence 55443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-20 Score=163.92 Aligned_cols=140 Identities=19% Similarity=0.346 Sum_probs=116.6
Q ss_pred cccccccceEEEEEEECCceEEEEEeeCCCCChh--HHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEec
Q 019304 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPE--KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~ 218 (343)
+.||+|++|.||+|.+.+..|++|+......... .......++.+|+.++..+.|+++.....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5799999999999999999999998764332221 11222356889999999999999877776666667789999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
+|++|.+++.... . ....++.+++.+|.+||+.+++|+|++|+|||++ ++.++|+|||.++.
T Consensus 82 ~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999986421 2 7789999999999999999999999999999999 78999999999875
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.1e-22 Score=179.55 Aligned_cols=195 Identities=21% Similarity=0.352 Sum_probs=154.0
Q ss_pred cceecccccccccccccccceEEEEEEE-------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceE
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l 201 (343)
+..+...++++...+-+|.||.||+|.| +.+.|-+|.++... .+.....+++|..++..+.|||+..+
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-----S~iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-----SQIQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-----cHHHHHHHHHHHHHHhcCcCCCccce
Confidence 3445566788888899999999999966 23457777765322 22334678999999999999999999
Q ss_pred EEEEEe-CCeEEEEEEecCCCCHHHHHHhh------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC
Q 019304 202 IGACRK-RMVWCIVTEYAKGGSVRQFLTRR------QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274 (343)
Q Consensus 202 ~~~~~~-~~~~~iv~E~~~~gsL~~~l~~~------~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~ 274 (343)
.+++.+ ...+++++.++.-|+|..|+..- ..+.+.......++.|++.||+|||++|+||.||.++|++|++.
T Consensus 353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh
Confidence 998855 45678899999889999999821 12346667788999999999999999999999999999999999
Q ss_pred CcEEEeccccccccccCCC--c-cCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccccccc
Q 019304 275 KSIKIADFGVARIEVQTEG--M-TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTW 334 (343)
Q Consensus 275 ~~vkl~DFg~a~~~~~~~~--~-~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~~~ 334 (343)
-.|||+|=.++|-.-+..- . ...-....||+||.+ .+..|+.++|+| ++++++|
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal-----~n~~yssasDvW-sfGVllW 489 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEAL-----QNSHYSSASDVW-SFGVLLW 489 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHH-----hhhhhcchhhhH-HHHHHHH
Confidence 9999999999985432211 0 112235799999999 899999999999 6666666
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.9e-20 Score=168.95 Aligned_cols=182 Identities=25% Similarity=0.407 Sum_probs=153.0
Q ss_pred cccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCC-CcceEEEEEEeCCeEEEEE
Q 019304 137 LNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL-NIVRFIGACRKRMVWCIVT 215 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~iv~ 215 (343)
|.+.+.||.|+||.||++... ..+++|.+........ .....+.+|+.+++.+.|+ +|+++++.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS---KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch---hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence 566788999999999999887 7889999976555432 1246789999999999988 7999999998777789999
Q ss_pred EecCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC-cEEEeccccccccccCC-
Q 019304 216 EYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTE- 292 (343)
Q Consensus 216 E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~-~vkl~DFg~a~~~~~~~- 292 (343)
+++.++++.+++..... ..++......++.|++.+++|+|+.+++|||+||+||+++..+ .++++|||.++......
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999999977764321 2588999999999999999999999999999999999999888 79999999987544322
Q ss_pred ------CccCCCCCcceecCCCCCCCCCCC---CCCceeeeeee
Q 019304 293 ------GMTPETGTYRWMAPGNSFFSPLPH---PSFEHKWSAKE 327 (343)
Q Consensus 293 ------~~~~~~gt~~y~APE~~~~~~~~~---~~~~~~sDi~~ 327 (343)
......||..|+|||.+ .. ..+....|+|+
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~-----~~~~~~~~~~~~D~~s 196 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVL-----LGLSLAYASSSSDIWS 196 (384)
T ss_pred cccccccccccccccccCCHHHh-----cCCCCCCCCchHhHHH
Confidence 23556899999999999 55 68889999994
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.8e-20 Score=160.57 Aligned_cols=137 Identities=20% Similarity=0.327 Sum_probs=109.9
Q ss_pred ccccccceEEEEEEECCceEEEEEeeCCCCCh-h-HHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEecC
Q 019304 142 AFAQGAFGKLYRGTYNGEDVAIKILERPENNP-E-KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAK 219 (343)
Q Consensus 142 ~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~-~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~~ 219 (343)
.||+|+||.||+|.+++..|++|......... + .......++.+|+.++..+.|+++.....++......++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 38999999999999999999999976443221 1 122234678899999999988876554444455566789999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 220 GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 220 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
|++|.+++.... . .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||+++..
T Consensus 81 g~~l~~~~~~~~-----~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGN-----D----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcH-----H----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999998875421 0 7899999999999999999999999999999 899999999998763
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.8e-20 Score=182.74 Aligned_cols=141 Identities=21% Similarity=0.292 Sum_probs=115.6
Q ss_pred cccccccccccceEEEEEEECCceEEEEEeeCCCCC-h-hHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEE
Q 019304 137 LNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENN-P-EKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~-~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv 214 (343)
|...+.||+|+||.||+|.+.+..+++|+....... . .......+++.+|+++++.++|++++..+.++......++|
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 345789999999999999997777777764332211 1 11222346789999999999999999887777776777899
Q ss_pred EEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
|||+++++|.+++. ....++.+++.+|.|||+.|++||||||+|||+ .++.++|+|||+++..
T Consensus 415 ~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 415 MEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999999885 246789999999999999999999999999999 5789999999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-20 Score=165.35 Aligned_cols=147 Identities=18% Similarity=0.206 Sum_probs=112.1
Q ss_pred ccccccccccccceEEEEEE-E--CCceEEEEEeeCCCCChh------------------HHHHHHHHHHHHHHHHhcCC
Q 019304 136 KLNMGTAFAQGAFGKLYRGT-Y--NGEDVAIKILERPENNPE------------------KAQVMEQQFQQEVMMLATLK 194 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~-~--~~~~vavK~~~~~~~~~~------------------~~~~~~~~~~~E~~~l~~l~ 194 (343)
-|.+.+.||+|++|.||+|. . +|+.||||+++....... ........+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46778899999999999998 3 789999999976432110 01112245678999999997
Q ss_pred CC--CcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeCCCCCCcEEE
Q 019304 195 HL--NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG-FIHRDLKSDNLLI 271 (343)
Q Consensus 195 h~--nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~g-iiHrDlkp~NILv 271 (343)
+. .+.+.++. . ..++||||+++.+|...... ...........++.|++.++.+||+.| ++||||||+||++
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 53 34455543 2 24799999999888665422 223555667899999999999999999 9999999999999
Q ss_pred cCCCcEEEeccccccccc
Q 019304 272 SADKSIKIADFGVARIEV 289 (343)
Q Consensus 272 ~~~~~vkl~DFg~a~~~~ 289 (343)
+ ++.++|+|||.+....
T Consensus 183 ~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred E-CCCEEEEEChhhhccC
Confidence 9 8899999999987543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.6e-19 Score=154.30 Aligned_cols=136 Identities=19% Similarity=0.160 Sum_probs=107.6
Q ss_pred cccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeEEEEEEe
Q 019304 139 MGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 139 ~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
....|++|+||+|+.+...+.+++.+.+.....-... .....+.+|+++|++|. |+++++++++ ...+++|||
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~--~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRG--VAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhh--HHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467999999999988888889988877654432111 11236889999999995 5889999886 335899999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC-CCCcEEEcCCCcEEEeccccccccc
Q 019304 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDL-KSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDl-kp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
++|.+|.+.+.. . ...++.|++.+|+++|++||+|||| ||+|||++.++.++|+|||+|....
T Consensus 80 I~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 80 LAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred ecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 999988654321 1 1346789999999999999999999 7999999999999999999998543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.3e-21 Score=196.86 Aligned_cols=130 Identities=15% Similarity=0.153 Sum_probs=97.6
Q ss_pred CCC-CCcceEEEEE-------EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC
Q 019304 193 LKH-LNIVRFIGAC-------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDL 264 (343)
Q Consensus 193 l~h-~nIv~l~~~~-------~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDl 264 (343)
++| +||.++++.+ .....+++++|++ +++|.+++... ...+++..+..++.||+.||+|||++||+||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 344 5677777766 2234577889988 56999999743 345899999999999999999999999999999
Q ss_pred CCCcEEEcC-------------------CCcEEEeccccccccccCC-----------------CccCCCCCcceecCCC
Q 019304 265 KSDNLLISA-------------------DKSIKIADFGVARIEVQTE-----------------GMTPETGTYRWMAPGN 308 (343)
Q Consensus 265 kp~NILv~~-------------------~~~vkl~DFg~a~~~~~~~-----------------~~~~~~gt~~y~APE~ 308 (343)
||+||||+. ++.+|++|||+++...... .....+||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999954 4456667777665321100 0011358899999999
Q ss_pred CCCCCCCCCCCceeeeeeecc
Q 019304 309 SFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 309 ~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+ ....|+.++|||++.
T Consensus 187 ~-----~~~~~~~~sDVwSlG 202 (793)
T PLN00181 187 D-----NGSSSNCASDVYRLG 202 (793)
T ss_pred h-----ccCCCCchhhhhhHH
Confidence 9 778899999999533
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-19 Score=155.11 Aligned_cols=140 Identities=20% Similarity=0.210 Sum_probs=107.9
Q ss_pred cccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHH----------------HHHHHHHHHHHHHHhcCCCC--C
Q 019304 137 LNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKA----------------QVMEQQFQQEVMMLATLKHL--N 197 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~--n 197 (343)
|.+.+.||+|+||.||++.. +|+.||||++.......... ......+.+|..++..+.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 56678899999999999988 78999999986543211100 01123467889999988777 4
Q ss_pred cceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcE
Q 019304 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277 (343)
Q Consensus 198 Iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~v 277 (343)
++..++. ...++||||+++++|...... .....++.+++.++.++|+.|++||||||+||+++.++.+
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 4555542 345899999999988765421 2346788999999999999999999999999999999999
Q ss_pred EEecccccccc
Q 019304 278 KIADFGVARIE 288 (343)
Q Consensus 278 kl~DFg~a~~~ 288 (343)
+|+|||.+...
T Consensus 165 ~liDfg~~~~~ 175 (198)
T cd05144 165 YIIDWPQMVST 175 (198)
T ss_pred EEEECCccccC
Confidence 99999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1e-18 Score=178.31 Aligned_cols=189 Identities=20% Similarity=0.265 Sum_probs=146.2
Q ss_pred CccceecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC---CCCcceEE
Q 019304 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNIVRFI 202 (343)
Q Consensus 127 ~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~ 202 (343)
..+.++..+.|.+.+.||+|+||.||+|+. +|+.||+|+=+++.--. |.-=.+++.+|+ -+.|..+.
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---------fYI~~q~~~RLk~~~~~~~~~~~ 760 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---------FYICLQVMERLKPQMLPSIMHIS 760 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---------eeehHHHHHhhchhhhcchHHHH
Confidence 345677778899999999999999999987 78999999876554321 222223334444 22334444
Q ss_pred EEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-------CC
Q 019304 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-------DK 275 (343)
Q Consensus 203 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~-------~~ 275 (343)
.+..-.+.-++|+||.+.|+|.+++. ..+.+++..++.++.|++..++.||..+|||+||||+|+||.. ..
T Consensus 761 ~a~~~~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 761 SAHVFQNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred HHHccCCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCccc
Confidence 44444455579999999999999997 4566899999999999999999999999999999999999952 34
Q ss_pred cEEEeccccccc---cccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecccc
Q 019304 276 SIKIADFGVARI---EVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLK 331 (343)
Q Consensus 276 ~vkl~DFg~a~~---~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~ 331 (343)
-++|+|||.+.- ..+....+..++|-.+-.+|.. .+.+++...|.|.++++
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~-----~grpWtYq~DyfGlAa~ 892 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMR-----EGRPWTYQIDYFGLAAT 892 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHh-----cCCCCchhhhhHHHHHH
Confidence 699999998763 3344445667889999999999 99999999999965554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.4e-19 Score=175.25 Aligned_cols=182 Identities=20% Similarity=0.258 Sum_probs=139.1
Q ss_pred ccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEE
Q 019304 138 NMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (343)
Q Consensus 138 ~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~ 215 (343)
.....+|.|++|.|+.... ..+.++.|.........+........+..|..+-..++|||++..+..+.+....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999997776654 33444444433110012222223334778888889999999988777776666666669
Q ss_pred EecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC---
Q 019304 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE--- 292 (343)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~--- 292 (343)
||+++ +|..++... ..+....+..++.|++.|++|||+.||.|||||++|+++..+|.+||+|||.+.......
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 99999 999999764 347788889999999999999999999999999999999999999999999987643322
Q ss_pred --CccCCCCCcceecCCCCCCCCCCCCCCc-eeeeeee
Q 019304 293 --GMTPETGTYRWMAPGNSFFSPLPHPSFE-HKWSAKE 327 (343)
Q Consensus 293 --~~~~~~gt~~y~APE~~~~~~~~~~~~~-~~sDi~~ 327 (343)
.....+|+..|+|||.+ ....|. ...|||+
T Consensus 478 ~~~~~g~~gS~pY~apE~~-----~~~~ydpr~vDiwS 510 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVL-----TGKEYDPRAVDVWS 510 (601)
T ss_pred hhhhcCcccCCcCcCcccc-----cccccCcchhhhhh
Confidence 23456899999999999 788888 6779995
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=143.30 Aligned_cols=140 Identities=21% Similarity=0.231 Sum_probs=98.5
Q ss_pred ccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHH------------------HHHHHHHHHHHhcCCCC--Cc
Q 019304 140 GTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVM------------------EQQFQQEVMMLATLKHL--NI 198 (343)
Q Consensus 140 ~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~------------------~~~~~~E~~~l~~l~h~--nI 198 (343)
++.||+|+||.||+|.. +++.||||++............. ......|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999988 58999999987644322211110 01123566666666443 34
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCCHHHH-HHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCc
Q 019304 199 VRFIGACRKRMVWCIVTEYAKGGSVRQF-LTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKS 276 (343)
Q Consensus 199 v~l~~~~~~~~~~~iv~E~~~~gsL~~~-l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~giiHrDlkp~NILv~~~~~ 276 (343)
.+.+++. ..++||||++++.+... +.... . ...+..++.+++.++.++|. .+++|+||||+||+++ ++.
T Consensus 82 ~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 82 PKPIDLN----RHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CceEecC----CCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 4555432 34899999998543211 11110 1 15678899999999999999 9999999999999999 999
Q ss_pred EEEecccccccc
Q 019304 277 IKIADFGVARIE 288 (343)
Q Consensus 277 vkl~DFg~a~~~ 288 (343)
++|+|||.++..
T Consensus 153 ~~liDfg~a~~~ 164 (187)
T cd05119 153 VYIIDVPQAVEI 164 (187)
T ss_pred EEEEECcccccc
Confidence 999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.2e-17 Score=147.47 Aligned_cols=142 Identities=19% Similarity=0.199 Sum_probs=107.8
Q ss_pred ccccc-cccceEEEEEEECCceEEEEEeeCCCCChh-------HHHHHHHHHHHHHHHHhcCCCCCc--ceEEEEEEeCC
Q 019304 140 GTAFA-QGAFGKLYRGTYNGEDVAIKILERPENNPE-------KAQVMEQQFQQEVMMLATLKHLNI--VRFIGACRKRM 209 (343)
Q Consensus 140 ~~~lg-~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~nI--v~l~~~~~~~~ 209 (343)
...|| .|+.|.||.+...+..++||.+.+...-.. -......++.+|+.++..+.|++| +..++......
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 34677 788899999988899999999865332000 001123568899999999998775 67777654322
Q ss_pred ----eEEEEEEecCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccc
Q 019304 210 ----VWCIVTEYAKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (343)
Q Consensus 210 ----~~~iv~E~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~ 284 (343)
..++|||+++| .+|.+++.. ..++.. .+.+++.+|.+||++||+||||||.|||++.++.++|+|||.
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 23599999997 689888754 234544 356889999999999999999999999999889999999999
Q ss_pred cccc
Q 019304 285 ARIE 288 (343)
Q Consensus 285 a~~~ 288 (343)
++..
T Consensus 189 ~~~~ 192 (239)
T PRK01723 189 GELR 192 (239)
T ss_pred cccC
Confidence 8763
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-19 Score=156.91 Aligned_cols=201 Identities=28% Similarity=0.412 Sum_probs=156.3
Q ss_pred eecccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 210 (343)
-|+.+++.+..+|.+...|+.|+|+|.|..++.|++......+... +.|..|.-.|+.+.||||+.++|.|..+..
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~ris----rdfneefp~lrifshpnilpvlgacnsppn 261 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARIS----RDFNEEFPALRIFSHPNILPVLGACNSPPN 261 (448)
T ss_pred CcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhc----chhhhhCcceeeecCCchhhhhhhccCCCC
Confidence 3677888889999999999999999999999999997666554432 679999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cee-CCCCCCcEEEcCCCcEEEecccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG-FIH-RDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~g-iiH-rDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
+.++..||+.|+|+..++...+-..+..++.+++.++++||+|||+.. +|- --|....++||++-+.+|+ .+-+++.
T Consensus 262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfs 340 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS 340 (448)
T ss_pred ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceee
Confidence 999999999999999999876666778889999999999999999874 443 3688899999999888774 2222211
Q ss_pred ccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecccccccCCCCccCC
Q 019304 289 VQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTWPPPWRHIL 342 (343)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~~~~~p~~~~~~ 342 (343)
-+ .....=.|.||+||.++..|. ..--.++|+| ++++..|-.-.+.+|
T Consensus 341 fq---e~gr~y~pawmspealqrkpe--d~n~raadmw-sfaillwel~trevp 388 (448)
T KOG0195|consen 341 FQ---EVGRAYSPAWMSPEALQRKPE--DLNIRAADMW-SFAILLWELNTREVP 388 (448)
T ss_pred ee---ccccccCcccCCHHHHhcCch--hcchhhhhHH-HHHHHHHHhhccccc
Confidence 01 011123589999999953322 2223678999 666666766555544
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.9e-17 Score=133.89 Aligned_cols=131 Identities=21% Similarity=0.266 Sum_probs=111.5
Q ss_pred ccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCC--CCcceEEEEEEeCCeEEEEEEe
Q 019304 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 140 ~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
.+.||+|.++.||++..++..+++|....... ...+.+|+.+++.++| ..++++++.....+..++++||
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc--------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 46799999999999999888999999865433 1467899999999976 5899999988877788999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL---GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
++++.+..+ +......++.+++.+|++||.. +++|+|++|+||++++.+.++++|||.++.
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 998777543 4455677889999999999985 699999999999999989999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-18 Score=167.52 Aligned_cols=169 Identities=22% Similarity=0.306 Sum_probs=139.3
Q ss_pred cccccceEEEEEE-----ECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeEEEEEE
Q 019304 143 FAQGAFGKLYRGT-----YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTE 216 (343)
Q Consensus 143 lg~G~fg~Vy~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~iv~E 216 (343)
+|+|+||.|+++. ..+.-+|+|++++........ .....|..++..++ ||.++++..+++.+...+++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~----~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld 77 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR----THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD 77 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccc----cccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence 7899999999764 256678999887655433222 14456777888886 9999999999999999999999
Q ss_pred ecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCccC
Q 019304 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTP 296 (343)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~~~ 296 (343)
+..+|.|...+.+. ..+.+.....+...++.+++++|+.+++|||+|++||+++.+|++|+.|||+++.....+..
T Consensus 78 ~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred hcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 99999998887654 34667777788889999999999999999999999999999999999999999875543332
Q ss_pred CCCCcceecCCCCCCCCCCCCCCceeeeeee
Q 019304 297 ETGTYRWMAPGNSFFSPLPHPSFEHKWSAKE 327 (343)
Q Consensus 297 ~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~ 327 (343)
|||..|||||++ . .....+|.|+
T Consensus 154 -cgt~eymApEI~-----~--gh~~a~D~ws 176 (612)
T KOG0603|consen 154 -CGTYEYRAPEII-----N--GHLSAADWWS 176 (612)
T ss_pred -ccchhhhhhHhh-----h--ccCCcccchh
Confidence 999999999999 4 6677889884
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.4e-16 Score=144.23 Aligned_cols=199 Identities=22% Similarity=0.305 Sum_probs=133.3
Q ss_pred cceecccccccccccccccceEEEEEEEC--C-----------------------------------ceEEEEEeeCCCC
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYN--G-----------------------------------EDVAIKILERPEN 171 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~--~-----------------------------------~~vavK~~~~~~~ 171 (343)
+-.+..++|.+++.||+|..+.||.++.. + -+.|||.+-.-..
T Consensus 151 dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~ 230 (598)
T KOG4158|consen 151 DSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEH 230 (598)
T ss_pred hcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccccc
Confidence 33455688999999999999999988541 0 0345555432222
Q ss_pred ChhHHHHHHHHHHHHHH------H-----------Hh----c-CCCCCcceEEEEEEe----------------------
Q 019304 172 NPEKAQVMEQQFQQEVM------M-----------LA----T-LKHLNIVRFIGACRK---------------------- 207 (343)
Q Consensus 172 ~~~~~~~~~~~~~~E~~------~-----------l~----~-l~h~nIv~l~~~~~~---------------------- 207 (343)
... .....+..-+|+- . ++ . -+|||||++.+.|.+
T Consensus 231 ~s~-~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p 309 (598)
T KOG4158|consen 231 DSG-DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYP 309 (598)
T ss_pred CCc-hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecc
Confidence 211 1222233333331 0 11 1 259999999887742
Q ss_pred -----CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc--CCC--cEE
Q 019304 208 -----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS--ADK--SIK 278 (343)
Q Consensus 208 -----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~--~~~--~vk 278 (343)
+..+|+||..++. +|.+++..+. .+.....-++.|+++|+.|||++||.|||||.+||||. +|+ .+.
T Consensus 310 ~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LV 385 (598)
T KOG4158|consen 310 SGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLV 385 (598)
T ss_pred cccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEE
Confidence 2357999999965 9999997643 67778888999999999999999999999999999984 444 467
Q ss_pred EeccccccccccCCC-------ccCCCCCcceecCCCCCCCCCCCCCCc-eeeeeeecccccc
Q 019304 279 IADFGVARIEVQTEG-------MTPETGTYRWMAPGNSFFSPLPHPSFE-HKWSAKESCLKTT 333 (343)
Q Consensus 279 l~DFg~a~~~~~~~~-------~~~~~gt~~y~APE~~~~~~~~~~~~~-~~sDi~~~~~~~~ 333 (343)
|+|||.+--...... .-..-|...-||||+...-|=.....+ .|.|.| .|++.-
T Consensus 386 vaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~W-A~Gala 447 (598)
T KOG4158|consen 386 VADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTW-AAGALA 447 (598)
T ss_pred EcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhh-hhhhhH
Confidence 899998742211000 112347889999999854333333334 788999 555443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.8e-16 Score=133.23 Aligned_cols=92 Identities=21% Similarity=0.205 Sum_probs=79.2
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCccCCCCC
Q 019304 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300 (343)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~~~~~gt 300 (343)
|+|.+++... ...+++..++.++.|++.||.|||+++ ||+|||++.++.+|+ ||+++..... ...||
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~ 67 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVD 67 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCc
Confidence 6899999754 346999999999999999999999998 999999999999999 9998865432 23689
Q ss_pred cceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 301 YRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 301 ~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+.|||||++ ....++.++|||++..
T Consensus 68 ~~y~aPE~~-----~~~~~~~~~DiwSlG~ 92 (176)
T smart00750 68 PYFMAPEVI-----QGQSYTEKADIYSLGI 92 (176)
T ss_pred ccccChHHh-----cCCCCcchhhHHHHHH
Confidence 999999999 7888999999996433
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.6e-15 Score=145.27 Aligned_cols=143 Identities=20% Similarity=0.248 Sum_probs=98.9
Q ss_pred cccccccceEEEEEEE-CCceEEEEEeeCCCCChhHH----------------------------HH------HHHHHHH
Q 019304 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKA----------------------------QV------MEQQFQQ 185 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~----------------------------~~------~~~~~~~ 185 (343)
+.||+|++|+||+|+. +|+.||||+.++........ .. .+-.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 6799999999999998 89999999986543211110 00 0113556
Q ss_pred HHHHHhcCC----CCCcc---eEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 019304 186 EVMMLATLK----HLNIV---RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR-GMAYVHGL 257 (343)
Q Consensus 186 E~~~l~~l~----h~nIv---~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~-gL~yLH~~ 257 (343)
|+..+.+++ |.+-+ +++..+. ...++||||++|++|.++...... ... ...++.+++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~--~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRT--SERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhc--CCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhC
Confidence 666665552 33223 3333222 234899999999999887753221 122 2345555555 47889999
Q ss_pred CceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 258 giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
|++|+|++|.||+++.++.++++|||++....
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.2e-16 Score=140.99 Aligned_cols=187 Identities=17% Similarity=0.296 Sum_probs=115.1
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCC----------CCcceEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH----------LNIVRFI 202 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~nIv~l~ 202 (343)
+.+..+..||.|+++.||.+++ +++++|+|++..+....... .+++.+|.-....+.+ -.++--+
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~---~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~ 88 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANE---YEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL 88 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTH---HHHHHHHHHGGGGSTT--SHHHHHHHH-B---S
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHH---HHHHHHHHHHhhhhccCCCHHHHHHhceEEeee
Confidence 4566778999999999999999 67999999987766333222 3556666655544332 1222222
Q ss_pred EEEEe------------CC-----eEEEEEEecCCCCHHHHHHh---hCCC--CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 019304 203 GACRK------------RM-----VWCIVTEYAKGGSVRQFLTR---RQNR--AVPLKLAVKQALDVARGMAYVHGLGFI 260 (343)
Q Consensus 203 ~~~~~------------~~-----~~~iv~E~~~~gsL~~~l~~---~~~~--~~~~~~~~~i~~qi~~gL~yLH~~gii 260 (343)
+...- .. ..+++|+-+. ++|.+++.. .... .+.......+..|+++.+++||..|++
T Consensus 89 d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlV 167 (288)
T PF14531_consen 89 DLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLV 167 (288)
T ss_dssp EEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceE
Confidence 22211 11 2367888885 588887652 2221 122334456668999999999999999
Q ss_pred eCCCCCCcEEEcCCCcEEEeccccccccccCCCccCCCCCcceecCCCCCCC---CCCCCCCceeeeeee
Q 019304 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFS---PLPHPSFEHKWSAKE 327 (343)
Q Consensus 261 HrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~~~~~~~sDi~~ 327 (343)
|+||+|+|++++.+|.+.|.||+........ ......+..|.+||..... +...-.++.+.|.|.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~--~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~ 235 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTR--YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ 235 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEE--EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCce--eeccCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence 9999999999999999999999887653332 2213455778999976110 002235888999995
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=7.5e-15 Score=144.10 Aligned_cols=152 Identities=18% Similarity=0.245 Sum_probs=94.5
Q ss_pred ccccccccccccccceEEEEEEE-C-CceEEEEEeeCCCCCh----------------------------hHHHHHH---
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY-N-GEDVAIKILERPENNP----------------------------EKAQVME--- 180 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~-~-~~~vavK~~~~~~~~~----------------------------~~~~~~~--- 180 (343)
+.+|.. +.||+|++|+||+|+. + |+.||||+.++..... +-.....
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 445655 7899999999999998 4 8999999997543111 0001111
Q ss_pred ---HHHHHHHHHHhcCC----CCCcceEEEEEEe-CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q 019304 181 ---QQFQQEVMMLATLK----HLNIVRFIGACRK-RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMA 252 (343)
Q Consensus 181 ---~~~~~E~~~l~~l~----h~nIv~l~~~~~~-~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~ 252 (343)
-++.+|+..+.+++ +...+.+-.++.+ ....++||||++|+.+.++..-.. ...+.........+ .-+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~-~g~d~~~la~~~v~--~~~~ 274 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA-AGTDMKLLAERGVE--VFFT 274 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh-cCCCHHHHHHHHHH--HHHH
Confidence 23455555554442 4333333333321 223479999999999987532111 11222222211111 1233
Q ss_pred HHHhCCceeCCCCCCcEEEcCCC----cEEEeccccccccc
Q 019304 253 YVHGLGFIHRDLKSDNLLISADK----SIKIADFGVARIEV 289 (343)
Q Consensus 253 yLH~~giiHrDlkp~NILv~~~~----~vkl~DFg~a~~~~ 289 (343)
.+...|++|+|+||.||+++.++ .++++|||++....
T Consensus 275 Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 275 QVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 45579999999999999999888 99999999987543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=4e-15 Score=150.25 Aligned_cols=158 Identities=23% Similarity=0.355 Sum_probs=110.5
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
.+|..++.|..|++|.||..++ ..+++|+|+-+. . .+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~-----------lilRn--ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-N-----------LILRN--ILTFAGNPFVV------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhccccc-c-----------hhhhc--cccccCCccee-------------
Confidence 5677889999999999999987 467899954321 1 11111 22222333332
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~- 291 (343)
|+-...++.. ++++.. ++.+++|||+.||+|||+||+|.||..-|++|+.|||+++.....
T Consensus 136 --------gDc~tllk~~--g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 --------GDCATLLKNI--GPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred --------chhhhhcccC--CCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 4444555432 223332 267899999999999999999999999999999999998742110
Q ss_pred ---------------CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCccCC
Q 019304 292 ---------------EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRHIL 342 (343)
Q Consensus 292 ---------------~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~~~ 342 (343)
-.-+..||||.|.|||++ ..+.|...+|+|++.+ .++--||+++||
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi-----lrqgygkpvdwwamGiIlyeFLVgcvpffGdtp 263 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI-----LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 263 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhh-----hhhccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence 012345899999999999 8899999999996444 335556777654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.52 E-value=6e-14 Score=118.22 Aligned_cols=127 Identities=16% Similarity=0.167 Sum_probs=95.8
Q ss_pred cccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCeEEEEEEecC
Q 019304 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVWCIVTEYAK 219 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~iv~E~~~ 219 (343)
+.|+.|.++.||+++..++.+++|+........ ..+.+|+.+++.+.+.++ .+++..... ..++||||++
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~~-------~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i~ 74 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTELL-------INRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFIE 74 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcccc-------cCHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEecC
Confidence 568899999999999999999999976543211 235678888888765443 455554432 3479999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 220 GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF-----IHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 220 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~gi-----iHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
|.++.+.. . ....++.+++.+|..||+.++ +|+|++|.||+++ ++.++++||+.+..
T Consensus 75 G~~l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCcccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 98775430 1 113356789999999999885 9999999999999 67899999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.3e-15 Score=154.01 Aligned_cols=186 Identities=18% Similarity=0.192 Sum_probs=135.3
Q ss_pred ccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~ 215 (343)
++...+.||++.|=+|.+|+++...|+||++-+....-.- ...++ -+.|++ ....+|||.+.+.-+.......|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL-~~~~q-rL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISL-RPFKQ-RLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCc-hHHHH-HHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 5667789999999999999996666999998765532221 11222 234444 55669999999888877777778999
Q ss_pred EecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc--ccC--
Q 019304 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE--VQT-- 291 (343)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~--~~~-- 291 (343)
+|... +|+|.+..+. -+...+..-|+.|++.||+.+|..||+|+|||.+||||+.=+-+.|+||..-+.. +.+
T Consensus 101 qyvkh-nLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHhh-hhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 99965 9999987543 2566667778999999999999999999999999999999999999999765421 111
Q ss_pred CCccCC----CCCcceecCCCCCCCC-----CC-CCCCceeeeeee
Q 019304 292 EGMTPE----TGTYRWMAPGNSFFSP-----LP-HPSFEHKWSAKE 327 (343)
Q Consensus 292 ~~~~~~----~gt~~y~APE~~~~~~-----~~-~~~~~~~sDi~~ 327 (343)
...+-+ ..-.+|+|||.+.... .. ....+++-|||+
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS 223 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFS 223 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhh
Confidence 111111 2237899999995411 11 122678889995
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.7e-12 Score=107.06 Aligned_cols=148 Identities=22% Similarity=0.308 Sum_probs=108.8
Q ss_pred ccccccccceEEEEEEECCceEEEEEe-eCCCCChh-HHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEe
Q 019304 140 GTAFAQGAFGKLYRGTYNGEDVAIKIL-ERPENNPE-KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 140 ~~~lg~G~fg~Vy~~~~~~~~vavK~~-~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
...+-+|+-+.|+++.+.|+...||.- .+....+. +.+...++..+|++++.++.--.|.-.-=++.+...-.|+|||
T Consensus 12 l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred ceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 467889999999999999999888853 23333332 2333457788999999988644443322233344444789999
Q ss_pred cCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC---cEEEeccccccc
Q 019304 218 AKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SIKIADFGVARI 287 (343)
Q Consensus 218 ~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~---~vkl~DFg~a~~ 287 (343)
++| .++.+++................+.+|-+.+.-||..+|||+||..+||++.+++ .+.++|||++..
T Consensus 92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 976 4788888765544344444478888898999999999999999999999997655 458999999875
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.4e-12 Score=110.78 Aligned_cols=140 Identities=14% Similarity=0.143 Sum_probs=98.8
Q ss_pred cccccccceEEEEEEEC--------CceEEEEEeeCCCCChh--------------------HHHHHHHHHHHHHHHHhc
Q 019304 141 TAFAQGAFGKLYRGTYN--------GEDVAIKILERPENNPE--------------------KAQVMEQQFQQEVMMLAT 192 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~--------~~~vavK~~~~~~~~~~--------------------~~~~~~~~~~~E~~~l~~ 192 (343)
..||.|--+.||.|... +..+|||+++.....=. .......-..+|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999753 36899999764321100 011111223489999998
Q ss_pred CCC--CCcceEEEEEEeCCeEEEEEEecCCCCHHH-HHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeCCCCCCc
Q 019304 193 LKH--LNIVRFIGACRKRMVWCIVTEYAKGGSVRQ-FLTRRQNRAVPLKLAVKQALDVARGMAYV-HGLGFIHRDLKSDN 268 (343)
Q Consensus 193 l~h--~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~-~l~~~~~~~~~~~~~~~i~~qi~~gL~yL-H~~giiHrDlkp~N 268 (343)
+.. -++...+++ ..-+|||||+.+..+.. .++. ..++......+..+++.+|..| |+.|+||+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 853 566777764 23479999997654422 2221 2245556677789999999998 89999999999999
Q ss_pred EEEcCCCcEEEecccccccc
Q 019304 269 LLISADKSIKIADFGVARIE 288 (343)
Q Consensus 269 ILv~~~~~vkl~DFg~a~~~ 288 (343)
||+. ++.++|+|||.+...
T Consensus 156 IL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred EEEE-CCcEEEEECCCceeC
Confidence 9997 577999999988653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=3e-12 Score=107.15 Aligned_cols=138 Identities=22% Similarity=0.310 Sum_probs=102.3
Q ss_pred cccccccceEEEEEEECCceEEEEEe-eCCCCChhHHH-HHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEec
Q 019304 141 TAFAQGAFGKLYRGTYNGEDVAIKIL-ERPENNPEKAQ-VMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~~~~vavK~~-~~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~ 218 (343)
..+++|+-+.++.+.+-|.++++|.- .+.-..++-.+ ....+..+|+.++..++--.|...+=+..+.....|+|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 35789999999999888878777753 33344443322 23467889999999886554444333344455557999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
+|..|.+++... ...++..|-.-+.-||..||+|+||.++||++..++ +.++|||++.+.
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 998888888653 144566666677789999999999999999998554 999999999853
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.6e-14 Score=144.39 Aligned_cols=192 Identities=19% Similarity=0.265 Sum_probs=147.8
Q ss_pred ccccccccccccccceEEEEEEE---CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCC
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRM 209 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~ 209 (343)
...|.+.+.||+|+|+.|-.... ....+|+|.+..+.... ........|..+-+.+. |+|++.+++.....+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~----~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~ 94 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSE----DSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR 94 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCcc----chhhhcCccccccccccccccccccCCccCCCc
Confidence 35667778899999999987765 33457777776554221 11245566888888886 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCCCcEEEcCCC-cEEEeccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIHRDLKSDNLLISADK-SIKIADFGVARI 287 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH-~~giiHrDlkp~NILv~~~~-~vkl~DFg~a~~ 287 (343)
..++++|+.+++++.+.+........+....-.++.|+..++.|+| ..++.|||+||+|.+++..+ ..|++|||+|..
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999999999988883222224666777889999999999999 99999999999999999999 999999999986
Q ss_pred ccc-CC---CccCCCC-CcceecCCCCCCCCCCCC-CCceeeeeeecccccccC
Q 019304 288 EVQ-TE---GMTPETG-TYRWMAPGNSFFSPLPHP-SFEHKWSAKESCLKTTWP 335 (343)
Q Consensus 288 ~~~-~~---~~~~~~g-t~~y~APE~~~~~~~~~~-~~~~~sDi~~~~~~~~~~ 335 (343)
... .. .....+| ++.|+|||.. ... ......|+| +++++.-.
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~-----~~~~~~~~~~d~~-S~g~~l~~ 222 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHL-----SGKAYRGPSVDVW-SLGIVLSA 222 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccc-----cchhhcCCCcccc-cccccccc
Confidence 544 22 2334578 9999999998 443 444777888 56555433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.35 E-value=5.9e-14 Score=133.04 Aligned_cols=113 Identities=27% Similarity=0.443 Sum_probs=97.3
Q ss_pred eEEEEEEecCCCCHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRR-QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
.+||.|++|+..+|.+++..+ .....+.-....++.|++.|++| ++.+|+|+||.||+...+..+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 579999999999999999743 34456778889999999999999 99999999999999999999999999998755
Q ss_pred ccCC-------CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 289 VQTE-------GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 289 ~~~~-------~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.... ..+..+||..||+||.+ .+..|+.|+|||++.+
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi-----~g~~y~~kvdIyaLGl 450 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQI-----RGQQYSEKVDIYALGL 450 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHH-----hhhhhhhhcchhhHHH
Confidence 4433 34566899999999999 8999999999996433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.6e-12 Score=123.61 Aligned_cols=141 Identities=25% Similarity=0.358 Sum_probs=112.0
Q ss_pred HhcCCCCCcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-eeCCCCCCc
Q 019304 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF-IHRDLKSDN 268 (343)
Q Consensus 190 l~~l~h~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~gi-iHrDlkp~N 268 (343)
|+.+.|.|+.+++|.+.+....++|.+|+..|+|.+.+.. ....+++.....+.++++.||.|||...| .|+.|+..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 4678999999999999999999999999999999999986 34457777888889999999999998865 999999999
Q ss_pred EEEcCCCcEEEeccccccccccC---CCccCCCCCcceecCCCCCCCCCC--CCCCceeeeeeecccc
Q 019304 269 LLISADKSIKIADFGVARIEVQT---EGMTPETGTYRWMAPGNSFFSPLP--HPSFEHKWSAKESCLK 331 (343)
Q Consensus 269 ILv~~~~~vkl~DFg~a~~~~~~---~~~~~~~gt~~y~APE~~~~~~~~--~~~~~~~sDi~~~~~~ 331 (343)
++++..-.+||+|||+..+.... .......-...|.|||.+-..... .+..+.+.|+|++.++
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii 147 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGII 147 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHH
Confidence 99999999999999998765421 111122345789999998332111 1236788999965553
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.7e-11 Score=106.28 Aligned_cols=139 Identities=19% Similarity=0.270 Sum_probs=102.2
Q ss_pred cccccccceEEEEEEECC-ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCC--CCcceEEEEEEeCC---eEEEE
Q 019304 141 TAFAQGAFGKLYRGTYNG-EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRFIGACRKRM---VWCIV 214 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~---~~~iv 214 (343)
+.|+.|..+.||++...+ +.+++|+........ ....+.+|..+++.+++ ..+.+++....... ..++|
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~-----~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v 78 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLP-----SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYV 78 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCc-----ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEE
Confidence 568999999999998854 899999976543311 11357899999999875 34577777766542 56899
Q ss_pred EEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 019304 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-------------------------------------- 256 (343)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-------------------------------------- 256 (343)
|||++|.++.+.+.. ..++......++.+++..|..||+
T Consensus 79 ~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 79 MERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 999999877665421 235555566666666666666663
Q ss_pred ------------------CCceeCCCCCCcEEEcC--CCcEEEeccccccc
Q 019304 257 ------------------LGFIHRDLKSDNLLISA--DKSIKIADFGVARI 287 (343)
Q Consensus 257 ------------------~giiHrDlkp~NILv~~--~~~vkl~DFg~a~~ 287 (343)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24699999999999998 67789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.9e-10 Score=102.98 Aligned_cols=140 Identities=16% Similarity=0.105 Sum_probs=97.8
Q ss_pred ceEEEEEEECCceEEEEEeeCCCCChhHHH-----HHHHHHHHHHHHHhcCCCCCc--ceEEEEEEe-----CCeEEEEE
Q 019304 148 FGKLYRGTYNGEDVAIKILERPENNPEKAQ-----VMEQQFQQEVMMLATLKHLNI--VRFIGACRK-----RMVWCIVT 215 (343)
Q Consensus 148 fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~nI--v~l~~~~~~-----~~~~~iv~ 215 (343)
...|.+..+.|+.+.||.........--.. .-...+.+|...+..|...+| +..+++... ...-++||
T Consensus 35 ~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 35 GRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred CceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 344778888999999997743321100000 000136788888877743333 334444332 22457999
Q ss_pred EecCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-------CCcEEEeccccccc
Q 019304 216 EYAKGG-SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-------DKSIKIADFGVARI 287 (343)
Q Consensus 216 E~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~-------~~~vkl~DFg~a~~ 287 (343)
|++++. +|.+++........+......++.+++..+.-||..||+|+|+++.|||++. +..+.|+||+.++.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999875 7999886443344566777889999999999999999999999999999975 46899999998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.2e-10 Score=98.10 Aligned_cols=129 Identities=22% Similarity=0.300 Sum_probs=81.9
Q ss_pred EEEEEEE-CCceEEEEEeeCCCCC--------------------hhHHHHHHHHHHHHHHHHhcCCCC--CcceEEEEEE
Q 019304 150 KLYRGTY-NGEDVAIKILERPENN--------------------PEKAQVMEQQFQQEVMMLATLKHL--NIVRFIGACR 206 (343)
Q Consensus 150 ~Vy~~~~-~~~~vavK~~~~~~~~--------------------~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~ 206 (343)
.||.|.. ++..+|||+.+..... ............+|.+.|..+... ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899987 7889999997642110 011122345678999999999765 566776542
Q ss_pred eCCeEEEEEEecC--CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH-HHhCCceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 207 KRMVWCIVTEYAK--GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY-VHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 207 ~~~~~~iv~E~~~--~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~y-LH~~giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
.. .|||||++ |..+..+.... ++......++.+++..+.. +|..||+|+||.+.|||++++ .+.|+|||
T Consensus 80 -~~--~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~ 151 (188)
T PF01163_consen 80 -RN--VIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFG 151 (188)
T ss_dssp -TT--EEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GT
T ss_pred -CC--EEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecC
Confidence 32 69999998 65554433221 1123345566677775554 579999999999999999876 89999999
Q ss_pred cccc
Q 019304 284 VARI 287 (343)
Q Consensus 284 ~a~~ 287 (343)
.+..
T Consensus 152 qav~ 155 (188)
T PF01163_consen 152 QAVD 155 (188)
T ss_dssp TEEE
T ss_pred ccee
Confidence 8864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.4e-11 Score=113.52 Aligned_cols=181 Identities=19% Similarity=0.229 Sum_probs=142.1
Q ss_pred ccccccccccc--ccceEEEEEEE----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 019304 135 RKLNMGTAFAQ--GAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK 207 (343)
Q Consensus 135 ~~~~~~~~lg~--G~fg~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 207 (343)
..+...+.+|. |.+|.||.+.. ++..+|+|.-+.+...+... .+=.+|......+ .|++.++.+..+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~----~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS----KRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc----ccccchhhcccccCccccccccCccccc
Confidence 45566788999 99999998865 56789999855444422211 1224666666666 59999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHH----HHHHHHhCCceeCCCCCCcEEEcCC-CcEEEecc
Q 019304 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADF 282 (343)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~----gL~yLH~~giiHrDlkp~NILv~~~-~~vkl~DF 282 (343)
.+..++-+|++ +.+|.++..... ..++...++....+... ||.++|..+++|-|+||+||+...+ ..+++.||
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred CCcceeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence 99999999999 568888887543 34788888999999999 9999999999999999999999999 88999999
Q ss_pred ccccccccCCCc------cCCCCCcceecCCCCCCCCCCCCCCceeeeeee
Q 019304 283 GVARIEVQTEGM------TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKE 327 (343)
Q Consensus 283 g~a~~~~~~~~~------~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~ 327 (343)
|+...+....-. ....|...|++||.. ...++.+.|+++
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~------~~l~~~~~di~s 312 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL------NGLATFASDIFS 312 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh------ccccchHhhhcc
Confidence 998765544311 122578999999987 677888899985
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.2e-09 Score=92.01 Aligned_cols=106 Identities=21% Similarity=0.283 Sum_probs=82.3
Q ss_pred HHHHHHHHHHhcCCCC--CcceEEEEEEeCC----eEEEEEEecCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q 019304 181 QQFQQEVMMLATLKHL--NIVRFIGACRKRM----VWCIVTEYAKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253 (343)
Q Consensus 181 ~~~~~E~~~l~~l~h~--nIv~l~~~~~~~~----~~~iv~E~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~y 253 (343)
.+..+|...+..|... .....+++..... .-++|+|++++ .+|.+++..... .+......++.+++..+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 4577888877777433 3345555554422 34899999987 479999876332 5566678899999999999
Q ss_pred HHhCCceeCCCCCCcEEEcCCC---cEEEecccccccc
Q 019304 254 VHGLGFIHRDLKSDNLLISADK---SIKIADFGVARIE 288 (343)
Q Consensus 254 LH~~giiHrDlkp~NILv~~~~---~vkl~DFg~a~~~ 288 (343)
||+.||+|+|+++.|||++.++ .+.++||+-++..
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999999999999999877 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.4e-09 Score=106.51 Aligned_cols=118 Identities=15% Similarity=0.305 Sum_probs=99.9
Q ss_pred CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCC
Q 019304 157 NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP 236 (343)
Q Consensus 157 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~ 236 (343)
++.+|.|..++.... +. .....+-+..|+.++||+|++++..+.....+|||+|.+ ..|..++.+. .
T Consensus 36 ~~~~vsVF~~~~~~~--~~----~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l-----~ 102 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--EV----TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL-----G 102 (690)
T ss_pred cCCceEEEEEeCCCc--hh----hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh-----H
Confidence 678899988876555 11 134667788899999999999999999999999999999 4788888763 3
Q ss_pred HHHHHHHHHHHHHHHHHHH-hCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 237 LKLAVKQALDVARGMAYVH-GLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 237 ~~~~~~i~~qi~~gL~yLH-~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
......-+.||+.||.+|| .++++|++|..+.|+|+..|..||.+|.++..
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~ 154 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSK 154 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEec
Confidence 5566677899999999998 56899999999999999999999999998764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.5e-09 Score=104.77 Aligned_cols=144 Identities=17% Similarity=0.269 Sum_probs=95.7
Q ss_pred cccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHH----------------------------H------HHHHHHH
Q 019304 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQ----------------------------V------MEQQFQQ 185 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~----------------------------~------~~~~~~~ 185 (343)
+.|+.++-|+||+|++ +|+.||||+.++.-...-... . .+-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6899999999999999 699999999865443221111 0 1123455
Q ss_pred HHHHHhcCC-----CCC--cceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019304 186 EVMMLATLK-----HLN--IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258 (343)
Q Consensus 186 E~~~l~~l~-----h~n--Iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~g 258 (343)
|+..+.+++ .+. |.++|.-+..+. .++|||++|..+.++..... ...+.+.+.....++ -+..+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~--VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRR--VLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCc--EEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcC
Confidence 555555542 232 233443333333 79999999999998864332 335544443333332 244455689
Q ss_pred ceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 259 FIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 259 iiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
+.|.|.+|.||+|..+|.+.+.|||......
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999986543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.7e-09 Score=93.77 Aligned_cols=139 Identities=19% Similarity=0.220 Sum_probs=98.3
Q ss_pred ccccccccccceEEEEEEE-CCceEEEEEeeCCCCCh--------------hHH--HHHHHHHHHHHHHHhcCCCC--Cc
Q 019304 138 NMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNP--------------EKA--QVMEQQFQQEVMMLATLKHL--NI 198 (343)
Q Consensus 138 ~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~--------------~~~--~~~~~~~~~E~~~l~~l~h~--nI 198 (343)
.++.+||-|--+.||.|.. .|.++|||.-+....+- ... ........+|..+|++|... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4567899999999999988 69999999754221100 000 12234567899999998654 66
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEE
Q 019304 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278 (343)
Q Consensus 199 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vk 278 (343)
.+.+++ +...+|||+++|..|...- +..+..-.++..|+.-+.-+-..|+||+|+.+=||+|+++|.+.
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 666654 3457999999997665432 12233334455555555555589999999999999999999999
Q ss_pred Eeccccccc
Q 019304 279 IADFGVARI 287 (343)
Q Consensus 279 l~DFg~a~~ 287 (343)
++||-.+..
T Consensus 243 vIDwPQ~v~ 251 (304)
T COG0478 243 VIDWPQAVP 251 (304)
T ss_pred EEeCccccc
Confidence 999987754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.5e-10 Score=107.97 Aligned_cols=194 Identities=19% Similarity=0.108 Sum_probs=140.4
Q ss_pred cccccccccccccccceEEEEEEE---CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 208 (343)
...++..+..||.|.|+.|+.... ++..+++|.+.+.-...... ..-..|+.+...+ .|.++++++..|...
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d----i~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD----IFSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh----hcchhhhhHhhHhhcccccCCCCCCcccc
Confidence 346788899999999999998765 46678888776544333221 1223555555555 589999999999888
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-CcEEEeccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARI 287 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~-~~vkl~DFg~a~~ 287 (343)
...|+-.||++++++...... ...+.+...+++..|++.++.++|+..++|+|+||+||++..+ +..++.|||....
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred ccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence 888999999999988776633 2347788899999999999999999999999999999999876 7889999998763
Q ss_pred cccCCCccCCCCCccee--cCCCCCCCCCCCCCCceeeeeeec-----ccccccCCCCc
Q 019304 288 EVQTEGMTPETGTYRWM--APGNSFFSPLPHPSFEHKWSAKES-----CLKTTWPPPWR 339 (343)
Q Consensus 288 ~~~~~~~~~~~gt~~y~--APE~~~~~~~~~~~~~~~sDi~~~-----~~~~~~~p~~~ 339 (343)
..-. .......-.++ +|+.. ....+-.+.|++++ +.+++.+.+|.
T Consensus 417 ~~~~--~~~~~~~~r~~p~~~~~~-----e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~ 468 (524)
T KOG0601|consen 417 LAFS--SGVFHHIDRLYPIAEILL-----EDYPHLSKADIFSLGLSVDEAITGSPLSES 468 (524)
T ss_pred ccee--cccccccccccccchhhc-----cccccccccccccccccccccccCcccCcc
Confidence 2111 11112333344 44444 56677788888753 34556666654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.5e-09 Score=97.91 Aligned_cols=136 Identities=23% Similarity=0.300 Sum_probs=103.5
Q ss_pred HHhcCCCCCcceEEEEEEeCC-----eEEEEEEecCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC--Cc
Q 019304 189 MLATLKHLNIVRFIGACRKRM-----VWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGL--GF 259 (343)
Q Consensus 189 ~l~~l~h~nIv~l~~~~~~~~-----~~~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~--gi 259 (343)
-+-++.|.|||+++.+|.+.. ...+++|||+.|+|.++|++.+ ...+......+++.||+.||.|||+. -|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 344567999999999886543 4789999999999999998543 34577888899999999999999998 49
Q ss_pred eeCCCCCCcEEEcCCCcEEEecccccccc-----ccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 260 IHRDLKSDNLLISADKSIKIADFGVARIE-----VQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 260 iHrDlkp~NILv~~~~~vkl~DFg~a~~~-----~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+|+++..+-|++..+|-+|+.---..... ..........+.++|.|||.= .-..-+..+|||.+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg-----~~tn~~~a~dIy~fg 269 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG-----TTTNTTGASDIYKFG 269 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC-----cccccccchhhhhhh
Confidence 99999999999999998887432211110 011122334577999999976 667778899998654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.88 E-value=4.7e-08 Score=84.63 Aligned_cols=144 Identities=12% Similarity=0.093 Sum_probs=101.0
Q ss_pred ccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCC--CcceEEEEEEe--C--CeEEEEEEe
Q 019304 144 AQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL--NIVRFIGACRK--R--MVWCIVTEY 217 (343)
Q Consensus 144 g~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~--~--~~~~iv~E~ 217 (343)
|+||-+-|++..+.|+.+-+|.-..--...-....-+..|.+|...++.|... .+.+....... . -.-+||+|-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 55888889998888888888865310000000000124688999999888532 24444422111 1 235899998
Q ss_pred cCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc--EEEeccccccc
Q 019304 218 AKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVARI 287 (343)
Q Consensus 218 ~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~--vkl~DFg~a~~ 287 (343)
+++ .+|.+++....-.+.+......++.+++..+.-||+.|+.|+|+-+.|||++.++. ++++||.-++.
T Consensus 107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 853 68888886544344677777899999999999999999999999999999986666 99999987764
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.78 E-value=2e-07 Score=81.13 Aligned_cols=141 Identities=16% Similarity=0.219 Sum_probs=88.6
Q ss_pred cccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHH---HHHHHHHHHHhcCCC---CCcceEEEEEEe-
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVME---QQFQQEVMMLATLKH---LNIVRFIGACRK- 207 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~---~~~~~E~~~l~~l~h---~nIv~l~~~~~~- 207 (343)
.+|...+.+-.....-|.+-..+++.+++|..+....-.++.-... ....+++..+..++. .....++.+...
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk 110 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK 110 (229)
T ss_pred CCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence 4556666666666666777777999999998765443322211100 112233333333322 222333333322
Q ss_pred ----CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 208 ----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 208 ----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
....+++|||++|..|.++.. +++ .++..+..++.-||+.|+.|+|..|.|++++.++ ++++||+
T Consensus 111 ~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 111 IFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred eccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECc
Confidence 234468999999988876642 222 2345667789999999999999999999998554 9999998
Q ss_pred ccc
Q 019304 284 VAR 286 (343)
Q Consensus 284 ~a~ 286 (343)
..+
T Consensus 180 ~k~ 182 (229)
T PF06176_consen 180 GKR 182 (229)
T ss_pred ccc
Confidence 765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=6.3e-08 Score=94.79 Aligned_cols=144 Identities=19% Similarity=0.319 Sum_probs=94.5
Q ss_pred cccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHH-------------------------------HHHHHHHHHH
Q 019304 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQV-------------------------------MEQQFQQEVM 188 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~-------------------------------~~~~~~~E~~ 188 (343)
+.||..+.|+||+|+. +|+.||||+-++.-........ .+-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999998 8899999997654433211110 1123455554
Q ss_pred HHhc----CCCCC------cceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019304 189 MLAT----LKHLN------IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258 (343)
Q Consensus 189 ~l~~----l~h~n------Iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~g 258 (343)
-..+ ++|-+ |.++|..+.... .++||||+|..+.+.-.-. ...++...+..-+.+.. ++-|-..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~R--VLtME~~~G~~i~Dl~~i~-~~gi~~~~i~~~l~~~~--~~qIf~~G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKR--VLTMEYVDGIKINDLDAID-KRGISPHDILNKLVEAY--LEQIFKTG 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcce--EEEEEecCCccCCCHHHHH-HcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 4333 34555 566666555444 6999999998886654322 12355554433333322 23344578
Q ss_pred ceeCCCCCCcEEEcC----CCcEEEeccccccccc
Q 019304 259 FIHRDLKSDNLLISA----DKSIKIADFGVARIEV 289 (343)
Q Consensus 259 iiHrDlkp~NILv~~----~~~vkl~DFg~a~~~~ 289 (343)
++|+|-+|.||+|.+ ++.+.+.|||+.....
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999984 6789999999987543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1e-07 Score=91.12 Aligned_cols=138 Identities=17% Similarity=0.250 Sum_probs=106.5
Q ss_pred ceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe----CCeEEEEEEecCC-
Q 019304 148 FGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----RMVWCIVTEYAKG- 220 (343)
Q Consensus 148 fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~iv~E~~~~- 220 (343)
-.+.|++.. +|..+++|+++-...... .....-++.++++.|+|+|++.+++.. ...+++|++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~------nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s 362 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST------NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSS 362 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc------ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence 346888876 899999999843221111 112345778999999999999998863 3468999999875
Q ss_pred CCHHHHHHhh-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 221 GSVRQFLTRR-------------QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 221 gsL~~~l~~~-------------~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
++|.++.... .+...++..+|.++.|+..||.++|+.|+..+-|.|.+||++.+.+++|+..|...+
T Consensus 363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceee
Confidence 6777765432 122467899999999999999999999999999999999999888999998888776
Q ss_pred cccC
Q 019304 288 EVQT 291 (343)
Q Consensus 288 ~~~~ 291 (343)
...+
T Consensus 443 l~~d 446 (655)
T KOG3741|consen 443 LQED 446 (655)
T ss_pred ecCC
Confidence 5443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.3e-07 Score=82.19 Aligned_cols=136 Identities=14% Similarity=0.142 Sum_probs=84.5
Q ss_pred cccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCC--CcceEEEEEEeCCeEEEEEEec
Q 019304 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL--NIVRFIGACRKRMVWCIVTEYA 218 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~~~~~~iv~E~~ 218 (343)
..||+|..+.||+. .+..+++|+..... .. ....+|.++++.+..- .+.+.+++........+|||++
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-~~-------~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-DK-------ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC-CH-------HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence 46899999999984 35577889886433 11 2357889888888543 3467788887777788999999
Q ss_pred CCCC-HH--------------HHHHh----hCC---CCCCHHHHH-HHHH----------HHHH-HHHHHHh----CCce
Q 019304 219 KGGS-VR--------------QFLTR----RQN---RAVPLKLAV-KQAL----------DVAR-GMAYVHG----LGFI 260 (343)
Q Consensus 219 ~~gs-L~--------------~~l~~----~~~---~~~~~~~~~-~i~~----------qi~~-gL~yLH~----~gii 260 (343)
+|.. +. ..+.+ -.. ...+..... .+.. .+.. ...+|.+ ..++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 9863 11 11111 110 011111110 0100 1111 1223331 2478
Q ss_pred eCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 261 HRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 261 HrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
|+|+.|.||++++++ +.|+||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.7e-07 Score=78.32 Aligned_cols=136 Identities=21% Similarity=0.298 Sum_probs=97.6
Q ss_pred cccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcc-eEEEEEEeCCeE
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV-RFIGACRKRMVW 211 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~ 211 (343)
.....+..+.|++|.++.||+|.|.+..+|+|+-..+... ..+..|+++|..++-.++. ++|.+..+
T Consensus 20 ~~~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r--------~~l~kEakiLeil~g~~~~p~vy~yg~~---- 87 (201)
T COG2112 20 GKYELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSPR--------RNLEKEAKILEILAGEGVTPEVYFYGED---- 87 (201)
T ss_pred cchhhhhhhhhhcccccEEEEeeccCceEEEEEecCCcch--------hhHHHHHHHHHHhhhcCCCceEEEechh----
Confidence 3445567788999999999999999999999987654322 4688999999999876664 45555443
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC-CCcEEEcCCCcEEEeccccccccc
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK-SDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlk-p~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
++.|||++|-+|.+.... ...+. ...+++.---|-..||-|..|. |...+|..++.+.|+||..|+...
T Consensus 88 ~i~me~i~G~~L~~~~~~-----~~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIG-----GDRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred hhhhhhhcCcchhhhhhc-----ccHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 466999999888777542 12233 3344445444667799999985 455555556699999999998543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.61 E-value=5e-07 Score=79.57 Aligned_cols=140 Identities=20% Similarity=0.192 Sum_probs=92.6
Q ss_pred ccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHH-----------------HH-HHHHHHHHHHhcCC--CCCcce
Q 019304 142 AFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQV-----------------ME-QQFQQEVMMLATLK--HLNIVR 200 (343)
Q Consensus 142 ~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~-----------------~~-~~~~~E~~~l~~l~--h~nIv~ 200 (343)
.|.+|--+.||+|.. ++..+|||+++.....-.+... .. .=...|...|+++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 577788889999976 7889999998754433222111 11 11245666666663 333444
Q ss_pred EEEEEEeCCeEEEEEEecCCCC-HHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEE
Q 019304 201 FIGACRKRMVWCIVTEYAKGGS-VRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIK 278 (343)
Q Consensus 201 l~~~~~~~~~~~iv~E~~~~gs-L~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~giiHrDlkp~NILv~~~~~vk 278 (343)
.+++.. -.+||||+.... -.-.| ..-++..+.+..+..++++.+.-|-. .+++|+||..=|||+. ++.+.
T Consensus 135 Pi~~~~----nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 135 PIAFRN----NVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred ceeecC----CeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 444322 269999995431 11111 11123333577778888888888776 8999999999999999 89999
Q ss_pred Eeccccccccc
Q 019304 279 IADFGVARIEV 289 (343)
Q Consensus 279 l~DFg~a~~~~ 289 (343)
|+||+.|....
T Consensus 207 iID~~QaV~~~ 217 (268)
T COG1718 207 IIDVSQAVTID 217 (268)
T ss_pred EEECccccccC
Confidence 99999987544
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=8.6e-07 Score=83.05 Aligned_cols=182 Identities=18% Similarity=0.216 Sum_probs=125.0
Q ss_pred ccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcce--------EEEEEEeC
Q 019304 138 NMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVR--------FIGACRKR 208 (343)
Q Consensus 138 ~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~--------l~~~~~~~ 208 (343)
..++.||+|+-+.+|-.---+ ..+-|+++.+.-.... +.+..|... .||-+-. ++|- ...
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~-d~VAKIYh~Pppa~~a---------qk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~ 82 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR-DQVAKIYHAPPPAAQA---------QKVAELAATPDAPLLNYRVAWPQATLHGG-RRG 82 (637)
T ss_pred CCCccccCCccceeeecchhh-chhheeecCCCchHHH---------HHHHHhccCCCCcchhhhhcccHHHhhCC-Ccc
Confidence 456789999999999543222 3345888776654321 122333333 5664332 1221 122
Q ss_pred CeEEEEEEecCCCC-HHHHHH---hhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 209 MVWCIVTEYAKGGS-VRQFLT---RRQN-RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 209 ~~~~iv~E~~~~gs-L~~~l~---~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
..+.+.|..+.+.. +..++. +++. ....|..+++.++.++.+.+-||+.|..-+|+.++|+||++++.|.|.|-+
T Consensus 83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccc
Confidence 34778898887643 233332 1121 235688899999999999999999999999999999999999999999877
Q ss_pred cccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 284 VARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.-.+...+......+|.+.|++||...-..+.+-.-+...|.|.++.
T Consensus 163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLav 209 (637)
T COG4248 163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAV 209 (637)
T ss_pred ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHH
Confidence 66655555566677899999999987545556667778889986444
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.2e-06 Score=73.75 Aligned_cols=132 Identities=19% Similarity=0.326 Sum_probs=94.8
Q ss_pred ccccccccccccccc-eEEEEEEECCceEEEEEeeC---CCC--------Ch----hHHHHHHHHHHHHHHHHhcCC---
Q 019304 134 LRKLNMGTAFAQGAF-GKLYRGTYNGEDVAIKILER---PEN--------NP----EKAQVMEQQFQQEVMMLATLK--- 194 (343)
Q Consensus 134 ~~~~~~~~~lg~G~f-g~Vy~~~~~~~~vavK~~~~---~~~--------~~----~~~~~~~~~~~~E~~~l~~l~--- 194 (343)
..+++.++.||.|.- |.||++..+|+.+|+|++.. ... .. .........|..|.+...+|+
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 378889999999999 99999999999999999321 000 00 011133457899999877775
Q ss_pred CCCc--ceEEEEEEeC------------------CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 019304 195 HLNI--VRFIGACRKR------------------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254 (343)
Q Consensus 195 h~nI--v~l~~~~~~~------------------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yL 254 (343)
+.++ |+.+|+..-. ..+.||-||++... .+. .+-+.+|.+-|.-+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHHH
Confidence 4566 8888887322 13578888886643 122 23355666778889
Q ss_pred HhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 255 H~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
|..||+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999987 3588999864
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.3e-06 Score=76.53 Aligned_cols=137 Identities=16% Similarity=0.143 Sum_probs=84.5
Q ss_pred ccccccc-eEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeEEEEEEecC
Q 019304 142 AFAQGAF-GKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTEYAK 219 (343)
Q Consensus 142 ~lg~G~f-g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~iv~E~~~ 219 (343)
.|..|.. ..||+....+..+.||+..... . ..+.+|+.+++.+. +--+.++++.....+..++|||+++
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~--~-------~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 75 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP--T-------YELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVP 75 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc--c-------cchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeC
Confidence 3455555 6899998777788889875432 1 23557888877773 3446678887776666789999999
Q ss_pred CCCHHHHH----------------HhhCCC-----CCCHH--HHHHHHH--------------------HHHHHHHHHH-
Q 019304 220 GGSVRQFL----------------TRRQNR-----AVPLK--LAVKQAL--------------------DVARGMAYVH- 255 (343)
Q Consensus 220 ~gsL~~~l----------------~~~~~~-----~~~~~--~~~~i~~--------------------qi~~gL~yLH- 255 (343)
|.+|.... .+-... ++... ....... .+...+..|-
T Consensus 76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 155 (244)
T cd05150 76 GVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEA 155 (244)
T ss_pred CccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHh
Confidence 97776432 111110 11100 0000000 0111122221
Q ss_pred ------hCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 256 ------GLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 256 ------~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
...++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 156 TRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred hCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 12489999999999999888889999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.36 E-value=7.3e-06 Score=72.00 Aligned_cols=139 Identities=19% Similarity=0.228 Sum_probs=82.2
Q ss_pred cccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCC--CcceEEEEEEe---CCeEEEEE
Q 019304 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL--NIVRFIGACRK---RMVWCIVT 215 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~---~~~~~iv~ 215 (343)
+.|+.|..+.||+...++..+++|..... .....+.+|..+++.+... .+.+++..... ....+++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH--------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC--------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 57899999999999997789999997543 1124567888888777433 35567764432 33578999
Q ss_pred EecCCCCHHH----------------HHHh---h--CCCCCCHHH---------HHHH------------HHHHHH-HHH
Q 019304 216 EYAKGGSVRQ----------------FLTR---R--QNRAVPLKL---------AVKQ------------ALDVAR-GMA 252 (343)
Q Consensus 216 E~~~~gsL~~----------------~l~~---~--~~~~~~~~~---------~~~i------------~~qi~~-gL~ 252 (343)
++++|..+.. .+.. . ......... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987776 1111 1 001111100 0000 011222 233
Q ss_pred HHHh-------CCceeCCCCCCcEEEc-CCCcEEEeccccccc
Q 019304 253 YVHG-------LGFIHRDLKSDNLLIS-ADKSIKIADFGVARI 287 (343)
Q Consensus 253 yLH~-------~giiHrDlkp~NILv~-~~~~vkl~DFg~a~~ 287 (343)
.+++ ..++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 3332 3599999999999999 666678999998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=7e-08 Score=98.76 Aligned_cols=198 Identities=19% Similarity=0.167 Sum_probs=132.2
Q ss_pred eecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
......+.+.+.+-+|+++.++.+.- .+...++|+......-... ..+...++-.++-..++|.+++..-.+...
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~---~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r 876 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTN---DYESIRSKSNILITPRSPAVVRSFPSFPCR 876 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccc---cccccCCccCccccCCCCceecccCCCCCC
Confidence 34556677778889999999988765 4444555554322211100 011223333344344567666665555566
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
...+++++|+.+++|...++... +.+.+-+......+..+++|||...+.|+|++|.|+|+..++..++.||+.....
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccc
Confidence 67899999999999999887543 3455555666778888999999999999999999999999999999999833211
Q ss_pred cc---------------------C-----------CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----c
Q 019304 289 VQ---------------------T-----------EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----K 331 (343)
Q Consensus 289 ~~---------------------~-----------~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~ 331 (343)
.- . .......||+.|.|||.. .+..-...+|+|.... .
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~-----lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEIL-----LGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccc-----ccccCCCcchhhhhhhhhhhhh
Confidence 00 0 001123589999999999 7777788888774332 3
Q ss_pred cccCCCC
Q 019304 332 TTWPPPW 338 (343)
Q Consensus 332 ~~~~p~~ 338 (343)
++-|||-
T Consensus 1030 ~g~pp~n 1036 (1205)
T KOG0606|consen 1030 TGIPPFN 1036 (1205)
T ss_pred cCCCCCC
Confidence 3555553
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.29 E-value=7.7e-06 Score=85.79 Aligned_cols=77 Identities=13% Similarity=0.198 Sum_probs=55.0
Q ss_pred cccccccceEEEEEEECC----ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCc--ceEEEEEEeC---Ce
Q 019304 141 TAFAQGAFGKLYRGTYNG----EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNI--VRFIGACRKR---MV 210 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI--v~l~~~~~~~---~~ 210 (343)
+.++.|.+..+|+....+ ..+++|+......... ...+.+|..+++.+. |+++ .+++.+|.+. ..
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~-----~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~ 118 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS-----AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT 118 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc-----HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence 578999999999987743 4677776543222111 135779999999985 6654 7888888764 35
Q ss_pred EEEEEEecCCCC
Q 019304 211 WCIVTEYAKGGS 222 (343)
Q Consensus 211 ~~iv~E~~~~gs 222 (343)
.|+||||++|..
T Consensus 119 ~flVME~v~G~~ 130 (822)
T PLN02876 119 AFYIMEYLEGRI 130 (822)
T ss_pred ceEEEEecCCcc
Confidence 689999998864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=5.3e-07 Score=88.32 Aligned_cols=169 Identities=19% Similarity=0.164 Sum_probs=120.0
Q ss_pred cccccccccceEEEEEEECCc-eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCC-cceEEEEEEeCCeEEEEEE
Q 019304 139 MGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN-IVRFIGACRKRMVWCIVTE 216 (343)
Q Consensus 139 ~~~~lg~G~fg~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~iv~E 216 (343)
..+.++++++++++|.+...+ ....+.+... ....-++++|.+++||| .+..++-+..+...+++++
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-----------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc-----------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 445678899999999876332 2334444322 12346788999999999 7788888888888999999
Q ss_pred ecCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCcc
Q 019304 217 YAKGG-SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMT 295 (343)
Q Consensus 217 ~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~~ 295 (343)
++.++ +...... .....+..-....+++.-.++++++|+.--+|+| ||+.. ++..|..||+...........+
T Consensus 315 i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~~~~ 388 (829)
T KOG0576|consen 315 ICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTMKPR 388 (829)
T ss_pred hhcCCccccccCC-hhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCcccccc
Confidence 99876 2211110 0011123333455566777899999998778998 77765 4789999999887665544455
Q ss_pred CCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 296 PETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 296 ~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+..+|+.|+|||+. ....+..+.|.|+..
T Consensus 389 t~~~~~~~~~pev~-----~~~~~~~~p~~~~~~ 417 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVI-----QENTIDGCPDSGSLA 417 (829)
T ss_pred cCCCCCCCCCchhh-----cccccccCCCccCCC
Confidence 66899999999999 788899999999654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.18 E-value=5.3e-06 Score=71.25 Aligned_cols=101 Identities=23% Similarity=0.319 Sum_probs=80.0
Q ss_pred HHHHHHHhcCCC-CCcceEEEEEEeCCeEEEEEEecCCCCHHHHHHh-hCCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 019304 184 QQEVMMLATLKH-LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTR-RQNRAVPLKLAVKQALDVARGMAYVHG---LG 258 (343)
Q Consensus 184 ~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~qi~~gL~yLH~---~g 258 (343)
..|.-+++.+++ +++++++|.|.. ++|+||...+++...... .+-...++..+.++|.+++..+.+|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468889999976 699999999954 689999987666421000 011236899999999999999999997 34
Q ss_pred ceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 259 FIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 259 iiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
+.-.|++++|+-|++++++|++|.+.+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 778899999999999999999999977653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.18 E-value=5e-05 Score=65.68 Aligned_cols=139 Identities=17% Similarity=0.273 Sum_probs=93.6
Q ss_pred ccccccccceEEEEEEECCceEEEEEeeCCCCChhH----------HHHHHHHHHHHHHHHhcCC------CCCcceEEE
Q 019304 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEK----------AQVMEQQFQQEVMMLATLK------HLNIVRFIG 203 (343)
Q Consensus 140 ~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~----------~~~~~~~~~~E~~~l~~l~------h~nIv~l~~ 203 (343)
...||+|+.-.||.-- ......||+.......... .....++..+|+.-...+. +.+|.++||
T Consensus 6 ~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 3579999999998532 3445688998765500000 0001245666766655555 789999999
Q ss_pred EEEeCCeEEEEEEecCC------CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC--C
Q 019304 204 ACRKRMVWCIVTEYAKG------GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD--K 275 (343)
Q Consensus 204 ~~~~~~~~~iv~E~~~~------gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~--~ 275 (343)
...++..+.+|+|.+.+ -+|.+++... .++. ...+.+ -.-..||-+.+|+.+||+|.||++... +
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L---~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQAL---DEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHH---HHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 99999999999999854 4578887542 2444 333333 344568889999999999999999632 2
Q ss_pred --cEEEec-ccccc
Q 019304 276 --SIKIAD-FGVAR 286 (343)
Q Consensus 276 --~vkl~D-Fg~a~ 286 (343)
.+.|+| ||...
T Consensus 158 ~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 158 EFRLVLIDGLGEKE 171 (199)
T ss_pred ceEEEEEeCCCCcc
Confidence 577777 56544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.9e-05 Score=70.23 Aligned_cols=30 Identities=30% Similarity=0.555 Sum_probs=26.2
Q ss_pred CceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 258 GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 258 giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
+++|+|+.+.|||++.++...|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 489999999999998776678999998764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00015 Score=66.90 Aligned_cols=76 Identities=16% Similarity=0.128 Sum_probs=55.6
Q ss_pred ccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCC---CCcceEEEEEEeC---CeEEE
Q 019304 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH---LNIVRFIGACRKR---MVWCI 213 (343)
Q Consensus 140 ~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~~---~~~~i 213 (343)
.+.||.|..+.||+....+..+.+|..+. .... ..+.+|...++.+.. -.+.++++++... +..++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~-~~~~-------~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGNPMPLMARS-FSTP-------GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeecCCccceeEEEEEcCCCCEEEEEecc-cccc-------hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 45799999999999877555677787533 1111 357899999988843 3678888887543 55799
Q ss_pred EEEecCCCCH
Q 019304 214 VTEYAKGGSV 223 (343)
Q Consensus 214 v~E~~~~gsL 223 (343)
|||++++.++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998754
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00017 Score=66.88 Aligned_cols=141 Identities=18% Similarity=0.203 Sum_probs=80.5
Q ss_pred cccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCC--CcceEEEEE------EeCCe
Q 019304 139 MGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL--NIVRFIGAC------RKRMV 210 (343)
Q Consensus 139 ~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~------~~~~~ 210 (343)
..+.++.|....+|+...++..+++|+.+.... . ..+..|.+++..|... .+.+++... ...+.
T Consensus 26 ~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~-~-------~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTDVGRYILTLYEKRVK-A-------EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred eccccCCccccceEEEEeCCCcEEEEEecCCCC-H-------HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 346678887789999877666788998754221 1 1234455555555321 233433321 12345
Q ss_pred EEEEEEecCCCCHH-----------HHH---Hhh-CCC--C----CCHH---HHH------------HHHHHHHHHHHHH
Q 019304 211 WCIVTEYAKGGSVR-----------QFL---TRR-QNR--A----VPLK---LAV------------KQALDVARGMAYV 254 (343)
Q Consensus 211 ~~iv~E~~~~gsL~-----------~~l---~~~-~~~--~----~~~~---~~~------------~i~~qi~~gL~yL 254 (343)
.++++||++|..+. ..+ +.. ..- . .... ... .....+...++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 78999999885431 111 110 000 0 0000 000 0011233445555
Q ss_pred Hh-------CCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 255 HG-------LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 255 H~-------~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
.. .+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 42 5799999999999999888779999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00016 Score=66.43 Aligned_cols=139 Identities=19% Similarity=0.188 Sum_probs=82.7
Q ss_pred ccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCC--CcceEEEE------EEeCCeE
Q 019304 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL--NIVRFIGA------CRKRMVW 211 (343)
Q Consensus 140 ~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~------~~~~~~~ 211 (343)
.+.|..|....+|+...++..+++|+... ... ..+..|+.++..+.+. .+.+++.. ....+..
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~--~~~-------~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK--VSA-------EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC--CCh-------HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 45677788889999887777899998764 111 2355677776666432 24444332 1233456
Q ss_pred EEEEEecCCCCHHH-----------HHH---hh-CC--CC------CCHHHH----------HHHHHHHHHHHHHHHh--
Q 019304 212 CIVTEYAKGGSVRQ-----------FLT---RR-QN--RA------VPLKLA----------VKQALDVARGMAYVHG-- 256 (343)
Q Consensus 212 ~iv~E~~~~gsL~~-----------~l~---~~-~~--~~------~~~~~~----------~~i~~qi~~gL~yLH~-- 256 (343)
++|++|++|..+.. .+. .. .. .. ..+... ......+...+.++.+
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999999866421 111 00 00 00 000000 0011112334445543
Q ss_pred -----CCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 257 -----LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 257 -----~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
.+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4699999999999999887789999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.84 E-value=1.3e-05 Score=79.45 Aligned_cols=88 Identities=16% Similarity=0.199 Sum_probs=66.6
Q ss_pred HHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEeccccccccccCCC-----ccC-----CCCCcceecCCCCCCC
Q 019304 244 ALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-----MTP-----ETGTYRWMAPGNSFFS 312 (343)
Q Consensus 244 ~~qi~~gL~yLH~~-giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~-----~~~-----~~gt~~y~APE~~~~~ 312 (343)
+.+++.||.|+|.. ++||+.|.|++|.++..+..||+.|+++........ +.. ......|.|||++
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~--- 181 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL--- 181 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh---
Confidence 34555899999976 899999999999999999999999998764332111 111 1245899999999
Q ss_pred CCCCCCCceeeeeeecccccccCCC
Q 019304 313 PLPHPSFEHKWSAKESCLKTTWPPP 337 (343)
Q Consensus 313 ~~~~~~~~~~sDi~~~~~~~~~~p~ 337 (343)
.+..-+.++|++ +.++.+|+-+
T Consensus 182 --~~~~~~~~sd~f-SlG~li~~i~ 203 (700)
T KOG2137|consen 182 --LGTTNTPASDVF-SLGVLIYTIY 203 (700)
T ss_pred --ccccccccccce-eeeeEEEEEe
Confidence 788888999999 4555544444
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00065 Score=63.21 Aligned_cols=31 Identities=39% Similarity=0.462 Sum_probs=26.8
Q ss_pred CCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 257 ~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
.++||+|+.|.|||++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3799999999999999766678999998753
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00027 Score=62.58 Aligned_cols=72 Identities=13% Similarity=0.204 Sum_probs=46.2
Q ss_pred cccccccceEEEEEEEC---CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCC-CcceEEEEEEeCCeEEEEEE
Q 019304 141 TAFAQGAFGKLYRGTYN---GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL-NIVRFIGACRKRMVWCIVTE 216 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~iv~E 216 (343)
+.|..|-...+|+.... ++.+++|+........ -...+|+.+++.+... -.+++++.+. . .++||
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-------~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e 72 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-------IDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYE 72 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-------ecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEE
Confidence 46777888899998874 5789999775422111 1223678788777433 3345554432 2 47999
Q ss_pred ecCCCCH
Q 019304 217 YAKGGSV 223 (343)
Q Consensus 217 ~~~~gsL 223 (343)
|++|.++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9998665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.74 E-value=3.6e-05 Score=70.42 Aligned_cols=139 Identities=17% Similarity=0.223 Sum_probs=93.3
Q ss_pred cccccccccccceEEEEEEE-CCceEEEEEeeCCCCC---h-----------hHHHHHH--HHHHHHHHHHhcCCC--CC
Q 019304 137 LNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENN---P-----------EKAQVME--QQFQQEVMMLATLKH--LN 197 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~---~-----------~~~~~~~--~~~~~E~~~l~~l~h--~n 197 (343)
+.++..||-|--+.||.+.+ .|++.++|+-+....+ . .-.+... -...+|...|+.|.. --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 34678899999999999988 6999999964321100 0 0011121 235678888888842 23
Q ss_pred cceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcE
Q 019304 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277 (343)
Q Consensus 198 Iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~v 277 (343)
+.+.+++ ...++|||++.+..|...-+- .... .+...+..-+.-|..+|+||+|..-=||+|.+++.+
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-----~d~~---~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i 241 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV-----EDPP---TLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI 241 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeec-----CChH---HHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence 4444443 345899999999888655321 1222 223333344556788999999999999999999999
Q ss_pred EEeccccccc
Q 019304 278 KIADFGVARI 287 (343)
Q Consensus 278 kl~DFg~a~~ 287 (343)
+++||-.+..
T Consensus 242 ~vIDFPQmvS 251 (465)
T KOG2268|consen 242 VVIDFPQMVS 251 (465)
T ss_pred EEeechHhhc
Confidence 9999987643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.0008 Score=60.56 Aligned_cols=135 Identities=18% Similarity=0.199 Sum_probs=77.5
Q ss_pred ccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCeEEEEEEecCC
Q 019304 142 AFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVWCIVTEYAKG 220 (343)
Q Consensus 142 ~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~iv~E~~~~ 220 (343)
.+..|-...+|+...+++.+++|+......... -...+|..+++.+....+ .+++.... + ++|+||++|
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~------~~r~~E~~~l~~l~~~g~~P~~i~~~~--~--~~v~e~i~G 72 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKALG------VDRQREYQILQALSALGLAPKPILVNE--H--WLLVEWLEG 72 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCccccccc------CcHHHHHHHHHHHHhcCCCCceEEEeC--C--EEEEEeccC
Confidence 345677889999988888899997643221110 023577778877753323 34454432 2 689999998
Q ss_pred CCHHH--------------HHHhhCC-----CCCCHH-HHHHHHHH---------HHHHHHHHHh--------CCceeCC
Q 019304 221 GSVRQ--------------FLTRRQN-----RAVPLK-LAVKQALD---------VARGMAYVHG--------LGFIHRD 263 (343)
Q Consensus 221 gsL~~--------------~l~~~~~-----~~~~~~-~~~~i~~q---------i~~gL~yLH~--------~giiHrD 263 (343)
..+.. .+.+-.. .+++.. .+..+..+ +...+..+-. ..++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 66431 1221111 111211 11111111 1111222221 2489999
Q ss_pred CCCCcEEEcCCCcEEEeccccccc
Q 019304 264 LKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 264 lkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
+.|.||++++++ +.|+||..|..
T Consensus 153 l~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 153 VHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CCcCcEEEeCCC-CEEEeccccCc
Confidence 999999999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00058 Score=65.35 Aligned_cols=80 Identities=13% Similarity=0.019 Sum_probs=51.6
Q ss_pred cccccccceEEEEEEEC-C-ceEEEEEeeCCCCC-hhHHHHHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCeEEEE
Q 019304 141 TAFAQGAFGKLYRGTYN-G-EDVAIKILERPENN-PEKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWCIV 214 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~-~-~~vavK~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~iv 214 (343)
+.||.|.+..||++... | +.++||.-.+.... .+.......++..|.+.|+.+. ...+++++.+.. ...++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence 57899999999999884 4 48999985422110 0100111245667777777752 346777887744 345799
Q ss_pred EEecCCCC
Q 019304 215 TEYAKGGS 222 (343)
Q Consensus 215 ~E~~~~gs 222 (343)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0016 Score=60.07 Aligned_cols=73 Identities=12% Similarity=0.225 Sum_probs=45.7
Q ss_pred cccccccceEEEEEEEC--------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCC-cceEEEEEEeCCeE
Q 019304 141 TAFAQGAFGKLYRGTYN--------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN-IVRFIGACRKRMVW 211 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~ 211 (343)
+.|..|-...+|+.... ++.+++|+........ ....+|..+++.+.... ..++++.+..
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~-------~~r~~E~~~~~~l~~~g~~P~~~~~~~~---- 72 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELL-------IDRERELVVFARLSERNLGPKLYGIFPN---- 72 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcce-------echHHHHHHHHHHHhCCCCCceEEEeCC----
Confidence 34566777789988764 4789999976533221 13457777777764322 3455655532
Q ss_pred EEEEEecCCCCHH
Q 019304 212 CIVTEYAKGGSVR 224 (343)
Q Consensus 212 ~iv~E~~~~gsL~ 224 (343)
.+|+||++|..+.
T Consensus 73 ~~v~e~i~G~~l~ 85 (302)
T cd05156 73 GRIEEFIPSRTLT 85 (302)
T ss_pred CchhheeCCCcCC
Confidence 3689999886653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0035 Score=58.08 Aligned_cols=144 Identities=17% Similarity=0.248 Sum_probs=82.4
Q ss_pred ccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCC--CCcceEEEEEEeCC--eEEEEEEe
Q 019304 142 AFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRFIGACRKRM--VWCIVTEY 217 (343)
Q Consensus 142 ~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~--~~~iv~E~ 217 (343)
.+..|..-.+|....++++++++ ........+. .....+|..+++.+.- --+...++.|.+.. ..+.||+|
T Consensus 32 ~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~----~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 32 EISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVES----AHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred eccCCcccceEEEecCCceEEEe-cCCccccchh----hhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 34344444566666668888888 3221222222 2455678888877743 23455677776665 67999999
Q ss_pred cCCCCH------------------HHHHHhhCC------CCC------CHHHHHHHHH--------------HHHHHHHH
Q 019304 218 AKGGSV------------------RQFLTRRQN------RAV------PLKLAVKQAL--------------DVARGMAY 253 (343)
Q Consensus 218 ~~~gsL------------------~~~l~~~~~------~~~------~~~~~~~i~~--------------qi~~gL~y 253 (343)
++|..+ .++|..-.. ... ....+..+.. ....-..|
T Consensus 107 veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W 186 (321)
T COG3173 107 VEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW 186 (321)
T ss_pred ecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence 998322 122221000 000 0001111111 11222445
Q ss_pred HHhC--------CceeCCCCCCcEEEcCCCcEEEecccccccccc
Q 019304 254 VHGL--------GFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 254 LH~~--------giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~ 290 (343)
|+++ .++|+|+++.|+++++++-+-|+||+.+.+..+
T Consensus 187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 5532 489999999999999988899999999876443
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0091 Score=55.13 Aligned_cols=30 Identities=30% Similarity=0.590 Sum_probs=25.9
Q ss_pred CCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 257 ~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47899999999999987 6789999997653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0049 Score=57.75 Aligned_cols=142 Identities=19% Similarity=0.158 Sum_probs=89.5
Q ss_pred cccccccceEEEEEEE-CCceEEEEEeeCCCCChh--------------------HHHHHHHHHHHHHHHHhcCCCCCcc
Q 019304 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPE--------------------KAQVMEQQFQQEVMMLATLKHLNIV 199 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~--------------------~~~~~~~~~~~E~~~l~~l~h~nIv 199 (343)
..|..|--+-||.++- +|..+|||+++.....-. ...+..-=...|++-|+++....|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 3466677788999987 888999999764322110 0011111234567777777655443
Q ss_pred eEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCCCcEEEcCCCcEE
Q 019304 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIHRDLKSDNLLISADKSIK 278 (343)
Q Consensus 200 ~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH-~~giiHrDlkp~NILv~~~~~vk 278 (343)
..--+... . ..|||+|+.. +=+-.- +.+...++...+..+-.+++.-|.-|- .++++|.||.-=|+|+. +|.+.
T Consensus 230 ~PePIlLk-~-hVLVM~FlGr-dgw~aP-kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~ly 304 (520)
T KOG2270|consen 230 CPEPILLK-N-HVLVMEFLGR-DGWAAP-KLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKLY 304 (520)
T ss_pred CCCceeee-c-ceEeeeeccC-CCCcCc-ccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEEE
Confidence 22111111 2 2689999943 221111 112334666677777778887777665 56999999999999996 78899
Q ss_pred Eeccccccc
Q 019304 279 IADFGVARI 287 (343)
Q Consensus 279 l~DFg~a~~ 287 (343)
|+|.+.+..
T Consensus 305 iIDVSQSVE 313 (520)
T KOG2270|consen 305 IIDVSQSVE 313 (520)
T ss_pred EEEcccccc
Confidence 999988753
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=97.13 E-value=9.4e-05 Score=75.98 Aligned_cols=75 Identities=12% Similarity=-0.016 Sum_probs=53.6
Q ss_pred eeCCCCCC-cEEEcCCCcEEEeccccccccccCC---CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecccc----
Q 019304 260 IHRDLKSD-NLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLK---- 331 (343)
Q Consensus 260 iHrDlkp~-NILv~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~---- 331 (343)
.+++.+|. |+++...+..++.|||.++...... .....+||+.|+|||++ ....++.++|||+++++
T Consensus 499 ~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l-----~~~~~~~~~DiwSlG~il~El 573 (669)
T cd05610 499 PTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELL-----LGKPHGPAVDWWALGVCLFEF 573 (669)
T ss_pred CCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHc-----CCCCCCcHHHHHHHHHHHHHH
Confidence 45566666 6777778888999999987643322 12345799999999999 67778999999965443
Q ss_pred -cccCCCCc
Q 019304 332 -TTWPPPWR 339 (343)
Q Consensus 332 -~~~~p~~~ 339 (343)
++.+||.+
T Consensus 574 ltG~~pf~~ 582 (669)
T cd05610 574 LTGIPPFND 582 (669)
T ss_pred HHCCCCCCC
Confidence 35566644
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.003 Score=59.42 Aligned_cols=77 Identities=10% Similarity=-0.054 Sum_probs=44.7
Q ss_pred ccccccceEEEEEEECC--ceEEEEEeeCCCCC-hhHHHHHHHHHHHHHHHHhcCC--CC-CcceEEEEEEeCCeEEEEE
Q 019304 142 AFAQGAFGKLYRGTYNG--EDVAIKILERPENN-PEKAQVMEQQFQQEVMMLATLK--HL-NIVRFIGACRKRMVWCIVT 215 (343)
Q Consensus 142 ~lg~G~fg~Vy~~~~~~--~~vavK~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~--h~-nIv~l~~~~~~~~~~~iv~ 215 (343)
.||.|...-||++...+ +.|+||.-.+--.. .+....-..+..-|...|+... -| .++++|.+-. ....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~--e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDT--EMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEcc--ccceehH
Confidence 57999999999998743 57999964311110 0000111134456666666552 23 4556665433 3346999
Q ss_pred EecCC
Q 019304 216 EYAKG 220 (343)
Q Consensus 216 E~~~~ 220 (343)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99965
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.015 Score=55.70 Aligned_cols=79 Identities=11% Similarity=-0.030 Sum_probs=50.4
Q ss_pred ccccccccceEEEEEEECCceEEEEEeeCCCCChhH-HHHHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCeEEEEE
Q 019304 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEK-AQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWCIVT 215 (343)
Q Consensus 140 ~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~iv~ 215 (343)
.+.||.|....||+....+..++||.-......... ......+-..|...|+.+. ...+.++|.++.+.. +++|
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~--vlvM 114 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMA--LIGM 114 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCC--EEEE
Confidence 367899999999998887778999976522211000 0000123334556555543 357888998888553 6899
Q ss_pred EecCC
Q 019304 216 EYAKG 220 (343)
Q Consensus 216 E~~~~ 220 (343)
|++++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99977
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.011 Score=55.67 Aligned_cols=137 Identities=15% Similarity=0.244 Sum_probs=77.7
Q ss_pred cccccccceEEEEEEEC------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCeEEE
Q 019304 141 TAFAQGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVWCI 213 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~i 213 (343)
+.|-.|-.-.+|+..+. ++.|++|+.......- . ...+|..+++.+...++ .++++.+.. ..
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~------i-dR~~E~~~~~~l~~~gl~P~~~~~~~~----g~ 110 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF------F-DRDDEIRTFECMSRHGQGPRLLGRFPN----GR 110 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee------e-chHHHHHHHHHHHHcCCCCceEEEECC----ce
Confidence 34555888899998752 2578999875532111 1 12568888877754333 355665532 25
Q ss_pred EEEecCCCCHHHH--------------HHhhCCC-------CCCHHHHHHHHHH-----------------HHHHHHHH-
Q 019304 214 VTEYAKGGSVRQF--------------LTRRQNR-------AVPLKLAVKQALD-----------------VARGMAYV- 254 (343)
Q Consensus 214 v~E~~~~gsL~~~--------------l~~~~~~-------~~~~~~~~~i~~q-----------------i~~gL~yL- 254 (343)
|+||+++.+|... +.+-... ....+.+.++..+ +...+..|
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 7999987665311 1110000 1112222222211 11112222
Q ss_pred ---H----hCCceeCCCCCCcEEEcC-CCcEEEecccccccc
Q 019304 255 ---H----GLGFIHRDLKSDNLLISA-DKSIKIADFGVARIE 288 (343)
Q Consensus 255 ---H----~~giiHrDlkp~NILv~~-~~~vkl~DFg~a~~~ 288 (343)
. ...++|+|+++.|||+++ ++.+.++||..|...
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 1 125899999999999986 478999999988753
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.012 Score=55.29 Aligned_cols=141 Identities=13% Similarity=0.216 Sum_probs=78.4
Q ss_pred cccccccccccccceEEEEEEECC-----ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeC
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTYNG-----EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKR 208 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~ 208 (343)
..+++. .|..|-...+|+....+ ..|++|+........ -.-.+|..+++.+...++ .++++.+. .
T Consensus 15 ~~i~i~-~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-------IdR~~E~~il~~l~~~gl~P~~l~~~~-~ 85 (330)
T PLN02421 15 SDFSVE-RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-------IDRERELQAIKYLSAAGFGAKLLGVFG-N 85 (330)
T ss_pred CceEEE-EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-------echHHHHHHHHHHHhcCCCCceeEEeC-C
Confidence 344443 44447778899987643 378999875432211 122478888888765444 35565552 2
Q ss_pred CeEEEEEEecCCCCHHH--------------HHHhhCCCC------C-CHHHHHHHHHHH--------------------
Q 019304 209 MVWCIVTEYAKGGSVRQ--------------FLTRRQNRA------V-PLKLAVKQALDV-------------------- 247 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~--------------~l~~~~~~~------~-~~~~~~~i~~qi-------------------- 247 (343)
. +|.+|+++..|.. .+.+-.... . .+..+.++..++
T Consensus 86 G---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~ 162 (330)
T PLN02421 86 G---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFE 162 (330)
T ss_pred c---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHH
Confidence 2 5899998765421 111111111 1 122222222111
Q ss_pred --HHHHH----HHHhCC----ceeCCCCCCcEEEcC-CCcEEEeccccccc
Q 019304 248 --ARGMA----YVHGLG----FIHRDLKSDNLLISA-DKSIKIADFGVARI 287 (343)
Q Consensus 248 --~~gL~----yLH~~g----iiHrDlkp~NILv~~-~~~vkl~DFg~a~~ 287 (343)
..-+. ++...+ ++|.|+.+.|||+++ ++.++++||..|..
T Consensus 163 ~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 163 ELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11111 222222 799999999999974 57899999998864
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0041 Score=59.25 Aligned_cols=79 Identities=11% Similarity=0.082 Sum_probs=48.3
Q ss_pred ccccccccceEEEEEEEC--CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC--CC-CcceEEEEEEeCCeEEEE
Q 019304 140 GTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HL-NIVRFIGACRKRMVWCIV 214 (343)
Q Consensus 140 ~~~lg~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~-nIv~l~~~~~~~~~~~iv 214 (343)
.+.||.|.-.-||++... ++.|+||.-.+--...+....-.++..-|...|+... -| .++++|.+-. ....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~--e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS--VMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc--HHhhHH
Confidence 367899999999999874 6789999643221111111111245556777776652 23 5666765433 334689
Q ss_pred EEecCC
Q 019304 215 TEYAKG 220 (343)
Q Consensus 215 ~E~~~~ 220 (343)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999865
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.012 Score=53.79 Aligned_cols=31 Identities=26% Similarity=0.498 Sum_probs=26.0
Q ss_pred CceeCCCCCCcEEEcCCCc-EEEecccccccc
Q 019304 258 GFIHRDLKSDNLLISADKS-IKIADFGVARIE 288 (343)
Q Consensus 258 giiHrDlkp~NILv~~~~~-vkl~DFg~a~~~ 288 (343)
.++|+|++|.|||+++++. .-|+||+.+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997554 579999988753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.0044 Score=56.83 Aligned_cols=74 Identities=16% Similarity=0.190 Sum_probs=47.9
Q ss_pred cccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCeEEEEE
Q 019304 139 MGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWCIVT 215 (343)
Q Consensus 139 ~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~iv~ 215 (343)
-.+.++.|....+|+...+++.+-||+-..... ..|..|..-|+.|. .-.+++.+++....+.-++||
T Consensus 21 ~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~---------~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLDTDGGSYFVKVNSESGR---------DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp EEEEE--SSSSEEEEEETTS-EEEEEEEEGGGC---------CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeEecCCCChhheEEEECCCccEEEEecChhhH---------HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 346788899999999888888999998863222 25778888777773 445778888887777779999
Q ss_pred EecCCC
Q 019304 216 EYAKGG 221 (343)
Q Consensus 216 E~~~~g 221 (343)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.0063 Score=64.27 Aligned_cols=140 Identities=16% Similarity=0.167 Sum_probs=103.7
Q ss_pred HHHHHHHHHHhcCCCCCcceEEEEEEeCCeE----EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 019304 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVW----CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256 (343)
Q Consensus 181 ~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~----~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~ 256 (343)
+...-|...+..+.|+|++.++.+....... .+..|++...++...+... ...+..+.+.+..+..+||.|+|+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHH
Confidence 3445567778888999999999887655432 3456788888888888764 358889999999999999999999
Q ss_pred CCceeCCCCCC---cEEEcCCCcEEEe--ccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCc--eeeeeee
Q 019304 257 LGFIHRDLKSD---NLLISADKSIKIA--DFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFE--HKWSAKE 327 (343)
Q Consensus 257 ~giiHrDlkp~---NILv~~~~~vkl~--DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~--~~sDi~~ 327 (343)
....|.-|..+ +-.++.++.+.+. ||+.++............-+..|.|||.. ....+. ...|+|.
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~-----~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDL-----KENTAKKSRLTDLWC 377 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCcccccccccc-----ccccchhhhhhHHHH
Confidence 97777666555 5555667777777 99988766655555555667788899988 444444 4469984
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.038 Score=51.68 Aligned_cols=136 Identities=18% Similarity=0.212 Sum_probs=77.4
Q ss_pred ccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCC------cceEEE----EEEeCCeE
Q 019304 142 AFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN------IVRFIG----ACRKRMVW 211 (343)
Q Consensus 142 ~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~----~~~~~~~~ 211 (343)
.|.+ .-..+|+....+..+++|+.++. ... .++.-|...+..|.-.. +..+-| ........
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~iLki~~~~-~~~-------~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~ 103 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRYILKIYRPG-WTR-------AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRP 103 (331)
T ss_pred cccc-ccCceEEEEecCCCeEEEEecCC-CCH-------HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCcee
Confidence 3444 45579999886666699999775 333 23445566665552111 222222 12222366
Q ss_pred EEEEEecCCCCHHH------------HH---Hh-hCCC---------CCCHHH-------------HHHHHHHHHHHHHH
Q 019304 212 CIVTEYAKGGSVRQ------------FL---TR-RQNR---------AVPLKL-------------AVKQALDVARGMAY 253 (343)
Q Consensus 212 ~iv~E~~~~gsL~~------------~l---~~-~~~~---------~~~~~~-------------~~~i~~qi~~gL~y 253 (343)
+-+.+|++|..+.. ++ +. .++. ...+.. ......++...++.
T Consensus 104 a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~ 183 (331)
T COG2334 104 AALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDR 183 (331)
T ss_pred EEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHH
Confidence 78999999877762 11 00 0000 011110 01123344444554
Q ss_pred HHh--------CC--ceeCCCCCCcEEEcCCC-cEEEecccccc
Q 019304 254 VHG--------LG--FIHRDLKSDNLLISADK-SIKIADFGVAR 286 (343)
Q Consensus 254 LH~--------~g--iiHrDlkp~NILv~~~~-~vkl~DFg~a~ 286 (343)
+.+ .+ +||+|+.|.||+++.+. .+.++||+.|.
T Consensus 184 ~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 184 LLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 443 23 99999999999999877 48999999876
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.073 Score=49.32 Aligned_cols=30 Identities=17% Similarity=0.262 Sum_probs=27.8
Q ss_pred CceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 258 GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 258 giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
+++|+|+.+.|+|++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.012 Score=55.89 Aligned_cols=60 Identities=28% Similarity=0.365 Sum_probs=43.3
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH-HHhCCceeCCCCCCcEEEcCC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY-VHGLGFIHRDLKSDNLLISAD 274 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~y-LH~~giiHrDlkp~NILv~~~ 274 (343)
.++-+|+.|.++..++.... .+++...+++.--+.|+-- |--.+++|.|+.|.||++-..
T Consensus 321 vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred eeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 57778899999999886532 4555666666655555443 345689999999999999643
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.056 Score=51.71 Aligned_cols=30 Identities=33% Similarity=0.409 Sum_probs=25.2
Q ss_pred CCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 257 ~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
..++|.|+-+.|||.+ ++.++++||..|..
T Consensus 227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDF-NQGIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEec-CCCEEEEEeccccC
Confidence 3579999999999976 45699999998864
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.033 Score=52.28 Aligned_cols=71 Identities=18% Similarity=0.273 Sum_probs=52.8
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
...|++|++- |+++... . ...++++..++.+.+.-+.-+... .+-|||+...||||+ +|.|.|+||-++|.
T Consensus 299 ~y~yl~~kdh-gt~is~i-k-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDH-GTPISII-K-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecC-Cceeeee-e-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 3456777765 5555322 1 145677788888777666666654 689999999999999 99999999999985
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.00039 Score=74.83 Aligned_cols=143 Identities=11% Similarity=-0.005 Sum_probs=102.7
Q ss_pred HHHHHHHHHHHhcCCCCCcceEEEEEEe--CCeEEEEEEecCCCCHHHHHHhhCCCCCC--HHHHHHHHHHHHHHHHHHH
Q 019304 180 EQQFQQEVMMLATLKHLNIVRFIGACRK--RMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVH 255 (343)
Q Consensus 180 ~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~iv~E~~~~gsL~~~l~~~~~~~~~--~~~~~~i~~qi~~gL~yLH 255 (343)
.+....|...++...|+++...+.-... ....+..++++.+|.+.+.+.+...+..+ ..-+...-.+......-+|
T Consensus 1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 3455666667777889988877665533 23458899999999999999875433222 2222222223255666666
Q ss_pred hC-C----ceeCCCCCCcEEEcCCCcEEEecccccccccc-CCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeee
Q 019304 256 GL-G----FIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKE 327 (343)
Q Consensus 256 ~~-g----iiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~ 327 (343)
+. + .+|++||+.|.+|..+..+|+.++|+.++..+ ........+++.|++|+.. ++-+++.++|+|.
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~-----N~ik~t~rsdilr 1425 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIK-----NEIKFTKRSDILR 1425 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHH-----HHHhhhhHHHHHH
Confidence 54 2 68999999999999999999999999994333 2233445788999999998 8999999999995
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.14 Score=45.13 Aligned_cols=75 Identities=19% Similarity=0.220 Sum_probs=54.3
Q ss_pred cccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCeEEEEEEe
Q 019304 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
+.+.-|.--..|...+...++-||+-.+. ....|..|+.-|..+. .-.+.+++.+..+....|+|+||
T Consensus 22 ~~v~gG~inea~~v~dg~~~~FvK~n~~~---------~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~ 92 (286)
T COG3001 22 EEVSGGDINEAWRLRDGTDPFFVKCNQRE---------QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEY 92 (286)
T ss_pred cccCCccccceeEeecCCcceEEEecchh---------hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEee
Confidence 44555666667777777788999975331 2356778887666663 45678889999999999999999
Q ss_pred cCCCCHH
Q 019304 218 AKGGSVR 224 (343)
Q Consensus 218 ~~~gsL~ 224 (343)
++-+.+.
T Consensus 93 L~~~~~d 99 (286)
T COG3001 93 LPTGPLD 99 (286)
T ss_pred ccCCCCC
Confidence 9876654
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.57 Score=43.74 Aligned_cols=29 Identities=31% Similarity=0.401 Sum_probs=24.6
Q ss_pred CCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 257 ~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
.++||+|+.+.|||++ + .+.|+||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 3689999999999995 4 578999998763
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.3 Score=52.73 Aligned_cols=30 Identities=40% Similarity=0.597 Sum_probs=25.5
Q ss_pred CCceeCCCCCCcEEEcCCC--cEE-Eecccccc
Q 019304 257 LGFIHRDLKSDNLLISADK--SIK-IADFGVAR 286 (343)
Q Consensus 257 ~giiHrDlkp~NILv~~~~--~vk-l~DFg~a~ 286 (343)
.++||+|+.+.|||++.++ .+. |+|||.+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4799999999999999775 454 99999875
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.16 Score=49.56 Aligned_cols=77 Identities=12% Similarity=0.177 Sum_probs=46.0
Q ss_pred cccccccccccccceEEEEEEEC----------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcc-eEEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTYN----------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV-RFIG 203 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~ 203 (343)
+++ -.+.|..|-.-.+|++... ++.|.+|+.-.....-- .-.+|..+++.+....|- ++++
T Consensus 106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-------dR~~E~~v~~~ls~~gi~P~l~~ 177 (442)
T PTZ00296 106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-------NPISEFEVYKTMSKYRIAPQLLN 177 (442)
T ss_pred ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-------CHHHHHHHHHHHHHCCCCCceEE
Confidence 344 3356666777889988753 45788888754322111 224577777766544443 4555
Q ss_pred EEEeCCeEEEEEEecCCCCH
Q 019304 204 ACRKRMVWCIVTEYAKGGSV 223 (343)
Q Consensus 204 ~~~~~~~~~iv~E~~~~gsL 223 (343)
.+. + +.|.||++|..|
T Consensus 178 ~f~--g--g~I~efi~g~~l 193 (442)
T PTZ00296 178 TFS--G--GRIEEWLYGDPL 193 (442)
T ss_pred EeC--C--CEEEEeeCCccC
Confidence 542 2 468999988643
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.085 Score=46.29 Aligned_cols=113 Identities=12% Similarity=0.089 Sum_probs=67.9
Q ss_pred ceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEecCCCCHHHHH
Q 019304 148 FGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL 227 (343)
Q Consensus 148 fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l 227 (343)
..+.-.++.+-.+..+|.+....-.-.. .-|.++.+++.++. .|+++..- ..-.+.++.|+|-...
T Consensus 75 NsTl~~~kt~iG~L~lKKi~slp~~~~~-----~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~----- 140 (308)
T PF07387_consen 75 NSTLLIGKTKIGPLFLKKIRSLPCCIND-----ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK----- 140 (308)
T ss_pred ceEEEEeccccchhhhhhccCCCcccch-----hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-----
Confidence 3344444333345667766544433111 24677888888775 46666522 3335678999883210
Q ss_pred HhhCCCCCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCCCcEEEcCCCcEEEecccc
Q 019304 228 TRRQNRAVPLKLAVKQALDVARGMAYVHG--LGFIHRDLKSDNLLISADKSIKIADFGV 284 (343)
Q Consensus 228 ~~~~~~~~~~~~~~~i~~qi~~gL~yLH~--~giiHrDlkp~NILv~~~~~vkl~DFg~ 284 (343)
-.... .+.+ =+.+|.-.|+ .+.+|+|-.|+||+-|..|.+||.|=+.
T Consensus 141 ------i~~~N---~i~a-gi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 141 ------INFSN---FITA-GIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ------cchhH---HHHH-hHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 01111 1111 1345677784 3799999999999999999999999764
|
The function of this family is unknown. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 343 | ||||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-14 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-11 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-10 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-10 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 5e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-04 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 2e-04 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 2e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-04 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 3e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 4e-04 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 5e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 8e-04 |
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 1e-82
Identities = 65/190 (34%), Positives = 102/190 (53%), Gaps = 8/190 (4%)
Query: 121 TEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVME 180
+G + D+ I LN+ G+FG ++R ++G DVA+KIL + + E
Sbjct: 23 FQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAE----RV 78
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-AVPLKL 239
+F +EV ++ L+H NIV F+GA + IVTEY GS+ + L + R + +
Sbjct: 79 NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 240 AVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-MTP 296
+ A DVA+GM Y+H +HR+LKS NLL+ ++K+ DFG++R++ T
Sbjct: 139 RLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS 198
Query: 297 ETGTYRWMAP 306
GT WMAP
Sbjct: 199 AAGTPEWMAP 208
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 2e-79
Identities = 54/206 (26%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 107 DDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKIL 166
+ +L A R ++ EW I +L +G +G FG++Y G ++G +VAI+++
Sbjct: 5 NLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLI 63
Query: 167 ERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQF 226
+ +N + + F++EVM +H N+V F+GAC I+T KG ++
Sbjct: 64 DIERDNED----QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSV 119
Query: 227 LTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ R + + + A ++ +GM Y+H G +H+DLKS N+ + + I DFG+
Sbjct: 120 V-RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFS 177
Query: 287 IE------VQTEGMTPETGTYRWMAP 306
I + + + + G +AP
Sbjct: 178 ISGVLQAGRREDKLRIQNGWLCHLAP 203
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 1e-78
Identities = 62/194 (31%), Positives = 100/194 (51%), Gaps = 10/194 (5%)
Query: 116 DHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEK 175
H + + D+W I ++ +G G+FG +Y+G ++G DVA+K+L P+
Sbjct: 5 HHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ- 62
Query: 176 AQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV 235
Q F+ EV +L +H+NI+ F+G + IVT++ +G S+ L
Sbjct: 63 ---QLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHL-HASETKF 117
Query: 236 PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-- 293
+K + A ARGM Y+H IHRDLKS+N+ + D ++KI DFG+A + + G
Sbjct: 118 EMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177
Query: 294 -MTPETGTYRWMAP 306
+G+ WMAP
Sbjct: 178 QFEQLSGSILWMAP 191
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 1e-76
Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 12/183 (6%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV 187
ID ++LN T + G+L++G + G D+ +K+L+ + + + F +E
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR----KSRDFNEEC 58
Query: 188 MMLATLKHLNIVRFIGACRKRMVW--CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
L H N++ +GAC+ ++T + GS+ L N V AVK AL
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118
Query: 246 DVARGMAYVHGLGF--IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
D+ARGMA++H L L S +++I D + +I+ V M W
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM----YAPAW 174
Query: 304 MAP 306
+AP
Sbjct: 175 VAP 177
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 4e-76
Identities = 69/188 (36%), Positives = 102/188 (54%), Gaps = 17/188 (9%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
ID +L + G FGK+YR + G++VA+K R + + + +Q +E +QE +
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAA-RHDPDEDISQTIEN-VRQEAKL 59
Query: 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
A LKH NI+ G C K C+V E+A+GG + + L + +P + V A+ +AR
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIAR 116
Query: 250 GMAYVHGLG---FIHRDLKSDNLLIS--------ADKSIKIADFGVARIEVQTEGMTPET 298
GM Y+H IHRDLKS N+LI ++K +KI DFG+AR +T M+
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS-AA 175
Query: 299 GTYRWMAP 306
G Y WMAP
Sbjct: 176 GAYAWMAP 183
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 1e-74
Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 113 ALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPE 170
A+ +P T+ ++ +G FG +++G + VAIK L +
Sbjct: 2 AMGGSEFPK-----SRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56
Query: 171 NNPEKAQVME-QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTR 229
+ E + + Q+FQ+EV +++ L H NIV+ G +V E+ G + L
Sbjct: 57 SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRL-L 113
Query: 230 RQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLIS-----ADKSIKIADF 282
+ + + ++ LD+A G+ Y+ +HRDL+S N+ + A K+ADF
Sbjct: 114 DKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 283 GVARIEVQTEGMTPETGTYRWMAP 306
G+++ V + ++ G ++WMAP
Sbjct: 174 GLSQQSVHS--VSGLLGNFQWMAP 195
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 1e-72
Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 24/197 (12%)
Query: 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQ 184
L G +G FG+ + T+ GE + +K L R + ++ F
Sbjct: 2 MPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE------TQRTFL 55
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
+EV ++ L+H N+++FIG K +TEY KGG++R + + + P V A
Sbjct: 56 KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFA 114
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE------------ 292
D+A GMAY+H + IHRDL S N L+ +K++ +ADFG+AR+ V +
Sbjct: 115 KDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 293 ---GMTPETGTYRWMAP 306
G WMAP
Sbjct: 175 DRKKRYTVVGNPYWMAP 191
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 3e-71
Identities = 60/183 (32%), Positives = 88/183 (48%), Gaps = 17/183 (9%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
ID +++ + +GAFG + + + +DVAIK +E + F E+
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES--------ERKAFIVELR 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL-TRRQNRAVPLKLAVKQALDV 247
L+ + H NIV+ GAC + C+V EYA+GGS+ L A+ L
Sbjct: 54 QLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC 111
Query: 248 ARGMAYVHGL---GFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTPETGTYRW 303
++G+AY+H + IHRDLK NLL+ A +KI DFG A MT G+ W
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAW 169
Query: 304 MAP 306
MAP
Sbjct: 170 MAP 172
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 5e-68
Identities = 47/195 (24%), Positives = 83/195 (42%), Gaps = 27/195 (13%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
+++ M +G +G+++ G + GE VA+K+ E + E+
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEA-------SWFRETEIY 83
Query: 189 MLATLKHLNIVRFIGACRK----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
++H NI+ FI A K ++T+Y + GS+ +L ++ + K +K A
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLA 140
Query: 245 LDVARGMAYVHGLGF--------IHRDLKSDNLLISADKSIKIADFGVARIEVQTEG--- 293
G+ ++H F HRDLKS N+L+ + + IAD G+A +
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200
Query: 294 --MTPETGTYRWMAP 306
GT R+M P
Sbjct: 201 IPPNTRVGTKRYMPP 215
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 4e-66
Identities = 52/189 (27%), Positives = 88/189 (46%), Gaps = 27/189 (14%)
Query: 135 RKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194
R + + +G +G+++RG++ GE+VA+KI + + E+ L+
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEK-------SWFRETELYNTVMLR 60
Query: 195 HLNIVRFIGACRK----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
H NI+ FI + ++T Y + GS+ +L Q + ++ L +A G
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASG 117
Query: 251 MAYVHGLGF--------IHRDLKSDNLLISADKSIKIADFGVARIEVQTE-----GMTPE 297
+A++H F HRDLKS N+L+ + IAD G+A + Q+ G P
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 298 TGTYRWMAP 306
GT R+MAP
Sbjct: 178 VGTKRYMAP 186
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 2e-65
Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 37/207 (17%)
Query: 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQ 184
E ++DL L + +G +G +Y+G+ + VA+K+ Q F
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN---------RQNFI 53
Query: 185 QE--VMMLATLKHLNIVRFIGACRK-----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
E + + ++H NI RFI + RM + +V EY GS+ ++L+
Sbjct: 54 NEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDW 110
Query: 238 KLAVKQALDVARGMAYVHG---------LGFIHRDLKSDNLLISADKSIKIADFGVARIE 288
+ + A V RG+AY+H HRDL S N+L+ D + I+DFG++
Sbjct: 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170
Query: 289 VQTE---------GMTPETGTYRWMAP 306
E GT R+MAP
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAP 197
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-65
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 117 HRYPTEGLE-NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEK 175
H + + G++ + L + A+G FG +++ E VA+KI +
Sbjct: 5 HHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQ--- 61
Query: 176 AQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----RMVWCIVTEYAKGGSVRQFLTRRQ 231
Q + EV L +KH NI++FIGA ++ + ++T + + GS+ FL
Sbjct: 62 ----SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV 117
Query: 232 NRAVPLKLAVKQALDVARGMAYVHG----------LGFIHRDLKSDNLLISADKSIKIAD 281
V A +ARG+AY+H HRD+KS N+L+ + + IAD
Sbjct: 118 ---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 282 FGVARI---EVQTEGMTPETGTYRWMAP 306
FG+A + GT R+MAP
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAP 202
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 6e-64
Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 28/204 (13%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
GL + TI R + + + +G FG+++RG + GE+VA+KI E
Sbjct: 28 SGSGLPLLVQRTI-ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER------- 79
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRK----RMVWCIVTEYAKGGSVRQFLTRRQNRAV 235
+ E+ L+H NI+ FI A K +V++Y + GS+ +L R V
Sbjct: 80 SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TV 136
Query: 236 PLKLAVKQALDVARGMAYVHG--------LGFIHRDLKSDNLLISADKSIKIADFGVARI 287
++ +K AL A G+A++H HRDLKS N+L+ + + IAD G+A
Sbjct: 137 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 196
Query: 288 EVQTE-----GMTPETGTYRWMAP 306
GT R+MAP
Sbjct: 197 HDSATDTIDIAPNHRVGTKRYMAP 220
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-46
Identities = 55/190 (28%), Positives = 89/190 (46%), Gaps = 16/190 (8%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
+ W +++++L + +G FG + G Y G VA+K + K
Sbjct: 7 AQDEFY-RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI--------KNDAT 57
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
Q F E ++ L+H N+V+ +G ++ IVTEY GS+ +L R +
Sbjct: 58 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 117
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR--IEVQTEGMTP 296
+K +LDV M Y+ G F+HRDL + N+L+S D K++DFG+ + Q G P
Sbjct: 118 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 177
Query: 297 ETGTYRWMAP 306
+W AP
Sbjct: 178 ----VKWTAP 183
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-45
Identities = 53/190 (27%), Positives = 94/190 (49%), Gaps = 15/190 (7%)
Query: 123 GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE--DVAIKILERPENNPEKAQVME 180
G NYD+W ++ + M G +G++Y G + VA+K L K ME
Sbjct: 1 GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--------KEDTME 52
Query: 181 QQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
+ F +E ++ +KH N+V+ +G C + + I+TE+ G++ +L + V +
Sbjct: 53 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 112
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
+ A ++ M Y+ FIHRDL + N L+ + +K+ADFG++R+ + + T G
Sbjct: 113 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAG 171
Query: 300 T---YRWMAP 306
+W AP
Sbjct: 172 AKFPIKWTAP 181
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-45
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 103 HALNDDALAQALMD-----HRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN 157
+ + D L L+ + W +++++L + +G FG + G Y
Sbjct: 156 YTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR 215
Query: 158 GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTE 216
G VA+K + K Q F E ++ L+H N+V+ +G ++ IVTE
Sbjct: 216 GNKVAVKCI--------KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267
Query: 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276
Y GS+ +L R + +K +LDV M Y+ G F+HRDL + N+L+S D
Sbjct: 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV 327
Query: 277 IKIADFGVAR--IEVQTEGMTPETGTYRWMAP 306
K++DFG+ + Q G P +W AP
Sbjct: 328 AKVSDFGLTKEASSTQDTGKLP----VKWTAP 355
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-44
Identities = 58/184 (31%), Positives = 90/184 (48%), Gaps = 15/184 (8%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQ-FQQ 185
DEW + L + G FG+++ G YNG VA+K L K M F
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL--------KQGSMSPDAFLA 57
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
E ++ L+H +VR + ++ I+TEY + GS+ FL + + + A
Sbjct: 58 EANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YR 302
+A GMA++ +IHRDL++ N+L+S S KIADFG+AR+ ++ T G +
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIK 175
Query: 303 WMAP 306
W AP
Sbjct: 176 WTAP 179
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-44
Identities = 56/213 (26%), Positives = 87/213 (40%), Gaps = 22/213 (10%)
Query: 103 HALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE--D 160
L + D+W ++ L +G +G FG+++ G +
Sbjct: 85 LLSTQQPLTKKS---GVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTL 141
Query: 161 VAIKILERPENNPEKAQVMEQQ---FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
VA+K + + F QE +L H NIVR IG C ++ IV E
Sbjct: 142 VAVKSC--------RETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193
Query: 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
+GG FL R + + +K ++ D A GM Y+ IHRDL + N L++ +
Sbjct: 194 VQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVL 252
Query: 278 KIADFGVARIEVQTEGMTPETGT----YRWMAP 306
KI+DFG++R E G +W AP
Sbjct: 253 KISDFGMSREEADGV-YAASGGLRQVPVKWTAP 284
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-43
Identities = 57/191 (29%), Positives = 88/191 (46%), Gaps = 16/191 (8%)
Query: 121 TEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVM 179
T GL Y W ID + L G FG + G + G+ DVAIK++ K M
Sbjct: 11 TAGLG-YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI--------KEGSM 61
Query: 180 EQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
+ F +E ++ L H +V+ G C K+ I+TEY G + +L R +
Sbjct: 62 SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQ 120
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET 298
++ DV M Y+ F+HRDL + N L++ +K++DFG++R V + T
Sbjct: 121 QLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSV 179
Query: 299 GT---YRWMAP 306
G+ RW P
Sbjct: 180 GSKFPVRWSPP 190
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 1e-43
Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 21/216 (9%)
Query: 103 HALNDDALAQAL------MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY 156
H+ D L L + NYD+W ++ + M G +G++Y G +
Sbjct: 182 HSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVW 241
Query: 157 NGE--DVAIKILERPENNPEKAQVMEQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213
VA+K L K ME + F +E ++ +KH N+V+ +G C + + I
Sbjct: 242 KKYSLTVAVKTL--------KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
+TE+ G++ +L + V + + A ++ M Y+ FIHR+L + N L+
Sbjct: 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGE 353
Query: 274 DKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 306
+ +K+ADFG++R+ + + T G +W AP
Sbjct: 354 NHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAP 388
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-43
Identities = 46/210 (21%), Positives = 89/210 (42%), Gaps = 29/210 (13%)
Query: 118 RYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENN 172
R E ++ ID L +G +G FG + G ED VA+K + + +N+
Sbjct: 17 RGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNS 75
Query: 173 PEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC-----IVTEYAKGGSVRQFL 227
++ ++F E + H N++R +G C + ++ + K G + +L
Sbjct: 76 SQREI---EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL 132
Query: 228 TRRQNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283
+ P + ++ +D+A GM Y+ F+HRDL + N ++ D ++ +ADFG
Sbjct: 133 LYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG 192
Query: 284 VARI-------EVQTEGMTPETGTYRWMAP 306
+++ P +W+A
Sbjct: 193 LSKKIYSGDYYRQGRIAKMP----VKWIAI 218
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-43
Identities = 59/209 (28%), Positives = 86/209 (41%), Gaps = 38/209 (18%)
Query: 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQV 178
I R + + +GAFGK++ VA+K L +
Sbjct: 6 GIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL------KDPTLA 59
Query: 179 MEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR-------- 230
+ FQ+E +L L+H +IV+F G C +V EY K G + +FL
Sbjct: 60 ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILV 119
Query: 231 --QNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284
Q R +L + Q A +A GM Y+ F+HRDL + N L+ A+ +KI DFG+
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGM 179
Query: 285 ARI-------EVQTEGMTPETGTYRWMAP 306
+R V M P RWM P
Sbjct: 180 SRDVYSTDYYRVGGHTMLP----IRWMPP 204
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-43
Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 29/210 (13%)
Query: 115 MDHRYPTEGL--ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG------EDVAIKIL 166
M H + D + R L + +G FG + Y+ VA+K L
Sbjct: 1 MGHHHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL 60
Query: 167 ERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC--RKRMVWCIVTEYAKGGSVR 224
+ + P++ ++ FQ+E+ +L L IV++ G R +V EY G +R
Sbjct: 61 Q--HSGPDQ----QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 114
Query: 225 QFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284
FL +R + + + + +GM Y+ +HRDL + N+L+ ++ +KIADFG+
Sbjct: 115 DFL-QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGL 173
Query: 285 ARI--------EVQTEGMTPETGTYRWMAP 306
A++ V+ G +P W AP
Sbjct: 174 AKLLPLDKDYYVVREPGQSP----IFWYAP 199
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 7e-43
Identities = 71/264 (26%), Positives = 116/264 (43%), Gaps = 26/264 (9%)
Query: 54 GSVSMSVDNSSVGSNDSLTH----ILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDA 109
GS S+SV + D++ H L + G + ++ + V + +D
Sbjct: 106 GSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDH-----YKKGNDG 160
Query: 110 LAQALMD--HRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKIL 166
L Q L + D W I L + G FG+++ TYN VA+K +
Sbjct: 161 LCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM 220
Query: 167 ERPENNPEKAQVMEQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQ 225
K M + F E ++ TL+H +V+ K ++ I+TE+ GS+
Sbjct: 221 --------KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLD 271
Query: 226 FLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
FL + PL + + +A GMA++ +IHRDL++ N+L+SA KIADFG+A
Sbjct: 272 FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 331
Query: 286 RIEVQTEGMTPETGT---YRWMAP 306
R+ ++ T G +W AP
Sbjct: 332 RV-IEDNEYTAREGAKFPIKWTAP 354
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 8e-43
Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 36/220 (16%)
Query: 103 HALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG---- 158
H + + L + G D R L +G FGK+ Y+
Sbjct: 7 HHHHHHGALEVL----FQGPG----DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDG 58
Query: 159 --EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV--WCIV 214
E VA+K L + + P+ ++QE+ +L TL H +I+++ G C +V
Sbjct: 59 TGEMVAVKAL-KADAGPQ----HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113
Query: 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274
EY GS+R +L ++ L + A + GMAY+H +IHRDL + N+L+ D
Sbjct: 114 MEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND 170
Query: 275 KSIKIADFGVARI--------EVQTEGMTPETGTYRWMAP 306
+ +KI DFG+A+ V+ +G +P W AP
Sbjct: 171 RLVKIGDFGLAKAVPEGHEYYRVREDGDSP----VFWYAP 206
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 9e-43
Identities = 54/183 (29%), Positives = 90/183 (49%), Gaps = 15/183 (8%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQ-FQQE 186
+W ID +L G FG ++ G + + VAIK + + M ++ F +E
Sbjct: 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI--------REGAMSEEDFIEE 53
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
++ L H +V+ G C ++ C+VTE+ + G + +L ++ L + LD
Sbjct: 54 AEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-LGMCLD 112
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRW 303
V GMAY+ IHRDL + N L+ ++ IK++DFG+ R V + T TGT +W
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKW 171
Query: 304 MAP 306
+P
Sbjct: 172 ASP 174
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-42
Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 112 QALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED------VAIKI 165
+ L E+ D + R L +G FG + Y+ VA+K
Sbjct: 18 ENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK 77
Query: 166 LERPENNPEKAQVMEQQ--FQQEVMMLATLKHLNIVRFIGAC--RKRMVWCIVTEYAKGG 221
L + E F++E+ +L +L+H NIV++ G C R ++ EY G
Sbjct: 78 L--------QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 222 SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281
S+R +L + + R +KL ++ + +GM Y+ +IHRDL + N+L+ + +KI D
Sbjct: 130 SLRDYLQKHKERIDHIKL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGD 188
Query: 282 FGVARI--------EVQTEGMTPETGTYRWMAP 306
FG+ ++ +V+ G +P W AP
Sbjct: 189 FGLTKVLPQDKEYYKVKEPGESP----IFWYAP 217
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-42
Identities = 43/201 (21%), Positives = 84/201 (41%), Gaps = 30/201 (14%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQ 182
++ I ++ +G +G FG + ED VA+K+L + + + E
Sbjct: 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML--KADIIASSDIEE-- 71
Query: 183 FQQEVMMLATLKHLNIVRFIGAC------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP 236
F +E + H ++ + +G + + ++ + K G + FL + P
Sbjct: 72 FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131
Query: 237 LKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----- 287
L ++ +D+A GM Y+ FIHRDL + N +++ D ++ +ADFG++R
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 288 --EVQTEGMTPETGTYRWMAP 306
P +W+A
Sbjct: 192 YYRQGCASKLP----VKWLAL 208
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-42
Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 31/197 (15%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG------EDVAIKILERPENNPEKAQVMEQ 181
D + R L +G FG + Y+ E VA+K L + E
Sbjct: 3 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--------QHSTEEH 54
Query: 182 Q--FQQEVMMLATLKHLNIVRFIGACRK--RMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
F++E+ +L +L+H NIV++ G C R ++ EY GS+R +L + + R +
Sbjct: 55 LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 114
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--------EV 289
KL ++ + +GM Y+ +IHRDL + N+L+ + +KI DFG+ ++ +V
Sbjct: 115 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV 173
Query: 290 QTEGMTPETGTYRWMAP 306
+ G +P W AP
Sbjct: 174 KEPGESP----IFWYAP 186
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-42
Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 103 HALNDDALAQAL---MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE 159
++ + D L L P D W I L + QG FG+++ GT+NG
Sbjct: 149 YSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT 208
Query: 160 -DVAIKILERPENNPEKAQVMEQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
VAIK L K M + F QE ++ L+H +V+ + ++ IVTEY
Sbjct: 209 TRVAIKTL--------KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEY 259
Query: 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
GS+ FL + + L V A +A GMAYV + ++HRDL++ N+L+ +
Sbjct: 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 319
Query: 278 KIADFGVARIEVQTEGMTPETGT---YRWMAP 306
K+ADFG+AR ++ T G +W AP
Sbjct: 320 KVADFGLAR-LIEDNEYTARQGAKFPIKWTAP 350
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-42
Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 18/191 (9%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQ 181
D + R L +G FGK+ Y GE VA+K L +PE+
Sbjct: 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGN----HIA 68
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRK--RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
++E+ +L L H NIV++ G C + ++ E+ GS++++L + +N+ +
Sbjct: 69 DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ 128
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET 298
+K A+ + +GM Y+ ++HRDL + N+L+ ++ +KI DFG+ + IE E T +
Sbjct: 129 -LKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 187
Query: 299 GT---YRWMAP 306
W AP
Sbjct: 188 DRDSPVFWYAP 198
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-42
Identities = 54/182 (29%), Positives = 84/182 (46%), Gaps = 15/182 (8%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQ-FQQEV 187
+ ++ + G FG + G + G+ DVA+K++ K M + F QE
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI--------KEGSMSEDEFFQEA 54
Query: 188 MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDV 247
+ L H +V+F G C K IVTEY G + +L R + + ++ DV
Sbjct: 55 QTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDV 113
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWM 304
GMA++ FIHRDL + N L+ D +K++DFG+ R V + GT +W
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWS 172
Query: 305 AP 306
AP
Sbjct: 173 AP 174
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-42
Identities = 63/208 (30%), Positives = 90/208 (43%), Gaps = 41/208 (19%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
I R + + +GAFGK++ + VA+K L E ++
Sbjct: 34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL------KEASESAR 87
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR------- 233
Q FQ+E +L L+H +IVRF G C + +V EY + G + +FL R +
Sbjct: 88 QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL--RSHGPDAKLLA 145
Query: 234 ----AVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
P L + Q A VA GM Y+ GL F+HRDL + N L+ +KI DFG++
Sbjct: 146 GGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
Query: 286 R-------IEVQTEGMTPETGTYRWMAP 306
R V M P RWM P
Sbjct: 206 RDIYSTDYYRVGGRTMLP----IRWMPP 229
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-42
Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 31/201 (15%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
DEW + K+ M QG+FG +Y G G VAIK + N +
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRER 72
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR----QNRAVP 236
+F E ++ ++VR +G + ++ E G ++ +L N V
Sbjct: 73 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 132
Query: 237 LKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----- 287
++ + A ++A GMAY++ F+HRDL + N +++ D ++KI DFG+ R
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
Query: 288 --EVQTEGMTPETGTYRWMAP 306
+G+ P RWM+P
Sbjct: 193 YYRKGGKGLLP----VRWMSP 209
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-41
Identities = 61/255 (23%), Positives = 99/255 (38%), Gaps = 35/255 (13%)
Query: 77 HPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENY--DEWTIDL 134
+ + Y S + + + + + Y G + D +
Sbjct: 11 DYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPR 70
Query: 135 RKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVMEQQ-FQQE 186
+ + + GAFG++Y G +G VA+K L PE ++ F E
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL------PEVCSEQDELDFLME 124
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL-TRRQNRAVPLKLAVKQ-- 243
++++ H NIVR IG + + I+ E GG ++ FL R + P LA+
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 184
Query: 244 --ALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVAR-------IEVQT 291
A D+A G Y+ FIHRD+ + N L++ + KI DFG+AR
Sbjct: 185 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG 244
Query: 292 EGMTPETGTYRWMAP 306
M P +WM P
Sbjct: 245 CAMLP----VKWMPP 255
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-41
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 35/213 (16%)
Query: 119 YPTEGLENY--DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERP 169
Y G + D + + + + GAFG++Y G +G VA+K L
Sbjct: 12 YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--- 68
Query: 170 ENNPEKAQVMEQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL- 227
PE ++ F E ++++ H NIVR IG + + I+ E GG ++ FL
Sbjct: 69 ---PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR 125
Query: 228 TRRQNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIA 280
R + P LA+ A D+A G Y+ FIHRD+ + N L++ + KI
Sbjct: 126 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185
Query: 281 DFGVAR-------IEVQTEGMTPETGTYRWMAP 306
DFG+AR M P +WM P
Sbjct: 186 DFGMARDIYRASYYRKGGCAMLP----VKWMPP 214
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-41
Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 103 HALNDDALAQAL---MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE 159
++ + D L L P D W I L + QG FG+++ GT+NG
Sbjct: 232 YSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT 291
Query: 160 -DVAIKILERPENNPEKAQVMEQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
VAIK L K M + F QE ++ L+H +V+ + ++ IVTEY
Sbjct: 292 TRVAIKTL--------KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEY 342
Query: 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
GS+ FL + + L V A +A GMAYV + ++HRDL++ N+L+ +
Sbjct: 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 402
Query: 278 KIADFGVARIEVQTEGMTPETGT---YRWMAP 306
K+ADFG+AR ++ T G +W AP
Sbjct: 403 KVADFGLAR-LIEDNEYTARQGAKFPIKWTAP 433
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-41
Identities = 51/205 (24%), Positives = 83/205 (40%), Gaps = 37/205 (18%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVMEQQ 182
I L + + FGK+Y+G G VAIK L + + ++
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLR---EE 58
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR----------QN 232
F+ E M+ A L+H N+V +G K ++ Y G + +FL R +
Sbjct: 59 FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 233 RAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI- 287
R V L +A GM Y+ +H+DL + N+L+ ++KI+D G+ R
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV 178
Query: 288 ------EVQTEGMTPETGTYRWMAP 306
++ + P RWMAP
Sbjct: 179 YAADYYKLLGNSLLP----IRWMAP 199
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-41
Identities = 61/245 (24%), Positives = 91/245 (37%), Gaps = 49/245 (20%)
Query: 100 KVTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE 159
+ L D L M R P + +GAFG++++ G
Sbjct: 12 TLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGL 71
Query: 160 D-------VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212
VA+K+L E Q FQ+E ++A + NIV+ +G C C
Sbjct: 72 LPYEPFTMVAVKML--KEEASADMQ---ADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 126
Query: 213 IVTEYAKGGSVRQFLTRRQNR--------------------AVPLKLAVKQ----ALDVA 248
++ EY G + +FL R P L+ + A VA
Sbjct: 127 LLFEYMAYGDLNEFL--RSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 184
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-------EVQTEGMTPETGTY 301
GMAY+ F+HRDL + N L+ + +KIADFG++R + P
Sbjct: 185 AGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIP----I 240
Query: 302 RWMAP 306
RWM P
Sbjct: 241 RWMPP 245
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-40
Identities = 44/188 (23%), Positives = 89/188 (47%), Gaps = 16/188 (8%)
Query: 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQ 181
++ I + + +G FG++Y G Y VA+K + ++
Sbjct: 4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-----KKDCTLDNKE 58
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV 241
+F E +++ L H +IV+ IG + W I+ E G + +L R ++ + V
Sbjct: 59 KFMSEAVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYL-ERNKNSLKVLTLV 116
Query: 242 KQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT- 300
+L + + MAY+ + +HRD+ N+L+++ + +K+ DFG++R ++ E + T
Sbjct: 117 LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY-IEDEDYYKASVTR 175
Query: 301 --YRWMAP 306
+WM+P
Sbjct: 176 LPIKWMSP 183
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-40
Identities = 53/188 (28%), Positives = 87/188 (46%), Gaps = 16/188 (8%)
Query: 128 DEWTIDLRKLNM-GTAFAQGAFGKLYRGTYNGE----DVAIKILERPENNPEKAQVMEQQ 182
E +D + L + G FG + +G Y + VA+KIL + E N + +
Sbjct: 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPAL---KDE 64
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
E ++ L + IVR IG C +V E A+ G + ++L +QNR V K ++
Sbjct: 65 LLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIE 121
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT- 300
V+ GM Y+ F+HRDL + N+L+ KI+DFG+++ + +T
Sbjct: 122 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 301 --YRWMAP 306
+W AP
Sbjct: 182 WPVKWYAP 189
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-40
Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 117 HRYPTEGLENY-DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED----VAIKILERPEN 171
H + + + +D + +G FG++ + + AIK +
Sbjct: 6 HHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM----- 60
Query: 172 NPEKAQVMEQQ---FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL 227
K + F E+ +L L H NI+ +GAC R + EYA G++ FL
Sbjct: 61 ---KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL 117
Query: 228 TRRQNRAVPL------------KLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLI 271
R++R + L+ +Q A DVARGM Y+ FIHRDL + N+L+
Sbjct: 118 --RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 175
Query: 272 SADKSIKIADFGVARIE----VQTEGMTPETGTYRWMAP 306
+ KIADFG++R + +T G P RWMA
Sbjct: 176 GENYVAKIADFGLSRGQEVYVKKTMGRLP----VRWMAI 210
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-40
Identities = 55/191 (28%), Positives = 87/191 (45%), Gaps = 21/191 (10%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-----DVAIKILERPENNPEKAQVMEQQ 182
I+ ++++ G G++ G VAIK L KA E+Q
Sbjct: 42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--------KAGYTERQ 93
Query: 183 ---FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
F E ++ H NI+R G + + IVTEY + GS+ FL + ++L
Sbjct: 94 RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL 153
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET 298
V V GM Y+ LG++HRDL + N+L+ ++ K++DFG++R +E + T
Sbjct: 154 -VGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT 212
Query: 299 GT---YRWMAP 306
G RW AP
Sbjct: 213 GGKIPIRWTAP 223
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-40
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 42/211 (19%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
+W +L+ G GAFGK+ T G VA+K+L A + E
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML------KPSAHLTE 69
Query: 181 QQ-FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV--- 235
++ E+ +L+ L H+NIV +GAC ++TEY G + FL R+++ +
Sbjct: 70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129
Query: 236 ---------PLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282
L L ++ + VA+GMA++ IHRDL + N+L++ + KI DF
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDF 189
Query: 283 GVARI-------EVQTEGMTPETGTYRWMAP 306
G+AR V+ P +WMAP
Sbjct: 190 GLARDIKNDSNYVVKGNARLP----VKWMAP 216
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-40
Identities = 55/192 (28%), Positives = 87/192 (45%), Gaps = 22/192 (11%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE------DVAIKILERPENNPEKAQVMEQ 181
I + G FG++Y+G VAIK L KA E+
Sbjct: 37 FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--------KAGYTEK 88
Query: 182 Q---FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
Q F E ++ H NI+R G K I+TEY + G++ +FL + L+
Sbjct: 89 QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ 148
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPE 297
L V +A GM Y+ + ++HRDL + N+L++++ K++DFG++R +E E
Sbjct: 149 L-VGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207
Query: 298 TGT---YRWMAP 306
+G RW AP
Sbjct: 208 SGGKIPIRWTAP 219
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-40
Identities = 51/200 (25%), Positives = 83/200 (41%), Gaps = 27/200 (13%)
Query: 124 LENYDEWTIDLR--KLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKA 176
++ I ++ +G FG +Y GT D A+K L
Sbjct: 12 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGE 69
Query: 177 QVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAV 235
QF E +++ H N++ +G C R +V Y K G +R F+ R +
Sbjct: 70 V---SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNP 125
Query: 236 PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR--------- 286
+K + L VA+GM Y+ F+HRDL + N ++ ++K+ADFG+AR
Sbjct: 126 TVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 185
Query: 287 IEVQTEGMTPETGTYRWMAP 306
+ +T P +WMA
Sbjct: 186 VHNKTGAKLP----VKWMAL 201
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-39
Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 51/218 (23%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
+W + L +G +G FGK+ + T VA+K+L E A E
Sbjct: 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML------KENASPSE 69
Query: 181 QQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
+ E +L + H ++++ GAC + ++ EYAK GS+R FL R++R V
Sbjct: 70 LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL--RESRKVGPGY 127
Query: 240 AVKQ------------------------ALDVARGMAYVHGLGFIHRDLKSDNLLISADK 275
A +++GM Y+ + +HRDL + N+L++ +
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR 187
Query: 276 SIKIADFGVARI-------EVQTEGMTPETGTYRWMAP 306
+KI+DFG++R +++G P +WMA
Sbjct: 188 KMKISDFGLSRDVYEEDSYVKRSQGRIP----VKWMAI 221
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-39
Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 16/171 (9%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+F +Y+G T +VA L+ + Q+F++E ML L+H NIVRF
Sbjct: 36 RGSFKTVYKGLDTETTVEVAWCELQDRKLTKS----ERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 203 GA----CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH--G 256
+ + + +VTE G+++ +L R + + +K+ + +G+ ++H
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 257 LGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
IHRDLK DN+ I+ S+KI D G+A ++ + GT +MAP
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VIGTPEFMAP 199
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-39
Identities = 53/188 (28%), Positives = 84/188 (44%), Gaps = 14/188 (7%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQ 182
I + L + G+FG + RG ++ VA+K L+ + +A
Sbjct: 11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM---DD 67
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
F +EV + +L H N++R G + +VTE A GS+ L R+ L +
Sbjct: 68 FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL-RKHQGHFLLGTLSR 125
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT- 300
A+ VA GM Y+ FIHRDL + NLL++ +KI DFG+ R + + +
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 301 --YRWMAP 306
+ W AP
Sbjct: 186 VPFAWCAP 193
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-39
Identities = 66/267 (24%), Positives = 103/267 (38%), Gaps = 46/267 (17%)
Query: 74 ILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENYDEWTID 133
+ + Y +G + L M L W +
Sbjct: 8 HHHDYDIPTTENLYFNGMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELP 67
Query: 134 LRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQVMEQQ-F 183
+L +G +GAFG++ G D VA+K+L A +
Sbjct: 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML------KSDATEKDLSDL 121
Query: 184 QQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
E+ M+ + KH NI+ +GAC + ++ EYA G++R++L + R L+ +
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL--QARRPPGLEYSYN 179
Query: 243 Q----------------ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
A VARGM Y+ IHRDL + N+L++ D +KIADFG+AR
Sbjct: 180 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
Query: 287 I-------EVQTEGMTPETGTYRWMAP 306
+ T G P +WMAP
Sbjct: 240 DIHHIDYYKKTTNGRLP----VKWMAP 262
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-39
Identities = 49/201 (24%), Positives = 84/201 (41%), Gaps = 29/201 (14%)
Query: 124 LENYDEWTI--DLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKA 176
L + I + + +G FG +Y G Y + AIK L
Sbjct: 8 LAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL------SRIT 61
Query: 177 QVME-QQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRA 234
++ + + F +E +++ L H N++ IG + ++ Y G + QF+ R R
Sbjct: 62 EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRN 120
Query: 235 VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------- 286
+K + L VARGM Y+ F+HRDL + N ++ ++K+ADFG+AR
Sbjct: 121 PTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180
Query: 287 -IEVQTEGMTPETGTYRWMAP 306
++ P +W A
Sbjct: 181 SVQQHRHARLP----VKWTAL 197
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 42/211 (19%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQV 178
+W KL +G +GAFG++ G D VA+K+L + A
Sbjct: 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML------KDDATE 81
Query: 179 MEQQ-FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR------ 230
+ E+ M+ + KH NI+ +GAC + ++ EYA G++R++L R
Sbjct: 82 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 141
Query: 231 ----QNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282
NR ++ K +ARGM Y+ IHRDL + N+L++ + +KIADF
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 283 GVARI-------EVQTEGMTPETGTYRWMAP 306
G+AR + T G P +WMAP
Sbjct: 202 GLARDINNIDYYKKTTNGRLP----VKWMAP 228
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 56/207 (27%), Positives = 87/207 (42%), Gaps = 38/207 (18%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
++W L G GAFGK+ T G VA+K+L A E
Sbjct: 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML------KSTAHADE 92
Query: 181 QQ-FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR-------- 230
++ E+ +++ L +H NIV +GAC ++TEY G + FL R+
Sbjct: 93 KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 231 QNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ + + VA+GMA++ IHRD+ + N+L++ KI DFG+AR
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 287 I-------EVQTEGMTPETGTYRWMAP 306
V+ P +WMAP
Sbjct: 213 DIMNDSNYIVKGNARLP----VKWMAP 235
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-39
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 42/211 (19%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQV 178
+W KL +G +G FG++ G D VA+K+L + A
Sbjct: 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML------KDDATE 127
Query: 179 MEQQ-FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR------ 230
+ E+ M+ + KH NI+ +GAC + ++ EYA G++R++L R
Sbjct: 128 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 187
Query: 231 ----QNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282
NR ++ K +ARGM Y+ IHRDL + N+L++ + +KIADF
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 247
Query: 283 GVARI-------EVQTEGMTPETGTYRWMAP 306
G+AR + T G P +WMAP
Sbjct: 248 GLARDINNIDYYKKTTNGRLP----VKWMAP 274
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-39
Identities = 55/191 (28%), Positives = 86/191 (45%), Gaps = 21/191 (10%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQ 182
+D +++ G FG++ G VAIK L K E+Q
Sbjct: 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--------KVGYTEKQ 89
Query: 183 ---FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
F E ++ H NI+R G K IVTEY + GS+ FL + + ++L
Sbjct: 90 RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 149
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET 298
V +A GM Y+ +G++HRDL + N+LI+++ K++DFG+ R +E E
Sbjct: 150 -VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208
Query: 299 GT---YRWMAP 306
G RW +P
Sbjct: 209 GGKIPIRWTSP 219
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-39
Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 39/209 (18%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
+W +L +G +GAFG++ G D VA+K+L
Sbjct: 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEH 74
Query: 181 QQFQQEVMMLATL-KHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRR-------- 230
+ E+ +L + HLN+V +GAC + ++ E+ K G++ +L +
Sbjct: 75 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 231 --QNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284
L ++ + VA+GM ++ IHRDL + N+L+S +KI DFG+
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 194
Query: 285 ARI-------EVQTEGMTPETGTYRWMAP 306
AR + + P +WMAP
Sbjct: 195 ARDIYKDPDYVRKGDARLP----LKWMAP 219
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-39
Identities = 42/187 (22%), Positives = 80/187 (42%), Gaps = 22/187 (11%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGED------VAIKILERPENNPEKAQVMEQQ--- 182
+ + GAFG +Y+G + E VAIK L + +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--------REATSPKANKE 63
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
E ++A++ + ++ R +G C V ++T+ G + ++ R + + +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLN 121
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT-- 300
+ +A+GM Y+ +HRDL + N+L+ + +KI DFG+A++ E G
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 301 -YRWMAP 306
+WMA
Sbjct: 182 PIKWMAL 188
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-39
Identities = 48/188 (25%), Positives = 83/188 (44%), Gaps = 16/188 (8%)
Query: 128 DEWTIDLRKLNMG-TAFAQGAFGKLYRGTYNGE----DVAIKILERPENNPEKAQVMEQQ 182
+ + L + G FG + +G Y DVAIK+L + ++
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKA----DTEE 56
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
+E ++ L + IVR IG C+ + +V E A GG + +FL + +P+ +
Sbjct: 57 MMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFL-VGKREEIPVSNVAE 114
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT- 300
V+ GM Y+ F+HRDL + N+L+ KI+DFG+++ + T +
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 301 --YRWMAP 306
+W AP
Sbjct: 175 WPLKWYAP 182
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-39
Identities = 48/188 (25%), Positives = 90/188 (47%), Gaps = 16/188 (8%)
Query: 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQ 181
++ I ++ +G +G FG +++G Y + VAIK + + +
Sbjct: 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-----KNCTSDSVRE 61
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV 241
+F QE + + H +IV+ IG + VW I+ E G +R FL R+ L +
Sbjct: 62 KFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASL-I 119
Query: 242 KQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT- 300
A ++ +AY+ F+HRD+ + N+L+S++ +K+ DFG++R ++ +
Sbjct: 120 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGK 178
Query: 301 --YRWMAP 306
+WMAP
Sbjct: 179 LPIKWMAP 186
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 27/205 (13%)
Query: 119 YPTEGLENYDEWTIDLR--KLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPEN 171
E ++ I ++ +G FG +Y GT D A+K L
Sbjct: 71 LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRI 128
Query: 172 NPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRR 230
QF E +++ H N++ +G C R +V Y K G +R F+ R
Sbjct: 129 TDIGE---VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RN 184
Query: 231 QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR---- 286
+ +K + L VA+GM ++ F+HRDL + N ++ ++K+ADFG+AR
Sbjct: 185 ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244
Query: 287 -----IEVQTEGMTPETGTYRWMAP 306
+ +T P +WMA
Sbjct: 245 KEFDSVHNKTGAKLP----VKWMAL 265
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-38
Identities = 46/187 (24%), Positives = 87/187 (46%), Gaps = 18/187 (9%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGED------VAIKILERPENNPEKAQVMEQQ- 182
+L G FG +++G + E V IK++E +K+ Q
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE------DKSGRQSFQA 61
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
++ + +L H +IVR +G C + +VT+Y GS+ + R+ A+ +L +
Sbjct: 62 VTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHV-RQHRGALGPQLLLN 119
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT-- 300
+ +A+GM Y+ G +HR+L + N+L+ + +++ADFGVA + + +
Sbjct: 120 WGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 179
Query: 301 -YRWMAP 306
+WMA
Sbjct: 180 PIKWMAL 186
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-37
Identities = 58/220 (26%), Positives = 89/220 (40%), Gaps = 47/220 (21%)
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKA 176
E +W L G GAFGK+ T G VA+K+L EKA
Sbjct: 34 YEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML------KEKA 87
Query: 177 QVMEQQ-FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA 234
E++ E+ M+ L H NIV +GAC ++ EY G + +L ++ +
Sbjct: 88 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKF 147
Query: 235 VPLKLAVKQ---------------------ALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
++ + A VA+GM ++ +HRDL + N+L++
Sbjct: 148 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 207
Query: 274 DKSIKIADFGVARI-------EVQTEGMTPETGTYRWMAP 306
K +KI DFG+AR V+ P +WMAP
Sbjct: 208 GKVVKICDFGLARDIMSDSNYVVRGNARLP----VKWMAP 243
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 53/252 (21%), Positives = 103/252 (40%), Gaps = 27/252 (10%)
Query: 71 LTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENY--- 127
+ ++P + + + D+ + + Y
Sbjct: 321 VNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMP 380
Query: 128 --DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVME 180
++ I ++ +G +G FG +++G Y + VAIK + +
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-----KNCTSDSVR 435
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA 240
++F QE + + H +IV+ IG + VW I+ E G +R FL R+ L
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASL- 493
Query: 241 VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI------EVQTEGM 294
+ A ++ +AY+ F+HRD+ + N+L+S++ +K+ DFG++R ++G
Sbjct: 494 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 295 TPETGTYRWMAP 306
P +WMAP
Sbjct: 554 LP----IKWMAP 561
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-37
Identities = 45/182 (24%), Positives = 78/182 (42%), Gaps = 32/182 (17%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G FG++++ +G+ IK ++ ++EV LA L H+NIV
Sbjct: 21 SGGFGQVFKAKHRIDGKTYVIKRVKYNN------------EKAEREVKALAKLDHVNIVH 68
Query: 201 FIGA----------------CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
+ G K I E+ G++ Q++ +R+ + LA++
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWM 304
+ +G+ Y+H I+RDLK N+ + K +KI DFG+ T GT R+M
Sbjct: 129 EQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 188
Query: 305 AP 306
+P
Sbjct: 189 SP 190
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-37
Identities = 42/184 (22%), Positives = 81/184 (44%), Gaps = 16/184 (8%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGED------VAIKILERPENNPEKAQVMEQQFQQ 185
+ + GAFG +Y+G + E VAIK L + ++
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-----REATSPKANKEILD 66
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
E ++A++ + ++ R +G C V ++T+ G + ++ R + + + +
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNWCV 124
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YR 302
+A+GM Y+ +HRDL + N+L+ + +KI DFG+A++ E G +
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 303 WMAP 306
WMA
Sbjct: 185 WMAL 188
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-37
Identities = 36/195 (18%), Positives = 77/195 (39%), Gaps = 29/195 (14%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQVME 180
I L + QG F K+++G V +K+L + +
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL------DKAHRNYS 56
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA 240
+ F + M++ L H ++V G C +V E+ K GS+ +L ++ + +
Sbjct: 57 ESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWK 115
Query: 241 VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--------IKIADFGVAR-IEVQT 291
++ A +A M ++ IH ++ + N+L+ ++ IK++D G++ + +
Sbjct: 116 LEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
Query: 292 EGMTPETGTYRWMAP 306
W+ P
Sbjct: 176 ILQER----IPWVPP 186
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 56/259 (21%), Positives = 95/259 (36%), Gaps = 23/259 (8%)
Query: 64 SVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
S SN S + P + + A M
Sbjct: 257 SSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFE 316
Query: 124 LENYDEWTIDLRKLNM--------GTAFAQGAFGKLYRGTYNGE----DVAIKILERPEN 171
D + +KL + G FG + +G Y DVAIK+L +
Sbjct: 317 SPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGT 375
Query: 172 NPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ 231
++ +E ++ L + IVR IG C+ + +V E A GG + +FL +
Sbjct: 376 EKA----DTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFL-VGK 429
Query: 232 NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQ 290
+P+ + V+ GM Y+ F+HR+L + N+L+ KI+DFG+++ +
Sbjct: 430 REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489
Query: 291 TEGMTPETGT---YRWMAP 306
T + +W AP
Sbjct: 490 DSYYTARSAGKWPLKWYAP 508
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 40/218 (18%), Positives = 80/218 (36%), Gaps = 27/218 (12%)
Query: 110 LAQALMDHRYPTEGLENYDE---WTIDLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIK 164
+ + H + + Y + ID + +G F + G ++G A+K
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALK 60
Query: 165 ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW----CIVTEYAKG 220
+ E ++ Q+E M H NI+R + C + ++ + K
Sbjct: 61 RILCHEQQ------DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKR 114
Query: 221 GSVRQFLTRRQNRAVPL--KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278
G++ + R +++ L + L + RG+ +H G+ HRDLK N+L+ +
Sbjct: 115 GTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPV 174
Query: 279 IADFGVARIE----------VQTEGMTPETGTYRWMAP 306
+ D G + + + T + AP
Sbjct: 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 42/166 (25%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FGK L + T +G IK + K + ++ ++EV +LA +KH NIV++
Sbjct: 34 EGSFGKAILVKSTEDGRQYVIKEI-NISRMSSKER---EESRREVAVLANMKHPNIVQYR 89
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ + IV +Y +GG + + + ++ + + + + +VH +HR
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHR 149
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
D+KS N+ ++ D ++++ DFG+AR+ T + GT +++P
Sbjct: 150 DIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA-RACIGTPYYLSP 194
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-34
Identities = 53/173 (30%), Positives = 83/173 (47%), Gaps = 23/173 (13%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G +Y G N +AIK + E+ Q +E+ + LKH NIV+++
Sbjct: 32 KGTYGIVYAGRDLSNQVRIAIKEIP------ERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA-------VKQALDVARGMAYVH 255
G+ + I E GGS+ L +++ PLK KQ L G+ Y+H
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIGFYTKQIL---EGLKYLH 139
Query: 256 GLGFIHRDLKSDNLLI-SADKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 306
+HRD+K DN+LI + +KI+DFG + R+ TGT ++MAP
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 192
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-34
Identities = 45/196 (22%), Positives = 77/196 (39%), Gaps = 46/196 (23%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QGAFG++ + + AIK + + EVM+LA+L H +VR+
Sbjct: 16 QGAFGQVVKARNALDSRYYAIKKIR-------HTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 203 GA-------------CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
A +K+ I EY + G++ + L + + R
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFR 123
Query: 250 ----GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------- 298
++Y+H G IHRDLK N+ I +++KI DFG+A+ ++ +
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 299 --------GTYRWMAP 306
GT ++A
Sbjct: 184 SDNLTSAIGTAMYVAT 199
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-34
Identities = 38/167 (22%), Positives = 77/167 (46%), Gaps = 8/167 (4%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F ++YR +G VA+K ++ + KA+ +E+ +L L H N++++
Sbjct: 42 RGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKAR---ADCIKEIDLLKQLNHPNVIKYY 98
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK--LAVKQALDVARGMAYVHGLGFI 260
+ + IV E A G + + + + + + K + + + ++H +
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVM 158
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI-EVQTEGMTPETGTYRWMAP 306
HRD+K N+ I+A +K+ D G+ R +T GT +M+P
Sbjct: 159 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 21/177 (11%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA + E VAIK + N EK Q + +E+ ++ H NIV +
Sbjct: 25 SGATAVVQAAYCAPKKEKVAIKRI-----NLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79
Query: 203 GA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL------DVARGMAYVH 255
+ K +W +V + GGSV + + + ++ +V G+ Y+H
Sbjct: 80 TSFVVKDELW-LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
G IHRD+K+ N+L+ D S++IADFGV+ +T GT WMAP
Sbjct: 139 KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-33
Identities = 36/165 (21%), Positives = 66/165 (40%), Gaps = 9/165 (5%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRF 201
G++G++++ +G A+K P P+ + EV + +H VR
Sbjct: 67 HGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD----RARKLAEVGSHEKVGQHPCCVRL 122
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
A + + + TE G S++Q ++P D +A++H G +H
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLHSQGLVH 180
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
D+K N+ + K+ DFG+ + G R+MAP
Sbjct: 181 LDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAP 225
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-33
Identities = 39/190 (20%), Positives = 74/190 (38%), Gaps = 33/190 (17%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG + + + AIK + P + ++ +EV LA L+H IVR+
Sbjct: 15 RGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR-----EKVMREVKALAKLEHPGIVRYF 69
Query: 203 GAC------------RKRMVWCIVTEYAKGGSVRQFL-TRRQNRAVPLKLAVKQALDVAR 249
A ++ I + + +++ ++ R + + L +A
Sbjct: 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-------------EVQTEGMTP 296
+ ++H G +HRDLK N+ + D +K+ DFG+ T
Sbjct: 130 AVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 297 ETGTYRWMAP 306
+ GT +M+P
Sbjct: 190 QVGTKLYMSP 199
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-33
Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 28/174 (16%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG+++R G A+K + +E +E++ A L IV
Sbjct: 68 RGSFGEVHRMKDKQTGFQCAVKKVR-----------LEVFRVEELVACAGLSSPRIVPLY 116
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA---VKQALDVARGMAYVHGLGF 259
GA R+ I E +GGS+ Q + +Q +P A + QAL G+ Y+H
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQAL---EGLEYLHTRRI 171
Query: 260 IHRDLKSDNLLISAD-KSIKIADFGVA-RIEVQTEGMTPET-----GTYRWMAP 306
+H D+K+DN+L+S+D + DFG A ++ G + T GT MAP
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-32
Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 115 MDHRYPTEGLENYDEWTIDLRKL-NMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPEN 171
M H GL D +L +G+FG++++G N + VAIKI+
Sbjct: 1 MAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII----- 55
Query: 172 NPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRR 230
+ E+A+ + QQE+ +L+ + ++ G+ K +W I+ EY GGS L
Sbjct: 56 DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW-IIMEYLGGGSALDLLEPG 114
Query: 231 QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290
+ +++ L +G+ Y+H IHRD+K+ N+L+S +K+ADFGVA Q
Sbjct: 115 PLDETQIATILREIL---KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA---GQ 168
Query: 291 -TEGMTPET---GTYRWMAP 306
T+ GT WMAP
Sbjct: 169 LTDTQIKRNTFVGTPFWMAP 188
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-32
Identities = 45/186 (24%), Positives = 69/186 (37%), Gaps = 31/186 (16%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRF 201
G FG +++ +G AIK ++P EQ +EV A L +H ++VR+
Sbjct: 21 SGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHAVLGQHSHVVRY 76
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK--LAVKQALDVARGMAYVHGLGF 259
A + I EY GGS+ ++ K L V RG+ Y+H +
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 136
Query: 260 IHRDLKSDNLLISADKSI-------------------KIADFGVARIEVQTEGMTPETGT 300
+H D+K N+ IS KI D G + E G
Sbjct: 137 VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---RISSPQVEEGD 193
Query: 301 YRWMAP 306
R++A
Sbjct: 194 SRFLAN 199
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-32
Identities = 50/169 (29%), Positives = 83/169 (49%), Gaps = 18/169 (10%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFGK+Y+ G A K++E ++ E + + E+ +LAT H IV+ +
Sbjct: 29 DGAFGKVYKAKNKETGALAAAKVIE-TKSEEEL-----EDYIVEIEILATCDHPYIVKLL 82
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--KQALDVARGMAYVHGLGFI 260
GA I+ E+ GG+V + ++ V +Q L + ++H I
Sbjct: 83 GAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML---EALNFLHSKRII 139
Query: 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET---GTYRWMAP 306
HRDLK+ N+L++ + I++ADFGV+ ++T + GT WMAP
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKRDSFIGTPYWMAP 186
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 42/172 (24%), Positives = 65/172 (37%), Gaps = 16/172 (9%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
QGA ++RG G+ AIK+ +E +L L H NIV+
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVFNN-----ISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 201 -FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-AVPLKLAVKQALDVARGMAYVHGLG 258
R ++ E+ GS+ L N +P + DV GM ++ G
Sbjct: 74 AIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 259 FIHRDLKSDNLLIS----ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HR++K N++ K+ DFG AR E GT ++ P
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-31
Identities = 42/172 (24%), Positives = 65/172 (37%), Gaps = 16/172 (9%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
QGA ++RG G+ AIK+ +E +L L H NIV+
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVFNN-----ISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 201 -FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-AVPLKLAVKQALDVARGMAYVHGLG 258
R ++ E+ GS+ L N +P + DV GM ++ G
Sbjct: 74 AIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 259 FIHRDLKSDNLLIS----ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HR++K N++ K+ DFG AR E GT ++ P
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-30
Identities = 33/168 (19%), Positives = 67/168 (39%), Gaps = 14/168 (8%)
Query: 145 QGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRF 201
G K+++ + AIK + E + + ++ E+ L L+ I+R
Sbjct: 66 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD----SYRNEIAYLNKLQQHSDKIIRL 121
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+V E + +L ++++ + ++ + +H G +H
Sbjct: 122 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVH 178
Query: 262 RDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET--GTYRWMAP 306
DLK N LI D +K+ DFG+A ++ T + ++ G +M P
Sbjct: 179 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 34/168 (20%), Positives = 68/168 (40%), Gaps = 14/168 (8%)
Query: 145 QGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRF 201
G K+++ + AIK + E + + ++ E+ L L+ I+R
Sbjct: 19 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD----SYRNEIAYLNKLQQHSDKIIRL 74
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+V E + +L ++++ + ++ + +H G +H
Sbjct: 75 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVH 131
Query: 262 RDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET--GTYRWMAP 306
DLK N LI D +K+ DFG+A ++ T + ++ GT +M P
Sbjct: 132 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 34/168 (20%), Positives = 69/168 (41%), Gaps = 14/168 (8%)
Query: 145 QGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN--IVRF 201
G K+++ + AIK + E + + ++ E+ L L+ + I+R
Sbjct: 38 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ----TLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+V E + +L ++++ + ++ + +H G +H
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVH 150
Query: 262 RDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET--GTYRWMAP 306
DLK N LI D +K+ DFG+A ++ T + ++ GT +M P
Sbjct: 151 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 50/172 (29%), Positives = 88/172 (51%), Gaps = 24/172 (13%)
Query: 144 AQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G++G +Y+ + G+ VAIK + E++ ++ +E+ ++ ++V++
Sbjct: 38 GEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQE-------IIKEISIMQQCDSPHVVKY 89
Query: 202 IGACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--KQALDVARGMAYVHGLG 258
G+ K +W IV EY GSV + R ++A + L +G+ Y+H +
Sbjct: 90 YGSYFKNTDLW-IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL---KGLEYLHFMR 145
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPET---GTYRWMAP 306
IHRD+K+ N+L++ + K+ADFGVA Q T+ M GT WMAP
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVA---GQLTDTMAKRNTVIGTPFWMAP 194
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-30
Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 30/174 (17%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QGA G +Y G++VAI+ + + P+K + E++++ K+ NIV ++
Sbjct: 30 QGASGTVYTAMDVATGQEVAIRQMN-LQQQPKK-----ELIINEILVMRENKNPNIVNYL 83
Query: 203 GACRKRM-VWCIVTEYAKGGSVRQFLTRR-----QNRAVPLKLAVKQALDVARGMAYVHG 256
+ +W +V EY GGS+ +T Q AV ++ L + + ++H
Sbjct: 84 DSYLVGDELW-VVMEYLAGGSLTDVVTETCMDEGQIAAV-----CRECL---QALEFLHS 134
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPET---GTYRWMAP 306
IHRD+KSDN+L+ D S+K+ DFG Q T + + GT WMAP
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFC---AQITPEQSKRSTMVGTPYWMAP 185
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-30
Identities = 55/168 (32%), Positives = 84/168 (50%), Gaps = 10/168 (5%)
Query: 145 QGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204
+G FG +Y+G N VA+K L + + ++QQF QE+ ++A +H N+V +G
Sbjct: 41 EGGFGVVYKGYVNNTTVAVKKLA-AMVDITTEE-LKQQFDQEIKVMAKCQHENLVELLGF 98
Query: 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL--KLAVKQALDVARGMAYVHGLGFIHR 262
C+V Y GS+ L+ PL + K A A G+ ++H IHR
Sbjct: 99 SSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-PLSWHMRCKIAQGAANGINFLHENHHIHR 157
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET----GTYRWMAP 306
D+KS N+L+ + KI+DFG+AR + T T GT +MAP
Sbjct: 158 DIKSANILLDEAFTAKISDFGLARA-SEKFAQTVMTSRIVGTTAYMAP 204
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-30
Identities = 52/225 (23%), Positives = 100/225 (44%), Gaps = 28/225 (12%)
Query: 86 NYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQ 145
+ F+ G VTH AL + ++D P L++Y + +
Sbjct: 10 GVDLGTENLYFQSGVVTHEQFKAAL-RMVVDQGDPRLLLDSYVK-------------IGE 55
Query: 146 GAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G+ G + G VA+K+++ + + EV+++ +H N+V
Sbjct: 56 GSTGIVCLAREKHSGRQVAVKMMD-LRKQQRR-----ELLFNEVVIMRDYQHFNVVEMYK 109
Query: 204 ACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ +W ++ E+ +GG++ +++ + + + L + +AY+H G IHR
Sbjct: 110 SYLVGEELW-VLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL---QALAYLHAQGVIHR 165
Query: 263 DLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 306
D+KSD++L++ D +K++DFG A+I GT WMAP
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 210
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-30
Identities = 36/177 (20%), Positives = 66/177 (37%), Gaps = 26/177 (14%)
Query: 146 GAFGKLYRGTY--NGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+ Y GE V ++ LE N M Q E+ + H NIV +
Sbjct: 38 EDLMTVNLARYKPTGEYVTVRRINLEACSNE------MVTFLQGELHVSKLFNHPNIVPY 91
Query: 202 IGA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP-LKLAV--KQALDVARGMAYVHGL 257
+W +VT + GS + + + L +A + L + + Y+H +
Sbjct: 92 RATFIADNELW-VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL---KALDYIHHM 147
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVA--------RIEVQTEGMTPETGTYRWMAP 306
G++HR +K+ ++LIS D + ++ R V + W++P
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-30
Identities = 51/167 (30%), Positives = 75/167 (44%), Gaps = 16/167 (9%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G+FG +Y E VAIK + + Q +EV L L+H N +++
Sbjct: 64 HGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK---WQDIIKEVRFLQKLRHPNTIQYR 120
Query: 203 GACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--KQALDVARGMAYVHGLGF 259
G + W +V EY GS L + +++A AL +G+AY+H
Sbjct: 121 GCYLREHTAW-LVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHSHNM 175
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
IHRD+K+ N+L+S +K+ DFG A I GT WMAP
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAP 219
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-29
Identities = 50/176 (28%), Positives = 87/176 (49%), Gaps = 25/176 (14%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRF 201
G +G++Y+G + G+ AIK+++ + E++ +QE+ ML H NI +
Sbjct: 34 NGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-------EEEIKQEINMLKKYSHHRNIATY 86
Query: 202 IGACRKRMV-------WCIVTEYAKGGSVRQFLTRRQNRAVP-LKLAV--KQALDVARGM 251
GA K+ W +V E+ GSV + + + +A ++ L RG+
Sbjct: 87 YGAFIKKNPPGMDDQLW-LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL---RGL 142
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-MTPETGTYRWMAP 306
+++H IHRD+K N+L++ + +K+ DFGV+ +T G GT WMAP
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 4e-29
Identities = 50/204 (24%), Positives = 84/204 (41%), Gaps = 30/204 (14%)
Query: 118 RYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEK 175
R P+ + W + +L G FG + R GE VAIK + E
Sbjct: 4 RSPSLPTQTCGPWEMK-ERLG------TGGFGYVLRWIHQDTGEQVAIKQCRQ-----EL 51
Query: 176 AQVMEQQFQQEVMMLATLKHLNIVRFI------GACRKRMVWCIVTEYAKGGSVRQFLTR 229
+ +++ E+ ++ L H N+V + + EY +GG +R++L +
Sbjct: 52 SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ 111
Query: 230 RQNRAVPLKLAVKQAL----DVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIADF 282
+N L D++ + Y+H IHRDLK +N+++ KI D
Sbjct: 112 FENCC---GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168
Query: 283 GVARIEVQTEGMTPETGTYRWMAP 306
G A+ Q E T GT +++AP
Sbjct: 169 GYAKELDQGELCTEFVGTLQYLAP 192
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 45/175 (25%), Positives = 76/175 (43%), Gaps = 18/175 (10%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G++G+ R +G+ + K L+ + +Q EV +L LKH NIVR+
Sbjct: 16 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE----KQMLVSEVNLLRELKHPNIVRYY 71
Query: 203 GA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL--KLAVKQALDVARGMAYVHGLG 258
R IV EY +GG + +T+ L + ++ + + H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 259 F-----IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+HRDLK N+ + +++K+ DFG+ARI +T GT +M+P
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA-KTFVGTPYYMSP 185
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 7e-28
Identities = 59/172 (34%), Positives = 84/172 (48%), Gaps = 17/172 (9%)
Query: 145 QGAFGKLYRGT-YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
+G FGK+Y+G +G VA+K L+ E+ Q E QFQ EV M++ H N++R G
Sbjct: 40 RGGFGKVYKGRLADGTLVAVKRLKE-----ERTQGGELQFQTEVEMISMAVHRNLLRLRG 94
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA--VKQALDVARGMAYVH---GLG 258
C +V Y GSV L R PL + AL ARG+AY+H
Sbjct: 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 154
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET----GTYRWMAP 306
IHRD+K+ N+L+ + + DFG+A++ T T GT +AP
Sbjct: 155 IIHRDVKAANILLDEEFEAVVGDFGLAKL--MDYKDTHVTTAVRGTIGHIAP 204
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-28
Identities = 47/172 (27%), Positives = 87/172 (50%), Gaps = 20/172 (11%)
Query: 145 QGAFGKLYRGT-YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G FGK+Y+G +G VA+K PE +Q ++F+ E+ L+ +H ++V IG
Sbjct: 49 HGVFGKVYKGVLRDGAKVALKRR-----TPESSQ-GIEEFETEIETLSFCRHPHLVSLIG 102
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL--KLAVKQALDVARGMAYVHGLGFIH 261
C +R ++ +Y + G++++ L + + + ++ + ARG+ Y+H IH
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIH 162
Query: 262 RDLKSDNLLISADKSIKIADFGVARIE-------VQTEGMTPETGTYRWMAP 306
RD+KS N+L+ + KI DFG+++ + T GT ++ P
Sbjct: 163 RDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK----GTLGYIDP 210
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-28
Identities = 50/186 (26%), Positives = 89/186 (47%), Gaps = 22/186 (11%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQV----MEQQ 182
+W ++ +G +G FG +Y R + +A+K+L KAQ+ +E Q
Sbjct: 5 QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF-------KAQLEKAGVEHQ 55
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
++EV + + L+H NI+R G ++ EYA G+V + L ++ ++ +
Sbjct: 56 LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSK-FDEQRTAT 113
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GT 300
++A ++Y H IHRD+K +NLL+ + +KIADFG + V GT
Sbjct: 114 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGT 170
Query: 301 YRWMAP 306
++ P
Sbjct: 171 LDYLPP 176
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 44/170 (25%), Positives = 69/170 (40%), Gaps = 19/170 (11%)
Query: 131 TIDLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
+ +L + A+G F +Y + +G + A+K L E + QEV
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE------KNRAIIQEVC 77
Query: 189 MLATLK-HLNIVRFIGAC--------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
+ L H NIV+F A + + ++TE KG V +
Sbjct: 78 FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137
Query: 240 AVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSIKIADFGVARI 287
+K R + ++H IHRDLK +NLL+S +IK+ DFG A
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 36/188 (19%), Positives = 71/188 (37%), Gaps = 35/188 (18%)
Query: 145 QGAFGKLYRGTYNGEDVAIKILER-----------PENNPEKAQVMEQQFQQEVMMLATL 193
QG F K+ + + A+K E+ N+ + F+ E+ ++ +
Sbjct: 41 QGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100
Query: 194 KHLNIVRFIGACRKRMVW------CIVTEYAKGGSV------RQFLTRRQNRAVPLKLAV 241
K+ + G + I+ EY + S+ L + +P+++
Sbjct: 101 KNEYCLTCEG------IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 242 KQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-- 298
V +Y+H HRD+K N+L+ + +K++DFG + +
Sbjct: 155 CIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES---EYMVDKKIKGSR 211
Query: 299 GTYRWMAP 306
GTY +M P
Sbjct: 212 GTYEFMPP 219
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 36/153 (23%), Positives = 68/153 (44%), Gaps = 19/153 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
+G++GK+ A+KIL++ + E ++E+ +L L+H N+++
Sbjct: 15 EGSYGKVKEVLDSETLCRRAVKILKK--KKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 201 --FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYV 254
+++M +V EY G + + V QA G+ Y+
Sbjct: 73 DVLYNEEKQKM--YMVMEYCVCGMQEML-----DSVPEKRFPVCQAHGYFCQLIDGLEYL 125
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
H G +H+D+K NLL++ ++KI+ GVA
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 40/154 (25%), Positives = 65/154 (42%), Gaps = 7/154 (4%)
Query: 134 LRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLA 191
R+ G +G F K + + E A KI+ + ++ E+ +
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH---QREKMSMEISIHR 70
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
+L H ++V F G +V E + S+ + RR +A+ A + G
Sbjct: 71 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGC 128
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
Y+H IHRDLK NL ++ D +KI DFG+A
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 40/154 (25%), Positives = 65/154 (42%), Gaps = 7/154 (4%)
Query: 134 LRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLA 191
R+ G +G F K + + E A KI+ + ++ E+ +
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH---QREKMSMEISIHR 96
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
+L H ++V F G +V E + S+ + RR +A+ A + G
Sbjct: 97 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGC 154
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
Y+H IHRDLK NL ++ D +KI DFG+A
Sbjct: 155 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 26/175 (14%)
Query: 145 QGAFGK-LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFI 202
GA G +YRG ++ DVA+K + PE ++ EV +L +H N++R+
Sbjct: 34 HGAEGTIVYRGMFDNRDVAVKRI-----LPECFSFADR----EVQLLRESDEHPNVIRYF 84
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA--VKQALDVARGMAYVHGLGFI 260
+ R I E ++++++ ++ + L+ ++Q G+A++H L +
Sbjct: 85 CTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTS---GLAHLHSLNIV 140
Query: 261 HRDLKSDNLLISADKS-----IKIADFGVARIEVQTEG----MTPETGTYRWMAP 306
HRDLK N+LIS + I+DFG+ + + GT W+AP
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 49/182 (26%), Positives = 87/182 (47%), Gaps = 14/182 (7%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQE 186
++TID ++G +G FG +Y R N +A+K+L + + E +E Q ++E
Sbjct: 10 KFTID--DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG---VEHQLRRE 64
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
+ + + L+H NI+R R ++ E+A G + + L + + + +
Sbjct: 65 IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEE 122
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWM 304
+A + Y H IHRD+K +NLL+ +KIADFG + V + T GT ++
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRRTMCGTLDYL 179
Query: 305 AP 306
P
Sbjct: 180 PP 181
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 46/175 (26%), Positives = 72/175 (41%), Gaps = 22/175 (12%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERP--ENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
GA G++ + VAI+I+ + + + E+ +L L H I++
Sbjct: 145 SGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 204
Query: 201 FIGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
IV E +GG + L + Q L + Y+
Sbjct: 205 IKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQMLL---AVQYL 255
Query: 255 HGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
H G IHRDLK +N+L+S+ D IKI DFG ++I +T M GT ++AP
Sbjct: 256 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 40/174 (22%), Positives = 81/174 (46%), Gaps = 20/174 (11%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILER---PENNPEKAQVMEQQFQQEVMMLATLK-HLNI 198
+G + R + ++ A+KI++ + E+ Q + + +EV +L + H NI
Sbjct: 27 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86
Query: 199 VRFIGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMA 252
++ + +V + K G + + L+ ++ R + ++ L+V +
Sbjct: 87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-----MRALLEV---IC 138
Query: 253 YVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+H L +HRDLK +N+L+ D +IK+ DFG + E + GT ++AP
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-25
Identities = 44/149 (29%), Positives = 73/149 (48%), Gaps = 18/149 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQV----MEQQFQQEVMMLATLKHLNI 198
+G+F +YR + G +VAIK+++ K + M Q+ Q EV + LKH +I
Sbjct: 21 KGSFAGVYRAESIHTGLEVAIKMID-------KKAMYKAGMVQRVQNEVKIHCQLKHPSI 73
Query: 199 VRFIG--ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + +V E G + ++L + + + A + GM Y+H
Sbjct: 74 LELYNYFEDSNYVY--LVLEMCHNGEMNRYL-KNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVA 285
G +HRDL NLL++ + +IKIADFG+A
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-25
Identities = 42/169 (24%), Positives = 84/169 (49%), Gaps = 14/169 (8%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
+GA+G + + + G+ +A+K + R N ++ +++ ++ + + T+ V F
Sbjct: 17 RGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQE----QKRLLMDLDISMRTVDCPFTVTF 71
Query: 202 IGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--KQALDVARGMAYVHG-L 257
GA R+ VW I E S+ +F + ++ + + K A+ + + + ++H L
Sbjct: 72 YGALFREGDVW-ICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
IHRD+K N+LI+A +K+ DFG++ V + G +MAP
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAP 178
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 11/165 (6%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G G +++ ++ G +A K++ E P Q +E+ +L IV F
Sbjct: 43 AGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAI----RNQIIRELQVLHECNSPYIVGFY 97
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIH 261
GA I E+ GGS+ Q L ++ +P ++ K ++ V +G+ Y+ +H
Sbjct: 98 GAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMH 155
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
RD+K N+L+++ IK+ DFGV+ + + + GT +M+P
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSP 199
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-25
Identities = 40/161 (24%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPE--NNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
G +Y T VAIK + E ++F++EV + L H NIV
Sbjct: 20 GGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEE----TLKRFEREVHNSSQLSHQNIV 74
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
I + + +V EY +G ++ +++ + + + A+ + G+ + H +
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300
+HRD+K N+LI ++K++KI DFG+A+ + +T +T
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKA-LSETSLT-QTNH 171
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-25
Identities = 47/175 (26%), Positives = 73/175 (41%), Gaps = 22/175 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERP--ENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
GA G++ + VAIKI+ + + + E+ +L L H I++
Sbjct: 20 SGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 79
Query: 201 FIGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
+ IV E +GG + L + Q L + Y+
Sbjct: 80 IKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQMLL---AVQYL 130
Query: 255 HGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
H G IHRDLK +N+L+S+ D IKI DFG ++I +T M GT ++AP
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 42/173 (24%), Positives = 74/173 (42%), Gaps = 23/173 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG++ + ++ A+K++ + + +EV +L L H NI++
Sbjct: 32 KGSFGEVLKCKDRITQQEYAVKVINKASAKNKD----TSTILREVELLKKLDHPNIMKLF 87
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ IV E GG R+ + + +KQ + Y+H
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFSG---ITYMHK 139
Query: 257 LGFIHRDLKSDNLLISA---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HRDLK +N+L+ + D IKI DFG++ Q M GT ++AP
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 36/173 (20%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERP--ENNPEKAQVMEQQFQQEVMMLATLK-HLNIV 199
+G + R + G + A+KI+E +PE+ + + + ++E +L + H +I+
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163
Query: 200 RFIGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
I + +V + + G + + L+ ++ R++ ++ L+ +++
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI-----MRSLLEA---VSF 215
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+H +HRDLK +N+L+ + I+++DFG + E + GT ++AP
Sbjct: 216 LHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAP 268
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-24
Identities = 50/172 (29%), Positives = 81/172 (47%), Gaps = 18/172 (10%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFG ++ +G + IK + + +++QV +Q + E+ +L +L H NI++
Sbjct: 32 SGAFGDVHLVEERSSGLERVIKTINK-----DRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVARGMAYVHGL 257
IV E +GG + + + Q R L +KQ ++ +AY H
Sbjct: 87 EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA---LAYFHSQ 143
Query: 258 GFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+H+DLK +N+L S IKI DFG+A + E T GT +MAP
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 39/169 (23%), Positives = 83/169 (49%), Gaps = 13/169 (7%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
+GA+G + + + G+ +A+K + R + ++ ++Q ++ +++ + IV+F
Sbjct: 32 RGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKE----QKQLLMDLDVVMRSSDCPYIVQF 86
Query: 202 IGAC-RKRMVWCIVTEYAKGGSVR--QFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-L 257
GA R+ W I E + +++ + +P ++ K L + + ++ L
Sbjct: 87 YGALFREGDCW-ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
IHRD+K N+L+ +IK+ DFG++ V + T + G +MAP
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 194
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 53/170 (31%), Positives = 80/170 (47%), Gaps = 20/170 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F K+ G +VAIKI+++ + NP Q+ +EV ++ L H NIV+
Sbjct: 25 KGNFAKVKLARHILTGREVAIKIIDKTQLNPT----SLQKLFREVRIMKILNHPNIVKLF 80
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLG 258
++ EYA GG V +L ++ K+A R + Y H
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHG------RMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+HRDLK++NLL+ AD +IKIADFG + T G + G + AP
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFCGAPPYAAP 182
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 40/172 (23%), Positives = 75/172 (43%), Gaps = 23/172 (13%)
Query: 144 AQGAFGKLYRGT---YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
A G G +Y NG V +K L + E + E LA + H +IV+
Sbjct: 89 AHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAE----AQAMAMAERQFLAEVVHPSIVQ 143
Query: 201 ------FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
+ + IV EY G S+++ ++ +P+ A+ L++ ++Y+
Sbjct: 144 IFNFVEHTDRHGDPVGY-IVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYL 198
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
H +G ++ DLK +N++++ ++ +K+ D G G GT + AP
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSF-GYL--YGTPGFQAP 246
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-24
Identities = 43/165 (26%), Positives = 72/165 (43%), Gaps = 15/165 (9%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPE--NNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
G +++ + DVA+K+L R + +P +F++E A L H IV
Sbjct: 21 GFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPS----FYLRFRREAQNAAALNHPAIV 75
Query: 200 RF--IGACRKRMVWC--IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
G IV EY G ++R + + K A++ D + + + H
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSH 133
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300
G IHRD+K N++ISA ++K+ DFG+AR + +T
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 5e-24
Identities = 40/149 (26%), Positives = 73/149 (48%), Gaps = 17/149 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GA+G++ E VA+KI++ ++A + ++E+ + L H N+V+F
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDM-----KRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLG 258
G R+ + + EY GG + + + A G+ Y+HG+G
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARI 287
HRD+K +NLL+ ++KI+DFG+A +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATV 154
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 39/180 (21%), Positives = 82/180 (45%), Gaps = 26/180 (14%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILER-------PENNPEKAQVMEQQFQQEVMMLATLKH 195
GA+G++ + AIK++++ ++ + + ++ E+ +L +L H
Sbjct: 46 SGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH 105
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVAR 249
NI++ + + +VTE+ +GG + R + +KQ L
Sbjct: 106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI-----MKQILSG-- 158
Query: 250 GMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+ Y+H +HRD+K +N+L+ ++ +IKI DFG++ + + GT ++AP
Sbjct: 159 -ICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 40/187 (21%), Positives = 74/187 (39%), Gaps = 35/187 (18%)
Query: 145 QGAFGKL-YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRFI 202
G+ G + ++G++ G VA+K + E+ ++ + H N++R+
Sbjct: 25 YGSSGTVVFQGSFQGRPVAVKRMLID---------FCDIALMEIKLLTESDDHPNVIRYY 75
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA-----LDVARGMAYVHGL 257
+ I E +++ + + LKL + +A G+A++H L
Sbjct: 76 CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134
Query: 258 GFIHRDLKSDNLLISADKS-------------IKIADFGVARIEVQTEG-----MTPETG 299
IHRDLK N+L+S I I+DFG+ + + + +G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194
Query: 300 TYRWMAP 306
T W AP
Sbjct: 195 TSGWRAP 201
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-23
Identities = 46/188 (24%), Positives = 75/188 (39%), Gaps = 30/188 (15%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILER--------------------PENNPEKAQVMEQQ 182
+G++G L + A+K+L + + + +Q
Sbjct: 23 KGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82
Query: 183 FQQEVMMLATLKHLNIVRF---IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
QE+ +L L H N+V+ + + +V E G V +
Sbjct: 83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDH-LYMVFELVNQGPV--MEVPTLKP-LSEDQ 138
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET- 298
A D+ +G+ Y+H IHRD+K NLL+ D IKIADFGV+ ++ + T
Sbjct: 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV 198
Query: 299 GTYRWMAP 306
GT +MAP
Sbjct: 199 GTPAFMAP 206
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 43/173 (24%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG++ G++ A+K++ + K + ++ +EV +L L H NI++
Sbjct: 36 KGSFGEVILCKDKITGQECAVKVISK---RQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 203 GACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + +V E GG + R+ + + ++Q L + Y+H
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-----IRQVLSG---ITYMHK 144
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HRDLK +NLL+ S D +I+I DFG++ ++ M + GT ++AP
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 197
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-23
Identities = 39/151 (25%), Positives = 70/151 (46%), Gaps = 21/151 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GA+G++ E VA+KI++ ++A + ++E+ + L H N+V+F
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDM-----KRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 203 G--ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHG 256
G + EY GG + + + A G+ Y+HG
Sbjct: 72 GHRREGNIQ--YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHG 123
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287
+G HRD+K +NLL+ ++KI+DFG+A +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATV 154
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 45/173 (26%), Positives = 74/173 (42%), Gaps = 23/173 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA+G++ + AIKI+ + + + +EV +L L H NI++
Sbjct: 47 SGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS----NSKLLEEVAVLKLLDHPNIMKLY 102
Query: 203 GACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + +V E KGG + R + +KQ L + Y+H
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI-----IKQVLSG---VTYLHK 154
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HRDLK +NLL+ D IKI DFG++ + + M GT ++AP
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAP 207
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 98.9 bits (246), Expect = 1e-23
Identities = 43/238 (18%), Positives = 80/238 (33%), Gaps = 44/238 (18%)
Query: 107 DDALAQALMDH-RYPTEGLENYDEWTIDLRKLNMGTAFA-------------QGAFGKLY 152
DD L L+ P N EW L + T F +GAF ++Y
Sbjct: 23 DDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVY 82
Query: 153 RGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205
T N + +K+ + NP + + Q + L ++F A
Sbjct: 83 EATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQ----LMERLKPSMQHMFMKFYSAH 136
Query: 206 RKRMVWCIVTEYAKGGSVRQFLTRRQN---RAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ +V E G++ + +N + +P L + A+ + + VH IH
Sbjct: 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHG 196
Query: 263 DLKSDNLLIS-----------ADKSIKIADFGVAR-IEVQTEGMTPET--GTYRWMAP 306
D+K DN ++ + + D G + +++ +G T +
Sbjct: 197 DIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCV 254
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-23
Identities = 37/166 (22%), Positives = 73/166 (43%), Gaps = 11/166 (6%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
G G++++ + G +A+K + R N E+ ++ ++ ++L + IV+
Sbjct: 35 SGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEE----NKRILMDLDVVLKSHDCPYIVQC 89
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFI 260
G I E + + L +R +P ++ K + + + + Y+ G I
Sbjct: 90 FGTFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVI 147
Query: 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
HRD+K N+L+ IK+ DFG++ V + G +MAP
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAP 193
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-23
Identities = 44/173 (25%), Positives = 75/173 (43%), Gaps = 26/173 (15%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAF +++ G+ A+K +++ + + E+ +L +KH NIV
Sbjct: 19 SGAFSEVFLVKQRLTGKLFALKCIKK------SPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ +V + GG R T + V ++Q L + Y+H
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQVLSA---VKYLHE 124
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G +HRDLK +NLL + I I DFG++++E Q M+ GT ++AP
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAP 176
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 98.6 bits (245), Expect = 2e-23
Identities = 28/204 (13%), Positives = 48/204 (23%), Gaps = 38/204 (18%)
Query: 135 RKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT 192
RKL + G ++ ED A+K+ N ++ + A
Sbjct: 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRS---ELERLHEATFAAAR 118
Query: 193 LKHLNIVRFIGACRKRMVW--------------------------CIVTEYAKG--GSVR 224
L + R + ++ A +
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178
Query: 225 QFLTRRQNRAVPLKLAVKQAL--DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282
L + L + R A + G +H DNL I D + + D
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDV 238
Query: 283 GVARIEVQTEGMTPETGTYRWMAP 306
P + AP
Sbjct: 239 SALWKVGTR---GPASSVPVTYAP 259
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-23
Identities = 42/174 (24%), Positives = 70/174 (40%), Gaps = 27/174 (15%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQV-MEQQFQQEVMMLATLKHLNIVRF 201
+G++G++ A K + K V +F+QE+ ++ +L H NI+R
Sbjct: 19 RGSWGEVKIAVQKGTRIRRAAKKIP-------KYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 202 IGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
+V E GG ++ + +K L +AY H
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-----MKDVLSA---VAYCH 123
Query: 256 GLGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
L HRDLK +N L S D +K+ DFG+A + M + GT +++P
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 177
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-23
Identities = 38/149 (25%), Positives = 70/149 (46%), Gaps = 15/149 (10%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G FGK+ G G VA+KIL R + + + ++E+ L +H +I++
Sbjct: 21 VGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLD---VVGKIKREIQNLKLFRHPHIIKLY 77
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLG 258
+ +V EY GG + ++ + ++ +A + + + Y H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHG------RVEEMEARRLFQQILSAVDYCHRHM 131
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARI 287
+HRDLK +N+L+ A + KIADFG++ +
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNM 160
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-23
Identities = 42/173 (24%), Positives = 74/173 (42%), Gaps = 23/173 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG++ + ++ A+K++ + + +EV +L L H NI++
Sbjct: 32 KGSFGEVLKCKDRITQQEYAVKVINKASAKNKD----TSTILREVELLKKLDHPNIMKLF 87
Query: 203 GACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ IV E GG + R+ + + +KQ + Y+H
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFSG---ITYMHK 139
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HRDLK +N+L+ D IKI DFG++ Q M GT ++AP
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-23
Identities = 44/173 (25%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GAF + R G + A KI+ + + Q+ ++E + L+H NIVR
Sbjct: 16 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLH 71
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ ++ +V + GG R+F + ++Q L+ +AY H
Sbjct: 72 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQILES---IAYCHS 123
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G +HR+LK +NLL+ + ++K+ADFG+A +E GT +++P
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 176
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 4e-23
Identities = 39/174 (22%), Positives = 75/174 (43%), Gaps = 20/174 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F + + G++ A K +++ + + V ++ ++EV +L ++H NI+
Sbjct: 15 SGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLH 74
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ ++ E GG + ++ LT + +KQ LD G+ Y+H
Sbjct: 75 DIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-----LKQILD---GVHYLHS 126
Query: 257 LGFIHRDLKSDNLLI----SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
H DLK +N+++ + IK+ DFG+A GT ++AP
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 8e-23
Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 33/176 (18%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G FG R E VA+K +E + +++ Q+E++ +L+H NIVRF
Sbjct: 30 SGNFGVARLMRDKLTKELVAVKYIE-------RGAAIDENVQREIINHRSLRHPNIVRFK 82
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR--------GMAYV 254
I+ EYA GG + + + + + D AR G++Y
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICNAG------RFSE----DEARFFFQQLLSGVSYC 132
Query: 255 HGLGFIHRDLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
H + HRDLK +N L+ + +KI DFG ++ P++ GT ++AP
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKSTVGTPAYIAP 186
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-22
Identities = 39/174 (22%), Positives = 74/174 (42%), Gaps = 20/174 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F + + G + A K +++ ++ + V ++ ++EV +L + H NI+
Sbjct: 22 SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81
Query: 203 GACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
R ++ E GG + ++ L+ + + +KQ LD G+ Y+H
Sbjct: 82 DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYLHT 133
Query: 257 LGFIHRDLKSDNLLI----SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
H DLK +N+++ IK+ DFG+A GT ++AP
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-22
Identities = 38/174 (21%), Positives = 74/174 (42%), Gaps = 20/174 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F + + G + A K +++ ++ + V ++ ++EV +L + H N++
Sbjct: 22 SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
R ++ E GG + ++ L+ + + +KQ LD G+ Y+H
Sbjct: 82 DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYLHT 133
Query: 257 LGFIHRDLKSDNLLI----SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
H DLK +N+++ IK+ DFG+A GT ++AP
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-22
Identities = 40/173 (23%), Positives = 69/173 (39%), Gaps = 21/173 (12%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPE--NNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G G +Y T VA+K++ ++P + Q+E L+ ++V
Sbjct: 43 GRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPV----FRTRMQREARTAGRLQEPHVV 97
Query: 200 RF--IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
G ++ + G + L R+ + AV + + H
Sbjct: 98 PIHDFGE-IDGQLY-VDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET----GTYRWMAP 306
G HRD+K +N+L+SAD + DFG+A E +T + GT +MAP
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLT-QLGNTVGTLYYMAP 204
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-22
Identities = 47/173 (27%), Positives = 78/173 (45%), Gaps = 27/173 (15%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GA +YR + A+K+L++ + ++ + E+ +L L H NI++
Sbjct: 63 RGATSIVYRCKQKGTQKPYALKVLKKTVD--------KKIVRTEIGVLLRLSHPNIIKLK 114
Query: 203 GACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+V E GG + + + + R VKQ L+ +AY+H
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA-----VKQILEA---VAYLHE 166
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G +HRDLK +NLL + D +KIADFG+++I M GT + AP
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAP 219
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 4e-22
Identities = 35/222 (15%), Positives = 77/222 (34%), Gaps = 15/222 (6%)
Query: 100 KVTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLN-MGTAFAQGAFGKLYRGTYNG 158
+ + ++D A + E L KL G A+ + +
Sbjct: 24 EAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83
Query: 159 EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218
E I + + + P + ++ + N V + ++ I +
Sbjct: 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLC 143
Query: 219 KGGSVRQFLTRRQNRAVP-LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
+ +++ ++ RR + + + + +A + ++H G +HRDLK N+ + D +
Sbjct: 144 RKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV 203
Query: 278 KIADFGVARI-------------EVQTEGMTPETGTYRWMAP 306
K+ DFG+ T + GT +M+P
Sbjct: 204 KVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-22
Identities = 44/173 (25%), Positives = 80/173 (46%), Gaps = 23/173 (13%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GAF + R + G + A KI+ + + Q+ ++E + L+H NIVR
Sbjct: 39 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLH 94
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ ++ +V + GG R+F + ++Q L+ +AY H
Sbjct: 95 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQILES---IAYCHS 146
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G +HR+LK +NLL+ + ++K+ADFG+A +E GT +++P
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 199
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-22
Identities = 39/174 (22%), Positives = 71/174 (40%), Gaps = 20/174 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F + + G A K +++ + V + ++EV +L ++H N++
Sbjct: 21 SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ ++ E GG + ++ LT + +KQ L+ G+ Y+H
Sbjct: 81 EVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILN---GVYYLHS 132
Query: 257 LGFIHRDLKSDNLLIS----ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
L H DLK +N+++ IKI DFG+A GT ++AP
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 9e-22
Identities = 47/209 (22%), Positives = 78/209 (37%), Gaps = 48/209 (22%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QG++G + AIKI+ + + + +E+ + EV ++ L H NI R
Sbjct: 36 QGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVER-IKTEVRLMKKLHHPNIARLY 94
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--------------------- 241
C+V E GG + L + +
Sbjct: 95 EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSI 154
Query: 242 -------------KQALDVAR----GMAYVHGLGFIHRDLKSDNLLISADKS--IKIADF 282
K ++ R + Y+H G HRD+K +N L S +KS IK+ DF
Sbjct: 155 HGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDF 214
Query: 283 GVARI-----EVQTEGMTPETGTYRWMAP 306
G+++ + GMT + GT ++AP
Sbjct: 215 GLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-21
Identities = 29/171 (16%), Positives = 63/171 (36%), Gaps = 22/171 (12%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG ++R + + K ++ + ++E+ +L +H NI+
Sbjct: 15 RGEFGIVHRCVETSSKKTYMAKFVK-------VKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-----AVPLKLAVKQALDVARGMAYVHGL 257
+ ++ E+ G + + + V V Q + + ++H
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY---VHQVCE---ALQFLHSH 121
Query: 258 GFIHRDLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPETGTYRWMAP 306
H D++ +N++ +S IKI +FG AR + + AP
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FGK+ T + VA+K + R M + ++E+ L L+H +I++
Sbjct: 19 EGSFGKVKLATHYKTQQKVALKFISRQLLKKSD---MHMRVEREISYLKLLRHPHIIKLY 75
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLG 258
+V EYA GG + ++ ++ ++ + + + Y H
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVEKK------RMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292
+HRDLK +NLL+ + ++KIADFG++ I
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-21
Identities = 34/145 (23%), Positives = 65/145 (44%), Gaps = 8/145 (5%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL--NIVR 200
G FG +Y G + VAIK +E+ + + EV++L + ++R
Sbjct: 53 SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112
Query: 201 FIGACRKRMVWCIVTEYAKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + ++ E + + F+T R + +LA V + + H G
Sbjct: 113 LLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCGV 170
Query: 260 IHRDLKSDNLLISADK-SIKIADFG 283
+HRD+K +N+LI ++ +K+ DFG
Sbjct: 171 LHRDIKDENILIDLNRGELKLIDFG 195
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK-ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G++G + + G VAIK LE ++ K M +E+ +L L+H N+V
Sbjct: 35 EGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM-----REIKLLKQLRHENLVNL 89
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLGF 259
+ C+K+ W +V E+ ++ L N ++ + Q + G+ + H
Sbjct: 90 LEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII---NGIGFCHSHNI 145
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT--YRWMAP 306
IHRD+K +N+L+S +K+ DFG AR + E E T YR AP
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR--AP 193
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-21
Identities = 34/146 (23%), Positives = 68/146 (46%), Gaps = 7/146 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKIL--ERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
GAFG ++ ++V +K + E+ + + E+ +L+ ++H NI++
Sbjct: 34 SGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIK 93
Query: 201 FIGACRKRMVWCIVTE-YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + +V E + G + F+ R + LA + + Y+
Sbjct: 94 VLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLKDI 151
Query: 260 IHRDLKSDNLLISADKSIKIADFGVA 285
IHRD+K +N++I+ D +IK+ DFG A
Sbjct: 152 IHRDIKDENIVIAEDFTIKLIDFGSA 177
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-21
Identities = 50/170 (29%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK-ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G++G +++ G+ VAIK LE ++ K + +E+ ML LKH N+V
Sbjct: 13 EGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL-----REIRMLKQLKHPNLVNL 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLGF 259
+ R++ +V EY +V L R Q +K Q L + + + H
Sbjct: 68 LEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL---QAVNFCHKHNC 123
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT--YRWMAP 306
IHRD+K +N+LI+ IK+ DFG AR + ++ E T YR +P
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR--SP 171
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 40/174 (22%), Positives = 79/174 (45%), Gaps = 24/174 (13%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GAF + R G++ A I+ + + Q+ ++E + LKH NIVR
Sbjct: 21 KGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD----HQKLEREARICRLLKHPNIVRLH 76
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + ++ + GG R++ + ++Q L+ + + H
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----IQQILEA---VLHCHQ 128
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
+G +HR+LK +NLL+ ++K+ADFG+A +E + + GT +++P
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 15/149 (10%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G FGK+ G G VA+KIL R + + + ++E+ L +H +I++
Sbjct: 26 VGTFGKVKVGKHELTGHKVAVKILNRQKIRSLD---VVGKIRREIQNLKLFRHPHIIKLY 82
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLG 258
+V EY GG + ++ + +L K++ + + G+ Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNG------RLDEKESRRLFQQILSGVDYCHRHM 136
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARI 287
+HRDLK +N+L+ A + KIADFG++ +
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNM 165
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 5e-21
Identities = 34/173 (19%), Positives = 71/173 (41%), Gaps = 25/173 (14%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFG ++R T G + A K + + ++ ++E+ ++ L+H +V
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFV------MTPHESDKETVRKEIQTMSVLRHPTLVNLH 220
Query: 203 GACRKRMVWCIVTEYAKGG-------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
A ++ E+ GG ++ + ++Q G+ ++H
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-----MRQVCK---GLCHMH 272
Query: 256 GLGFIHRDLKSDNLLIS--ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
++H DLK +N++ + +K+ DFG+ + + TGT + AP
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 325
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-21
Identities = 34/171 (19%), Positives = 69/171 (40%), Gaps = 21/171 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFG ++R G K + + + + E+ ++ L H ++
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFI------NTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-----AVPLKLAVKQALDVARGMAYVHGL 257
A + ++ E+ GG + + + + ++QA + G+ ++H
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY---MRQACE---GLKHMHEH 168
Query: 258 GFIHRDLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+H D+K +N++ K+ +KI DFG+A E + T T + AP
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 219
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 6e-21
Identities = 30/205 (14%), Positives = 64/205 (31%), Gaps = 39/205 (19%)
Query: 135 RKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT 192
R L GT Q T GE + + E P A +Q ++EV+ L
Sbjct: 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAI---KQMKEEVLRLRL 134
Query: 193 L----------------------KHLNIVRFIGACRKRMVWCIVTEY-------AKGGSV 223
L K + I +++ + + +
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 224 RQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281
+ L ++++ ++ L V R +A +H G +H L+ ++++ + +
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 282 FGVARIEVQTEGMTPETGTYRWMAP 306
F + ++P + P
Sbjct: 255 FEHLVRD-GASAVSPIGRGF--APP 276
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 1e-20
Identities = 35/259 (13%), Positives = 77/259 (29%), Gaps = 36/259 (13%)
Query: 78 PGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKL 137
PG + ++ +V + + D ++ +L + P E R L
Sbjct: 19 PGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERP---RTL 75
Query: 138 NMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQ------------------ 177
GT Q T GE + + E P A
Sbjct: 76 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135
Query: 178 ----VMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY----AKGGSVRQFLTR 229
+ +F ++ + ++R R V Y + + + L
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195
Query: 230 --RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
++++ ++ L V R +A +H G +H L+ ++++ + + F
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL-- 253
Query: 288 EVQTEGMTPETGTYRWMAP 306
V+ + + + P
Sbjct: 254 -VRDGARVVSSVSRGFEPP 271
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-20
Identities = 43/173 (24%), Positives = 75/173 (43%), Gaps = 25/173 (14%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G FG++++ G +A KI+ + +++ + E+ ++ L H N+++
Sbjct: 99 GGRFGQVHKCEETATGLKLAAKII------KTRGMKDKEEVKNEISVMNQLDHANLIQLY 152
Query: 203 GACRKRMVWCIVTEYAKGG-------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
A + +V EY GG LT +KQ + G+ ++H
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF-----MKQICE---GIRHMH 204
Query: 256 GLGFIHRDLKSDNLLIS--ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+ +H DLK +N+L K IKI DFG+AR E + GT ++AP
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAP 257
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-20
Identities = 37/173 (21%), Positives = 68/173 (39%), Gaps = 15/173 (8%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F + R G+ A+KI++ + + ++E + LKH +IV +
Sbjct: 34 KGPFSVVRRCINRETGQQFAVKIVDV-AKFTSSPGLSTEDLKREASICHMLKHPHIVELL 92
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVARGMAYVHGL 257
+ +V E+ G + + +R + ++Q L+ + Y H
Sbjct: 93 ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA---LRYCHDN 149
Query: 258 GFIHRDLKSDNLLI---SADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
IHRD+K +L+ +K+ FGVA + GT +MAP
Sbjct: 150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-20
Identities = 37/176 (21%), Positives = 69/176 (39%), Gaps = 26/176 (14%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL-NIVRF 201
+G F + + G++ A K L++ + + E+ +L K ++
Sbjct: 39 RGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC----RAEILHEIAVLELAKSCPRVINL 94
Query: 202 IGACRKRMVWCIVTEYAKGG--------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
++ EYA GG + + ++ + +KQ L+ G+ Y
Sbjct: 95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL-----IKQILE---GVYY 146
Query: 254 VHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+H +H DLK N+L+ IKI DFG++R + GT ++AP
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-19
Identities = 20/145 (13%), Positives = 46/145 (31%), Gaps = 9/145 (6%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+ ++ T VA+ ++ P+ Q+ + L+ + + R
Sbjct: 40 GGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVL---QETLSRTLRLSRIDKPGVARV 96
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ R +V E+ +GGS+++ A++ +A H G
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVAL 152
Query: 262 RDLKSDNLLISADKSIKIADFGVAR 286
+ +S D + +A
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 36/180 (20%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK-ILERPENNPEKAQVMEQQFQQ-EVMMLATLKHLNIVR 200
G+FG +Y+ +GE VAIK +L+ +++F+ E+ ++ L H NIVR
Sbjct: 64 NGSFGVVYQAKLCDSGELVAIKKVLQ------------DKRFKNRELQIMRKLDHCNIVR 111
Query: 201 ----FIGACRKRMVWCI--VTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVAR 249
F + K+ + V +Y +V + L KL + Q R
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF---R 167
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTEGMTPETGT--YRWMAP 306
+AY+H G HRD+K NLL+ D +K+ DFG A+ V+ E + YR AP
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--AP 225
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 41/182 (22%), Positives = 76/182 (41%), Gaps = 34/182 (18%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRF 201
+GA ++ ++ A+KI+E+ + + + +EV ML + H N++
Sbjct: 23 EGAHARVQTCINLITSQEYAVKIIEK------QPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 202 IGACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
I + + +V E +GGS+ R+ + V V+ VA + ++H
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV-----VQD---VASALDFLH 128
Query: 256 GLGFIHRDLKSDNLLI---SADKSIKIADFGVARI--------EVQTEGMTPETGTYRWM 304
G HRDLK +N+L + +KI DF + + T + G+ +M
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 305 AP 306
AP
Sbjct: 189 AP 190
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-19
Identities = 31/147 (21%), Positives = 59/147 (40%), Gaps = 10/147 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL----KHLNI 198
+G FG ++ G + VAIK++ R EV +L + H +
Sbjct: 41 KGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV 100
Query: 199 VRFIGACRKRMVWCIVTEYA-KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+R + + + +V E + ++T + + + V + + H
Sbjct: 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCHSR 158
Query: 258 GFIHRDLKSDNLLISADK-SIKIADFG 283
G +HRD+K +N+LI + K+ DFG
Sbjct: 159 GVVHRDIKDENILIDLRRGCAKLIDFG 185
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-19
Identities = 40/172 (23%), Positives = 67/172 (38%), Gaps = 22/172 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
G GK+ G+ A+K+L +QEV +IV
Sbjct: 39 LGVNGKVLECFHRRTGQKCALKLLYDSPK-----------ARQEVDHHWQASGGPHIVCI 87
Query: 202 IGAC----RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ + I+ E +GG + + R ++A + A + D+ + ++H
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH 147
Query: 258 GFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
HRD+K +NLL D +K+ DFG A+ Q TP T ++AP
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAP 198
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 51/185 (27%), Positives = 82/185 (44%), Gaps = 37/185 (20%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QG FG++++ G+ VA+K + EN E + + E+ +L LKH N+V I
Sbjct: 27 QGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALR---EIKILQLLKHENVVNLI 82
Query: 203 GACRKRMVWC--------IVTEYA----KG--GSVRQFLTRRQNRAVPLKLAVKQALDVA 248
CR + +V ++ G +V T + +K ++ L
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE-----IKRVMQMLL--- 134
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-----IEVQTEGMTPETGT--Y 301
G+ Y+H +HRD+K+ N+LI+ D +K+ADFG+AR Q T T Y
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194
Query: 302 RWMAP 306
R P
Sbjct: 195 R--PP 197
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 39/175 (22%), Positives = 77/175 (44%), Gaps = 30/175 (17%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRF 201
+G+F + + + A+KI+ + ME Q+E+ L + H NIV+
Sbjct: 21 EGSFSICRKCVHKKSNQAFAVKIISKR---------MEANTQKEITALKLCEGHPNIVKL 71
Query: 202 IGACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
++ +V E GG + ++ + + + +++ + ++++H
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-----MRKLVSA---VSHMH 123
Query: 256 GLGFIHRDLKSDNLLI---SADKSIKIADFGVARI-EVQTEGMTPETGTYRWMAP 306
+G +HRDLK +NLL + + IKI DFG AR+ + + T + AP
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-18
Identities = 39/172 (22%), Positives = 70/172 (40%), Gaps = 21/172 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
G GK+ + E A+K+L+ + ++EV + + +IVR
Sbjct: 72 LGINGKVLQIFNKRTQEKFALKMLQD-----------CPKARREVELHWRASQCPHIVRI 120
Query: 202 IGAC----RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ R IV E GG + + R ++A + A + + + Y+H +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 180
Query: 258 GFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
HRD+K +NLL + +K+ DFG A+ +T T ++AP
Sbjct: 181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 47/180 (26%), Positives = 77/180 (42%), Gaps = 37/180 (20%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK--ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G+FG +++ + E VAIK + ++ N +E+ ++ +KH N+V
Sbjct: 50 NGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN------------RELQIMRIVKHPNVVD 96
Query: 201 ----FIGACRKRMVWCI--VTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVAR 249
F K+ + V EY +V + + KL + Q L R
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLL---R 152
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTEGMTPE--TGTYRWMAP 306
+AY+H +G HRD+K NLL+ +K+ DFG A+I + E + YR AP
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR--AP 210
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 6e-18
Identities = 50/228 (21%), Positives = 99/228 (43%), Gaps = 28/228 (12%)
Query: 88 SVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGA 147
++ Q + V++ ++++ +D+++ + + +T+ ++ GA
Sbjct: 17 KIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEV-GDSTFTVL-KRYQNLKPIGSGA 74
Query: 148 FGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR----F 201
G + +VAIK L RP N A+ + +E++++ + H NI+ F
Sbjct: 75 QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK----RAYRELVLMKCVNHKNIISLLNVF 130
Query: 202 IGACRKRM---VWCIVTEYAK---GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
V+ +V E ++ L + + + Q L G+ ++H
Sbjct: 131 TPQKTLEEFQDVY-LVMELMDANLCQVIQMELDHERMSYL-----LYQML---CGIKHLH 181
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
G IHRDLK N+++ +D ++KI DFG+AR + MTP T R+
Sbjct: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT-RY 228
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 41/176 (23%), Positives = 77/176 (43%), Gaps = 32/176 (18%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
G++ R + A+KI+++ + +P +E+ ++L +H NI+
Sbjct: 32 VGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----------TEEIEILLRYGQHPNIITL 81
Query: 202 IGACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
+VTE KGG + ++F + R+ AV + + + + Y+H
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV-----LFT---ITKTVEYLH 133
Query: 256 GLGFIHRDLKSDNLLISADK----SIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
G +HRDLK N+L + SI+I DFG A+ + + + T ++AP
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-17
Identities = 53/178 (29%), Positives = 79/178 (44%), Gaps = 31/178 (17%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK--ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G + +Y+G G VA+K L+ E P A +E+ ++ LKH NIVR
Sbjct: 15 NGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-------REISLMKELKHENIVR 67
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP-------LKLAVKQALDVARGMAY 253
+V E+ +++++ R P +K Q L +G+A+
Sbjct: 68 LYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL---QGLAF 123
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 306
H +HRDLK NLLI+ +K+ DFG+AR I V T + E T YR AP
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT--FSSEVVTLWYR--AP 177
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 37/163 (22%), Positives = 63/163 (38%), Gaps = 22/163 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVM-MLATLKHLNIVRF 201
G GK+ + E A+K+L+ ++EV + +IVR
Sbjct: 28 LGINGKVLQIFNKRTQEKFALKMLQDCPK-----------ARREVELHWRASQCPHIVRI 76
Query: 202 IGAC----RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ R IV E GG + + R ++A + A + + + Y+H +
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 136
Query: 258 GFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPE 297
HRD+K +NLL + +K+ DFG A+ E E
Sbjct: 137 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTGEKYDKS 178
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-17
Identities = 63/194 (32%), Positives = 85/194 (43%), Gaps = 36/194 (18%)
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIK--ILERPENNPEKAQVM 179
+E Y + L KL +G + +Y+G VA+K LE E P A
Sbjct: 1 METYIK----LDKLG------EGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-- 48
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--L 237
+EV +L LKH NIV +V EY ++Q+L N +
Sbjct: 49 -----REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNV 102
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGM 294
KL + Q L RG+AY H +HRDLK NLLI+ +K+ADFG+AR I +T
Sbjct: 103 KLFLFQLL---RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--Y 157
Query: 295 TPETGT--YRWMAP 306
E T YR P
Sbjct: 158 DNEVVTLWYR--PP 169
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-17
Identities = 46/214 (21%), Positives = 94/214 (43%), Gaps = 15/214 (7%)
Query: 104 ALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTA-F------AQGAFGK--LYRG 154
++ + A L +Y + L+ + + L+++ + F +GAF + + +
Sbjct: 23 GVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKM 82
Query: 155 TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214
G+ A+KI+ + ++ +V F++E +L I + A + +V
Sbjct: 83 KQTGQVYAMKIM-NKWDMLKRGEV--SCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139
Query: 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274
EY GG + L + +P ++A ++ + VH LG++HRD+K DN+L+
Sbjct: 140 MEYYVGGDL-LTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC 198
Query: 275 KSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
I++ADFG + GT +++P
Sbjct: 199 GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 4e-17
Identities = 54/172 (31%), Positives = 85/172 (49%), Gaps = 22/172 (12%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G +Y+ GE VA+K + R + E +E+ +L L H NIV+ +
Sbjct: 13 EGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPS---TAIREISLLKELNHPNIVKLL 68
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL---KLAVKQALDVARGMAYVHGLGF 259
+V E+ +++F+ +PL K + Q L +G+A+ H
Sbjct: 69 DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL---QGLAFCHSHRV 124
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 306
+HRDLK NLLI+ + +IK+ADFG+AR + V+T T E T YR AP
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYR--AP 172
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-17
Identities = 50/187 (26%), Positives = 82/187 (43%), Gaps = 27/187 (14%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQE 186
+T+ R N+ GA G + +VAIK L RP N A+ + +E
Sbjct: 20 TFTVLKRYQNL-KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK----RAYRE 74
Query: 187 VMMLATLKHLNIVR----FIGACRKRM---VWCIVTEYAK---GGSVRQFLTRRQNRAVP 236
++++ + H NI+ F V+ IV E ++ L +
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY-IVMELMDANLCQVIQMELDHER----- 128
Query: 237 LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTP 296
+ + Q L G+ ++H G IHRDLK N+++ +D ++KI DFG+AR + MTP
Sbjct: 129 MSYLLYQML---CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 185
Query: 297 ETGTYRW 303
T R+
Sbjct: 186 YVVT-RY 191
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 6e-17
Identities = 47/218 (21%), Positives = 94/218 (43%), Gaps = 23/218 (10%)
Query: 104 ALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTA-FA------QGAFGK--LYRG 154
L D+ L + E LE +T ++++ + F +GAFG+ + +
Sbjct: 36 CLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKL 95
Query: 155 TYNGEDVAIKILERPENNPEKAQVMEQQ----FQQEVMMLATLKHLNIVRFIGACRKRMV 210
+ A+KIL K +++++ F++E +L I A +
Sbjct: 96 KNADKVFAMKILN-------KWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148
Query: 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270
+V +Y GG + L + +P ++A ++ + VH L ++HRD+K DN+L
Sbjct: 149 LYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 207
Query: 271 ISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+ + I++ADFG ++ + GT +++P
Sbjct: 208 MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 7e-17
Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 28/171 (16%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
GA+G + +GE VAIK L RP + A+ + +E+++L ++H N++
Sbjct: 34 SGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK----RAYRELLLLKHMQHENVIGLL 89
Query: 201 --FIGACRKRM---VWCIVTEYAK---GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMA 252
F A R + +V + + + + + ++ V Q L +G+
Sbjct: 90 DVFTPASSLRNFYDFY-LVMPFMQTDLQKIMGLKFSEEK-----IQYLVYQML---KGLK 140
Query: 253 YVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
Y+H G +HRDLK NL ++ D +KI DFG+AR MT T RW
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVT-RW 188
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 8e-17
Identities = 39/176 (22%), Positives = 72/176 (40%), Gaps = 26/176 (14%)
Query: 145 QGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQ-----EVMMLATLKHLNI 198
G++G + G + G VAIK + ++ ++ F E+ +L H NI
Sbjct: 32 SGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91
Query: 199 VR----FIGACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDV 247
+ F+ M ++ +VTE + Q + ++ + + + + L
Sbjct: 92 LGLRDIFVHFEEPAMHKLY-LVTELM-RTDLAQVIHDQR---IVISPQHIQYFMYHIL-- 144
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
G+ +H G +HRDL N+L++ + I I DF +AR + T RW
Sbjct: 145 -LGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH-RW 198
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 9e-17
Identities = 55/174 (31%), Positives = 80/174 (45%), Gaps = 28/174 (16%)
Query: 145 QGAFGKLYRGTYN-GEDVAIKILERPENN----PEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G +Y+ N GE A+K + R E P +E+ +L LKH NIV
Sbjct: 12 EGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTI-------REISILKELKHSNIV 63
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGL 257
+ + +V E+ +++ L + K + Q L G+AY H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYCHDR 119
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 306
+HRDLK NLLI+ + +KIADFG+AR I V+ T E T YR AP
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIVTLWYR--AP 169
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 77.9 bits (193), Expect = 1e-16
Identities = 47/171 (27%), Positives = 80/171 (46%), Gaps = 21/171 (12%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G +++ E VA+K + R +++ E +E+ +L LKH NIVR
Sbjct: 12 EGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPS---SALREICLLKELKHKNIVRLH 67
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLGFI 260
+V E+ ++++ P +K + Q L +G+ + H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGFCHSRNVL 123
Query: 261 HRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 306
HRDLK NLLI+ + +K+A+FG+AR I V+ + E T YR P
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYR--PP 170
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-16
Identities = 53/170 (31%), Positives = 84/170 (49%), Gaps = 20/170 (11%)
Query: 145 QGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
+G +G +Y+ G VA+K + R + E +E+ +L L H NIV I
Sbjct: 31 EGTYGVVYKAKDSQGRIVALKRI-RLDAEDEGIPS---TAIREISLLKELHHPNIVSLID 86
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLGFIH 261
+V E+ + +++ L + +K+ + Q L RG+A+ H +H
Sbjct: 87 VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQHRILH 142
Query: 262 RDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 306
RDLK NLLI++D ++K+ADFG+AR I V++ T E T YR AP
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYR--AP 188
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-16
Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 22/177 (12%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNIV 199
GA+G +Y+ ++G VA+K + R N + +EV +L L+ H N+V
Sbjct: 19 VGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVV 77
Query: 200 RFIGACRKRMVWC-----IVTEYAKGGSVRQFLTRRQNRAVPL---KLAVKQALDVARGM 251
R + C +V E+ +R +L + +P K ++Q L RG+
Sbjct: 78 RLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFL---RGL 133
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT--YRWMAP 306
++H +HRDLK +N+L+++ ++K+ADFG+ARI +TP T YR AP
Sbjct: 134 DFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYR--AP 188
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 43/180 (23%), Positives = 73/180 (40%), Gaps = 36/180 (20%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLNI 198
+G+F L R + AIKILE K ++++ V +++ L H
Sbjct: 40 EGSFSTVVLARELATSREYAIKILE-------KRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR--------G 250
V+ + YAK G + +++ + R
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----------SFDETCTRFYTAEIVSA 142
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET----GTYRWMAP 306
+ Y+HG G IHRDLK +N+L++ D I+I DFG A+ + E GT ++++P
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANSFVGTAQYVSP 201
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 3e-16
Identities = 43/186 (23%), Positives = 78/186 (41%), Gaps = 20/186 (10%)
Query: 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQV 178
+ +W +L +G +GAFG++ G D VA+K+L+ + E
Sbjct: 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--- 69
Query: 179 MEQQFQQEV-MMLATLKHLNIVRFIGACRKRMV-WCIVTEYAKGGSVRQFLTRRQNRAVP 236
+ E+ +++ HLN+V +GAC K ++ E+ K G++ +L ++N VP
Sbjct: 70 --RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 127
Query: 237 LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTP 296
K + +G Y +G I DLK I++ +S + F + E
Sbjct: 128 YKT---KGARFRQGKDY---VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181
Query: 297 ETGTYR 302
Y+
Sbjct: 182 PEDLYK 187
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 24/70 (34%), Positives = 36/70 (51%), Gaps = 11/70 (15%)
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-------EVQTEGMTP 296
+ VA+GM ++ IHRDL + N+L+S +KI DFG+AR + + P
Sbjct: 199 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 297 ETGTYRWMAP 306
+WMAP
Sbjct: 259 ----LKWMAP 264
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 3e-16
Identities = 42/174 (24%), Positives = 82/174 (47%), Gaps = 24/174 (13%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F +Y+ + VAIK + + + E + + +E+ +L L H NI+ +
Sbjct: 20 EGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 78
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA-VK----QALDVARGMAYVHGL 257
A + +V ++ + + + ++ ++ L + +K L +G+ Y+H
Sbjct: 79 DAFGHKSNISLVFDFMET-DLEVII---KDNSLVLTPSHIKAYMLMTL---QGLEYLHQH 131
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 306
+HRDLK +NLL+ + +K+ADFG+A+ + T + T YR AP
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYR--AP 181
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 36/159 (22%), Positives = 70/159 (44%), Gaps = 22/159 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL------ 196
+G+FG++ + + VA+K++ N +Q +E+ +L L+
Sbjct: 107 KGSFGQVVKAYDHKVHQHVALKMVR---NEKR----FHRQAAEEIRILEHLRKQDKDNTM 159
Query: 197 NIVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
N++ + R + C+ E ++ + + + + + L L K A + + + +
Sbjct: 160 NVIHMLENFTFRNHI--CMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 255 HGLGFIHRDLKSDN-LLISADKS-IKIADFGVARIEVQT 291
H IH DLK +N LL +S IK+ DFG + E Q
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR 255
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 7e-16
Identities = 48/186 (25%), Positives = 76/186 (40%), Gaps = 42/186 (22%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK-ILERPENNPEKAQVMEQQFQ----QEVMMLATLKHLN 197
QG FG + G G VAIK +++ P +F+ Q + LA L H N
Sbjct: 33 QGTFGTVQLGKEKSTGMSVAIKKVIQDP------------RFRNRELQIMQDLAVLHHPN 80
Query: 198 IVR----FIGACRKRMV---WCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQAL 245
IV+ F + +V EY ++ + R V K+ + Q +
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 246 DVARGMAYVH--GLGFIHRDLKSDNLLI-SADKSIKIADFGVARIEVQTEGMTPETGT-- 300
R + +H + HRD+K N+L+ AD ++K+ DFG A+ +E +
Sbjct: 140 ---RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY 196
Query: 301 YRWMAP 306
YR AP
Sbjct: 197 YR--AP 200
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 9e-16
Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 25/218 (11%)
Query: 104 ALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTA-FA------QGAFGK--LYRG 154
AL D AL ++ L Y + +R L M + +GAFG+ L R
Sbjct: 31 ALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRH 90
Query: 155 TYNGEDVAIKILERPENNPEKAQVMEQQ----FQQEVMMLATLKHLNIVRFIGACRKRMV 210
+ A+K+L K +++++ F +E ++A +V+ A +
Sbjct: 91 KSTRKVYAMKLLS-------KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143
Query: 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270
+V EY GG + N VP K A +V + +H +GFIHRD+K DN+L
Sbjct: 144 LYMVMEYMPGG---DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 200
Query: 271 ISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+ +K+ADFG + + +T GT +++P
Sbjct: 201 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 37/208 (17%), Positives = 78/208 (37%), Gaps = 60/208 (28%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK-ILERPENNPEKAQVMEQQFQQ-EVMMLATLKHLNIVR 200
G+FG + +G+ A+K +L+ + +++ E+ ++ L H+NI++
Sbjct: 17 TGSFGIVCEVFDIESGKRFALKKVLQ------------DPRYKNRELDIMKVLDHVNIIK 64
Query: 201 ----FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA---------------- 240
F + + + +++V + +
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124
Query: 241 ---------VKQALDVA----------RGMAYVHGLGFIHRDLKSDNLLI-SADKSIKIA 280
+++ + R + ++H LG HRD+K NLL+ S D ++K+
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLC 184
Query: 281 DFGVARIEVQTEGMTPETGT--YRWMAP 306
DFG A+ + +E + YR AP
Sbjct: 185 DFGSAKKLIPSEPSVAYICSRFYR--AP 210
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 39/162 (24%), Positives = 66/162 (40%), Gaps = 30/162 (18%)
Query: 145 QGAFGKLYRG----TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G +G +Y+ + +D A+K +E A +E+ +L LKH N++
Sbjct: 31 RGTYGHVYKAKRKDGKDDKDYALKQIEG-TGISMSAC-------REIALLRELKHPNVIS 82
Query: 201 FIGACRKRMVWCI--VTEYA----KGGSVRQFLTRRQNRAVPLKLA-VK----QALDVAR 249
+ + +YA ++ + V L VK Q L
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL---D 139
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKS----IKIADFGVARI 287
G+ Y+H +HRDLK N+L+ + +KIAD G AR+
Sbjct: 140 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 50/183 (27%), Positives = 78/183 (42%), Gaps = 41/183 (22%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPE----KAQVMEQQFQQEVMMLATLKHLNI 198
+G +G++Y+ T E VAIK + R E+ E A +EV +L L+H NI
Sbjct: 44 EGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAI-------REVSLLKELQHRNI 95
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVARGMAY 253
+ ++ EY L + ++ + K + Q + G+ +
Sbjct: 96 IELKSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLI---NGVNF 147
Query: 254 VHGLGFIHRDLKSDNLLISADKS-----IKIADFGVAR---IEVQTEGMTPETGT--YRW 303
H +HRDLK NLL+S + +KI DFG+AR I ++ T E T YR
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ--FTHEIITLWYR- 204
Query: 304 MAP 306
P
Sbjct: 205 -PP 206
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 51/262 (19%), Positives = 99/262 (37%), Gaps = 28/262 (10%)
Query: 60 VDNSSVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRY 119
N + L + + + +F+ L + L+ A
Sbjct: 106 TQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQE---LTRLTHEYLSVAPFADYL 162
Query: 120 PTEGLENYDEWT-IDLRKLNMGTAFA------QGAFGK--LYRGTYNGEDVAIKILERPE 170
+ + +W ++ + + T F +G FG+ + G+ A K LE
Sbjct: 163 DSIYFNRFLQWKWLERQPVTKNT-FRQYRVLGKGGFGEVCACQVRATGKMYACKKLE--- 218
Query: 171 NNPEKAQVMEQQFQQEVM----MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQF 226
K ++ +++ + + +L + +V A + C+V GG ++
Sbjct: 219 ----KKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFH 274
Query: 227 LTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ P AV A ++ G+ +H ++RDLK +N+L+ I+I+D G+A
Sbjct: 275 IYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV 334
Query: 287 IEVQTEGMTPET--GTYRWMAP 306
V EG T + GT +MAP
Sbjct: 335 -HV-PEGQTIKGRVGTVGYMAP 354
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-15
Identities = 47/183 (25%), Positives = 78/183 (42%), Gaps = 20/183 (10%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQE 186
W + ++ GA+G + G VAIK L RP + A+ + +E
Sbjct: 20 AWEVRAVYRDL-QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK----RAYRE 74
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWC------IVTEYAKGGSVRQFLTRRQNRAVPLKLA 240
+ +L ++H N++ + +V + G + + + + ++
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFL 133
Query: 241 VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300
V Q L +G+ Y+H G IHRDLK NL ++ D +KI DFG+AR MT T
Sbjct: 134 VYQML---KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMTGYVVT 188
Query: 301 YRW 303
RW
Sbjct: 189 -RW 190
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 4e-15
Identities = 31/167 (18%), Positives = 72/167 (43%), Gaps = 25/167 (14%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVR- 200
+G + +++ N E V +KIL +P V +++ ++E+ +L L+ NI+
Sbjct: 46 RGKYSEVFEAINITNNEKVVVKIL-KP--------VKKKKIKREIKILENLRGGPNIITL 96
Query: 201 ---FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ +V E+ +Q + + + + + L + + Y H +
Sbjct: 97 ADIVKDPVSRTPA--LVFEHVNNTDFKQLYQTLTDYDI--RFYMYEIL---KALDYCHSM 149
Query: 258 GFIHRDLKSDNLLI-SADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
G +HRD+K N++I + +++ D+G+A + + R+
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RY 195
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-15
Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 21/168 (12%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
GA+G + T G VA+K L RP + A+ + +E+ +L +KH N++
Sbjct: 39 SGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYRELRLLKHMKHENVIGLL 94
Query: 201 --FIGACRKRM---VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
F A V+ +VT G + + ++ ++ + Q L RG+ Y+H
Sbjct: 95 DVFTPARSLEEFNDVY-LVTHLM-GADLNNIVKCQKLTDDHVQFLIYQIL---RGLKYIH 149
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
IHRDLK NL ++ D +KI DFG+AR + MT T RW
Sbjct: 150 SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVAT-RW 194
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 39/170 (22%), Positives = 75/170 (44%), Gaps = 19/170 (11%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQ----FQQEVMMLATLKHLNI 198
+G+FGK + + + A+K + K + +E+ +E+ ++ L+H +
Sbjct: 25 KGSFGKVCIVQKNDTKKMYAMKYMN-------KQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 199 VRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
V + + M +V + GG +R L +QN + ++ + Y+
Sbjct: 78 VNLWYSFQDEEDM--FMVVDLLLGGDLRYHL--QQNVHFKEETVKLFICELVMALDYLQN 133
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
IHRD+K DN+L+ + I DF +A + + +T GT +MAP
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAP 183
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 23/170 (13%)
Query: 146 GAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQ----EVMMLATLKHLNIV 199
G+FG+ L + +G A+KIL+ K +V++ + + E +L + +V
Sbjct: 52 GSFGRVMLVKHKESGNHYAMKILD-------KQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + +V EY GG + F R+ A A + Y+H L
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 260 IHRDLKSDNLLISADKSIKIADFGVA-RIEVQTEGM--TPETGTYRWMAP 306
I+RDLK +NLLI I++ DFG A R++ +T + TPE +AP
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE---A--LAP 207
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 73.0 bits (178), Expect = 1e-14
Identities = 44/254 (17%), Positives = 76/254 (29%), Gaps = 64/254 (25%)
Query: 115 MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKI--LERPENN 172
H PTE L+ K+ +G FG++++ + VAIKI +E P+
Sbjct: 13 FSHCLPTEKLQR-------CEKI------GEGVFGEVFQTIADHTPVAIKIIAIEGPDLV 59
Query: 173 PEKAQVMEQQFQQEVMMLATLKHL---------NIVRFIGAC------------------ 205
Q ++ E+++ L L +
Sbjct: 60 NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119
Query: 206 ------------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
K IV E+ GG + + + + K + Q + +A
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQ---LTASLAV 176
Query: 254 VH-GLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTY---RWMAPGN 308
L F HRDL N+L+ K+ + + + G+ Y R G
Sbjct: 177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGI 236
Query: 309 SFFSPL--PHPSFE 320
F + F
Sbjct: 237 VVFCDVSMDEDLFT 250
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 42/172 (24%), Positives = 75/172 (43%), Gaps = 18/172 (10%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLNI 198
+G FG+ + G+ A K L K ++ +++ Q M +LA + I
Sbjct: 195 RGGFGEVFACQMKATGKLYACKKLN-------KKRLKKRKGYQGAMVEKKILAKVHSRFI 247
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHG 256
V A + C+V GG +R + N A+ + G+ ++H
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
I+RDLK +N+L+ D +++I+D G+A E++ + GT +MAP
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKGYAGTPGFMAP 358
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 43/193 (22%), Positives = 73/193 (37%), Gaps = 32/193 (16%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
G++G + VAIK + R + + + +E+ +L L H ++V+
Sbjct: 63 TGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRI----LREIAILNRLNHDHVVKVL 118
Query: 201 --FIGACRKRM--VWCIVTEYA--------KGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
I ++ ++ +V E A + +LT +K + L
Sbjct: 119 DIVIPKDVEKFDELY-VVLEIADSDFKKLFRTP---VYLTELH-----IKTLLYNLL--- 166
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGN 308
G+ YVH G +HRDLK N L++ D S+K+ DFG+AR E + N
Sbjct: 167 VGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 309 SFFSPLPHPSFEH 321
P
Sbjct: 227 LVTFPHTKNLKRQ 239
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 5e-14
Identities = 52/172 (30%), Positives = 84/172 (48%), Gaps = 25/172 (14%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQ-----EVMMLATLKHLN 197
G+FG+ L R +NG A+K+L+ K V+ + Q E +ML+ + H
Sbjct: 16 TGSFGRVHLIRSRHNGRYYAMKVLK-------KEIVVRLK-QVEHTNDERLMLSIVTHPF 67
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
I+R G + ++ +Y +GG + L R+ R P +A A +V + Y+H
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLL-RKSQR-FPNPVAKFYAAEVCLALEYLHSK 125
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVA-RIEVQTEGM--TPETGTYRWMAP 306
I+RDLK +N+L+ + IKI DFG A + T + TP+ Y +AP
Sbjct: 126 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPD---Y--IAP 172
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 48/174 (27%), Positives = 73/174 (41%), Gaps = 24/174 (13%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRF 201
G+FG +Y GT GE+VAIK+ E + Q E + ++ + I
Sbjct: 19 SGSFGDIYLGTDIAAGEEVAIKL--------ECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ +V E G S+ L +R LK + A + + Y+H FIH
Sbjct: 71 RWCGAEGDYNVMVMELL-GPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 128
Query: 262 RDLKSDNLLISADK---SIKIADFGVAR--IEVQTEGMTPE------TGTYRWM 304
RD+K DN L+ K + I DFG+A+ + +T P TGT R+
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 1e-13
Identities = 52/182 (28%), Positives = 81/182 (44%), Gaps = 34/182 (18%)
Query: 145 QGAFGKLYRGT---YNGEDVAIKILERPENN----PEKAQVMEQQFQQEVMMLATLK--- 194
+GA+GK+++ G VA+K + R + P +EV +L L+
Sbjct: 21 EGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTI-------REVAVLRHLETFE 72
Query: 195 HLNIVRFIGACRKRMVWC-----IVTEYAKGGSVRQFLTRRQNRAVPL---KLAVKQALD 246
H N+VR C +V E+ + +L + VP K + Q L
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL- 130
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT--YRWM 304
RG+ ++H +HRDLK N+L+++ IK+ADFG+ARI +T T YR
Sbjct: 131 --RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYR-- 186
Query: 305 AP 306
AP
Sbjct: 187 AP 188
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 46/185 (24%), Positives = 74/185 (40%), Gaps = 26/185 (14%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
+G++G +Y ++VAIK + R + + + +E+ +L LK I+R
Sbjct: 36 RGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK----RILREITILNRLKSDYIIRLY 91
Query: 201 --FIGACRKRM--VWCIVTEYA-----KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
I + ++ IV E A K FLT +K + L G
Sbjct: 92 DLIIPDDLLKFDELY-IVLEIADSDLKKLFKTPIFLTEEH-----IKTILYNLL---LGE 142
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFF 311
++H G IHRDLK N L++ D S+K+ DFG+AR + PG
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 312 SPLPH 316
+
Sbjct: 203 NLKKQ 207
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 28/175 (16%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLKHLN 197
+G FGK L R G A+KIL K ++ + + + L +H
Sbjct: 15 KGTFGKVILVREKATGRYYAMKILR-------KEVIIAKD-EVAHTVTESRVLQNTRHPF 66
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ A + C V EYA GG + F + R + A ++ + Y+H
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
++RD+K +NL++ D IKI DFG+ + EG++ GT ++AP
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAP 174
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 45/159 (28%), Positives = 65/159 (40%), Gaps = 20/159 (12%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL------ 196
+G+FG++ + E VAIKI++ N Q Q EV +L +
Sbjct: 64 KGSFGQVVKAYDRVEQEWVAIKIIK---NKKA----FLNQAQIEVRLLELMNKHDTEMKY 116
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
IV R C+V E ++ L R V L L K A + + ++
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 257 --LGFIHRDLKSDN-LLISADKS-IKIADFGVARIEVQT 291
L IH DLK +N LL + +S IKI DFG + Q
Sbjct: 176 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 214
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-13
Identities = 48/176 (27%), Positives = 76/176 (43%), Gaps = 33/176 (18%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
+GA+G + N VAIK + E+ Q Q+ +E+ +L +H NI+
Sbjct: 37 EGAYGMVCSAYDNLNKVRVAIKKISPFEH-----QTYCQRTLREIKILLRFRHENIIGIN 91
Query: 201 --FIGACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVARGM 251
++M V+ IV + + + L + L + Q L RG+
Sbjct: 92 DIIRAPTIEQMKDVY-IVQDLM-ETDLYKLL-----KTQHLSNDHICYFLYQIL---RGL 141
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYRW 303
Y+H +HRDLK NLL++ +KI DFG+AR+ T +T T RW
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT-RW 196
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 68.5 bits (167), Expect = 7e-13
Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 27/175 (15%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLKHLN 197
+G+FGK L E A+KIL+ K V++ + M+ K
Sbjct: 351 KGSFGKVMLSERKGTDELYAVKILK-------KDVVIQDDDVECTMVEKRVLALPGKPPF 403
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ + + V EY GG + +Q AV A ++A G+ ++
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
G I+RDLK DN+++ ++ IKIADFG+ + E + GT ++AP
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGVTTKTFCGTPDYIAP 511
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 49/178 (27%), Positives = 69/178 (38%), Gaps = 26/178 (14%)
Query: 143 FAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIV 199
G FG+L G Y E VAIK+ E + Q E L I
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKL--------EPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ +V E G S+ L +R LK + A+ + M YVH
Sbjct: 69 QVYYFGPCGKYNAMVLELL-GPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 260 IHRDLKSDNLLI-----SADKSIKIADFGVAR--IEVQTEGMTPE------TGTYRWM 304
I+RD+K +N LI + I I DF +A+ I+ +T+ P TGT R+M
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 20/188 (10%), Positives = 61/188 (32%), Gaps = 32/188 (17%)
Query: 145 QGAFGKLYRGT----------YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194
+ G LY + ++K+ + ++ + Q + + + K
Sbjct: 52 RDNQGILYEAAPTSTLTCDSGPQKQKFSLKL-D-AKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 195 HLNIVRFIGACRKRMVWCIVTEYAK--------GGSVRQFLTRRQNRAVPLKLAVKQALD 246
L + + V + G S++ L + + ++ A
Sbjct: 110 KLYSTPLLAIPT--CMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVAR--------IEVQTEGMTP 296
+ + ++H ++H ++ ++N+ + + + +A +G A + +P
Sbjct: 168 LLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSP 227
Query: 297 ETGTYRWM 304
G ++
Sbjct: 228 HEGDLEFI 235
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 38/171 (22%), Positives = 73/171 (42%), Gaps = 19/171 (11%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLN- 197
+G FG++Y R G+ A+K L+ K ++ +Q + + ML+ + +
Sbjct: 199 RGGFGEVYGCRKADTGKMYAMKCLD-------KKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 198 --IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
IV A + + GG + L Q+ A ++ G+ ++H
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
++RDLK N+L+ ++I+D G+A + + GT+ +MAP
Sbjct: 310 NRFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAP 359
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 37/169 (21%), Positives = 59/169 (34%), Gaps = 40/169 (23%)
Query: 145 QGAFGKLYRGT---YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL----- 196
+GAFGK+ G VA+KI++ N + + E+ +L L
Sbjct: 24 EGAFGKVVECIDHKAGGRHVAVKIVK---NVDR----YCEAARSEIQVLEHLNTTDPNST 76
Query: 197 -NIVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
V+ + + CIV E G S F+ L K A + + + +
Sbjct: 77 FRCVQMLEWFEHHGHI--CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 254 VHGLGFIHRDLKSDNLLIS-------------------ADKSIKIADFG 283
+H H DLK +N+L + IK+ DFG
Sbjct: 134 LHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 4e-12
Identities = 42/176 (23%), Positives = 74/176 (42%), Gaps = 29/176 (16%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM------LATLKHL 196
+G+FGK L R G+ A+K+L+ K +++ E M H
Sbjct: 33 KGSFGKVMLARVKETGDLYAVKVLK-------KDVILQDD-DVECTMTEKRILSLARNHP 84
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + + V E+ GG + +++R A A ++ + ++H
Sbjct: 85 FLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISALMFLHD 142
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
G I+RDLK DN+L+ + K+ADFG+ + EG+ GT ++AP
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGICNGVTTATFCGTPDYIAP 193
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 5e-12
Identities = 43/178 (24%), Positives = 78/178 (43%), Gaps = 33/178 (18%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM-----MLATLKHLN 197
+G++ K L R A+K+++ K V + + V H
Sbjct: 19 RGSYAKVLLVRLKKTDRIYAMKVVK-------KELVNDDEDIDWVQTEKHVFEQASNHPF 71
Query: 198 IVRFIGAC---RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
+V +C R+ V EY GG + ++ R +P + A + +++ + Y+
Sbjct: 72 LVGLH-SCFQTESRL--FFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
H G I+RDLK DN+L+ ++ IK+ D+G+ + EG+ P GT ++AP
Sbjct: 127 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAP 179
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 5e-12
Identities = 35/167 (20%), Positives = 66/167 (39%), Gaps = 36/167 (21%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL------ 196
G F ++ N VA+KI+ +V + + E+ +L +
Sbjct: 29 WGHFSTVWLAKDMVNNTHVAMKIVR-------GDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 197 -----NIVR------FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
+I++ G + +V E G ++ + + ++R +PL + +
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHV--VMVFE-VLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 246 DVARGMAYVH-GLGFIHRDLKSDNLLIS------ADKSIKIADFGVA 285
+ G+ Y+H G IH D+K +N+L+ IKIAD G A
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-12
Identities = 41/176 (23%), Positives = 68/176 (38%), Gaps = 26/176 (14%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRF 201
+G+FG ++ GT N + VAIK E + Q + E L I
Sbjct: 20 EGSFGVIFEGTNLLNNQQVAIKF--------EPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
++ + +V + G S+ L R +K A + + +H ++
Sbjct: 72 YYFGQEGLHNVLVIDLL-GPSLEDLL-DLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 129
Query: 262 RDLKSDNLLISADKS-----IKIADFGVAR--IEVQTEGMTPE------TGTYRWM 304
RD+K DN LI S I + DFG+ + + T+ P +GT R+M
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 6e-12
Identities = 44/175 (25%), Positives = 72/175 (41%), Gaps = 27/175 (15%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM----LATLKHLNI 198
+G FGK L + G A+KIL+ K ++ + + L +H +
Sbjct: 158 KGTFGKVILVKEKATGRYYAMKILK-------KEVIVAKDEVAHTLTENRVLQNSRHPFL 210
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-L 257
+ + C V EYA GG + F + R A ++ + Y+H
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
++RDLK +NL++ D IKI DFG+ + EG+ GT ++AP
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKTFCGTPEYLAP 318
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 8e-12
Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 40/183 (21%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
+GA+G + T+ GE VAIK + P + P A + +E+ +L KH NI+
Sbjct: 21 EGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFAL----RTLREIKILKHFKHENIITIF 75
Query: 201 --FIGACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVARGM 251
+ V+ I+ E + + + L + + Q L R +
Sbjct: 76 NIQRPDSFENFNEVY-IIQELM-QTDLHRVI-----STQMLSDDHIQYFIYQTL---RAV 125
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-----------EVQTEGMTPETGT 300
+HG IHRDLK NLLI+++ +K+ DFG+ARI Q GM T
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 301 YRW 303
RW
Sbjct: 186 -RW 187
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 9e-12
Identities = 42/178 (23%), Positives = 78/178 (43%), Gaps = 33/178 (18%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM-----MLATLKHLN 197
+G++ K L R A+++++ K V + + V H
Sbjct: 62 RGSYAKVLLVRLKKTDRIYAMRVVK-------KELVNDDEDIDWVQTEKHVFEQASNHPF 114
Query: 198 IVRFIGAC---RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
+V +C R+ V EY GG + ++ R +P + A + +++ + Y+
Sbjct: 115 LVGLH-SCFQTESRL--FFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
H G I+RDLK DN+L+ ++ IK+ D+G+ + EG+ P GT ++AP
Sbjct: 170 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAP 222
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 9e-12
Identities = 45/175 (25%), Positives = 72/175 (41%), Gaps = 27/175 (15%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLKHLN 197
+G+FGK L + AIK L+ K V+ + M+ +H
Sbjct: 27 KGSFGKVFLAEFKKTNQFFAIKALK-------KDVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ + + V EY GG + + L A A ++ G+ ++H
Sbjct: 80 LTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 137
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
G ++RDLK DN+L+ D IKIADFG+ + E M + GT ++AP
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCK-----ENMLGDAKTNTFCGTPDYIAP 187
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 27/175 (15%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLKHLN 197
+G+FGK L E A+KIL+ K V++ + M+ K
Sbjct: 30 KGSFGKVMLSERKGTDELYAVKILK-------KDVVIQDDDVECTMVEKRVLALPGKPPF 82
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ + + V EY GG + +Q AV A ++A G+ ++
Sbjct: 83 LTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
G I+RDLK DN+++ ++ IKIADFG+ + E + GT ++AP
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGVTTKTFCGTPDYIAP 190
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 39/177 (22%), Positives = 77/177 (43%), Gaps = 26/177 (14%)
Query: 145 QGAFGKLY-----RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLK 194
GA+GK++ G G+ A+K+L+ KA ++++ E L ++
Sbjct: 64 TGAYGKVFLVRKISGHDTGKLYAMKVLK-------KATIVQKAKTTEHTRTERQVLEHIR 116
Query: 195 HLN-IVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
+V A ++ ++ +Y GG + F Q ++ +
Sbjct: 117 QSPFLVTLHYAFQTETKL--HLILDYINGGEL--FTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
++H LG I+RD+K +N+L+ ++ + + DFG+++ V E GT +MAP
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 45/174 (25%), Positives = 72/174 (41%), Gaps = 24/174 (13%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRF 201
G+FG++Y GT E+VAIK+ E + Q E + L+ I
Sbjct: 17 SGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ +V + G S+ L +R + LK + A + + +VH F+H
Sbjct: 69 RWFGVEGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
Query: 262 RDLKSDNLLISADKS---IKIADFGVAR--IEVQTEGMTPE------TGTYRWM 304
RD+K DN L+ + + I DFG+A+ + T P TGT R+
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 37/171 (21%), Positives = 59/171 (34%), Gaps = 40/171 (23%)
Query: 145 QGAFGKLYR---GTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL----- 196
+G FGK+ VA+KI+ N + + + E+ +L +K
Sbjct: 29 EGTFGKVVECLDHARGKSQVALKIIR---NVGK----YREAARLEINVLKKIKEKDKENK 81
Query: 197 -NIVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
V M CI E G + +FL + PL A + + +
Sbjct: 82 FLCVLMSDWFNFHGHM--CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 138
Query: 254 VHGLGFIHRDLKSDNLLISADK-------------------SIKIADFGVA 285
+H H DLK +N+L + SI++ADFG A
Sbjct: 139 LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 2e-11
Identities = 42/174 (24%), Positives = 78/174 (44%), Gaps = 22/174 (12%)
Query: 145 QGAFGKLY-----RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLK 194
+G +GK++ G G+ A+K+L+ KA ++ L +K
Sbjct: 27 KGGYGKVFQVRKVTGANTGKIFAMKVLK-------KAMIVRNAKDTAHTKAERNILEEVK 79
Query: 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
H IV I A + ++ EY GG + F+ + A +++ + ++
Sbjct: 80 HPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMALGHL 137
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
H G I+RDLK +N++++ +K+ DFG+ + + +T T GT +MAP
Sbjct: 138 HQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT-HTFCGTIEYMAP 190
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 42/175 (24%), Positives = 80/175 (45%), Gaps = 27/175 (15%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLKHLN 197
+G+FGK L R A+K+L+ K +++++ ++ +M L +KH
Sbjct: 48 KGSFGKVLLARHKAEEVFYAVKVLQ-------KKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+V + + V +Y GG + F ++ R A A ++A + Y+H L
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHSL 158
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
++RDLK +N+L+ + I + DFG+ + E + + GT ++AP
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCK-----ENIEHNSTTSTFCGTPEYLAP 208
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 46/184 (25%), Positives = 72/184 (39%), Gaps = 40/184 (21%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQ----EVMMLATLKHLNI 198
G G ++ + VAIK K + + Q + E+ ++ L H NI
Sbjct: 21 CGGNGLVFSAVDNDCDKRVAIK----------KIVLTDPQSVKHALREIKIIRRLDHDNI 70
Query: 199 VR---FIGACRKRMVWC-----------IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
V+ +G ++ IV EY + L + +L + Q
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQL 129
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLI-SADKSIKIADFGVARI----EVQTEGMTPETG 299
L RG+ Y+H +HRDLK NL I + D +KI DFG+ARI ++
Sbjct: 130 L---RGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 300 TYRW 303
T +W
Sbjct: 187 T-KW 189
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 4e-11
Identities = 42/173 (24%), Positives = 81/173 (46%), Gaps = 22/173 (12%)
Query: 145 QGAFGKLY-----RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM----LATLKH 195
QG+FGK++ G+ + A+K+L+ KA + + + M L + H
Sbjct: 34 QGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRD-RVRTKMERDILVEVNH 85
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
IV+ A + ++ ++ +GG + F + + ++A + ++H
Sbjct: 86 PFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALALDHLH 143
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
LG I+RDLK +N+L+ + IK+ DFG+++ + E + GT +MAP
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA-YSFCGTVEYMAP 195
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 32/173 (18%), Positives = 66/173 (38%), Gaps = 44/173 (25%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL-----N 197
G FG++ N + A+K++ N + + + E +L +++ N
Sbjct: 45 DGTFGRVLLCQHIDNKKYYAVKVVR---NIKK----YTRSAKIEADILKKIQNDDINNNN 97
Query: 198 IVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
IV++ G M C++ E G S+ + +TR ++ +++ + + Y+
Sbjct: 98 IVKYHGKFMYYDHM--CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR 154
Query: 256 GLGFIHRDLKSDNLLI-------------------------SADKSIKIADFG 283
+ H DLK +N+L+ + IK+ DFG
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 46/179 (25%), Positives = 78/179 (43%), Gaps = 31/179 (17%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRF 201
+GA+G +++ GE VA+K + N AQ + +E+M+L L H NIV
Sbjct: 19 KGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ----RTFREIMILTELSGHENIVNL 74
Query: 202 IGACR---KRMVWCIVTEYA--------KGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
+ R R V+ +V +Y + L + V Q + +
Sbjct: 75 LNVLRADNDRDVY-LVFDYMETDLHAVIRA----NILEPVH-----KQYVVYQLI---KV 121
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNS 309
+ Y+H G +HRD+K N+L++A+ +K+ADFG++R V +T N
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 35/186 (18%), Positives = 64/186 (34%), Gaps = 31/186 (16%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKI--LERPENNPEKAQVMEQQFQQEVM---MLATLKHLN 197
G FG +Y E A + +E EN P E +F Q V +
Sbjct: 47 SGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF---SELKFYQRVAKKDCIKKWIERK 103
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGS---VRQFL------TRRQNRAVPLKLAVKQALDVA 248
+ ++G +TE+ V + L QN ++ + +
Sbjct: 104 QLDYLGIPL--FYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRML 161
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVAR--------IEVQTEGMTPET 298
+ Y+H ++H D+K+ NLL+ + +AD+G++ + Q
Sbjct: 162 DVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHN 221
Query: 299 GTYRWM 304
GT +
Sbjct: 222 GTIEFT 227
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 39/229 (17%), Positives = 85/229 (37%), Gaps = 30/229 (13%)
Query: 116 DHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEK 175
+ + + ++ +RKL G + L + VA+K+++ E+ E
Sbjct: 24 GGYHLVKIGDLFNGRYHVIRKLGWGHF----STVWLSWDIQGKKFVAMKVVKSAEHYTET 79
Query: 176 AQVMEQQFQQEVMMLATLKHLN--------IVRFI------GACRKRMVWCIVTEYAKGG 221
A E+ +L ++++ + +V+ + G + C+V E G
Sbjct: 80 AL-------DEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHI--CMVFEVL-GH 129
Query: 222 SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISA-DKSIKI 279
+ +++ + + +PL K V +G+ Y+H IH D+K +N+L+S ++ I+
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189
Query: 280 ADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES 328
+ + A +F P K K +
Sbjct: 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 32/190 (16%), Positives = 63/190 (33%), Gaps = 36/190 (18%)
Query: 145 QGAFGKLYRGT-YNGEDVAIKILERPENNPEKAQ--VMEQQFQQEV---MMLATLKHLNI 198
QG FG +Y + E V + P E +F Q +
Sbjct: 45 QGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRK 104
Query: 199 VRFIGACRKRMVWCIVTEYAKG----------GSVRQFLTRRQNRAVPLK----LAVKQA 244
++++G + + + GS Q + + K L++ +
Sbjct: 105 LKYLGVPK--YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSL-RI 161
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVAR--IEVQTEGMTPE--- 297
LD+ + Y+H ++H D+K+ NLL++ + + D+G+A
Sbjct: 162 LDI---LEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPK 218
Query: 298 ---TGTYRWM 304
GT +
Sbjct: 219 RCHDGTIEFT 228
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 37/184 (20%), Positives = 69/184 (37%), Gaps = 23/184 (12%)
Query: 118 RYPTEGLE-NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKI-LERPENNPE- 174
Y T+ +E N+ + ++ +GA + R +Y DV IK +++ +
Sbjct: 318 NYRTDMVEVNWIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERL 377
Query: 175 KAQVMEQQFQQEVMMLATLKHLNI----VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR 230
+ + + +E LA +K I + + KR I+ Y G + +
Sbjct: 378 DENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR----IMMSYINGKLAKDVIEDN 433
Query: 231 QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290
+ A + + +H IH DL + N + DK + I DFG+ +I
Sbjct: 434 LDIAY----------KIGEIVGKLHKNDVIHNDLTTSNFIF--DKDLYIIDFGLGKISNL 481
Query: 291 TEGM 294
E
Sbjct: 482 DEDK 485
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 343 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.98 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.98 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.98 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.98 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.98 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.98 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.98 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.98 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.49 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.29 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.92 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.8 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.72 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.61 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.58 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.54 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.4 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.35 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.34 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.97 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.94 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.8 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.78 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.64 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.63 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.48 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.37 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.3 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 97.25 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.22 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.16 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.67 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.58 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.1 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.47 | |
| 3maz_A | 125 | Signal-transducing adaptor protein 1; modular doma | 92.49 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.1 | |
| 1aot_F | 106 | FYN protein-tyrosine kinase; SH2 domain, signal tr | 84.83 | |
| 3s9k_A | 118 | Tyrosine-protein kinase ITK/TSK; proline isomeriza | 81.08 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.25 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=354.73 Aligned_cols=205 Identities=30% Similarity=0.523 Sum_probs=167.5
Q ss_pred CCccceecccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
....|+|+.++++++++||+|+||+||+|++.+ .||||+++......+. .+.|.+|+.++++++|||||+++|++
T Consensus 27 ~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~----~~~f~~E~~il~~l~HpNIV~l~g~~ 101 (307)
T 3omv_A 27 SSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQ----FQAFRNEVAVLRKTRHVNILLFMGYM 101 (307)
T ss_dssp --CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHH----HHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 346799999999999999999999999998765 5999999765544332 36899999999999999999999988
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
.+ +.++||||||++|+|.+++... ...+++..++.++.|||.||+|||+++||||||||+||||+.++++||+|||+|
T Consensus 102 ~~-~~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 179 (307)
T 3omv_A 102 TK-DNLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLA 179 (307)
T ss_dssp CS-SSCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred EC-CeEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCc
Confidence 65 4579999999999999999754 346999999999999999999999999999999999999999999999999999
Q ss_pred cccccC---CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 286 RIEVQT---EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 286 ~~~~~~---~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
+..... ......+||+.|||||++... ....|+.++|||++.+ +++.+||.+
T Consensus 180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~--~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~ 239 (307)
T 3omv_A 180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQ--DNNPFSFQSDVYSYGIVLYELMTGELPYSH 239 (307)
T ss_dssp BC------------CCCCTTSCCHHHHHCC--SSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eecccCCcceeecccccCCCccCHHHhhcc--CCCCCCcHHHhHhHHHHHHHHHHCCCCCCC
Confidence 865432 233456899999999998321 2457999999995433 335566643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=358.79 Aligned_cols=199 Identities=21% Similarity=0.304 Sum_probs=168.2
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 210 (343)
..++|++++.||+|+||+||+|++ +|+.||||++......... .+.+.+|+.+|+.++|||||++++++.+.+.
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 97 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE----REESRREVAVLANMKHPNIVQYRESFEENGS 97 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHH----HHHHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence 346899999999999999999998 6899999999876654432 3678999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~ 290 (343)
+|||||||+||+|.+++...+...+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+....
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999999999999999876666789999999999999999999999999999999999999999999999999987544
Q ss_pred CC-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 291 TE-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 291 ~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
.. .....+||+.|||||++ .+..|+.++|||++.+ +++.+||.+.
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l-----~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 228 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEIC-----ENKPYNNKSDIWALGCVLYELCTLKHAFEAG 228 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHH-----TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CcccccccCCCccccCHHHH-----CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 32 23456899999999999 7888999999996333 4577777654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=350.87 Aligned_cols=197 Identities=22% Similarity=0.318 Sum_probs=170.3
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++++.||+|+||+||+|++ +++.||||++.+..... ....+.+.+|+.+|+.++|||||++++++.+.+.+
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 36799999999999999999998 78899999997432111 11235789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
||||||++||+|.+++.+.+ .+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 108 yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999999998754 5999999999999999999999999999999999999999999999999999876432
Q ss_pred ---CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc-----cccccCCCCcc
Q 019304 292 ---EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC-----LKTTWPPPWRH 340 (343)
Q Consensus 292 ---~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~-----~~~~~~p~~~~ 340 (343)
....+.+||+.|||||++ ....|+.++|||++. ++++.+||.+.
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl-----~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 237 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELL-----TEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHH-----HHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcccccCcccCcccCCHHHH-----cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 234567999999999999 778899999999632 25588888654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=352.44 Aligned_cols=193 Identities=22% Similarity=0.348 Sum_probs=169.7
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.+.|++.++||+|+||+||+|++ +|+.||||++........ +.+.+|+.+|+.++|||||++++++.+.+.+
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~------~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ 146 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR------ELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 146 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSG------GGGHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHH------HHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35688899999999999999998 688999999975443322 4578999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
|||||||+||+|.+++.+. .+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.....
T Consensus 147 ~ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp EEEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred EEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 9999999999999999753 4999999999999999999999999999999999999999999999999999876443
Q ss_pred -CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 292 -EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 292 -~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
......+||+.|||||++ ....|+.++|||++.+ +++.+||.+.
T Consensus 224 ~~~~~~~~GTp~YmAPEvl-----~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 273 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELI-----SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 273 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHH-----TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCcccccccCcCcCCHHHH-----CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 345667999999999999 7888999999996333 4578888664
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=348.05 Aligned_cols=192 Identities=26% Similarity=0.419 Sum_probs=164.8
Q ss_pred cceecccccccccccccccceEEEEEEE-------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceE
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l 201 (343)
-++++..++++.++||+|+||+||+|.+ +++.||||+++....... .++|.+|+.++++++|||||++
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~-----~~~f~~E~~il~~l~HpNIV~l 94 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL-----REEFRHEAMLRARLQHPNVVCL 94 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-C-----HHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHH-----HHHHHHHHHHHHhCCCCCCCCc
Confidence 3467888999999999999999999986 356899999975433222 2579999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q 019304 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSD 267 (343)
Q Consensus 202 ~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~ 267 (343)
+|+|.+...++||||||++|+|.++|.... ...+++..++.++.||+.||+|||+++||||||||+
T Consensus 95 ~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~ 174 (308)
T 4gt4_A 95 LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATR 174 (308)
T ss_dssp EEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 999999999999999999999999997532 235899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeccccccccccCC---CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 268 NLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 268 NILv~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
||||++++++||+|||+|+...... .....+||+.|||||++ ....|+.++|||++..
T Consensus 175 NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l-----~~~~~s~ksDVwSfGv 235 (308)
T 4gt4_A 175 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAI-----MYGKFSIDSDIWSYGV 235 (308)
T ss_dssp GEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred ceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHH-----hCCCCCccchhhhHHH
Confidence 9999999999999999998654322 23456899999999999 7889999999995433
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=348.59 Aligned_cols=189 Identities=27% Similarity=0.432 Sum_probs=161.9
Q ss_pred ceecccccccccccccccceEEEEEEE-------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEE
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~ 202 (343)
+.|+.++|.+.+.||+|+||+||+|++ +++.||||+++... . ...++|.+|+.+|++++|||||+++
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~----~~~~~f~~E~~il~~l~HpnIV~l~ 81 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--D----NARKDFHREAELLTNLQHEHIVKFY 81 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--H----HHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--h----HHHHHHHHHHHHHHhCCCCCCccEE
Confidence 357788999999999999999999986 35689999997532 1 1236799999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCCHHHHHHhhC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE
Q 019304 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQ-----------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271 (343)
Q Consensus 203 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv 271 (343)
|+|.+.+.+|||||||++|+|.+++.+.. ...+++..++.++.||+.||+|||+++||||||||+|||+
T Consensus 82 g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl 161 (299)
T 4asz_A 82 GVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV 161 (299)
T ss_dssp EEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE
Confidence 99999999999999999999999997632 3468999999999999999999999999999999999999
Q ss_pred cCCCcEEEeccccccccccCCCc---cCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 272 SADKSIKIADFGVARIEVQTEGM---TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 272 ~~~~~vkl~DFg~a~~~~~~~~~---~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+.++++||+|||+|+........ ...+||+.|||||++ ....|+.++|||++.
T Consensus 162 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~-----~~~~~~~k~DVwS~G 217 (299)
T 4asz_A 162 GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI-----MYRKFTTESDVWSLG 217 (299)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHH-----HHCCCCHHHHHHHHH
T ss_pred CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHH-----cCCCCCchhhHHHHH
Confidence 99999999999999865443222 234689999999999 788999999999543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=354.19 Aligned_cols=193 Identities=22% Similarity=0.348 Sum_probs=170.2
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.+.|++.++||+|+||.||+|++ +|+.||||++........ +.+.+|+.+|+.++|||||++++++.+.+.+
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~------~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ 223 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR------ELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 223 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSG------GGHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHH------HHHHHHHHHHHhCCCCCCCceEEEEEECCEE
Confidence 46789999999999999999998 689999999986544332 4588999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
|||||||+||+|.+++... .+++..+..++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 224 ~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 224 WVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp EEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred EEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 9999999999999999753 4999999999999999999999999999999999999999999999999999875443
Q ss_pred -CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 292 -EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 292 -~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
......+||+.|||||++ ....|+.++|||++.+ +++.+||.+.
T Consensus 301 ~~~~~~~~GTp~YmAPEvl-----~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 350 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELI-----SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 350 (423)
T ss_dssp CCCBCCCEECTTTCCHHHH-----TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CccccccccCcCcCCHHHH-----CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 345667999999999999 7889999999996333 4578888654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=347.08 Aligned_cols=190 Identities=31% Similarity=0.464 Sum_probs=158.0
Q ss_pred cceecccccccccccccccceEEEEEEE-------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceE
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l 201 (343)
.+.|+.+++.+.++||+|+||+||+|++ +++.||||+++... . ...++|.+|+.+|++++|||||++
T Consensus 35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~----~~~~~f~~E~~il~~l~HpnIV~l 108 (329)
T 4aoj_A 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--E----SARQDFQREAELLTMLQHQHIVRF 108 (329)
T ss_dssp SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--H----HHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred hcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--H----HHHHHHHHHHHHHHhCCCCCCCcE
Confidence 4567788999999999999999999986 35789999996432 1 123679999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCCHHHHHHhhC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCc
Q 019304 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQ-------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDN 268 (343)
Q Consensus 202 ~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~-------------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~N 268 (343)
+|+|.+...+|||||||++|+|.+++.+.. ..++++..++.++.||+.||+|||+++||||||||+|
T Consensus 109 ~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~N 188 (329)
T 4aoj_A 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRN 188 (329)
T ss_dssp EEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred EEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhh
Confidence 999999999999999999999999997542 2358999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeccccccccccCC---CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 269 LLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 269 ILv~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
|||+.++++||+|||+|+...... .....+||+.|||||++ ....|+.++|||++.
T Consensus 189 ILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~-----~~~~~~~~sDvwS~G 247 (329)
T 4aoj_A 189 CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI-----LYRKFTTESDVWSFG 247 (329)
T ss_dssp EEEETTTEEEECCCC----------------CCCCGGGCCHHHH-----TTCCCCHHHHHHHHH
T ss_pred EEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhh-----cCCCCCccccccchH
Confidence 999999999999999998654332 22345799999999999 888999999999543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=336.50 Aligned_cols=195 Identities=22% Similarity=0.368 Sum_probs=152.3
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
.+|++++.||+|+||+||+|.+ +++.||||++.+....... ..+++.+|+.+++.++|||||++++++.+.+.+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 89 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSD---MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII 89 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHH---HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 5789999999999999999987 6899999999865443222 2357899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+||||+ +|+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 90 ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 90 MVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999999 67999999764 459999999999999999999999999999999999999999999999999998776655
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCC-ceeeeeeeccc-----ccccCCCCcc
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSF-EHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~-~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
...+.+||+.|||||++ .+..| +.++|||++.+ +++.+||.+.
T Consensus 167 ~~~~~~GT~~Y~APE~~-----~~~~y~~~~~DiwSlGvily~lltg~~PF~~~ 215 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVI-----SGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215 (275)
T ss_dssp --------CTTSCHHHH-----SSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCCeeECcccCChhhh-----cCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence 56677999999999999 66665 57999996332 4577777543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=343.45 Aligned_cols=191 Identities=25% Similarity=0.269 Sum_probs=163.3
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
...+.|++.++||+|+||+||+|++ +|+.||||+++.... ..+|+.+++.++|||||++++++.+.+
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----------~~~E~~il~~l~HpnIV~l~~~~~~~~ 123 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----------RVEELVACAGLSSPRIVPLYGAVREGP 123 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----------CTHHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----------HHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 3456788899999999999999998 688999999976432 247999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC-cEEEecccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIE 288 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~-~vkl~DFg~a~~~ 288 (343)
.+|||||||+||+|.+++.+.. .+++..+..++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+..
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 201 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence 9999999999999999998753 599999999999999999999999999999999999999887 6999999999875
Q ss_pred ccCCC------ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 289 VQTEG------MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 289 ~~~~~------~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
..... ....+||+.|||||++ .+..|+.++|||++.+ +++.+||.+.
T Consensus 202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~-----~~~~y~~~~DiwSlGvilyemltG~~Pf~~~ 259 (336)
T 4g3f_A 202 QPDGLGKSLLTGDYIPGTETHMAPEVV-----MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY 259 (336)
T ss_dssp ------------CCCCCCGGGCCHHHH-----TTCCCCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred cCCCcccceecCCccccCccccCHHHH-----CCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 43221 2235799999999999 7888999999996333 4577777553
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=346.04 Aligned_cols=199 Identities=21% Similarity=0.278 Sum_probs=164.5
Q ss_pred eecccccccccccccccceEEEEEEE-----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
.++.++|++++.||+|+||+||+|+. +++.||||++++........ .++.+|+.+|++++|||||++++++
T Consensus 20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~----~~~~~E~~il~~l~HpnIv~l~~~~ 95 (304)
T 3ubd_A 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR----VRTKMERDILVEVNHPFIVKLHYAF 95 (304)
T ss_dssp CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEEC----C------CCCCCCCCTTEECEEEEE
T ss_pred cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHH----HHHHHHHHHHHHCCCCCCCeEEEEE
Confidence 35668899999999999999999986 35689999997654322211 3578999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
.+++.+|||||||+||+|.+++.+.. .+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|
T Consensus 96 ~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla 173 (304)
T 3ubd_A 96 QTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173 (304)
T ss_dssp EETTEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred EECCEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccc
Confidence 99999999999999999999998754 5999999999999999999999999999999999999999999999999999
Q ss_pred ccccc-CCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 286 RIEVQ-TEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 286 ~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
+.... .....+.+||+.|||||++ ....|+.++|||++.+ +++.+||.+.
T Consensus 174 ~~~~~~~~~~~~~~GT~~YmAPE~~-----~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 174 KESIDHEKKAYSFCGTVEYMAPEVV-----NRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp EC-----CCCCSCCCCGGGCCHHHH-----HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeccCCCccccccccCcccCCHHHh-----ccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 86433 2344567999999999999 7888999999996332 5577887654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=336.76 Aligned_cols=192 Identities=27% Similarity=0.429 Sum_probs=162.1
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe----C
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----R 208 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~ 208 (343)
+.|++.++||+|+||+||+|.+ +++.||||++......... .++|.+|+.+++.++|||||++++++.+ .
T Consensus 26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 101 (290)
T 3fpq_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE----RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH----HHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTE
T ss_pred ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHH----HHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCC
Confidence 3457788999999999999998 6789999999765544322 3679999999999999999999999865 3
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCcEEEc-CCCcEEEeccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLIS-ADKSIKIADFGVA 285 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~g--iiHrDlkp~NILv~-~~~~vkl~DFg~a 285 (343)
..+|||||||++|+|.+++.+.. .+++..+..++.||+.||+|||+++ ||||||||+||||+ .++.+||+|||+|
T Consensus 102 ~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla 179 (290)
T 3fpq_A 102 KCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred cEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence 56899999999999999998753 5899999999999999999999998 99999999999997 4799999999999
Q ss_pred cccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 286 RIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
+.... ....+.+||+.|||||++ . ++|+.++|||++.+ +++.+||.+
T Consensus 180 ~~~~~-~~~~~~~GTp~YmAPE~~-----~-~~y~~~~DiwSlGvilyelltg~~Pf~~ 231 (290)
T 3fpq_A 180 TLKRA-SFAKAVIGTPEFMAPEMY-----E-EKYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp GGCCT-TSBEESCSSCCCCCGGGG-----G-TCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EeCCC-CccCCcccCccccCHHHc-----C-CCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 86443 344567999999999988 4 35999999996333 446777754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=335.80 Aligned_cols=186 Identities=24% Similarity=0.423 Sum_probs=149.2
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC---
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--- 209 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--- 209 (343)
++|++.+.||+|+||+||+|++ +++.||||+++..... ...+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 79 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-----LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE 79 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence 4688899999999999999998 6889999999764422 22367899999999999999999999997544
Q ss_pred ---------eEEEEEEecCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEE
Q 019304 210 ---------VWCIVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (343)
Q Consensus 210 ---------~~~iv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl 279 (343)
.+|+|||||++|+|.+++..... ...++..++.++.||+.||+|||++|||||||||+|||++.++.+||
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence 37999999999999999976432 23456678899999999999999999999999999999999999999
Q ss_pred eccccccccccCCC-------------ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 280 ADFGVARIEVQTEG-------------MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 280 ~DFg~a~~~~~~~~-------------~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+|||+|+....... .+..+||+.|||||++ ....|+.++|||++.+
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~-----~~~~y~~~~DiwSlGv 218 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI-----HGNSYSHKVDIFSLGL 218 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHH-----TTCCCCTHHHHHHHHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHH-----cCCCCCCHHHHHHHHH
Confidence 99999986543221 2345799999999999 7888999999995333
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=347.52 Aligned_cols=194 Identities=26% Similarity=0.490 Sum_probs=165.3
Q ss_pred CccceecccccccccccccccceEEEEEEECC-------ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCC-CCc
Q 019304 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNI 198 (343)
Q Consensus 127 ~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nI 198 (343)
.++|+|+.++|++++.||+|+||+||+|.+.+ +.||||.+.......+ .+.|.+|+.+|+++.| |||
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~-----~~~~~~E~~il~~l~hhpnI 130 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLNV 130 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHH-----HHHHHHHHHHHHHHCCCTTB
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHH-----HHHHHHHHHHHHHcCCCCcE
Confidence 35799999999999999999999999998732 5799999975443222 3679999999999965 899
Q ss_pred ceEEEEEEeC-CeEEEEEEecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCC
Q 019304 199 VRFIGACRKR-MVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (343)
Q Consensus 199 v~l~~~~~~~-~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrD 263 (343)
|+++|+|.+. ..++||||||++|+|.++|++.. ...+++..++.++.|||.||+|||+++|||||
T Consensus 131 V~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRD 210 (353)
T 4ase_A 131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 210 (353)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCc
Confidence 9999999764 56899999999999999998642 23478999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 264 LKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 264 lkp~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|||+|||++.++++||+|||+|+....... ....+||+.|||||++ ....|+.++|||++.+
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l-----~~~~y~~ksDVwS~Gv 275 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI-----FDRVYTIQSDVWSFGV 275 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHH-----hcCCCCCcccEeehHH
Confidence 999999999999999999999986543322 2345789999999999 7889999999995433
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=328.11 Aligned_cols=189 Identities=31% Similarity=0.432 Sum_probs=151.5
Q ss_pred cccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----e
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM----V 210 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~ 210 (343)
++|.+.+.||+|+||+||+|+++|+.||||+++... . ....+..|+..+..++|||||+++++|.+.+ .
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~----~---~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----E---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG----H---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----h---hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 568889999999999999999999999999996421 1 1123345677778899999999999998654 5
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeCCCCCCcEEEcCCCcEEEecc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL--------GFIHRDLKSDNLLISADKSIKIADF 282 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~--------giiHrDlkp~NILv~~~~~vkl~DF 282 (343)
+|||||||++|+|.+++... .+++..+.+++.|++.||+|||++ +||||||||+||||+.++++||+||
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 79999999999999999763 489999999999999999999987 9999999999999999999999999
Q ss_pred ccccccccCCC-----ccCCCCCcceecCCCCCCCC-CCCCCCceeeeeeeccccccc
Q 019304 283 GVARIEVQTEG-----MTPETGTYRWMAPGNSFFSP-LPHPSFEHKWSAKESCLKTTW 334 (343)
Q Consensus 283 g~a~~~~~~~~-----~~~~~gt~~y~APE~~~~~~-~~~~~~~~~sDi~~~~~~~~~ 334 (343)
|+|+....... ....+||+.|||||++.+.. ..+..|+.++|||+ +++++|
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS-~Gvvl~ 209 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA-MGLVFW 209 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHH-HHHHHH
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhh-HHHHHH
Confidence 99987544322 22357999999999983221 12235889999995 444433
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=344.89 Aligned_cols=202 Identities=17% Similarity=0.219 Sum_probs=168.2
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
+..++|++++.||+|+||+||+|+. +|+.||||++.+................+++.+++.++|||||++++++.+..
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 3467899999999999999999998 78899999997532211111112223345577888899999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
.+||||||++||+|.+++.+.. .+++..+..++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 9999999999999999998753 59999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
.. ...+.+||+.|||||++. ....|+.++|+|++.+ +++.+||.+.
T Consensus 344 ~~-~~~t~~GTp~YmAPEvl~----~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 344 KK-KPHASVGTHGYMAPEVLQ----KGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp SC-CCCSCCSCGGGCCHHHHS----TTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred CC-CCCCccCCcCccCHHHHh----CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 43 345679999999999982 2457999999996333 5588888653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=326.51 Aligned_cols=195 Identities=22% Similarity=0.282 Sum_probs=163.2
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC----
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~---- 208 (343)
++|++++.||+|+||+||+|.+ +|+.||||+++........ .+++.+|+.+|+.++|||||++++++...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN----AKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHH----HHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHH----HHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 5799999999999999999998 6899999999765544332 35788999999999999999999998643
Q ss_pred --CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 209 --MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 209 --~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
..+|||||||+ |+|.+++.+. ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+
T Consensus 130 ~~~~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 130 EFKSVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp TCCCEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred cCCEEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceee
Confidence 57899999996 5899999653 469999999999999999999999999999999999999999999999999998
Q ss_pred ccccC-----CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 287 IEVQT-----EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 287 ~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
..... ......+||+.|||||++. ....|+.++|||++++ +++.+||.+.
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~----~~~~~~~~~DiWSlG~il~ell~G~~pF~g~ 266 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELML----SLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 266 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHT----TCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred ecccCccccccccccceeChHhcCHHHhc----CCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence 65322 2345679999999999983 3356799999996333 4478888654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=315.59 Aligned_cols=188 Identities=21% Similarity=0.309 Sum_probs=156.6
Q ss_pred cccccccccccccceEEEEEEE-----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 208 (343)
++|++.+.||+|+||+||+|+. +++.||||.+.+... ..++.+|+.+|+.+ .||||+++++++.+.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--------~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--------PIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--------HHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--------HHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 5699999999999999999976 357899999865432 13578999999998 699999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-CcEEEeccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARI 287 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~-~~vkl~DFg~a~~ 287 (343)
+.+|+||||+++++|.+++. .+++..+..++.|++.||+|||++|||||||||+|||++.+ +.+||+|||+|+.
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999999983 38999999999999999999999999999999999999876 8999999999975
Q ss_pred cccC-----------------------------CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccc
Q 019304 288 EVQT-----------------------------EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTT 333 (343)
Q Consensus 288 ~~~~-----------------------------~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~ 333 (343)
.... ...++.+||+.|+|||++. ....|+.++|||++.+ +++
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~----~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLT----KCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHT----TCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHc----CCCCCCCccchhhhHHHHHHHHHC
Confidence 3321 1233458999999999983 2346899999996333 447
Q ss_pred cCCCCc
Q 019304 334 WPPPWR 339 (343)
Q Consensus 334 ~~p~~~ 339 (343)
.+||+.
T Consensus 244 ~~Pf~~ 249 (361)
T 4f9c_A 244 RYPFYK 249 (361)
T ss_dssp CSSSSC
T ss_pred CCCCCC
Confidence 788864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=333.66 Aligned_cols=195 Identities=20% Similarity=0.333 Sum_probs=170.2
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++++.||+|+||.||+|.+ +|+.||||++...... ..+.+.+|+.+|+.++|||||++++++.+...+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~------~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 229 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES------DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 229 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH------HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh------hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 46899999999999999999998 7889999999764321 135688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC--CcEEEeccccccccc
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD--KSIKIADFGVARIEV 289 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~--~~vkl~DFg~a~~~~ 289 (343)
|||||||+||+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 230 ~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 9999999999999999643 3458999999999999999999999999999999999999854 899999999999876
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
........+||+.|||||++ .+..|+.++|||++.+ +++.+||.+.
T Consensus 309 ~~~~~~~~~GT~~y~APEv~-----~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~ 359 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVA-----EGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 359 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHH-----TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CCCceeeeEECccccCHHHh-----CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 66566677999999999999 7888999999995332 4477888653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=330.03 Aligned_cols=273 Identities=27% Similarity=0.402 Sum_probs=210.7
Q ss_pred cCCCCCCcccccccCCCCeEEEEeecCCCCCCCcccccccCCCCCcCC-Ccceeecceeeec--CCcccc-ccCchHHHH
Q 019304 37 GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDDALAQ 112 (343)
Q Consensus 37 ~~~~~~~~~~~~~s~~~g~~s~s~~~ss~~s~~~~~~~~~~~~~~~~~-~~~s~~~~~~~~~--~~~~~~-~~~~d~l~~ 112 (343)
-.|+|+++.|.. ..|.+++|+...+... ...++|+.+.... +.|.+. ....|. ...+.+ ....++++.
T Consensus 92 ~~G~FLvR~s~~---~~g~y~lsv~~~~~~~----~~~v~H~~I~~~~~g~~~i~-~~~~F~sl~eLv~~y~~~~~~l~~ 163 (454)
T 1qcf_A 92 MLGSFMIRDSET---TKGSYSLSVRDYDPRQ----GDTVKHYKIRTLDNGGFYIS-PRSTFSTLQELVDHYKKGNDGLCQ 163 (454)
T ss_dssp CTTCEEEEECSS---STTSEEEEEEEEETTT----EEEEEEEEEEECTTSCEESS-SSSCBSSHHHHHHHHTSSCTTSSS
T ss_pred CCceEEEEECcC---CCCeEEEEEEecccCC----CCceEEEEEEEcCCCcEEEe-CccccCCHHHHHHHHHhccCCccc
Confidence 469999998865 5689999998643222 1256778777644 556654 223332 122222 344555655
Q ss_pred HHhcCCCCCCC--CCCCccceecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHH
Q 019304 113 ALMDHRYPTEG--LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189 (343)
Q Consensus 113 ~l~~~~~~~~~--~~~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~ 189 (343)
.+..++..... ....+.|+++.++|++.+.||+|+||.||+|.+ ++..||||+++..... .+.|.+|+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~ 236 (454)
T 1qcf_A 164 KLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-------VEAFLAEANV 236 (454)
T ss_dssp CCCSBCCCCCCCCCCCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC-------HHHHHHHHHH
T ss_pred cccccccccCccccccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc-------HHHHHHHHHH
Confidence 55555543222 223578999999999999999999999999999 5778999999764432 2578999999
Q ss_pred HhcCCCCCcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcE
Q 019304 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNL 269 (343)
Q Consensus 190 l~~l~h~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NI 269 (343)
++.++||||+++++++. ...+++||||+++|+|.+++.......+++..++.++.||+.||+|||+++|+||||||+||
T Consensus 237 l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Ni 315 (454)
T 1qcf_A 237 MKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI 315 (454)
T ss_dssp HTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGE
T ss_pred HhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 99999999999999987 55689999999999999999865434588999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeccccccccccCC--CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 270 LISADKSIKIADFGVARIEVQTE--GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 270 Lv~~~~~vkl~DFg~a~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|++.++.+||+|||+++...... ......+++.|+|||++ ....++.++|||++..
T Consensus 316 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DvwslG~ 373 (454)
T 1qcf_A 316 LVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI-----NFGSFTIKSDVWSFGI 373 (454)
T ss_dssp EECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred EECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHh-----ccCCCCcHHHHHhHHH
Confidence 99999999999999998654321 12233567899999999 7788999999996443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=328.96 Aligned_cols=269 Identities=23% Similarity=0.398 Sum_probs=210.7
Q ss_pred cCCCCCCcccccccCCCCeEEEEeecCCCCCCCcccccccCCCCCcCC-Ccceeecceeeec--CCcccc-ccCchHHHH
Q 019304 37 GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDDALAQ 112 (343)
Q Consensus 37 ~~~~~~~~~~~~~s~~~g~~s~s~~~ss~~s~~~~~~~~~~~~~~~~~-~~~s~~~~~~~~~--~~~~~~-~~~~d~l~~ 112 (343)
..|+|+++.|.+ ..|.+++|+... ..++|+.+.... +.+.+. ....|. ...+.| ....++++.
T Consensus 125 ~~G~fLvR~s~~---~~~~~~lsv~~~---------~~v~h~~I~~~~~g~~~~~-~~~~F~sl~eLv~~~~~~~~g~~~ 191 (495)
T 1opk_A 125 INGSFLVRESES---SPGQRSISLRYE---------GRVYHYRINTASDGKLYVS-SESRFNTLAELVHHHSTVADGLIT 191 (495)
T ss_dssp CTTEEEEEECSS---STTCEEEEEEET---------TEEEEEECEECTTSCEESS-TTSCBSSHHHHHHHHTTCCTTSSS
T ss_pred CCceEEEEeCCC---CCCceEEEEeeC---------CeEEEEEEEecCCCceEec-cCccchhHHHHhhhhcccccccch
Confidence 479999998765 568899999852 146788887654 445543 233332 222222 344455554
Q ss_pred HHhcCCCCCC------CCCCCccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHH
Q 019304 113 ALMDHRYPTE------GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQ 184 (343)
Q Consensus 113 ~l~~~~~~~~------~~~~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~ 184 (343)
.+..++.... ....++.|++...+|++.+.||+|+||.||+|.+ .+..||||+++..... .+.|.
T Consensus 192 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~ 264 (495)
T 1opk_A 192 TLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFL 264 (495)
T ss_dssp CCCEECCCCSCCCCSSSCSSSSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC-------HHHHH
T ss_pred hccccccccccccccccCccccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc-------hHHHH
Confidence 4443332111 1124678999999999999999999999999998 3789999999765433 25689
Q ss_pred HHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC
Q 019304 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDL 264 (343)
Q Consensus 185 ~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDl 264 (343)
+|+.+++.++||||+++++++.....+++||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||
T Consensus 265 ~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDl 344 (495)
T 1opk_A 265 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNL 344 (495)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 99999999999999999999999999999999999999999998765667899999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeccccccccccCCC--ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 265 KSDNLLISADKSIKIADFGVARIEVQTEG--MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 265 kp~NILv~~~~~vkl~DFg~a~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
||+|||++.++.+||+|||+++....... .....+++.|+|||++ ....++.++|||++..
T Consensus 345 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~sDvwSlG~ 407 (495)
T 1opk_A 345 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKFSIKSDVWAFGV 407 (495)
T ss_dssp SGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHH-----HHCEECHHHHHHHHHH
T ss_pred ChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHH-----hcCCCCcHHhHHhHHH
Confidence 99999999999999999999986543221 2233567899999999 7788999999996443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=324.21 Aligned_cols=266 Identities=25% Similarity=0.425 Sum_probs=203.3
Q ss_pred cCCCCCCcccccccCCCCeEEEEeecCCCCCCCcccccccCCCCCcCCCcceeecceeeec--CCcccc-ccCchHHHHH
Q 019304 37 GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFR--PGKVTH-ALNDDALAQA 113 (343)
Q Consensus 37 ~~~~~~~~~~~~~s~~~g~~s~s~~~ss~~s~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~--~~~~~~-~~~~d~l~~~ 113 (343)
..|+|+++.|.+ ..|.+++++.... .++|+.+....+.+++. ....|. ...+.+ ....++++..
T Consensus 100 ~~G~FlvR~S~~---~~g~~~Lsv~~~~---------~v~H~~I~~~~~~~~i~-~~~~F~sl~eLv~~y~~~~~~~~~~ 166 (450)
T 1k9a_A 100 ETGLFLVRESTN---YPGDYTLCVSCEG---------KVEHYRIMYHASKLSID-EEVYFENLMQLVEHYTTDADGLCTR 166 (450)
T ss_dssp CTTEEEEEECSS---STTSEEEEEECSS---------SEEEEEEEEETTEEESS-SSSCBSSHHHHHHHHHHCCTTSSSC
T ss_pred CCceEEEEecCC---CCCceEEEEEeCC---------eeeEEEEEecCCceEec-cccccccHHHHHhhhcccccchhhh
Confidence 569999998765 5688999986411 34666665444556654 222232 111221 2333444433
Q ss_pred HhcCCCCCCCCC-----CCccceecccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHH
Q 019304 114 LMDHRYPTEGLE-----NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188 (343)
Q Consensus 114 l~~~~~~~~~~~-----~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~ 188 (343)
+..++....... ....|+++.++|++.+.||+|+||.||+|.+.++.||||+++.... .+.|.+|+.
T Consensus 167 l~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~ 238 (450)
T 1k9a_A 167 LIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEAS 238 (450)
T ss_dssp CCEECCCTTCEEHHHHHHHTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTT--------SHHHHHHHH
T ss_pred ccccccccCcccchhhhcccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchH--------HHHHHHHHH
Confidence 333332221111 1367999999999999999999999999999999999999976431 257899999
Q ss_pred HHhcCCCCCcceEEEEEEeCC-eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q 019304 189 MLATLKHLNIVRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSD 267 (343)
Q Consensus 189 ~l~~l~h~nIv~l~~~~~~~~-~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~ 267 (343)
++++++||||+++++++.... .+++||||+++|+|.+++.......+++..++.++.|++.||+|||++|++||||||+
T Consensus 239 ~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~ 318 (450)
T 1k9a_A 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 318 (450)
T ss_dssp HHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred HHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHh
Confidence 999999999999999987765 7899999999999999998776556799999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 268 NLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 268 NILv~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|||++.++.+||+|||+++..... .....+++.|+|||++ ....++.++|||++..
T Consensus 319 Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~-----~~~~~~~~sDvwslG~ 374 (450)
T 1k9a_A 319 NVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEAL-----REKKFSTKSDVWSFGI 374 (450)
T ss_dssp GEEECTTSCEEECCCTTCEECC--------CCCTTTSCHHHH-----HSSCCCHHHHHHHHHH
T ss_pred hEEECCCCCEEEeeCCCccccccc--ccCCCCCcceeCHHHh-----cCCCCCcHHHHHHHHH
Confidence 999999999999999999854322 2233678999999999 7788999999996443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=327.60 Aligned_cols=272 Identities=26% Similarity=0.408 Sum_probs=206.9
Q ss_pred CCCCCCcccccccCCCCeEEEEeecCCCCCCCcccccccCCCCCcCC-Ccceeecceeeec--CCcccc-ccCchHHHHH
Q 019304 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDDALAQA 113 (343)
Q Consensus 38 ~~~~~~~~~~~~s~~~g~~s~s~~~ss~~s~~~~~~~~~~~~~~~~~-~~~s~~~~~~~~~--~~~~~~-~~~~d~l~~~ 113 (343)
.|+|+++.|.. ..|.+++|+....... ...++|+.+.... +.|.+.. ...|. ...+.+ ....++++..
T Consensus 88 ~G~FLvR~s~~---~~g~y~lsv~~~~~~~----~~~v~h~~I~~~~~g~~~~~~-~~~F~Sl~~Li~~y~~~~~~l~~~ 159 (452)
T 1fmk_A 88 RGTFLVRESET---TKGAYCLSVSDFDNAK----GLNVKHYKIRKLDSGGFYITS-RTQFNSLQQLVAYYSKHADGLCHR 159 (452)
T ss_dssp TTEEEEEECSS---STTCEEEEEEEEETTT----EEEEEEEEEEECTTSCEESST-TSEESSHHHHHHHHTTCCTTSSSC
T ss_pred CceEEEEeCCC---CCCceEEEEEeeccCC----CCcEEEEEEEEcCCCCEEEec-CcccCCHHHHHHHhhhccccchhh
Confidence 39999998765 5688999998643221 1256788887654 5566653 33343 223332 4455666665
Q ss_pred HhcCCCCCC---CCCCCccceecccccccccccccccceEEEEEEEC-CceEEEEEeeCCCCChhHHHHHHHHHHHHHHH
Q 019304 114 LMDHRYPTE---GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189 (343)
Q Consensus 114 l~~~~~~~~---~~~~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~ 189 (343)
+..++.... .....+.|+++.++|++.+.||+|+||.||+|.+. +..||||+++...... +.|.+|+.+
T Consensus 160 l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~ 232 (452)
T 1fmk_A 160 LTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-------EAFLQEAQV 232 (452)
T ss_dssp CCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH-------HHHHHHHHH
T ss_pred ccccccccccccCCCCccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCH-------HHHHHHHHH
Confidence 555553221 11235789999999999999999999999999995 4679999997654332 468999999
Q ss_pred HhcCCCCCcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcE
Q 019304 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNL 269 (343)
Q Consensus 190 l~~l~h~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NI 269 (343)
++.++||||+++++++.+ ..+++||||+++|+|.+++.......+++..++.++.|++.||+|||++||+||||||+||
T Consensus 233 l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Ni 311 (452)
T 1fmk_A 233 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 311 (452)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhE
Confidence 999999999999999876 5689999999999999999765445689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeccccccccccCCC--ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 270 LISADKSIKIADFGVARIEVQTEG--MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 270 Lv~~~~~vkl~DFg~a~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|++.++.+||+|||+++....... .....+++.|+|||.+ ....++.++|||+++.
T Consensus 312 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~sDvwslG~ 369 (452)
T 1fmk_A 312 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-----LYGRFTIKSDVWSFGI 369 (452)
T ss_dssp EECGGGCEEECCCCTTC--------------CCGGGSCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred EECCCCCEEECCCccceecCCCceecccCCcccccccCHhHH-----hcCCCCccccHHhHHH
Confidence 999999999999999986543221 1233567899999999 6778999999996433
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=329.99 Aligned_cols=272 Identities=26% Similarity=0.410 Sum_probs=211.1
Q ss_pred CCCCCCcccccccCCCCeEEEEeecCCCCCCCcccccccCCCCCcCC-Ccceeecceeeec--CCccc-cccCchHHHHH
Q 019304 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVT-HALNDDALAQA 113 (343)
Q Consensus 38 ~~~~~~~~~~~~s~~~g~~s~s~~~ss~~s~~~~~~~~~~~~~~~~~-~~~s~~~~~~~~~--~~~~~-~~~~~d~l~~~ 113 (343)
.|+|+++.|.. ..|.|++||....... ...++|+.+.... +.|.+..+ ..|. ...+. +..+.++++..
T Consensus 171 ~G~FLvR~S~~---~~g~y~lsv~~~~~~~----~~~v~h~~I~~~~~g~~~i~~~-~~F~SL~eLv~~y~~~~~~~~~~ 242 (535)
T 2h8h_A 171 RGTFLVRESET---TKGAYCLSVSDFDNAK----GLNVKHYKIRKLDSGGFYITSR-TQFNSLQQLVAYYSKHADGLCHR 242 (535)
T ss_dssp TTEEEEEECSS---STTCEEEEEEEEETTT----EEEEEEEEEBC-CCSCEEEETT-EEESSHHHHHHHHHHCCTTSSSC
T ss_pred CCeEEEEecCC---CCCcEEEEEEeeccCC----CCceEEEEEEEcCCCcEEeecc-ccccChHHhheeeccccCccccc
Confidence 49999998865 5689999998633221 1256788887754 55776633 3343 22332 24455666665
Q ss_pred HhcCCCCCC---CCCCCccceecccccccccccccccceEEEEEEEC-CceEEEEEeeCCCCChhHHHHHHHHHHHHHHH
Q 019304 114 LMDHRYPTE---GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189 (343)
Q Consensus 114 l~~~~~~~~---~~~~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~ 189 (343)
+..+|.... .....+.|+++.++|++.+.||+|+||.||+|.+. +..||||+++...... +.|.+|+.+
T Consensus 243 l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~ 315 (535)
T 2h8h_A 243 LTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-------EAFLQEAQV 315 (535)
T ss_dssp CCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCH-------HHHHHHHHH
T ss_pred cccccccccccccccCccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCH-------HHHHHHHHH
Confidence 555543211 11236789999999999999999999999999995 4679999997654332 468999999
Q ss_pred HhcCCCCCcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcE
Q 019304 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNL 269 (343)
Q Consensus 190 l~~l~h~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NI 269 (343)
|+.++||||+++++++.+ ..+++||||+++|+|.+++.......+++..++.++.||+.||+|||+++|+||||||+||
T Consensus 316 l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 394 (535)
T 2h8h_A 316 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 394 (535)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhE
Confidence 999999999999999876 5689999999999999999765445689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeccccccccccCC--CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 270 LISADKSIKIADFGVARIEVQTE--GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 270 Lv~~~~~vkl~DFg~a~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
||+.++.+||+|||+++...... ......+++.|+|||++ ....++.++|||++.+
T Consensus 395 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~sDvwSlGv 452 (535)
T 2h8h_A 395 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-----LYGRFTIKSDVWSFGI 452 (535)
T ss_dssp EECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred EEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHh-----ccCCCCchhhHHHHHH
Confidence 99999999999999998654321 12234577899999999 6778999999996433
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=310.90 Aligned_cols=265 Identities=25% Similarity=0.392 Sum_probs=191.3
Q ss_pred cCCCCCCcccccccCCCCeEEEEeecCCCCCCCcccccccCCCCCcCCCcceeecceeeec--CCcccccc-CchHHHHH
Q 019304 37 GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFR--PGKVTHAL-NDDALAQA 113 (343)
Q Consensus 37 ~~~~~~~~~~~~~s~~~g~~s~s~~~ss~~s~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~--~~~~~~~~-~~d~l~~~ 113 (343)
..|+|++++|.+ .+ .+++|+.... .++|+.+....+.|.+. + ..|. +..+.|-. +.+.+...
T Consensus 31 ~~G~flvR~s~~---~~-~~~lsv~~~~---------~~~h~~i~~~~~~~~~~-~-~~F~sl~~LI~~y~~~~~~l~~~ 95 (377)
T 3cbl_A 31 HSGDFLVRESQG---KQ-EYVLSVLWDG---------LPRHFIIQSLDNLYRLE-G-EGFPSIPLLIDHLLSTQQPLTKK 95 (377)
T ss_dssp STTEEEEEECC-----C-CEEEEC--------------CCEEEC----CCCCC------CCSHHHHHHHHHHHTCCC---
T ss_pred cCCCEEEEEeCC---CC-cEEEEEEECC---------CccchhhccccceEEec-c-eeccchHHHHHHHhhccCCcccc
Confidence 479999998865 23 7999987421 35677777655544432 2 2232 22222211 11111000
Q ss_pred HhcCCCCCCCCCCCccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHh
Q 019304 114 LMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLA 191 (343)
Q Consensus 114 l~~~~~~~~~~~~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~ 191 (343)
...........+.|.++.++|++.+.||+|+||.||+|.+ +++.||||+++.... . ...+.|.+|+.+++
T Consensus 96 ---~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~----~~~~~~~~E~~~l~ 167 (377)
T 3cbl_A 96 ---SGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP-P----DLKAKFLQEARILK 167 (377)
T ss_dssp -----CCCCEECCCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC-H----HHHTTTTHHHHHHT
T ss_pred ---cCcccccCccccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC-H----HHHHHHHHHHHHHH
Confidence 0011111123468999999999999999999999999998 578999999875322 1 12357889999999
Q ss_pred cCCCCCcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE
Q 019304 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271 (343)
Q Consensus 192 ~l~h~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv 271 (343)
.++||||+++++++.....+++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+|||+
T Consensus 168 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~ 246 (377)
T 3cbl_A 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV 246 (377)
T ss_dssp TCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred hCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE
Confidence 9999999999999999999999999999999999998643 358999999999999999999999999999999999999
Q ss_pred cCCCcEEEeccccccccccCCCc---cCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 272 SADKSIKIADFGVARIEVQTEGM---TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 272 ~~~~~vkl~DFg~a~~~~~~~~~---~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+.++.+||+|||+++........ ....+++.|+|||.+ ....++.++|||+++.
T Consensus 247 ~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DvwslG~ 303 (377)
T 3cbl_A 247 TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL-----NYGRYSSESDVWSFGI 303 (377)
T ss_dssp CTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHH-----HHCEEEHHHHHHHHHH
T ss_pred cCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHh-----ccCCCCchhhHHHHHH
Confidence 99999999999999864332111 112346789999999 7788999999996433
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=294.30 Aligned_cols=196 Identities=26% Similarity=0.379 Sum_probs=169.9
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 210 (343)
...+|++.+.||+|+||.||+|.+ +++.||||++......... .+++.+|+.+++.++||||+++++++.....
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS----LQKLFREVRIMKILNHPNIVKLFEVIETEKT 88 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 357899999999999999999998 7889999999875544332 3578899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~ 290 (343)
+|+||||+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 999999999999999997653 489999999999999999999999999999999999999999999999999987665
Q ss_pred CCCccCCCCCcceecCCCCCCCCCCCCCCc-eeeeeeeccc-----ccccCCCCc
Q 019304 291 TEGMTPETGTYRWMAPGNSFFSPLPHPSFE-HKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 291 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~-~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.......+||+.|+|||++ ....+. .++|||+++. +++.+||.+
T Consensus 167 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 216 (328)
T 3fe3_A 167 GGKLDAFCGAPPYAAPELF-----QGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216 (328)
T ss_dssp SCGGGTTSSSGGGCCHHHH-----HTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCccccccCCcceeCcccc-----cCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 5556677999999999999 556654 8999996333 335666643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=295.53 Aligned_cols=199 Identities=20% Similarity=0.306 Sum_probs=170.8
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++++.||+|+||.||+|.. +++.||||++..............+.+.+|+.+++.++||||+++++++.+...++
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 5688999999999999999998 68899999998755432211111256889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC----cEEEecccccccc
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK----SIKIADFGVARIE 288 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~----~vkl~DFg~a~~~ 288 (343)
+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 92 lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 92 LILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999999653 4599999999999999999999999999999999999998776 7999999999876
Q ss_pred ccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 289 VQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
.........+||+.|+|||++ ....++.++|+|+++. +++.+||++.
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~ 221 (361)
T 2yab_A 170 EDGVEFKNIFGTPEFVAPEIV-----NYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (361)
T ss_dssp CTTCCCCCCCSCGGGCCHHHH-----TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CCCCccccCCCCccEECchHH-----cCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 665555667899999999999 7788999999996433 4477888654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=294.05 Aligned_cols=198 Identities=22% Similarity=0.311 Sum_probs=167.8
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
+..++|++.+.||+|+||.||+|+. +++.||||++++.... .......+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 78 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII---AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh---hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC
Confidence 4567899999999999999999998 6889999999642110 0111256889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
.+|+||||+++|+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 9999999999999999997653 48999999999999999999999999999999999999999999999999998532
Q ss_pred -cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 290 -QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 290 -~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
........+||+.|+|||++ ....++.++|+|+++. +++.+||.+
T Consensus 157 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 207 (337)
T 1o6l_A 157 SDGATMKTFCGTPEYLAPEVL-----EDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGG-----SSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCCcccccccChhhCChhhh-----cCCCCCchhhcccchhHHHHHhcCCCCCCC
Confidence 23344566899999999999 7788999999996433 346667654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=298.73 Aligned_cols=198 Identities=19% Similarity=0.294 Sum_probs=167.6
Q ss_pred eecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK 207 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 207 (343)
.+..++|++.+.||+|+||+||+|+. +++.||||++++....... ..+.+.+|..++.++ +||||+++++++.+
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~---~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~ 124 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE---DIDWVQTEKHVFEQASNHPFLVGLHSCFQT 124 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-------CCHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHH---HHHHHHHHHHHHHhcCCCCCcCeeEEEEEE
Confidence 45678999999999999999999998 5788999999865433221 124577899998876 89999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
...+|+||||+++|+|..++.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 125 ~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 125 ESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CCEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 999999999999999999998653 499999999999999999999999999999999999999999999999999986
Q ss_pred c-ccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 288 E-VQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 288 ~-~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
. .........+||+.|+|||++ ....++.++|+|+++. +++.+||.
T Consensus 203 ~~~~~~~~~~~~gt~~Y~aPE~l-----~~~~~~~~~DiwslGvllyell~G~~Pf~ 254 (396)
T 4dc2_A 203 GLRPGDTTSTFCGTPNYIAPEIL-----RGEDYGFSVDWWALGVLMFEMMAGRSPFD 254 (396)
T ss_dssp CCCTTCCBCCCCBCGGGCCHHHH-----TTCCBCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred cccCCCccccccCCcccCCchhh-----cCCCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 3 333445667899999999999 7888999999996333 34667763
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=289.63 Aligned_cols=195 Identities=33% Similarity=0.535 Sum_probs=159.1
Q ss_pred CCccceecccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
..+.|+++..+|++.+.||+|+||.||+|.++++.||||++......... .+.+.+|+.++++++||||+++++++
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~ 103 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAER----VNEFLREVAIMKRLRHPNIVLFMGAV 103 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHH----HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34678889999999999999999999999999999999999776554432 35789999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCcEEEcCCCcEEEecc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSIKIADF 282 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~g--iiHrDlkp~NILv~~~~~vkl~DF 282 (343)
.....+++||||+++++|.+++.+... ..+++..++.++.|++.||+|||++| |+||||||+|||++.++.+||+||
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence 999999999999999999999975321 23889999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCC-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 283 GVARIEVQTE-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 283 g~a~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
|+++...... ......||+.|+|||++ ....++.++|||+++
T Consensus 184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG 226 (309)
T 3p86_A 184 GLSRLKASTFLSSKSAAGTPEWMAPEVL-----RDEPSNEKSDVYSFG 226 (309)
T ss_dssp C-----------------CCTTSCHHHH-----TTCCCCTTHHHHHHH
T ss_pred CCCccccccccccccCCCCccccChhhh-----cCCCCCchhhHHHHH
Confidence 9998644332 23445799999999999 778889999999643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=297.49 Aligned_cols=203 Identities=18% Similarity=0.246 Sum_probs=171.8
Q ss_pred cceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
.+.+..++|++.+.||+|+||.||++.. +++.||||++.+..... ....+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE---RNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 4567789999999999999999999998 67889999986422111 111357889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
+...+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~ 163 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA 163 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceee
Confidence 999999999999999999999753 459999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 287 IEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
...........+||+.|+|||++... ....++.++|+|++++ +++.+||.
T Consensus 164 ~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~~~~DiwSlG~il~elltG~~Pf~ 218 (384)
T 4fr4_A 164 MLPRETQITTMAGTKPYMAPEMFSSR--KGAGYSFAVDWWSLGVTAYELLRGRRPYH 218 (384)
T ss_dssp ECCTTCCBCCCCSCGGGCCGGGTCCC--SSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred eccCCCceeccCCCccccCCeeeccC--CCCCCCccceeechHHHHHHHHhCCCCCC
Confidence 77665566778999999999998321 2456899999996433 34666664
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=283.14 Aligned_cols=190 Identities=32% Similarity=0.512 Sum_probs=163.5
Q ss_pred cceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
.+.+..++|++++.||+|+||.||+|.+ +++.||+|++.... . ...+.+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~--~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 77 (310)
T 3s95_A 4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD--E----ETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77 (310)
T ss_dssp CEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC--H----HHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC--H----HHHHHHHHHHHHHHhCCCcCcccEEEEEe
Confidence 4556778999999999999999999998 57899999985422 1 12367899999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
+....++||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 156 (310)
T 3s95_A 78 KDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLAR 156 (310)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred cCCeeEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccce
Confidence 999999999999999999999864 3458999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCc---------------cCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 287 IEVQTEGM---------------TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 287 ~~~~~~~~---------------~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
........ ...+||+.|+|||++ ....++.++|||+++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~slG~ 210 (310)
T 3s95_A 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI-----NGRSYDEKVDVFSFGI 210 (310)
T ss_dssp ECC--------------------CCCCSCGGGCCHHHH-----TTCCCCTHHHHHHHHH
T ss_pred ecccccccccccccccccccccccccCCCcceeCHHHh-----cCCCCCcHHHHHHHHH
Confidence 65332211 145799999999999 7888999999996443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=290.07 Aligned_cols=197 Identities=19% Similarity=0.300 Sum_probs=168.7
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 208 (343)
+..++|++.+.||+|+||.||+|+. +++.||||++.+....... ..+.+.+|..+++.+ +||||+++++++.+.
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 82 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE---DIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 82 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHH---HHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchH---HHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence 4567899999999999999999998 5789999999865443322 235688999999987 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
..+|+||||+++++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 99999999999999999998653 4899999999999999999999999999999999999999999999999999853
Q ss_pred c-cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 289 V-QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 289 ~-~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
. ........+||+.|+|||++ ....++.++|+|+++. +++.+||.
T Consensus 161 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~ 211 (345)
T 3a8x_A 161 LRPGDTTSTFCGTPNYIAPEIL-----RGEDYGFSVDWWALGVLMFEMMAGRSPFD 211 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHH-----TTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCCCCcccccCCCccccCcccc-----CCCCCChHHhHHHHHHHHHHHHhCCCCcC
Confidence 2 22344566899999999999 7788999999996433 34666664
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=289.67 Aligned_cols=195 Identities=23% Similarity=0.382 Sum_probs=169.4
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||+|.+ +++.||||++......... .+.+.+|+.+++.++||||+++++++.+....|
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHH----HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 5788999999999999999998 6789999999876554332 357889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC---CcEEEeccccccccc
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD---KSIKIADFGVARIEV 289 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~---~~vkl~DFg~a~~~~ 289 (343)
+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 105 lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999999999999654 458999999999999999999999999999999999999864 459999999998766
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
........+||+.|+|||++ ....++.++|||+++. +++.+||++.
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 233 (362)
T 2bdw_A 183 DSEAWHGFAGTPGYLSPEVL-----KKDPYSKPVDIWACGVILYILLVGYPPFWDE 233 (362)
T ss_dssp TCCSCCCSCSCTTTCCHHHH-----TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcccccCCCCccccCHHHH-----ccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 55555667899999999999 7778999999996333 4577888753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=282.74 Aligned_cols=193 Identities=24% Similarity=0.377 Sum_probs=166.1
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 210 (343)
..++|++.+.||+|+||.||+|.+ +++.||||++........ +.+.+|+.+++.++||||+++++++.....
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 91 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK------ELIINEILVMRENKNPNIVNYLDSYLVGDE 91 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCH------HHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHH------HHHHHHHHHHhcCCCCCCCeEeEEEEECCE
Confidence 347899999999999999999986 788999999975443322 468899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~ 290 (343)
+++||||+++++|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp EEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999999999999764 489999999999999999999999999999999999999999999999999886544
Q ss_pred CC-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 291 TE-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 291 ~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.. .....+||+.|+|||++ ....++.++|||+++. +++.+||..
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~ 218 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVV-----TRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHH-----HCSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccCCccCCcCccChhhh-----cCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 32 23456899999999999 7788999999996433 335566543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=295.29 Aligned_cols=198 Identities=19% Similarity=0.244 Sum_probs=161.6
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 208 (343)
+..++|++.+.||+|+||.||+|+. +++.||||++.+.... .....+.+.+|..+++.+ +||||+++++++.+.
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~---~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL---QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH---HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc---chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 4567899999999999999999998 6789999999742211 111235678999999988 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
..+|+||||+++|+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999999998753 4999999999999999999999999999999999999999999999999999853
Q ss_pred cc-CCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 289 VQ-TEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 289 ~~-~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.. .......+||+.|+|||++ ....++.++|+|+++. +++.+||.+
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 226 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEIL-----QEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226 (353)
T ss_dssp CC---------CCGGGCCHHHH-----HHHHCTTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCccccccCCCcCeEChhhc-----CCCCcCCccCCCcchHHHHHHHhCCCCCCC
Confidence 32 2334556899999999999 7778999999996433 346677644
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=285.67 Aligned_cols=196 Identities=23% Similarity=0.364 Sum_probs=167.1
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
+..++|++.+.||+|+||.||+++. +++.||+|++.+..... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 79 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR---LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 79 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC
Confidence 3457899999999999999999998 68899999996421110 011356789999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
.+|+||||+++++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999999999764 358999999999999999999999999999999999999999999999999998654
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
. .....+||+.|+|||++ ....++.++|+|+++. +++.+||..
T Consensus 158 ~--~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~ 205 (318)
T 1fot_A 158 D--VTYTLCGTPDYIAPEVV-----STKPYNKSIDWWSFGILIYEMLAGYTPFYD 205 (318)
T ss_dssp S--CBCCCCSCTTTCCHHHH-----TTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred C--ccccccCCccccCHhHh-----cCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 3 33456899999999999 7788999999996433 446677654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=285.24 Aligned_cols=198 Identities=20% Similarity=0.305 Sum_probs=168.7
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||+|.. +++.||||++..............+.+.+|+.+++.++||||+++++++.....++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 5788999999999999999998 58899999998655432211111256889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC----cEEEecccccccc
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK----SIKIADFGVARIE 288 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~----~vkl~DFg~a~~~ 288 (343)
+||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999999999653 4589999999999999999999999999999999999999877 8999999999876
Q ss_pred ccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 289 VQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.........+||+.|+|||++ ....++.++|+|+++. +++.+||.+
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 219 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIV-----NYEPLGLEADMWSIGVITYILLSGASPFLG 219 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHH-----TTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CCCCccccccCCcCcCCceee-----cCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence 555555667899999999999 7788999999996433 346666654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=299.71 Aligned_cols=201 Identities=21% Similarity=0.301 Sum_probs=167.3
Q ss_pred cceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
++.+..++|++.+.||+|+||.||+|++ +++.||+|++.+...... ...+.+.+|+.+++.++||||+++++++.
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR---SDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT---CCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhh---HHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4456678999999999999999999998 678999999964211000 00134779999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
+...+|+||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 999999999999999999999753 48999999999999999999999999999999999999999999999999998
Q ss_pred ccccCC--CccCCCCCcceecCCCCCCCCCCCCC----Cceeeeeeeccc-----ccccCCCCcc
Q 019304 287 IEVQTE--GMTPETGTYRWMAPGNSFFSPLPHPS----FEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 287 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~----~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
...... .....+||+.|+|||++ .... ++.++|+|+++. +++.+||.+.
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l-----~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 276 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVL-----KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHH-----HTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred eeccCCcccccCCcCCccccCHHHh-----hccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence 654432 23456899999999999 3333 889999996333 4477787654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=315.35 Aligned_cols=190 Identities=29% Similarity=0.491 Sum_probs=154.3
Q ss_pred cceecccccccc-cccccccceEEEEEEE----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEE
Q 019304 129 EWTIDLRKLNMG-TAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (343)
Q Consensus 129 ~~~i~~~~~~~~-~~lg~G~fg~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~ 203 (343)
+|.++.+.+.+. +.||+|+||.||+|.+ .++.||||+++....... ..+++.+|+.+++.++||||+++++
T Consensus 362 ~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~l~~ 437 (635)
T 4fl3_A 362 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----LKDELLAEANVMQQLDNPYIVRMIG 437 (635)
T ss_dssp SSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGG----GHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHH----HHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 455565666554 4799999999999976 346899999976443332 2357999999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 204 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
++... .+++||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus 438 ~~~~~-~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFG 514 (635)
T 4fl3_A 438 ICEAE-SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG 514 (635)
T ss_dssp EEESS-SEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTT
T ss_pred EEecC-CEEEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcC
Confidence 99754 578999999999999999754 458999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 284 VARIEVQTEG----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 284 ~a~~~~~~~~----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+++....... .....+|+.|+|||++ ....++.++|||++++
T Consensus 515 la~~~~~~~~~~~~~~~~~~t~~y~APE~~-----~~~~~~~~sDvwSlGv 560 (635)
T 4fl3_A 515 LSKALRADENYYKAQTHGKWPVKWYAPECI-----NYYKFSSKSDVWSFGV 560 (635)
T ss_dssp HHHHTTC-------------CGGGSCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred CccccccCccccccccCCCCceeeeChhhh-----cCCCCCcHHHHHHHHH
Confidence 9986543321 2233567899999999 7888999999996443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=290.40 Aligned_cols=200 Identities=16% Similarity=0.192 Sum_probs=168.3
Q ss_pred CCccceecccccccccccccccceEEEEEE-----E--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC---C
Q 019304 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGT-----Y--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---H 195 (343)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~-----~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h 195 (343)
...++++..++|++.+.||+|+||.||+|. . .++.||||++.... ...+.+|+.+++.++ |
T Consensus 56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~e~~~~~~l~~~~~ 126 (365)
T 3e7e_A 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---------PWEFYIGTQLMERLKPSMQ 126 (365)
T ss_dssp SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---------HHHHHHHHHHHHHSCGGGG
T ss_pred cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---------hhHHHHHHHHHHHhhhhhh
Confidence 446778888999999999999999999993 2 67899999996532 135778888888886 9
Q ss_pred CCcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc
Q 019304 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR---QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272 (343)
Q Consensus 196 ~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~ 272 (343)
+||+++++++...+..++||||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 127 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~ 206 (365)
T 3e7e_A 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILG 206 (365)
T ss_dssp GGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC
T ss_pred hhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEec
Confidence 99999999999999999999999999999999753 245699999999999999999999999999999999999999
Q ss_pred C-----------CCcEEEeccccccccc---cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccc
Q 019304 273 A-----------DKSIKIADFGVARIEV---QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTT 333 (343)
Q Consensus 273 ~-----------~~~vkl~DFg~a~~~~---~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~ 333 (343)
. ++.+||+|||+|+... ........+||+.|+|||++ ....++.++|||++++ +++
T Consensus 207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~elltg 281 (365)
T 3e7e_A 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML-----SNKPWNYQIDYFGVAATVYCMLFG 281 (365)
T ss_dssp GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHH-----TTCCBSTHHHHHHHHHHHHHHHHS
T ss_pred ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHh-----cCCCCCccccHHHHHHHHHHHHhC
Confidence 8 8999999999997543 22234566899999999999 7788999999996333 345
Q ss_pred cCCCCc
Q 019304 334 WPPPWR 339 (343)
Q Consensus 334 ~~p~~~ 339 (343)
.+||+.
T Consensus 282 ~~pf~~ 287 (365)
T 3e7e_A 282 TYMKVK 287 (365)
T ss_dssp SCCCEE
T ss_pred CCcccc
Confidence 566643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=289.81 Aligned_cols=194 Identities=28% Similarity=0.483 Sum_probs=164.8
Q ss_pred CccceecccccccccccccccceEEEEEEEC---------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCC
Q 019304 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHL 196 (343)
Q Consensus 127 ~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 196 (343)
...|.+..++|++++.||+|+||.||+|.+. +..||||+++..... ...+.+.+|+.+++.+ +||
T Consensus 73 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~~hp 147 (370)
T 2psq_A 73 DPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-----KDLSDLVSEMEMMKMIGKHK 147 (370)
T ss_dssp CTTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH-----HHHHHHHHHHHHHHHSCCCT
T ss_pred cccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH-----HHHHHHHHHHHHHHHhcCCC
Confidence 3467888999999999999999999999862 246999999754321 1236789999999999 899
Q ss_pred CcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeC
Q 019304 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------------RAVPLKLAVKQALDVARGMAYVHGLGFIHR 262 (343)
Q Consensus 197 nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~gL~yLH~~giiHr 262 (343)
||+++++++.....+|+||||+++|+|.+++..... ..+++..++.++.||+.||+|||++||+||
T Consensus 148 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr 227 (370)
T 2psq_A 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 227 (370)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred CEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 999999999999999999999999999999986532 347889999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 263 DLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 263 Dlkp~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
||||+|||++.++.+||+|||+++....... .....+|+.|+|||++ ....++.++|||++++
T Consensus 228 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~-----~~~~~~~~~DvwslG~ 293 (370)
T 2psq_A 228 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGV 293 (370)
T ss_dssp CCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHH-----HTCCCCHHHHHHHHHH
T ss_pred ccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHh-----cCCCCCcHHHHHHHHH
Confidence 9999999999999999999999986543221 2334678999999999 6788999999996433
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=300.29 Aligned_cols=208 Identities=19% Similarity=0.240 Sum_probs=169.3
Q ss_pred cceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
++.+..++|++.+.||+|+||+||+|++ +++.||||++.+...... .....+.+|..++..++||||+++++++.
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR---AETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHT---TTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhH---HHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 3456678999999999999999999998 568899999964211000 01123789999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
+...+|+||||+++|+|.+++.+. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 999999999999999999999763 3459999999999999999999999999999999999999999999999999997
Q ss_pred ccccCCC--ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 287 IEVQTEG--MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 287 ~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
....... ....+||+.|+|||++.........|+.++|||+++. +++.+||.+.
T Consensus 224 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 284 (437)
T 4aw2_A 224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284 (437)
T ss_dssp ECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred hcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence 6543322 2346899999999998211112567999999996333 4477777653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=293.75 Aligned_cols=195 Identities=21% Similarity=0.334 Sum_probs=166.9
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||+|.. +++.+|+|++......... .+.+.+|+.+++.++||||+++++++.+....|
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD----HQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHH----HHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHH----HHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 6788999999999999999987 7889999999876543322 357899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc---CCCcEEEeccccccccc
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS---ADKSIKIADFGVARIEV 289 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~---~~~~vkl~DFg~a~~~~ 289 (343)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 87 lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999999999999865 4599999999999999999999999999999999999998 46789999999998654
Q ss_pred cCC-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 290 QTE-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 290 ~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
... .....+||+.|+|||++ ....++.++|||+++. +++.+||++.
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l-----~~~~~~~~~DIwSlGvilyell~G~~Pf~~~ 216 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVL-----RKDPYGKPVDLWACGVILYILLVGYPPFWDE 216 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHH-----TTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCceeecccCCcccCCHHHh-----cCCCCCCccccHHHHHHHHHHHhCCCCCCCc
Confidence 432 23456899999999999 7788999999996333 4577888654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=279.87 Aligned_cols=195 Identities=23% Similarity=0.369 Sum_probs=162.6
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++.+.||+|+||.||+|.+ +++.||+|++........ ...+.+.+|+.+++.++||||+++++++.....+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKE---ETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCH---HHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccH---HHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 47899999999999999999987 678999999976554432 2346789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||+++++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999999998653 5899999999999999999999999999999999999999999999999999865433
Q ss_pred C--CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 292 E--GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 292 ~--~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
. .....+||+.|+|||.+ ....++.++|+|+++. +++.+||.
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~slG~~l~~ll~g~~pf~ 213 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQA-----KGEATDECTDIYSIGIVLYEMLVGEPPFN 213 (294)
T ss_dssp ----------CCSSCCHHHH-----HTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccCccccCccccCHhHh-----cCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 2 22345799999999999 7778899999996433 33556654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=312.07 Aligned_cols=190 Identities=25% Similarity=0.472 Sum_probs=154.4
Q ss_pred cceeccccccccc-ccccccceEEEEEEE----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEE
Q 019304 129 EWTIDLRKLNMGT-AFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (343)
Q Consensus 129 ~~~i~~~~~~~~~-~lg~G~fg~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~ 203 (343)
.|.+...++.+.+ .||+|+||.||+|.+ ++..||||+++....... .+.|.+|+.+++.++||||+++++
T Consensus 329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~-----~~~~~~E~~il~~l~hpniv~l~~ 403 (613)
T 2ozo_A 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-----TEEMMREAQIMHQLDNPYIVRLIG 403 (613)
T ss_dssp CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTT-----HHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHH-----HHHHHHHHHHHHhCCCCCEeeEEE
Confidence 3555556666665 799999999999987 345799999976533222 257899999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 204 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
++.. +.+++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus 404 ~~~~-~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFG 481 (613)
T 2ozo_A 404 VCQA-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFG 481 (613)
T ss_dssp EEES-SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCS
T ss_pred Eecc-CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeecc
Confidence 9976 4589999999999999999653 4568999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCc----cCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 284 VARIEVQTEGM----TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 284 ~a~~~~~~~~~----~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+++........ ....+++.|+|||++ ....++.++|||++++
T Consensus 482 la~~~~~~~~~~~~~~~~~~~~~y~APE~~-----~~~~~~~~sDvwSlGv 527 (613)
T 2ozo_A 482 LSKALGADDSYYTARSAGKWPLKWYAPECI-----NFRKFSSRSDVWSYGV 527 (613)
T ss_dssp TTTTCC--------------CCTTSCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred CcccccCCCceeeeccCCCCccceeCHhhh-----cCCCCCcHHHHHHHHH
Confidence 99865432211 122456899999999 7788999999996443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=287.56 Aligned_cols=199 Identities=22% Similarity=0.304 Sum_probs=165.7
Q ss_pred eecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK 207 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 207 (343)
.+..++|++.+.||+|+||.||+|++ +++.||||++++..... ....+.+.+|..+++.+ +||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~ 89 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM---DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT 89 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh---hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence 35568899999999999999999998 67899999997532100 01124577889888876 99999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
...+|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999999998653 489999999999999999999999999999999999999999999999999985
Q ss_pred ccc-CCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 288 EVQ-TEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 288 ~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
... .......+||+.|+|||++ ....++.++|+|+++. +++.+||.+
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEIL-----LGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHH-----TTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCCCcccCCCCCcccCChhhh-----cCCCCCChhhhHHHHHHHHHHhcCCCCCCC
Confidence 432 2334566899999999999 7788999999996433 446677654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=276.90 Aligned_cols=190 Identities=26% Similarity=0.487 Sum_probs=165.5
Q ss_pred ccceecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
.+|.++.++|++.+.||+|+||.||+|.+ +++.||+|++....... +++.+|+.++++++||||+++++++.
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~ 75 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-------EDFIEEAEVMMKLSHPKLVQLYGVCL 75 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH-------HHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH-------HHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 46889999999999999999999999998 77889999997654432 46889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
+....++||||+++++|.+++... ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 76 EQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR 154 (269)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred cCCceEEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccc
Confidence 999999999999999999999754 3458999999999999999999999999999999999999999999999999998
Q ss_pred ccccCC--CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 287 IEVQTE--GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 287 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
...... ......+|+.|+|||.+ ....++.++|+|+++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 195 (269)
T 4hcu_A 155 FVLDDQYTSSTGTKFPVKWASPEVF-----SFSRYSSKSDVWSFGV 195 (269)
T ss_dssp GBCCHHHHSTTSTTCCGGGCCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred cccccccccccCcccccccCCHHHh-----cCCCCCchhhhHHHHH
Confidence 653321 22344678899999999 7788999999996443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=288.99 Aligned_cols=198 Identities=21% Similarity=0.308 Sum_probs=160.4
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHH-HhcCCCCCcceEEEEEEeC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-LATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~ 208 (343)
+..++|++.+.||+|+||.||+|+. +++.||||++.+....... ..+.+.+|..+ ++.++||||+++++++.+.
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~---~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~ 111 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK---EEKHIMSERNVLLKNVKHPFLVGLHFSFQTA 111 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC----------------CCBCCCCCTTBCCEEEEEECS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhH---HHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence 4567899999999999999999998 5778999999765432221 12456677776 5778999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
..+|+||||+++|+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 99999999999999999998653 4889999999999999999999999999999999999999999999999999863
Q ss_pred c-cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 289 V-QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 289 ~-~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
. ........+||+.|+|||++ ....++.++|+|+++. +++.+||.+
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 241 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVL-----HKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHH-----TTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccCCCccccccCCccccCHHHh-----CCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 3 23344567899999999999 7788999999996433 446677754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=287.73 Aligned_cols=198 Identities=23% Similarity=0.260 Sum_probs=166.1
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 208 (343)
+..++|++.+.||+|+||.||+|+. +++.||||++.+..... ....+.+.+|..++..+ +||+|+++++++.+.
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~---~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ---DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 93 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH---TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc---chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence 4567899999999999999999998 46789999997532110 01125678999999988 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
..+|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999999998653 4899999999999999999999999999999999999999999999999999853
Q ss_pred c-cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 289 V-QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 289 ~-~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
. ........+||+.|+|||++ ....++.++|+|+++. +++.+||.+
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 223 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEII-----AYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHH-----TTCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCcccccccCCccccChhhh-----cCCCcCCcccccchHHHHHHHHcCCCCCCC
Confidence 3 22334566899999999999 7788999999996433 346677654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=287.67 Aligned_cols=195 Identities=22% Similarity=0.346 Sum_probs=165.5
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
..+|++.+.||+|+||.||+|.+ +++.||||++.+..... ....+.+.+|+.+++.++||||+++++++.....+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK---SDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccc---hhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 47899999999999999999998 78899999986421110 11124688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||+ +|+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999999 679999997653 4899999999999999999999999999999999999999999999999999876665
Q ss_pred CCccCCCCCcceecCCCCCCCCCCCCCC-ceeeeeeeccc-----ccccCCCCc
Q 019304 292 EGMTPETGTYRWMAPGNSFFSPLPHPSF-EHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~~~~~~~~-~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
......+||+.|+|||++ ....+ +.++|||+++. +++.+||..
T Consensus 162 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~ 210 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVI-----NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210 (336)
T ss_dssp BTTCCCTTSTTTSCGGGS-----CCSGGGCHHHHHHHHHHHHHHHHHSSCSSBC
T ss_pred cccccccCCcCcCCHHHH-----cCCCCCCCccchhHHHHHHHHHHhCCCCCCC
Confidence 556677899999999999 66665 68999996333 345666643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=283.59 Aligned_cols=193 Identities=16% Similarity=0.208 Sum_probs=166.7
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++++.||+|+||.||+|.. +++.||+|++..... ....+.+|+.+++.++||||+++++++.+...++
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-------DQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-------HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc-------cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 6788999999999999999998 678999999864321 1246889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC--CCcEEEecccccccccc
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA--DKSIKIADFGVARIEVQ 290 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~--~~~vkl~DFg~a~~~~~ 290 (343)
+||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 78 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 78 MIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999999999653 345899999999999999999999999999999999999987 78999999999987655
Q ss_pred CCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 291 TEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 291 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
........||+.|+|||++ ....++.++|+|+++. +++.+||++.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 206 (321)
T 1tki_A 157 GDNFRLLFTAPEYYAPEVH-----QHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp TCEEEEEESCGGGSCHHHH-----TTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCccccccCChhhcCcHHh-----cCCCCCchhhHHHHHHHHHHHHhCCCCCcCC
Confidence 5445556799999999999 7778899999996333 4466777654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=295.37 Aligned_cols=208 Identities=20% Similarity=0.244 Sum_probs=170.4
Q ss_pred cceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
++.+..++|++.+.||+|+||.||+++. +++.||||++.+.... .....+.+.+|..++..++||||+++++++.
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~---~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML---KRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH---HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh---hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 4456778999999999999999999998 6889999999642111 1111235789999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
+...+|+||||+++|+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 9999999999999999999998653 358999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCC--ccCCCCCcceecCCCCCC--CCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 287 IEVQTEG--MTPETGTYRWMAPGNSFF--SPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 287 ~~~~~~~--~~~~~gt~~y~APE~~~~--~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
....... ....+||+.|+|||++.. .......|+.++|+|+++. +++.+||.+.
T Consensus 211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 273 (412)
T 2vd5_A 211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273 (412)
T ss_dssp ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence 6544332 234589999999999821 0001467899999996433 4477777543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=280.69 Aligned_cols=186 Identities=24% Similarity=0.415 Sum_probs=155.2
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC---
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--- 209 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--- 209 (343)
++|++.+.||+|+||.||+|++ +++.||||++........ .+.+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-----REKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTH-----HHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 6788999999999999999998 688999999976543322 257899999999999999999999986543
Q ss_pred ------------------------------------------------------eEEEEEEecCCCCHHHHHHhhCC-CC
Q 019304 210 ------------------------------------------------------VWCIVTEYAKGGSVRQFLTRRQN-RA 234 (343)
Q Consensus 210 ------------------------------------------------------~~~iv~E~~~~gsL~~~l~~~~~-~~ 234 (343)
..++||||+++++|.+++..... ..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 37999999999999999986432 23
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-------------CccCCCCCc
Q 019304 235 VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-------------GMTPETGTY 301 (343)
Q Consensus 235 ~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~-------------~~~~~~gt~ 301 (343)
.++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...... .....+||+
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 4566789999999999999999999999999999999999999999999998654431 223457999
Q ss_pred ceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 302 RWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 302 ~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.|+|||++ ....++.++|||+++.
T Consensus 241 ~y~aPE~~-----~~~~~~~~~Di~slG~ 264 (332)
T 3qd2_B 241 LYMSPEQI-----HGNNYSHKVDIFSLGL 264 (332)
T ss_dssp GGSCHHHH-----HCCCCCTHHHHHHHHH
T ss_pred CccChHHh-----cCCCCcchhhHHHHHH
Confidence 99999999 7788999999996443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=286.39 Aligned_cols=196 Identities=22% Similarity=0.291 Sum_probs=167.4
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
...++|++.+.||+|+||.||+++. +++.||||++.+..... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 114 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK---LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 3457899999999999999999998 68899999996422111 011356889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
.+|+||||+++++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc
Confidence 9999999999999999998753 48999999999999999999999999999999999999999999999999998654
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
. .....+||+.|+|||++ ....++.++|+|++++ +++.+||.+
T Consensus 193 ~--~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 240 (350)
T 1rdq_E 193 G--RTWTLCGTPEALAPEII-----LSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp S--CBCCCEECGGGCCHHHH-----TTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred C--CcccccCCccccCHHHh-----cCCCCCCcCCEecccHhHhHHhhCCCCCCC
Confidence 3 23456899999999999 7788999999996433 346677654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=303.24 Aligned_cols=201 Identities=20% Similarity=0.261 Sum_probs=173.0
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
+..++|++.+.||+|+||.||+|+. +++.||||++.+..... ......+.+|+.+++.++||||+++++++.+..
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~---~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---RKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 257 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence 5678899999999999999999998 68899999996422111 111246789999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
.+|+||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999999999987655569999999999999999999999999999999999999999999999999998766
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
........+||+.|+|||++ ....++.++|+|+++. +++.+||...
T Consensus 338 ~~~~~~~~~GT~~Y~APEvl-----~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAPEVV-----KNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp TTCCEECCCSCGGGCCHHHH-----TTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred cCccccccCCCccccCHHHH-----cCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 55555667999999999999 7788999999996433 4467777653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=282.90 Aligned_cols=201 Identities=21% Similarity=0.269 Sum_probs=158.9
Q ss_pred ceecccccccccccccccceEEEEEEE-----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEE
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 204 (343)
..+..++|++.+.||+|+||.||++.. +++.||||++++...... ......+.+|+.+++.++||||++++++
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN--AKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC----------------HHHHHHHCCCTTBCCEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhh--hhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 345678999999999999999999986 578899999976532211 1122467899999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccc
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~ 284 (343)
+.....+|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 999999999999999999999998653 488999999999999999999999999999999999999999999999999
Q ss_pred ccccccC-CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 285 ARIEVQT-EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 285 a~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
++..... ......+||+.|+|||++ ....++.++|+|+++. +++.+||.+
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~el~~g~~pf~~ 223 (327)
T 3a62_A 168 CKESIHDGTVTHTFCGTIEYMAPEIL-----MRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223 (327)
T ss_dssp C----------CTTSSCCTTSCHHHH-----TTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccCCccccccCCCcCccCHhhC-----cCCCCCCcccchhHHHHHHHHHHCCCCCCC
Confidence 9754322 234456899999999999 7788999999996433 345666643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=285.51 Aligned_cols=193 Identities=28% Similarity=0.341 Sum_probs=162.4
Q ss_pred CccceecccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 127 ~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
-.+|.++.++|++.+.||+|+||.||+|++.++.||||++..... ....+.+|+.+++.++||||+++++++.
T Consensus 16 ~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (322)
T 3soc_A 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDK-------QSWQNEYEVYSLPGMKHENILQFIGAEK 88 (322)
T ss_dssp CCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGH-------HHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred ccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCch-------HHHHHHHHHHHHhcCCCCCchhhcceec
Confidence 356888999999999999999999999999999999999964211 1234567999999999999999999998
Q ss_pred eCC----eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeCCCCCCcEEEc
Q 019304 207 KRM----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL----------GFIHRDLKSDNLLIS 272 (343)
Q Consensus 207 ~~~----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~----------giiHrDlkp~NILv~ 272 (343)
... .+++||||+++++|.+++... .+++..++.++.|++.||+|||+. ||+||||||+|||++
T Consensus 89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~ 165 (322)
T 3soc_A 89 RGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK 165 (322)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC
T ss_pred cCCCCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC
Confidence 754 479999999999999999763 489999999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 273 ADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 273 ~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.++.+||+|||+++....... ....+||+.|+|||++.+.......++.++|||++.
T Consensus 166 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG 225 (322)
T 3soc_A 166 NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMG 225 (322)
T ss_dssp TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHH
T ss_pred CCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHH
Confidence 999999999999976543322 334579999999999843222235778899999633
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=276.70 Aligned_cols=192 Identities=26% Similarity=0.474 Sum_probs=163.7
Q ss_pred CCccceecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEE
Q 019304 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (343)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 204 (343)
....|+++.++|++.+.||+|+||.||++.+ ++..||||++....... +++.+|+.+++.++||||++++++
T Consensus 15 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~ 87 (283)
T 3gen_A 15 GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-------DEFIEEAKVMMNLSHEKLVQLYGV 87 (283)
T ss_dssp -CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH-------HHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH-------HHHHHHHHHHhcCCCCCEeeEEEE
Confidence 4678999999999999999999999999998 55689999997654432 468899999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccc
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~ 284 (343)
+.+....++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 166 (283)
T 3gen_A 88 CTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGL 166 (283)
T ss_dssp ECSSSSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred EecCCCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccc
Confidence 999999999999999999999997632 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC--CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 285 ARIEVQTE--GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 285 a~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
++...... ......+|+.|+|||.+ ....++.++|+|+++.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slG~ 209 (283)
T 3gen_A 167 SRYVLDDEYTSSVGSKFPVRWSPPEVL-----MYSKFSSKSDIWAFGV 209 (283)
T ss_dssp GGGBCCHHHHSTTSTTSCGGGCCHHHH-----HHCCCSHHHHHHHHHH
T ss_pred cccccccccccccCCccCcccCCHHHh-----ccCCCCchhhHHHHHH
Confidence 98653321 22334578899999999 6778999999996433
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=286.11 Aligned_cols=197 Identities=30% Similarity=0.502 Sum_probs=168.1
Q ss_pred CCCCccceecccccccccccccccceEEEEEEECC---------ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-
Q 019304 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG---------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL- 193 (343)
Q Consensus 124 ~~~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 193 (343)
+.....|++..++|++++.||+|+||.||+|.+.+ ..||||++...... ...+++.+|+.+++.+
T Consensus 58 ~~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~ 132 (382)
T 3tt0_A 58 LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-----KDLSDLISEMEMMKMIG 132 (382)
T ss_dssp CCCCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH-----HHHHHHHHHHHHHHHHC
T ss_pred cccCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH-----HHHHHHHHHHHHHHHhc
Confidence 33456789999999999999999999999998622 46999999754322 1236788999999999
Q ss_pred CCCCcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 019304 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------------RAVPLKLAVKQALDVARGMAYVHGLGF 259 (343)
Q Consensus 194 ~h~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~gL~yLH~~gi 259 (343)
+||||+++++++......++||||+++++|.+++..... ..+++..++.++.|++.||+|||++||
T Consensus 133 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 212 (382)
T 3tt0_A 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC 212 (382)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 999999999999999999999999999999999987542 358999999999999999999999999
Q ss_pred eeCCCCCCcEEEcCCCcEEEeccccccccccCC---CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 260 iHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+||||||+|||++.++.+||+|||+++...... ......+|+.|+|||++ ....++.++|||+++.
T Consensus 213 vH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~-----~~~~~~~~~DiwslG~ 281 (382)
T 3tt0_A 213 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-----FDRIYTHQSDVWSFGV 281 (382)
T ss_dssp CCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHH-----HSCCCCHHHHHHHHHH
T ss_pred ecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHh-----cCCCCCchhHHHHHHH
Confidence 999999999999999999999999998654322 22334678999999999 7788999999996443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=278.19 Aligned_cols=194 Identities=25% Similarity=0.501 Sum_probs=170.1
Q ss_pred CCCccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEE
Q 019304 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (343)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~ 202 (343)
..+++|++..++|++.+.||+|+||.||+|.+ +++.||||++...... .+.+.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~ 75 (288)
T 3kfa_A 3 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLL 75 (288)
T ss_dssp TTCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH-------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CchhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH-------HHHHHHHHHHHHhCCCCCEeeEE
Confidence 46789999999999999999999999999998 4788999999753321 25688999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 019304 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (343)
Q Consensus 203 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DF 282 (343)
+++.+....++||||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+||
T Consensus 76 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Df 155 (288)
T 3kfa_A 76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF 155 (288)
T ss_dssp EEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred EEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccC
Confidence 99999999999999999999999998766667999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCC--ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 283 GVARIEVQTEG--MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 283 g~a~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|+++....... .....+|+.|+|||.+ ....++.++|+|+++.
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 200 (288)
T 3kfa_A 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKFSIKSDVWAFGV 200 (288)
T ss_dssp CGGGTSCSSSSEEETTEEECGGGCCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred ccceeccCCccccccCCccccCcCChhhh-----ccCCCCchhhHHHHHH
Confidence 99986543322 1223567899999999 7778999999996443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=285.39 Aligned_cols=201 Identities=16% Similarity=0.243 Sum_probs=169.5
Q ss_pred ceecccccccccccccc--cceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 130 WTIDLRKLNMGTAFAQG--AFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G--~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
+....++|++.+.||+| +||.||+|++ +++.||||++........ ..+.+.+|+.+++.++||||+++++++
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~ 95 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE----MVTFLQGELHVSKLFNHPNIVPYRATF 95 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChH----HHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence 34466899999999999 9999999998 588999999986544332 346788999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
.+...+++||||+++++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||.+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred EECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence 99999999999999999999998765567999999999999999999999999999999999999999999999999987
Q ss_pred cccccC--------CCccCCCCCcceecCCCCCCCCCCC--CCCceeeeeeeccc-----ccccCCCCc
Q 019304 286 RIEVQT--------EGMTPETGTYRWMAPGNSFFSPLPH--PSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 286 ~~~~~~--------~~~~~~~gt~~y~APE~~~~~~~~~--~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
...... ......+||+.|+|||++ .. ..++.++|||+++. +++.+||.+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL-----QQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHH-----STTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eeeccccccccccccccccccccccccCHHHH-----hccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 643221 112234789999999999 44 67999999996333 335666643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=280.27 Aligned_cols=193 Identities=21% Similarity=0.270 Sum_probs=161.8
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM- 209 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~- 209 (343)
..++|++.+.||+|+||.||+|.+ +++.||||++........ .+.+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-----VDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch-----HHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence 457899999999999999999998 488999999965332211 246789999999999999999999998765
Q ss_pred -eEEEEEEecCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE----cCCCcEEEeccc
Q 019304 210 -VWCIVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI----SADKSIKIADFG 283 (343)
Q Consensus 210 -~~~iv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv----~~~~~vkl~DFg 283 (343)
..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 78999999999999999986432 348999999999999999999999999999999999999 777889999999
Q ss_pred cccccccCCCccCCCCCcceecCCCCCC---CCCCCCCCceeeeeeeccc
Q 019304 284 VARIEVQTEGMTPETGTYRWMAPGNSFF---SPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~~~~~~~sDi~~~~~ 330 (343)
+++............||+.|+|||++.. .......++.++|||+++.
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~ 211 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHH
T ss_pred CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHH
Confidence 9987666555566789999999998721 1112578999999996433
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=273.24 Aligned_cols=185 Identities=21% Similarity=0.345 Sum_probs=158.1
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||+|.+ +++.||||++......... .+.+.+|+.+++.++||||+++++++.+...++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV----PSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTH----HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCc----chHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEE
Confidence 5788999999999999999998 6789999999866543322 256789999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~- 291 (343)
+||||+++ +|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 78 lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 78 LVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred EEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99999975 677776653 356999999999999999999999999999999999999999999999999999865432
Q ss_pred CCccCCCCCcceecCCCCCCCCCCCC-CCceeeeeeeccc
Q 019304 292 EGMTPETGTYRWMAPGNSFFSPLPHP-SFEHKWSAKESCL 330 (343)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~~~~~~-~~~~~sDi~~~~~ 330 (343)
.......||+.|+|||++ ... .++.++|||+++.
T Consensus 156 ~~~~~~~~t~~y~aPE~~-----~~~~~~~~~~DiwslG~ 190 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVL-----FGAKLYSTSIDMWSAGC 190 (292)
T ss_dssp SCCCSCCSCGGGCCHHHH-----TTCSCCCTHHHHHHHHH
T ss_pred ccccCCccccCCcChHHH-----cCCCCcCchHHHHHHHH
Confidence 234456899999999998 444 4899999996433
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=296.78 Aligned_cols=201 Identities=21% Similarity=0.302 Sum_probs=159.9
Q ss_pred cceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
.+.+..++|++.+.||+|+||.||+|.. +++.||||++....... ......+.+|+.+++.++||||+++++++.
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 218 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA---KDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC----------------CCCCCSCTTSCCEEEEEE
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhh---hHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence 4556778999999999999999999998 67899999997432111 112246789999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
....+++||||+++++|.+++.... .+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|
T Consensus 219 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a 296 (446)
T 4ejn_A 219 THDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296 (446)
T ss_dssp ETTEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred eCCEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCc
Confidence 9999999999999999999997653 58999999999999999999998 99999999999999999999999999999
Q ss_pred ccccc-CCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 286 RIEVQ-TEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 286 ~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
+.... .......+||+.|+|||++ ....++.++|||+++. +++.+||.+
T Consensus 297 ~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 351 (446)
T 4ejn_A 297 KEGIKDGATMKTFCGTPEYLAPEVL-----EDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351 (446)
T ss_dssp CTTCC-----CCSSSCGGGCCHHHH-----HTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eeccCCCcccccccCCccccCHhhc-----CCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 86332 2334567899999999999 7788999999996433 335666643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=284.90 Aligned_cols=194 Identities=25% Similarity=0.310 Sum_probs=155.3
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
.+.++|++.+.||+|+||.||+++. +++.||||++....... +.+.+|+.+++.++||||+++++++....
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 89 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-------ENVQREIINHRSLRHPNIVRFKEVILTPT 89 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC-------HHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc-------HHHHHHHHHHHhCCCCCCCcEEEEEeeCC
Confidence 4567899999999999999999998 67899999998654433 35779999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc--EEEeccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVARI 287 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~--vkl~DFg~a~~ 287 (343)
.+++||||+++++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 90 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 9999999999999999997654 4999999999999999999999999999999999999987665 99999999985
Q ss_pred cccCCCccCCCCCcceecCCCCCCCCCCCCCCcee-eeeeeccc-----ccccCCCCc
Q 019304 288 EVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHK-WSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~-sDi~~~~~-----~~~~~p~~~ 339 (343)
..........+||+.|+|||++ ....++.+ +|||+++. +++.+||.+
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (361)
T 3uc3_A 168 SVLHSQPKSTVGTPAYIAPEVL-----LRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220 (361)
T ss_dssp -------------CTTSCHHHH-----HCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred ccccCCCCCCcCCCCcCChhhh-----cCCCCCCCeeeeehhHHHHHHHHhCCCCCCC
Confidence 4444445566899999999999 56666555 89996433 335566643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=274.36 Aligned_cols=196 Identities=20% Similarity=0.229 Sum_probs=158.3
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHh-cCCCCCcceEEEEEEeC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLA-TLKHLNIVRFIGACRKR 208 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~ 208 (343)
+-.++|++.++||+|+||.||+|.+ +++.||||++.......... .++..|+..+. ..+||||+++++++.+.
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR----ARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHH----HHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 3447899999999999999999998 68899999987655443322 34445555554 45999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
..+++||||+ +++|.+++.... ..+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred CEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 9999999999 679999987653 46999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecccc-----cccCCCCc
Q 019304 289 VQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLK-----TTWPPPWR 339 (343)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~~-----~~~~p~~~ 339 (343)
..........||+.|+|||++ .. .++.++|||+++.+ ++..||++
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~-----~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 208 GTAGAGEVQEGDPRYMAPELL-----QG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp C------CCCCCGGGCCGGGG-----GT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred ccCCCCcccCCCccccCHhHh-----cC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 555555566799999999988 43 68999999964432 34455553
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=282.98 Aligned_cols=200 Identities=19% Similarity=0.286 Sum_probs=163.9
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++.+.||+|+||.||+|.. +++.||||++......... ....+.+.+|+.+++.++||||+++++++.+...+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP-GLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSS-SCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccc-cchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 36789999999999999999988 6889999998632110000 00125688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc---EEEecccccc
Q 019304 212 CIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIADFGVAR 286 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~---vkl~DFg~a~ 286 (343)
|+||||+++++|.+++.+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999999888653 2345899999999999999999999999999999999999986554 9999999998
Q ss_pred ccccCCC-ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 287 IEVQTEG-MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 287 ~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
....... ....+||+.|+|||++ ....++.++|||++.. +++.+||.+
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (351)
T 3c0i_A 182 QLGESGLVAGGRVGTPHFMAPEVV-----KREPYGKPVDVWGCGVILFILLSGCLPFYG 235 (351)
T ss_dssp ECCTTSCBCCCCCSCGGGCCHHHH-----TTCCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred EecCCCeeecCCcCCcCccCHHHH-----cCCCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence 7554332 3456899999999999 7788999999996333 346666644
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=271.61 Aligned_cols=189 Identities=25% Similarity=0.443 Sum_probs=164.3
Q ss_pred cceecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 207 (343)
+|++..++|++.+.||+|+||.||+|.+ ++..||||++....... +++.+|+.+++.++||||+++++++..
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-------DEFFQEAQTMMKLSHPKLVKFYGVCSK 74 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH-------HHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH-------HHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 5778889999999999999999999988 55689999997654432 468899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
....++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 75 EYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153 (268)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred CCceEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCcccee
Confidence 999999999999999999997643 3589999999999999999999999999999999999999999999999999986
Q ss_pred cccCCC--ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 288 EVQTEG--MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 288 ~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
...... .....+|+.|+|||.+ ....++.++|+|+++.
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 193 (268)
T 3sxs_A 154 VLDDQYVSSVGTKFPVKWSAPEVF-----HYFKYSSKSDVWAFGI 193 (268)
T ss_dssp CCTTCEEECCSCCCCGGGCCHHHH-----HHSEEETTHHHHHHHH
T ss_pred cchhhhhcccCCCcCcccCCHHHH-----hccCCchhhhhHHHHH
Confidence 543322 2234567889999999 7778999999996443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=282.04 Aligned_cols=193 Identities=26% Similarity=0.440 Sum_probs=164.1
Q ss_pred ccceecccccccccccccccceEEEEEEECC-------ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcce
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~ 200 (343)
..|.+..++|++.+.||+|+||.||+|.+.+ +.||||+++..... ...+.+.+|+.+++.++||||++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~ 114 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-----DMQADFQREAALMAEFDNPNIVK 114 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-----HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH-----HHHHHHHHHHHHHHhCCCCCEEE
Confidence 3467788999999999999999999998843 78999999754321 22367899999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCCHHHHHHhhCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019304 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN----------------------RAVPLKLAVKQALDVARGMAYVHGLG 258 (343)
Q Consensus 201 l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~----------------------~~~~~~~~~~i~~qi~~gL~yLH~~g 258 (343)
+++++......++||||+++++|.+++..... ..+++..++.++.||+.||.|||++|
T Consensus 115 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 194 (343)
T 1luf_A 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 194 (343)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986421 46899999999999999999999999
Q ss_pred ceeCCCCCCcEEEcCCCcEEEeccccccccccCC---CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 259 iiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|+||||||+|||++.++.+||+|||+++...... ......+|+.|+|||.+ ....++.++|+|+++.
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~-----~~~~~~~~~Di~slG~ 264 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI-----FYNRYTTESDVWAYGV 264 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhh-----ccCCcCcccccHHHHH
Confidence 9999999999999999999999999998643322 22344688999999999 6778999999996443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=280.42 Aligned_cols=199 Identities=26% Similarity=0.432 Sum_probs=164.1
Q ss_pred ceecccccccccccccccceEEEEEEE--C---CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEE
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--N---GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~---~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 204 (343)
+++..++|++.+.||+|+||.||+|.+ + +..||||++....... ..+.+.+|+.+++.++||||++++++
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~ 118 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER-----QRRDFLSEASIMGQFDHPNIIRLEGV 118 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHH-----HHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHH-----HHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 467788999999999999999999988 2 3359999997543221 23678999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccc
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~ 284 (343)
+.+....++||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 197 (325)
T 3kul_A 119 VTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197 (325)
T ss_dssp ECGGGCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred EEeCCccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCc
Confidence 99999999999999999999999754 34689999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----cc-ccCCCCc
Q 019304 285 ARIEVQTEG----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KT-TWPPPWR 339 (343)
Q Consensus 285 a~~~~~~~~----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~-~~~p~~~ 339 (343)
++....... .....+|+.|+|||++ ....++.++|||+++. ++ +.+||+.
T Consensus 198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~-----~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 257 (325)
T 3kul_A 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAI-----AFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257 (325)
T ss_dssp CEECC----CCEECC---CCGGGSCHHHH-----HHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccccCccceeeccCCCCcccccCHhHh-----cCCCCCcHHHHHHHHHHHHHHHcCCCCCccc
Confidence 986543221 1223567899999999 7788999999996443 22 4555543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=267.94 Aligned_cols=195 Identities=23% Similarity=0.382 Sum_probs=168.5
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||+|.+ +++.||+|++......... .+.+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHH----HHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 6788999999999999999988 5789999999765544332 357889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc---EEEeccccccccc
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIADFGVARIEV 289 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~---vkl~DFg~a~~~~ 289 (343)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++. +||+|||++....
T Consensus 82 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999999999987653 4899999999999999999999999999999999999986554 9999999998766
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
.........||+.|+|||.+ ....++.++|||+++. +++.+||+..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 210 (284)
T 3kk8_A 160 DSEAWHGFAGTPGYLSPEVL-----KKDPYSKPVDIWACGVILYILLVGYPPFWDE 210 (284)
T ss_dssp SSCBCCCSCSCGGGCCHHHH-----TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCccccCCCCCcCCcCchhh-----cCCCCCcccchHHHHHHHHHHHHCCCCCCCC
Confidence 55555667899999999999 7788999999996433 4466776543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=296.16 Aligned_cols=201 Identities=20% Similarity=0.237 Sum_probs=170.1
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
+..++|++.+.||+|+||.||+|+. +++.||||++.+..... ....+.+.+|+.+++.++||||+++++++....
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~---~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 258 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK---RKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT 258 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh---hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC
Confidence 4567899999999999999999998 68899999996422111 111356889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
.+|+||||++||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 9999999999999999997643 34689999999999999999999999999999999999999999999999999987
Q ss_pred cccCCC-ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 288 EVQTEG-MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 288 ~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
...... ....+||+.|+|||++ ....++.++|+|+++. +++.+||.+.
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l-----~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELL-----LGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHH-----TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred ccCCCcccccccCCccccChhhh-----cCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 554332 3345899999999999 7788999999996433 4477777653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=276.29 Aligned_cols=196 Identities=28% Similarity=0.462 Sum_probs=167.5
Q ss_pred CCCccceecccccccccccccccceEEEEEEE-------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCC
Q 019304 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHL 196 (343)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 196 (343)
....+|+++.++|++++.||+|+||.||+|++ +++.||||++....... ..+.+.+|+.+++.+ +||
T Consensus 13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~ 87 (313)
T 1t46_A 13 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT-----EREALMSELKVLSYLGNHM 87 (313)
T ss_dssp CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCT
T ss_pred CCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHH-----HHHHHHHHHHHHhhcccCC
Confidence 34567999999999999999999999999985 34689999997543321 236789999999999 999
Q ss_pred CcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 019304 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR----------------AVPLKLAVKQALDVARGMAYVHGLGFI 260 (343)
Q Consensus 197 nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~----------------~~~~~~~~~i~~qi~~gL~yLH~~gii 260 (343)
||+++++++......++||||+++++|.+++...... .+++..++.++.|++.||.|||++|++
T Consensus 88 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 167 (313)
T 1t46_A 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI 167 (313)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred CeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 9999999999999999999999999999999865422 489999999999999999999999999
Q ss_pred eCCCCCCcEEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 261 HrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
||||||+|||++.++.+||+|||+++....... .....+|+.|+|||.+ ....++.++|||+++.
T Consensus 168 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 235 (313)
T 1t46_A 168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI-----FNCVYTFESDVWSYGI 235 (313)
T ss_dssp CSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred cCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHh-----cCCCCChHHHHHHHHH
Confidence 999999999999999999999999986544322 1234577899999998 6778999999996433
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=279.19 Aligned_cols=199 Identities=19% Similarity=0.299 Sum_probs=168.8
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++.+.||+|+||.||+|.. +++.||||++..............+.+.+|+.+++.++||||+++++++.....+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 36788999999999999999998 6789999999765543321111135788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC----cEEEeccccccc
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK----SIKIADFGVARI 287 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~----~vkl~DFg~a~~ 287 (343)
++||||+++++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 9999999999999999753 4589999999999999999999999999999999999999887 799999999987
Q ss_pred cccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 288 EVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
...........||+.|+|||.+ ....++.++|+|+++. +++.+||.+
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 220 (321)
T 2a2a_A 169 IEDGVEFKNIFGTPEFVAPEIV-----NYEPLGLEADMWSIGVITYILLSGASPFLG 220 (321)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHH-----TTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred cCccccccccCCCCCccCcccc-----cCCCCCCccccHHHHHHHHHHHHCCCCCCC
Confidence 6655455566899999999999 7788999999996433 335566643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=281.30 Aligned_cols=193 Identities=26% Similarity=0.441 Sum_probs=162.4
Q ss_pred ccceecccccccccccccccceEEEEEEE-------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcc
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIV 199 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv 199 (343)
.+|+++.++|++++.||+|+||.||+|.+ +++.||||++....... ..+.+.+|+.+++.+ +||||+
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~iv 112 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-----EREALMSELKMMTQLGSHENIV 112 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBC
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHH-----HHHHHHHHHHHHHhhcCCCCee
Confidence 47899999999999999999999999986 34579999997543221 125788999999999 899999
Q ss_pred eEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019304 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---------------------RAVPLKLAVKQALDVARGMAYVHGLG 258 (343)
Q Consensus 200 ~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~qi~~gL~yLH~~g 258 (343)
++++++.....+++||||+++++|.+++..... ..+++..++.++.|++.||+|||++|
T Consensus 113 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 192 (344)
T 1rjb_A 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 192 (344)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999986432 23788999999999999999999999
Q ss_pred ceeCCCCCCcEEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 259 iiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|+||||||+|||++.++.+||+|||+++....... .....||+.|+|||.+ ....++.++|||+++.
T Consensus 193 ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~-----~~~~~~~~~Di~slG~ 262 (344)
T 1rjb_A 193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL-----FEGIYTIKSDVWSYGI 262 (344)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHh-----ccCCCChhHhHHHHHH
Confidence 99999999999999999999999999986544322 1233578899999998 6778999999996433
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=270.37 Aligned_cols=189 Identities=26% Similarity=0.380 Sum_probs=163.1
Q ss_pred cceecccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
.+.++.++|++.+.||+|+||.||+|+++++.||||++......... .+.+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRK----SRDFNEECPRLRIFSHPNVLPVLGACQSP 79 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHH----HHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHH----HHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence 45678899999999999999999999999999999999876544432 25789999999999999999999999887
Q ss_pred --CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCcEEEcCCCcEEEecccc
Q 019304 209 --MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSIKIADFGV 284 (343)
Q Consensus 209 --~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~g--iiHrDlkp~NILv~~~~~vkl~DFg~ 284 (343)
..+++||||+++++|.+++.......+++..++.++.|++.||+|||+++ ++||||||+|||++.++.++|+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 80 PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV 159 (271)
T ss_dssp TSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred CCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccc
Confidence 77899999999999999998765556899999999999999999999999 99999999999999999999999998
Q ss_pred ccccccCCCccCCCCCcceecCCCCCCCCCCCCC---Cceeeeeeeccc
Q 019304 285 ARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPS---FEHKWSAKESCL 330 (343)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~---~~~~sDi~~~~~ 330 (343)
+... ......||+.|+|||.+ .... ++.++|||+++.
T Consensus 160 ~~~~----~~~~~~~t~~y~aPE~~-----~~~~~~~~~~~~Di~slG~ 199 (271)
T 3kmu_A 160 KFSF----QSPGRMYAPAWVAPEAL-----QKKPEDTNRRSADMWSFAV 199 (271)
T ss_dssp CCTT----SCTTCBSCGGGSCHHHH-----HSCGGGSCHHHHHHHHHHH
T ss_pred eeee----cccCccCCccccChhhh-----ccCCCCCCCchhhHHHHHH
Confidence 7542 22345789999999999 4443 344899996433
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=283.55 Aligned_cols=190 Identities=22% Similarity=0.344 Sum_probs=151.3
Q ss_pred cccccc-cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHH-hcCCCCCcceEEEEEEe---
Q 019304 135 RKLNMG-TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML-ATLKHLNIVRFIGACRK--- 207 (343)
Q Consensus 135 ~~~~~~-~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~--- 207 (343)
++|.+. +.||+|+||.||+|.+ +++.||||++... ..+.+|+.++ +..+||||+++++++..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 455554 6899999999999998 6789999999631 2456788876 45689999999999875
Q ss_pred -CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC---CCcEEEeccc
Q 019304 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFG 283 (343)
Q Consensus 208 -~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~---~~~vkl~DFg 283 (343)
...+|+||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 567899999999999999998755556999999999999999999999999999999999999997 7899999999
Q ss_pred cccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 284 VARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
+++...........+||+.|+|||++ ....++.++|||+++. +++.+||.+.
T Consensus 210 ~a~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 266 (400)
T 1nxk_A 210 FAKETTSHNSLTTPCYTPYYVAPEVL-----GPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_dssp TCEECC-----------CTTCCGGGS-----CCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred cccccCCCCccccCCCCCCccCHhhc-----CCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 99876554445667899999999999 7888999999996433 4477777543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=285.26 Aligned_cols=195 Identities=26% Similarity=0.481 Sum_probs=163.6
Q ss_pred CCccceecccccccccccccccceEEEEEEE-------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCC
Q 019304 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (343)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 197 (343)
....|+++.++|++++.||+|+||.||+|.+ +++.||||++....... ..+.+.+|+.+++.+ +|||
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~hpn 87 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-----EHRALMSELKILIHIGHHLN 87 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCTT
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHH-----HHHHHHHHHHHHHhhcCCcc
Confidence 3467999999999999999999999999985 34689999997543222 135789999999999 7899
Q ss_pred cceEEEEEEeCC-eEEEEEEecCCCCHHHHHHhhCC--------------------------------------------
Q 019304 198 IVRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRRQN-------------------------------------------- 232 (343)
Q Consensus 198 Iv~l~~~~~~~~-~~~iv~E~~~~gsL~~~l~~~~~-------------------------------------------- 232 (343)
|+++++++.+.. .+++||||+++|+|.+++.....
T Consensus 88 iv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 999999998755 48999999999999999986432
Q ss_pred --------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 233 --------------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 233 --------------------~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 128889999999999999999999999999999999999999999999999998653322
Q ss_pred C---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 293 G---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 293 ~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
. .....||+.|+|||++ ....++.++|||+++.
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~-----~~~~~~~~~Di~slG~ 283 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETI-----FDRVYTIQSDVWSFGV 283 (359)
T ss_dssp TCEEC--CEECGGGCCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred cchhccccCCCceeEChhhh-----cCCCCCchhhhhhHHH
Confidence 1 2334688999999999 6788999999996443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=275.65 Aligned_cols=196 Identities=24% Similarity=0.314 Sum_probs=160.4
Q ss_pred ccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
.++|++.+.||+|+||.||+|.+ +++.||||++........ ..+.+.+|+.+++.++||||+++++++.+...++
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEG----IPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------C----HHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccch----hhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 47899999999999999999998 788999999975433221 2357889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~- 291 (343)
+||||+++ +|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 96 lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEEECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EEEcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 99999975 888888754 345899999999999999999999999999999999999999999999999999865432
Q ss_pred CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 292 EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.......||+.|+|||++. ....++.++|||+++. +++.+||.+
T Consensus 174 ~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 222 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLM----GSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222 (311)
T ss_dssp C---CCCCCCTTCCHHHHT----TCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccCCcccCCcCCHHHhc----CCCCCCchHHhHHHHHHHHHHHhCCCCCCC
Confidence 2344558999999999983 2366899999996333 345566543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=278.73 Aligned_cols=196 Identities=24% Similarity=0.361 Sum_probs=157.8
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-- 209 (343)
.++|++.+.||+|+||.||+|.+ +++.||||++........ ...+.+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP---SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSH---HHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCH---HHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 46789999999999999999997 778999999976544332 23467899999999999999999999987654
Q ss_pred --eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 210 --VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 210 --~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
..|+||||+++++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred CcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 3499999999999999998653 589999999999999999999999999999999999999999999999999986
Q ss_pred cccCC----CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 288 EVQTE----GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 288 ~~~~~----~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
..... .....+||+.|+|||++ ....++.++|||+++. +++.+||.+
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~slG~~l~~ll~g~~pf~~ 221 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQA-----RGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221 (311)
T ss_dssp ----------------CCTTCCHHHH-----HTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccCcCcccCCHHHh-----cCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 54322 12334689999999999 7788999999996433 335566543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=290.54 Aligned_cols=189 Identities=22% Similarity=0.326 Sum_probs=146.7
Q ss_pred ceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 207 (343)
|.+. ++|++++.||+|+||.||+|.+ +++.||||++......... .+++.+|+.+++.++||||+++++++..
T Consensus 49 ~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~ 123 (458)
T 3rp9_A 49 WQIP-DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID----CKRILREIAILNRLNHDHVVKVLDIVIP 123 (458)
T ss_dssp CCSC-TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHH----HHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred CccC-CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHH----HHHHHHHHHHHHhCCCCCCCceEEEEec
Confidence 4443 6799999999999999999987 6789999999765443322 3678999999999999999999999954
Q ss_pred C-----CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 019304 208 R-----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (343)
Q Consensus 208 ~-----~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DF 282 (343)
. ..+|+||||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+||
T Consensus 124 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DF 200 (458)
T 3rp9_A 124 KDVEKFDELYVVLEIAD-SDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDF 200 (458)
T ss_dssp SCTTTCCCEEEEECCCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcccCceEEEEEeccc-cchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeeccc
Confidence 3 56899999984 6999998653 45999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCC----------------------------CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 283 GVARIEVQTE----------------------------GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 283 g~a~~~~~~~----------------------------~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|+|+...... ..+..+||+.|+|||++. ....|+.++|||++++
T Consensus 201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~~~~~~~DiwSlG~ 272 (458)
T 3rp9_A 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL----LQENYTEAIDVWSIGC 272 (458)
T ss_dssp TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHT----TCCCCCTHHHHHHHHH
T ss_pred ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhh----CCCCCCcHhHHHHHHH
Confidence 9998653211 234457899999999762 4667999999996433
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=275.83 Aligned_cols=195 Identities=25% Similarity=0.478 Sum_probs=166.0
Q ss_pred CCccceecccccccccccccccceEEEEEEE-------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCc
Q 019304 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198 (343)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI 198 (343)
....|+++.++|++.+.||+|+||.||+|.+ +++.||||++..... . ...+.+.+|+.+++.++||||
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~----~~~~~~~~E~~~l~~l~hp~i 88 (314)
T 2ivs_A 14 EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-P----SELRDLLSEFNVLKQVNHPHV 88 (314)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC-H----HHHHHHHHHHHHHTTCCCTTB
T ss_pred CCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC-H----HHHHHHHHHHHHHhhCCCCce
Confidence 3467889999999999999999999999986 236899999975432 1 123678999999999999999
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCC----------------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 019304 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN----------------------RAVPLKLAVKQALDVARGMAYVHG 256 (343)
Q Consensus 199 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~----------------------~~~~~~~~~~i~~qi~~gL~yLH~ 256 (343)
+++++++......++||||+++++|.+++..... ..+++..++.++.|++.||.|||+
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 168 (314)
T 2ivs_A 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE 168 (314)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH
T ss_pred eeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999986432 237899999999999999999999
Q ss_pred CCceeCCCCCCcEEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 257 ~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+||+||||||+|||++.++.+||+|||+++....... .....+|+.|+|||.+ ....++.++|||+++.
T Consensus 169 ~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 240 (314)
T 2ivs_A 169 MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESL-----FDHIYTTQSDVWSFGV 240 (314)
T ss_dssp TTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHH-----HHCEECHHHHHHHHHH
T ss_pred CCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhh-----cCCCcCchhhHHHHHH
Confidence 9999999999999999999999999999986543222 2334678999999999 6778999999996433
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=280.88 Aligned_cols=191 Identities=24% Similarity=0.402 Sum_probs=159.7
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||+|.+ +++.||||++....... ..+.+.+|+.+++.++||||+++++++.+....+
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-----CPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc-----hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 6788999999999999999988 67899999997543322 1256889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~- 291 (343)
+||||+++++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp EEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999999998643 45899999999999999999999999999999999999999999999999999864322
Q ss_pred --CCccCCCCCcceecCCCCCCCCCCCCCC-ceeeeeeeccc-----ccccCCC
Q 019304 292 --EGMTPETGTYRWMAPGNSFFSPLPHPSF-EHKWSAKESCL-----KTTWPPP 337 (343)
Q Consensus 292 --~~~~~~~gt~~y~APE~~~~~~~~~~~~-~~~sDi~~~~~-----~~~~~p~ 337 (343)
......+||+.|+|||++ ....+ +.++|||+++. +++.+||
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~~DiwslG~il~~ll~g~~pf 208 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELL-----KRREFHAEPVDVWSCGIVLTAMLAGELPW 208 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHH-----HCSSBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccCCCccCcCccCcHHh-----ccCCCCCCcccHHHHHHHHHHHHhCCCCC
Confidence 223456899999999999 55555 78999996433 3355555
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=282.51 Aligned_cols=194 Identities=18% Similarity=0.255 Sum_probs=165.8
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++.+.||+|+||.||+|.. +++.||+|++...... ....+.+|+.+++.++||||+++++++.+...+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL------DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH------HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh------hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence 36789999999999999999998 6789999999754311 124688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC--CCcEEEeccccccccc
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA--DKSIKIADFGVARIEV 289 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~--~~~vkl~DFg~a~~~~ 289 (343)
++||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 124 ~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 9999999999999998653 345899999999999999999999999999999999999974 5789999999998765
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
........+||+.|+|||++ ....++.++|||++++ +++.+||.+
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 252 (387)
T 1kob_A 203 PDEIVKVTTATAEFAAPEIV-----DREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252 (387)
T ss_dssp TTSCEEEECSSGGGCCHHHH-----TTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CCcceeeeccCCCccCchhc-----cCCCCCCcccEeeHhHHHHHHHhCCCCCCC
Confidence 54444556899999999999 7788999999996433 346666654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=294.75 Aligned_cols=198 Identities=23% Similarity=0.363 Sum_probs=167.8
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
+..++|.+++.||+|+||.||+|++ +|+.||||++.+.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR---SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH---HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4457899999999999999999998 6889999999642211 1112357889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
.+++||||+++++|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999999999653 459999999999999999999999999999999999999999999999999998766
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCC-ceeeeeeeccc-----ccccCCCCc
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSF-EHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~-~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
........+||+.|+|||++ ....+ +.++|||+++. +++.+||..
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 218 (476)
T 2y94_A 168 DGEFLRTSCGSPNYAAPEVI-----SGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218 (476)
T ss_dssp TTCCBCCCCSCSTTCCHHHH-----TTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccccccCCCcCeEChhhc-----cCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence 55555667899999999999 55555 68999996333 345666543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=281.14 Aligned_cols=191 Identities=23% Similarity=0.349 Sum_probs=148.2
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++.+.||+|+||.||+|.+ +++.||||++..... .+.+.+|+.+++.++||||+++++++.....+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--------KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh--------HHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence 36788999999999999999998 567899999975431 24678999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC---CCcEEEecccccccc
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIE 288 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~---~~~vkl~DFg~a~~~ 288 (343)
++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 124 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999999999653 45899999999999999999999999999999999999975 889999999999876
Q ss_pred ccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 289 VQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.........+||+.|+|||++ ....++.++|||+++. +++.+||..
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~ 252 (349)
T 2w4o_A 202 EHQVLMKTVCGTPGYCAPEIL-----RGCAYGPEVDMWSVGIITYILLCGFEPFYD 252 (349)
T ss_dssp -----------CGGGSCHHHH-----TTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CcccccccccCCCCccCHHHh-----cCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 554445566899999999999 7778999999996433 335566543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=283.95 Aligned_cols=192 Identities=26% Similarity=0.394 Sum_probs=161.3
Q ss_pred cceecccccccccccccccceEEEEEEE-------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceE
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l 201 (343)
.+++..++|++.+.||+|+||.||+|.+ +++.||||++....... ....+.+|+.+++.++||||+++
T Consensus 65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~ 139 (367)
T 3l9p_A 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ-----DELDFLMEALIISKFNHQNIVRC 139 (367)
T ss_dssp SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHH-----HHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChh-----hHHHHHHHHHHHHhCCCCCCCeE
Confidence 3567788999999999999999999985 34689999996433221 23568899999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCCHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC-
Q 019304 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQN-----RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK- 275 (343)
Q Consensus 202 ~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~- 275 (343)
++++......++||||+++++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 140 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 219 (367)
T 3l9p_A 140 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 219 (367)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST
T ss_pred EEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCC
Confidence 9999999999999999999999999987542 3588999999999999999999999999999999999999554
Q ss_pred --cEEEeccccccccccCC---CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 276 --SIKIADFGVARIEVQTE---GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 276 --~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.+||+|||+++...... ......||+.|+|||++ ....++.++|||+++.
T Consensus 220 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~-----~~~~~~~~~DvwslG~ 274 (367)
T 3l9p_A 220 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAF-----MEGIFTSKTDTWSFGV 274 (367)
T ss_dssp TCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred CceEEECCCccccccccccccccCCCcCCcccEECHHHh-----cCCCCCcHHHHHHHHH
Confidence 59999999998543322 22334689999999999 6788999999996443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=267.69 Aligned_cols=189 Identities=26% Similarity=0.498 Sum_probs=165.1
Q ss_pred cceecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 207 (343)
+|.++.++|++.+.||+|+||.||+|.+ +++.||+|++....... +.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~ 74 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-------EDFIEEAEVMMKLSHPKLVQLYGVCLE 74 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH-------HHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH-------HHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 6889999999999999999999999998 67789999997654432 468899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
....++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 153 (267)
T 3t9t_A 75 QAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153 (267)
T ss_dssp SSSCEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred CCCeEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccc
Confidence 99999999999999999999764 34589999999999999999999999999999999999999999999999999986
Q ss_pred cccCC--CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 288 EVQTE--GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 288 ~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
..... ......+++.|+|||++ ....++.++|+|+++.
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 193 (267)
T 3t9t_A 154 VLDDQYTSSTGTKFPVKWASPEVF-----SFSRYSSKSDVWSFGV 193 (267)
T ss_dssp BCCHHHHSTTSTTCCGGGCCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred cccccccccccccccccccChhhh-----cCCCccchhchhhhHH
Confidence 43321 22344678899999999 6778899999996443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=273.89 Aligned_cols=190 Identities=22% Similarity=0.378 Sum_probs=162.8
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
.|...+.||+|+||.||+|+. +|+.||||++....... .+.+.+|+.+++.++||||+++++++......++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 119 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR------RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWV 119 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS------HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH------HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEE
Confidence 456667899999999999998 68899999997654432 2468899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~- 292 (343)
||||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 120 v~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 120 LMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp EECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred EEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc
Confidence 9999999999999864 358999999999999999999999999999999999999999999999999988654432
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
......||+.|+|||++ ....++.++|||+++. +++.+||..
T Consensus 197 ~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~slG~il~el~~g~~pf~~ 243 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVI-----SRSLYATEVDIWSLGIMVIEMVDGEPPYFS 243 (321)
T ss_dssp CBCCCCSCGGGCCHHHH-----TTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccCCccccCHhhh-----cCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 33456899999999999 7788999999996433 335566543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=275.13 Aligned_cols=190 Identities=24% Similarity=0.399 Sum_probs=156.1
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC---CCCCcceEEEEEEe
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACRK 207 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~ 207 (343)
..++|++.+.||+|+||.||+|++ +++.||||++.......... .....+.+|+.+++.+ +||||+++++++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGG-GLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSS-CCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccccc-ccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 347899999999999999999996 78899999987433211100 0012455677776666 49999999999987
Q ss_pred CC-----eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 019304 208 RM-----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (343)
Q Consensus 208 ~~-----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DF 282 (343)
.. .+++||||++ ++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 65 5899999997 59999998766566999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 283 GVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 283 g~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
|+++...........+||+.|+|||++ ....++.++|||+++
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG 206 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVL-----LQSTYATPVDMWSVG 206 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHH-----HTSCCCSTHHHHHHH
T ss_pred ccccccCCCcccCCccccccccCchHH-----cCCCCCchHHHHHHH
Confidence 999876655555667899999999999 778899999999633
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=274.25 Aligned_cols=195 Identities=23% Similarity=0.346 Sum_probs=149.1
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++.+.||+|+||.||+|.. +++.||||++......... +.+.+|+.+++.++||||+++++++...+.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-----~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP-----STAIREISLMKELKHENIVRLYDVIHTENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSC-----HHHHHHHHHHTTCCBTTBCCEEEEECCTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccH-----HHHHHHHHHHHhcCCCCcceEEEEEEECCeE
Confidence 36788999999999999999987 6889999999765432211 4678999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 212 CIVTEYAKGGSVRQFLTRRQ----NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
++||||++ ++|.+++.... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 99999997 59999987542 23588999999999999999999999999999999999999999999999999986
Q ss_pred cccC-CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 288 EVQT-EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 288 ~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.... .......||+.|+|||++. ....++.++|||+++. +++.+||.
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~el~~g~~pf~ 210 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLM----GSRTYSTSIDIWSCGCILAEMITGKPLFP 210 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHT----TCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCCCcccCCCCcccccccCchHhh----CCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 5432 2334568999999999982 2356899999996433 34556653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=270.05 Aligned_cols=188 Identities=20% Similarity=0.345 Sum_probs=158.6
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||+|.. +++.||+|++..............+.+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 5788999999999999999998 57899999998655432211112357889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC----cEEEecccccccc
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK----SIKIADFGVARIE 288 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~----~vkl~DFg~a~~~ 288 (343)
+||||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++..
T Consensus 85 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 9999999999999997643 489999999999999999999999999999999999998877 8999999999876
Q ss_pred ccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 289 VQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
..........||+.|+|||.+ ....++.++|+|+++
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG 198 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEIV-----NYEPLGLEADMWSIG 198 (283)
T ss_dssp C--------CCCGGGCCHHHH-----TTCCCCTHHHHHHHH
T ss_pred cCCCcccccCCCcCccCccee-----cCCCCCcchhhhhHH
Confidence 554445556799999999999 778899999999643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=271.75 Aligned_cols=190 Identities=29% Similarity=0.501 Sum_probs=163.4
Q ss_pred ccceecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
++|+++.++|++.+.||+|+||.||+|.+ +++.||||++....... +.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~ 78 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-------DAFLAEANLMKQLQHQRLVRLYAVVT 78 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH-------HHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccH-------HHHHHHHHHHHhCCCcCcceEEEEEc
Confidence 67999999999999999999999999998 45689999997654332 46889999999999999999999987
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
.. ..++||||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+++
T Consensus 79 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 79 QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157 (279)
T ss_dssp SS-SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CC-CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccc
Confidence 54 57899999999999999975433358999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCC--ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 287 IEVQTEG--MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 287 ~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
....... .....+++.|+|||.+ ....++.++|+|+++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 198 (279)
T 1qpc_A 158 LIEDNEYTAREGAKFPIKWTAPEAI-----NYGTFTIKSDVWSFGI 198 (279)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHH-----HHCEECHHHHHHHHHH
T ss_pred cccCcccccccCCCCccCccChhhh-----ccCCCCchhhhHHHHH
Confidence 6543321 2234578899999999 6778999999996443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=288.40 Aligned_cols=193 Identities=25% Similarity=0.369 Sum_probs=160.8
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++++.||+|+||.||+|+. +++.||||++......... ...+.+|+.+++.++||||+++++++.+...+|
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS----NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT----THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH----HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 5789999999999999999998 6789999999865433222 246889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC---CCcEEEeccccccccc
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIEV 289 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~---~~~vkl~DFg~a~~~~ 289 (343)
+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 113 lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999999999997653 4899999999999999999999999999999999999975 4569999999998776
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
........+||+.|+|||++ . ..++.++|||+++. +++.+||.+
T Consensus 191 ~~~~~~~~~gt~~y~aPE~l-----~-~~~~~~~DiwslG~il~~ll~g~~pf~~ 239 (494)
T 3lij_A 191 NQKKMKERLGTAYYIAPEVL-----R-KKYDEKCDVWSIGVILFILLAGYPPFGG 239 (494)
T ss_dssp TTBCBCCCCSCTTTCCHHHH-----T-TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCccccccCCCcCeeCHHHH-----c-ccCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 65556677899999999988 3 46999999996333 446677654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=272.14 Aligned_cols=194 Identities=25% Similarity=0.312 Sum_probs=158.1
Q ss_pred cccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
++|++.+.||+|+||.||+|.. +++.||||++......... .+.+.+|+.+++.++||||+++++++.....+++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI----PSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCC----CHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccccc----chhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEE
Confidence 5788999999999999999998 5889999999754432211 2467899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-C
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-E 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~-~ 292 (343)
||||+++ +|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 78 v~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 78 VFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 9999975 999998753 345899999999999999999999999999999999999999999999999999865432 2
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
......||+.|+|||++. ....++.++|||+++. +++.+||.
T Consensus 156 ~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~ 202 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLM----GSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (288)
T ss_dssp ------CCCTTCCHHHHT----TCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccCchhee----CCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 334457899999999983 2356899999996433 34556654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=273.42 Aligned_cols=199 Identities=24% Similarity=0.311 Sum_probs=157.4
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhH--------------------HHHHHHHHHHHHHH
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEK--------------------AQVMEQQFQQEVMM 189 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~--------------------~~~~~~~~~~E~~~ 189 (343)
+..++|++.+.||+|+||.||+|.. +++.||||++......... .....+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 4457899999999999999999987 6789999999765432110 01123568899999
Q ss_pred HhcCCCCCcceEEEEEEe--CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q 019304 190 LATLKHLNIVRFIGACRK--RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSD 267 (343)
Q Consensus 190 l~~l~h~nIv~l~~~~~~--~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~ 267 (343)
++.++||||+++++++.+ ...+++||||+++++|.+++. ...+++..++.++.|++.||+|||++||+||||||+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 999999999999999987 568899999999999987653 346899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeccccccccccCC-CccCCCCCcceecCCCCCCCCCCCCC---Cceeeeeeeccc-----ccccCCCC
Q 019304 268 NLLISADKSIKIADFGVARIEVQTE-GMTPETGTYRWMAPGNSFFSPLPHPS---FEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 268 NILv~~~~~vkl~DFg~a~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~---~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
|||++.++.+||+|||+++...... ......||+.|+|||.+ .... ++.++|||+++. +++.+||.
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESL-----SETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGC-----CTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhh-----ccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 9999999999999999998654332 23456899999999998 4433 478899996433 33555654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=282.82 Aligned_cols=199 Identities=26% Similarity=0.441 Sum_probs=155.7
Q ss_pred ceecccccccccccccccceEEEEEEEC-----CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEE
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 204 (343)
.+++.++|++.+.||+|+||.||+|++. +..||||+++..... ...+.|.+|+.++++++||||++++++
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~ 114 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE-----KQRRDFLGEASIMGQFDHPNIIRLEGV 114 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH-----HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 3567789999999999999999999863 567999999754321 123679999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccc
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~ 284 (343)
+......++||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 115 VTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EeeCCceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcc
Confidence 99999999999999999999999754 34689999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----cc-ccCCCCc
Q 019304 285 ARIEVQTEG----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KT-TWPPPWR 339 (343)
Q Consensus 285 a~~~~~~~~----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~-~~~p~~~ 339 (343)
++....... .....+++.|+|||++ ....++.++|||+++. ++ +.+||+.
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~ 253 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAI-----AYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253 (373)
T ss_dssp --------------------CTTSCHHHH-----HHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT
T ss_pred ccccccCCccceeccCCCcCCCccChhhh-----ccCCcCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence 986543221 1122457889999999 7788999999996443 22 4556553
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=285.20 Aligned_cols=186 Identities=22% Similarity=0.288 Sum_probs=156.1
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC---
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--- 208 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--- 208 (343)
.++|++.+.||+|+||.||+|.+ +++.||||++........ ..+++.+|+.+++.++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI----DCKRILREITILNRLKSDYIIRLYDLIIPDDLL 100 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHH----HHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChH----HHHHHHHHHHHHHHcCCCCcceEEEEEecCCCC
Confidence 36899999999999999999988 678999999976544332 236789999999999999999999999776
Q ss_pred --CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 209 --MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 209 --~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
..+|+||||++ ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+
T Consensus 101 ~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 101 KFDELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cCCeEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 56899999996 5999999653 458999999999999999999999999999999999999999999999999998
Q ss_pred ccccCC-----------------------CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 287 IEVQTE-----------------------GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 287 ~~~~~~-----------------------~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
...... ..+..+||+.|+|||++. ....++.++|||++++
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~----~~~~~~~~~DiwSlG~ 240 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL----LQENYTKSIDIWSTGC 240 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHT----TCSCCCTHHHHHHHHH
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHh----cCCCCCcccccchHHH
Confidence 654321 235568999999999863 5667999999996443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=276.39 Aligned_cols=191 Identities=24% Similarity=0.254 Sum_probs=162.6
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCe
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMV 210 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 210 (343)
.++|++.+.||+|+||.||+|.. +++.||||++...... +.+.+|+.+++.+ +||||+++++++.....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--------PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS--------CCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch--------HHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence 46789999999999999999996 7889999999765432 2477999999999 99999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc-----EEEeccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS-----IKIADFGVA 285 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~-----vkl~DFg~a 285 (343)
.++||||+ +++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred cEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 99999999 89999999864 356999999999999999999999999999999999999998887 999999999
Q ss_pred cccccCCC--------ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 286 RIEVQTEG--------MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 286 ~~~~~~~~--------~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
+....... ....+||+.|+|||++ ....++.++|||+++. +++.+||.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~slG~il~ell~g~~Pf~~ 219 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTH-----LGKEQSRRDDLEALGHMFMYFLRGSLPWQG 219 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH-----TTCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHH-----cCCCCCchhHHHHHHHHHHHHhcCCCCccc
Confidence 86543221 2356899999999999 7888999999996433 335566543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=279.72 Aligned_cols=194 Identities=24% Similarity=0.328 Sum_probs=151.6
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCC-
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRM- 209 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~- 209 (343)
.++|++.+.||+|+||.||+|.+ +++.||||++......... .+++.+|+.+++.+. ||||+++++++...+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTD----AQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHH----HHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHH----HHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 46899999999999999999987 6889999999765444332 357789999999997 999999999997654
Q ss_pred -eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 210 -VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 210 -~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
.+|+||||++ ++|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred CEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 6899999997 5899998763 5899999999999999999999999999999999999999999999999999864
Q ss_pred cc----------------------CCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 289 VQ----------------------TEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 289 ~~----------------------~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.. ....+..+||+.|+|||++. ....++.++|||++++ +++.+||.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL----GSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHT----TCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhc----CCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 32 11234458999999999983 2367999999996333 446677654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=273.98 Aligned_cols=189 Identities=26% Similarity=0.473 Sum_probs=156.2
Q ss_pred ceecccccccccccccccceEEEEEEE------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEE
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~ 203 (343)
.++..++|++.+.||+|+||.||+|++ +++.||||++.... . ...+.+.+|+.+++.++||||+++++
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~----~~~~~~~~E~~~l~~l~h~~iv~~~~ 78 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--E----EHLRDFEREIEILKSLQHDNIVKYKG 78 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--H----HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--H----HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 346678999999999999999999985 57889999996432 1 12357899999999999999999999
Q ss_pred EEEeC--CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEec
Q 019304 204 ACRKR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (343)
Q Consensus 204 ~~~~~--~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~D 281 (343)
++... ..+++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|
T Consensus 79 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~D 157 (295)
T 3ugc_A 79 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGD 157 (295)
T ss_dssp EECHHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred EEecCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEcc
Confidence 98653 45899999999999999997643 3589999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCC----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 282 FGVARIEVQTEG----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 282 Fg~a~~~~~~~~----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
||+++....... .....+++.|+|||.+ ....++.++|||+++.
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 205 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESL-----TESKFSVASDVWSFGV 205 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred CcccccccCCcceeeeccCCCCccceeCcHHh-----cCCCCChHHHHHHHHH
Confidence 999986543321 2234577889999999 7778999999996443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=274.53 Aligned_cols=195 Identities=25% Similarity=0.421 Sum_probs=165.9
Q ss_pred CCccceecccccccccccccccceEEEEEEEC-------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCc
Q 019304 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198 (343)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI 198 (343)
..++|++..++|++.+.||+|+||.||+|.+. ++.||||++....... ....+.+|+.+++.++||||
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i 90 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-----ERIEFLNEASVMKEFNCHHV 90 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH-----HHHHHHHHHHHGGGCCCTTB
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHH-----HHHHHHHHHHHHHhcCCCCE
Confidence 45789999999999999999999999999763 5689999997543221 23568899999999999999
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEE
Q 019304 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270 (343)
Q Consensus 199 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NIL 270 (343)
+++++++......++||||+++++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+|||
T Consensus 91 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIl 170 (322)
T 1p4o_A 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 170 (322)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEE
T ss_pred eeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEE
Confidence 999999999999999999999999999997532 135689999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 271 ISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 271 v~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
++.++.+||+|||+++....... .....+|+.|+|||.+ ....++.++|||+++.
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 228 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL-----KDGVFTTYSDVWSFGV 228 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhh-----ccCCCCchhhHHHHHH
Confidence 99999999999999986543221 2233578999999999 6778999999996443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=275.72 Aligned_cols=197 Identities=18% Similarity=0.234 Sum_probs=166.8
Q ss_pred ccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-----CCCcce
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-----HLNIVR 200 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~nIv~ 200 (343)
.+..+-.++|++.+.||+|+||.||+|.+ +++.||||++.... ...+.+..|+.+++.++ ||||++
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-------KYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-------HHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-------hhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 34445568899999999999999999998 77899999996421 12356778999999886 999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-------
Q 019304 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA------- 273 (343)
Q Consensus 201 l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~------- 273 (343)
+++++......++||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEE
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccc
Confidence 999999999999999999 889999998776667999999999999999999999999999999999999975
Q ss_pred ------------------CCcEEEeccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----
Q 019304 274 ------------------DKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL----- 330 (343)
Q Consensus 274 ------------------~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~----- 330 (343)
++.+||+|||+++.... ......||+.|+|||++ ....++.++|||++++
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVI-----LNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHH-----TTCCCCTTHHHHHHHHHHHHH
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHH-----cCCCCCCccchHHHHHHHHHH
Confidence 78999999999986433 33456899999999999 7788999999996333
Q ss_pred ccccCCCCc
Q 019304 331 KTTWPPPWR 339 (343)
Q Consensus 331 ~~~~~p~~~ 339 (343)
+++.+||..
T Consensus 253 l~g~~pf~~ 261 (360)
T 3llt_A 253 YTGSLLFRT 261 (360)
T ss_dssp HHSSCSCCC
T ss_pred HHCCCCCCC
Confidence 335566543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=288.93 Aligned_cols=195 Identities=24% Similarity=0.417 Sum_probs=163.2
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++.+.||+|+||.||+|.. +++.||||++......... .+.+.+|+.+++.++||||+++++++.+...+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD----TSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSC----HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchH----HHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence 36789999999999999999998 6889999998643211111 25688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc---CCCcEEEecccccccc
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS---ADKSIKIADFGVARIE 288 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~---~~~~vkl~DFg~a~~~ 288 (343)
++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999999999997653 489999999999999999999999999999999999995 4568999999999876
Q ss_pred ccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 289 VQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
.........+||+.|+|||++ . +.++.++|||+++. +++.+||.+.
T Consensus 175 ~~~~~~~~~~gt~~y~aPE~~-----~-~~~~~~~DiwslG~il~~ll~g~~pf~~~ 225 (486)
T 3mwu_A 175 QQNTKMKDRIGTAYYIAPEVL-----R-GTYDEKCDVWSAGVILYILLSGTPPFYGK 225 (486)
T ss_dssp CCC----CCTTGGGGCCGGGG-----G-SCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCCccCCCcCCCCCCCHHHh-----C-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 655556667899999999998 3 35899999996333 4467777543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=291.45 Aligned_cols=192 Identities=22% Similarity=0.258 Sum_probs=156.1
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC---
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--- 208 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--- 208 (343)
.++|++++.||+|+||.||+|.+ +++.||||++....... ...+++.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ----THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSH----HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccCh----HHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc
Confidence 57899999999999999999988 68899999997653332 2246788999999999999999999999655
Q ss_pred ---CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 209 ---MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 209 ---~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
..+|+||||+++ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 137 ~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 137 EEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred ccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 357999999976 57777642 3889999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 286 RIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
+........+..+||+.|+|||++ ....|+.++|||+++. +++.+||-+
T Consensus 212 ~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG~il~ell~g~~pF~g 265 (464)
T 3ttj_A 212 RTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENVDIWSVGCIMGEMVRHKILFPG 265 (464)
T ss_dssp -----CCCC----CCCTTCCHHHH-----TTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eecCCCcccCCCcccccccCHHHH-----cCCCCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 877665556677999999999999 6778999999996333 335566643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=265.92 Aligned_cols=190 Identities=23% Similarity=0.337 Sum_probs=163.4
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||+|.+ ++..||+|++....... .+.+.+|+.+++.++||||+++++++.+....+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED------VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC------HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch------HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 5788999999999999999998 55689999997644332 246889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE---cCCCcEEEeccccccccc
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIEV 289 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv---~~~~~vkl~DFg~a~~~~ 289 (343)
+||||+++++|.+++.... .+++..++.++.|++.||+|||++|++||||||+|||+ +.++.+||+|||++....
T Consensus 83 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999999999997653 48999999999999999999999999999999999999 788999999999998766
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.........||+.|+|||.+ .. .++.++|+|+++. +++.+||.
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~-----~~-~~~~~~Di~slG~~l~~l~~g~~p~~ 208 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVL-----EG-LYGPECDEWSAGVMMYVLLCGYPPFS 208 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHH-----TT-CBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CccchhccCCCCCccChHHh-----cc-cCCchhhehhHHHHHHHHHHCCCCCC
Confidence 55555667899999999988 33 4899999996433 33555553
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=274.80 Aligned_cols=196 Identities=23% Similarity=0.399 Sum_probs=165.2
Q ss_pred cccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
..++|++.+.||+|+||.||+|.+ +++.||||++....... .+.+.+|+.+++.++||||+++++++......
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG------IEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSH------HHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHH------HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 457899999999999999999998 67899999987654322 25788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 212 CIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
++||||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+++...
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 99999999999999986533 2358999999999999999999999999999999999999999999999999998643
Q ss_pred cCC---CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 290 QTE---GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 290 ~~~---~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
... ......||+.|+|||++ ....++.++|||+++. +++.+||..
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~slG~il~ell~g~~p~~~ 243 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYF-----IKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHH-----HHCBCCTHHHHHHHHHHHHHHHHCCTTCSC
T ss_pred cccccccccccCCCccccCHHHh-----cCCCCCcccchHhHHHHHHHHHhCCCcccc
Confidence 221 22334689999999999 6778999999996433 345566654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=270.17 Aligned_cols=191 Identities=25% Similarity=0.449 Sum_probs=151.1
Q ss_pred CccceecccccccccccccccceEEEEEEEC-----CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceE
Q 019304 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (343)
Q Consensus 127 ~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l 201 (343)
..+|++..++|++.+.||+|+||.||+|.+. +..||+|++..... ....+.+.+|+.+++.++||||+++
T Consensus 7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~ 81 (281)
T 1mp8_A 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-----DSVREKFLQEALTMRQFDHPHIVKL 81 (281)
T ss_dssp --CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-----HHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred ccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC-----HHHHHHHHHHHHHHHhCCCCccceE
Confidence 3567889999999999999999999999872 34699999865332 1223678999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEec
Q 019304 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (343)
Q Consensus 202 ~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~D 281 (343)
++++.+ +..++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|
T Consensus 82 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D 159 (281)
T 1mp8_A 82 IGVITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD 159 (281)
T ss_dssp EEEECS-SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred EEEEcc-CccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECc
Confidence 999854 5678999999999999999764 34589999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCC--ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 282 FGVARIEVQTEG--MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 282 Fg~a~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
||+++....... .....+|+.|+|||.+ ....++.++|+|+++
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG 204 (281)
T 1mp8_A 160 FGLSRYMEDSTYYKASKGKLPIKWMAPESI-----NFRRFTSASDVWMFG 204 (281)
T ss_dssp -------------------CCGGGCCHHHH-----HHCCCSHHHHHHHHH
T ss_pred cccccccCcccccccccCCCcccccChhhc-----ccCCCCCccCchHHH
Confidence 999986544322 2233577899999999 677899999999644
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=281.26 Aligned_cols=190 Identities=21% Similarity=0.303 Sum_probs=157.4
Q ss_pred ccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEE
Q 019304 138 NMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (343)
Q Consensus 138 ~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~ 215 (343)
...+.||+|+||.||+|.. +++.||+|++...... ..+.+.+|+.+++.++||||+++++++.....+++||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 165 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK------DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHH------HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc------cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 3467899999999999988 6889999999764321 2357899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE--cCCCcEEEeccccccccccCCC
Q 019304 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI--SADKSIKIADFGVARIEVQTEG 293 (343)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv--~~~~~vkl~DFg~a~~~~~~~~ 293 (343)
||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 166 E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~ 244 (373)
T 2x4f_A 166 EYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244 (373)
T ss_dssp ECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred eCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence 999999999998753 2358999999999999999999999999999999999999 5678999999999987665555
Q ss_pred ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 294 MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 294 ~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
....+||+.|+|||++ ....++.++|||++++ +++.+||.+
T Consensus 245 ~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~elltg~~pf~~ 290 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVV-----NYDFVSFPTDMWSVGVIAYMLLSGLSPFLG 290 (373)
T ss_dssp CCCCCSSCTTCCHHHH-----TTCBCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cccccCCCcEeChhhc-----cCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 5566899999999999 7788999999996433 335566643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=275.95 Aligned_cols=196 Identities=29% Similarity=0.487 Sum_probs=165.7
Q ss_pred CCCccceecccccccccccccccceEEEEEEE---------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-C
Q 019304 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY---------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-K 194 (343)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 194 (343)
.....|+++.++|++++.||+|+||.||+|.+ ++..||||++...... ...+.+.+|+.+++.+ +
T Consensus 25 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~~ 99 (334)
T 2pvf_A 25 PEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-----KDLSDLVSEMEMMKMIGK 99 (334)
T ss_dssp CCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH-----HHHHHHHHHHHHHHHHCC
T ss_pred CCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH-----HHHHHHHHHHHHHHHhhc
Confidence 34567899999999999999999999999986 2457999999754321 1235788999999999 8
Q ss_pred CCCcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 019304 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------------RAVPLKLAVKQALDVARGMAYVHGLGFI 260 (343)
Q Consensus 195 h~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~gL~yLH~~gii 260 (343)
||||+++++++.....+++||||+++++|.+++..... ..+++..++.++.|++.||+|||++||+
T Consensus 100 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 179 (334)
T 2pvf_A 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI 179 (334)
T ss_dssp CTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred CCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 99999999999999999999999999999999986432 2488999999999999999999999999
Q ss_pred eCCCCCCcEEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 261 HrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
||||||+|||++.++.+||+|||+++....... .....+|+.|+|||++ ....++.++|||+++.
T Consensus 180 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 247 (334)
T 2pvf_A 180 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGV 247 (334)
T ss_dssp CSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHH-----HHCEECHHHHHHHHHH
T ss_pred CCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHh-----cCCCcChHHHHHHHHH
Confidence 999999999999999999999999986543321 2334678999999999 6778999999996443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=269.05 Aligned_cols=194 Identities=25% Similarity=0.445 Sum_probs=162.1
Q ss_pred CCccceecccccccccccccccceEEEEEEE------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcc
Q 019304 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199 (343)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv 199 (343)
..+...+..++|++.+.||+|+||.||+|++ +++.||||++........ .+.+.+|+.+++.++||||+
T Consensus 12 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~ 86 (302)
T 4e5w_A 12 EVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH-----IADLKKEIEILRNLYHENIV 86 (302)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CC-----HHHHHHHHHHHHTCCCTTBC
T ss_pred ecChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchh-----HHHHHHHHHHHHhCCCCCee
Confidence 3455566778899999999999999999984 678999999975432221 25688999999999999999
Q ss_pred eEEEEEEeC--CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcE
Q 019304 200 RFIGACRKR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277 (343)
Q Consensus 200 ~l~~~~~~~--~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~v 277 (343)
++++++... ..+++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~ 165 (302)
T 4e5w_A 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQV 165 (302)
T ss_dssp CEEEEEEC---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred eeeeEEecCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCE
Confidence 999999876 66899999999999999997643 458999999999999999999999999999999999999999999
Q ss_pred EEeccccccccccCC----CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 278 KIADFGVARIEVQTE----GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 278 kl~DFg~a~~~~~~~----~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
||+|||+++...... ......||+.|+|||.+ ....++.++|+|+++.
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 217 (302)
T 4e5w_A 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL-----MQSKFYIASDVWSFGV 217 (302)
T ss_dssp EECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHH-----HHCEEEHHHHHHHHHH
T ss_pred EECcccccccccCCCcceeccCCCCCCccccCCeee-----cCCCCCcchhHHHHHH
Confidence 999999998654432 12345688999999999 7788999999996444
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=270.62 Aligned_cols=196 Identities=31% Similarity=0.566 Sum_probs=152.2
Q ss_pred CCccceecccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
..+.+++..++|++.+.||+|+||.||+|.+.+ .||||+++........ .+.+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILLFMGYS 89 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHH----HHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHH----HHHHHHHHHHHHhCCCCcEEEEEeec
Confidence 457788999999999999999999999998755 5999999766544332 36789999999999999999999965
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
.....++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 90 -~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 167 (289)
T 3og7_A 90 -TAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167 (289)
T ss_dssp -CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred -cCCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceec
Confidence 445678999999999999999653 345899999999999999999999999999999999999999999999999999
Q ss_pred cccccC---CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 286 RIEVQT---EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 286 ~~~~~~---~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+..... .......||+.|+|||.+... ....++.++|||+++.
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~Di~slG~ 213 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQ--DSNPYSFQSDVYAFGI 213 (289)
T ss_dssp ----------------CCCTTCCHHHHC------CCSCHHHHHHHHHH
T ss_pred cccccccccccccccCCCccccCchhhccc--CCCCCCcccchHHHHH
Confidence 754331 223445799999999998211 2677899999996433
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=268.58 Aligned_cols=193 Identities=24% Similarity=0.341 Sum_probs=158.2
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|.+.+.||+|+||.||++.. +++.||+|++........ .+.+.+|+.+++.++||||+++++++.+....+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-----MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC-----HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh-----HHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence 6788999999999999999998 678999999976543322 256889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE---cCCCcEEEeccccccc
Q 019304 213 IVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARI 287 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv---~~~~~vkl~DFg~a~~ 287 (343)
+||||+++++|.+++... ....+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999999998643 23569999999999999999999999999999999999999 4567899999999987
Q ss_pred cccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 288 EVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
...........||+.|+|||.+ . ..++.++|+|+++. +++.+||.
T Consensus 177 ~~~~~~~~~~~~t~~y~aPE~~-----~-~~~~~~~Di~slG~il~~ll~g~~pf~ 226 (285)
T 3is5_A 177 FKSDEHSTNAAGTALYMAPEVF-----K-RDVTFKCDIWSAGVVMYFLLTGCLPFT 226 (285)
T ss_dssp ----------CTTGGGCCHHHH-----T-TCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCcccCcCcccccCcCChHHh-----c-cCCCcccCeehHHHHHHHHHhCCCCCC
Confidence 6555555667899999999988 3 46889999996433 33555554
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=274.14 Aligned_cols=203 Identities=22% Similarity=0.372 Sum_probs=171.1
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCC--ChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPEN--NPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM 209 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 209 (343)
.+|++.+.||+|+||.||+|.+ +|+.||||++..... .........+.+.+|+.+++.+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5788999999999999999998 588999999976543 2233344557789999999999 7999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
..++||||+++++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 9999999999999999998653 48999999999999999999999999999999999999999999999999998766
Q ss_pred cCCCccCCCCCcceecCCCCCCCC-CCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSP-LPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~-~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
........+||+.|+|||++.+.. .....++.++|||+++. +++.+||+.
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 307 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence 555556678999999999883211 12456899999996433 346677754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=286.45 Aligned_cols=198 Identities=21% Similarity=0.375 Sum_probs=163.6
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChh-------HHHHHHHHHHHHHHHHhcCCCCCcceEEEE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPE-------KAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 204 (343)
.++|++++.||+|+||.||+|.. +++.||||++........ ......+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 36788999999999999999998 578999999976543211 001123678999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC---cEEEec
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SIKIAD 281 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~---~vkl~D 281 (343)
+.+...+++||||+++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 999999999999999999999997653 489999999999999999999999999999999999998765 699999
Q ss_pred cccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 282 FGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 282 Fg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
||+++...........+||+.|+|||++ . ..++.++|||+++. +++.+||.+
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~-----~-~~~~~~~DiwslG~il~~ll~g~~pf~~ 249 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVL-----K-KKYNEKCDVWSCGVIMYILLCGYPPFGG 249 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHH-----T-TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHh-----c-cCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999877665556677899999999998 4 46999999996333 446677654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=299.31 Aligned_cols=201 Identities=22% Similarity=0.248 Sum_probs=166.6
Q ss_pred cceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGAC 205 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 205 (343)
...+..++|++.+.||+|+||.||+|.+ +++.||||++++.... .....+.+.+|..++..+ +||+|+++++++
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~---~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~ 411 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI---QDDDVECTMVEKRVLALPGKPPFLTQLHSCF 411 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH---HTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc---cHHHHHHHHHHHHHHHhccCCCeEEEEEEEE
Confidence 3456678999999999999999999998 5678999999742110 011124678899999988 799999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
.+...+|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|
T Consensus 412 ~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 412 QTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp BCSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred EeCCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeeccee
Confidence 99999999999999999999998754 4999999999999999999999999999999999999999999999999999
Q ss_pred cccc-cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 286 RIEV-QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 286 ~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
+... ........+||+.|+|||++ ....|+.++|+|++.. +++.+||.+
T Consensus 490 ~~~~~~~~~~~~~~GT~~Y~APE~l-----~~~~~~~~~DvwSlGvilyelltG~~Pf~~ 544 (674)
T 3pfq_A 490 KENIWDGVTTKTFCGTPDYIAPEII-----AYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544 (674)
T ss_dssp EECCCTTCCBCCCCSCSSSCCHHHH-----TCCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eccccCCcccccccCCCcccCHhhh-----cCCCCCccceEechHHHHHHHHcCCCCCCC
Confidence 8533 23344567899999999999 7889999999996433 346677654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=278.39 Aligned_cols=197 Identities=20% Similarity=0.290 Sum_probs=164.4
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhH--HHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEK--AQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 210 (343)
++|++.+.||+|+||.||+|.+ +++.||||++......... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 6789999999999999999987 7889999999875432210 00011356789999999999999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 211 WCIVTEYAKGG-SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 211 ~~iv~E~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
+++||||+.+| +|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 99999999766 999999754 359999999999999999999999999999999999999999999999999998766
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCC-ceeeeeeeccc-----ccccCCCC
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSF-EHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~-~~~sDi~~~~~-----~~~~~p~~ 338 (343)
........+||+.|+|||++ ....+ +.++|||+++. +++.+||.
T Consensus 182 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~~DiwslG~il~el~~g~~pf~ 231 (335)
T 3dls_A 182 RGKLFYTFCGTIEYCAPEVL-----MGNPYRGPELEMWSLGVTLYTLVFEENPFC 231 (335)
T ss_dssp TTCCBCEECSCGGGCCHHHH-----TTCCBCSHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred CCCceeccCCCccccChhhh-----cCCCCCCCcccchhHHHHHHHHHhCCCchh
Confidence 55555566899999999999 56666 78999996433 33555553
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=275.51 Aligned_cols=195 Identities=27% Similarity=0.458 Sum_probs=165.4
Q ss_pred CCccceecccccccccccccccceEEEEEEEC--C-----ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCC
Q 019304 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN--G-----EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (343)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~--~-----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 197 (343)
..++|+++.++|++.+.||+|+||.||+|.+. + +.||+|++....... ..+.+.+|+.+++.+ +|||
T Consensus 37 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~ 111 (333)
T 2i1m_A 37 YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD-----EKEALMSELKIMSHLGQHEN 111 (333)
T ss_dssp CCGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCTT
T ss_pred ccccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChH-----HHHHHHHHHHHHHhhcCCCC
Confidence 34678999999999999999999999999973 2 369999997544221 235789999999999 8999
Q ss_pred cceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Q 019304 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (343)
Q Consensus 198 Iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlk 265 (343)
|+++++++.....+++||||+++++|.+++.... ...+++..++.++.|++.||.|||++||+|||||
T Consensus 112 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 191 (333)
T 2i1m_A 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVA 191 (333)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred eeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcc
Confidence 9999999999999999999999999999997542 3457899999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 266 SDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 266 p~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|+|||++.++.+||+|||+++....... .....+|+.|+|||.+ ....++.++|||+++.
T Consensus 192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 254 (333)
T 2i1m_A 192 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI-----FDCVYTVQSDVWSYGI 254 (333)
T ss_dssp GGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred cceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHh-----ccCCCChHHHHHHHHH
Confidence 9999999999999999999986543322 1234567899999998 6778999999996443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=267.56 Aligned_cols=181 Identities=25% Similarity=0.451 Sum_probs=159.4
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-----
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----- 207 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----- 207 (343)
.+|++.+.||+|+||.||+|.+ +++.||||++.... +.+.+|+.+++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 5788999999999999999998 58899999997543 246689999999999999999998864
Q ss_pred -----------CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc
Q 019304 208 -----------RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276 (343)
Q Consensus 208 -----------~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~ 276 (343)
...+++||||+++++|.+++.......+++..++.++.|++.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC
Confidence 445899999999999999998765567999999999999999999999999999999999999999999
Q ss_pred EEEeccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 277 IKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 277 vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+||+|||+++............||+.|+|||.+ ....++.++|+|+++.
T Consensus 161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 209 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQI-----SSQDYGKEVDLYALGL 209 (284)
T ss_dssp EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHH-----HCSCCCTHHHHHHHHH
T ss_pred EEECcchhheeccccccccccCCcccccChhhh-----ccCCCcchhhhHHHHH
Confidence 999999999876555445566899999999999 6778999999995443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=288.17 Aligned_cols=196 Identities=23% Similarity=0.386 Sum_probs=166.9
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 210 (343)
-.++|++.+.||+|+||.||+|.. +++.||||++.......... .+.+.+|+.+++.++||||+++++++.+...
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 100 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD---KESLLREVQLLKQLDHPNIMKLYEFFEDKGY 100 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSC---HHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchH---HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 346899999999999999999998 68899999997654332111 2578899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE---cCCCcEEEeccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARI 287 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv---~~~~~vkl~DFg~a~~ 287 (343)
+++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999999999754 458999999999999999999999999999999999999 4678999999999987
Q ss_pred cccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 288 EVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
..........+||+.|+|||++ .. .++.++|||+++. +++.+||.+
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~-----~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 229 (484)
T 3nyv_A 179 FEASKKMKDKIGTAYYIAPEVL-----HG-TYDEKCDVWSTGVILYILLSGCPPFNG 229 (484)
T ss_dssp BCCCCSHHHHTTGGGTCCHHHH-----HT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccccccccCCCCccccCceee-----cC-CCCCcceeHHHHHHHHHHHHCCCCCCC
Confidence 6655555566899999999998 33 6899999996333 446677654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=270.45 Aligned_cols=193 Identities=24% Similarity=0.359 Sum_probs=157.5
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||+|.+ +++.||||++........ ..+.+.+|+.+++.++||||+++++++......+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV----IKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH 78 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchH----HHHHHHHHHHHHHhCCCCCccchhheeecCCeEE
Confidence 5788999999999999999998 588999999976544332 2367889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~- 291 (343)
+||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999999998887643 45899999999999999999999999999999999999999999999999999865432
Q ss_pred CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCC
Q 019304 292 EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPP 337 (343)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~ 337 (343)
.......||+.|+|||++. ....++.++|+|+++. +++.+||
T Consensus 157 ~~~~~~~~~~~y~aPE~~~----~~~~~~~~~Di~slG~il~~l~~g~~p~ 203 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLV----GDTQYGPPVDVWAIGCVFAELLSGVPLW 203 (311)
T ss_dssp ---------GGGCCHHHHH----TCSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccCCCcCCccccChHHHh----cCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 2334568999999999983 3467899999996433 3355555
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=273.15 Aligned_cols=183 Identities=22% Similarity=0.340 Sum_probs=139.7
Q ss_pred ccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeEEEEEE
Q 019304 140 GTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTE 216 (343)
Q Consensus 140 ~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~iv~E 216 (343)
.+.||+|+||.||+|.+ +++.||||++.... ...+.+|+.+++.+. ||||+++++++.+....|+|||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 86 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME 86 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG---------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhh---------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence 47899999999999998 57899999996421 246779999999997 9999999999999999999999
Q ss_pred ecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC---cEEEeccccccccccC-C
Q 019304 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SIKIADFGVARIEVQT-E 292 (343)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~---~vkl~DFg~a~~~~~~-~ 292 (343)
|+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++..... .
T Consensus 87 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 87 LLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp CCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 99999999999864 4599999999999999999999999999999999999998665 8999999999865432 2
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.....+||+.|+|||++ ....++.++|||+++. +++.+||.
T Consensus 165 ~~~~~~~t~~y~aPE~~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~ 210 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELL-----NQNGYDESCDLWSLGVILYTMLSGQVPFQ 210 (325)
T ss_dssp ------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccccCCCcCccCHHHh-----cCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 33456899999999999 7888999999996333 33556654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=270.00 Aligned_cols=188 Identities=29% Similarity=0.525 Sum_probs=156.5
Q ss_pred ccceecccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 207 (343)
..|.++.++|++.+.||+|+||.||++.++++.||||++..... .+.+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (278)
T 1byg_A 14 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIVE 85 (278)
T ss_dssp -CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----------HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred ccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhH--------HHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 46888999999999999999999999999999999999975431 2568899999999999999999999765
Q ss_pred C-CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 208 R-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 208 ~-~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
. ...++||||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 165 (278)
T 1byg_A 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165 (278)
T ss_dssp C--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred CCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccc
Confidence 4 468999999999999999986544447899999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 287 IEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
..... .....+++.|+|||.+ ....++.++|+|+++.
T Consensus 166 ~~~~~--~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 202 (278)
T 1byg_A 166 EASST--QDTGKLPVKWTAPEAL-----REKKFSTKSDVWSFGI 202 (278)
T ss_dssp ------------CCTTTSCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred ccccc--ccCCCccccccCHHHh-----CCCCCCchhcHHHHHH
Confidence 54432 2334678999999999 6788999999996443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=270.11 Aligned_cols=181 Identities=29% Similarity=0.475 Sum_probs=150.6
Q ss_pred cccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhc--CCCCCcceEEEEEEeC--
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT--LKHLNIVRFIGACRKR-- 208 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~-- 208 (343)
-.++|++.+.||+|+||.||+|+++++.||||++.... ...+.+|.+++.. ++||||+++++++...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD---------EKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG---------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc---------chhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 35789999999999999999999999999999986421 1345566666655 8999999999987543
Q ss_pred --CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeCCCCCCcEEEcCCCcEE
Q 019304 209 --MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH--------GLGFIHRDLKSDNLLISADKSIK 278 (343)
Q Consensus 209 --~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH--------~~giiHrDlkp~NILv~~~~~vk 278 (343)
..+++||||+++++|.+++.. ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+|
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred CCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence 458999999999999999954 35899999999999999999999 99999999999999999999999
Q ss_pred EeccccccccccCCC-----ccCCCCCcceecCCCCCCCCCCCC------CCceeeeeeeccc
Q 019304 279 IADFGVARIEVQTEG-----MTPETGTYRWMAPGNSFFSPLPHP------SFEHKWSAKESCL 330 (343)
Q Consensus 279 l~DFg~a~~~~~~~~-----~~~~~gt~~y~APE~~~~~~~~~~------~~~~~sDi~~~~~ 330 (343)
|+|||+++....... .....||+.|+|||++ ... .++.++|||+++.
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~~~~~~~DvwslG~ 211 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL-----DETIQVDCFDSYKRVDIWAFGL 211 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHH-----TTCCCTTCHHHHHHHHHHHHHH
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhh-----cCcCCCCcccCCchhhHHHHHH
Confidence 999999976543322 2334799999999999 444 5678999996443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=277.99 Aligned_cols=193 Identities=29% Similarity=0.429 Sum_probs=163.3
Q ss_pred ccceecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
.++.+..++|++.+.||+|+||.||+|.. +++.||||++........ ...+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 23 RELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG-----ELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp HHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C-----CCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred HHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH-----HHHHHHHHHHHHhccCCCccceEEEEe
Confidence 44556678999999999999999999987 688999999975433221 135889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCCCcEEEcCCCcEEEec
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGL---GFIHRDLKSDNLLISADKSIKIAD 281 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~---giiHrDlkp~NILv~~~~~vkl~D 281 (343)
.....++||||+++++|.+++.... ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999998643 23489999999999999999999999 999999999999999999999999
Q ss_pred cccccccccCC--CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 282 FGVARIEVQTE--GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 282 Fg~a~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
||+++...... ......||+.|+|||.+ ....++.++|||+++.
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~slG~ 223 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-----STGKSSEKTDVFGYGV 223 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHH-----HHSEECHHHHHHHHHH
T ss_pred CccccccCcccccccccccCCcCccCHHHh-----ccCCCCccccchhHHH
Confidence 99998654322 23345699999999999 6778999999996433
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=274.06 Aligned_cols=196 Identities=20% Similarity=0.393 Sum_probs=148.5
Q ss_pred CCccceecccccccccccccccceEEEEEEEC--Cc---eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcce
Q 019304 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN--GE---DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (343)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~--~~---~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~ 200 (343)
...++.+..++|++++.||+|+||.||+|.+. +. .||||++......... .+.+.+|+.+++.++||||++
T Consensus 14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~ 89 (323)
T 3qup_A 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD----IEEFLREAACMKEFDHPHVAK 89 (323)
T ss_dssp --CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHH----HHHHHHHHHHHTTCCCTTBCC
T ss_pred HhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHH----HHHHHHHHHHHHHCCCCceeh
Confidence 45667788899999999999999999999872 22 7999999765433322 367899999999999999999
Q ss_pred EEEEEEeCCeE------EEEEEecCCCCHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEE
Q 019304 201 FIGACRKRMVW------CIVTEYAKGGSVRQFLTRRQ----NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270 (343)
Q Consensus 201 l~~~~~~~~~~------~iv~E~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NIL 270 (343)
+++++...... ++||||+++++|.+++.... ...+++..++.++.|++.||+|||++||+||||||+|||
T Consensus 90 ~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIl 169 (323)
T 3qup_A 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCM 169 (323)
T ss_dssp CCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred hhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEE
Confidence 99999877654 89999999999999997543 125899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccccccccccCCCc---cCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 271 ISADKSIKIADFGVARIEVQTEGM---TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 271 v~~~~~vkl~DFg~a~~~~~~~~~---~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
++.++.+||+|||+++........ ....+++.|+|||.+ ....++.++|||+++.
T Consensus 170 i~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 227 (323)
T 3qup_A 170 LAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESL-----ADNLYTVHSDVWAFGV 227 (323)
T ss_dssp ECTTSCEEECCCCC-----------------CCGGGCCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred EcCCCCEEEeeccccccccccccccccccccCcccccCchhh-----cCCCCCCccchhhHHH
Confidence 999999999999999865433221 233567899999999 7788999999996443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=262.76 Aligned_cols=204 Identities=23% Similarity=0.341 Sum_probs=170.2
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCC---ChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEe
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPEN---NPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRK 207 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~ 207 (343)
.++|++.+.||+|+||.||+|.+ +++.||||++..... ..+......+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 46888999999999999999998 678999999976542 22333445578899999999995 9999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
....++||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++..
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999999999865 3589999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCccCCCCCcceecCCCCCCCC-CCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 288 EVQTEGMTPETGTYRWMAPGNSFFSP-LPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
...........||+.|+|||++.... .....++.++|+|+++. +++.+||+.
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 231 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC
Confidence 65555555668999999999872110 02567899999996433 335566543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=267.38 Aligned_cols=187 Identities=25% Similarity=0.373 Sum_probs=157.7
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
+..++|++.+.||+|+||.||+|.+ +++.||||++...... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE---KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---HHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccc---hhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence 3458899999999999999999988 5678999998642211 1112357889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
..++||||+++++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 9999999999999999998653 48999999999999999999999999999999999999999999999999986543
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.. ......||+.|+|||.+ ....++.++|+|+++
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG 194 (279)
T 3fdn_A 161 SS-RRTDLCGTLDYLPPEMI-----EGRMHDEKVDLWSLG 194 (279)
T ss_dssp --------CCCCTTCCHHHH-----TTCCCCTTHHHHHHH
T ss_pred cc-cccccCCCCCccCHhHh-----ccCCCCccchhHhHH
Confidence 32 23455899999999999 778889999999643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=264.79 Aligned_cols=186 Identities=24% Similarity=0.290 Sum_probs=161.8
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++.+.||+|+||.||++.+ +++.||+|++......... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH---QREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHH---HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHH---HHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 46889999999999999999998 5778999999765433221 236788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||+++++|.+++.... .+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+++.....
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999999999987653 5899999999999999999999999999999999999999999999999999865432
Q ss_pred -CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 292 -EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 292 -~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.......||+.|+|||.+ ....++.++|+|+++
T Consensus 169 ~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG 202 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVL-----SKKGHSFEVDVWSIG 202 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHH-----TTSCBCTHHHHHHHH
T ss_pred ccccccccCCCCcCCcchh-----ccCCCCchhhHHHHH
Confidence 233445799999999999 778899999999643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=267.38 Aligned_cols=197 Identities=35% Similarity=0.571 Sum_probs=154.1
Q ss_pred eecccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 210 (343)
+++.++|++.+.||+|+||.||+|.+.++.||||++....... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDED--ISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCccc--HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 4567899999999999999999999999999999987543322 11223578899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCCCcEEEcC--------CCcEEE
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG---FIHRDLKSDNLLISA--------DKSIKI 279 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~g---iiHrDlkp~NILv~~--------~~~vkl 279 (343)
.++||||+++++|.+++.. ..+++..++.++.|++.||.|||++| ++||||||+|||++. ++.+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred eEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 9999999999999999853 45899999999999999999999999 999999999999986 778999
Q ss_pred eccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 280 ADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 280 ~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
+|||+++...... .....||+.|+|||.+ ....++.++|+|+++. +++.+||.
T Consensus 158 ~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 215 (271)
T 3dtc_A 158 TDFGLAREWHRTT-KMSAAGAYAWMAPEVI-----RASMFSKGSDVWSYGVLLWELLTGEVPFR 215 (271)
T ss_dssp CCCCC--------------CCGGGSCHHHH-----HHCCCSHHHHHHHHHHHHHHHHHCCCTTT
T ss_pred ccCCccccccccc-ccCCCCccceeCHHHh-----ccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999998654432 3345799999999999 6778999999996433 33555553
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=276.62 Aligned_cols=192 Identities=23% Similarity=0.256 Sum_probs=152.2
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-- 209 (343)
.++|++.+.||+|+||.||+|.. +++.||||++........ ..+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 99 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT----HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 99 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHH----HHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChH----HHHHHHHHHHHHHhcCCCCccceEEeecccccc
Confidence 46899999999999999999987 688999999986544332 2357889999999999999999999997664
Q ss_pred ----eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 210 ----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 210 ----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
.+++||||+++ +|.+++.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 100 EEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ccccceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999975 78888852 3889999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 286 RIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
+...........+||+.|+|||++ ....++.++|||+++. +++.+||.+
T Consensus 175 ~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~el~~g~~pf~~ 228 (371)
T 2xrw_A 175 RTAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENVDIWSVGCIMGEMIKGGVLFPG 228 (371)
T ss_dssp ---------------CTTCCHHHH-----TTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccccccccCCceecCCccCHHHh-----cCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 876554445566899999999999 6778999999996333 335566543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=262.70 Aligned_cols=184 Identities=24% Similarity=0.328 Sum_probs=156.3
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 211 (343)
++|++.+.||+|+||.||+|.+ +++.||||++......... ..++.+|+..+..+ +||||+++++++.+...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHH----HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHH----HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 6788999999999999999998 6889999999876544332 35788999999998 999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC---------------
Q 019304 212 CIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD--------------- 274 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~--------------- 274 (343)
++||||+++++|.+++.... ...+++..++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999999998642 2558999999999999999999999999999999999999844
Q ss_pred ----CcEEEeccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 275 ----KSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 275 ----~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
..+||+|||.+...... ....||+.|+|||.+. ....++.++|||+++
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~----~~~~~~~~~Di~slG 218 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQ----ENYTHLPKADIFALA 218 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHT----TCCTTHHHHHHHHHH
T ss_pred cCCceEEEEcccccccccCCc---cccCCCccccChhHhc----CCCCCCchhhHHHHH
Confidence 47999999999865432 3346999999999983 233677899999643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=266.81 Aligned_cols=190 Identities=23% Similarity=0.357 Sum_probs=162.4
Q ss_pred ceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 207 (343)
..+..++|++.+.||+|+||.||+|.. +++.||||++....... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK---EGVEHQLRREIEIQSHLRHPNILRMYNYFHD 85 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch---HHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence 345668899999999999999999998 56789999986421111 1123578899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
....++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++..
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 163 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH 163 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEeccccccc
Confidence 999999999999999999998753 489999999999999999999999999999999999999999999999999875
Q ss_pred cccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 288 EVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.... ......||+.|+|||.+ ....++.++|+|+++.
T Consensus 164 ~~~~-~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 200 (284)
T 2vgo_A 164 APSL-RRRTMCGTLDYLPPEMI-----EGKTHDEKVDLWCAGV 200 (284)
T ss_dssp CSSS-CBCCCCSCGGGCCHHHH-----TTCCBCTTHHHHHHHH
T ss_pred Cccc-ccccccCCCCcCCHHHh-----ccCCCCcccchhhHHH
Confidence 4332 33456899999999999 7788999999996433
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=276.89 Aligned_cols=186 Identities=19% Similarity=0.214 Sum_probs=150.7
Q ss_pred ecccccccccccccccceEEEEEEECCceEEEEEeeCCCCChh--HHHHHHHHHHHHHHHHhcCC---------CCCcce
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPE--KAQVMEQQFQQEVMMLATLK---------HLNIVR 200 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~---------h~nIv~ 200 (343)
+..++|++.+.||+|+||.||+|+++++.||||++........ ......+.+.+|+.+++.++ ||||++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 4568899999999999999999999999999999986543200 00001245777888877775 899998
Q ss_pred EEEEEE------------------------------eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHH
Q 019304 201 FIGACR------------------------------KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250 (343)
Q Consensus 201 l~~~~~------------------------------~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~g 250 (343)
+.+++. ....+|+||||+++|++.+.+.+ ..+++..+..++.||+.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 888753 25789999999999987776643 458999999999999999
Q ss_pred HHHHH-hCCceeCCCCCCcEEEcCCC--------------------cEEEeccccccccccCCCccCCCCCcceecCCCC
Q 019304 251 MAYVH-GLGFIHRDLKSDNLLISADK--------------------SIKIADFGVARIEVQTEGMTPETGTYRWMAPGNS 309 (343)
Q Consensus 251 L~yLH-~~giiHrDlkp~NILv~~~~--------------------~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~ 309 (343)
|+||| ++||+||||||+|||++.++ .+||+|||+|+..... ..+||+.|+|||++
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGG
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhh
Confidence 99999 99999999999999999887 8999999999875432 34799999999999
Q ss_pred CCCCCCCCCCceeeeeeeccc
Q 019304 310 FFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 310 ~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.... +.++|||++++
T Consensus 250 -----~g~~-~~~~Diwsl~~ 264 (336)
T 2vuw_A 250 -----TGDG-DYQFDIYRLMK 264 (336)
T ss_dssp -----CCCS-SHHHHHHHHHH
T ss_pred -----cCCC-ccceehhhhhC
Confidence 4444 88999996543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=270.77 Aligned_cols=186 Identities=24% Similarity=0.288 Sum_probs=161.9
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|.+++.||+|+||.||++.+ +++.||+|++........ ...+.+.+|+.+++.++||||+++++++.+...+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP---HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 46899999999999999999998 567899999976543322 1236788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 117 ~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999999998765 35899999999999999999999999999999999999999999999999999865432
Q ss_pred -CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 292 -EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 292 -~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.......||+.|+|||++ ....++.++|||+++
T Consensus 195 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~slG 228 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVL-----SKKGHSFEVDVWSIG 228 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHH-----HTSCBCTHHHHHHHH
T ss_pred cccccccCCCccccCHHHh-----ccCCCCchhhHHHHH
Confidence 233456799999999999 677889999999643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=266.20 Aligned_cols=195 Identities=22% Similarity=0.307 Sum_probs=149.2
Q ss_pred ceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 207 (343)
|++..++|++.+.||+|+||.||+|.+ +++.||||++........ ..+.+.++...++.++||||+++++++.+
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~~~~~~~~h~~iv~~~~~~~~ 77 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE----QKRLLMDLDISMRTVDCPFTVTFYGALFR 77 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHH----HHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHH----HHHHHHHHHHHHHhCCCCeEEEEeeeeec
Confidence 567789999999999999999999998 788999999975433222 22345566666888999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEecccc
Q 019304 208 RMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGV 284 (343)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~-giiHrDlkp~NILv~~~~~vkl~DFg~ 284 (343)
....++||||+++ +|.+++.. .....+++..++.++.|++.||+|||++ |++||||||+|||++.++.+||+|||+
T Consensus 78 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T 3fme_A 78 EGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGI 156 (290)
T ss_dssp SSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred cCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCC
Confidence 9999999999975 88888764 2345699999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 285 ARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
++............||+.|+|||.+. .......++.++|+|+++.
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~~~~Di~slG~ 201 (290)
T 3fme_A 157 SGYLVDDVAKDIDAGCKPYMAPERIN-PELNQKGYSVKSDIWSLGI 201 (290)
T ss_dssp -------------CCCCCCSCHHHHS-CCTTC--CCHHHHHHHHHH
T ss_pred cccccccccccccCCCccccChhhcC-hhhcCcCCCcHHHHHHHHH
Confidence 98765554445568999999999951 1115677899999996433
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=263.10 Aligned_cols=189 Identities=23% Similarity=0.395 Sum_probs=152.8
Q ss_pred eecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
.+..++|++++.||+|+||.||+|.+ +++.||||++..... ......+.+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI---RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP 83 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH---HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc---cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 34568899999999999999999998 688999999864211 1111235788999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
...++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++...
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred CeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 99999999999999999998653 4899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCccCCCCCcceecCCCCCCCCCCCCCC-ceeeeeeecc
Q 019304 289 VQTEGMTPETGTYRWMAPGNSFFSPLPHPSF-EHKWSAKESC 329 (343)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~-~~~sDi~~~~ 329 (343)
..........||+.|+|||.+ ....+ +.++|+|+++
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~~Di~slG 198 (276)
T 2h6d_A 162 SDGEFLRTSCGSPNYAAPEVI-----SGRLYAGPEVDIWSCG 198 (276)
T ss_dssp CC-------------CCTGGG-----TTSCCCHHHHHHHHHH
T ss_pred CCCcceecccCCccccCHHHH-----cCCCCCCccchHHHHH
Confidence 554444556799999999999 55554 6899999643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=272.62 Aligned_cols=196 Identities=26% Similarity=0.388 Sum_probs=163.8
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.+.|+..+.||+|+||.||+|.. +++.||||++........ ...+.+.+|+.+++.++||||+++++++......
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 129 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA 129 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccch---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeE
Confidence 35688889999999999999997 788999999976544332 2236789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||++ |+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 130 ~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 130 WLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp EEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 99999997 58888886543 4689999999999999999999999999999999999999999999999999986533
Q ss_pred CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 292 EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
....+||+.|+|||++... ....++.++|||+++. +++.+||..
T Consensus 207 --~~~~~gt~~y~aPE~~~~~--~~~~~~~~~DiwslG~il~ell~g~~p~~~ 255 (348)
T 1u5q_A 207 --ANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKPPLFN 255 (348)
T ss_dssp --BCCCCSCGGGCCHHHHHTT--SSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred --CCcccCCcceeCHhhhccc--cCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2346899999999987321 2567899999996433 335566543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=264.88 Aligned_cols=187 Identities=26% Similarity=0.408 Sum_probs=140.1
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++.+.||+|+||.||+|.. +++.||||++...... .....+.+.+|+.+++.++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY---KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh---hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 36788999999999999999997 7889999999642111 111235788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 9999999999999999753 346899999999999999999999999999999999999999999999999999865432
Q ss_pred -CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 292 -EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 292 -~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.......||+.|+|||.+ ....++.++|+|+++
T Consensus 166 ~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG 199 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIA-----TRSAHGLESDVWSLG 199 (278)
T ss_dssp -------------------------------CTHHHHHH
T ss_pred CCcceeccCCCCcCCcchh-----cCCCCCchhhHHHHH
Confidence 223345799999999999 777889999999643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=274.34 Aligned_cols=200 Identities=18% Similarity=0.218 Sum_probs=158.5
Q ss_pred eecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCC--CCcceEEEEEEe
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRFIGACRK 207 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~ 207 (343)
.+..++|++.+.||+|+||.||++.. +++.||||++......... .+.+.+|+.+++.++| |||+++++++..
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 80 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT----LDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 80 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHH----HHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHH----HHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence 45668899999999999999999988 6788999999866544322 3678999999999976 999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
...+++|||+ .+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++ ++.+||+|||+++.
T Consensus 81 ~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 81 DQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp SSEEEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred CCEEEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccc
Confidence 9999999995 578999999864 4589999999999999999999999999999999999997 68899999999986
Q ss_pred cccCCC---ccCCCCCcceecCCCCCCCC------CCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 288 EVQTEG---MTPETGTYRWMAPGNSFFSP------LPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 288 ~~~~~~---~~~~~gt~~y~APE~~~~~~------~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
...... ....+||+.|+|||++.... .....++.++|||++.. +++.+||.
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 221 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcch
Confidence 543322 23457999999999983210 01277899999996433 33555553
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=284.19 Aligned_cols=193 Identities=21% Similarity=0.277 Sum_probs=160.1
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM- 209 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~- 209 (343)
..++|++.+.||+|+||.||+|.+ +++.||||++........ .+.+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-----VDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch-----HHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence 357899999999999999999998 588999999964332111 246789999999999999999999998765
Q ss_pred -eEEEEEEecCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE----cCCCcEEEeccc
Q 019304 210 -VWCIVTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI----SADKSIKIADFG 283 (343)
Q Consensus 210 -~~~iv~E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv----~~~~~vkl~DFg 283 (343)
..++||||+++++|.+++.... ...+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 7899999999999999997543 2338999999999999999999999999999999999999 777889999999
Q ss_pred cccccccCCCccCCCCCcceecCCCCCCCCCC---CCCCceeeeeeeccc
Q 019304 284 VARIEVQTEGMTPETGTYRWMAPGNSFFSPLP---HPSFEHKWSAKESCL 330 (343)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~---~~~~~~~sDi~~~~~ 330 (343)
+++............||+.|+|||++...... ...++.++|||+++.
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~ 211 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHH
T ss_pred CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHH
Confidence 99876655555667899999999998211101 157889999996443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=275.95 Aligned_cols=194 Identities=21% Similarity=0.362 Sum_probs=158.2
Q ss_pred eecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK- 207 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~- 207 (343)
+...++|++++.||+|+||.||+|.. +++.||||++...... ..+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----------~~~E~~il~~l~hpnIv~l~~~~~~~ 72 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----------KNRELDIMKVLDHVNIIKLVDYFYTT 72 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----------CCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----------HHHHHHHHHHcCCCCccchhheeeec
Confidence 34567899999999999999999988 7889999999754322 2379999999999999999999844
Q ss_pred -------------------------------------CCeEEEEEEecCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHH
Q 019304 208 -------------------------------------RMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVA 248 (343)
Q Consensus 208 -------------------------------------~~~~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~ 248 (343)
...+++||||++ ++|.+.+.. .....+++..+..++.|++
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~ 151 (383)
T 3eb0_A 73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLF 151 (383)
T ss_dssp -------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence 334889999997 488887764 3445699999999999999
Q ss_pred HHHHHHHhCCceeCCCCCCcEEEc-CCCcEEEeccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeee
Q 019304 249 RGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKE 327 (343)
Q Consensus 249 ~gL~yLH~~giiHrDlkp~NILv~-~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~ 327 (343)
.||+|||++||+||||||+|||++ .++.+||+|||+|+............||+.|+|||.+. ....++.++|||+
T Consensus 152 ~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~Diws 227 (383)
T 3eb0_A 152 RAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELML----GATEYTPSIDLWS 227 (383)
T ss_dssp HHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHT----TCSSCCTHHHHHH
T ss_pred HHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhc----CCCCCCcchhhhh
Confidence 999999999999999999999997 68999999999998766555566678999999999982 2345899999996
Q ss_pred ccc-----ccccCCCCc
Q 019304 328 SCL-----KTTWPPPWR 339 (343)
Q Consensus 328 ~~~-----~~~~~p~~~ 339 (343)
++. +++.+||.+
T Consensus 228 lG~il~ell~g~~pf~~ 244 (383)
T 3eb0_A 228 IGCVFGELILGKPLFSG 244 (383)
T ss_dssp HHHHHHHHHHSSCSSCC
T ss_pred HHHHHHHHHhCCCCCCC
Confidence 333 346666644
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=266.46 Aligned_cols=195 Identities=20% Similarity=0.280 Sum_probs=155.0
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++.+.||+|+||.||+|.+ +++.||||++....... ....+.+.+|+.+++.++||||+++++++.....+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD---PVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccC---HHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 47889999999999999999997 67899999987543221 22346789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||+++++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999999998653 5899999999999999999999999999999999999999999999999998765432
Q ss_pred C--CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 292 E--GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 292 ~--~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
. ......||+.|+|||.+ ....++.++|+|+++. +++.+||.
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERF-----SESHATYRADIYALTCVLYECLTGSPPYQ 236 (309)
T ss_dssp ---------CCGGGCCGGGT-----CC----CCCHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccccccCCCcCccCHHHH-----cCCCCCchHhHHHHHHHHHHHHHCCCCCC
Confidence 2 22345799999999999 7788999999996433 33555553
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=274.74 Aligned_cols=186 Identities=22% Similarity=0.333 Sum_probs=161.1
Q ss_pred eecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
++..++|++.+.||+|+||.||+|.+ +++.||+|++...... ...+.+.+|+.+++.++||||+++++++...
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-----AIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCH-----HHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCH-----HHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence 35568899999999999999999998 5889999999765321 2236789999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
..+++||||+++++|.+++.... .+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred CEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 99999999999999999998753 489999999999999999999996 999999999999999999999999999975
Q ss_pred cccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 288 EVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
.... ......||+.|+|||++ ....++.++|||+++
T Consensus 182 ~~~~-~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~slG 217 (360)
T 3eqc_A 182 LIDS-MANSFVGTRSYMSPERL-----QGTHYSVQSDIWSMG 217 (360)
T ss_dssp HHHH-C----CCCCTTCCHHHH-----TTCCCSHHHHHHHHH
T ss_pred cccc-cccCCCCCCCeECHHHH-----cCCCCCchhhHHHHH
Confidence 5432 33456899999999999 778899999999643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=272.27 Aligned_cols=194 Identities=22% Similarity=0.335 Sum_probs=153.0
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 210 (343)
..++|++.+.||+|+||.||+|.. +++.||||++........ ..+.+.+|+.+++.++||||+++++++.....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG----VPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC------------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccc----cchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 347899999999999999999987 788999999975543221 23567899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc-----CCCcEEEeccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-----ADKSIKIADFGVA 285 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~-----~~~~vkl~DFg~a 285 (343)
+++||||+++ +|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEEEecCCC-CHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 9999999975 9999997643 489999999999999999999999999999999999994 4556999999999
Q ss_pred cccccC-CCccCCCCCcceecCCCCCCCCCCC-CCCceeeeeeeccc-----ccccCCCC
Q 019304 286 RIEVQT-EGMTPETGTYRWMAPGNSFFSPLPH-PSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 286 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~-~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
+..... ......+||+.|+|||++ .. ..++.++|||++.. +++.+||.
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aPE~~-----~~~~~~~~~~DiwslG~il~ell~g~~pf~ 239 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPPEIL-----LGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239 (329)
T ss_dssp HHHC-----------CCTTCCHHHH-----TTCCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccCCcccccCCCcCCccccCHHHh-----cCCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 865432 233455789999999998 44 45899999996433 33555554
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=273.68 Aligned_cols=189 Identities=21% Similarity=0.328 Sum_probs=159.6
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCe
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMV 210 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 210 (343)
.++|++.+.||+|+||.||+|.. +++.||||++.+.... ..+|+.++.++ +||||+++++++.+...
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~ 90 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----------PTEEIEILLRYGQHPNIITLKDVYDDGKY 90 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----------CHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----------hHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence 36788999999999999999998 6789999999765432 24677778777 79999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC----CcEEEecccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD----KSIKIADFGVAR 286 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~----~~vkl~DFg~a~ 286 (343)
+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+..+ +.+||+|||+++
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 99999999999999999754 458999999999999999999999999999999999998533 359999999998
Q ss_pred ccccC-CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 287 IEVQT-EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 287 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
..... ......+||+.|+|||++ ....++.++|+|+++. +++.+||++
T Consensus 169 ~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 222 (342)
T 2qr7_A 169 QLRAENGLLMTPCYTANFVAPEVL-----ERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222 (342)
T ss_dssp ECBCTTCCBCCSSCCSSCCCHHHH-----HHHHHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred cCcCCCCceeccCCCccccCHHHh-----cCCCCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence 65433 234556899999999999 6677999999996433 446777764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=281.25 Aligned_cols=200 Identities=23% Similarity=0.295 Sum_probs=152.3
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChh--HHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPE--KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
.++|.+.+.||+|+||.||+|.. +++.||||++........ ........+.+|+.++++++||||+++++++.. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 46789999999999999999988 678999999975432111 111122358899999999999999999999865 4
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC---CcEEEecccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD---KSIKIADFGVAR 286 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~---~~vkl~DFg~a~ 286 (343)
..++||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.+ ..+||+|||+++
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred ceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 578999999999999988643 458999999999999999999999999999999999999754 459999999998
Q ss_pred ccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 287 IEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
...........+||+.|+|||++... ....++.++|||+++. +++.+||-
T Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~ 345 (419)
T 3i6u_A 291 ILGETSLMRTLCGTPTYLAPEVLVSV--GTAGYNRAVDCWSLGVILFICLSGYPPFS 345 (419)
T ss_dssp SCC-----------CTTCCTTTTC------CTTHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ecCCCccccccCCCCCccCceeeecC--CCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 77665555667899999999998311 2477899999996433 34666663
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=275.60 Aligned_cols=199 Identities=16% Similarity=0.219 Sum_probs=158.0
Q ss_pred cccccccccccccccceEEEEEEEC-------CceEEEEEeeCCCCChhHHHHH-----HHHHHHHHHHHhcCCCCCcce
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVM-----EQQFQQEVMMLATLKHLNIVR 200 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~-----~~~~~~E~~~l~~l~h~nIv~ 200 (343)
..++|++.+.||+|+||.||+|.+. ++.||||++............. ...+.+|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 4568999999999999999999882 4689999987644211111111 123556777888999999999
Q ss_pred EEEEEEeC----CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc--CC
Q 019304 201 FIGACRKR----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS--AD 274 (343)
Q Consensus 201 l~~~~~~~----~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~--~~ 274 (343)
+++++... ...++||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++ .+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 99998764 4589999999 99999999764 35699999999999999999999999999999999999999 88
Q ss_pred CcEEEeccccccccccCCC--------ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 275 KSIKIADFGVARIEVQTEG--------MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 275 ~~vkl~DFg~a~~~~~~~~--------~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
+.+||+|||+++....... ....+||+.|+|||++ ....++.++|||++.. +++.+||.
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAH-----NGVAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHH-----TTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHh-----CCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999999999976543221 1334599999999999 7788999999996433 34556654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=276.57 Aligned_cols=202 Identities=17% Similarity=0.205 Sum_probs=160.7
Q ss_pred ceecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC--CCCcceEEEEEE
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVRFIGACR 206 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~ 206 (343)
..+..++|++.+.||+|+||.||++.. +++.||||++........ ..+.+.+|+.+++.++ ||||+++++++.
T Consensus 51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~ 126 (390)
T 2zmd_A 51 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ----TLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 126 (390)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHH----HHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred ccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHH----HHHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence 345567799999999999999999987 678899999987654432 2367899999999996 599999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
....+|+||| +.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++
T Consensus 127 ~~~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 127 TDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 202 (390)
T ss_dssp CSSEEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred cCCEEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccc
Confidence 9999999999 55789999998653 588999999999999999999999999999999999995 6899999999998
Q ss_pred ccccCC---CccCCCCCcceecCCCCCCCCC------CCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 287 IEVQTE---GMTPETGTYRWMAPGNSFFSPL------PHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 287 ~~~~~~---~~~~~~gt~~y~APE~~~~~~~------~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
...... .....+||+.|+|||++..... ....++.++|||++++ +++.+||..
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 654322 2345689999999999832100 1247999999996433 346666654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=269.09 Aligned_cols=199 Identities=21% Similarity=0.333 Sum_probs=161.3
Q ss_pred eecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
....++|++.+.||+|+||.||+|.+ +++.||||++........ ..+.+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 96 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM----VKKIAMREIKLLKQLRHENLVNLLEVCKKK 96 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchH----HHHHHHHHHHHHhhCCCCCEeeEEEEeecC
Confidence 34568899999999999999999998 578999999976554432 235688999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
..+++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred CEEEEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 9999999999998888876543 45899999999999999999999999999999999999999999999999999765
Q ss_pred ccC-CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 289 VQT-EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 289 ~~~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
... .......||+.|+|||.+. ....++.++|||+++. +++.+||.+
T Consensus 175 ~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (331)
T 4aaa_A 175 AAPGEVYDDEVATRWYRAPELLV----GDVKYGKAVDVWAIGCLVTEMFMGEPLFPG 227 (331)
T ss_dssp ---------CCCCCTTCCHHHHT----TCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCccccCCCcCCccccCccccc----CCCCcchHHHHHHHHHHHHHHHhCCCCCCC
Confidence 432 2334567999999999982 2347899999996433 335556543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=264.04 Aligned_cols=190 Identities=22% Similarity=0.362 Sum_probs=151.8
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 210 (343)
...+|++.+.||+|+||.||+|.. +++.||||++......... ..+.+.+|+.+++.++||||+++++++.....
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK---ARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHH---HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence 457899999999999999999997 6889999999764433221 23678899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
.++||||+++++|.+++... ....+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++..
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 99999999999999999752 3456899999999999999999999999999999999999999999999999998865
Q ss_pred ccCC-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 289 VQTE-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 289 ~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.... ......||+.|+|||.+ ....++.++|+|+++.
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slG~ 224 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERI-----HENGYNFKSDIWSLGC 224 (310)
T ss_dssp ------------CCSSCCHHHH-----TTCCCCHHHHHHHHHH
T ss_pred cCCCccccccCCCeeEeChHHh-----CCCCCCchhhHHHHHH
Confidence 4322 23345799999999999 7788999999996443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=270.44 Aligned_cols=189 Identities=28% Similarity=0.457 Sum_probs=157.1
Q ss_pred ecccccccccccccccceEEEEEEE--CCce--EEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGED--VAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~--vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 206 (343)
++.++|++.+.||+|+||.||+|.+ ++.. +|||.+....... ..+.+.+|+.+++.+ +||||+++++++.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 96 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-----DHRDFAGELEVLCKLGHHPNIINLLGACE 96 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-----------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchH-----HHHHHHHHHHHHHhccCCCchhhhceeee
Confidence 4568899999999999999999987 5554 4999987533221 125688999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~ 272 (343)
.....++||||+++++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176 (327)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc
Confidence 9999999999999999999997642 24689999999999999999999999999999999999999
Q ss_pred CCCcEEEeccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 273 ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 273 ~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.++.+||+|||+++............+++.|+|||.+ ....++.++|||+++.
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 229 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL-----NYSVYTTNSDVWSYGV 229 (327)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHH-----HHCEECHHHHHHHHHH
T ss_pred CCCeEEEcccCcCccccccccccCCCCCccccChhhh-----ccccCCchhcchHHHH
Confidence 9999999999999754433333445678999999999 6778899999996433
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=270.11 Aligned_cols=189 Identities=25% Similarity=0.413 Sum_probs=155.5
Q ss_pred ceecccccccccccccccceEEEEEEECC------ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEE
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNG------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~ 203 (343)
++++.++|++.+.||+|+||.||+|.+.. ..||||++...... .....+.+|+.+++.++||||+++++
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~ 113 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-----KQRVDFLGEAGIMGQFSHHNIIRLEG 113 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-----HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH-----HHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 46778899999999999999999998732 35999999754321 12357899999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 204 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
++......++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 114 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 192 (333)
T 1mqb_A 114 VISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG 192 (333)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred EEecCCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCC
Confidence 999999999999999999999999764 3468999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 284 VARIEVQTEG----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 284 ~a~~~~~~~~----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+++....... .....+|+.|+|||.+ ....++.++|||+++
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG 237 (333)
T 1mqb_A 193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAI-----SYRKFTSASDVWSFG 237 (333)
T ss_dssp C-----------------CCCGGGSCHHHH-----HSCCCCHHHHHHHHH
T ss_pred cchhhccccccccccCCCCccccccCchhc-----ccCCCCchhhhHHHH
Confidence 9986543221 1223467899999999 778899999999643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=267.96 Aligned_cols=185 Identities=21% Similarity=0.368 Sum_probs=157.2
Q ss_pred eecccccccccccccccceEEEEEEE--CC-------ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceE
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l 201 (343)
++..++|++.+.||+|+||.||+|.+ ++ ..||+|++...... ..+.+.+|+.+++.++||||+++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~ 77 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN------YSESFFEAASMMSKLSHKHLVLN 77 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG------GHHHHHHHHHHHHTSCCTTBCCE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH------HHHHHHHHHHHHHhCCCCCEeEE
Confidence 45678999999999999999999987 33 46999998643221 12578999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc-----
Q 019304 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS----- 276 (343)
Q Consensus 202 ~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~----- 276 (343)
++++.+....++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.
T Consensus 78 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 156 (289)
T 4fvq_A 78 YGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGN 156 (289)
T ss_dssp EEEECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTB
T ss_pred EEEEEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccc
Confidence 999999999999999999999999998643 34899999999999999999999999999999999999998876
Q ss_pred ---EEEeccccccccccCCCccCCCCCcceecCCCCCCCCCCC-CCCceeeeeeeccc
Q 019304 277 ---IKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPH-PSFEHKWSAKESCL 330 (343)
Q Consensus 277 ---vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~-~~~~~~sDi~~~~~ 330 (343)
+||+|||+++..... ....||+.|+|||++ .. ..++.++|||+++.
T Consensus 157 ~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~-----~~~~~~~~~~DiwslG~ 206 (289)
T 4fvq_A 157 PPFIKLSDPGISITVLPK---DILQERIPWVPPECI-----ENPKNLNLATDKWSFGT 206 (289)
T ss_dssp CCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHH-----HCGGGCCHHHHHHHHHH
T ss_pred cceeeeccCcccccccCc---cccCCcCcccCHHHh-----CCCCCCCchhHHHHHHH
Confidence 999999998754321 223578999999998 45 67899999996443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=262.28 Aligned_cols=193 Identities=21% Similarity=0.259 Sum_probs=163.1
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 208 (343)
+..++|++.+.||+|+||.||+|.. +++.||||++...... +.+.+|+.+++.+ +|++++++++++...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 78 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--------PQLRDEYRTYKLLAGCTGIPNVYYFGQEG 78 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--------CCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc--------HHHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence 4457899999999999999999996 7889999998754432 2467899999999 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc-----EEEeccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS-----IKIADFG 283 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~-----vkl~DFg 283 (343)
...++||||+ +++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||
T Consensus 79 ~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 79 LHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred ceeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 9999999999 89999999864 345899999999999999999999999999999999999987765 9999999
Q ss_pred cccccccCCC--------ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 284 VARIEVQTEG--------MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 284 ~a~~~~~~~~--------~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
+++....... .....||+.|+|||++ ....++.++|||+++. +++.+||.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~slG~il~el~~g~~pf~~ 220 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH-----LGREQSRRDDLEALGHVFMYFLRGSLPWQG 220 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH-----TTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cccccccccccccccccCccCCCCCcccCCchhh-----cCCCCChHHHHHHHHHHHHHHHcCCCCcch
Confidence 9986544321 2345799999999999 7788999999996433 335555543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=271.34 Aligned_cols=187 Identities=22% Similarity=0.448 Sum_probs=151.5
Q ss_pred ecccccccccccccccceEEEEEEE--CCce----EEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGED----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~----vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
+..++|++.+.||+|+||.||+|.+ +++. ||+|.+...... ...+.+.+|+.+++.++||||+++++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 86 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-----KANKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC------------CHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCH-----HHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 4557899999999999999999987 4443 578877543221 1235789999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
.... .++|+||+++|+|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 87 LTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp ESSS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred ecCC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcce
Confidence 8765 679999999999999998643 46899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 286 RIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 286 ~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+....... .....+|+.|+|||.+ ....++.++|||+++.
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~-----~~~~~~~~~Di~slG~ 207 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESI-----LHRIYTHQSDVWSYGV 207 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred eEccCCcccccccCCCccccccChHHh-----ccCCCCchhhhhhhHH
Confidence 86543322 2233568899999999 7788999999996443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=265.19 Aligned_cols=191 Identities=29% Similarity=0.486 Sum_probs=157.2
Q ss_pred ccceeccccccccc-ccccccceEEEEEEE----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEE
Q 019304 128 DEWTIDLRKLNMGT-AFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (343)
Q Consensus 128 ~~~~i~~~~~~~~~-~lg~G~fg~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~ 202 (343)
.++.++.++|++.+ .||+|+||.||+|.+ .++.||||++........ ..+.+.+|+.+++.++||||++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~ 84 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----LKDELLAEANVMQQLDNPYIVRMI 84 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CH----HHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHH----HHHHHHHHHHHHHhCCCCCEEEEE
Confidence 46678889999988 999999999999965 357899999976543322 236789999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 019304 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (343)
Q Consensus 203 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DF 282 (343)
+++ .....++||||+++++|.+++... ..+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+||
T Consensus 85 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 85 GIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp EEE-ESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred EEE-CCCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccC
Confidence 999 556678999999999999999764 35899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCC----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 283 GVARIEVQTEG----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 283 g~a~~~~~~~~----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|+++....... .....+++.|+|||.+ ....++.++|+|+++.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 208 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECI-----NYYKFSSKSDVWSFGV 208 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHH-----HHCEEEHHHHHHHHHH
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHh-----ccCCCChhhhHHHHHH
Confidence 99986543322 1223567899999999 6778999999996443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=260.14 Aligned_cols=185 Identities=28% Similarity=0.452 Sum_probs=157.5
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe---
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--- 207 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--- 207 (343)
+.+.|++.+.||+|+||.||+|.+ ++..||+|++......... .+.+.+|+.+++.++||||+++++++..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE----RQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH----HHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHH----HHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence 446788899999999999999998 5678999999765544332 3678999999999999999999999875
Q ss_pred -CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCcEEEc-CCCcEEEeccc
Q 019304 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLIS-ADKSIKIADFG 283 (343)
Q Consensus 208 -~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~g--iiHrDlkp~NILv~-~~~~vkl~DFg 283 (343)
...+++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ ++||||||+|||++ .++.+||+|||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 100 GKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred CCceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 356899999999999999998653 4899999999999999999999999 99999999999998 78999999999
Q ss_pred cccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 284 VARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
++...... ......||+.|+|||++ . ..++.++|+|+++.
T Consensus 178 ~~~~~~~~-~~~~~~~t~~y~aPE~~-----~-~~~~~~~Di~slG~ 217 (290)
T 1t4h_A 178 LATLKRAS-FAKAVIGTPEFMAPEMY-----E-EKYDESVDVYAFGM 217 (290)
T ss_dssp GGGGCCTT-SBEESCSSCCCCCGGGG-----G-TCCCTHHHHHHHHH
T ss_pred Cccccccc-ccccccCCcCcCCHHHH-----h-ccCCCcchHHHHHH
Confidence 99754432 33455799999999987 3 45899999996443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=272.04 Aligned_cols=196 Identities=19% Similarity=0.262 Sum_probs=160.5
Q ss_pred cccccc-cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCe
Q 019304 135 RKLNMG-TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMV 210 (343)
Q Consensus 135 ~~~~~~-~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 210 (343)
++|.+. +.||+|+||.||+|.. +++.||||++......... ...+.+|+.+++.+ .||||+++++++.....
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC----RAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEEC----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHH----HHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 455555 8899999999999998 5889999999765443322 25688999999999 46999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC---CCcEEEeccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVARI 287 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~---~~~vkl~DFg~a~~ 287 (343)
+++||||+++++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 999999999999999986655567999999999999999999999999999999999999987 78999999999987
Q ss_pred cccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 288 EVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
...........||+.|+|||++ ....++.++|+|+++. +++.+||.+
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (327)
T 3lm5_A 184 IGHACELREIMGTPEYLAPEIL-----NYDPITTATDMWNIGIIAYMLLTHTSPFVG 235 (327)
T ss_dssp C---------CCCGGGCCHHHH-----TTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCccccccccCCcCccCCeee-----cCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 6655555566899999999999 7888999999996433 335666543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=267.71 Aligned_cols=188 Identities=15% Similarity=0.296 Sum_probs=160.9
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEe--
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRK-- 207 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~-- 207 (343)
..++|++.+.||+|+||.||+|.. +++.||||++.... .+.+.+|+.+++.++ ||||+++++++..
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 104 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---------KKKIKREIKILENLRGGPNIITLADIVKDPV 104 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence 357899999999999999999987 78899999996422 146889999999997 9999999999987
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC-cEEEecccccc
Q 019304 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVAR 286 (343)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~-~vkl~DFg~a~ 286 (343)
....++||||+++++|.+++.. +++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 105 ~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 105 SRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp TCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 5678999999999999998753 88999999999999999999999999999999999999776 89999999998
Q ss_pred ccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 287 IEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
............||+.|+|||.+. ....++.++|||+++. +++.+||+
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 180 FYHPGQEYNVRVASRYFKGPELLV----DYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp ECCTTCCCCSCCSCGGGCCHHHHT----TCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred EcCCCCccccccccccccChhhhc----CCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 766555566678999999999982 3377999999996443 33555553
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=266.24 Aligned_cols=196 Identities=22% Similarity=0.417 Sum_probs=155.3
Q ss_pred CCccceecccccccccccccccceEEEEEEEC-----CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcce
Q 019304 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (343)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~ 200 (343)
..+++.++.++|++++.||+|+||.||+|.+. ++.||||++......... .+.+.+|+.+++.++||||++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~ 100 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE----IEEFLSEAACMKDFSHPNVIR 100 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHH----HHHHHHHHHHHHTCCCTTBCC
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhH----HHHHHHHHHHHhcCCCCCeee
Confidence 45677889999999999999999999999872 347999999765544322 357899999999999999999
Q ss_pred EEEEEEeCC-----eEEEEEEecCCCCHHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE
Q 019304 201 FIGACRKRM-----VWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271 (343)
Q Consensus 201 l~~~~~~~~-----~~~iv~E~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv 271 (343)
+++++.... ..++||||+++++|.+++... ....+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 101 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli 180 (313)
T 3brb_A 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML 180 (313)
T ss_dssp CCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE
T ss_pred eeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE
Confidence 999997754 359999999999999999642 33568999999999999999999999999999999999999
Q ss_pred cCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 272 SADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 272 ~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+.++.+||+|||+++....... .....+++.|+|||.+ ....++.++|+|+++.
T Consensus 181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 237 (313)
T 3brb_A 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL-----ADRVYTSKSDVWAFGV 237 (313)
T ss_dssp CTTSCEEECSCSCC----------------CCGGGSCHHHH-----HSSCCCHHHHHHHHHH
T ss_pred cCCCcEEEeecCcceecccccccCcccccCCCccccCchhh-----cCCCccchhhhHHHHH
Confidence 9999999999999986543221 2234578899999999 7788999999996443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=264.45 Aligned_cols=191 Identities=23% Similarity=0.382 Sum_probs=161.3
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|.+.+.||+|+||.||+++. +++.||||++....... .+.+.+|+.+++.++||||+++++++.+....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR------DSSLENEIAVLKKIKHENIVTLEDIYESTTHY 81 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc------hHHHHHHHHHHHhCCCCCeeehhhhcccCCEE
Confidence 36788999999999999999998 68899999998643221 24688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE---cCCCcEEEecccccccc
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIE 288 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv---~~~~~vkl~DFg~a~~~ 288 (343)
++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+|||+ +.++.+||+|||+++..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp EEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred EEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 99999999999999997653 48999999999999999999999999999999999999 77889999999999754
Q ss_pred ccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 289 VQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
... .....+||+.|+|||.+ ....++.++|+|+++. +++.+||.
T Consensus 160 ~~~-~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~il~~l~~g~~pf~ 208 (304)
T 2jam_A 160 QNG-IMSTACGTPGYVAPEVL-----AQKPYSKAVDCWSIGVITYILLCGYPPFY 208 (304)
T ss_dssp CCB-TTHHHHSCCCBCCTTTB-----SSCSCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCC-ccccccCCCCccChHHh-----ccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 332 23344699999999999 7788999999996433 33555553
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=263.01 Aligned_cols=184 Identities=27% Similarity=0.424 Sum_probs=161.2
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.+.|++.+.||+|+||.||+|.. +++.||||++........ .+.+.+|+.+++.++||||+++++++......
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-----IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTT-----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHH-----HHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 46788999999999999999987 678999999976554322 25788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 96 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp EEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999999999864 45899999999999999999999999999999999999999999999999999765443
Q ss_pred C-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 292 E-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 292 ~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
. ......||+.|+|||.+ ....++.++|+|+++.
T Consensus 173 ~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 207 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVI-----KQSAYDSKADIWSLGI 207 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHH-----TTCCBCTHHHHHHHHH
T ss_pred ccccCccCCCcCccCHHHH-----hcCCCCchhhhHHHHH
Confidence 2 23455799999999999 7788999999996433
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=263.44 Aligned_cols=189 Identities=25% Similarity=0.463 Sum_probs=159.9
Q ss_pred cceeccccccccc-ccccccceEEEEEEE----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEE
Q 019304 129 EWTIDLRKLNMGT-AFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (343)
Q Consensus 129 ~~~i~~~~~~~~~-~lg~G~fg~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~ 203 (343)
+|.++.++|.+.+ .||+|+||.||+|.+ ++..||||++...... ...+.+.+|+.+++.++||||+++++
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~ 77 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-----ADTEEMMREAQIMHQLDNPYIVRLIG 77 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH-----HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch-----hHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 5677788888877 999999999999985 5678999999764321 12367899999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 204 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
++. .+..++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||
T Consensus 78 ~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 78 VCQ-AEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp EEE-SSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred Eec-CCCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccc
Confidence 994 55689999999999999999643 3458999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 284 VARIEVQTEG----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 284 ~a~~~~~~~~----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+++....... .....+|+.|+|||.+ ....++.++|+|+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG 200 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECI-----NFRKFSSRSDVWSYG 200 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHH-----HHCEECHHHHHHHHH
T ss_pred ceeeeccCcceeeccccccccccccCHHHh-----ccCCCCchhhHHHHH
Confidence 9986543222 2234578999999999 677899999999643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=267.57 Aligned_cols=186 Identities=30% Similarity=0.475 Sum_probs=157.6
Q ss_pred ecccccccccccccccceEEEEEEE------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
++.+.|++++.||+|+||.||++.+ +++.||||++..... . ...+.+.+|+.+++.++||||+++++++
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG-P----QHRSGWKQEIDILRTLYHEHIIKYKGCC 102 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC-H----HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC-h----HHHHHHHHHHHHHHhCCCcchhhEEEEE
Confidence 4556669999999999999999875 567899999975432 1 1236789999999999999999999999
Q ss_pred EeC--CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 206 RKR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 206 ~~~--~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
.+. ..+++||||+++++|.+++... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 103 EDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp EETTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred ecCCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcc
Confidence 874 6789999999999999999653 38999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 284 VARIEVQTEG----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 284 ~a~~~~~~~~----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+++....... .....+|+.|+|||.+ ....++.++|||+++.
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 225 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECL-----KEYKFYYASDVWSFGV 225 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHH-----HHCEEEHHHHHHHHHH
T ss_pred ccccccccccccccccCCCCCceeeChHHh-----cCCCCCcHHHHHHHHH
Confidence 9987544321 2334688999999999 7778999999996443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=274.53 Aligned_cols=192 Identities=22% Similarity=0.304 Sum_probs=155.9
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-- 209 (343)
.++|++.+.||+|+||.||+|.+ +++.||||++....... ...+++.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 99 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE----LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 99 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH----HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCH----HHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcc
Confidence 36799999999999999999998 68899999997654432 23467899999999999999999999997653
Q ss_pred ----eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 210 ----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 210 ----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
.+|+||||+ +++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 100 DDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 7899999876 34899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 286 RIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
+.... .....+||+.|+|||++. ....++.++|+|+++. +++.+||.+
T Consensus 176 ~~~~~--~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~ell~g~~pf~~ 228 (367)
T 1cm8_A 176 RQADS--EMTGYVVTRWYRAPEVIL----NWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228 (367)
T ss_dssp EECCS--SCCSSCSCGGGCCTHHHH----TTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccc--ccCcCcCCCCcCCHHHHh----CCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 86433 345568999999999983 2367999999996433 335666643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=266.69 Aligned_cols=197 Identities=21% Similarity=0.315 Sum_probs=155.4
Q ss_pred cccccc-cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCe
Q 019304 135 RKLNMG-TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMV 210 (343)
Q Consensus 135 ~~~~~~-~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 210 (343)
+.|++. +.||+|+||.||+|.. +++.||||++....... .+.+.+|+.++.++ +||||+++++++.+.+.
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI------RSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC------HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh------HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 456664 7899999999999987 78899999997654332 24688999999885 79999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc---EEEeccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIADFGVARI 287 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~---vkl~DFg~a~~ 287 (343)
+++||||+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999999999998753 4899999999999999999999999999999999999997765 99999999875
Q ss_pred cccC--------CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 288 EVQT--------EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 288 ~~~~--------~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.... ......+||+.|+|||++.........++.++|||+++. +++.+||.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 228 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcc
Confidence 4321 112334699999999998211001256889999996433 346666643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=266.59 Aligned_cols=194 Identities=24% Similarity=0.409 Sum_probs=154.8
Q ss_pred ceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 206 (343)
.....++|++.+.||+|+||.||+|.+ +++.||||++....... +.+.+|+.+++.+ +||||+++++++.
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-------EEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTT-------HHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccH-------HHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 334567899999999999999999998 78899999997654332 4678999999998 8999999999997
Q ss_pred e------CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEe
Q 019304 207 K------RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (343)
Q Consensus 207 ~------~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~ 280 (343)
. ...+++||||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEe
Confidence 7 4578999999999999999987555669999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCC-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 281 DFGVARIEVQTE-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 281 DFg~a~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|||++....... ......||+.|+|||++.........++.++|||+++.
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~ 222 (326)
T 2x7f_A 172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGI 222 (326)
T ss_dssp CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHH
T ss_pred eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHH
Confidence 999987654322 23445799999999998322222677899999996433
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=271.41 Aligned_cols=194 Identities=24% Similarity=0.322 Sum_probs=154.0
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||+|.. +++.||||++........ ...+.+|+.+++.++||||+++++++......+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc-----chhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEE
Confidence 5788999999999999999998 678999999965432211 124568999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~- 291 (343)
+||||++ ++|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 77 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp EEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred EEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 9999997 5999998764 346899999999999999999999999999999999999999999999999999864432
Q ss_pred CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 292 EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.......||+.|+|||++. ....++.++|||+++. +++.+||.+
T Consensus 155 ~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILL----GSTDYSTQIDMWGVGCIFYEMATGRPLFPG 203 (324)
T ss_dssp --------CGGGCCHHHHT----TCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccCcccccChhhhc----CCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2334457899999999983 3367899999996433 345566543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=273.77 Aligned_cols=190 Identities=29% Similarity=0.437 Sum_probs=149.5
Q ss_pred cceecccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHH--HhcCCCCCcceEEEEEE
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM--LATLKHLNIVRFIGACR 206 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~nIv~l~~~~~ 206 (343)
++.++.++|++.+.||+|+||.||+|+++++.||||++..... +.+..|..+ +..++||||+++++.+.
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~---------~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR---------QNFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGH---------HHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccch---------hhHHHHHHHHHHHhccCcchhhheeccc
Confidence 4557789999999999999999999999999999999964221 233344444 55689999999998664
Q ss_pred e-----CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeCCCCCCcEEEc
Q 019304 207 K-----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL---------GFIHRDLKSDNLLIS 272 (343)
Q Consensus 207 ~-----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---------giiHrDlkp~NILv~ 272 (343)
. ...+++||||+++++|.+++.... .++..++.++.|++.||+|||+. ||+||||||+|||++
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~ 154 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK 154 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc
Confidence 3 235789999999999999997643 58889999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccccccccC---------CCccCCCCCcceecCCCCCCCCCC--CCCCceeeeeeeccc
Q 019304 273 ADKSIKIADFGVARIEVQT---------EGMTPETGTYRWMAPGNSFFSPLP--HPSFEHKWSAKESCL 330 (343)
Q Consensus 273 ~~~~vkl~DFg~a~~~~~~---------~~~~~~~gt~~y~APE~~~~~~~~--~~~~~~~sDi~~~~~ 330 (343)
.++.+||+|||+++..... ......+||+.|+|||++.+.... ...++.++|||++.+
T Consensus 155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~ 223 (336)
T 3g2f_A 155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223 (336)
T ss_dssp TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHH
T ss_pred CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHH
Confidence 9999999999999764322 112345799999999998321000 146778999996443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=272.02 Aligned_cols=187 Identities=25% Similarity=0.471 Sum_probs=152.9
Q ss_pred ecccccccccccccccceEEEEEEE--CCce----EEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGED----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~----vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
+..++|++.+.||+|+||.||+|.+ +++. ||+|.+........ .+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS-----FQAVTDHMLAIGSLDHAHIVRLLGLC 84 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSC-----BCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHH-----HHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 4557899999999999999999987 4444 78888754432221 13567899999999999999999988
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
.. ...++||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 85 ~~-~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 85 PG-SSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp CB-SSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred cC-CccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcc
Confidence 64 5578999999999999999753 245888999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 286 RIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 286 ~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+....... .....||+.|+|||++ ....++.++|||+++.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 205 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESI-----HFGKYTHQSDVWSYGV 205 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred cccCcccccccccCCCCcccccChHHh-----ccCCCChhhHhHHhHH
Confidence 87544322 2344678899999999 7778999999996433
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=260.49 Aligned_cols=184 Identities=24% Similarity=0.429 Sum_probs=158.1
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||.||+|.. +++.||||++....... ..+.+.+|+.+++.++||||+++++++.+....+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-----CPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT-----HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh-----hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence 6788999999999999999998 58899999997543322 1257889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~- 291 (343)
+||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp EEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999999988643 45899999999999999999999999999999999999999999999999999764322
Q ss_pred --CCccCCCCCcceecCCCCCCCCCCCCCC-ceeeeeeeccc
Q 019304 292 --EGMTPETGTYRWMAPGNSFFSPLPHPSF-EHKWSAKESCL 330 (343)
Q Consensus 292 --~~~~~~~gt~~y~APE~~~~~~~~~~~~-~~~sDi~~~~~ 330 (343)
.......||+.|+|||.+ ....+ +.++|+|+++.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~~Di~slG~ 196 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELL-----KRREFHAEPVDVWSCGI 196 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGG-----TCSSBCHHHHHHHHHHH
T ss_pred chhcccCCccccCccChHHH-----hcCCCCCCcchHHHHHH
Confidence 223456799999999999 55554 78999996433
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=269.42 Aligned_cols=187 Identities=23% Similarity=0.341 Sum_probs=156.1
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC---
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--- 208 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--- 208 (343)
..+|++.+.||+|+||.||+|++ +++.||||++......... ...+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF----PITALREIKILQLLKHENVVNLIEICRTKASP 91 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS----CHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc----hHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence 47899999999999999999998 6789999998665443321 14677999999999999999999999873
Q ss_pred -----CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 209 -----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 209 -----~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
..+++||||+++ +|.+.+... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 92 YNRCKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -----CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred cccCCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999975 888887654 2458999999999999999999999999999999999999999999999999
Q ss_pred ccccccc-----CCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 284 VARIEVQ-----TEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 284 ~a~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+++.... ........||+.|+|||++. ....++.++|||+++.
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~ 217 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLL----GERDYGPPIDLWGAGC 217 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHT----TCCSCCTHHHHHHHHH
T ss_pred hcccccccccccccccCCcccccCccCchhhc----CCCCCCcHhHHHHHHH
Confidence 9986542 12234557899999999882 2356899999996433
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=268.03 Aligned_cols=182 Identities=34% Similarity=0.549 Sum_probs=150.2
Q ss_pred ecccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
++.++|++.+.||+|+||.||+|.+.++.||||++.... ..+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~ 74 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES--------ERKAFIVELRQLSRVNHPNIVKLYGACLN--PV 74 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTT--------HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TT
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChh--------HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--Cc
Confidence 567899999999999999999999999999999986421 12578999999999999999999998874 36
Q ss_pred EEEEEecCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCCCcEEEcCCCc-EEEecccccc
Q 019304 212 CIVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHG---LGFIHRDLKSDNLLISADKS-IKIADFGVAR 286 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~---~giiHrDlkp~NILv~~~~~-vkl~DFg~a~ 286 (343)
++||||+++++|.+++..... ..++...++.++.|++.||+|||+ +||+||||||+|||++.++. +||+|||+++
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 899999999999999975432 246888999999999999999999 89999999999999998876 7999999997
Q ss_pred ccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 287 IEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.... ......||+.|+|||++ ....++.++|||+++.
T Consensus 155 ~~~~--~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~slG~ 191 (307)
T 2eva_A 155 DIQT--HMTNNKGSAAWMAPEVF-----EGSNYSEKCDVFSWGI 191 (307)
T ss_dssp ------------CCTTSSCHHHH-----TCCCCCTHHHHHHHHH
T ss_pred cccc--ccccCCCCCceEChhhh-----CCCCCCcHHHHHHHHH
Confidence 5433 23345799999999999 7788999999996433
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=268.81 Aligned_cols=194 Identities=26% Similarity=0.480 Sum_probs=162.8
Q ss_pred CccceecccccccccccccccceEEEEEEE-------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCc
Q 019304 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNI 198 (343)
Q Consensus 127 ~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI 198 (343)
..+|.+..++|++.+.||+|+||.||+|.+ +++.||||++....... ..+.+.+|+.+++.+ +||||
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~i 93 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-----EHRALMSELKILIHIGHHLNV 93 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCTTB
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcH-----HHHHHHHHHHHHHhcccCCCe
Confidence 457889999999999999999999999985 34789999997543221 235788999999999 79999
Q ss_pred ceEEEEEEeCC-eEEEEEEecCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCC
Q 019304 199 VRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRRQN--------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (343)
Q Consensus 199 v~l~~~~~~~~-~~~iv~E~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~gL~yLH~~giiHrD 263 (343)
+++++++.... .+++||||+++++|.+++..... ..+++..++.++.|++.||.|||++||+|||
T Consensus 94 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~d 173 (316)
T 2xir_A 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 173 (316)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred eeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCccccc
Confidence 99999987754 58999999999999999986432 1278999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 264 LKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 264 lkp~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|||+|||++.++.+||+|||+++....... .....||+.|+|||++ ....++.++|||+++.
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~-----~~~~~~~~~Di~slG~ 238 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI-----FDRVYTIQSDVWSFGV 238 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhh-----ccccccchhHHHHHHH
Confidence 999999999999999999999986543222 1234578899999999 6788999999996433
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=282.23 Aligned_cols=199 Identities=15% Similarity=0.159 Sum_probs=155.6
Q ss_pred cceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHH---HHHhcCCCCCcceEE-
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEV---MMLATLKHLNIVRFI- 202 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~nIv~l~- 202 (343)
+|....++|++.+.||+|+||.||+|++ +++.||||++......... ..+.+.+|+ .+++.++||||++++
T Consensus 67 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~~l~hpniv~~~~ 143 (377)
T 3byv_A 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN---AIKQMKEEVLRLRLLRGIKNQKQAKVHL 143 (377)
T ss_dssp SSSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTT---HHHHHHHHHHGGGGSTTCCSHHHHHHHH
T ss_pred ecCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchH---HHHHHHHHHHHHHhccccCCHHHHHHHh
Confidence 4445568899999999999999999986 6899999999754332222 135788999 555666899999988
Q ss_pred ------EEEEeCC-----------------eEEEEEEecCCCCHHHHHHhhCCC-----CCCHHHHHHHHHHHHHHHHHH
Q 019304 203 ------GACRKRM-----------------VWCIVTEYAKGGSVRQFLTRRQNR-----AVPLKLAVKQALDVARGMAYV 254 (343)
Q Consensus 203 ------~~~~~~~-----------------~~~iv~E~~~~gsL~~~l~~~~~~-----~~~~~~~~~i~~qi~~gL~yL 254 (343)
+++...+ ..|+||||+ +|+|.+++...... .+++..++.++.||+.||+||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 222 (377)
T 3byv_A 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 222 (377)
T ss_dssp CBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 7666553 278999999 57999999864321 122477888999999999999
Q ss_pred HhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCccCCCCCcceecCCCCCCCCCCCC-----------CCceee
Q 019304 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHP-----------SFEHKW 323 (343)
Q Consensus 255 H~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~-----------~~~~~s 323 (343)
|++||+||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++ ... .++.++
T Consensus 223 H~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~-----~~~~~~~~~~~~~~~~~~~~ 294 (377)
T 3byv_A 223 HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELE-----ARRATISYHRDRRTLMTFSF 294 (377)
T ss_dssp HHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHH-----HHHTSTHHHHCCEEECCHHH
T ss_pred HhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhh-----cccccccccccccccCChhh
Confidence 999999999999999999999999999999985332 3445678 999999999 555 799999
Q ss_pred eeeeccc-----ccccCCCCc
Q 019304 324 SAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 324 Di~~~~~-----~~~~~p~~~ 339 (343)
|||+++. +++.+||.+
T Consensus 295 DvwSlG~il~elltg~~Pf~~ 315 (377)
T 3byv_A 295 DAWALGLVIYWIWCADLPITK 315 (377)
T ss_dssp HHHHHHHHHHHHHHSSCCC--
T ss_pred hHHHHHHHHHHHHHCCCCCcc
Confidence 9996433 335556543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=274.18 Aligned_cols=201 Identities=25% Similarity=0.343 Sum_probs=156.8
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++.+.||+|+||.||+|.+ +++.||+|++....... ......+.+.+|+.+++.++||||+++++++.+....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ-INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC----CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcc-cCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 36789999999999999999988 67789999986431100 0011236789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhC--------------------------------------CCCCCHHHHHHHHHHHHHHHHH
Q 019304 212 CIVTEYAKGGSVRQFLTRRQ--------------------------------------NRAVPLKLAVKQALDVARGMAY 253 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~--------------------------------------~~~~~~~~~~~i~~qi~~gL~y 253 (343)
++||||+++++|.+++.... ...+++..++.++.|++.||+|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 99999999999999985210 1123567788999999999999
Q ss_pred HHhCCceeCCCCCCcEEEcCCC--cEEEeccccccccccCC-----CccCCCCCcceecCCCCCCCCCCCCCCceeeeee
Q 019304 254 VHGLGFIHRDLKSDNLLISADK--SIKIADFGVARIEVQTE-----GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAK 326 (343)
Q Consensus 254 LH~~giiHrDlkp~NILv~~~~--~vkl~DFg~a~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~ 326 (343)
||++||+||||||+|||++.++ .+||+|||+++...... ......||+.|+|||++.. ....++.++|||
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~Diw 260 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT---TNESYGPKCDAW 260 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC---SSSCCCTHHHHH
T ss_pred HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc---CCCCCCcHHHHH
Confidence 9999999999999999998776 89999999998643321 1345579999999999821 236789999999
Q ss_pred eccc-----ccccCCCC
Q 019304 327 ESCL-----KTTWPPPW 338 (343)
Q Consensus 327 ~~~~-----~~~~~p~~ 338 (343)
+++. +++.+||.
T Consensus 261 slG~il~el~~g~~pf~ 277 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFP 277 (345)
T ss_dssp HHHHHHHHHHHSSCSSC
T ss_pred HHHHHHHHHHHCCCCCC
Confidence 6433 33555553
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=261.78 Aligned_cols=189 Identities=22% Similarity=0.437 Sum_probs=157.5
Q ss_pred cceecccccccccccccccceEEEEEEECC-----ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEE
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-----EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~ 203 (343)
.|.+..++|++.+.||+|+||.||+|.+.+ ..||||++...... ...+.+.+|+.+++.++||||+++++
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~ 80 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL-----DNKEKFMSEAVIMKNLDHPHIVKLIG 80 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH-----HHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc-----hHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 467788999999999999999999998722 35999998754321 12367899999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 204 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
++.+. ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~-~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 158 (281)
T 3cc6_A 81 IIEEE-PTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG 158 (281)
T ss_dssp EECSS-SCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred EEcCC-CCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccC
Confidence 98765 4689999999999999997643 458999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC--ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 284 VARIEVQTEG--MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 284 ~a~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+++....... .....+|+.|+|||.+ ....++.++|+|+++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG 201 (281)
T 3cc6_A 159 LSRYIEDEDYYKASVTRLPIKWMSPESI-----NFRRFTTASDVWMFA 201 (281)
T ss_dssp GGGCC---------CCCCCGGGCCHHHH-----HHCCCCHHHHHHHHH
T ss_pred CCcccccccccccccCCCCcceeCchhh-----ccCCCCchhccHHHH
Confidence 9986543322 2334678899999999 677899999999643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=262.69 Aligned_cols=195 Identities=28% Similarity=0.395 Sum_probs=161.1
Q ss_pred ccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~ 215 (343)
.+..++.||+|+||.||+|.++++.||||++........ ....+.+.+|+.+++.++||||+++++++......++||
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT--EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCT--TTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ccccCCccccCCCeEEEEEEECCceEEEEEEecccCcch--HHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence 345568999999999999999999999999975432211 112367899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCC-
Q 019304 216 EYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG- 293 (343)
Q Consensus 216 E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~- 293 (343)
||+++++|.+++.... ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence 9999999999997532 34689999999999999999999999999999999999999999999999999986543221
Q ss_pred --ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 294 --MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 294 --~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.....||+.|+|||.+ . +.++.++|+|+++. +++.+||.
T Consensus 190 ~~~~~~~g~~~y~aPE~~-----~-~~~~~~~Dv~slG~il~~l~~g~~p~~ 235 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEAL-----R-GEITPKSDIYSFGVVLLEIITGLPAVD 235 (307)
T ss_dssp EECSSCCSCGGGCCHHHH-----T-TEECTHHHHHHHHHHHHHHHHCCCSBC
T ss_pred ccccccCCCcCcCChHHh-----c-CCCCccchhHHHHHHHHHHHHCCCCcc
Confidence 2345799999999988 3 35889999996433 33555553
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=266.63 Aligned_cols=187 Identities=27% Similarity=0.456 Sum_probs=159.5
Q ss_pred ecccccccccccccccceEEEEEEE------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
++.++|++.+.||+|+||.||+|++ +++.||||++.... . ...+.+.+|+.+++.++||||+++++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--P----DQQRDFQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--H----HHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--H----HHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence 4668999999999999999999984 56789999997532 1 1235789999999999999999999998
Q ss_pred E--eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 206 R--KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 206 ~--~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
. ....+++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 94 YGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp ECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGG
T ss_pred ecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccc
Confidence 7 4566899999999999999998643 358999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC----CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 284 VARIEVQTE----GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 284 ~a~~~~~~~----~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+++...... ......||+.|+|||++ ....++.++|||+++.
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 218 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESL-----SDNIFSRQSDVWSFGV 218 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHH-----HHCEEEHHHHHHHHHH
T ss_pred cceecccCCccceeeccCCccccccCHHHh-----ccCCCChHHhHHHHHH
Confidence 998654332 12334688999999999 7788999999996443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=259.45 Aligned_cols=198 Identities=26% Similarity=0.433 Sum_probs=161.4
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHH-HHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQ-VMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
+..++|++.+.||+|+||.||+|.+ +++.||||++........... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 4557899999999999999999998 688999999976544332211 1125789999999999999999999999766
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCcEEEcCCCc-----EEEec
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKS-----IKIAD 281 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~g--iiHrDlkp~NILv~~~~~-----vkl~D 281 (343)
. ++||||+++++|.+++... ...+++..++.++.|++.||+|||++| ++||||||+|||++.++. +||+|
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred C--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 5 6999999999999998754 346899999999999999999999999 999999999999987776 99999
Q ss_pred cccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCC
Q 019304 282 FGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPP 337 (343)
Q Consensus 282 Fg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~ 337 (343)
||+++.... ......||+.|+|||++.. ....++.++|||+++. +++.+||
T Consensus 173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf 228 (287)
T 4f0f_A 173 FGLSQQSVH--SVSGLLGNFQWMAPETIGA---EEESYTEKADTYSFAMILYTILTGEGPF 228 (287)
T ss_dssp CTTCBCCSS--CEECCCCCCTTSCGGGSSC---SSCEECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCccccccc--cccccCCCccccCchhhcc---CCCCcCchhhHHHHHHHHHHHHcCCCCC
Confidence 999975332 3445689999999999822 2456789999996433 3355555
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=276.30 Aligned_cols=200 Identities=19% Similarity=0.273 Sum_probs=160.4
Q ss_pred ecccccccccccccccceEEEEEEE-----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGAC 205 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 205 (343)
+..++|++.+.||+|+||.||+++. +++.||||+++........ ...+.+.+|+.+++.+ +||||+++++++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA--KTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE--SSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhh--hHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 4457899999999999999999987 6789999998643211000 0013466899999999 699999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
.....+++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999999998654 4899999999999999999999999999999999999999999999999999
Q ss_pred cccccCC--CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 286 RIEVQTE--GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 286 ~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
+...... .....+||+.|+|||++.+ ....++.++|||+++. +++.+||.
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~DvwslG~il~ell~g~~pf~ 263 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRG---GDSGHDKAVDWWSLGVLMYELLTGASPFT 263 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTT---CC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred eecccCCCCcccCcccCcCccChhhhcC---CCCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence 8643222 2334579999999999831 1345789999996433 33556654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=268.20 Aligned_cols=201 Identities=24% Similarity=0.339 Sum_probs=147.3
Q ss_pred ccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
..|.+..++|++.+.||+|+||.||+|.+ +++.||||++...... ...+.+.+|+.+++.++||||+++++++
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 82 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ-----TSMDELLKEIQAMSQCHHPNIVSYYTSF 82 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC---------------------CCCCCCCTTBCCEEEEE
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc-----hhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence 45778889999999999999999999986 7889999998653321 1235688999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhh------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEE
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRR------QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~------~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl 279 (343)
...+..++||||+++++|.+++... ....+++..++.++.|++.||.|||++|++||||||+||+++.++.+||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEE
Confidence 9999999999999999999999742 2345899999999999999999999999999999999999999999999
Q ss_pred eccccccccccCC------CccCCCCCcceecCCCCCCCCCCC-CCCceeeeeeeccc-----ccccCCCC
Q 019304 280 ADFGVARIEVQTE------GMTPETGTYRWMAPGNSFFSPLPH-PSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 280 ~DFg~a~~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~-~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
+|||+++...... ......||+.|+|||.+ .. ..++.++|+|+++. +++.+||.
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 228 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM-----EQVRGYDFKADIWSFGITAIELATGAAPYH 228 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHH-----HHHHCCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHh-----ccccCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 9999987643321 12345799999999998 43 56889999996433 33555553
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=264.17 Aligned_cols=180 Identities=27% Similarity=0.428 Sum_probs=148.3
Q ss_pred ccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhc--CCCCCcceEEEEEEeC---
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT--LKHLNIVRFIGACRKR--- 208 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~--- 208 (343)
.++|++.+.||+|+||.||+|+++++.||||++.... . ..+.+|.+++.. ++||||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE----E-----ASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG----H-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc----c-----chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 4789999999999999999999999999999986421 1 234455555555 4999999999999887
Q ss_pred -CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeCCCCCCcEEEcCCCcEEE
Q 019304 209 -MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL--------GFIHRDLKSDNLLISADKSIKI 279 (343)
Q Consensus 209 -~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~--------giiHrDlkp~NILv~~~~~vkl 279 (343)
..+++||||+++++|.+++... .+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 6889999999999999999753 489999999999999999999998 9999999999999999999999
Q ss_pred eccccccccccCCC-----ccCCCCCcceecCCCCCCCCCCCCCCce------eeeeeeccc
Q 019304 280 ADFGVARIEVQTEG-----MTPETGTYRWMAPGNSFFSPLPHPSFEH------KWSAKESCL 330 (343)
Q Consensus 280 ~DFg~a~~~~~~~~-----~~~~~gt~~y~APE~~~~~~~~~~~~~~------~sDi~~~~~ 330 (343)
+|||+++....... ....+||+.|+|||++ ....+.. ++|||++..
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~~~~~~~DiwslG~ 240 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL-----DESLNRNHFQSYIMADMYSFGL 240 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHH-----TTCCCTTCTHHHHHHHHHHHHH
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhc-----ccccCCccccCccccchHHHHH
Confidence 99999975433221 1245799999999998 4444444 499995433
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=270.67 Aligned_cols=198 Identities=15% Similarity=0.193 Sum_probs=155.7
Q ss_pred cccccccccccccccceEEEEEEE-----CCceEEEEEeeCCCCChhHHHH-----HHHHHHHHHHHHhcCCCCCcceEE
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQV-----MEQQFQQEVMMLATLKHLNIVRFI 202 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~ 202 (343)
..++|++++.||+|+||.||+|.+ .+..||||++............ ....+.+|+..++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 457899999999999999999998 4568999999765432211111 123477899999999999999999
Q ss_pred EEEEe----CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC--c
Q 019304 203 GACRK----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK--S 276 (343)
Q Consensus 203 ~~~~~----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~--~ 276 (343)
+++.. ....++||||+ +++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++ .
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTS
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCc
Confidence 99988 67899999999 999999997644 589999999999999999999999999999999999999877 9
Q ss_pred EEEeccccccccccCCC--------ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 277 IKIADFGVARIEVQTEG--------MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 277 vkl~DFg~a~~~~~~~~--------~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
+||+|||+++....... .....||+.|+|||++ ....++.++|||+++. +++.+||.
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~slG~il~ell~g~~pf~ 261 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAH-----KGVALSRRSDVEILGYCMLRWLCGKLPWE 261 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHH-----HTCCCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHh-----cCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 99999999976533211 1345799999999999 6778999999996433 33555553
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=265.30 Aligned_cols=194 Identities=19% Similarity=0.242 Sum_probs=156.7
Q ss_pred ccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
+.+.++.++|++.+.||+|+||.||++.. +++.||||++.... . ...+.+.+|+.+++.++||||+++++++
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 95 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--Q----QDREEAQREADMHRLFNHPNILRLVAYC 95 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS--H----HHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC--H----HHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34567889999999999999999999997 78899999986532 1 1235788999999999999999999998
Q ss_pred Ee----CCeEEEEEEecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEE
Q 019304 206 RK----RMVWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (343)
Q Consensus 206 ~~----~~~~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl 279 (343)
.. ....++||||+++++|.+++... ....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl 175 (317)
T 2buj_A 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVL 175 (317)
T ss_dssp EEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEE
T ss_pred EeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEE
Confidence 63 34789999999999999999863 3456899999999999999999999999999999999999999999999
Q ss_pred eccccccccccCCC----------ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 280 ADFGVARIEVQTEG----------MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 280 ~DFg~a~~~~~~~~----------~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+|||+++....... .....||+.|+|||.+... ....++.++|||+++
T Consensus 176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~Di~slG 233 (317)
T 2buj_A 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ--SHCVIDERTDVWSLG 233 (317)
T ss_dssp CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCC--SEEEECTHHHHHHHH
T ss_pred EecCcchhcccccccccccccccccccccCCcccCCHhHhccC--CCcCCCchhhHHHHH
Confidence 99998875322110 1223579999999998211 122378899999643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=269.18 Aligned_cols=189 Identities=20% Similarity=0.298 Sum_probs=151.6
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++.+.||+|+||.||+|.+ +++.||||++........ .....+.+.+|+.+++.++||||+++++++......
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA-KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC-------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchh-hhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 46889999999999999999988 578999999975432221 111224678999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||+++ +|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 999999986 898888653 345888899999999999999999999999999999999999999999999999865432
Q ss_pred -CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 292 -EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 292 -~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
......+||+.|+|||++. ....++.++|||+++
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG 200 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLF----GARMYGVGVDMWAVG 200 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHT----TCSCCCHHHHHHHHH
T ss_pred cccCCcccccccccCchHhh----CCCCCCchhhhHhHH
Confidence 2345568999999999983 234589999999643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=260.35 Aligned_cols=184 Identities=25% Similarity=0.380 Sum_probs=155.0
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
...++|++.+.||+|+||.||+|.+ +++.||||++...... +.+.+|+.+++.++||||+++++++....
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--------QEIIKEISIMQQCDSPHVVKYYGSYFKNT 97 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCC--------HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHH--------HHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence 3457889999999999999999998 4889999999764322 46889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
.+++||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++....
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred EEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 999999999999999999743 3468999999999999999999999999999999999999999999999999997654
Q ss_pred cCC-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 290 QTE-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 290 ~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
... ......||+.|+|||.+ ....++.++|+|+++
T Consensus 177 ~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG 212 (314)
T 3com_A 177 DTMAKRNTVIGTPFWMAPEVI-----QEIGYNCVADIWSLG 212 (314)
T ss_dssp TTBSCBCCCCSCGGGCCHHHH-----SSSCBCTTHHHHHHH
T ss_pred hhccccCccCCCCCccChhhc-----CCCCCCccccHHHHH
Confidence 332 23445799999999999 777899999999643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=274.10 Aligned_cols=190 Identities=24% Similarity=0.342 Sum_probs=155.1
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC----
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~---- 208 (343)
.+|++.+.||+|+||.||+|++ +++.||||++..... .+.+|+.+++.++||||+++++++...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence 5688899999999999999998 688999999975432 234799999999999999999998542
Q ss_pred --CeEEEEEEecCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-CcEEEeccc
Q 019304 209 --MVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFG 283 (343)
Q Consensus 209 --~~~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~-~~vkl~DFg 283 (343)
..+++||||+++ +|.+.+.. .....+++..++.++.||+.||+|||++||+||||||+||||+.+ +.+||+|||
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence 246799999975 77776653 234569999999999999999999999999999999999999955 678999999
Q ss_pred cccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 284 VARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
+++...........+||+.|+|||++. ....++.++|||++++ +++.+||.+
T Consensus 203 ~a~~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwSlG~il~ell~G~~pf~~ 259 (420)
T 1j1b_A 203 SAKQLVRGEPNVSYICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPG 259 (420)
T ss_dssp TCEECCTTCCCCSCCSCTTSCCHHHHT----TCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hhhhcccCCCceeeeeCCCcCCHHHHc----CCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 998765555555678999999999983 2347999999996433 346666644
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=265.43 Aligned_cols=195 Identities=24% Similarity=0.364 Sum_probs=160.4
Q ss_pred ccccccccccccccceEEEEEEE---CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC---CCCCcceEEEEEE-
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACR- 206 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~- 206 (343)
.++|++.+.||+|+||.||+|.+ +++.||||++.......... ..+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP----LSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB----CTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCC----chhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 47899999999999999999987 46789999987543322111 2355677666655 8999999999987
Q ss_pred ----eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 019304 207 ----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (343)
Q Consensus 207 ----~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DF 282 (343)
.....++||||++ ++|.+++.......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence 4567899999997 59999998766566999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 283 GVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 283 g~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
|+++............||+.|+|||++ ....++.++|||+++. +++.+||.
T Consensus 165 g~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~il~~l~~g~~pf~ 220 (326)
T 1blx_A 165 GLARIYSFQMALTSVVVTLWYRAPEVL-----LQSSYATPVDLWSVGCIFAEMFRRKPLFR 220 (326)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHH-----TTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccCCCCccccccccceeCHHHH-----hcCCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence 999876544445566899999999999 6778999999996433 33555554
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-34 Score=258.44 Aligned_cols=201 Identities=24% Similarity=0.362 Sum_probs=164.1
Q ss_pred CccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEE
Q 019304 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (343)
Q Consensus 127 ~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 204 (343)
..++.+...++.....||+|+||.||+|.+ +++.||||++....... .+.+.+|+.+++.++||||++++++
T Consensus 14 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~ 87 (295)
T 2clq_A 14 LLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY------SQPLHEEIALHKHLKHKNIVQYLGS 87 (295)
T ss_dssp CCCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---------HHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHH------HHHHHHHHHHHHhCCCCCEeeEeeE
Confidence 345566677777778999999999999998 67899999997653221 2568899999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-CCcEEEecc
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADF 282 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~-~~~vkl~DF 282 (343)
+......++||||+++++|.+++.... ...+++..+..++.|++.||.|||++|++|+||||+|||++. ++.+||+||
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Df 167 (295)
T 2clq_A 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDF 167 (295)
T ss_dssp EEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCT
T ss_pred EEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeec
Confidence 999999999999999999999998653 234678889999999999999999999999999999999987 899999999
Q ss_pred ccccccccCC-CccCCCCCcceecCCCCCCCCCCCC--CCceeeeeeeccc-----ccccCCCC
Q 019304 283 GVARIEVQTE-GMTPETGTYRWMAPGNSFFSPLPHP--SFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 283 g~a~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~--~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
|+++...... ......||+.|+|||++ ... .++.++|+|+++. +++.+||.
T Consensus 168 g~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (295)
T 2clq_A 168 GTSKRLAGINPCTETFTGTLQYMAPEII-----DKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226 (295)
T ss_dssp TTCEESCC-----CCCCCCGGGCCHHHH-----HHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred ccccccCCCCCcccccCCCccccChhhh-----cCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 9998654322 23445799999999998 433 3889999996433 33555554
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=266.38 Aligned_cols=191 Identities=26% Similarity=0.412 Sum_probs=156.8
Q ss_pred ceecccccccccccccccceEEEEEEE-------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEE
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~ 202 (343)
+++..++|++.+.||+|+||.||+|.+ +++.||||++....... ...++.+|+.+++.++||||++++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~ 99 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ-----DELDFLMEALIISKFNHQNIVRCI 99 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHH-----HHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchh-----hHHHHHHHHHHHhhCCCCCCCeEE
Confidence 346778999999999999999999983 45689999996433221 235788999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCCHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC---C
Q 019304 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQN-----RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---D 274 (343)
Q Consensus 203 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~---~ 274 (343)
+++......++||||+++++|.+++..... ..+++..++.++.|++.||.|||++||+||||||+|||++. +
T Consensus 100 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~ 179 (327)
T 2yfx_A 100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 179 (327)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred EEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCc
Confidence 999999999999999999999999987532 34889999999999999999999999999999999999984 4
Q ss_pred CcEEEeccccccccccCC---CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 275 KSIKIADFGVARIEVQTE---GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 275 ~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
..+||+|||+++...... ......||+.|+|||.+ ....++.++|||+++.
T Consensus 180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 233 (327)
T 2yfx_A 180 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF-----MEGIFTSKTDTWSFGV 233 (327)
T ss_dssp CCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred ceEEECccccccccccccccccCCCcCCCcceeCHhHh-----cCCCCCchhhHHHHHH
Confidence 569999999997543322 12234678999999999 6778999999996433
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=262.14 Aligned_cols=197 Identities=20% Similarity=0.316 Sum_probs=142.6
Q ss_pred CccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHH-HHhcCCCCCcceEEE
Q 019304 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVM-MLATLKHLNIVRFIG 203 (343)
Q Consensus 127 ~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~nIv~l~~ 203 (343)
...|.+..++|++.+.||+|+||.||+|.. +++.||||++........ ..++.+|+. +++.++||||+++++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~e~~~~~~~~~h~niv~~~~ 88 (327)
T 3aln_A 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-----QKQLLMDLDVVMRSSDCPYIVQFYG 88 (327)
T ss_dssp CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHH-----HHHHHHHHHHHHSSCCCTTBCCEEE
T ss_pred HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchH-----HHHHHHHHHHHHHcCCCCcEeeeee
Confidence 357888899999999999999999999998 588999999976543221 234555555 778889999999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEE
Q 019304 204 ACRKRMVWCIVTEYAKGGSVRQFLTR---RQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKI 279 (343)
Q Consensus 204 ~~~~~~~~~iv~E~~~~gsL~~~l~~---~~~~~~~~~~~~~i~~qi~~gL~yLH~~-giiHrDlkp~NILv~~~~~vkl 279 (343)
++...+..++||||+++ +|.+++.. .....+++..+..++.|++.||.|||+. |++||||||+|||++.++.+||
T Consensus 89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 89 ALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp EEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEE
T ss_pred EEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEE
Confidence 99999999999999975 88887763 2345689999999999999999999999 9999999999999999999999
Q ss_pred eccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 280 ADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 280 ~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+|||+++............||+.|+|||++.. ......++.++|||+++.
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~Di~slG~ 217 (327)
T 3aln_A 168 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDP-SASRQGYDVRSDVWSLGI 217 (327)
T ss_dssp CCCSSSCC-------------------------------CCSHHHHHHHHH
T ss_pred ccCCCceecccccccccCCCCccccCceeecc-ccCcCCCCchhhHHHHHH
Confidence 99999987655444445579999999999821 112456889999996433
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=271.78 Aligned_cols=191 Identities=19% Similarity=0.273 Sum_probs=161.0
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC------CCCCcceEEEEE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL------KHLNIVRFIGAC 205 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~l~~~~ 205 (343)
..+|++.+.||+|+||.||+|.+ +++.||||++.... ...+.+.+|+.+++.+ .|+||+++++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~ 168 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-------RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF 168 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-------chHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence 46799999999999999999988 57899999996421 1224566777777766 577999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc--EEEeccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFG 283 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~--vkl~DFg 283 (343)
.....+++||||+. ++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||
T Consensus 169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 169 TFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred ccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999999999996 59999998776667999999999999999999999999999999999999998887 9999999
Q ss_pred cccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 284 VARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
+++.... .....+||+.|+|||++ ....++.++|||++.+ +++.+||.+
T Consensus 248 ~a~~~~~--~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 248 SSCYEHQ--RVYTYIQSRFYRAPEVI-----LGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp TCEETTC--CCCSSCSCGGGCCHHHH-----HTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cceecCC--cccccCCCCCccChHHH-----hCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 9975433 34456899999999999 6778999999996333 446666644
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=267.09 Aligned_cols=199 Identities=23% Similarity=0.315 Sum_probs=157.0
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChh--HHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPE--KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 210 (343)
++|++.+.||+|+||.||+|.+ +++.||||++........ ........+.+|+.+++.++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5788999999999999999998 678999999975432211 11112245889999999999999999999987765
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc---EEEeccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIADFGVARI 287 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~---vkl~DFg~a~~ 287 (343)
.++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 79999999999999998653 45899999999999999999999999999999999999986654 99999999986
Q ss_pred cccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 288 EVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
...........||+.|+|||++... ....++.++|||+++. +++.+||.
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~ 220 (322)
T 2ycf_A 167 LGETSLMRTLCGTPTYLAPEVLVSV--GTAGYNRAVDCWSLGVILFICLSGYPPFS 220 (322)
T ss_dssp CCCCHHHHHHHSCCTTCCHHHHHHT--TTTTCTTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccccccccCCcCccCchhhccC--CCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 5443333345799999999986211 3567899999996433 33556653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=258.24 Aligned_cols=184 Identities=24% Similarity=0.389 Sum_probs=150.1
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-----
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----- 207 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----- 207 (343)
++|++.+.||+|+||.||+|+. +++.||||++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-------EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-------HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence 5788899999999999999997 6889999999642 1223678999999999999999999998865
Q ss_pred --------CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEE
Q 019304 208 --------RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (343)
Q Consensus 208 --------~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl 279 (343)
....++||||+++++|.+++... ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+||
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEE
Confidence 35689999999999999999863 345788899999999999999999999999999999999999999999
Q ss_pred eccccccccccC---------------CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 280 ADFGVARIEVQT---------------EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 280 ~DFg~a~~~~~~---------------~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+|||+++..... .......||+.|+|||++. ....++.++|+|+++.
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~Di~slG~ 219 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD----GTGHYNEKIDMYSLGI 219 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHT----SCSCCCTHHHHHHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCccccc----CCCCCcchhhHHHHHH
Confidence 999998754321 1223457899999999982 2347899999996444
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=263.68 Aligned_cols=190 Identities=26% Similarity=0.479 Sum_probs=159.0
Q ss_pred cceecccccccccccccccceEEEEEEE------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEE
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~ 202 (343)
...+..++|++.+.||+|+||.||+|.+ +++.||||++..... . ..+.+.+|+.+++.++||||++++
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~----~~~~~~~E~~~l~~l~h~~iv~~~ 108 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--E----HLRDFEREIEILKSLQHDNIVKYK 108 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS--H----HHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH--H----HHHHHHHHHHHHHhCCCCCeeeEE
Confidence 3445678899999999999999999985 578999999976322 1 235789999999999999999999
Q ss_pred EEEEeCC--eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEe
Q 019304 203 GACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (343)
Q Consensus 203 ~~~~~~~--~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~ 280 (343)
+++.... .+++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+
T Consensus 109 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~ 187 (326)
T 2w1i_A 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIG 187 (326)
T ss_dssp EEECC----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEEC
T ss_pred EEEEecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEe
Confidence 9986644 6899999999999999998643 458999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCC----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 281 DFGVARIEVQTEG----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 281 DFg~a~~~~~~~~----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|||+++....... .....+++.|+|||.+ ....++.++|||+++.
T Consensus 188 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 236 (326)
T 2w1i_A 188 DFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL-----TESKFSVASDVWSFGV 236 (326)
T ss_dssp CCTTCEECCSSCSEEECSSCCSCCGGGCCHHHH-----HHCEEEHHHHHHHHHH
T ss_pred cCcchhhccccccccccccCCCCceeEECchhh-----cCCCCCchhhHHHHHH
Confidence 9999986544322 2234578889999999 6778999999996443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=272.64 Aligned_cols=196 Identities=23% Similarity=0.312 Sum_probs=145.4
Q ss_pred cceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
.|++. ++|++.+.||+|+||.||+|.+ +++.||||++........ ..+++.+|+.+++.++||||+++++++.
T Consensus 24 ~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 98 (367)
T 2fst_X 24 IWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII----HAKRTYRELRLLKHMKHENVIGLLDVFT 98 (367)
T ss_dssp EEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHH----HHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred ccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHH----HHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 34454 7899999999999999999987 688999999976544332 2367889999999999999999999997
Q ss_pred eC------CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEe
Q 019304 207 KR------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (343)
Q Consensus 207 ~~------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~ 280 (343)
.. ..+++|+|++ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~ 174 (367)
T 2fst_X 99 PARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174 (367)
T ss_dssp SCSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEe
Confidence 54 4579999999 6799998865 359999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 281 DFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 281 DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
|||+++.... .....+||+.|+|||++. ....++.++|||++++ +++.+||.+
T Consensus 175 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~ell~g~~pf~~ 232 (367)
T 2fst_X 175 DFGLARHTAD--EMTGYVATRWYRAPEIML----NWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232 (367)
T ss_dssp C-----------------CCCTTCCHHHHT----TCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eccccccccc--cCCCcCcCcCccChHHHc----CCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999986443 244568999999999983 2367899999996433 335666643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=269.59 Aligned_cols=192 Identities=18% Similarity=0.260 Sum_probs=159.8
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC--------CCCcceE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--------HLNIVRF 201 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~l 201 (343)
+-.++|++.+.||+|+||.||+|.. +++.||||++... ....+.+.+|+.+++.++ |+||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~ 106 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-------EHYTETALDEIRLLKSVRNSDPNDPNREMVVQL 106 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-------CcchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence 3457899999999999999999987 6789999999642 122357889999999885 7889999
Q ss_pred EEEEE----eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCC-
Q 019304 202 IGACR----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADK- 275 (343)
Q Consensus 202 ~~~~~----~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-giiHrDlkp~NILv~~~~- 275 (343)
++++. ....+++||||+ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHH
T ss_pred ecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccch
Confidence 99997 456789999999 66888888766556799999999999999999999998 999999999999999775
Q ss_pred ------------------------------------------------cEEEeccccccccccCCCccCCCCCcceecCC
Q 019304 276 ------------------------------------------------SIKIADFGVARIEVQTEGMTPETGTYRWMAPG 307 (343)
Q Consensus 276 ------------------------------------------------~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE 307 (343)
.+||+|||+++.... .....+||+.|+|||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE 263 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHH
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCCh
Confidence 799999999986543 344568999999999
Q ss_pred CCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 308 NSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 308 ~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
++ ....++.++|||+++. +++.+||.
T Consensus 264 ~~-----~~~~~~~~~DiwslG~il~elltg~~pf~ 294 (397)
T 1wak_A 264 VL-----IGSGYNTPADIWSTACMAFELATGDYLFE 294 (397)
T ss_dssp HH-----HTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hh-----cCCCCCcHHHHHHHHHHHHHHhhCCCCCC
Confidence 99 6777999999996433 33555553
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=264.91 Aligned_cols=185 Identities=32% Similarity=0.456 Sum_probs=154.2
Q ss_pred ccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhc--CCCCCcceEEEEEEeCC--
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT--LKHLNIVRFIGACRKRM-- 209 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~-- 209 (343)
.++|++.+.||+|+||.||+|+++++.||||++.... .+.+.+|.++++. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG---------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh---------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 4688999999999999999999999999999995321 1457788888877 79999999999998876
Q ss_pred --eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeCCCCCCcEEEcCCCcEEE
Q 019304 210 --VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH--------GLGFIHRDLKSDNLLISADKSIKI 279 (343)
Q Consensus 210 --~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH--------~~giiHrDlkp~NILv~~~~~vkl 279 (343)
..++||||+++++|.+++.+. .+++..++.++.|++.||.||| +.||+||||||+|||++.++.+||
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred cceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence 789999999999999999763 4899999999999999999999 899999999999999999999999
Q ss_pred eccccccccccCC-----CccCCCCCcceecCCCCCCCCCC-CCCCceeeeeeeccc
Q 019304 280 ADFGVARIEVQTE-----GMTPETGTYRWMAPGNSFFSPLP-HPSFEHKWSAKESCL 330 (343)
Q Consensus 280 ~DFg~a~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~~-~~~~~~~sDi~~~~~ 330 (343)
+|||+++...... ......||+.|+|||++...... ...++.++|||+++.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~ 245 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 245 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHH
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHH
Confidence 9999998654433 23445799999999998321110 014558999996433
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=268.20 Aligned_cols=191 Identities=21% Similarity=0.319 Sum_probs=155.4
Q ss_pred ccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC---
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--- 209 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--- 209 (343)
..+|++.+.||+|+||.||+|++ .+..||+|++...... ..+|+.+++.++||||+++++++....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----------~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 108 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----------KNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----------CCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----------HHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence 36789999999999999999998 5566999988654322 237999999999999999999996543
Q ss_pred ---eEEEEEEecCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc-CCCcEEEeccc
Q 019304 210 ---VWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIADFG 283 (343)
Q Consensus 210 ---~~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~-~~~~vkl~DFg 283 (343)
.+++||||+++ ++...+.. .....+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 109 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 109 DEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp SCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 37899999976 45444432 2345699999999999999999999999999999999999999 79999999999
Q ss_pred cccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 284 VARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
+|+............||+.|+|||++. ....++.++|||+++. +++.+||.+
T Consensus 188 ~a~~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 244 (394)
T 4e7w_A 188 SAKILIAGEPNVSYICSRYYRAPELIF----GATNYTTNIDIWSTGCVMAELMQGQPLFPG 244 (394)
T ss_dssp TCEECCTTCCCCSSCSCGGGCCHHHHT----TCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CcccccCCCCCcccccCcCccCHHHHc----CCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 998765555556678999999999983 3346899999996333 346666644
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=263.57 Aligned_cols=193 Identities=25% Similarity=0.341 Sum_probs=146.2
Q ss_pred ccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGA 204 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~ 204 (343)
..+++...+|++.+.||+|+||.||+|.+ +++.||||++..... ...+.+.+|+.+++.+. ||||++++++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 94 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE------EKNRAIIQEVCFMKKLSGHPNIVQFCSA 94 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH------HHHHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch------HHHHHHHHHHHHHHHhccCCChhhcccc
Confidence 45667778999999999999999999998 788999999854321 12357889999999996 9999999999
Q ss_pred EE--------eCCeEEEEEEecCCCCHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCcEEEcC
Q 019304 205 CR--------KRMVWCIVTEYAKGGSVRQFLTRR-QNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISA 273 (343)
Q Consensus 205 ~~--------~~~~~~iv~E~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~g--iiHrDlkp~NILv~~ 273 (343)
+. ....+++||||++ |+|.+++... ....+++..++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~ 173 (337)
T 3ll6_A 95 ASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN 173 (337)
T ss_dssp EEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECT
T ss_pred ccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECC
Confidence 94 3345899999996 6999998752 3456999999999999999999999999 999999999999999
Q ss_pred CCcEEEeccccccccccCCCc-------------cCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 274 DKSIKIADFGVARIEVQTEGM-------------TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 274 ~~~vkl~DFg~a~~~~~~~~~-------------~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
++.+||+|||+++........ ....||+.|+|||++.. .....++.++|||+++
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~~~Dv~slG 240 (337)
T 3ll6_A 174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDL--YSNFPIGEKQDIWALG 240 (337)
T ss_dssp TSCEEBCCCTTCBCCSSCC-------------------------------C--CTTSCSSHHHHHHHHH
T ss_pred CCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhc--cccCCCChHHhHHHHH
Confidence 999999999999865432211 13468999999998721 1456789999999643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=261.08 Aligned_cols=188 Identities=23% Similarity=0.358 Sum_probs=157.5
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CC
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RM 209 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~ 209 (343)
.++|++.+.||+|+||.||++.. +++.||+|++......... .+.+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE----KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHH----HHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence 46888999999999999999998 6789999999876554332 3678999999999999999999998854 56
Q ss_pred eEEEEEEecCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeCCCCCCcEEEcCCCcEEEecc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLG-----FIHRDLKSDNLLISADKSIKIADF 282 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~g-----iiHrDlkp~NILv~~~~~vkl~DF 282 (343)
.+++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 8899999999999999997532 345899999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCC-ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 283 GVARIEVQTEG-MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 283 g~a~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|+++....... .....||+.|+|||.+ ....++.++|+|+++.
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 204 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQM-----NRMSYNEKSDIWSLGC 204 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHH-----HCC-CCHHHHHHHHHH
T ss_pred chheeeccccccccccCCCccccChHHh-----ccCCCCchhhHHHHHH
Confidence 99986543221 2234689999999999 6778999999996433
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=268.05 Aligned_cols=201 Identities=18% Similarity=0.232 Sum_probs=154.2
Q ss_pred cccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChh-----HHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPE-----KAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
..++|++.+.||+|+||.||+|.. +++.||||++........ ......+.+.+|+.+++.++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 347889999999999999999987 788999999865433221 12233468999999999999999999999985
Q ss_pred e-----CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEec
Q 019304 207 K-----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (343)
Q Consensus 207 ~-----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~D 281 (343)
. ...+++||||++ ++|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 4 236899999997 5898888753 34689999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 282 FGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 282 Fg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
||+++............||+.|+|||++. ....++.++|||+++. +++.+||.+
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVM----QFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp TTC---------------CGGGCCHHHHT----TCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCcccccccccccceecccceecCcHHhc----CCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence 99998655555555668999999999982 2367899999996433 335555543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=264.50 Aligned_cols=187 Identities=22% Similarity=0.451 Sum_probs=150.3
Q ss_pred ecccccccccccccccceEEEEEEE--CCce----EEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGED----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~----vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
+..++|++.+.||+|+||.||+|.+ +++. ||+|.+........ .+.+.+|+.+++.++||||+++++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~ 86 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-----NKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCC-----HHHHHHHHHHHTTCCBTTBCCCCEEE
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHH-----HHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 3457899999999999999999987 4554 47777754332222 25788999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
.... .++|+|++++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 87 LTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp ESSS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred ecCC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 8765 689999999999999998643 45899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 286 RIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 286 ~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+....... .....+|+.|+|||.+ ....++.++|||+++.
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~-----~~~~~~~~~Di~slG~ 207 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESI-----LHRIYTHQSDVWSYGV 207 (327)
T ss_dssp ---------------CCCGGGSCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred eEccCccccccccCCCccccccCHHHH-----cCCCCChHHHHHHHHH
Confidence 86543222 2233568899999999 7788999999996443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=271.15 Aligned_cols=199 Identities=14% Similarity=0.099 Sum_probs=146.8
Q ss_pred cceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHH---HHHhcCCCCCcceEE-
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEV---MMLATLKHLNIVRFI- 202 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~nIv~l~- 202 (343)
.|....++|++.+.||+|+||.||+|.+ +++.||||++......... ..+.+.+|+ .+++. +||||++++
T Consensus 56 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~~~~l~~-~hp~iv~~~~ 131 (371)
T 3q60_A 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRS---ELERLHEATFAAARLLG-ESPEEARDRR 131 (371)
T ss_dssp TTTCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHH---HHHHHHHHHHHHHHHHC-----------
T ss_pred cCCCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccccccc---HHHHHHHHHHHHHHhcc-cChhhhhhce
Confidence 3444567799999999999999999997 6789999999876553322 235677785 45555 799988865
Q ss_pred ------EEEEeC-----------------CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHH------HHHHHHHHHHHHH
Q 019304 203 ------GACRKR-----------------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA------VKQALDVARGMAY 253 (343)
Q Consensus 203 ------~~~~~~-----------------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~------~~i~~qi~~gL~y 253 (343)
+++... ..+|+||||++ ++|.+++..... .++...+ +.++.||+.||+|
T Consensus 132 ~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~ 209 (371)
T 3q60_A 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAAN 209 (371)
T ss_dssp CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHH
Confidence 555433 33799999998 799999986422 2444555 6778999999999
Q ss_pred HHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCccCCCCCcceecCCCCCCCCCCC--CCCceeeeeeeccc-
Q 019304 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPH--PSFEHKWSAKESCL- 330 (343)
Q Consensus 254 LH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~--~~~~~~sDi~~~~~- 330 (343)
||++||+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++ .. ..++.++|||++..
T Consensus 210 LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~-----~~~~~~~~~~~DiwSlG~i 282 (371)
T 3q60_A 210 LQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFL-----NASTATFTHALNAWQLGLS 282 (371)
T ss_dssp HHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHH-----TCSEEECCHHHHHHHHHHH
T ss_pred HHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhc-----cCCCCCcCccccHHHHHHH
Confidence 99999999999999999999999999999999865332 2244677999999999 55 77999999996333
Q ss_pred ----ccccCCCCcc
Q 019304 331 ----KTTWPPPWRH 340 (343)
Q Consensus 331 ----~~~~~p~~~~ 340 (343)
+++.+||.+.
T Consensus 283 l~elltg~~Pf~~~ 296 (371)
T 3q60_A 283 IYRVWCLFLPFGLV 296 (371)
T ss_dssp HHHHHHSSCSTTBC
T ss_pred HHHHHhCCCCCCCc
Confidence 3366666544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=267.41 Aligned_cols=192 Identities=22% Similarity=0.294 Sum_probs=159.2
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC----
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~---- 208 (343)
.+|++.+.||+|+||.||+|.. +++.||||++...... ...+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-----TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH-----HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc-----HHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 5899999999999999999988 6788999999753321 2236788999999999999999999999765
Q ss_pred -CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 209 -MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 209 -~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
...++||||++ ++|.+++... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 102 MKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp CCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 36899999997 4999998753 489999999999999999999999999999999999999999999999999986
Q ss_pred cccCCC----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 288 EVQTEG----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 288 ~~~~~~----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
...... ....+||+.|+|||++. ....++.++|||+++. +++.+||.+
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~ell~g~~pf~~ 234 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHH----TBCSCSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCCCCccccccccccccCCCCCHHhc----CCCCCCcchhHHHHHHHHHHHHHCCCCCCC
Confidence 543322 24458999999999863 4456899999996433 335566543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=255.07 Aligned_cols=192 Identities=26% Similarity=0.390 Sum_probs=157.3
Q ss_pred ccceeccc--ccccccccccccceEEEEEEE--CCc---eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcce
Q 019304 128 DEWTIDLR--KLNMGTAFAQGAFGKLYRGTY--NGE---DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (343)
Q Consensus 128 ~~~~i~~~--~~~~~~~lg~G~fg~Vy~~~~--~~~---~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~ 200 (343)
.++.++.+ .|...+.||+|+||.||+|.+ +++ .||+|++....... ..+.+.+|+.+++.++||||++
T Consensus 12 ~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~ 86 (298)
T 3pls_A 12 KDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ-----QVEAFLREGLLMRGLNHPNVLA 86 (298)
T ss_dssp GGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHH-----HHHHHHHHHHHHHTCCCTTBCC
T ss_pred hheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHH-----HHHHHHHHHHHHHhCCCCCeee
Confidence 34444444 445679999999999999986 332 69999986533221 2367899999999999999999
Q ss_pred EEEEEEeCCeE-EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEE
Q 019304 201 FIGACRKRMVW-CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (343)
Q Consensus 201 l~~~~~~~~~~-~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl 279 (343)
+++++.+.+.. ++||||+.+++|.+++... ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl 165 (298)
T 3pls_A 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKV 165 (298)
T ss_dssp CCEEECCSSSCCEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEE
T ss_pred EEEEEecCCCCcEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEe
Confidence 99999876654 8999999999999999753 356899999999999999999999999999999999999999999999
Q ss_pred eccccccccccC-----CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 280 ADFGVARIEVQT-----EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 280 ~DFg~a~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+|||+++..... .......+|+.|+|||.+ ....++.++|+|+++.
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 216 (298)
T 3pls_A 166 ADFGLARDILDREYYSVQQHRHARLPVKWTALESL-----QTYRFTTKSDVWSFGV 216 (298)
T ss_dssp CCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHH-----TTCCCCHHHHHHHHHH
T ss_pred CcCCCcccccCCcccccccCcCCCCCccccChhhh-----ccCCCChhhchhhHHH
Confidence 999999754322 122344688999999999 7888999999996443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=270.93 Aligned_cols=185 Identities=28% Similarity=0.451 Sum_probs=145.6
Q ss_pred cccccccccccccceEEEEEEE--C-C--ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-C
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--N-G--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-R 208 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~-~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~ 208 (343)
..|++.+.||+|+||.||+|.+ + + ..||||.+........ .++|.+|+.+++.++||||+++++++.. .
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 163 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSHPNVLSLLGICLRSE 163 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHH-----HHHHHHHHTTSTTCCCTTBCCCCEEECCCS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHH-----HHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 3567789999999999999987 2 2 3589999875433222 3678999999999999999999998754 4
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
...++||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCeEEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccc
Confidence 5789999999999999999753 345889999999999999999999999999999999999999999999999999854
Q ss_pred ccCCC-----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 289 VQTEG-----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 289 ~~~~~-----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
..... .....+|+.|+|||.+ ....++.++|||+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DvwSlG~ 284 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESL-----QTQKFTTKSDVWSFGV 284 (373)
T ss_dssp ---------------CCGGGSCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred cccccccccccCCCCCcccccChHHh-----cCCCCCcHHHHHHHHH
Confidence 33221 2234578899999999 7788999999996433
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-34 Score=258.13 Aligned_cols=184 Identities=24% Similarity=0.415 Sum_probs=157.8
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++.+.||+|+||.||+|.. +++.||||++......... .+.+.+|+.+++.++||||+++++++......
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD----TSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHH----HHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 36889999999999999999998 6889999999754433221 25688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC---CcEEEecccccccc
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD---KSIKIADFGVARIE 288 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~---~~vkl~DFg~a~~~ 288 (343)
++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+++..
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999999999987654 48999999999999999999999999999999999999754 47999999999876
Q ss_pred ccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 289 VQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
..........||+.|+|||.+ . ..++.++|+|+++
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~-----~-~~~~~~~Di~slG 209 (287)
T 2wei_A 175 QQNTKMKDRIGTAYYIAPEVL-----R-GTYDEKCDVWSAG 209 (287)
T ss_dssp CCCSSCSCHHHHHTTCCHHHH-----T-TCCCTHHHHHHHH
T ss_pred cCCCccccccCcccccChHHh-----c-CCCCCchhhHhHH
Confidence 554444455689999999988 3 3488999999643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-34 Score=259.15 Aligned_cols=185 Identities=28% Similarity=0.436 Sum_probs=152.6
Q ss_pred cccccccccccccceEEEEEEEC---C--ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE-eC
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTYN---G--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR-KR 208 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~ 208 (343)
.+|++.+.||+|+||.||+|.+. + ..||+|.+...... ...+.+.+|+.+++.++||||+++++++. ..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-----GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 99 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH-----HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH-----HHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence 56888999999999999999862 1 25899998653322 12367899999999999999999999864 45
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
...++||||+++++|.+++... ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+++..
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 5789999999999999999753 355889999999999999999999999999999999999999999999999999864
Q ss_pred ccCC-----CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 289 VQTE-----GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 289 ~~~~-----~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.... ......+|+.|+|||.+ ....++.++|+|+++.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 220 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESL-----QTQKFTTKSDVWSFGV 220 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred cccchhccccccCCCCCccccChHHh-----cCCCCChHHHHHHHHH
Confidence 3322 12334578899999999 7788999999996433
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=265.70 Aligned_cols=201 Identities=20% Similarity=0.303 Sum_probs=166.1
Q ss_pred ecccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHH-----------HHHHHHHHHHHHHHhcCCCCCcce
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKA-----------QVMEQQFQQEVMMLATLKHLNIVR 200 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~nIv~ 200 (343)
+..++|++.+.||+|+||.||+|.++++.||||++.......... ....+.+.+|+.+++.++||||++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 446799999999999999999999999999999986432111000 001157889999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCCHHHH------HHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcC
Q 019304 201 FIGACRKRMVWCIVTEYAKGGSVRQF------LTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISA 273 (343)
Q Consensus 201 l~~~~~~~~~~~iv~E~~~~gsL~~~------l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~giiHrDlkp~NILv~~ 273 (343)
+++++.....+++||||+++++|.++ +.......+++..++.++.|++.||.|||+ +|++||||||+|||++.
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 99999999999999999999999998 654435679999999999999999999999 99999999999999999
Q ss_pred CCcEEEeccccccccccCCCccCCCCCcceecCCCCCCCCCCCC-CCce-eeeeeeccc-----ccccCCCC
Q 019304 274 DKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHP-SFEH-KWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 274 ~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~-~~~~-~sDi~~~~~-----~~~~~p~~ 338 (343)
++.+||+|||+++..... ......||+.|+|||++ ... .++. ++|+|+++. +++.+||.
T Consensus 188 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~-----~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 253 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFF-----SNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253 (348)
T ss_dssp TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGG-----SSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCcEEEeccccccccccc-cccCCCCCcCccCchhh-----cCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999865443 34556899999999999 555 6766 999996433 33555554
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=259.68 Aligned_cols=183 Identities=22% Similarity=0.316 Sum_probs=156.9
Q ss_pred ecccccccccccccccceEEEEEEE---CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCC------CcceEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL------NIVRFI 202 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------nIv~l~ 202 (343)
+-.++|++.+.||+|+||.||+|.+ +++.||||++.... ...+.+.+|+.+++.++|+ ++++++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-------RYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-------HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-------chhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 3457899999999999999999987 57899999996421 1235678889888888655 499999
Q ss_pred EEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC---------
Q 019304 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA--------- 273 (343)
Q Consensus 203 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~--------- 273 (343)
+++.....+++||||+ +++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence 9999999999999999 889999998766567899999999999999999999999999999999999987
Q ss_pred ----------CCcEEEeccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 274 ----------DKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 274 ----------~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
++.+||+|||+++.... ......||+.|+|||++ ....++.++|||+++
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~slG 221 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVI-----LALGWSQPCDVWSIG 221 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHH-----TTSCCCTHHHHHHHH
T ss_pred ccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHh-----hCCCCCcchhhHHHH
Confidence 66899999999986433 33456899999999999 778899999999643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=269.31 Aligned_cols=189 Identities=12% Similarity=0.180 Sum_probs=157.6
Q ss_pred ccccccccccccccceEEEEEEEC----------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcce---
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTYN----------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR--- 200 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~--- 200 (343)
.++|++.+.||+|+||.||+|.+. ++.||||++... +.+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~ 109 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----------GRLFNEQNFFQRAAKPLQVNKWK 109 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----------STHHHHHHHHHHHCCHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----------chHHHHHHHHHHhcccchhhhhh
Confidence 478999999999999999999873 678999999753 24779999999999999887
Q ss_pred ------------EEEEEEe-CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q 019304 201 ------------FIGACRK-RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSD 267 (343)
Q Consensus 201 ------------l~~~~~~-~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~ 267 (343)
+++++.. ....++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+
T Consensus 110 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~ 188 (352)
T 2jii_A 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAE 188 (352)
T ss_dssp HHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGG
T ss_pred hhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHH
Confidence 6777766 67889999999 999999998754456999999999999999999999999999999999
Q ss_pred cEEEcCCC--cEEEeccccccccccCC--------CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----cc
Q 019304 268 NLLISADK--SIKIADFGVARIEVQTE--------GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KT 332 (343)
Q Consensus 268 NILv~~~~--~vkl~DFg~a~~~~~~~--------~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~ 332 (343)
|||++.++ .+||+|||+++...... ......||+.|+|||++ ....++.++|||+++. ++
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~slG~il~el~~ 263 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLH-----KGCGPSRRSDLQSLGYCMLKWLY 263 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHH-----TTCCCCHHHHHHHHHHHHHHHHH
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHH-----ccCCCCchhhHHHHHHHHHHHHh
Confidence 99999988 99999999997654322 12334799999999999 7778999999996433 33
Q ss_pred ccCCCCc
Q 019304 333 TWPPPWR 339 (343)
Q Consensus 333 ~~~p~~~ 339 (343)
+.+||..
T Consensus 264 g~~pf~~ 270 (352)
T 2jii_A 264 GFLPWTN 270 (352)
T ss_dssp SCCTTGG
T ss_pred CCCCccc
Confidence 5556543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=260.60 Aligned_cols=191 Identities=25% Similarity=0.417 Sum_probs=155.1
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 210 (343)
..++|++.+.||+|+||.||+|.+ +++.||+|++....... .+.+.+|+.+++.++||||+++++++.....
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 90 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE------LEDYIVEIEILATCDHPYIVKLLGAYYHDGK 90 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC------HHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH------HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence 457899999999999999999998 47899999986543222 2578899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~ 290 (343)
+++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999999999987643 4589999999999999999999999999999999999999999999999998764322
Q ss_pred C-CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 291 T-EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 291 ~-~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
. .......||+.|+|||++.........++.++|+|+++.
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~ 210 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGI 210 (302)
T ss_dssp HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHH
T ss_pred cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHH
Confidence 1 123345799999999987322123567889999996433
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=267.22 Aligned_cols=196 Identities=22% Similarity=0.341 Sum_probs=159.0
Q ss_pred ccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
..|++. ++|.+.+.||+|+||.||+|.+ +++.||||++........ ..+.+.+|+.+++.++||||+++++++
T Consensus 36 ~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~ 110 (371)
T 4exu_A 36 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI----FAKRAYRELLLLKHMQHENVIGLLDVF 110 (371)
T ss_dssp EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHH----HHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred ceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchh----HHHHHHHHHHHHHhcCCCCchhhhhhe
Confidence 345554 6899999999999999999988 688999999976554332 346788999999999999999999999
Q ss_pred EeCCeE------EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEE
Q 019304 206 RKRMVW------CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (343)
Q Consensus 206 ~~~~~~------~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl 279 (343)
...... ++||||++ ++|.+++. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||
T Consensus 111 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL 185 (371)
T 4exu_A 111 TPASSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKI 185 (371)
T ss_dssp CSCSSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEE
T ss_pred eccCCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEE
Confidence 877654 99999997 58887763 34899999999999999999999999999999999999999999999
Q ss_pred eccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 280 ADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 280 ~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
+|||+++.... .....+||+.|+|||++. ....++.++|||+++. +++.+||.+
T Consensus 186 ~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~el~~g~~pf~~ 244 (371)
T 4exu_A 186 LDFGLARHADA--EMTGYVVTRWYRAPEVIL----SWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 244 (371)
T ss_dssp CSTTCC----------CTTCCCTTSCHHHHS----CCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EecCccccccc--CcCCcccCccccCHHHhc----CCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 99999986433 344568999999999982 2377899999996433 335666643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=254.24 Aligned_cols=189 Identities=24% Similarity=0.315 Sum_probs=157.1
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE-EeCCeE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVW 211 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~ 211 (343)
++|++.+.||+|+||.||+|.+ +++.||||++...... +.+.+|+.+++.++|++++..+..+ ......
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--------CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--------hHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 6789999999999999999996 7889999998765433 2578999999999988766655544 667788
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE---cCCCcEEEecccccccc
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIE 288 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv---~~~~~vkl~DFg~a~~~ 288 (343)
++||||+ +++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 9999999 88999999753 3469999999999999999999999999999999999999 47889999999999865
Q ss_pred ccCCC--------ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 289 VQTEG--------MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 289 ~~~~~--------~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
..... .....||+.|+|||.+ ....++.++|||+++. +++.+||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~slG~il~~l~~g~~pf~ 216 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTH-----LGIEQSRRDDLESLGYVLMYFNLGSLPWQ 216 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHH-----TTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cccccccccccccccccccccccCChhhh-----cCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 44322 2345799999999999 7788999999996433 33555554
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=271.79 Aligned_cols=189 Identities=21% Similarity=0.332 Sum_probs=142.3
Q ss_pred cccc-ccccccccceEEEEEEE----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--C
Q 019304 136 KLNM-GTAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--R 208 (343)
Q Consensus 136 ~~~~-~~~lg~G~fg~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~ 208 (343)
.|.+ +++||+|+||.||+|.+ +++.||||++...... ..+.+|+.+++.++||||+++++++.. .
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--------MSACREIALLRELKHPNVISLQKVFLSHAD 92 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--------HHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--------HHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence 3444 56899999999999996 3678999999754432 357799999999999999999999954 6
Q ss_pred CeEEEEEEecCCCCHHHHHHhhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE----cCCCcE
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQ-------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI----SADKSI 277 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~-------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv----~~~~~v 277 (343)
..+++||||+++ +|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||| +.++.+
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 93 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp TEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred CeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 689999999965 8888886321 2248999999999999999999999999999999999999 677899
Q ss_pred EEeccccccccccC----CCccCCCCCcceecCCCCCCCCCCC-CCCceeeeeeeccc-----ccccCCCC
Q 019304 278 KIADFGVARIEVQT----EGMTPETGTYRWMAPGNSFFSPLPH-PSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 278 kl~DFg~a~~~~~~----~~~~~~~gt~~y~APE~~~~~~~~~-~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
||+|||+++..... ......+||+.|+|||++ .. ..++.++|||++++ +++.+||.
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 237 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL-----LGARHYTKAIDIWAIGCIFAELLTSEPIFH 237 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHH-----TTCCSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhh-----cCCCcccchhhhHHHHHHHHHHHhCCCCCC
Confidence 99999999865432 223456899999999998 44 55999999996333 34666664
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=266.74 Aligned_cols=198 Identities=26% Similarity=0.487 Sum_probs=160.6
Q ss_pred CCccceecccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
....|+++.++|++.+.||+|+||.||+|.+.+ .+|+|++......... .+.+.+|+.+++.++||||+++++++
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~ 98 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQ----LKAFKREVMAYRQTRHENVVLFMGAC 98 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCC----CCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHH----HHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 457899999999999999999999999999865 5999998765433221 13577899999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
.....+++||||+++++|.+++... ...+++..++.++.|++.||+|||++|++||||||+|||++ ++.+||+|||++
T Consensus 99 ~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 99 MSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp ECSSCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred ecCCceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCc
Confidence 9999999999999999999999653 34688999999999999999999999999999999999998 789999999998
Q ss_pred ccccc------CCCccCCCCCcceecCCCCCCCC----CCCCCCceeeeeeeccc
Q 019304 286 RIEVQ------TEGMTPETGTYRWMAPGNSFFSP----LPHPSFEHKWSAKESCL 330 (343)
Q Consensus 286 ~~~~~------~~~~~~~~gt~~y~APE~~~~~~----~~~~~~~~~sDi~~~~~ 330 (343)
+.... ........||+.|+|||.+.... .....++.++|||+++.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~ 231 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHH
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHH
Confidence 75421 11223446899999999983210 01356899999996443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=259.19 Aligned_cols=197 Identities=20% Similarity=0.352 Sum_probs=142.7
Q ss_pred ccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
..|.+..++|++.+.||+|+||.||+|.+ +++.||||++........ ..+.+.++..+++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~~~~~~~~h~~i~~~~~~~ 93 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE----NKRILMDLDVVLKSHDCPYIVQCFGTF 93 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHH----HHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchH----HHHHHHHHHHHHHhcCCCceeeEEEEE
Confidence 45667788999999999999999999998 688999999976543222 223455566678889999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEecccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGV 284 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-giiHrDlkp~NILv~~~~~vkl~DFg~ 284 (343)
.....+++||||+ ++.+..+... ....+++..++.++.|++.||.|||++ |++||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~~~~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 171 (318)
T 2dyl_A 94 ITNTDVFIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI 171 (318)
T ss_dssp ECSSEEEEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCcEEEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCC
Confidence 9999999999999 5455555543 345689999999999999999999995 999999999999999999999999999
Q ss_pred ccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 285 ARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
++............||+.|+|||++.........++.++|||+++.
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~ 217 (318)
T 2dyl_A 172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGI 217 (318)
T ss_dssp C--------------CCTTCCHHHHC--------CCTHHHHHHHHH
T ss_pred chhccCCccccccCCCccccChhhcccccccccCCccccchhhHHH
Confidence 9866554444556799999999998432223567889999996433
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=254.69 Aligned_cols=189 Identities=24% Similarity=0.315 Sum_probs=153.9
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE-EeCCeE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVW 211 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~ 211 (343)
++|++.+.||+|+||.||+|.+ +++.||||++...... +.+.+|+.+++.++|++++..+..+ ......
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--------CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--------hHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 6789999999999999999996 7889999987654432 2477899999999988776665555 667788
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE---cCCCcEEEecccccccc
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIE 288 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv---~~~~~vkl~DFg~a~~~ 288 (343)
++||||+ +++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 9999999 89999999753 3459999999999999999999999999999999999999 78899999999999865
Q ss_pred ccCCC--------ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 289 VQTEG--------MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 289 ~~~~~--------~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
..... .....||+.|+|||.+ ....++.++|||+++. +++.+||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~slG~il~~l~~g~~pf~ 216 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTH-----LGIEQSRRDDLESLGYVLMYFNLGSLPWQ 216 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHH-----TTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cCcccCccCCCCcccccCCCccccchHHh-----cCCCCCchhHHHHHHHHHHHHhcCCCCCc
Confidence 44321 2345799999999999 7788999999996433 33555553
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=257.65 Aligned_cols=187 Identities=22% Similarity=0.343 Sum_probs=153.0
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE--eCCe
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR--KRMV 210 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~ 210 (343)
++|++++.||+|+||.||++.. +++.||||++....... .....+.+.+|+.+++.++||||+++++++. ....
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR--IPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc--cchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 6789999999999999999988 67899999996422110 0112367899999999999999999999984 4457
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~ 290 (343)
.++||||++++ |.+++.......+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 89999999875 88888776666799999999999999999999999999999999999999999999999999986532
Q ss_pred C---CCccCCCCCcceecCCCCCCCCCCCC--CCceeeeeeecc
Q 019304 291 T---EGMTPETGTYRWMAPGNSFFSPLPHP--SFEHKWSAKESC 329 (343)
Q Consensus 291 ~---~~~~~~~gt~~y~APE~~~~~~~~~~--~~~~~sDi~~~~ 329 (343)
. .......||+.|+|||++ ... .++.++|+|+++
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~~~Di~slG 200 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIA-----NGLDTFSGFKVDIWSAG 200 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHH-----TCCSCEESHHHHHHHHH
T ss_pred cccccccccCCCCCCCcChhhc-----cCcccCCcchhhHHHHH
Confidence 1 122345799999999998 433 347899999643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=262.56 Aligned_cols=193 Identities=24% Similarity=0.346 Sum_probs=157.5
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC---
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--- 208 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--- 208 (343)
.++|++.+.||+|+||.||+|.+ +++.||||++..... . .....+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK-P----LFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSS-H----HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccccc-c----hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 36889999999999999999998 588999999964322 1 2235788999999999999999999998764
Q ss_pred --CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 209 --MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 209 --~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
...++||||++ ++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 85 ~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 85 NFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp TCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 57899999997 599999876 348999999999999999999999999999999999999999999999999998
Q ss_pred ccccCC-----------CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 287 IEVQTE-----------GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 287 ~~~~~~-----------~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
...... .....+||+.|+|||++. ....++.++|+|+++. +++.+||.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 225 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVML----TSAKYSRAMDVWSCGCILAELFLRRPIFPG 225 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHH----SCCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccCccccccchhhccccccccCCeeec----cCCCccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 654221 122347899999999873 3477999999996433 335555543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=262.72 Aligned_cols=196 Identities=22% Similarity=0.266 Sum_probs=149.1
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
...++|++.+.||+|+||.||+|.+ +++.||||++....... ..+.+|+..++.++||||+++++++....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-------NRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC-------CHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc-------HHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 4557899999999999999999998 57899999987654332 24567888888899999999999996643
Q ss_pred e-------EEEEEEecCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCCCcEEEcC-CCcE
Q 019304 210 V-------WCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVH--GLGFIHRDLKSDNLLISA-DKSI 277 (343)
Q Consensus 210 ~-------~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH--~~giiHrDlkp~NILv~~-~~~v 277 (343)
. +++||||+++ +|...+.. .....+++..+..++.|++.||.||| ++||+||||||+|||++. ++.+
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEE
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcE
Confidence 3 7899999976 66555542 23456889999999999999999999 999999999999999996 8999
Q ss_pred EEeccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 278 KIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 278 kl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
||+|||+++............||+.|+|||++. ....++.++|||+++. +++.+||.+
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~Di~slG~il~ell~g~~pf~~ 234 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEPNVAYICSRYYRAPELIF----GNQHYTTAVDIWSVGCIFAEMMLGEPIFRG 234 (360)
T ss_dssp EECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHT----TCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEeeCCCceecCCCCCcccccCCcceeCHHHHc----CCCCCCcHHHHHHHHHHHHHHHhCCCCcCC
Confidence 999999998766655556678999999999982 3345899999996433 335666644
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=282.95 Aligned_cols=191 Identities=25% Similarity=0.450 Sum_probs=159.0
Q ss_pred CccceecccccccccccccccceEEEEEEEC-----CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceE
Q 019304 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (343)
Q Consensus 127 ~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l 201 (343)
...|++..++|++++.||+|+||.||+|.+. +..||||.+...... ...+.+.+|+.+++.++||||+++
T Consensus 382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l 456 (656)
T 2j0j_A 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD-----SVREKFLQEALTMRQFDHPHIVKL 456 (656)
T ss_dssp GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH-----HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH-----HHHHHHHHHHHHHHhCCCCCCCeE
Confidence 4567888899999999999999999999872 346999988653321 223678999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEec
Q 019304 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (343)
Q Consensus 202 ~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~D 281 (343)
++++.+ +..++||||+++|+|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 457 ~~~~~~-~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~D 534 (656)
T 2j0j_A 457 IGVITE-NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD 534 (656)
T ss_dssp EEEECS-SSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred EEEEec-CceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEe
Confidence 999854 5679999999999999999764 34589999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCC--ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 282 FGVARIEVQTEG--MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 282 Fg~a~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
||+++....... .....+|+.|+|||.+ ....++.++|||+++
T Consensus 535 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~~-----~~~~~~~~~DiwSlG 579 (656)
T 2j0j_A 535 FGLSRYMEDSTYYKASKGKLPIKWMAPESI-----NFRRFTSASDVWMFG 579 (656)
T ss_dssp CCCCCSCCC----------CCGGGCCHHHH-----HHCCCCHHHHHHHHH
T ss_pred cCCCeecCCCcceeccCCCCCcceeCHHHh-----cCCCCCchhhHHHHH
Confidence 999986544322 2234577899999999 677899999999644
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=256.54 Aligned_cols=191 Identities=29% Similarity=0.437 Sum_probs=149.6
Q ss_pred ceecccccccccccccccceEEEEEEE---CCc--eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEE
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY---NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 204 (343)
..+..++|++.+.||+|+||.||+|.+ +++ .||||+++....... ...+.+.+|+.+++.++||||++++++
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP---EAMDDFIREVNAMHSLDHRNLIRLYGV 89 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------C---HHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCH---HHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence 345678999999999999999999986 222 589999875433221 123678999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccc
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~ 284 (343)
+.... .++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 90 VLTPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp ECSSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred EccCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccc
Confidence 98765 789999999999999998643 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 285 ARIEVQTEG----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 285 a~~~~~~~~----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
++....... .....+|+.|+|||.+ ....++.++|+|+++.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~ 212 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESL-----KTRTFSHASDTWMFGV 212 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHH-----HHCEEEHHHHHHHHHH
T ss_pred cccccccccchhhhccCCCCceeeCchhh-----cCCCCCchhhHHHHHH
Confidence 986543321 2234678899999999 6778999999996443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-34 Score=265.17 Aligned_cols=194 Identities=22% Similarity=0.293 Sum_probs=157.9
Q ss_pred ccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC--CCCcceEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVRFIG 203 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~ 203 (343)
...+.-.++|++.+.||+|+||.||+|.+ +++.||||++..............+.+.+|+.+++.++ ||||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 34445568899999999999999999988 78899999997654322100000134678999999996 599999999
Q ss_pred EEEeCCeEEEEEEecCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc-CCCcEEEec
Q 019304 204 ACRKRMVWCIVTEYAKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIAD 281 (343)
Q Consensus 204 ~~~~~~~~~iv~E~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~-~~~~vkl~D 281 (343)
++......++|+|++.+ ++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence 99999999999999976 8999999865 3589999999999999999999999999999999999999 789999999
Q ss_pred cccccccccCCCccCCCCCcceecCCCCCCCCCCCCCC-ceeeeeeecc
Q 019304 282 FGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSF-EHKWSAKESC 329 (343)
Q Consensus 282 Fg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~-~~~sDi~~~~ 329 (343)
||+++..... ......||+.|+|||++ ....+ +.++|||+++
T Consensus 194 fg~~~~~~~~-~~~~~~gt~~y~aPE~~-----~~~~~~~~~~Di~slG 236 (320)
T 3a99_A 194 FGSGALLKDT-VYTDFDGTRVYSPPEWI-----RYHRYHGRSAAVWSLG 236 (320)
T ss_dssp CTTCEECCSS-CBCCCCSCGGGSCHHHH-----HHSCBCHHHHHHHHHH
T ss_pred Cccccccccc-cccCCCCCccCCChHHh-----ccCCCCCccchHHhHH
Confidence 9999865442 34456799999999998 44454 7889999643
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.3e-33 Score=258.81 Aligned_cols=188 Identities=20% Similarity=0.309 Sum_probs=136.0
Q ss_pred ccccccc-cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe---
Q 019304 134 LRKLNMG-TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--- 207 (343)
Q Consensus 134 ~~~~~~~-~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--- 207 (343)
.++|++. +.||+|+||.||+|.+ +++.||||++.... ....+....++.+.||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----------KARQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----------HHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----------HHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 3567774 4699999999999998 58899999996421 111222334567799999999999976
Q ss_pred -CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC---CCcEEEeccc
Q 019304 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFG 283 (343)
Q Consensus 208 -~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~---~~~vkl~DFg 283 (343)
...+++||||+++++|.+++.......+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 456899999999999999998766567999999999999999999999999999999999999975 4569999999
Q ss_pred cccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCC
Q 019304 284 VARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPP 337 (343)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~ 337 (343)
+++..... .....+||+.|+|||++ ....++.++|||+++. +++.+||
T Consensus 177 ~~~~~~~~-~~~~~~~t~~y~aPE~~-----~~~~~~~~~Di~slG~il~~l~~g~~pf 229 (336)
T 3fhr_A 177 FAKETTQN-ALQTPCYTPYYVAPEVL-----GPEKYDKSCDMWSLGVIMYILLCGFPPF 229 (336)
T ss_dssp TCEEC----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred cceecccc-ccccCCCCcCccChhhh-----CCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 99865432 34456889999999999 7888999999996433 3355665
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.4e-33 Score=255.64 Aligned_cols=196 Identities=18% Similarity=0.239 Sum_probs=156.2
Q ss_pred CccceecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC--CCCcceEEE
Q 019304 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVRFIG 203 (343)
Q Consensus 127 ~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~ 203 (343)
+....+..++|++.+.||+|+||.||++.. +++.||||++......... .+.+.+|+.+++.++ ||||+++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT----LDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHH----HHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccc----hHHHHHHHHHHHhccccCCceEEEEE
Confidence 345667778999999999999999999988 6788999999765544322 367899999999997 599999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 204 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
++.....+++||| +.+++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++ ++.+||+|||
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg 171 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFG 171 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecc
Confidence 9999999999999 5578999999864 3589999999999999999999999999999999999996 5899999999
Q ss_pred cccccccCCC---ccCCCCCcceecCCCCCCCCC------CCCCCceeeeeeeccc
Q 019304 284 VARIEVQTEG---MTPETGTYRWMAPGNSFFSPL------PHPSFEHKWSAKESCL 330 (343)
Q Consensus 284 ~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~------~~~~~~~~sDi~~~~~ 330 (343)
+++....... .....||+.|+|||.+..... ....++.++|||+++.
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~ 227 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 227 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHH
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHH
Confidence 9986543221 234579999999999832100 1257899999996433
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=268.25 Aligned_cols=182 Identities=25% Similarity=0.335 Sum_probs=154.7
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCC-CCcceEEEEEEeCCe
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRFIGACRKRMV 210 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~ 210 (343)
.++|++++.||+|+||.||+|.+ +++.||||++....... ++.+|+.+++.++| ++|..+..++.....
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~--------~~~~E~~il~~L~~~~~i~~i~~~~~~~~~ 77 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--------QLLYESKIYRILQGGTGIPNVRWFGVEGDY 77 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC--------CHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH--------HHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence 36799999999999999999997 68899999987654432 47789999999987 566667777788888
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE---cCCCcEEEeccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARI 287 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv---~~~~~vkl~DFg~a~~ 287 (343)
.++||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++.
T Consensus 78 ~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 78 NVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 99999999 89999999753 3469999999999999999999999999999999999999 5789999999999986
Q ss_pred cccCCC--------ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 288 EVQTEG--------MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 288 ~~~~~~--------~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
...... ....+||+.|+|||.+ ....++.++|||++++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-----~~~~~s~~sDvwSlGv 201 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTH-----LGIEQSRRDDLESLGY 201 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHH-----TTCCCCHHHHHHHHHH
T ss_pred ccCCccccccccccccccCCCccccCHHHh-----cCCCCChHHHHHHHHH
Confidence 544322 1255799999999999 7788999999996443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.8e-33 Score=257.77 Aligned_cols=190 Identities=21% Similarity=0.287 Sum_probs=159.2
Q ss_pred ccccccccccccccceEEEEEEE--CC-ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCC------cceEEEE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NG-EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN------IVRFIGA 204 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~-~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~ 204 (343)
.++|++.+.||+|+||.||+|.. ++ +.||||++.... ...+.+.+|+.+++.++|++ ++.++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-------KYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-------cchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 47899999999999999999987 34 689999996421 12356788999998887665 8999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE-------------
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI------------- 271 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv------------- 271 (343)
+......++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence 99999999999999 6688888877655679999999999999999999999999999999999999
Q ss_pred ------cCCCcEEEeccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 272 ------SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 272 ------~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
+.++.+||+|||+++.... ......||+.|+|||++ ....++.++|||+++. +++.+||.
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVI-----LELGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHH-----TTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeee-----ecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 5678999999999986433 33456899999999999 7788999999996433 33555654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-33 Score=261.60 Aligned_cols=194 Identities=23% Similarity=0.352 Sum_probs=156.4
Q ss_pred cceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
.|++. ++|.+.+.||+|+||.||+|.+ +++.||||++........ ..+++.+|+.+++.++||||+++++++.
T Consensus 19 ~~~l~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 93 (353)
T 3coi_A 19 AWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI----FAKRAYRELLLLKHMQHENVIGLLDVFT 93 (353)
T ss_dssp EEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHH----HHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred ccccC-ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchH----HHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence 34443 6789999999999999999988 688999999976543322 3367889999999999999999999998
Q ss_pred eCCe------EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEe
Q 019304 207 KRMV------WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (343)
Q Consensus 207 ~~~~------~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~ 280 (343)
.... +++||||++ ++|.+++. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+
T Consensus 94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~ 168 (353)
T 3coi_A 94 PASSLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL 168 (353)
T ss_dssp SCSSGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEEC
T ss_pred cccccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEe
Confidence 7654 499999997 58877763 248999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 281 DFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 281 DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
|||+++.... ......||+.|+|||++. ....++.++|+|+++. +++.+||.
T Consensus 169 Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~----~~~~~~~~~Di~slG~il~el~~g~~pf~ 225 (353)
T 3coi_A 169 DFGLARHADA--EMTGYVVTRWYRAPEVIL----SWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225 (353)
T ss_dssp STTCTTC----------CCSBCCSCHHHHS----CCSCCCTTHHHHHHHHHHHHHHHSSCSSB
T ss_pred ecccccCCCC--CccccccCcCcCCHHHHh----CcCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999986433 234558999999999982 2367899999996433 33555554
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=6.1e-33 Score=255.51 Aligned_cols=192 Identities=22% Similarity=0.256 Sum_probs=150.5
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE-----
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR----- 206 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~----- 206 (343)
.++|++.+.||+|+||.||+|.+ +++.||||++.... . ...+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--P----QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--H----HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--h----HHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence 36789999999999999999998 47899999987532 1 12367889999999999999999999873
Q ss_pred ---------eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc-CCCc
Q 019304 207 ---------KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKS 276 (343)
Q Consensus 207 ---------~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~-~~~~ 276 (343)
.....++||||++ ++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++ .++.
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp CCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTE
T ss_pred cccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCe
Confidence 3467899999997 599999854 4589999999999999999999999999999999999997 5679
Q ss_pred EEEeccccccccccC----CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 277 IKIADFGVARIEVQT----EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 277 vkl~DFg~a~~~~~~----~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
+||+|||+++..... .......+|+.|+|||.+. ....++.++|+|+++. +++.+||.+
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~Di~slG~il~el~~g~~pf~~ 227 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL----SPNNYTKAIDMWAAGCIFAEMLTGKTLFAG 227 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHH----CTTCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhc----CcccCCchhhhHhHHHHHHHHHhCCCCCCC
Confidence 999999999865322 1223346799999999873 3467899999996433 335555543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.98 E-value=5.8e-33 Score=261.57 Aligned_cols=194 Identities=20% Similarity=0.239 Sum_probs=160.7
Q ss_pred ceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-----------CC
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-----------HL 196 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~ 196 (343)
..+..++|++.+.||+|+||.||+|.+ +++.||||++.... ...+.+.+|+.+++.++ ||
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 86 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-------VYTEAAEDEIKLLQRVNDADNTKEDSMGAN 86 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-------cchhhhhHHHHHHHHhhcccccchhccccc
Confidence 345568899999999999999999997 78899999996421 12356788999988876 89
Q ss_pred CcceEEEEEEeCC----eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEE
Q 019304 197 NIVRFIGACRKRM----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLI 271 (343)
Q Consensus 197 nIv~l~~~~~~~~----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-giiHrDlkp~NILv 271 (343)
||+++++++.... .+++|||++ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||+
T Consensus 87 ~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll 165 (373)
T 1q8y_A 87 HILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM 165 (373)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEE
T ss_pred hHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEE
Confidence 9999999997654 789999999 88999999876666799999999999999999999998 99999999999999
Q ss_pred c------CCCcEEEeccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 272 S------ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 272 ~------~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
+ ..+.+||+|||+++.... ......||+.|+|||++ ....++.++|||+++. +++.+||-
T Consensus 166 ~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~-----~~~~~~~~~Di~slG~il~el~~g~~pf~ 236 (373)
T 1q8y_A 166 EIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVL-----LGAPWGCGADIWSTACLIFELITGDFLFE 236 (373)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHH-----HTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred eccCCCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHH-----hCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 4 344899999999986543 33455899999999999 6778999999996433 33555553
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=259.82 Aligned_cols=191 Identities=24% Similarity=0.286 Sum_probs=159.2
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CC-----CcceEEEEE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HL-----NIVRFIGAC 205 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~l~~~~ 205 (343)
.++|++.+.||+|+||.||+|.. +++.||||++.... ...+.+.+|+.+++.++ |+ +|+++++++
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-------AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-------HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-------HHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 47899999999999999999988 67889999996421 12356778888888774 44 499999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCCCcEEEc--CCCcEEEec
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH--GLGFIHRDLKSDNLLIS--ADKSIKIAD 281 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH--~~giiHrDlkp~NILv~--~~~~vkl~D 281 (343)
.....+++||||++ ++|.+++.......+++..+..++.|++.||.||| +.||+||||||+|||++ .++.+||+|
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999999996 59999998765566999999999999999999999 46999999999999995 477899999
Q ss_pred cccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 282 FGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 282 Fg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
||+++.... .....+||+.|+|||++ ....++.++|||++++ +++.+||.+
T Consensus 205 FG~a~~~~~--~~~~~~~t~~y~aPE~~-----~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 205 FGSSCQLGQ--RIYQYIQSRFYRSPEVL-----LGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CTTCEETTC--CCCSSCSCGGGCCHHHH-----TTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCceeccc--ccccccCCccccChHHH-----cCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999986543 34456899999999999 7778999999996433 446666654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-33 Score=259.24 Aligned_cols=190 Identities=19% Similarity=0.243 Sum_probs=149.7
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC----CCCCcceEEEEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL----KHLNIVRFIGAC 205 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~h~nIv~l~~~~ 205 (343)
.-.++|++.+.||+|+||.||+|.+ +++.||||++................+.+|+.+++.+ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3457899999999999999999987 6789999999765443322212224566789888888 899999999999
Q ss_pred EeCCeEEEEEEe-cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc-CCCcEEEeccc
Q 019304 206 RKRMVWCIVTEY-AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIADFG 283 (343)
Q Consensus 206 ~~~~~~~iv~E~-~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~-~~~~vkl~DFg 283 (343)
...+..++|+|+ +++++|.+++.... .+++..++.++.|++.||+|||++||+||||||+||+++ .++.+||+|||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 998899999999 78999999998753 489999999999999999999999999999999999999 88999999999
Q ss_pred cccccccCCCccCCCCCcceecCCCCCCCCCCCCCC-ceeeeeeecc
Q 019304 284 VARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSF-EHKWSAKESC 329 (343)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~-~~~sDi~~~~ 329 (343)
+++..... ......||+.|+|||++ ....+ +.++|||+++
T Consensus 186 ~~~~~~~~-~~~~~~~~~~y~aPE~~-----~~~~~~~~~~Di~slG 226 (312)
T 2iwi_A 186 SGALLHDE-PYTDFDGTRVYSPPEWI-----SRHQYHALPATVWSLG 226 (312)
T ss_dssp SCEECCSS-CBCCCCSCTTTSCHHHH-----HHSCBCHHHHHHHHHH
T ss_pred hhhhcccC-cccccCCcccccCceee-----ecCCCCCccchHHHHH
Confidence 99865543 34556799999999998 44555 4689999643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=280.34 Aligned_cols=179 Identities=22% Similarity=0.294 Sum_probs=149.8
Q ss_pred ecccccccccccccccceEEEEEEE---CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
+-.++|++.+.||+|+||.||+|.+ +++.||||++..... . .....+.+|+.+++.++||||+++++++...
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~-~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-A----EAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC-H----HHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC-H----HHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 4457899999999999999999987 478999999865332 1 1235788999999999999999999999876
Q ss_pred Ce-----EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 209 MV-----WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 209 ~~-----~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
.. .|+||||+++++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCT
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecc
Confidence 55 7999999999999987743 58999999999999999999999999999999999999875 89999999
Q ss_pred cccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 284 VARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+++..... ...+||+.|+|||++ ... ++.++|||+++
T Consensus 227 ~a~~~~~~---~~~~gt~~y~aPE~~-----~~~-~~~~sDi~slG 263 (681)
T 2pzi_A 227 AVSRINSF---GYLYGTPGFQAPEIV-----RTG-PTVATDIYTVG 263 (681)
T ss_dssp TCEETTCC---SCCCCCTTTSCTTHH-----HHC-SCHHHHHHHHH
T ss_pred cchhcccC---CccCCCccccCHHHH-----cCC-CCCceehhhhH
Confidence 99865432 456799999999998 333 48899999643
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=264.89 Aligned_cols=191 Identities=22% Similarity=0.296 Sum_probs=148.0
Q ss_pred CccceecccccccccccccccceE-EEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEE
Q 019304 127 YDEWTIDLRKLNMGTAFAQGAFGK-LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGA 204 (343)
Q Consensus 127 ~~~~~i~~~~~~~~~~lg~G~fg~-Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 204 (343)
...+.+...+|+..+.||+|+||. |+++..+++.||||++...... .+.+|+.+++.+ +||||++++++
T Consensus 16 ~~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---------~~~~E~~~l~~l~~HpnIv~l~~~ 86 (432)
T 3p23_A 16 TSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---------FADREVQLLRESDEHPNVIRYFCT 86 (432)
T ss_dssp --CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---------ECHHHHHHHHHSCCCTTBCCEEEE
T ss_pred CCcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---------HHHHHHHHHHhccCCCCcCeEEEE
Confidence 345677778899999999999998 5555668999999999653321 245899999999 89999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC---C--CcEEE
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---D--KSIKI 279 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~---~--~~vkl 279 (343)
+.+....|+||||++ ++|.+++.... .......++.++.||+.||+|||++||+||||||+|||++. + ..+||
T Consensus 87 ~~~~~~~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL 164 (432)
T 3p23_A 87 EKDRQFQYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMI 164 (432)
T ss_dssp EEETTEEEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred EecCCEEEEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEE
Confidence 999999999999996 59999997643 23444556789999999999999999999999999999953 2 35889
Q ss_pred eccccccccccCC----CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 280 ADFGVARIEVQTE----GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 280 ~DFg~a~~~~~~~----~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+|||+|+...... .....+||+.|+|||++... ....++.++|||++++
T Consensus 165 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~t~~~DiwSlG~ 217 (432)
T 3p23_A 165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED--CKENPTYTVDIFSAGC 217 (432)
T ss_dssp CCTTEEECC------------CCSCTTSCCGGGTSCC-----CCCTHHHHHHHHH
T ss_pred ecccceeeccCCCcceeeccccCCCcCccChhhhhcc--cccCCCcHHHHHHHHH
Confidence 9999998654321 23445799999999998321 1567788999996443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.5e-33 Score=276.88 Aligned_cols=195 Identities=24% Similarity=0.318 Sum_probs=162.1
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe----
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK---- 207 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~---- 207 (343)
.++|++.+.||+|+||.||+|.+ +++.||||++..... .. ..+.+.+|+.+++.++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~-~~----~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~ 87 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS-PK----NRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCC-HH----HHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCC-HH----HHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence 36788999999999999999987 688999999865432 21 23678999999999999999999999765
Q ss_pred --CCeEEEEEEecCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc---EEEec
Q 019304 208 --RMVWCIVTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIAD 281 (343)
Q Consensus 208 --~~~~~iv~E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~---vkl~D 281 (343)
....++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.||+||||||+|||++.++. +||+|
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 667899999999999999998643 235888999999999999999999999999999999999997664 99999
Q ss_pred cccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 282 FGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 282 Fg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
||+++............||+.|+|||.+ ....++.++|||+++. +++.+||.
T Consensus 168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l-----~~~~~s~ksDIwSLGviLyeLltG~~Pf~ 224 (676)
T 3qa8_A 168 LGYAKELDQGELCTEFVGTLQYLAPELL-----EQKKYTVTVDYWSFGTLAFECITGFRPFL 224 (676)
T ss_dssp CCCCCBTTSCCCCCCCCSCCTTCSSCSS-----CCSCCSTTHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccccccccccccccccCCcccCChHHh-----ccCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 9999876655555667899999999999 7888999999996433 34556664
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-32 Score=270.12 Aligned_cols=176 Identities=16% Similarity=0.131 Sum_probs=129.2
Q ss_pred ccccccceEEEEEEE--CCceEEEEEeeCCCC----ChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeEEEE
Q 019304 142 AFAQGAFGKLYRGTY--NGEDVAIKILERPEN----NPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIV 214 (343)
Q Consensus 142 ~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~----~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~iv 214 (343)
..+.|++|.+..++. .|+.+|||++..... ..++.+...++|.+|+++|+++ .|+||+++++++.+...+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 355667776665543 789999999976532 3344445567899999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-CC
Q 019304 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EG 293 (343)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~-~~ 293 (343)
|||++|++|.+++.+. .+++.. +|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..... ..
T Consensus 321 MEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC
T ss_pred EecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc
Confidence 9999999999999764 346654 57899999999999999999999999999999999999999999865433 23
Q ss_pred ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeec
Q 019304 294 MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES 328 (343)
Q Consensus 294 ~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~ 328 (343)
..+.+||+.|||||++ . +.+..++|+|+.
T Consensus 396 ~~t~vGTp~YmAPE~l-----~-g~~~~~~d~~s~ 424 (569)
T 4azs_A 396 PTNLVQSFFVFVNELF-----A-ENKSWNGFWRSA 424 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------
T ss_pred ccCceechhhccHHHh-----C-CCCCCccccccc
Confidence 4456899999999998 3 346678899953
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-32 Score=261.09 Aligned_cols=184 Identities=21% Similarity=0.261 Sum_probs=138.7
Q ss_pred ccccccccccccceEEEEE-EECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRG-TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~i 213 (343)
.|...+.||+|+||+||.+ ..+|+.||||++.... .+.+.+|+.+++.+ +||||+++++++.+...+++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 3445688999999999755 4489999999986421 13567899999876 89999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCC-----CHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-------------C
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAV-----PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-------------K 275 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~-----~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~-------------~ 275 (343)
||||++ ++|.+++........ .+..++.++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 999996 599999976432111 222357899999999999999999999999999999754 4
Q ss_pred cEEEeccccccccccCCC-----ccCCCCCcceecCCCCCCCC--CCCCCCceeeeeeecc
Q 019304 276 SIKIADFGVARIEVQTEG-----MTPETGTYRWMAPGNSFFSP--LPHPSFEHKWSAKESC 329 (343)
Q Consensus 276 ~vkl~DFg~a~~~~~~~~-----~~~~~gt~~y~APE~~~~~~--~~~~~~~~~sDi~~~~ 329 (343)
.+||+|||+++....... ....+||+.|+|||++.... .....++.++|||+++
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG 226 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG 226 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHH
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHH
Confidence 899999999986544321 23457999999999983211 1236799999999644
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-30 Score=233.24 Aligned_cols=143 Identities=13% Similarity=0.146 Sum_probs=125.7
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 210 (343)
-.++|++.+.||+|+||.||+|.+ +++.||||++......... ..+.+.+|+.+++.++||||+++++++...+.
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 105 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDD---VLQETLSRTLRLSRIDKPGVARVLDVVHTRAG 105 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHH---HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHH---HHHHHHHHHHHHhcCCCCCcceeeEEEEECCc
Confidence 346799999999999999999998 4889999999865544322 23678999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DF 282 (343)
.|+||||+++++|.+++... .....+..++.|++.||+|||++||+||||||+|||++.++.+||+++
T Consensus 106 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~ 173 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP 173 (286)
T ss_dssp EEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSC
T ss_pred EEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEec
Confidence 99999999999999998532 355678899999999999999999999999999999999999999744
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-31 Score=252.30 Aligned_cols=203 Identities=15% Similarity=0.147 Sum_probs=146.4
Q ss_pred ceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCC-CCc--------
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNI-------- 198 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nI-------- 198 (343)
+....+.|..++.||+|+||.||+|.+ +++.||||++........ ...+.+.+|+.+++.++| ++.
T Consensus 73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~ 149 (413)
T 3dzo_A 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS---NAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 149 (413)
T ss_dssp SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-------CCHHHHHHHHGGGGSTTCCSHHHHHHHTC
T ss_pred CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccH---HHHHHHHHHHHHHHhhccCCCHHHHHHhcc
Confidence 344557788999999999999999998 589999999874433322 123578899999999987 221
Q ss_pred -ce------------EEEEEEe-----CCeEEEEEEecCCCCHHHHHHh-----hCCCCCCHHHHHHHHHHHHHHHHHHH
Q 019304 199 -VR------------FIGACRK-----RMVWCIVTEYAKGGSVRQFLTR-----RQNRAVPLKLAVKQALDVARGMAYVH 255 (343)
Q Consensus 199 -v~------------l~~~~~~-----~~~~~iv~E~~~~gsL~~~l~~-----~~~~~~~~~~~~~i~~qi~~gL~yLH 255 (343)
+. +...+.. ...++++|+++ +++|.+++.. .....+++..++.++.|++.||+|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 228 (413)
T 3dzo_A 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 228 (413)
T ss_dssp BCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 11 1111111 12357777776 6799999852 22334677888999999999999999
Q ss_pred hCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCccCCCCCcceecCCCCCCCC-----CCCCCCceeeeeeeccc
Q 019304 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSP-----LPHPSFEHKWSAKESCL 330 (343)
Q Consensus 256 ~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~-----~~~~~~~~~sDi~~~~~ 330 (343)
++||+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++.... .....++.++|||++++
T Consensus 229 ~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 229 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred hCCcccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999999999865433 455678 9999999982110 03445888999996433
Q ss_pred -----ccccCCCCc
Q 019304 331 -----KTTWPPPWR 339 (343)
Q Consensus 331 -----~~~~~p~~~ 339 (343)
+++.+||..
T Consensus 306 il~elltg~~Pf~~ 319 (413)
T 3dzo_A 306 AIYWIWCADLPNTD 319 (413)
T ss_dssp HHHHHHHSSCCCCT
T ss_pred HHHHHHHCCCCCCC
Confidence 335566543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=231.17 Aligned_cols=167 Identities=22% Similarity=0.372 Sum_probs=140.3
Q ss_pred cccccc-cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHH-hcCCCCCcceEEEEEEe---
Q 019304 135 RKLNMG-TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML-ATLKHLNIVRFIGACRK--- 207 (343)
Q Consensus 135 ~~~~~~-~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~--- 207 (343)
.+|.+. +.||+|+||.||++.. +++.||||++... ..+.+|+.++ +.++||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 445555 7899999999999988 6789999999631 2466888887 66799999999999987
Q ss_pred -CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC---CCcEEEeccc
Q 019304 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFG 283 (343)
Q Consensus 208 -~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~---~~~vkl~DFg 283 (343)
...+++||||+++++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 677899999999999999998866667999999999999999999999999999999999999997 7899999999
Q ss_pred cccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 284 VARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
+++.. ....++.++|+|+++. +++.+||.
T Consensus 166 ~a~~~--------------------------~~~~~~~~~DiwslG~il~el~tg~~pf~ 199 (299)
T 3m2w_A 166 FAKET--------------------------TGEKYDKSCDMWSLGVIMYILLCGYPPFY 199 (299)
T ss_dssp TCEEC--------------------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccc--------------------------ccccCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 88532 2345788999996333 34666664
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=258.33 Aligned_cols=172 Identities=19% Similarity=0.189 Sum_probs=134.6
Q ss_pred cccccccccceEEEEEEECCceEEEEEeeCCCCChh--HHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEE
Q 019304 139 MGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPE--KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (343)
Q Consensus 139 ~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E 216 (343)
..+.||+|+||.||+|.+.++.+++|.......... ......+++.+|+.++++++||||+++..++......|+|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 357899999999999988999999998765433222 222335678999999999999999954444446666799999
Q ss_pred ecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCC---
Q 019304 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG--- 293 (343)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~--- 293 (343)
|+++++|.+++.. +..++.|++.||+|||++||+||||||+|||++. .+||+|||+++.......
T Consensus 420 ~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 420 YINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp CCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred CCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 9999999999864 5688999999999999999999999999999998 999999999987544221
Q ss_pred -----ccCCCCCcceecCCCCCCCCCCC--CCCceeeeeee
Q 019304 294 -----MTPETGTYRWMAPGNSFFSPLPH--PSFEHKWSAKE 327 (343)
Q Consensus 294 -----~~~~~gt~~y~APE~~~~~~~~~--~~~~~~sDi~~ 327 (343)
....+||+.|||||++ .. ..|+..+|+|+
T Consensus 488 ~~~~~~~~~~GT~~y~APEv~-----~~~~~~Y~~~~d~ws 523 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFDEIW-----ERFLEGYKSVYDRWE 523 (540)
T ss_dssp HHHHHHHHHHHHCGGGHHHHH-----HHHHHHHHHHCTTHH
T ss_pred chhhhhhhhcCCCCcCCHHHH-----HHHHHHHHHHHhHHH
Confidence 1345799999999999 54 66888889985
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.2e-26 Score=206.61 Aligned_cols=160 Identities=14% Similarity=0.092 Sum_probs=120.3
Q ss_pred CCCCccceecccc---------------cccccccccccceEEEEEEE-CCceEEEEEeeCCCCChh----HH-------
Q 019304 124 LENYDEWTIDLRK---------------LNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPE----KA------- 176 (343)
Q Consensus 124 ~~~~~~~~i~~~~---------------~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~----~~------- 176 (343)
...++.|.+.... |.+++.||+|+||.||+|.+ +++.||||+++....... ..
T Consensus 64 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w 143 (282)
T 1zar_A 64 QKDYEGSTFTFIGLSLYSLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHF 143 (282)
T ss_dssp CSSSCEEEECHHHHHHHHHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CH
T ss_pred CCCccceeeecCCccHHHHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhh
Confidence 3456777776333 34559999999999999999 688999999964322110 00
Q ss_pred -HHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 019304 177 -QVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255 (343)
Q Consensus 177 -~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH 255 (343)
......+.+|+.+++.++| +++++++.. +..++||||+++++|.+ +. . .....++.|++.||.|||
T Consensus 144 ~~~~~~~~~~E~~~l~~l~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH 210 (282)
T 1zar_A 144 SVLAIRSARNEFRALQKLQG---LAVPKVYAW-EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFY 210 (282)
T ss_dssp HHHHHHHHHHHHHHHHHTTT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhccC---CCcCeEEec-cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHH
Confidence 0134678999999999985 444444433 44599999999999987 42 1 124579999999999999
Q ss_pred hCCceeCCCCCCcEEEcCCCcEEEeccccccccccCCCccCCCCCcceecCCCC
Q 019304 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNS 309 (343)
Q Consensus 256 ~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~ 309 (343)
++||+||||||+|||++ ++.+||+|||+|+. +..++|||.+
T Consensus 211 ~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~------------~~~~~a~e~l 251 (282)
T 1zar_A 211 HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE------------VGEEGWREIL 251 (282)
T ss_dssp HTTEECSCCSTTSEEEE-TTEEEECCCTTCEE------------TTSTTHHHHH
T ss_pred HCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE------------CCCCCHHHHH
Confidence 99999999999999999 99999999999973 2346788877
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.6e-22 Score=180.28 Aligned_cols=141 Identities=16% Similarity=0.153 Sum_probs=107.1
Q ss_pred cccccccccccceEEEEEEE--CCce--EEEEEeeCCCCChhH------------------HHHHHHHHHHHHHHHhcCC
Q 019304 137 LNMGTAFAQGAFGKLYRGTY--NGED--VAIKILERPENNPEK------------------AQVMEQQFQQEVMMLATLK 194 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~--~~~~--vavK~~~~~~~~~~~------------------~~~~~~~~~~E~~~l~~l~ 194 (343)
|.+.+.||+|+||.||+|.+ +|+. ||||+++........ .......+.+|+.+++.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999988 8888 999998654221100 1122346889999999998
Q ss_pred CCCc--ceEEEEEEeCCeEEEEEEecCC-C----CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCC
Q 019304 195 HLNI--VRFIGACRKRMVWCIVTEYAKG-G----SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIHRDLKS 266 (343)
Q Consensus 195 h~nI--v~l~~~~~~~~~~~iv~E~~~~-g----sL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH-~~giiHrDlkp 266 (343)
|+++ +.+++. ...++||||+.+ | +|.++... .++..+..++.|++.+|.||| ++||+||||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 8753 445543 245899999942 3 67766432 224456789999999999999 99999999999
Q ss_pred CcEEEcCCCcEEEecccccccc
Q 019304 267 DNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 267 ~NILv~~~~~vkl~DFg~a~~~ 288 (343)
+|||++. .++|+|||+|...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999997 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=3.3e-19 Score=167.73 Aligned_cols=139 Identities=18% Similarity=0.170 Sum_probs=99.8
Q ss_pred cccccccccccceEEEEEEE-CCceEEEEEeeCCCCC--------------hhHHH--HHHHHHHHHHHHHhcCCCCCcc
Q 019304 137 LNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENN--------------PEKAQ--VMEQQFQQEVMMLATLKHLNIV 199 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~--------------~~~~~--~~~~~~~~E~~~l~~l~h~nIv 199 (343)
|.++..||+|++|.||+|.. +|+.||||+++..... ..... ...-...+|...|.++.+..+.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 67889999999999999987 7899999998642110 00000 1111234677777777555442
Q ss_pred --eEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC--
Q 019304 200 --RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-- 275 (343)
Q Consensus 200 --~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~-- 275 (343)
..++. .. .+|||||++|++|..+.. . .....++.|++.+|.|||++|||||||||.|||+++++
T Consensus 177 vp~p~~~--~~--~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 177 VPEPIAQ--SR--HTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CCCEEEE--ET--TEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCeeeec--cC--ceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 33332 22 279999999988754321 1 22456789999999999999999999999999998776
Q ss_pred --------cEEEeccccccc
Q 019304 276 --------SIKIADFGVARI 287 (343)
Q Consensus 276 --------~vkl~DFg~a~~ 287 (343)
.+.|+||+.+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 489999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=7.3e-14 Score=124.77 Aligned_cols=139 Identities=17% Similarity=0.138 Sum_probs=109.3
Q ss_pred ccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeEEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIV 214 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~iv 214 (343)
.|++...++.|+.+.||++...++.+++|+......... ..+.+|+.+++.+. +..+.++++++......|+|
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~------~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT------YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTST------TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCH------HHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 456667788888899999988888999999864211111 24778999998884 67788999999888889999
Q ss_pred EEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 019304 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-------------------------------------- 256 (343)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-------------------------------------- 256 (343)
|||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 89 ~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 99999999877631 111234678889999999998
Q ss_pred ---------------------CCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 257 ---------------------LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 257 ---------------------~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 3489999999999998766678999998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.31 E-value=6.2e-12 Score=111.44 Aligned_cols=125 Identities=13% Similarity=0.089 Sum_probs=93.5
Q ss_pred ccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCC--cceEEEEEEeCCeEEEEEEecCC
Q 019304 144 AQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN--IVRFIGACRKRMVWCIVTEYAKG 220 (343)
Q Consensus 144 g~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~iv~E~~~~ 220 (343)
+.|..+.||++.. +|+.+++|+...... ..+.+|+.+++.+.+.+ +.+++++....+..++||||++|
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~~---------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G 99 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGAL---------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 99 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCTT---------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcccc---------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCC
Confidence 4566699999976 467899999765311 24668888888885444 56788888887788999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 019304 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG------------------------------------------ 258 (343)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~g------------------------------------------ 258 (343)
.+|. ... ... ..++.+++..|..||+..
T Consensus 100 ~~l~--~~~-----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
T 1nd4_A 100 QDLL--SSH-----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 169 (264)
T ss_dssp EETT--TSC-----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred cccC--cCc-----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence 8873 211 121 245667777777777643
Q ss_pred ----------------ceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 259 ----------------FIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 259 ----------------iiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
++|+|++|.|||++.++.++|+||+.+..
T Consensus 170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776778999999865
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.29 E-value=7.2e-12 Score=117.10 Aligned_cols=139 Identities=13% Similarity=0.243 Sum_probs=105.1
Q ss_pred ccccccccceEEEEEEECCceEEEEEee--CCCCChhHHHHHHHHHHHHHHHHhcCC--CCCcceEEEEEEeC---CeEE
Q 019304 140 GTAFAQGAFGKLYRGTYNGEDVAIKILE--RPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVRFIGACRKR---MVWC 212 (343)
Q Consensus 140 ~~~lg~G~fg~Vy~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~---~~~~ 212 (343)
.+.|+.|.++.||+....+..+++|+.. ...... ....+.+|..+++.+. +..+++++..+.+. ...+
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~-----~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLP-----SAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC---------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCC-----cHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 3578999999999998877889999875 222111 1145778999999886 45678899988776 3478
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG------------------------------------ 256 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~------------------------------------ 256 (343)
+||||++|..+.+.. ...++......++.+++..|..||+
T Consensus 118 ~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 999999997774311 1236777888899999999999997
Q ss_pred ----------------------CCceeCCCCCCcEEEcCCC--cEEEeccccccc
Q 019304 257 ----------------------LGFIHRDLKSDNLLISADK--SIKIADFGVARI 287 (343)
Q Consensus 257 ----------------------~giiHrDlkp~NILv~~~~--~vkl~DFg~a~~ 287 (343)
..++|+|+++.|||++.++ .+.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 3589999999999999765 369999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.80 E-value=1.2e-08 Score=92.94 Aligned_cols=133 Identities=23% Similarity=0.243 Sum_probs=96.9
Q ss_pred cccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCC--cceEEEEEEeCC---eEEEE
Q 019304 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLN--IVRFIGACRKRM---VWCIV 214 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--Iv~l~~~~~~~~---~~~iv 214 (343)
+.++.|....||+.. ..+++|+.... .....+.+|..+++.+. +.. +.+.+....... ..|+|
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~--------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS--------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH--------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc--------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 458999999999864 67899986431 11256889999998873 322 445655544333 34789
Q ss_pred EEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 019304 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-------------------------------------- 256 (343)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-------------------------------------- 256 (343)
||+++|.+|.+.... .++......++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp EECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred EcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 999999888654322 26677777888888888888885
Q ss_pred --------------------CCceeCCCCCCcEEEcC--CCcEEEecccccccc
Q 019304 257 --------------------LGFIHRDLKSDNLLISA--DKSIKIADFGVARIE 288 (343)
Q Consensus 257 --------------------~giiHrDlkp~NILv~~--~~~vkl~DFg~a~~~ 288 (343)
..++|+|++|.||+++. ...+.|+||+.+...
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 13799999999999997 566899999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.72 E-value=1.8e-07 Score=85.36 Aligned_cols=133 Identities=19% Similarity=0.197 Sum_probs=90.2
Q ss_pred cccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCC---CcceEEEEEE-eCCeEEEEEE
Q 019304 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL---NIVRFIGACR-KRMVWCIVTE 216 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~-~~~~~~iv~E 216 (343)
+.++.|....||+. +..+++|+-.. . .....+.+|..+|+.+.+. .+.+.+.++. .....++|||
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~~----~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPKS----Q----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEESS----H----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eecCCCcceeEEEE---CCEEEEEecCC----c----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 45788888899988 68889998521 1 1225688999999998652 3566777664 3445689999
Q ss_pred ecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 019304 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL--------------------------------------- 257 (343)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~--------------------------------------- 257 (343)
+++|.+|.+.... .++......++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 94 KVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred ccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 9999888663211 123333444444444444444421
Q ss_pred ---------------------CceeCCCCCCcEEEcC---CCc-EEEecccccccc
Q 019304 258 ---------------------GFIHRDLKSDNLLISA---DKS-IKIADFGVARIE 288 (343)
Q Consensus 258 ---------------------giiHrDlkp~NILv~~---~~~-vkl~DFg~a~~~ 288 (343)
.++|+|++|.|||++. ++. +.|+||+.+...
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 4699999999999987 355 589999988753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=2.6e-07 Score=82.28 Aligned_cols=130 Identities=21% Similarity=0.172 Sum_probs=90.5
Q ss_pred cccccce-EEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeEEEEEEec
Q 019304 143 FAQGAFG-KLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTEYA 218 (343)
Q Consensus 143 lg~G~fg-~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~iv~E~~ 218 (343)
+..|..+ .||+... .+..+.+|+-... . ...+.+|...|+.+. +--+.++++++.+.+..++|||++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~----~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l 102 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----V----ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI 102 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH-----H----HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----C----HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence 4445554 6898765 4567899986531 1 145778998888774 334678899999989999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 019304 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG------------------------------------------ 256 (343)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~------------------------------------------ 256 (343)
+|.++.+...... .....++.+++..|.-||+
T Consensus 103 ~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 103 PGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred CCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 9988776553211 1122344444444555542
Q ss_pred ---------C-------CceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 257 ---------L-------GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 257 ---------~-------giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
. .++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1 279999999999999877788999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=1.9e-07 Score=86.66 Aligned_cols=78 Identities=9% Similarity=0.074 Sum_probs=52.9
Q ss_pred cccc-ccccceEEEEEEEC--------CceEEEEEeeCCC---CChhHHHHHHHHHHHHHHHHhcCC-C--CCcceEEEE
Q 019304 140 GTAF-AQGAFGKLYRGTYN--------GEDVAIKILERPE---NNPEKAQVMEQQFQQEVMMLATLK-H--LNIVRFIGA 204 (343)
Q Consensus 140 ~~~l-g~G~fg~Vy~~~~~--------~~~vavK~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~ 204 (343)
.+.| +.|....+|+.... ++.+++|+..... .... ..+.+|+.+++.+. + -.+.+++.+
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~------~~~~~E~~~l~~L~~~~~vpvP~v~~~ 98 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPT------YRLDHQFEVIRLVGELTDVPVPRVRWI 98 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSC------CCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCch------hHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence 3567 88889999998765 6789999865422 1000 23567777777773 2 356778888
Q ss_pred EEeC---CeEEEEEEecCCCCH
Q 019304 205 CRKR---MVWCIVTEYAKGGSV 223 (343)
Q Consensus 205 ~~~~---~~~~iv~E~~~~gsL 223 (343)
+.+. ...++|||+++|..+
T Consensus 99 ~~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 99 ETTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp ECSSTTTSSCEEEEECCCCBCC
T ss_pred ccCCCccCCceEEEEecCCCCh
Confidence 7655 346899999998654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=8.8e-07 Score=83.57 Aligned_cols=79 Identities=11% Similarity=-0.032 Sum_probs=47.4
Q ss_pred cccccccceEEEEEEE--CCceEEEEEeeCCCC-ChhHHHHHHHHHHHHHHHHhcCCC--C-CcceEEEEEEeCCeEEEE
Q 019304 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPEN-NPEKAQVMEQQFQQEVMMLATLKH--L-NIVRFIGACRKRMVWCIV 214 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~h--~-nIv~l~~~~~~~~~~~iv 214 (343)
+.||.|..+.||++.. .++.++||....... ..........++..|..+++.+.. | .+.+++.+. ....++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEEE
Confidence 5789999999999954 567899998653221 000000011345678888877632 3 344666543 3445799
Q ss_pred EEecCCC
Q 019304 215 TEYAKGG 221 (343)
Q Consensus 215 ~E~~~~g 221 (343)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.34 E-value=3.3e-06 Score=77.38 Aligned_cols=31 Identities=19% Similarity=0.383 Sum_probs=28.0
Q ss_pred CCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 257 ~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998788999999998754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.97 E-value=2.7e-05 Score=71.12 Aligned_cols=75 Identities=19% Similarity=0.173 Sum_probs=59.4
Q ss_pred ccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCeEEEEEE
Q 019304 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWCIVTE 216 (343)
Q Consensus 140 ~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~iv~E 216 (343)
.+.|+.|....+|+...++..+++|+..... ...+.+|...|+.|. ...+++++..+......++|||
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~---------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERSY---------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGGG---------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCccc---------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 3578999999999998888889999876421 245788888888773 3567888988888788899999
Q ss_pred ecCCCCH
Q 019304 217 YAKGGSV 223 (343)
Q Consensus 217 ~~~~gsL 223 (343)
|+++..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.94 E-value=5.3e-05 Score=71.93 Aligned_cols=32 Identities=19% Similarity=0.374 Sum_probs=28.0
Q ss_pred hCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 256 ~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
...++|+|++|.|||++.++ ++|+||+.+...
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 45799999999999998776 999999988753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.80 E-value=7.5e-05 Score=67.46 Aligned_cols=71 Identities=11% Similarity=0.124 Sum_probs=42.8
Q ss_pred ccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCeEEEEEEec
Q 019304 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVWCIVTEYA 218 (343)
Q Consensus 140 ~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~iv~E~~ 218 (343)
.+.|+.|....+|+. ..+++|+......... ...+|..+++.+....+ .++++...+ .-++++||+
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~~-------~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEYI-------NRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----CC-------CHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECC
T ss_pred eeEcCCcccccccee----eeEEEECCCCCcccee-------CHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeec
Confidence 567888999999998 6789998864321110 12356666665532222 456654332 236899999
Q ss_pred -CCCCH
Q 019304 219 -KGGSV 223 (343)
Q Consensus 219 -~~gsL 223 (343)
+|.+|
T Consensus 90 ~~g~~l 95 (301)
T 3dxq_A 90 AGAQTM 95 (301)
T ss_dssp TTCEEC
T ss_pred CCCccC
Confidence 66444
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.78 E-value=8.5e-05 Score=66.65 Aligned_cols=77 Identities=16% Similarity=0.148 Sum_probs=53.2
Q ss_pred cccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCC---CCcceEEEEEEeCCeEE
Q 019304 137 LNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH---LNIVRFIGACRKRMVWC 212 (343)
Q Consensus 137 ~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~~~~~~ 212 (343)
+.-.+.+|.|..+.||+.+. +|+.|.+|+......... ..|.+|+..|+.|.. -.+.+.+++. . -+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~------~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~ 86 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALD------GLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RT 86 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCT------THHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TE
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchh------hHHHHHHHHHHHHHhhCCCCcceEEecc--C--ce
Confidence 33456789999999999998 789999998654332211 247789888887742 2355666543 2 27
Q ss_pred EEEEecCCCCH
Q 019304 213 IVTEYAKGGSV 223 (343)
Q Consensus 213 iv~E~~~~gsL 223 (343)
+||||++++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999987653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00021 Score=64.93 Aligned_cols=140 Identities=14% Similarity=0.135 Sum_probs=76.8
Q ss_pred ccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-----CCCcceEE-E--EEEeCCeE
Q 019304 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-----HLNIVRFI-G--ACRKRMVW 211 (343)
Q Consensus 140 ~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~nIv~l~-~--~~~~~~~~ 211 (343)
.+.|+.|....+|+...++..+++|+...... . ..+..|+.+++.+. -|.++... | +....+..
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~-~-------~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKDPLILTLYEKRVE-K-------NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEECC---EEEEEEEESSCCEEEEEECC----C-------CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred eeccCCCcccceEEEEeCCccEEEEEeCCCCC-H-------HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 35678888899999988666899999865311 1 13445666655542 23333210 0 01223556
Q ss_pred EEEEEecCCCCHH-----------H---HHHhh-CC--CC----CC---HHHHHH------------HHHHHHHHHHHHH
Q 019304 212 CIVTEYAKGGSVR-----------Q---FLTRR-QN--RA----VP---LKLAVK------------QALDVARGMAYVH 255 (343)
Q Consensus 212 ~iv~E~~~~gsL~-----------~---~l~~~-~~--~~----~~---~~~~~~------------i~~qi~~gL~yLH 255 (343)
+++++|++|..+. . .++.. .. .+ .. +..... +...+...++.++
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 8999999985431 0 11111 01 00 11 111000 0011334455555
Q ss_pred h-------CCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 256 G-------LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 256 ~-------~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
+ .+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 2 3699999999999999776678999998754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.0003 Score=64.33 Aligned_cols=136 Identities=16% Similarity=0.196 Sum_probs=71.0
Q ss_pred cccccccceE-EEEEEEC-CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCC--CCcceEEEEEEeCCeEEEEEE
Q 019304 141 TAFAQGAFGK-LYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRFIGACRKRMVWCIVTE 216 (343)
Q Consensus 141 ~~lg~G~fg~-Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~iv~E 216 (343)
+.|+.|.... +|+.... ++.+++|........ .+..|+.+++.+.. -.+.+++.+..... +++||
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~~---------~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e 92 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEGG---------DTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIE 92 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTTC---------CSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEEC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCCc---------cccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEe
Confidence 4566565554 6677664 777888765432211 12345555555431 23456666644333 68999
Q ss_pred ecCCCCHHHHHHhhC---------------------C---CCCCHHHHH-------H-------------HHHHHHHHHH
Q 019304 217 YAKGGSVRQFLTRRQ---------------------N---RAVPLKLAV-------K-------------QALDVARGMA 252 (343)
Q Consensus 217 ~~~~gsL~~~l~~~~---------------------~---~~~~~~~~~-------~-------------i~~qi~~gL~ 252 (343)
++.+..+.+.+.... . ..+...... . ....+...+.
T Consensus 93 ~l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~ 172 (333)
T 3csv_A 93 DLGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFA 172 (333)
T ss_dssp CCCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHH
T ss_pred eCCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 997766655443110 0 011111110 0 0011112223
Q ss_pred HH------HhCCceeCCCCCCcEEEcCC----CcEEEeccccccc
Q 019304 253 YV------HGLGFIHRDLKSDNLLISAD----KSIKIADFGVARI 287 (343)
Q Consensus 253 yL------H~~giiHrDlkp~NILv~~~----~~vkl~DFg~a~~ 287 (343)
.+ +...++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 173 ~l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 173 QILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 33 12469999999999999874 6899999998875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.48 E-value=0.0007 Score=61.53 Aligned_cols=137 Identities=15% Similarity=0.136 Sum_probs=75.0
Q ss_pred cccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCC--CcceEEEE-----EEeCCeEE
Q 019304 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL--NIVRFIGA-----CRKRMVWC 212 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~-----~~~~~~~~ 212 (343)
+.|+ |....||+... +|+.+++|+........ ..+..|..+++.+... .+++++.. ....+..+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~-------~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~ 103 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA-------DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYF 103 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH-------HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCH-------HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEE
Confidence 3456 77789998876 56689999986443322 2345566666555311 13333322 12244567
Q ss_pred EEEEecCCCCHH-----H------H---HHhh-CC------CCCCHHHH----HHH---------------HHHHHHHHH
Q 019304 213 IVTEYAKGGSVR-----Q------F---LTRR-QN------RAVPLKLA----VKQ---------------ALDVARGMA 252 (343)
Q Consensus 213 iv~E~~~~gsL~-----~------~---l~~~-~~------~~~~~~~~----~~i---------------~~qi~~gL~ 252 (343)
+++|+++|..+. . . ++.. .. ........ ..+ ...+...++
T Consensus 104 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 183 (328)
T 1zyl_A 104 AVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIA 183 (328)
T ss_dssp EEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHH
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHH
Confidence 899999874321 1 1 1110 00 01111111 000 001111222
Q ss_pred HHH-------hCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 253 YVH-------GLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 253 yLH-------~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
.+. ...++|+|+++.|||++ + .+.|+||+.+..
T Consensus 184 ~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 184 AVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 332 23589999999999998 4 899999988764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.37 E-value=0.0002 Score=68.23 Aligned_cols=70 Identities=14% Similarity=0.224 Sum_probs=46.7
Q ss_pred cccccccceEEEEEEEC---------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCC-cceEEEEEEeCCe
Q 019304 141 TAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN-IVRFIGACRKRMV 210 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~ 210 (343)
+.|+.|....||++... ++.+++|+.... . .. ..+.+|..+++.+...+ ..++++.+. +
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~-~~------~~li~E~~~l~~L~~~g~~P~l~~~~~--~- 147 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E-TE------SHLVAESVIFTLLSERHLGPKLYGIFS--G- 147 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C-CH------HHHHHHHHHHHHHHHTTSSSCEEEEET--T-
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-C-cH------HHHHHHHHHHHHHHhCCCCCcEEEEeC--C-
Confidence 56788888999999874 468999998432 1 10 13447888887774333 356776653 2
Q ss_pred EEEEEEecCCCC
Q 019304 211 WCIVTEYAKGGS 222 (343)
Q Consensus 211 ~~iv~E~~~~gs 222 (343)
.+|+||++|.+
T Consensus 148 -g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 -GRLEEYIPSRP 158 (429)
T ss_dssp -EEEECCCCEEE
T ss_pred -CEEEEEeCCcc
Confidence 38999998633
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0037 Score=59.91 Aligned_cols=72 Identities=13% Similarity=0.083 Sum_probs=46.6
Q ss_pred cccccccceEEEEEEECC--ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCeEEEEEEe
Q 019304 141 TAFAQGAFGKLYRGTYNG--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~iv~E~ 217 (343)
+.|+.|-...+|+....+ ..+++|+......... ...+|..+++.|...++ .++++.+. + .+|+||
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-------dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~ 182 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-------NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEF 182 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-------CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-------CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEe
Confidence 567888889999999865 7899998754221110 11478888888764444 56777762 3 359999
Q ss_pred cCCCCH
Q 019304 218 AKGGSV 223 (343)
Q Consensus 218 ~~~gsL 223 (343)
++|.+|
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 987443
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=97.25 E-value=1.1e-05 Score=77.66 Aligned_cols=134 Identities=13% Similarity=0.060 Sum_probs=56.2
Q ss_pred cCCCCCCcccccccCCCCeEEEEeecCCCCCCCcccccccCCCCCcCCCcceeecceeeec--CCccccccCchHHHHHH
Q 019304 37 GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFR--PGKVTHALNDDALAQAL 114 (343)
Q Consensus 37 ~~~~~~~~~~~~~s~~~g~~s~s~~~ss~~s~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~--~~~~~~~~~~d~l~~~l 114 (343)
..|+|++++|.+ .+|.|++|++... .++|+.+.. ++.|.+. ...|. ++.+. |+++..+
T Consensus 70 ~~G~FLvR~S~~---~~g~~~Lsv~~~~---------~v~H~~I~~-~g~~~~~--~~~F~sl~~Lv~-----dGl~~~~ 129 (463)
T 3cxl_A 70 AEGSYLIRESQR---QPGTYTLALRFGS---------QTRNFRLYY-DGKHFVG--EKRFESIHDLVT-----DGLITLY 129 (463)
T ss_dssp STTEEEEEECSS---STTCEEEEEECSS---------SEEEEECEE-SSSEESS--SCCBSCHHHHHH-----HHHHHHH
T ss_pred CCCeEEEeccCC---CCCCEEEEEEECC---------EEEEEEEec-CCeEEEC--CCccCCHHHHHH-----HHHHhhh
Confidence 379999998876 5688999998621 357787766 5556643 23332 12221 5555555
Q ss_pred hcCCCCCCCCCCCccceecccccccccccccccceEEEEEEECC--ceEEE------EEeeCCCCChhHHHHHHHHHHHH
Q 019304 115 MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG--EDVAI------KILERPENNPEKAQVMEQQFQQE 186 (343)
Q Consensus 115 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~--~~vav------K~~~~~~~~~~~~~~~~~~~~~E 186 (343)
..+..... .....+ -.+.+.|| ||.||+|.+.+ .+||| |..+......+ ..+.|.+|
T Consensus 130 ~~~~~~~~----~l~~~i----~~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e----~~~~~~re 194 (463)
T 3cxl_A 130 IETKAAEY----IAKMTI----NPIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEK----RLTSLVRR 194 (463)
T ss_dssp HHHHTHHH----HHHTTS----SCSTTTSS---BCCC---------CCBGGGC---------------------------
T ss_pred ccCCCcch----hhcccc----ccccccCC---chhhhcccccccCCchhhhhccCcccccccccccc----cccccccc
Confidence 44321000 000001 14556777 99999999854 57888 66543222221 12468889
Q ss_pred HHHHhcCCCCCcceEEEEE
Q 019304 187 VMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 187 ~~~l~~l~h~nIv~l~~~~ 205 (343)
..+++.++|||+++.+++.
T Consensus 195 a~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 195 ATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp ------------CBCCCEE
T ss_pred ccccccccccccCCCcceE
Confidence 9999999999999987765
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00067 Score=63.50 Aligned_cols=141 Identities=14% Similarity=0.238 Sum_probs=79.9
Q ss_pred cccccccccccccceEEEEEEEC---------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGA 204 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~ 204 (343)
+.+++ +.|..|....+|++... ++.+++|+.-...... ..+.+|..+++.+. +.-..++++.
T Consensus 51 ~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~-------~~~~rE~~vl~~L~~~gv~P~ll~~ 122 (379)
T 3feg_A 51 EELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGV-------DSLVLESVMFAILAERSLGPQLYGV 122 (379)
T ss_dssp GGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCH-------HHHHHHHHHHHHHHHTTSSCCEEEE
T ss_pred CceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchH-------HHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 44443 46777888899998863 3688999863211111 24558888887774 2223566766
Q ss_pred EEeCCeEEEEEEecCCCCHH--------------HHHHhhC------CCCCC--HHHHHHHHHHHH--------------
Q 019304 205 CRKRMVWCIVTEYAKGGSVR--------------QFLTRRQ------NRAVP--LKLAVKQALDVA-------------- 248 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~--------------~~l~~~~------~~~~~--~~~~~~i~~qi~-------------- 248 (343)
+.. .+||||++|..|. +.+.+-. ..... +..+.++..++.
T Consensus 123 ~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~ 198 (379)
T 3feg_A 123 FPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLE 198 (379)
T ss_dssp ETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHH
T ss_pred cCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhh
Confidence 543 3899999985442 1111111 11111 233344443332
Q ss_pred -----HHHHHH----HhC----CceeCCCCCCcEEEcCC----CcEEEeccccccc
Q 019304 249 -----RGMAYV----HGL----GFIHRDLKSDNLLISAD----KSIKIADFGVARI 287 (343)
Q Consensus 249 -----~gL~yL----H~~----giiHrDlkp~NILv~~~----~~vkl~DFg~a~~ 287 (343)
..+..| ... .++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 199 ~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 199 MYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 123333 222 48999999999999876 7899999998864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00047 Score=64.04 Aligned_cols=71 Identities=11% Similarity=0.166 Sum_probs=41.7
Q ss_pred cccccccceEEEEEEECC----------ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCC-cceEEEEEEeCC
Q 019304 141 TAFAQGAFGKLYRGTYNG----------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN-IVRFIGACRKRM 209 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~ 209 (343)
+.|+.|....+|+....+ +.+++|+........ .....|..+++.+.... ..++++.. ..
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-------~~~~~E~~~l~~L~~~g~~P~~~~~~--~~ 109 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-------YNTISEFEVYKTMSKYKIAPQLLNTF--NG 109 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-------SCHHHHHHHHHHHHHTTSSCCEEEEE--TT
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-------ecHHHHHHHHHHHHhcCCCCceEEec--CC
Confidence 467788888999998754 678899875421110 01246777777664223 44666544 22
Q ss_pred eEEEEEEecCCCC
Q 019304 210 VWCIVTEYAKGGS 222 (343)
Q Consensus 210 ~~~iv~E~~~~gs 222 (343)
++||||++|..
T Consensus 110 --~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 --GRIEEWLYGDP 120 (369)
T ss_dssp --EEEEECCCSEE
T ss_pred --cEEEEEecCCc
Confidence 68999998753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.58 E-value=0.017 Score=52.92 Aligned_cols=31 Identities=26% Similarity=0.481 Sum_probs=27.7
Q ss_pred CCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 257 ~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3589999999999999888899999988765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.10 E-value=0.032 Score=52.85 Aligned_cols=71 Identities=11% Similarity=0.084 Sum_probs=45.2
Q ss_pred cccccccceEEEEEEEC---------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCe
Q 019304 141 TAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMV 210 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~ 210 (343)
+.|..|....+|+.... ++.+++|+......... ...+|..+++.+. +.-..++++.+ .+
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i-------dR~~E~~~l~~L~~~gi~P~l~~~~--~~- 145 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY-------DSKVELDVFRYLSNINIAPNIIADF--PE- 145 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC-------CHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc-------CHHHHHHHHHHHHhcCCCCCEEEEc--CC-
Confidence 45677888899999875 67899998644321111 1246777776663 22234566533 23
Q ss_pred EEEEEEecCCCC
Q 019304 211 WCIVTEYAKGGS 222 (343)
Q Consensus 211 ~~iv~E~~~~gs 222 (343)
++|+||++|..
T Consensus 146 -~~I~efI~G~~ 156 (424)
T 3mes_A 146 -GRIEEFIDGEP 156 (424)
T ss_dssp -EEEEECCCSEE
T ss_pred -CEEEEEeCCcc
Confidence 68999999855
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.47 E-value=0.096 Score=49.01 Aligned_cols=29 Identities=28% Similarity=0.556 Sum_probs=25.3
Q ss_pred ceeCCCCCCcEEE------cCCCcEEEeccccccc
Q 019304 259 FIHRDLKSDNLLI------SADKSIKIADFGVARI 287 (343)
Q Consensus 259 iiHrDlkp~NILv------~~~~~vkl~DFg~a~~ 287 (343)
++|+|+.+.|||+ +++..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567899999999875
|
| >3maz_A Signal-transducing adaptor protein 1; modular domain, phosphotyrosine, specificity, cytoplasm, phosphoprotein, SH2 domain, signaling protein; HET: PTR; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.49 E-value=0.006 Score=47.23 Aligned_cols=73 Identities=8% Similarity=0.093 Sum_probs=50.9
Q ss_pred cCCCCCCcccccccCCCCeEEEEeecCCCCCCCcccccccCCCCCcCCCcceeecc-eeeec--CCcccc-ccCchHHHH
Q 019304 37 GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVSVG-QSVFR--PGKVTH-ALNDDALAQ 112 (343)
Q Consensus 37 ~~~~~~~~~~~~~s~~~g~~s~s~~~ss~~s~~~~~~~~~~~~~~~~~~~~s~~~~-~~~~~--~~~~~~-~~~~d~l~~ 112 (343)
..|+|+++.|.+ . +++++||++... ...++||.|+...+.|.++.. ...|. ++.|.| ..+.++++.
T Consensus 36 ~~GaFLVR~Se~---~-~~ySLSVR~~~~------~~~VKHYkI~~~~G~y~I~~~~~~~F~SL~eLV~yY~~~adGl~~ 105 (125)
T 3maz_A 36 SLGNMILRPGSD---S-RNYSITIRQEID------IPRIKHYKVMSVGQNYTIELEKPVTLPNLFSVIDYFVKETRGNLR 105 (125)
T ss_dssp GGCSEEEEECTT---S-SSEEEEEEECSS------SCEEEEEEEEEETTEEEECSSSCEEESSHHHHHHHHHHHTTTCCC
T ss_pred CCCcEEEEeCCC---C-CCEEEEEEecCC------CCCEeeeEEEEeCCEEEEecCCCcCcCCHHHHHHHHHhCCCcCcc
Confidence 379999998854 2 379999997532 236899999988888998753 34564 455654 777888888
Q ss_pred HHhcCCC
Q 019304 113 ALMDHRY 119 (343)
Q Consensus 113 ~l~~~~~ 119 (343)
.|..+|.
T Consensus 106 ~L~~~c~ 112 (125)
T 3maz_A 106 PFIASTD 112 (125)
T ss_dssp BCCC---
T ss_pred ccccccc
Confidence 8877773
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.10 E-value=2.6 Score=35.76 Aligned_cols=87 Identities=10% Similarity=-0.020 Sum_probs=60.1
Q ss_pred CCCCcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC
Q 019304 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273 (343)
Q Consensus 194 ~h~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~ 273 (343)
.||++ --.+-.+.+.+.+.++.-+++.-...+++ .+....++++.+|+.... -|...-+|--|+|+||+++.
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-----~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL~f~~ 119 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-----TTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENLMFNR 119 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-----SCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGEEECT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-----cCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceEEEeC
Confidence 57777 33344666777777776644444444432 778888888888776543 12245678889999999999
Q ss_pred CCcEEEecccccccc
Q 019304 274 DKSIKIADFGVARIE 288 (343)
Q Consensus 274 ~~~vkl~DFg~a~~~ 288 (343)
++.+++.-.|+-..+
T Consensus 120 ~~~p~i~hRGi~~~l 134 (219)
T 4ano_A 120 ALEPFFLHVGVKESL 134 (219)
T ss_dssp TCCEEESCCEETTTB
T ss_pred CCcEEEEEcCCcccC
Confidence 999999988875433
|
| >1aot_F FYN protein-tyrosine kinase; SH2 domain, signal transduction, peptide complex, complex (proto-oncogene/early protein); HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1aou_F* | Back alignment and structure |
|---|
Probab=84.83 E-value=0.14 Score=38.24 Aligned_cols=51 Identities=18% Similarity=0.277 Sum_probs=34.3
Q ss_pred CCCCCCcccccccCCCCeEEEEeecCCCCCCCcccccccCCCCCcC-CCcceeecceeee
Q 019304 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVF 96 (343)
Q Consensus 38 ~~~~~~~~~~~~s~~~g~~s~s~~~ss~~s~~~~~~~~~~~~~~~~-~~~~s~~~~~~~~ 96 (343)
.|+|+++.|.+ ..|.+++|+.......+ ..++|+.|... .+.|.+. +...|
T Consensus 28 ~G~FLVR~S~~---~~g~~~LSv~~~~~~~~----~~v~H~~I~~~~~g~~~l~-~~~~F 79 (106)
T 1aot_F 28 RGTFLIRESET---TKGAYSLSIRDWDDMKG----DHVKHYKIRKLDNGGYYIT-TRAQF 79 (106)
T ss_dssp TTEECCBCBSS---SSSBBCCEEECCBTTTB----CCEEECCBEEETTTEEEEE-TTEEE
T ss_pred CcEEEEEeCCC---CCCCEEEEEEecccCCC----CcEEEEEEEEeCCCCEEEC-CCCcc
Confidence 79999998875 56899999985432111 24688888775 3667765 33444
|
| >3s9k_A Tyrosine-protein kinase ITK/TSK; proline isomerization, CIS proline, domain swapped dimer, SH transferase; HET: CIT; 2.35A {Mus musculus} PDB: 2etz_A* 2eu0_A* 1lui_A 1luk_A 1lum_A 1lun_A 2k79_B 2k7a_B | Back alignment and structure |
|---|
Probab=81.08 E-value=0.32 Score=36.87 Aligned_cols=83 Identities=23% Similarity=0.267 Sum_probs=47.1
Q ss_pred HHHHHhc-CCCCCCcccccccCCCCeEEEEeecCCCCCCCcccccccCCCC--Cc-CCCcceeecceeeec--CCcccc-
Q 019304 31 GFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGL--KP-VRHNYSVSVGQSVFR--PGKVTH- 103 (343)
Q Consensus 31 ~~~~~~~-~~~~~~~~~~~~s~~~g~~s~s~~~ss~~s~~~~~~~~~~~~~--~~-~~~~~s~~~~~~~~~--~~~~~~- 103 (343)
...+..+ .|+|+++.| + ..|.+++|+.....+... ..++|+.| .. ..+.|.+. +...|. +..+.+
T Consensus 23 ~lL~~~~~~G~FLVR~S-~---~~g~y~LSv~~~~~~~~~---~~v~H~~I~~~~~~~g~~~~~-~~~~F~sl~~LV~~y 94 (118)
T 3s9k_A 23 KLLLDTGKEGAFMVRDS-R---TPGTYTVSVFTKAIISEN---PCIKHYHIKETNDSPKRYYVA-EKYVFDSIPLLIQYH 94 (118)
T ss_dssp HHHHHHCCTTCEEEEEC-S---STTCEEEEEEECCSCSSS---CEEEEEEEEECSCSSCCEEEE-CSCCCSCHHHHHHHH
T ss_pred HHHHhcCCCCeEEEEee-C---CCCCEEEEEEecccccCC---CceEEEEEeEEECCCCCEEEC-CCcccCCHHHHHHHh
Confidence 3444443 899999988 4 468999999865322211 24678888 22 34667765 333443 333433
Q ss_pred ccCchHHHHHHhcCCCCC
Q 019304 104 ALNDDALAQALMDHRYPT 121 (343)
Q Consensus 104 ~~~~d~l~~~l~~~~~~~ 121 (343)
..+.+++...|..|+.+.
T Consensus 95 ~~~~~~l~~~L~~Pv~~~ 112 (118)
T 3s9k_A 95 QYNGGGLVTRLRYPVCGS 112 (118)
T ss_dssp HHCCTTSSSCCCCCCCCS
T ss_pred eeCCCCCccCCCCcCCCC
Confidence 444455555555555443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.25 E-value=1.8 Score=36.64 Aligned_cols=86 Identities=9% Similarity=-0.002 Sum_probs=59.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC
Q 019304 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273 (343)
Q Consensus 194 ~h~nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~ 273 (343)
.||+.+.. .+-.+.+.+.+.++.-+.+.-...+++ .+....++++.+|+....++ ..-+|--|+|+||+++.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~-----~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS-----FTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTR 114 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG-----SCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh-----cCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcC
Confidence 57888766 455566666666655542222222322 77888899999988766433 33478889999999999
Q ss_pred CCcEEEeccccccc
Q 019304 274 DKSIKIADFGVARI 287 (343)
Q Consensus 274 ~~~vkl~DFg~a~~ 287 (343)
++.+++.--|+-..
T Consensus 115 ~~~p~i~~RGik~~ 128 (215)
T 4ann_A 115 DGLPIAKTRGLQNV 128 (215)
T ss_dssp TSCEEESCCEETTT
T ss_pred CCCEEEEEccCccC
Confidence 99999988876443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 343 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-48 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-41 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-40 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-40 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-40 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-39 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-38 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-37 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-37 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-37 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-36 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-36 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-36 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-36 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-36 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-35 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-35 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-35 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-33 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-33 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-33 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-33 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-33 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-32 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-32 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-30 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-30 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-30 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-30 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-29 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-29 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-29 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-28 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-28 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-27 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-27 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-25 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-25 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-25 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-24 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-17 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-16 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 4e-48
Identities = 59/182 (32%), Positives = 99/182 (54%), Gaps = 10/182 (5%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV 187
D+W I ++ +G G+FG +Y+G ++G DVA+K+L P+ Q F+ EV
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ----QLQAFKNEV 55
Query: 188 MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDV 247
+L +H+NI+ F+G + IVT++ +G S+ L + + + + A
Sbjct: 56 GVLRKTRHVNILLFMGYSTAPQLA-IVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQT 113
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWM 304
A+GM Y+H IHRDLKS+N+ + D ++KI DFG+A ++ + G +G+ WM
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 305 AP 306
AP
Sbjct: 174 AP 175
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 5e-44
Identities = 51/178 (28%), Positives = 86/178 (48%), Gaps = 11/178 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
W +++++L + +G FG + G Y G VA+K ++ Q F E +
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--------TAQAFLAEASV 53
Query: 190 LATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
+ L+H N+V+ +G ++ IVTEY GS+ +L R + +K +LDV
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
M Y+ G F+HRDL + N+L+S D K++DFG+ + + +W AP
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVKWTAP 169
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 8e-42
Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 11/182 (6%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQE 186
DEW + L + G FG+++ G YN VA+K L+ + + F E
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-------QGSMSPDAFLAE 58
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
++ L+H +VR + ++ I+TEY + GS+ FL + + + A
Sbjct: 59 ANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQTEGMTPETGTYRWM 304
+A GMA++ +IHRDL++ N+L+S S KIADFG+AR+ + + +W
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 305 AP 306
AP
Sbjct: 178 AP 179
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (363), Expect = 2e-41
Identities = 53/228 (23%), Positives = 102/228 (44%), Gaps = 16/228 (7%)
Query: 115 MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENN 172
MD P NYD+W ++ + M G +G++Y G + VA+K L+
Sbjct: 2 MDPSSP-----NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----- 51
Query: 173 PEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN 232
+ + ++F +E ++ +KH N+V+ +G C + + I+TE+ G++ +L
Sbjct: 52 --EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 109
Query: 233 RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQ 290
+ V + + A ++ M Y+ FIHRDL + N L+ + +K+ADFG++R+
Sbjct: 110 QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169
Query: 291 TEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTWPPPW 338
+W AP + ++ S + + T P+
Sbjct: 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 4e-41
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 12/202 (5%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQV 178
T+GL D W I L + QG FG+++ GT+ VAIK L+ +
Sbjct: 3 QTQGL-AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-------PGTM 54
Query: 179 MEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
+ F QE ++ L+H +V+ + ++ IVTEY GS+ FL + + L
Sbjct: 55 SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLP 113
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQTEGMTP 296
V A +A GMAYV + ++HRDL++ N+L+ + K+ADFG+AR+ + +
Sbjct: 114 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173
Query: 297 ETGTYRWMAPGNSFFSPLPHPS 318
+W AP + + S
Sbjct: 174 AKFPIKWTAPEAALYGRFTIKS 195
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-40
Identities = 46/180 (25%), Positives = 85/180 (47%), Gaps = 10/180 (5%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQE 186
+W ++ +G +G FG +Y + +A+K+L + + +E Q ++E
Sbjct: 2 QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG---VEHQLRRE 56
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
V + + L+H NI+R G ++ EYA G+V + L ++ + +
Sbjct: 57 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 114
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+A ++Y H IHRD+K +NLL+ + +KIADFG + + T GT ++ P
Sbjct: 115 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTLCGTLDYLPP 173
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 1e-40
Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 11/165 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G G +++ ++ +G +A K++ + E + Q +E+ +L IV F
Sbjct: 16 AGNGGVVFKVSHKPSGLVMARKLI-----HLEIKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIH 261
GA I E+ GGS+ Q L + +P ++ K ++ V +G+ Y+ +H
Sbjct: 71 GAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMH 128
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
RD+K N+L+++ IK+ DFGV+ + + + GT +M+P
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRSYMSP 172
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (355), Expect = 5e-40
Identities = 47/164 (28%), Positives = 70/164 (42%), Gaps = 10/164 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G+FG +Y N E VAIK + + Q +EV L L+H N +++
Sbjct: 25 HGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE---KWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
G + +V EY G + L + + +G+AY+H IHR
Sbjct: 82 GCYLREHTAWLVMEYCLGSAS--DLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
D+K+ N+L+S +K+ DFG A I GT WMAP
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAP 180
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 9e-40
Identities = 45/167 (26%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GA+G++ E VA+KI+ + ++A + ++E+ + L H N+V+F
Sbjct: 15 EGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
G R+ + + EY GG + + + +P A + + G+ Y+HG+G HR
Sbjct: 70 GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 127
Query: 263 DLKSDNLLISADKSIKIADFGVARI---EVQTEGMTPETGTYRWMAP 306
D+K +NLL+ ++KI+DFG+A + + + GT ++AP
Sbjct: 128 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-39
Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 10/165 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFGK+Y+ A K+++ K++ + + E+ +LA+ H NIV+ +
Sbjct: 22 DGAFGKVYKAQNKETSVLAAAKVIDT------KSEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A I+ E+ GG+V + + R + + Y+H IHR
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHR 134
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 306
DLK+ N+L + D IK+ADFGV+ +T + GT WMAP
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 179
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-38
Identities = 50/212 (23%), Positives = 90/212 (42%), Gaps = 11/212 (5%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
ID + L G FG + G + DVAIK+++ + + E +F +E ++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-------EGSMSEDEFIEEAKVM 53
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L H +V+ G C K+ I+TEY G + +L ++R + ++ DV
Sbjct: 54 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEA 112
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQTEGMTPETGTYRWMAPGN 308
M Y+ F+HRDL + N L++ +K++DFG++R + + RW P
Sbjct: 113 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172
Query: 309 SFFSPLPHPSFEHKWSAKESCLKTTWPPPWRH 340
+S S + + + P+
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 204
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-37
Identities = 49/204 (24%), Positives = 84/204 (41%), Gaps = 15/204 (7%)
Query: 145 QGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G FG + +G Y DVAIK+L + ++ +E ++ L + IVR
Sbjct: 19 CGNFGSVRQGVYRMRKKQIDVAIKVL-----KQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
IG C+ +V E A GG + +FL + +P+ + V+ GM Y+ F+
Sbjct: 74 LIGVCQA-EALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYRWMAPGNSFFSPLPH 316
HRDL + N+L+ KI+DFG+++ + + +W AP F
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 317 PSFEHKWSAKESCLKTTWPPPWRH 340
S + + P++
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKK 215
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 134 bits (339), Expect = 3e-37
Identities = 38/184 (20%), Positives = 74/184 (40%), Gaps = 18/184 (9%)
Query: 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQ 184
YD + I L +L GAFG ++R G K + P + + +
Sbjct: 28 YDYYDI-LEEL------GSGAFGVVHRCVEKATGRVFVAKFINTPY------PLDKYTVK 74
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
E+ ++ L H ++ A + ++ E+ GG + + ++ + +
Sbjct: 75 NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEVINYM 133
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPETGTYR 302
G+ ++H +H D+K +N++ K+ +KI DFG+A E + T T
Sbjct: 134 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAE 193
Query: 303 WMAP 306
+ AP
Sbjct: 194 FAAP 197
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 4e-37
Identities = 53/179 (29%), Positives = 84/179 (46%), Gaps = 27/179 (15%)
Query: 145 QGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204
+G FG+++RG + GE+VA+KI + + E+ L+H NI+ FI A
Sbjct: 13 KGRFGEVWRGKWRGEEVAVKIFS-------SREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 205 CRKR----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH----- 255
K +V++Y + GS+ +L R V ++ +K AL A G+A++H
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 256 ---GLGFIHRDLKSDNLLISADKSIKIADFGVARI-----EVQTEGMTPETGTYRWMAP 306
HRDLKS N+L+ + + IAD G+A + GT R+MAP
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 6e-37
Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 32/223 (14%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVME 180
+W +L+ G GAFGK+ T VA+K+L P
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-----KPSAHLTER 70
Query: 181 QQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR------ 233
+ E+ +L+ L H+NIV +GAC ++TEY G + FL R+++
Sbjct: 71 EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 234 ----------AVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283
A+ L+ + + VA+GMA++ IHRDL + N+L++ + KI DFG
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 190
Query: 284 VARIEVQTEGMTPET---GTYRWMAPGNSFFSPLPHPSFEHKW 323
+AR + +WMAP + F S +
Sbjct: 191 LARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-36
Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 21/223 (9%)
Query: 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN----GEDVAIKILERPENNPEKAQVMEQ 181
+ T++ ++L G FG + +G Y + VA+KIL+ N+P ++
Sbjct: 4 DRKLLTLEDKEL------GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----LKD 53
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV 241
+ E ++ L + IVR IG C W +V E A+ G + ++L + NR V K +
Sbjct: 54 ELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQ--NRHVKDKNII 110
Query: 242 KQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPE 297
+ V+ GM Y+ F+HRDL + N+L+ KI+DFG+++ E + T
Sbjct: 111 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170
Query: 298 TGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTWPPPWRH 340
+W AP + S + + P+R
Sbjct: 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 213
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 1e-36
Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 11/178 (6%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
ID +L G FG ++ G + N + VAIK + + + E+ F +E ++
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-------EGAMSEEDFIEEAEVM 54
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L H +V+ G C ++ C+V E+ + G + + R Q + + LDV G
Sbjct: 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEG 113
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQTEGMTPETGTYRWMAP 306
MAY+ IHRDL + N L+ ++ IK++DFG+ R + Q T +W +P
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-36
Identities = 52/214 (24%), Positives = 82/214 (38%), Gaps = 38/214 (17%)
Query: 126 NYDE-WTIDLRKLNMGTAFAQGAFGKLYRG-------TYNGEDVAIKILERPENNPEKAQ 177
YD W L G GAFGK+ T VA+K+L +
Sbjct: 27 EYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-----KEKADS 81
Query: 178 VMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR--- 233
+ E+ M+ L H NIV +GAC ++ EY G + +L ++ +
Sbjct: 82 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 141
Query: 234 ------------------AVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK 275
+ + + A VA+GM ++ +HRDL + N+L++ K
Sbjct: 142 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK 201
Query: 276 SIKIADFGVARIEVQTEGMTPET---GTYRWMAP 306
+KI DFG+AR + +WMAP
Sbjct: 202 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 235
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-36
Identities = 50/185 (27%), Positives = 89/185 (48%), Gaps = 16/185 (8%)
Query: 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
+ D R L +G+F +Y+G +VA L+ + + Q+F++E
Sbjct: 5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE----RQRFKEEAE 60
Query: 189 MLATLKHLNIVRFIGAC----RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
ML L+H NIVRF + + + +VTE G+++ +L ++ + + +K+
Sbjct: 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWC 118
Query: 245 LDVARGMAYVH--GLGFIHRDLKSDNLLISA-DKSIKIADFGVARIEVQTEGMTPETGTY 301
+ +G+ ++H IHRDLK DN+ I+ S+KI D G+A + + GT
Sbjct: 119 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-KRASFAKAVIGTP 177
Query: 302 RWMAP 306
+MAP
Sbjct: 178 EFMAP 182
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 132 bits (333), Expect = 2e-36
Identities = 39/166 (23%), Positives = 79/166 (47%), Gaps = 11/166 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFG ++R T G + A K + P + ++ ++E+ ++ L+H +V
Sbjct: 36 TGAFGVVHRVTERATGNNFAAKFVMTPHES------DKETVRKEIQTMSVLRHPTLVNLH 89
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A ++ E+ GG + + + N+ + AV+ V +G+ ++H ++H
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENNYVHL 148
Query: 263 DLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPETGTYRWMAP 306
DLK +N++ + +S +K+ DFG+ + + TGT + AP
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 194
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 129 bits (326), Expect = 4e-36
Identities = 39/168 (23%), Positives = 76/168 (45%), Gaps = 8/168 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILER---PENNPEKAQVMEQQFQQEVMMLATLK-HLNI 198
+G + R + ++ A+KI++ + E+ Q + + +EV +L + H NI
Sbjct: 13 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 72
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
++ + +V + K G + +L + + K K + + +H L
Sbjct: 73 IQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVICALHKLN 130
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HRDLK +N+L+ D +IK+ DFG + E + GT ++AP
Sbjct: 131 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 6e-36
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QGA G +Y G++VAI+ + + P+K + E++++ K+ NIV ++
Sbjct: 30 QGASGTVYTAMDVATGQEVAIRQM-NLQQQPKK-----ELIINEILVMRENKNPNIVNYL 83
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ +V EY GGS+ +T + + + ++H IHR
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 263 DLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
D+KSDN+L+ D S+K+ DFG I + + GT WMAP
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-35
Identities = 51/219 (23%), Positives = 98/219 (44%), Gaps = 14/219 (6%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQF 183
++ I ++ +G +G FG +++G Y VAIK + + + ++F
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-----CTSDSVREKF 55
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QE + + H +IV+ IG + VW I+ E G +R FL R+ + L +
Sbjct: 56 LQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYS-LDLASLILY 113
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQTEGMTPETGTY 301
A ++ +AY+ F+HRD+ + N+L+S++ +K+ DFG++R + +
Sbjct: 114 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 302 RWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTWPPPWRH 340
+WMAP + F S + + P++
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 4e-35
Identities = 43/174 (24%), Positives = 79/174 (45%), Gaps = 16/174 (9%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G++G+ + +G+ + K L+ + +Q EV +L LKH NIVR+
Sbjct: 14 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE----KQMLVSEVNLLRELKHPNIVRYY 69
Query: 203 GAC--RKRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVH--- 255
R IV EY +GG + +T+ ++ + + + ++ + + H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 256 --GLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
G +HRDLK N+ + +++K+ DFG+AR + T GT +M+P
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (319), Expect = 7e-35
Identities = 47/210 (22%), Positives = 85/210 (40%), Gaps = 18/210 (8%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPE 174
P E + + + ID+ + + G FG++ G VAIK L
Sbjct: 12 PNEAVREFAK-EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-----KSG 65
Query: 175 KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA 234
+ + F E ++ H N++ G K I+TE+ + GS+ F R+ +
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF-LRQNDGQ 124
Query: 235 VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI------E 288
+ V +A GM Y+ + ++HRDL + N+L++++ K++DFG++R +
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 289 VQTEGMTPETGTYRWMAPGNSFFSPLPHPS 318
RW AP + S
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSAS 214
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-33
Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 14/216 (6%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQFQQE 186
I + L + G+FG + RG ++ VA+K L+ + +A F +E
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM---DDFIRE 61
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
V + +L H N++R G + +VTE A GS+ L + Q L + A+
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQ 119
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG----MTPETGTYR 302
VA GM Y+ FIHRDL + NLL++ +KI DFG+ R Q + +
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 303 WMAPGNSFFSPLPHPSFEHKWSAKESCLKTTWPPPW 338
W AP + H S + + T PW
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 215
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-33
Identities = 52/233 (22%), Positives = 91/233 (39%), Gaps = 27/233 (11%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVME 180
DEW + K+ M QG+FG +Y G VAIK + N +
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRER 67
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR------- 233
+F E ++ ++VR +G + ++ E G ++ +L +
Sbjct: 68 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 234 -AVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI---EV 289
L ++ A ++A GMAY++ F+HRDL + N +++ D ++KI DFG+ R
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 187
Query: 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC--LKTTWPPPWRH 340
RWM+P ++ WS + T P++
Sbjct: 188 YYRKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 238
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 4e-33
Identities = 53/194 (27%), Positives = 84/194 (43%), Gaps = 24/194 (12%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGE----DVAIKILERPENNPEKAQVMEQQFQQEV 187
+D + +G FG++ + + D AIK + ++ + F E+
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-----KEYASKDDHRDFAGEL 61
Query: 188 MMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------N 232
+L L H NI+ +GAC R + EYA G++ FL + +
Sbjct: 62 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 233 RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292
+ + + A DVARGM Y+ FIHRDL + N+L+ + KIADFG++R +
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 293 GMTPETGTYRWMAP 306
T RWMA
Sbjct: 182 KKTMGRLPVRWMAI 195
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 5e-33
Identities = 33/186 (17%), Positives = 72/186 (38%), Gaps = 19/186 (10%)
Query: 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQ 182
E Y+++ I L +G FG ++R T + + K ++ + +
Sbjct: 2 ELYEKYMI-AEDL------GRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-------QVL 47
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
++E+ +L +H NI+ + ++ E+ G + + + + + V
Sbjct: 48 VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVS 106
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPETGT 300
V + ++H H D++ +N++ +S IKI +FG AR +
Sbjct: 107 YVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA 166
Query: 301 YRWMAP 306
+ AP
Sbjct: 167 PEYYAP 172
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 5e-33
Identities = 53/241 (21%), Positives = 98/241 (40%), Gaps = 29/241 (12%)
Query: 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQV 178
+ +W +L +G +GAFG++ VA+K+L+ + E
Sbjct: 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--- 60
Query: 179 MEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
+ +++ HLN+V +GAC + ++ E+ K G++ +L ++N VP
Sbjct: 61 -RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 119
Query: 238 KL--------------AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283
K+ + + VA+GM ++ IHRDL + N+L+S +KI DFG
Sbjct: 120 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 284 VARIEVQTEGMTPET---GTYRWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTWPPPWRH 340
+AR + + +WMAP F S + + + P+
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239
Query: 341 I 341
+
Sbjct: 240 V 240
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 121 bits (305), Expect = 6e-33
Identities = 51/212 (24%), Positives = 82/212 (38%), Gaps = 37/212 (17%)
Query: 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVM 179
+ +GAFG++++ VA+K+L E + M
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-----KEEASADM 59
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV---- 235
+ FQ+E ++A + NIV+ +G C C++ EY G + +FL V
Sbjct: 60 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 236 ------------------PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
+ A VA GMAY+ F+HRDL + N L+ + +
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVV 179
Query: 278 KIADFGVARIEVQTEGMTPET---GTYRWMAP 306
KIADFG++R + + RWM P
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPP 211
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (306), Expect = 7e-33
Identities = 43/179 (24%), Positives = 74/179 (41%), Gaps = 12/179 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAF ++ + VAIK + + + E + E+ +L +KH NIV
Sbjct: 19 TGAFSEVILAEDKRTQKLVAIKCI-----AKKALEGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
++ + GG + + + + A + V + Y+H LG +HR
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 263 DLKSDNLLIS---ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPS 318
DLK +NLL D I I+DFG++++E ++ GT ++AP P
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAV 190
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 121 bits (304), Expect = 4e-32
Identities = 33/163 (20%), Positives = 70/163 (42%), Gaps = 5/163 (3%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG++Y G+ A+K L++ ++ + + + + +++T IV
Sbjct: 14 RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 73
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A + + GG + L Q+ A ++ G+ ++H ++R
Sbjct: 74 YAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR 131
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMA 305
DLK N+L+ ++I+D G+A + + GT+ +MA
Sbjct: 132 DLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMA 173
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 5e-32
Identities = 40/165 (24%), Positives = 75/165 (45%), Gaps = 7/165 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FGK++ + + AIK L++ + +E ++ ++ +H +
Sbjct: 12 KGSFGKVFLAEFKKTNQFFAIKALKK--DVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 69
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ + V EY GG + + + L A A ++ G+ ++H G ++R
Sbjct: 70 CTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 127
Query: 263 DLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
DLK DN+L+ D IKIADFG+ + + GT ++AP
Sbjct: 128 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAP 172
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 5e-32
Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 16/172 (9%)
Query: 145 QGAFGKLYRGTYNGED------VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
G FG++Y+G VAIK L + F E ++ H NI
Sbjct: 17 AGEFGEVYKGMLKTSSGKKEVPVAIKTL-----KAGYTEKQRVDFLGEAGIMGQFSHHNI 71
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
+R G K I+TEY + G++ +F R ++ + V +A GM Y+ +
Sbjct: 72 IRLEGVISKYKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLRGIAAGMKYLANMN 130
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYRWMAP 306
++HRDL + N+L++++ K++DFG++R+ T + RW AP
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 9e-32
Identities = 39/167 (23%), Positives = 71/167 (42%), Gaps = 10/167 (5%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+F + + AIKILE+ E +E +++ L H V+
Sbjct: 18 EGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFVKLY 74
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ YAK G + +++ + + ++ + Y+HG G IHR
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGIIHR 132
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET---GTYRWMAP 306
DLK +N+L++ D I+I DFG A++ GT ++++P
Sbjct: 133 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 2e-31
Identities = 39/172 (22%), Positives = 72/172 (41%), Gaps = 21/172 (12%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
G GK+ + E A+K+L+ + ++EV + + +IVR
Sbjct: 22 LGINGKVLQIFNKRTQEKFALKMLQD-----------CPKARREVELHWRASQCPHIVRI 70
Query: 202 IGACR----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ R IV E GG + + R ++A + A + + + Y+H +
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 258 GFIHRDLKSDNLLISA---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
HRD+K +NLL ++ + +K+ DFG A+ +T T ++AP
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 182
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 6e-31
Identities = 37/168 (22%), Positives = 71/168 (42%), Gaps = 8/168 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F + + G A K +++ + V + ++EV +L ++H N++
Sbjct: 20 SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 79
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ ++ E GG + FL +++ + + A + + G+ Y+H L H
Sbjct: 80 EVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 263 DLKSDNLLISAD----KSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
DLK +N+++ IKI DFG+A GT ++AP
Sbjct: 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-30
Identities = 35/167 (20%), Positives = 69/167 (41%), Gaps = 7/167 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVR 200
G FG +Y G + VAIK +E+ + + EV++L + ++R
Sbjct: 14 SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 73
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ + + ++ E + + + +LA V + + H G +
Sbjct: 74 LLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCGVL 132
Query: 261 HRDLKSDNLLISADK-SIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
HRD+K +N+LI ++ +K+ DFG + ++ T GT + P
Sbjct: 133 HRDIKDENILIDLNRGELKLIDFGSGAL-LKDTVYTDFDGTRVYSPP 178
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 3e-30
Identities = 47/204 (23%), Positives = 89/204 (43%), Gaps = 16/204 (7%)
Query: 145 QGAFGKLYRGTYNGED------VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
GAFG +Y+G + E VAIK L R +P+ ++ E ++A++ + ++
Sbjct: 19 SGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPK----ANKEILDEAYVMASVDNPHV 73
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
R +G C V I + G + ++ ++ + + + + +A+GM Y+
Sbjct: 74 CRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRR 131
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARI---EVQTEGMTPETGTYRWMAPGNSFFSPLP 315
+HRDL + N+L+ + +KI DFG+A++ E + +WMA +
Sbjct: 132 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 191
Query: 316 HPSFEHKWSAKESCLKTTWPPPWR 339
H S + L T P+
Sbjct: 192 HQSDVWSYGVTVWELMTFGSKPYD 215
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 4e-30
Identities = 49/198 (24%), Positives = 81/198 (40%), Gaps = 19/198 (9%)
Query: 122 EGLENYDEWTI--DLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPE 174
E ++ I ++ +G FG +Y GT A+K L N
Sbjct: 12 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-----NRI 66
Query: 175 KAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNR 233
QF E +++ H N++ +G C R +V Y K G +R F+ +
Sbjct: 67 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN 126
Query: 234 AVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293
+K + L VA+GM ++ F+HRDL + N ++ ++K+ADFG+AR E
Sbjct: 127 -PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185
Query: 294 MTPET-----GTYRWMAP 306
+ +WMA
Sbjct: 186 DSVHNKTGAKLPVKWMAL 203
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (285), Expect = 7e-30
Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 19/183 (10%)
Query: 130 WTID----LRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQF 183
+++ LR L G+FG+++ +NG A+K+L++ K +
Sbjct: 1 YSLQDFQILRTL------GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK---QVEHT 51
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
E +ML+ + H I+R G + ++ +Y +GG + L + Q P +A
Sbjct: 52 NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFY 109
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
A +V + Y+H I+RDLK +N+L+ + IKI DFG A+ + GT +
Sbjct: 110 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTYTLCGTPDY 167
Query: 304 MAP 306
+AP
Sbjct: 168 IAP 170
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 9e-30
Identities = 38/165 (23%), Positives = 75/165 (45%), Gaps = 6/165 (3%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F +Y+ + VAIK + + + E + + +E+ +L L H NI+ +
Sbjct: 8 EGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 66
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A + +V ++ + + + + + + L +G+ Y+H +HR
Sbjct: 67 DAFGHKSNISLVFDFMET--DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 124
Query: 263 DLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
DLK +NLL+ + +K+ADFG+A+ T + T + AP
Sbjct: 125 DLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAP 169
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-29
Identities = 44/172 (25%), Positives = 76/172 (44%), Gaps = 18/172 (10%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GA+G + N VAIK + +P + Q Q+ +E+ +L +H NI+
Sbjct: 18 EGAYGMVCSAYDNVNKVRVAIKKI-----SPFEHQTYCQRTLREIKILLRFRHENIIGIN 72
Query: 203 GACR----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
R ++M + + G + + L + + + + RG+ Y+H
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLL---KTQHLSNDHICYFLYQILRGLKYIHSAN 129
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYRWMAP 306
+HRDLK NLL++ +KI DFG+AR+ T +T T + AP
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 1e-29
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 32/206 (15%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQV 178
W + +L +G +GAFG++ G D VA+K+L + +
Sbjct: 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-----KSDATEK 60
Query: 179 MEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ------ 231
E+ M+ + KH NI+ +GAC + ++ EYA G++R++L R+
Sbjct: 61 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 120
Query: 232 --------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283
+ K V A VARGM Y+ IHRDL + N+L++ D +KIADFG
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG 180
Query: 284 VARIEVQTEGMT---PETGTYRWMAP 306
+AR + +WMAP
Sbjct: 181 LARDIHHIDYYKKTTNGRLPVKWMAP 206
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 111 bits (279), Expect = 3e-29
Identities = 46/194 (23%), Positives = 75/194 (38%), Gaps = 17/194 (8%)
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQ 182
+E Y L K+ +G +G +Y+ N GE A+K + + + +
Sbjct: 1 MEKYHG----LEKI------GEGTYGVVYKAQNNYGETFALKKIRLEKEDEG----IPST 46
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
+E+ +L LKH NIV+ + +V E+ + + A
Sbjct: 47 TIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKS 104
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR 302
L + G+AY H +HRDLK NLLI+ + +KIADFG+AR
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL 164
Query: 303 WMAPGNSFFSPLPH 316
W + +
Sbjct: 165 WYRAPDVLMGSKKY 178
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 110 bits (276), Expect = 7e-29
Identities = 43/172 (25%), Positives = 76/172 (44%), Gaps = 15/172 (8%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G +++ DVA+K+L + + +F++E A L H IV
Sbjct: 17 FGGMSEVHLARDLRLHRDVAVKVLRA---DLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 203 GACR----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
+ IV EY G ++R + + K A++ D + + + H G
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSHQNG 131
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET----GTYRWMAP 306
IHRD+K N++ISA ++K+ DFG+AR + +T GT ++++P
Sbjct: 132 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 3e-28
Identities = 50/186 (26%), Positives = 85/186 (45%), Gaps = 18/186 (9%)
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQ 181
+EN+ + + K+ +G +G +Y+ GE VA+K + +
Sbjct: 1 MENFQK----VEKI------GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG----VPS 46
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV 241
+E+ +L L H NIV+ + +V E+ +++F+ +PL L
Sbjct: 47 TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK 105
Query: 242 KQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT 300
+ +G+A+ H +HRDLK NLLI+ + +IK+ADFG+AR V T E T
Sbjct: 106 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 301 YRWMAP 306
+ AP
Sbjct: 166 LWYRAP 171
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 7e-28
Identities = 47/182 (25%), Positives = 80/182 (43%), Gaps = 10/182 (5%)
Query: 145 QGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GA+GK+++ G VA+K + R + E + + + L T +H N+VR
Sbjct: 17 EGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRL 75
Query: 202 IGAC-----RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
C + +V E+ + +L + VP + + RG+ ++H
Sbjct: 76 FDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPH 316
+HRDLK N+L+++ IK+ADFG+ARI +T T + AP S
Sbjct: 135 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT 194
Query: 317 PS 318
P
Sbjct: 195 PV 196
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 3e-27
Identities = 37/164 (22%), Positives = 68/164 (41%), Gaps = 8/164 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G +++ E VA+K + +++ + +E+ +L LKH NIVR
Sbjct: 12 EGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALREICLLKELKHKNIVRLH 67
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+V E+ + N + ++ + +G+ + H +HR
Sbjct: 68 DVLHSDKKLTLVFEFCD--QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHR 125
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
DLK NLLI+ + +K+A+FG+AR W P
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 7e-27
Identities = 45/165 (27%), Positives = 72/165 (43%), Gaps = 8/165 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FGK+ G A+KIL R E K +V E +L +H +
Sbjct: 15 KGTFGKVILVREKATGRYYAMKIL-RKEVIIAKDEV--AHTVTESRVLQNTRHPFLTALK 71
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A + C V EYA GG + L+R + + A ++ + Y+H ++R
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
D+K +NL++ D IKI DFG+ + + GT ++AP
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 6e-26
Identities = 44/172 (25%), Positives = 75/172 (43%), Gaps = 20/172 (11%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G+FG +Y+ +GE VAIK + + + + +E+ ++ L H NIVR
Sbjct: 30 NGSFGVVYQAKLCDSGELVAIKKVLQDK----------RFKNRELQIMRKLDHCNIVRLR 79
Query: 203 GAC------RKRMVWCIVTEYAKGGSVRQFLTR-RQNRAVPLKLAVKQALDVARGMAYVH 255
+ + +V +Y R R + +P+ + R +AY+H
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 256 GLGFIHRDLKSDNLLISADKS-IKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G HRD+K NLL+ D + +K+ DFG A+ V+ E + + AP
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 102 bits (255), Expect = 2e-25
Identities = 47/201 (23%), Positives = 79/201 (39%), Gaps = 16/201 (7%)
Query: 108 DALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKI 165
A L P++ D++ ++ L G+FG++ + +G A+KI
Sbjct: 21 KAKEDFLKKWETPSQNTAQLDQFDR-IKTL------GTGSFGRVMLVKHKESGNHYAMKI 73
Query: 166 LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQ 225
L++ + K + E +L + +V+ + + +V EY GG +
Sbjct: 74 LDKQKVVKLK---QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 226 FLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
L R A A + Y+H L I+RDLK +NLLI I++ DFG A
Sbjct: 131 HLRRIGR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 286 RIEVQTEGMTPETGTYRWMAP 306
+ GT +AP
Sbjct: 189 K--RVKGRTWTLCGTPEALAP 207
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 102 bits (254), Expect = 2e-25
Identities = 30/190 (15%), Positives = 78/190 (41%), Gaps = 23/190 (12%)
Query: 126 NYDEWTIDLRKLN---MGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVME 180
+Y+ ++ + + +G + +++ N E V +KIL+ V +
Sbjct: 23 DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---------VKK 73
Query: 181 QQFQQEVMMLATLK-HLNIVRFIGACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
++ ++E+ +L L+ NI+ + + +V E+ +Q + +
Sbjct: 74 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTD 128
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTP 296
++ + + Y H +G +HRD+K N++I + + +++ D+G+A +
Sbjct: 129 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 188
Query: 297 ETGTYRWMAP 306
+ + P
Sbjct: 189 RVASRYFKGP 198
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 101 bits (252), Expect = 2e-25
Identities = 44/176 (25%), Positives = 68/176 (38%), Gaps = 24/176 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G+FG +Y GT GE+VAIK+ + Q E + ++ + I
Sbjct: 17 SGSFGDIYLGTDIAAGEEVAIKLE--------CVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 203 GAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
C + +V E + L +R LK + A + + Y+H FIH
Sbjct: 69 RWCGAEGDYNVMVMELLGPSL--EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 126
Query: 262 RDLKSDNLLISADKS---IKIADFGVARIEVQTEG--------MTPETGTYRWMAP 306
RD+K DN L+ K + I DFG+A+ TGT R+ +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 2e-25
Identities = 41/170 (24%), Positives = 70/170 (41%), Gaps = 17/170 (10%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA G + +VAIK L RP N ++ +E++++ + H NI+ +
Sbjct: 27 SGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT----HAKRAYRELVLMKCVNHKNIISLL 82
Query: 203 GACRKRMVW------CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ +V E + + + G+ ++H
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHS 137
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G IHRDLK N+++ +D ++KI DFG+AR + MTP T + AP
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 3e-25
Identities = 42/177 (23%), Positives = 72/177 (40%), Gaps = 21/177 (11%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QG FG++++ + G+ VA+K + +E+ +L LKH N+V I
Sbjct: 20 QGTFGEVFKARHRKTGQKVALKKVLMENEKEG----FPITALREIKILQLLKHENVVNLI 75
Query: 203 GACRKRMV--------WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
CR + +V ++ + L + + G+ Y+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF--TLSEIKRVMQMLLNGLYYI 133
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARI-----EVQTEGMTPETGTYRWMAP 306
H +HRD+K+ N+LI+ D +K+ADFG+AR Q T T + P
Sbjct: 134 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 96.8 bits (240), Expect = 9e-24
Identities = 38/178 (21%), Positives = 65/178 (36%), Gaps = 26/178 (14%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN-IVRF 201
+G+FG ++ GT N + VAIK R + P Q + E L I
Sbjct: 15 EGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP--------QLRDEYRTYKLLAGCTGIPNV 66
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
++ + +V + G + L R +K A + + +H ++
Sbjct: 67 YYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124
Query: 262 RDLKSDNLLISA-----DKSIKIADFGVARI--------EVQTEGMTPETGTYRWMAP 306
RD+K DN LI I + DFG+ + + +GT R+M+
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 1e-23
Identities = 41/170 (24%), Positives = 69/170 (40%), Gaps = 18/170 (10%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA+G + G VAIK L RP + ++ +E+ +L ++H N++ +
Sbjct: 28 SGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL----FAKRAYRELRLLKHMRHENVIGLL 83
Query: 203 GACRKR------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ +V + ++ + + +G+ Y+H
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTD----LGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA 139
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G IHRDLK NL ++ D +KI DFG+AR MT T + AP
Sbjct: 140 AGIIHRDLKPGNLAVNEDCELKILDFGLARQA--DSEMTGYVVTRWYRAP 187
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 1e-23
Identities = 43/191 (22%), Positives = 89/191 (46%), Gaps = 22/191 (11%)
Query: 123 GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGT-----YNGEDVAIKILERPENNPEKAQ 177
G+EN++ L+ L GA+GK++ G+ A+K+L + +KA+
Sbjct: 22 GIENFEL----LKVL------GTGAYGKVFLVRKISGHDTGKLYAMKVL-KKATIVQKAK 70
Query: 178 VMEQQFQQEVMMLATLKHL-NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP 236
E + E +L ++ +V A + ++ +Y GG + L++R+
Sbjct: 71 TTEH-TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FT 127
Query: 237 LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR--IEVQTEGM 294
++ + ++H LG I+RD+K +N+L+ ++ + + DFG+++ + +TE
Sbjct: 128 EHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 187
Query: 295 TPETGTYRWMA 305
GT +MA
Sbjct: 188 YDFCGTIEYMA 198
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.0 bits (222), Expect = 7e-21
Identities = 44/169 (26%), Positives = 74/169 (43%), Gaps = 16/169 (9%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA+G + T G VA+K L RP + A+ + +E+ +L +KH N++ +
Sbjct: 28 SGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYRELRLLKHMKHENVIGLL 83
Query: 203 GACRKRMVWC-----IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ + G + + ++ ++ + Q + RG+ Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ---ILRGLKYIHSA 140
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
IHRDLK NL ++ D +KI DFG+AR MT T + AP
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAP 187
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.5 bits (190), Expect = 1e-17
Identities = 21/143 (14%), Positives = 52/143 (36%), Gaps = 3/143 (2%)
Query: 145 QGAFGKLYRGT-YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
+G ++ + +K + + +K + +LA N R +
Sbjct: 10 EGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ 69
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
+ V + + + + + ++ V ++ + + +A + G +H D
Sbjct: 70 KLQGLAVPKVY-AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGD 128
Query: 264 LKSDNLLISADKSIKIADFGVAR 286
L N+L+S ++ I I DF +
Sbjct: 129 LSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 76.6 bits (187), Expect = 3e-16
Identities = 36/215 (16%), Positives = 75/215 (34%), Gaps = 32/215 (14%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F ++ N VA+KI+ +V + + E+ +L + + +
Sbjct: 23 WGHFSTVWLAKDMVNNTHVAMKIVR-------GDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 203 GACRKRMV--------------WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ ++ G ++ + + ++R +PL + + +
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 249 RGMAYVH-GLGFIHRDLKSDNLLISADK------SIKIADFGVARIEVQTEGMTPETGTY 301
G+ Y+H G IH D+K +N+L+ IKIAD G A + + T
Sbjct: 136 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI--QTR 193
Query: 302 RWMAPGNSFFSPLPHPSFEHKWSAKESCLKTTWPP 336
+ +P +P + + L T
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 343 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.72 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.14 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.82 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.35 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.9 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.86 | |
| d2oq1a1 | 130 | Tyrosine-protein kinase zap-70 {Human (Homo sapien | 93.51 | |
| d1blja_ | 114 | P55 Blk protein tyrosine kinase {Mouse (Mus muscul | 80.68 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-47 Score=344.80 Aligned_cols=194 Identities=25% Similarity=0.501 Sum_probs=172.6
Q ss_pred CCCccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEE
Q 019304 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (343)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~ 202 (343)
+.+++|+|+.++|++.+.||+|+||+||+|++ +++.||||+++...... ++|.+|+.+|++++|||||+++
T Consensus 7 p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-------~~~~~E~~il~~l~HpnIv~~~ 79 (287)
T d1opja_ 7 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-------EEFLKEAAVMKEIKHPNLVQLL 79 (287)
T ss_dssp TTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCH-------HHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchH-------HHHHHHHHHHHhCCCCCEecCC
Confidence 46789999999999999999999999999998 57899999997654432 4689999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 019304 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (343)
Q Consensus 203 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DF 282 (343)
++|.+.+.+++||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+||
T Consensus 80 ~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DF 159 (287)
T d1opja_ 80 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF 159 (287)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred ccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccc
Confidence 99999999999999999999999998776677999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCC--ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 283 GVARIEVQTEG--MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 283 g~a~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|+|+....... .....||+.|+|||++ ....|+.++|||++++
T Consensus 160 G~a~~~~~~~~~~~~~~~g~~~y~aPE~~-----~~~~~~~k~DiwS~Gv 204 (287)
T d1opja_ 160 GLSRLMTGDTYTAHAGAKFPIKWTAPESL-----AYNKFSIKSDVWAFGV 204 (287)
T ss_dssp CCTTTCCSSSSEEETTEEECGGGCCHHHH-----HHCCCSHHHHHHHHHH
T ss_pred cceeecCCCCceeeccccccccccChHHH-----cCCCCCchhhhhhHHH
Confidence 99987544322 2233578999999999 7788999999996444
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=338.06 Aligned_cols=202 Identities=30% Similarity=0.532 Sum_probs=165.5
Q ss_pred ccceecccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 207 (343)
|+|+|+.++|++++.||+|+||+||+|++++ .||||+++........ .+.|.+|+.++++++|||||++++++.+
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 75 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILLFMGYSTA 75 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTH----HHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHH----HHHHHHHHHHHHhCCCCCEeeeeEEEec
Confidence 6899999999999999999999999998765 5999999765544432 3679999999999999999999998765
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
+.+++||||+++|+|.+++... ...+++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||+|+.
T Consensus 76 -~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 76 -PQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp -SSCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred -cEEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceee
Confidence 4579999999999999999754 34589999999999999999999999999999999999999999999999999986
Q ss_pred cccCC---CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 288 EVQTE---GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 288 ~~~~~---~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
..... ......||+.|||||++... ....|+.++|||++.. +++.+||.
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~ 210 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQ--DKNPYSFQSDVYAFGIVLYELMTGQLPYS 210 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTC--SSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccccCCcccccccccCcccCCHHHHhcc--cCCCCCchhhhhhhHHHHHHHHHCCCCCC
Confidence 54322 23456899999999998322 2456899999995333 23455554
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=333.12 Aligned_cols=192 Identities=29% Similarity=0.488 Sum_probs=167.4
Q ss_pred CCccceecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEE
Q 019304 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (343)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 204 (343)
.-++|+|+.++|++++.||+|+||.||+|.+ +++.||||+++...... +.|.+|+.++++++|||||+++++
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~-------~~~~~E~~~l~~l~HpnIv~~~g~ 76 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-------DAFLAEANLMKQLQHQRLVRLYAV 76 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH-------HHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCH-------HHHHHHHHHHHhCCCCCEeEEEee
Confidence 3478999999999999999999999999999 56789999997644332 468999999999999999999998
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccc
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~ 284 (343)
+.+ +.+++||||+++|+|.+++.......+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+
T Consensus 77 ~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGl 155 (272)
T d1qpca_ 77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155 (272)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred ecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccc
Confidence 865 4568999999999999988755545689999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC--CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 285 ARIEVQTE--GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 285 a~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|+...... ......||+.|+|||++ ....++.++|||+++.
T Consensus 156 a~~~~~~~~~~~~~~~gt~~y~APE~~-----~~~~~~~~sDvwS~Gv 198 (272)
T d1qpca_ 156 ARLIEDNEYTAREGAKFPIKWTAPEAI-----NYGTFTIKSDVWSFGI 198 (272)
T ss_dssp CEECSSSCEECCTTCCCCTTTSCHHHH-----HHCEECHHHHHHHHHH
T ss_pred eEEccCCccccccccCCcccccChHHH-----hCCCCCchhhhhhhHH
Confidence 98765432 23445789999999999 7788999999996443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=329.96 Aligned_cols=199 Identities=25% Similarity=0.386 Sum_probs=169.3
Q ss_pred cceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
+|.+ ++|++++.||+|+||+||+|++ +++.||||++.+..... ....+.+.+|+.+++.++|||||++++++.
T Consensus 2 ~~~l--~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 76 (263)
T d2j4za1 2 QWAL--EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK---AGVEHQLRREVEIQSHLRHPNILRLYGYFH 76 (263)
T ss_dssp CCCG--GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred Ccch--hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC---hHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence 4554 6899999999999999999998 67899999986422111 112357889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
+++.+|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~ 154 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV 154 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred ECCEEEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceee
Confidence 9999999999999999999998654 49999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 287 IEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
..... .....+||+.|||||++ ....|+.++|||++.+ +++.+||.+.
T Consensus 155 ~~~~~-~~~~~~Gt~~Y~APE~~-----~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 207 (263)
T d2j4za1 155 HAPSS-RRTTLCGTLDYLPPEMI-----EGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 207 (263)
T ss_dssp CCCCC-CCEETTEEGGGCCHHHH-----TTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ecCCC-cccccCCCCcccCHHHH-----cCCCCCchhhhhhHhHHHHHHhcCCCCCCCC
Confidence 65443 34556899999999999 7788999999995333 4466776543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=328.88 Aligned_cols=192 Identities=24% Similarity=0.384 Sum_probs=167.2
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||+||+|.+ +|+.||||++....... .+.+.+|+.+++.++|||||++++++.+.+.+|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC------HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH------HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEE
Confidence 5789999999999999999987 68999999997544332 256899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+||||+++|+|.+++.+. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 94 ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999999999988653 49999999999999999999999999999999999999999999999999998754432
Q ss_pred -CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 293 -GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
.....+||+.|+|||++ .+..|+.++|||++.+ +++.+||.+.
T Consensus 171 ~~~~~~~gt~~Y~aPE~~-----~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 219 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVV-----TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (293)
T ss_dssp CCBCCCCSCGGGCCHHHH-----SSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ccccccccCCCccChhhh-----cCCCCCchhceehHhHHHHHHhhCCCCCCCC
Confidence 34556899999999999 7888999999995333 4466777553
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=331.04 Aligned_cols=193 Identities=24% Similarity=0.391 Sum_probs=162.4
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++++.||+|+||+||+|++ +++.||||++....... ..+.+.+|+.++++++|||||++++++.+.+.+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ 79 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-----CPENIKKEICINKMLNHENVVKFYGHRREGNIQY 79 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-----HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeE
Confidence 5688899999999999999998 68899999997643221 1256889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~- 291 (343)
+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 80 ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999999998643 46999999999999999999999999999999999999999999999999999875432
Q ss_pred --CCccCCCCCcceecCCCCCCCCCCCCCC-ceeeeeeeccc-----ccccCCCCc
Q 019304 292 --EGMTPETGTYRWMAPGNSFFSPLPHPSF-EHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 292 --~~~~~~~gt~~y~APE~~~~~~~~~~~~-~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
......+||+.|||||++ ....+ +.++|||++.+ +++.+||..
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~-----~~~~~~~~~~DiwSlGvilyeml~G~~pf~~ 208 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELL-----KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHH-----HCSSBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ccccccceeeCcCccCHhHh-----cCCCCCCCceeeeHhHHHHHHHHhCCCCCCC
Confidence 234556899999999999 56665 68899995333 345666643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-45 Score=335.26 Aligned_cols=195 Identities=22% Similarity=0.304 Sum_probs=167.4
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
+..++|++.+.||+|+||+||+|++ +++.||+|+++....... .+++.+|+.+|+.++|||||++++++.+..
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 77 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI-----RNQIIRELQVLHECNSPYIVGFYGAFYSDG 77 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTH-----HHHHHHHGGGGGGCCCTTBCCEEEEEECSS
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4457899999999999999999998 688999999976543322 257899999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
.+|+||||+++|+|.+++.+.. .+++..+..++.|++.||.|||++ ||+||||||+|||++.++++||+|||+|+..
T Consensus 78 ~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 78 EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 9999999999999999998654 499999999999999999999974 9999999999999999999999999999865
Q ss_pred ccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 289 VQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
... ...+.+||+.|+|||++ .+..|+.++|||++.+ +++.+||.+
T Consensus 156 ~~~-~~~~~~GT~~Y~APEvl-----~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 156 IDS-MANSFVGTRSYMSPERL-----QGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp HHH-TC---CCSSCCCCHHHH-----HCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred CCC-ccccccCCccccCchHH-----cCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 543 34556999999999999 7788999999995333 346677754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=328.43 Aligned_cols=199 Identities=25% Similarity=0.382 Sum_probs=169.1
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
+.|++++.||+|+||.||+|++ +++.||||++....... .+.+.+|+.++++++|||||++++++.+.+.++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~------~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 85 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE------LEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 85 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG------GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH------HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEE
Confidence 4578899999999999999998 67899999997653322 246889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~- 291 (343)
+||||+++|+|.+++.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred EEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 9999999999999987543 46999999999999999999999999999999999999999999999999999764432
Q ss_pred CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 292 EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
......+||+.|+|||++.........|+.++|||++.+ +++.+||.+.
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~ 218 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence 223456899999999998655456778999999996333 4466777553
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=323.17 Aligned_cols=185 Identities=26% Similarity=0.461 Sum_probs=154.1
Q ss_pred ecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 210 (343)
|+.++|++.+.||+|+||.||+|.+ +++.||||+++...... ++|.+|+.++++++|||||+++|+|...+.
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~-------~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-------EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 74 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH-------HHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH-------HHHHHHHHHHHhcCCCCcccccceeccCCc
Confidence 5668899999999999999999998 67789999997644332 468999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~ 290 (343)
+++||||+++|+|.+++... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+|+....
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred eEEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccC
Confidence 99999999999999998754 35588999999999999999999999999999999999999999999999999987554
Q ss_pred CCC--ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 291 TEG--MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 291 ~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
... .....||+.|+|||++ ....|+.++|||+++
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l-----~~~~~~~k~DVwS~G 189 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVF-----SFSRYSSKSDVWSFG 189 (263)
T ss_dssp -----------CTTSCCHHHH-----TTCCCCHHHHHHHHH
T ss_pred CCceeecceecCcccCChHHh-----cCCCCCchhhhcchH
Confidence 322 2335789999999999 788899999999644
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-44 Score=321.76 Aligned_cols=196 Identities=23% Similarity=0.344 Sum_probs=156.6
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCe
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RMV 210 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~ 210 (343)
++|++.+.||+|+||+||+|++ +|+.||||++......... .+.+.+|+.++++++|||||++++++.+ ...
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 79 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE----KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 79 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHH----HHHHHHHHHHTTSCCCTTBCCEEEEEEC----C
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHH----HHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCE
Confidence 5788999999999999999988 6889999999876554332 3678999999999999999999999865 456
Q ss_pred EEEEEEecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLG-----FIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~g-----iiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
+|+||||+++|+|.+++.+. ....+++..++.++.|++.||+|||++| ||||||||+|||++.++.+||+|||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence 89999999999999998743 3456999999999999999999999876 9999999999999999999999999
Q ss_pred cccccccCC-CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 284 VARIEVQTE-GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 284 ~a~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
+|+...... .....+||+.|||||++ ....|+.++|||++.+ +++.+||.+
T Consensus 160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l-----~~~~~~~~~DIwSlGvilyel~tg~~Pf~~ 216 (269)
T d2java1 160 LARILNHDTSFAKAFVGTPYYMSPEQM-----NRMSYNEKSDIWSLGCLLYELCALMPPFTA 216 (269)
T ss_dssp HHHHC-----------CCCSCCCHHHH-----TTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ceeecccCCCccccCCCCcccCCHHHH-----cCCCCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence 998765433 33456899999999999 7888999999996333 446677654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.8e-44 Score=326.82 Aligned_cols=195 Identities=25% Similarity=0.387 Sum_probs=164.8
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
+.|+..+.||+|+||.||+|++ +++.||||++......... ..+.+.+|+.++++++|||||++++++.+.+.+|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE---KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHH---HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHH---HHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEE
Confidence 4588899999999999999997 6789999999876544322 2467899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+||||+++|+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+....
T Consensus 92 iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp EEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 999999999887766543 4599999999999999999999999999999999999999999999999999986433
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
....+||+.|||||++.+. ....|+.++|||++++ +++.+||.+
T Consensus 168 -~~~~~GT~~Y~APE~~~~~--~~~~y~~~~DiwSlGvilyel~~g~~Pf~~ 216 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTT--TSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -CCccccCccccCHHHHhcc--CCCCcCchhhhhhHHHHHHHHHHCCCCCCC
Confidence 3456899999999998321 3467999999995333 335566543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=329.10 Aligned_cols=199 Identities=22% Similarity=0.307 Sum_probs=170.9
Q ss_pred ecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 209 (343)
|..++|++++.||+|+||.||+|+. +++.||||++++..... ....+.+.+|+.+|+.++||||+++++++.+..
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 78 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA---KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC---HHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc
Confidence 5668899999999999999999998 78899999997432111 112356889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccc
Q 019304 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (343)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~ 289 (343)
.+|+||||+++|+|.+++.+.. .+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred ccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 9999999999999999998754 48999999999999999999999999999999999999999999999999998654
Q ss_pred c-CCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 290 Q-TEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 290 ~-~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
. .......+||+.|+|||++ .+..|+.++|+|++.+ +++.+||.+.
T Consensus 157 ~~~~~~~~~~GT~~Y~aPE~~-----~~~~y~~~~DiwSlGvilyeml~G~~pf~~~ 208 (337)
T d1o6la_ 157 SDGATMKTFCGTPEYLAPEVL-----EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGG-----SSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCcccccceeCHHHhhhhhc-----cCCCCChhhcccchhhHHHHHHHCCCCCCCc
Confidence 3 3344567899999999999 7889999999996333 4467777543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-44 Score=325.25 Aligned_cols=199 Identities=20% Similarity=0.306 Sum_probs=171.4
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++++.||+|+||+||+|++ +|+.||||++.+............+.+.+|+.+|++++|||||++++++.+...+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5689999999999999999998 68899999997655433222222367899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC----cEEEecccccccc
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK----SIKIADFGVARIE 288 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~----~vkl~DFg~a~~~ 288 (343)
+||||+++|+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 90 iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 9999999999999998754 599999999999999999999999999999999999998776 5999999999877
Q ss_pred ccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 289 VQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
..........||+.|+|||++ .+..++.++|||++.+ +++.+||.+.
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~-----~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 219 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIV-----NYEPLGLEADMWSIGVITYILLSGASPFLGD 219 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHH-----TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCccccccCCCCcccCHHHH-----cCCCCCCcccchhhhHHHHHHHcCCCCCCCC
Confidence 665566667899999999999 7888999999995333 3466666543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=327.78 Aligned_cols=197 Identities=21% Similarity=0.309 Sum_probs=165.5
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++++.||+|+||+||+|.+ +++.||||++.+..... ....+.+.+|+.++++++||||+++++++.+.+.+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC---HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 36799999999999999999998 68899999996422111 11235789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
|+||||+++|+|.+++...+ .+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999999999988654 5999999999999999999999999999999999999999999999999999875432
Q ss_pred C---CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 292 E---GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 292 ~---~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
. .....+||+.|+|||++ .+..|+.++|||++.+ +++.+||.+.
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~-----~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELL-----TEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp --------CCCCGGGCCHHHH-----HTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CcccccccccCCccccCceee-----ccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence 2 23456899999999999 7888999999996332 4477777543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=317.38 Aligned_cols=191 Identities=27% Similarity=0.433 Sum_probs=160.1
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe----C
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----R 208 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~ 208 (343)
+.|++.++||+|+||+||+|++ +++.||+|++......... .+.|.+|+++|++++|||||++++++.+ .
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 84 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE----RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 84 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH----HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHH----HHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence 4557778999999999999998 5778999999765544322 3578999999999999999999999865 3
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCcEEEc-CCCcEEEeccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLIS-ADKSIKIADFGVA 285 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~g--iiHrDlkp~NILv~-~~~~vkl~DFg~a 285 (343)
..+|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+|
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred CEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 46899999999999999998753 5899999999999999999999998 99999999999996 5789999999999
Q ss_pred cccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 286 RIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
+..... .....+||+.|||||++ . ++|+.++|||++.+ +++.+||.
T Consensus 163 ~~~~~~-~~~~~~GT~~Y~aPE~~-----~-~~~~~~~DIwSlGvilyel~~g~~Pf~ 213 (270)
T d1t4ha_ 163 TLKRAS-FAKAVIGTPEFMAPEMY-----E-EKYDESVDVYAFGMCMLEMATSEYPYS 213 (270)
T ss_dssp GGCCTT-SBEESCSSCCCCCGGGG-----G-TCCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred eeccCC-ccCCcccCccccCHHHh-----C-CCCCCcCchhhHHHHHHHHHHCCCCCC
Confidence 864432 34556899999999988 4 35999999996433 33556664
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-44 Score=328.32 Aligned_cols=193 Identities=23% Similarity=0.371 Sum_probs=150.0
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
+.|++.+.||+|+||+||+|++ +++.||||++.+...... ...+.+|+.+++.++|||||++++++.+...+|
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 83 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-----EGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC---------------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4589999999999999999998 678999999976543322 246889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc---CCCcEEEeccccccccc
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS---ADKSIKIADFGVARIEV 289 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~---~~~~vkl~DFg~a~~~~ 289 (343)
+||||++||+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||+. +++.+||+|||+|+...
T Consensus 84 lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999999999753 4599999999999999999999999999999999999995 57899999999998766
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
........+||+.|||||++ ....|+.++|||++.+ +++.+||.+
T Consensus 162 ~~~~~~~~~GT~~y~APE~~-----~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 211 (307)
T d1a06a_ 162 PGSVLSTACGTPGYVAPEVL-----AQKPYSKAVDCWSIGVIAYILLCGYPPFYD 211 (307)
T ss_dssp -----------CTTSCHHHH-----TTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCeeeeeeeCccccCcHHH-----cCCCCCcHHHhhhhhHHHHHHHhCCCCCCC
Confidence 65556667899999999999 7788999999995333 446677654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-44 Score=323.69 Aligned_cols=192 Identities=31% Similarity=0.510 Sum_probs=162.6
Q ss_pred CCccceecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEE
Q 019304 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (343)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 204 (343)
..++|+|+.++|++++.||+|+||+||+|++ +++.||||+++...... +.|.+|+.++++++|||||+++++
T Consensus 8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~-------~~~~~E~~~l~~l~h~nIv~~~g~ 80 (285)
T d1fmka3 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-------EAFLQEAQVMKKLRHEKLVQLYAV 80 (285)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH-------HHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH-------HHHHHHHHHHHhcccCCEeEEEEE
Confidence 4578999999999999999999999999998 55689999997654432 468999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccc
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~ 284 (343)
+.+ +..++||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+
T Consensus 81 ~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGl 159 (285)
T d1fmka3 81 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 159 (285)
T ss_dssp ECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred Eec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccch
Confidence 865 4578999999999999999865555699999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC--CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 285 ARIEVQTE--GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 285 a~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|+...... ......||+.|+|||++ ....++.++|||++.+
T Consensus 160 a~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~ksDI~S~Gi 202 (285)
T d1fmka3 160 ARLIEDNEYTARQGAKFPIKWTAPEAA-----LYGRFTIKSDVWSFGI 202 (285)
T ss_dssp TC--------------CCGGGSCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred hhhccCCCceeeccccccccccChHHH-----hCCCCCcHHhhhcchH
Confidence 98754332 23345799999999999 7889999999995443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=314.95 Aligned_cols=186 Identities=26% Similarity=0.441 Sum_probs=163.5
Q ss_pred ecccccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 210 (343)
++.++|+++++||+|+||+||+|++ +++.||||+++...... +.|.+|+.++++++||||++++|+|.++..
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~-------~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~ 73 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-------DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 73 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH-------HHHHHHHHHHHTCCCTTBCCEEEEECCSSS
T ss_pred CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH-------HHHHHHHHHHHhcCCCceeeEEEEEeeCCc
Confidence 3568899999999999999999999 56689999998765543 468999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~ 290 (343)
+++||||+++|+|.+++.... ..+++..+++++.|+++||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 74 ~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 74 IFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred eEEEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence 999999999999999987543 4588999999999999999999999999999999999999999999999999986554
Q ss_pred CCC--ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 291 TEG--MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 291 ~~~--~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
... .....||+.|+|||.+ ....++.++|||+++.
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~-----~~~~~~~ksDiwS~G~ 189 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVL-----MYSKFSSKSDIWAFGV 189 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred CCceeecccCCCCCcCCcHHh-----cCCCCCcceeecccch
Confidence 332 2335789999999999 7788999999995433
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=328.50 Aligned_cols=191 Identities=28% Similarity=0.469 Sum_probs=161.9
Q ss_pred ccceecccccccccccccccceEEEEEEECC-------ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcc
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIV 199 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv 199 (343)
.+|+|+.++|++++.||+|+||+||+|++.+ ..||+|.+........ .+.+.+|+.++.++ +|||||
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~HpnIv 104 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE-----REALMSELKMMTQLGSHENIV 104 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHH-----HHHHHHHHHHHHHhcCCCcEe
Confidence 4699999999999999999999999998722 2599999865433222 25788999999988 899999
Q ss_pred eEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019304 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---------------------RAVPLKLAVKQALDVARGMAYVHGLG 258 (343)
Q Consensus 200 ~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~qi~~gL~yLH~~g 258 (343)
++++++.+.+.+++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++
T Consensus 105 ~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~ 184 (325)
T d1rjba_ 105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 184 (325)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999976432 34788999999999999999999999
Q ss_pred ceeCCCCCCcEEEcCCCcEEEeccccccccccCCCc---cCCCCCcceecCCCCCCCCCCCCCCceeeeeeec
Q 019304 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM---TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKES 328 (343)
Q Consensus 259 iiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~~~---~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~ 328 (343)
||||||||+|||++.++.+||+|||+|+........ ....||+.|||||++ ....|+.++|||++
T Consensus 185 IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l-----~~~~~~~~~DiwS~ 252 (325)
T d1rjba_ 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL-----FEGIYTIKSDVWSY 252 (325)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH-----HHCCCCHHHHHHHH
T ss_pred eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHH-----cCCCCCcceeccch
Confidence 999999999999999999999999999875543322 234679999999999 78889999999963
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-43 Score=325.28 Aligned_cols=194 Identities=24% Similarity=0.370 Sum_probs=166.5
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++++.||+|+||+||+|++ +|+.||||++++..... ....+.+.+|+.+++.++|||||++++++.+...+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 79 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR---LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 79 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccC---HHHHHHHHHHHHHHHhccCcChhheeeeEeeCCee
Confidence 46899999999999999999998 68899999996422111 11235788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
|+||||++||+|..++.... .+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 80 ~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~- 156 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 156 (316)
T ss_dssp EEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred eeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-
Confidence 99999999999999987653 488899999999999999999999999999999999999999999999999987543
Q ss_pred CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 292 EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.....+||+.|||||++ ....|+.++|||++++ +++.+||.+
T Consensus 157 -~~~~~~Gt~~Y~APE~l-----~~~~y~~~~DiwSlGvilyemltG~~Pf~~ 203 (316)
T d1fota_ 157 -VTYTLCGTPDYIAPEVV-----STKPYNKSIDWWSFGILIYEMLAGYTPFYD 203 (316)
T ss_dssp -CBCCCCSCTTTCCHHHH-----TTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred -ccccccCcccccCHHHH-----cCCCCCchhhccccchhHHHHHhCCCCCCC
Confidence 34457899999999999 7888999999996333 446666644
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-43 Score=321.35 Aligned_cols=189 Identities=24% Similarity=0.429 Sum_probs=151.0
Q ss_pred eecccccccccccccccceEEEEEEE--CCc---eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGE---DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~---~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
+++.++|++.+.||+|+||+||+|.+ +++ .||||.+....... ..++|.+|+.+|++++|||||+++|++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-----QRRDFLSEASIMGQFDHPNVIHLEGVV 96 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHH-----HHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHH-----HHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 46778899999999999999999987 333 58888876533221 235799999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
.....+++||||+++|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+||||+.++++||+|||+|
T Consensus 97 ~~~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla 175 (299)
T d1jpaa_ 97 TKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS 175 (299)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred eeCCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccc
Confidence 9999999999999999999988754 345899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCc------cCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 286 RIEVQTEGM------TPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 286 ~~~~~~~~~------~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+........ ....||+.|||||.+ ....|+.++|||++++
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~-----~~~~~~~~sDvwS~Gv 221 (299)
T d1jpaa_ 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAI-----QYRKFTSASDVWSYGI 221 (299)
T ss_dssp --------------------CGGGSCHHHH-----HSCCCCHHHHHHHHHH
T ss_pred eEccCCCCcceeeecccccCCccccCHHHH-----hcCCCCcccccccchH
Confidence 875443221 123578999999999 7889999999996433
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.3e-43 Score=328.97 Aligned_cols=194 Identities=20% Similarity=0.334 Sum_probs=167.7
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++++.||+|+||.||+|++ +|+.||||++...... ..+.+.+|+.++++++|||||++++++.+.+.+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES------DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH------HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh------hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46899999999999999999998 6889999999654321 135788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC--CCcEEEeccccccccc
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA--DKSIKIADFGVARIEV 289 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~--~~~vkl~DFg~a~~~~ 289 (343)
|+|||||++|+|.+++.+. ...+++..+..++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+...
T Consensus 99 ~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 9999999999999998643 345999999999999999999999999999999999999963 5789999999998776
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
........+||+.|||||++ .+..|+.++|||++++ +++.+||.+
T Consensus 178 ~~~~~~~~~gT~~Y~aPEv~-----~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 227 (350)
T d1koaa2 178 PKQSVKVTTGTAEFAAPEVA-----EGKPVGYYTDMWSVGVLSYILLSGLSPFGG 227 (350)
T ss_dssp TTSCEEEECSCTTTCCHHHH-----HTCCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccccceecCcccccCHHHH-----cCCCCChhHhhhhhhHHHHHHHhCCCCCCC
Confidence 65555667899999999999 7888999999995333 335666644
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.6e-43 Score=325.02 Aligned_cols=193 Identities=18% Similarity=0.255 Sum_probs=168.4
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++++.||+|+||.||+|.+ +|+.||||++...... ..+.+.+|+.+|+.++|||||++++++.++..+|
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL------DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH------HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh------HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5689999999999999999998 6889999999764321 1256889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc--CCCcEEEecccccccccc
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS--ADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~--~~~~vkl~DFg~a~~~~~ 290 (343)
+||||+++|+|.+++.+. ...+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||+|+....
T Consensus 103 ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999999999887643 34699999999999999999999999999999999999998 578999999999998766
Q ss_pred CCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 291 TEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 291 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.......+||+.|+|||++ ....|+.++|||++++ +++.+||.+
T Consensus 182 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 230 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIV-----DREPVGFYTDMWAIGVLGYVLLSGLSPFAG 230 (352)
T ss_dssp TSCEEEECSSGGGCCHHHH-----TTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CCceeeccCcccccCHHHH-----cCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 6556667899999999999 7888999999996333 447777754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-43 Score=316.44 Aligned_cols=190 Identities=25% Similarity=0.468 Sum_probs=159.8
Q ss_pred cceeccccccccc-ccccccceEEEEEEE----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEE
Q 019304 129 EWTIDLRKLNMGT-AFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (343)
Q Consensus 129 ~~~i~~~~~~~~~-~lg~G~fg~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~ 203 (343)
+|.+..+++.+.+ +||+|+||.||+|.+ ++..||||+++...... ..++|.+|+.+|++++|||||+++|
T Consensus 2 ~l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~g 76 (285)
T d1u59a_ 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-----DTEEMMREAQIMHQLDNPYIVRLIG 76 (285)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHH-----HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ceeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHH-----HHHHHHHHHHHHHhCCCCCEeeEee
Confidence 4566777888887 499999999999976 34479999997543221 2367999999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 204 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
++.++ .+|+||||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 77 ~~~~~-~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFG 154 (285)
T d1u59a_ 77 VCQAE-ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 154 (285)
T ss_dssp EEESS-SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred eeccC-eEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccch
Confidence 98754 578999999999999998643 3468999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 284 VARIEVQTEG----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 284 ~a~~~~~~~~----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+|+....... ....+||+.|+|||++ ....++.++|||+++.
T Consensus 155 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~ksDVwS~Gv 200 (285)
T d1u59a_ 155 LSKALGADDSYYTARSAGKWPLKWYAPECI-----NFRKFSSRSDVWSYGV 200 (285)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHH-----HHCEECHHHHHHHHHH
T ss_pred hhhcccccccccccccccccCccccChHHH-----hCCCCCccchhhcchH
Confidence 9986543322 2344789999999999 7788999999995433
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.5e-42 Score=308.23 Aligned_cols=204 Identities=23% Similarity=0.343 Sum_probs=174.2
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCCh---hHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeC
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNP---EKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKR 208 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 208 (343)
++|++.+.||+|+||+||+|+. +++.||||++.+..... +......+++.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788999999999999999998 78999999998765433 333445577999999999997 99999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
+.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 99999999999999999998654 5999999999999999999999999999999999999999999999999999977
Q ss_pred ccCCCccCCCCCcceecCCCCCCCCC-CCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 289 VQTEGMTPETGTYRWMAPGNSFFSPL-PHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~~~~-~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
.........+||+.|+|||.+.+... ....++.++|||+++. +++.+||.+.
T Consensus 161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~ 218 (277)
T d1phka_ 161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 218 (277)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC
Confidence 66555566789999999999843211 3556899999996333 4466776543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=314.88 Aligned_cols=189 Identities=25% Similarity=0.426 Sum_probs=155.7
Q ss_pred eecccccccccccccccceEEEEEEECC------ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEE
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNG------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 204 (343)
+|+.++|+..+.||+|+||.||+|.+.+ ..||||++....... ...+|.+|+.++++++|||||+++|+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~-----~~~~~~~E~~il~~l~H~nIv~~~g~ 77 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-----QRVDFLGEAGIMGQFSHHNIIRLEGV 77 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH-----HHHHHHHHHHHHHhcCCCCEeeeeEE
Confidence 5677889999999999999999998732 369999996543221 23578999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccc
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~ 284 (343)
+.+...+++||||++++++.+++... ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+
T Consensus 78 ~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 78 ISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EecCCceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccch
Confidence 99999999999999999999988754 35699999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 285 ARIEVQTEG----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 285 a~~~~~~~~----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
|+....... .....||+.|||||++ ....++.++|||+++.
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l-----~~~~~~~~sDI~S~Gv 201 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAI-----SYRKFTSASDVWSFGI 201 (283)
T ss_dssp -----------------CCCGGGSCHHHH-----HSCCCCHHHHHHHHHH
T ss_pred hhcccCCCccceEeccCCCCccccCHHHH-----ccCCCCCcccccccHH
Confidence 987543221 2234689999999999 7889999999995433
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.9e-42 Score=323.21 Aligned_cols=201 Identities=17% Similarity=0.216 Sum_probs=165.3
Q ss_pred cccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 210 (343)
..++|++.+.||+|+||.||+|++ +|+.||||++.+................+|+.+++.++|||||++++++.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 346789999999999999999998 688999999864322211111122233455788888899999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccccc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~ 290 (343)
+|+||||+++|+|.+++.+.. .+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 999999999999999998753 488999999999999999999999999999999999999999999999999986654
Q ss_pred CCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 291 TEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 291 ~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
. .....+||+.|+|||++. ....|+.++|||++++ +++.+||.+.
T Consensus 160 ~-~~~~~~GT~~y~APE~~~----~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 209 (364)
T d1omwa3 160 K-KPHASVGTHGYMAPEVLQ----KGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209 (364)
T ss_dssp S-CCCSCCSCGGGCCHHHHS----TTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred C-cccccccccccchhHHhh----cCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence 3 345568999999999982 2456899999996333 4477777543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-43 Score=313.63 Aligned_cols=186 Identities=29% Similarity=0.535 Sum_probs=157.3
Q ss_pred ceecccccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-C
Q 019304 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-R 208 (343)
Q Consensus 130 ~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~ 208 (343)
|+|+.++|++++.||+|+||.||+|+++|+.||||+++.... .+.|.+|+.++++++||||++++|+|.+ .
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~--------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHH--------HHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 999999999999999999999999999999999999965321 2568899999999999999999999865 4
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
+.+++||||+++|+|.+++.+.....+++..+++++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++..
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceec
Confidence 56899999999999999998655456899999999999999999999999999999999999999999999999999865
Q ss_pred ccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 289 VQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
... .....+|+.|+|||++ ....++.++|||+++.
T Consensus 154 ~~~--~~~~~~~~~y~aPE~l-----~~~~~t~~sDIwSfG~ 188 (262)
T d1byga_ 154 SST--QDTGKLPVKWTAPEAL-----REKKFSTKSDVWSFGI 188 (262)
T ss_dssp ----------CCTTTSCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred CCC--CccccccccCCChHHH-----hCCCCChHHHHHhHHH
Confidence 432 3345789999999999 6788999999996444
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=312.84 Aligned_cols=185 Identities=29% Similarity=0.498 Sum_probs=150.8
Q ss_pred ccccccc-cccccccceEEEEEEEC----CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 134 LRKLNMG-TAFAQGAFGKLYRGTYN----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 134 ~~~~~~~-~~lg~G~fg~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
.+.+.+. ++||+|+||+||+|.+. ++.||||+++....... ..++|.+|+.+|++++|||||+++++|..+
T Consensus 5 ~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~~~g~~~~~ 80 (277)
T d1xbba_ 5 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----LKDELLAEANVMQQLDNPYIVRMIGICEAE 80 (277)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CH----HHHHHHHHHHHHHTCCCTTBCCEEEEEESS
T ss_pred hhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHH----HHHHHHHHHHHHHhCCCCCCceEEEEeccC
Confidence 3444443 47999999999999862 35799999975443322 236799999999999999999999999654
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
.+++||||+++|+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 81 -~~~lvmE~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 81 -SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 157 (277)
T ss_dssp -SEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred -CEEEEEEcCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhc
Confidence 568999999999999999764 45999999999999999999999999999999999999999999999999999865
Q ss_pred ccCCC----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 289 VQTEG----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 289 ~~~~~----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
..... .....||+.|||||.+ ....++.++|||+++.
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~l-----~~~~~~~~sDiwS~Gv 198 (277)
T d1xbba_ 158 RADENYYKAQTHGKWPVKWYAPECI-----NYYKFSSKSDVWSFGV 198 (277)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHH-----HHCEEEHHHHHHHHHH
T ss_pred cccccccccccccCCCceecCchhh-----cCCCCCchhhhccchh
Confidence 43222 2334689999999999 7788999999996443
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-42 Score=322.89 Aligned_cols=195 Identities=23% Similarity=0.293 Sum_probs=168.0
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
.++|++++.||+|+||.||+|++ +|+.||||++.+..... ....+.+.+|+.+|+.++|||||++++++.+...+
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK---LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC---HHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence 46889999999999999999998 68899999986422111 11235788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
++||||+.+|+|.+++.+.. .+++..+..++.||+.||.|||++|||||||||+|||++.++++||+|||+|+....
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~- 193 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred ccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc-
Confidence 99999999999999998754 499999999999999999999999999999999999999999999999999987543
Q ss_pred CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 292 EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
.....+||+.|||||++ .+..|+.++|||++++ +++.+||.+.
T Consensus 194 -~~~~~~Gt~~Y~APE~~-----~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 241 (350)
T d1rdqe_ 194 -RTWTLCGTPEALAPEII-----LSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp -CBCCCEECGGGCCHHHH-----TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -ccccccCccccCCHHHH-----cCCCCCccccccchhHHHHHHHhCCCCCCCc
Confidence 33456899999999999 7888999999996332 4477777553
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=311.66 Aligned_cols=189 Identities=25% Similarity=0.465 Sum_probs=151.8
Q ss_pred cceecccccccccccccccceEEEEEEEC-----CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEE
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~ 203 (343)
+|+|+.++|++++.||+|+||.||+|++. +..||||.++..... ...+.|.+|+.++++++|||||++++
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l~~ 75 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-----SVREKFLQEALTMRQFDHPHIVKLIG 75 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH-----HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH-----HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 59999999999999999999999999872 235888887543322 22367999999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 204 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
++.+ +.+++||||+++|+|.+++... ...+++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||
T Consensus 76 ~~~~-~~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 76 VITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp EECS-SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred EEec-CeEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccch
Confidence 9964 5679999999999999988754 3568999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC--CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc
Q 019304 284 VARIEVQTE--GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC 329 (343)
Q Consensus 284 ~a~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~ 329 (343)
+|+...... ......||+.|+|||++ ....|+.++|||+++
T Consensus 154 ~a~~~~~~~~~~~~~~~gt~~y~apE~l-----~~~~~~~~~DiwSlG 196 (273)
T d1mp8a_ 154 LSRYMEDSTYYKASKGKLPIKWMAPESI-----NFRRFTSASDVWMFG 196 (273)
T ss_dssp -----------------CCGGGCCHHHH-----HHCCCSHHHHHHHHH
T ss_pred hheeccCCcceeccceecCcccchhhHh-----ccCCCCCccccccch
Confidence 998754332 23345789999999999 788899999999643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-42 Score=313.95 Aligned_cols=195 Identities=25% Similarity=0.468 Sum_probs=154.8
Q ss_pred CCccceecccccccccccccccceEEEEEEEC-------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCC
Q 019304 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (343)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 197 (343)
..++|+|+.++|++++.||+|+||.||+|.+. ++.||||+++...... ..+.+.+|..++.++ +|+|
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~-----~~~~~~~e~~~l~~~~~h~~ 78 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-----EHRALMSELKILIHIGHHLN 78 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH-----HHHHHHHHHHHHHHHCCCTT
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH-----HHHHHHHHHHHHHhhcCCCe
Confidence 34789999999999999999999999999872 3579999986543322 235677888877776 6899
Q ss_pred cceEEEEEEeC-CeEEEEEEecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeC
Q 019304 198 IVRFIGACRKR-MVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262 (343)
Q Consensus 198 Iv~l~~~~~~~-~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHr 262 (343)
|+.+++++... ..+++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+++||||
T Consensus 79 iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHr 158 (299)
T d1ywna1 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 158 (299)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCC
Confidence 99999998765 46899999999999999997542 2347889999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEeccccccccccCC---CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 263 DLKSDNLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 263 Dlkp~NILv~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
||||+||||+.++++||+|||+|+...... .....+||+.|+|||++ ....++.++|||++++
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l-----~~~~~~~~sDiwS~Gv 224 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI-----FDRVYTIQSDVWSFGV 224 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHh-----hcCCCCcccceeehHH
Confidence 999999999999999999999998654332 23345799999999999 7888999999996443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=314.78 Aligned_cols=189 Identities=22% Similarity=0.342 Sum_probs=161.1
Q ss_pred cccccc-cccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHh-cCCCCCcceEEEEEEe---
Q 019304 135 RKLNMG-TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLA-TLKHLNIVRFIGACRK--- 207 (343)
Q Consensus 135 ~~~~~~-~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~--- 207 (343)
++|.+. +.||+|+||.||+|++ +++.||||+++.. ..+.+|+.++. ..+|||||++++++.+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 567765 4699999999999998 6889999999641 34678998865 4589999999999875
Q ss_pred -CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC---CCcEEEeccc
Q 019304 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFG 283 (343)
Q Consensus 208 -~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~---~~~vkl~DFg 283 (343)
...+|+|||||+||+|.+++.+.....+++..+..++.||+.||+|||++||+||||||+|||++. .+.+||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 456899999999999999998765567999999999999999999999999999999999999985 5679999999
Q ss_pred cccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeecc-----cccccCCCCc
Q 019304 284 VARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESC-----LKTTWPPPWR 339 (343)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~-----~~~~~~p~~~ 339 (343)
+|+...........+||+.|+|||++ ....|+.++|||++. ++++.+||-+
T Consensus 160 ~a~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~y~~~~DiwSlGvily~lltg~~Pf~~ 215 (335)
T d2ozaa1 160 FAKETTSHNSLTTPCYTPYYVAPEVL-----GPEKYDKSCDMWSLGVIMYILLCGYPPFYS 215 (335)
T ss_dssp TCEECCCCCCCCCCSCCCSSCCCCCC-----CGGGGSHHHHHHHHHHHHHHHTTSSCSCEE
T ss_pred eeeeccCCCccccccCCcccCCcHHH-----cCCCCCHHHHHHhhchhHHHHhhCCCCCCC
Confidence 99977666666777999999999999 788899999999633 2456677643
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.9e-42 Score=312.88 Aligned_cols=193 Identities=25% Similarity=0.420 Sum_probs=164.0
Q ss_pred ccceecccccccccccccccceEEEEEEEC-------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcce
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~ 200 (343)
.+|+++.++|++.+.||+|+||+||+|++. ++.||||+++..... ...++|.+|+.++++++||||++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~E~~il~~l~h~niv~ 80 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-----DMQADFQREAALMAEFDNPNIVK 80 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-----HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh-----HHHHHHHHHHHHHHhcCCCCccc
Confidence 357888899999999999999999999873 368999998754322 12367999999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCCHHHHHHhhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019304 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ----------------------NRAVPLKLAVKQALDVARGMAYVHGLG 258 (343)
Q Consensus 201 l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~gL~yLH~~g 258 (343)
++++|......+++|||+++|+|.+++.... ...+++..++.++.|++.||+|||+++
T Consensus 81 ~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ 160 (301)
T d1lufa_ 81 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 160 (301)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC
Confidence 9999999999999999999999999997532 124788899999999999999999999
Q ss_pred ceeCCCCCCcEEEcCCCcEEEeccccccccccCC---CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 259 iiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+|||||||+|||++.++.+||+|||+|+...... ......||+.|+|||.+ ....|+.++|||++..
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~t~ksDVwS~Gv 230 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI-----FYNRYTTESDVWAYGV 230 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHH-----ccCCCChhhhhccchh
Confidence 9999999999999999999999999998654332 22345789999999999 7888999999995333
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=313.10 Aligned_cols=194 Identities=15% Similarity=0.215 Sum_probs=166.9
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeE
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 211 (343)
+++|++++.||+|+||+||+|.+ +++.||||+++..... ...+.+|+.+|+.++|||||++++++.+...+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-------~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-------QVLVKKEISILNIARHRNILHLHESFESMEEL 76 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-------HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-------HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 36788999999999999999998 6789999999754211 24578999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC--CcEEEeccccccccc
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD--KSIKIADFGVARIEV 289 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~--~~vkl~DFg~a~~~~ 289 (343)
|+|||||+||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.+ ..+||+|||+++...
T Consensus 77 ~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 9999999999999999653 3458999999999999999999999999999999999999854 489999999998765
Q ss_pred cCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 290 QTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 290 ~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
........+||+.|+|||.+ ....|+.++|||++.+ +++.+||.+.
T Consensus 156 ~~~~~~~~~~t~~y~ape~~-----~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~ 206 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVH-----QHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHH-----TTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cCCcccccccccccccchhc-----cCCCCCchhhcccHHHHHHHHHhCCCCCCCC
Confidence 54445556899999999999 7888999999996332 4577777654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=312.64 Aligned_cols=196 Identities=22% Similarity=0.302 Sum_probs=163.4
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHH-hcCCCCCcceEEEEEEeCCeE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML-ATLKHLNIVRFIGACRKRMVW 211 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~~~~~ 211 (343)
++|++++.||+|+||+||+|++ +++.||||++++...... ...+.+.+|..++ +.++|||||++++++.+.+.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~---~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~ 78 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD---DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 78 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHT---TCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccCh---HHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCce
Confidence 5788999999999999999998 788999999964221100 0123456666665 478999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~ 291 (343)
|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 79 yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred eEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999999998654 4899999999999999999999999999999999999999999999999999865432
Q ss_pred -CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 292 -EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 292 -~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
...+..+||+.|+|||++ ....|+.++|||++.+ +++.+||.+.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlGvilyemltG~~PF~~~ 206 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEIL-----LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 206 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHH-----TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccCCCCCcCCHHHH-----cCCCCCchhhhhhhhHHHHHHHhCCCCCCCC
Confidence 334556899999999999 7889999999995332 3466777543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.9e-41 Score=303.60 Aligned_cols=196 Identities=24% Similarity=0.357 Sum_probs=159.1
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC---
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--- 209 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--- 209 (343)
++|++.+.||+|+||.||+|.+ +++.||||++++...... ...+.|.+|+.+++.++||||+++++++....
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP---SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCH---HHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 5688999999999999999997 688999999976544322 23467999999999999999999999997654
Q ss_pred -eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 210 -VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 210 -~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
.+|+||||++|++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.++..
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred ceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence 4799999999999999987653 5899999999999999999999999999999999999999999999999998754
Q ss_pred ccCC----CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 289 VQTE----GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 289 ~~~~----~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
.... .....+||+.|+|||++ ....++.++|||++.+ +++.+||.+.
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~-----~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 217 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQA-----RGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 217 (277)
T ss_dssp C----------------TTCCHHHH-----TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccCcccccCHHHH-----cCCCCCcceecccchHHHHHHHhCCCCCCCc
Confidence 3222 23455799999999999 7788999999996333 4567776543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-41 Score=309.24 Aligned_cols=197 Identities=25% Similarity=0.415 Sum_probs=168.5
Q ss_pred CCCCccceecccccccccccccccceEEEEEEEC-------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCC
Q 019304 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196 (343)
Q Consensus 124 ~~~~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 196 (343)
....++|+|+.++|++++.||+|+||.||+|.+. ++.||||+++...... ....|.+|+.++++++||
T Consensus 9 ~~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~-----~~~~~~~E~~il~~l~h~ 83 (308)
T d1p4oa_ 9 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-----ERIEFLNEASVMKEFNCH 83 (308)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH-----HHHHHHHHHHHGGGCCCT
T ss_pred CcCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChH-----HHHHHHHHHHHHHHcCCC
Confidence 4455789999999999999999999999999873 4689999997543221 235789999999999999
Q ss_pred CcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCc
Q 019304 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDN 268 (343)
Q Consensus 197 nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~N 268 (343)
||+++++++......++||||+++|+|.+++.... ...+++..+.+++.|++.||.|||+++|+||||||+|
T Consensus 84 nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~N 163 (308)
T d1p4oa_ 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 163 (308)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGG
T ss_pred CEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCc
Confidence 99999999999999999999999999999987431 1346888999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 269 LLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 269 ILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
||++.++++||+|||+|+....... .....||+.|+|||.+ ....++.++|||+++.
T Consensus 164 iLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l-----~~~~~~~~~Dv~S~G~ 223 (308)
T d1p4oa_ 164 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL-----KDGVFTTYSDVWSFGV 223 (308)
T ss_dssp EEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred eeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHH-----ccCCCCcccccccHHH
Confidence 9999999999999999986544322 2334689999999999 7888999999996443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-41 Score=305.32 Aligned_cols=194 Identities=30% Similarity=0.512 Sum_probs=161.3
Q ss_pred CccceecccccccccccccccceEEEEEEECC---------ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCC
Q 019304 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG---------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHL 196 (343)
Q Consensus 127 ~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 196 (343)
-.+|+|+.++|++++.||+|+||.||+|+..+ ..||||+++....... ...+.+|...+.++ +||
T Consensus 5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~-----~~~~~~e~~~l~~~~~Hp 79 (299)
T d1fgka_ 5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-----LSDLISEMEMMKMIGKHK 79 (299)
T ss_dssp CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHH-----HHHHHHHHHHHHHHCCCT
T ss_pred CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHH-----HHHHHHHHHHHHHhcCCC
Confidence 35699999999999999999999999998622 3699999976443222 25688898888887 899
Q ss_pred CcceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeC
Q 019304 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262 (343)
Q Consensus 197 nIv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~giiHr 262 (343)
|||+++++|.++..+++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++||||
T Consensus 80 nIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHr 159 (299)
T d1fgka_ 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 159 (299)
T ss_dssp TBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEee
Confidence 99999999999999999999999999999997543 2358999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 263 DLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 263 Dlkp~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
||||+|||++.++.+||+|||+++....... .....||+.|+|||.+ ..+.|+.++|||++++
T Consensus 160 DiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l-----~~~~y~~k~DiwS~Gv 225 (299)
T d1fgka_ 160 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-----FDRIYTHQSDVWSFGV 225 (299)
T ss_dssp CCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred eecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHh-----cCCCCCchhhhHHhHH
Confidence 9999999999999999999999986654332 3345789999999999 7789999999996444
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=304.32 Aligned_cols=195 Identities=24% Similarity=0.348 Sum_probs=160.4
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++.+.||+|+||+||+|++ +++.||||+++...... ...+++.+|+.++++++|||||++++++.+...+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~ 77 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE----GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 77 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcCh----HHHHHHHHHHHHHHhCCCCcEEEecccccccccee
Confidence 5788999999999999999998 68899999996543221 12357889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccC-
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~- 291 (343)
+||||+.+ ++.+++.......+++..+..++.|++.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 78 iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 78 LVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred EEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99999965 6666776655667999999999999999999999999999999999999999999999999999875433
Q ss_pred CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 292 EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 292 ~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
.......||+.|+|||.+. ....++.++|+|+++. +++.+||.
T Consensus 157 ~~~~~~~gt~~y~apE~~~----~~~~~~~~~DiwSlGvily~m~~G~~Pf~ 204 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILL----GCKYYSTAVDIWSLGCIFAEMVTRRALFP 204 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHT----TCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccceeecccceeeehhhhc----cccCCCccccccccchhhhHHhhCCCCCC
Confidence 3344568999999999873 3344678999995333 33566653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-41 Score=307.49 Aligned_cols=189 Identities=29% Similarity=0.473 Sum_probs=159.7
Q ss_pred ecccccccccccccccceEEEEEEE--CCc--eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 206 (343)
|+.++|++.+.||+|+||+||+|++ ++. .||||.+........ .+.|.+|+.+|+++ +|||||++++++.
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 81 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-----HRDFAGELEVLCKLGHHPNIINLLGACE 81 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-----------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHH-----HHHHHHHHHHHHhccCCCCEeeEEEEEe
Confidence 6778999999999999999999988 444 578888764332221 25799999999999 7999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc
Q 019304 207 KRMVWCIVTEYAKGGSVRQFLTRR--------------QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272 (343)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~ 272 (343)
+.+.+++||||+++|+|.+++++. ....+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161 (309)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc
Confidence 999999999999999999999753 235689999999999999999999999999999999999999
Q ss_pred CCCcEEEeccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 273 ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 273 ~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.++.+||+|||+|+............||+.|+|||.+ ....|+.++|||+++.
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l-----~~~~~~~~sDvwSfGv 214 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL-----NYSVYTTNSDVWSYGV 214 (309)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHH-----HHCEECHHHHHHHHHH
T ss_pred CCCceEEccccccccccccccccceecCCcccchHHh-----ccCCCCccceeehhHH
Confidence 9999999999999876555444556799999999999 7889999999996443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=305.62 Aligned_cols=194 Identities=29% Similarity=0.476 Sum_probs=167.1
Q ss_pred CccceecccccccccccccccceEEEEEEE-------CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC-CCCCc
Q 019304 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNI 198 (343)
Q Consensus 127 ~~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI 198 (343)
-.+|+++.++|++++.||+|+||.||+|++ +++.||||+++......+ ...|.+|+.+++.+ +||||
T Consensus 15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~E~~~~~~l~~HpnI 89 (311)
T d1t46a_ 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-----REALMSELKVLSYLGNHMNI 89 (311)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH-----HHHHHHHHHHHHHHCCCTTB
T ss_pred cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHH-----HHHHHHHHHHHHhccCCCCE
Confidence 357999999999999999999999999986 235799999976443222 35789999999999 69999
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCCHHHHHHhhCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeC
Q 019304 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN----------------RAVPLKLAVKQALDVARGMAYVHGLGFIHR 262 (343)
Q Consensus 199 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~----------------~~~~~~~~~~i~~qi~~gL~yLH~~giiHr 262 (343)
|+++++|.+....++||||+++|+|.+++.+... ..+++..+..++.||+.||+|||+++++||
T Consensus 90 v~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHr 169 (311)
T d1t46a_ 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR 169 (311)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 9999999999999999999999999999986432 258889999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEeccccccccccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 263 DLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 263 Dlkp~NILv~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
||||+|||++.++.+||+|||.++....... ....+||+.|+|||.+ ....++.++|||+++.
T Consensus 170 DLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DIwS~G~ 235 (311)
T d1t46a_ 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI-----FNCVYTFESDVWSYGI 235 (311)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred ccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHh-----cCCCCCCcccccchHH
Confidence 9999999999999999999999987544322 2345789999999999 7888999999995433
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-40 Score=304.08 Aligned_cols=184 Identities=23% Similarity=0.453 Sum_probs=151.6
Q ss_pred cccccccccccccceEEEEEEE--CCc----eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 208 (343)
.+|++++.||+|+||+||+|.+ +|+ +||+|.++...... ..++|.+|+.++++++|||||+++|+|.+.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-----ANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----C-----THHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 5789999999999999999987 343 58888886433222 135799999999999999999999999876
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
. .++++|++.+++|.+++... ...+++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||+|+..
T Consensus 84 ~-~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 84 T-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp S-EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred C-eeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 5 57889999999999988764 456999999999999999999999999999999999999999999999999999875
Q ss_pred ccCCC---ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 289 VQTEG---MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 289 ~~~~~---~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
..... .....||+.|+|||++ ....|+.++|||+++.
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l-----~~~~~~~~sDvwS~Gv 201 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESI-----LHRIYTHQSDVWSYGV 201 (317)
T ss_dssp TTTCC--------CCTTTSCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred ccccccccccccccCccccChHHH-----hcCCCChhhhhhhHHH
Confidence 44322 2234689999999999 7788999999996444
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-41 Score=305.60 Aligned_cols=193 Identities=20% Similarity=0.242 Sum_probs=153.6
Q ss_pred ccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEEEEEe
Q 019304 140 GTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (343)
Q Consensus 140 ~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~iv~E~ 217 (343)
++.||+|+||+||+|.+ +|+.||||+++....... .....+.+.+|+.+++.++|||||++++++.....+|+||||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA-KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC-------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhh-hHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 46899999999999987 688999999975443221 122235788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-CccC
Q 019304 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-GMTP 296 (343)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~-~~~~ 296 (343)
++++.+..+.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ....
T Consensus 82 ~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp CSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCC
T ss_pred hcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccc
Confidence 98876655543 34568889999999999999999999999999999999999999999999999998654432 3345
Q ss_pred CCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 297 ETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 297 ~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.+||+.|+|||++. ....|+.++|||++.+ +++.+||.+
T Consensus 160 ~~gt~~y~aPE~~~----~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 203 (299)
T d1ua2a_ 160 QVVTRWYRAPELLF----GARMYGVGVDMWAVGCILAELLLRVPFLPG 203 (299)
T ss_dssp SCCCCTTCCHHHHT----TCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eecChhhccHHHHc----cCCCCChhhhhhhcchHHHHHHhCcCCCCC
Confidence 68999999999983 3556899999995333 335666644
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-41 Score=304.18 Aligned_cols=197 Identities=21% Similarity=0.284 Sum_probs=159.6
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC--CCCcceEEEEEEeCCe
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVRFIGACRKRMV 210 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~ 210 (343)
++|++++.||+|+||.||+|++ +++.||||++.+.............++.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5789999999999999999998 68899999997543322110001124678999999986 8999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-CCcEEEecccccccc
Q 019304 211 WCIVTEYAKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFGVARIE 288 (343)
Q Consensus 211 ~~iv~E~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~-~~~vkl~DFg~a~~~ 288 (343)
+++||||+++ +++.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+..
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 9999999976 6788888765 35999999999999999999999999999999999999985 579999999999865
Q ss_pred ccCCCccCCCCCcceecCCCCCCCCCCCCCC-ceeeeeeeccc-----ccccCCCCc
Q 019304 289 VQTEGMTPETGTYRWMAPGNSFFSPLPHPSF-EHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 289 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~-~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
.. ...+..+||+.|+|||++ ....+ +.++|||++.+ +++.+||.+
T Consensus 162 ~~-~~~~~~~GT~~y~aPE~~-----~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 162 KD-TVYTDFDGTRVYSPPEWI-----RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp CS-SCBCCCCSCGGGSCHHHH-----HHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred cc-ccccccccCCCcCCHHHH-----cCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 44 345567899999999998 54444 67899995332 346666643
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-40 Score=298.44 Aligned_cols=190 Identities=29% Similarity=0.439 Sum_probs=150.1
Q ss_pred eecccccccccccccccceEEEEEEEC---C--ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 131 TIDLRKLNMGTAFAQGAFGKLYRGTYN---G--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 131 ~i~~~~~~~~~~lg~G~fg~Vy~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
.|+.++|++.+.||+|+||+||+|++. + ..||||++.+...... ...++|.+|+.++++++||||++++|++
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~~~g~~ 80 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP---EAMDDFIREVNAMHSLDHRNLIRLYGVV 80 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------C---HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCH---HHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 367789999999999999999999872 2 3689999876544332 2236799999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
.++ .+++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~-~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 81 LTP-PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp CSS-SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eec-chheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhh
Confidence 764 5789999999999999887653 45999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 286 RIEVQTEG----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 286 ~~~~~~~~----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
+....... .....|++.|+|||.+ ....++.++|||++..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~-----~~~~~~~~~Di~S~Gv 202 (273)
T d1u46a_ 159 RALPQNDDHYVMQEHRKVPFAWCAPESL-----KTRTFSHASDTWMFGV 202 (273)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHH-----HHCEEEHHHHHHHHHH
T ss_pred hhcccCCCcceecCccccCcccCCHHHH-----hCCCCCcchhhhhhHH
Confidence 87544322 2234678999999999 7888999999996443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=297.53 Aligned_cols=185 Identities=31% Similarity=0.420 Sum_probs=148.9
Q ss_pred cccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----e
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM----V 210 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~ 210 (343)
++|.+.+.||+|+||.||+|+++|+.||||+++... .. ...+..|+..+..++|||||++++++.+.. .
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~----~~---~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ER---SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG----HH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hh---HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 578888999999999999999999999999985321 11 122335666667889999999999997654 6
Q ss_pred EEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeCCCCCCcEEEcCCCcEEEecc
Q 019304 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG--------LGFIHRDLKSDNLLISADKSIKIADF 282 (343)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~--------~giiHrDlkp~NILv~~~~~vkl~DF 282 (343)
+++||||+++|+|.+++++. .+++..+++++.|++.||.|||+ +||+||||||+||||+.++.+||+||
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 89999999999999999763 48999999999999999999996 59999999999999999999999999
Q ss_pred ccccccccCC-----CccCCCCCcceecCCCCCCCCC-CCCCCceeeeeeecc
Q 019304 283 GVARIEVQTE-----GMTPETGTYRWMAPGNSFFSPL-PHPSFEHKWSAKESC 329 (343)
Q Consensus 283 g~a~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~-~~~~~~~~sDi~~~~ 329 (343)
|+++...... ......||+.|+|||++.+... ....++.++|||++.
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~G 205 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhH
Confidence 9998654432 2234579999999999832211 122478899999533
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-39 Score=295.11 Aligned_cols=196 Identities=24% Similarity=0.358 Sum_probs=158.5
Q ss_pred cccccccccccccceEEEEEEE--C-CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcC---CCCCcceEEEEEEe-
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--N-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACRK- 207 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~-~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~- 207 (343)
++|++++.||+|+||+||+|++ + ++.||||+++......... ..+.+|+.+++.+ +||||+++++++..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~----~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP----LSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB----CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHH----HHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 6899999999999999999987 3 5679999987543322111 2355677766655 89999999999853
Q ss_pred ----CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 208 ----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 208 ----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
...++++|||++++.+. +........+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~-~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHH-HHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccccCceEEEEEEeccCCchh-hhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchh
Confidence 24689999999876554 4444455668999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCcc
Q 019304 284 VARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWRH 340 (343)
Q Consensus 284 ~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~~ 340 (343)
+++...........+||+.|+|||++ ....|+.++|||++.+ +++.+||.+.
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~-----~~~~y~~~~DiwSlG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVL-----LQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHH-----TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hhhhhcccccCCCcccChhhcCcchh-----cCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence 99876655566677999999999999 7888999999996333 4477777543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2e-39 Score=294.15 Aligned_cols=194 Identities=24% Similarity=0.290 Sum_probs=158.4
Q ss_pred cccccccccccccceEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~i 213 (343)
++|++.+.||+|+||.||+|++ +++.||||++........ ..+++.+|+.+|+.++||||+++++++...+..++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG----IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGC----CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChH----HHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeE
Confidence 5789999999999999999998 678999999976543221 12578999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC-
Q 019304 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (343)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~- 292 (343)
++|++.++.+..+... ...+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||.|.......
T Consensus 78 ~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9999987655555433 3569999999999999999999999999999999999999999999999999998754332
Q ss_pred CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 293 GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 293 ~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
......|++.|+|||.+. ....++.++|+|++.. +++.+||.
T Consensus 156 ~~~~~~~~~~y~~pE~~~----~~~~~~~~~DiwslGv~l~el~~G~~pf~ 202 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLM----GSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (286)
T ss_dssp ------CCCTTCCHHHHT----TCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccceecccchhhhHHHHh----CCCCCCcceeehhcCcHHHHHHHCCCCCC
Confidence 234457999999999983 3456799999996333 44666664
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-38 Score=294.67 Aligned_cols=176 Identities=16% Similarity=0.328 Sum_probs=152.2
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeC--
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKR-- 208 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~-- 208 (343)
.++|+++++||+|+||+||+|++ +++.||||+++... .+++.+|+.+|+.++ ||||+++++++...
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~ 104 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---------KKKIKREIKILENLRGGPNIITLADIVKDPVS 104 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence 46799999999999999999998 68899999996432 146789999999995 99999999999744
Q ss_pred CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC-cEEEeccccccc
Q 019304 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARI 287 (343)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~-~vkl~DFg~a~~ 287 (343)
..+++||||+++++|..+. ..+++..+..++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|+.
T Consensus 105 ~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp CSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred CceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccccee
Confidence 5689999999999987653 3489999999999999999999999999999999999998654 699999999987
Q ss_pred cccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeee
Q 019304 288 EVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKE 327 (343)
Q Consensus 288 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~ 327 (343)
..........+||+.|+|||.+. ....++.++|+|+
T Consensus 180 ~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~Diws 215 (328)
T d3bqca1 180 YHPGQEYNVRVASRYFKGPELLV----DYQMYDYSLDMWS 215 (328)
T ss_dssp CCTTCCCCSCCSCGGGCCHHHHT----TCCCCCTHHHHHH
T ss_pred ccCCCcccccccCccccCccccc----CCCCCCcccchhh
Confidence 76655566778999999999983 3456899999995
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-38 Score=290.30 Aligned_cols=181 Identities=28% Similarity=0.442 Sum_probs=151.2
Q ss_pred cccccccccceEEEEEEEC---C--ceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CCeEE
Q 019304 139 MGTAFAQGAFGKLYRGTYN---G--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-RMVWC 212 (343)
Q Consensus 139 ~~~~lg~G~fg~Vy~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~ 212 (343)
+.++||+|+||+||+|++. + ..||||++++... .. ..++|.+|+.+|++++||||++++|++.. +...+
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~-~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IG----EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCC-HH----HHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccC-HH----HHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 3578999999999999872 2 2589999864332 21 23679999999999999999999999876 45789
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+||||+++++|.+++... ....++..+++++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++......
T Consensus 106 lv~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEEEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 999999999999998754 3457788899999999999999999999999999999999999999999999998654322
Q ss_pred C-----ccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 293 G-----MTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 293 ~-----~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
. .....||+.|+|||.+ ....++.++|||++..
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~ksDI~SfGi 222 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESL-----QTQKFTTKSDVWSFGV 222 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHH-----HHCCCCHHHHHHHHHH
T ss_pred cccceecccccccccccChHHH-----hcCCCCChhHhhhhHH
Confidence 1 2234689999999999 7788999999996443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-38 Score=295.05 Aligned_cols=181 Identities=23% Similarity=0.311 Sum_probs=148.2
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC---
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--- 209 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--- 209 (343)
.+|++++.||+|+||+||+|+. +++.||||++.+.... ...+++.+|+.+|+.++||||+++++++....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-----TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH-----HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcCh-----HHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence 3599999999999999999988 6899999999754322 22357889999999999999999999997653
Q ss_pred -eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccccc
Q 019304 210 -VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (343)
Q Consensus 210 -~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~ 288 (343)
..+++++++.+++|.+++... .+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||+|+..
T Consensus 83 ~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 83 MKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp CCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 224455566689999999753 4999999999999999999999999999999999999999999999999999864
Q ss_pred ccCC----CccCCCCCcceecCCCCCCCCCCCCCCceeeeeee
Q 019304 289 VQTE----GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKE 327 (343)
Q Consensus 289 ~~~~----~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~ 327 (343)
.... .....+||+.|+|||++. ....++.++|||+
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwS 198 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIML----NSKGYTKSIDIWS 198 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTT----TBCSCSTHHHHHH
T ss_pred cCCCccceeeccccccceechHHHhh----cCCCCCchhhhhc
Confidence 3322 234457999999999983 3456789999995
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-38 Score=295.65 Aligned_cols=195 Identities=23% Similarity=0.322 Sum_probs=157.1
Q ss_pred cceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 019304 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (343)
Q Consensus 129 ~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 206 (343)
.|++ .++|++++.||+|+||+||+|.+ +|+.||||++++...... ..+.+.+|+.+|+.++|||||+++++|.
T Consensus 13 ~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~----~~~~~~~Ei~il~~l~hpniv~l~~~~~ 87 (346)
T d1cm8a_ 13 AWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL----FAKRAYRELRLLKHMRHENVIGLLDVFT 87 (346)
T ss_dssp EECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHH----HHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred eeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChH----HHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence 4666 46899999999999999999998 689999999976544332 2367899999999999999999999997
Q ss_pred eCC------eEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEe
Q 019304 207 KRM------VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (343)
Q Consensus 207 ~~~------~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~ 280 (343)
..+ .+|+||||+ +.+|..+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~ 163 (346)
T d1cm8a_ 88 PDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKIL 163 (346)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred cCccccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccc
Confidence 654 469999999 5678777654 349999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 281 DFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 281 DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
|||+|+.... ..+...||+.|+|||++. ....++.++|||++.. +++.+||.
T Consensus 164 Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwSlGvil~ell~g~~pf~ 220 (346)
T d1cm8a_ 164 DFGLARQADS--EMTGYVVTRWYRAPEVIL----NWMRYTQTVDIWSVGCIMAEMITGKTLFK 220 (346)
T ss_dssp CCTTCEECCS--SCCSSCSCGGGCCTHHHH----TTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccceeccCC--ccccccccccccCHHHHc----CCCCCCccchhhcchHHHHHHHHCcCCCC
Confidence 9999986543 345678999999999983 3456789999996332 34656654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-38 Score=294.89 Aligned_cols=189 Identities=24% Similarity=0.342 Sum_probs=155.2
Q ss_pred ccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----
Q 019304 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR----- 208 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----- 208 (343)
+|+.++.||+|+||+||+|++ +++.||||++...... +.+|+.+|++++||||+++++++...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~ 90 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----------HHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence 688889999999999999998 6889999999764432 34799999999999999999998543
Q ss_pred -CeEEEEEEecCCCCHHHHHH--hhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC-cEEEecccc
Q 019304 209 -MVWCIVTEYAKGGSVRQFLT--RRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGV 284 (343)
Q Consensus 209 -~~~~iv~E~~~~gsL~~~l~--~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~-~vkl~DFg~ 284 (343)
..+++||||++++ +.+.+. ......+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 91 ~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 91 EVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp CCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred ceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccc
Confidence 3578999999765 444443 23445699999999999999999999999999999999999999765 899999999
Q ss_pred ccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 285 ARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
++...........+||+.|+|||.+. ....|+.++|||++.+ +++.+||..
T Consensus 170 a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DIwSlG~il~el~~g~~pf~~ 225 (350)
T d1q5ka_ 170 AKQLVRGEPNVSYICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPG 225 (350)
T ss_dssp CEECCTTSCCCSCCSCTTSCCHHHHT----TCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred hhhccCCcccccccccccccChHHhh----cccCCCcceeecccceEEEehhhCCCCCCC
Confidence 98776666666778999999999873 3567999999995333 335566643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-37 Score=283.06 Aligned_cols=189 Identities=21% Similarity=0.269 Sum_probs=158.3
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCC-CCcceEEEEEEeCCeE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRFIGACRKRMVW 211 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~ 211 (343)
++|++++.||+|+||+||+|++ +++.||||++...... ..+.+|++.++.++| +|++.+++++......
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc--------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 6789999999999999999998 6889999998654332 246688899999865 8999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-----CCcEEEecccccc
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-----DKSIKIADFGVAR 286 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~-----~~~vkl~DFg~a~ 286 (343)
++||||+ +++|.+++... ...++...+..++.|++.||+|||++|||||||||+|||++. ++.+||+|||+|+
T Consensus 77 ~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 9999999 67999988754 356899999999999999999999999999999999999974 5789999999998
Q ss_pred ccccCC--------CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 287 IEVQTE--------GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 287 ~~~~~~--------~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
...... .....+||+.|||||++ .+..++.++|||+++. +++.+||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~-----~~~~~~~~~DiwSlG~~l~elltg~~Pf~ 214 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTH-----LGREQSRRDDLEALGHVFMYFLRGSLPWQ 214 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH-----TTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred EcccCccccceeecccCceEEchhhcCHHHh-----cCCCCChHHHHHHhhHHHHHHHhCCCcCC
Confidence 654321 12345799999999999 7888999999996433 33555553
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-37 Score=281.32 Aligned_cols=186 Identities=22% Similarity=0.334 Sum_probs=158.7
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeEE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 212 (343)
++|++++.||+|+||+||+|++ +++.||||+++....... ..+++.+|+.+++.++||||+++++++......+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 77 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTT----HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChH----HHHHHHHHHHHHHhcCcCCEEeecccccccccee
Confidence 5789999999999999999998 678899999976554332 2367899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccccccccCC
Q 019304 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (343)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~~~~~~~ 292 (343)
+|+|++.+++|..++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+......
T Consensus 78 iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred EEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999998888777543 458999999999999999999999999999999999999999999999999998765433
Q ss_pred -CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 293 -GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 293 -~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
......+++.|+|||.+. ....++.++|||+++.
T Consensus 156 ~~~~~~~~~~~~~~pe~~~----~~~~~~~~~DiwSlG~ 190 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLF----GAKLYSTSIDMWSAGC 190 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHT----TCSCCCTHHHHHHHHH
T ss_pred ccceeeccccchhhhhHhc----cCCCCCchhhccccch
Confidence 233446789999999883 2344789999996333
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-38 Score=289.33 Aligned_cols=196 Identities=22% Similarity=0.305 Sum_probs=155.1
Q ss_pred ccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe----
Q 019304 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK---- 207 (343)
Q Consensus 134 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~---- 207 (343)
.++|++.++||+|+||+||+|++ +|+.||||++........ ..+++.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~ 84 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG----FPITALREIKILQLLKHENVVNLIEICRTKASP 84 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTS----SCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchH----HHHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence 58899999999999999999998 688999999865543321 12568899999999999999999999855
Q ss_pred ----CCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccc
Q 019304 208 ----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (343)
Q Consensus 208 ----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg 283 (343)
...+|+||||++++.+..+.. ....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 85 YNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp ------CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ccccCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecc
Confidence 345899999998765554432 34568999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC-----CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 284 VARIEVQTE-----GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 284 ~a~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
+++...... .....+||+.|+|||++. ....|+.++|||++.. +++.+||.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~----~~~~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLL----GERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHT----TCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHc----CCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 997544221 223457999999999983 3456899999996333 346666654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-37 Score=290.83 Aligned_cols=191 Identities=22% Similarity=0.256 Sum_probs=150.1
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC----
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~---- 208 (343)
++|+++++||+|+||+||+|.+ +|+.||||++......... .+++.+|+.++++++||||+++++++...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~----~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH----AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHH----HHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHH----HHHHHHHHHHHHhcCCCCeeEEEEEEecccccc
Confidence 6799999999999999999998 6899999999876654332 35788999999999999999999999643
Q ss_pred --CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 209 --MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 209 --~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
..+|+||||+.+ ++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++
T Consensus 93 ~~~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 93 EFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp TCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cCceeEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhh
Confidence 578999999976 5555553 348999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 287 IEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
...........+||+.|+|||++ ....++.++|||++.. +++.+||.+
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l-----~~~~~~~~~DiwSlG~~l~ell~g~~pF~~ 220 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVI-----LGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_dssp -------------CCTTCCHHHH-----TTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccccccccccccccccChhhh-----cCCCCCCCcccccccchHHHHhhCCCCCCC
Confidence 76665556667899999999999 7788999999996332 447777643
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-37 Score=279.24 Aligned_cols=181 Identities=24% Similarity=0.305 Sum_probs=149.3
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCeE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVW 211 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~ 211 (343)
++|++++.||+|+||.||+|++ +++.||||++...... .++.+|+++++.++|+++ +.+.+++.+....
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 78 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--------HHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence 4689999999999999999998 6889999998765433 246789999999987665 5556666788889
Q ss_pred EEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC---CCcEEEecccccccc
Q 019304 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIE 288 (343)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~---~~~vkl~DFg~a~~~ 288 (343)
++||||+ +++|.+.+... ...+++..+..++.|++.||+|||++|||||||||+|||++. +..+||+|||+|+..
T Consensus 79 ~ivme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 79 VMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 9999999 55777776543 356999999999999999999999999999999999999863 457999999999875
Q ss_pred ccCC--------CccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 289 VQTE--------GMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 289 ~~~~--------~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.... .....+||+.|||||.+ .+..++.++|||++..
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG~ 201 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTH-----LGIEQSRRDDLESLGY 201 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHH-----TTBCCCHHHHHHHHHH
T ss_pred cccccccceeccccCCcCCCccccCHHHH-----hCCCCCChhhEEecCH
Confidence 4322 12345799999999999 7888999999996443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-37 Score=288.22 Aligned_cols=197 Identities=22% Similarity=0.294 Sum_probs=158.6
Q ss_pred ccceecccccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 019304 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (343)
Q Consensus 128 ~~~~i~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 205 (343)
+.|+++ ++|++.+.||+|+||+||+|++ +|+.||||++.+....... .+++.+|+.+|+.++|||||++++++
T Consensus 12 ~~~~~~-~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~Ei~il~~l~h~~iv~~~~~~ 86 (348)
T d2gfsa1 12 TIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH----AKRTYRELRLLKHMKHENVIGLLDVF 86 (348)
T ss_dssp SEEEEE-TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHH----HHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred ccccCC-CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHH----HHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 457774 6799999999999999999987 6899999999866554432 35788999999999999999999998
Q ss_pred EeC-----CeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEe
Q 019304 206 RKR-----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (343)
Q Consensus 206 ~~~-----~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~ 280 (343)
... ...++++|++.+|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+|++
T Consensus 87 ~~~~~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~ 163 (348)
T d2gfsa1 87 TPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 163 (348)
T ss_dssp CSCSSTTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred eeccccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccccccc
Confidence 643 234566777889999999854 359999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCC
Q 019304 281 DFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPW 338 (343)
Q Consensus 281 DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~ 338 (343)
|||++..... ......||+.|+|||.+. ....++.++|||++.. +++.+||.
T Consensus 164 dfg~a~~~~~--~~~~~~g~~~y~apE~~~----~~~~~~~~~DiwSlGv~l~~ll~g~~pF~ 220 (348)
T d2gfsa1 164 DFGLARHTDD--EMTGYVATRWYRAPEIML----NWMHYNQTVDIWSVGCIMAELLTGRTLFP 220 (348)
T ss_dssp CC----CCTG--GGSSSCHHHHTSCHHHHT----TCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccchhcccCc--ccccccccccccCchhhc----CCccCCcccchhhhhHHHHHHHhCCCCCC
Confidence 9999975433 344568999999999872 4455789999995332 34566654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-37 Score=284.07 Aligned_cols=201 Identities=19% Similarity=0.273 Sum_probs=161.5
Q ss_pred ecccccccccccccccceEEEEEEE-----CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCC-CCcceEEEEE
Q 019304 132 IDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRFIGAC 205 (343)
Q Consensus 132 i~~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~ 205 (343)
+..++|++++.||+|+||+||+|.. +|+.||||++++....... ...+.+.+|+.++++++| |||+++++++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~--~~~~~~~~E~~il~~l~h~pnIv~~~~~~ 98 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA--KTTEHTRTERQVLEHIRQSPFLVTLHYAF 98 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE--SSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccch--HHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence 3458899999999999999999986 4678999998643221100 011457899999999976 8999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccccc
Q 019304 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (343)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~a 285 (343)
.+...++++|||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred ccCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999999999998764 4788999999999999999999999999999999999999999999999999
Q ss_pred cccccC--CCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc-----ccccCCCCc
Q 019304 286 RIEVQT--EGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL-----KTTWPPPWR 339 (343)
Q Consensus 286 ~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~-----~~~~~p~~~ 339 (343)
+..... .......|++.|+|||.+.. ....++.++|||++.+ +++.+||.+
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~---~~~~~~~ksDIWSlG~iLyelltG~~PF~~ 234 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRG---GDSGHDKAVDWWSLGVLMYELLTGASPFTV 234 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTT---CC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred hhhcccccccccccccccccchhHHhhc---CCcCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 864332 22344579999999999832 2335788999996333 446666644
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=1.6e-31 Score=249.22 Aligned_cols=182 Identities=19% Similarity=0.292 Sum_probs=144.7
Q ss_pred cccccccccccccceEEEEEEE--CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-----------CCCcceE
Q 019304 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-----------HLNIVRF 201 (343)
Q Consensus 135 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l 201 (343)
.+|+++++||+|+||+||+|+. +|+.||||+++.... ..+.+.+|+.+++.+. |+||+++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-------~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-------YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-------HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-------chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence 4699999999999999999998 689999999975321 2245678888887765 5789999
Q ss_pred EEEEEe--CCeEEEEEEecCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCC--
Q 019304 202 IGACRK--RMVWCIVTEYAKGG-SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADK-- 275 (343)
Q Consensus 202 ~~~~~~--~~~~~iv~E~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~giiHrDlkp~NILv~~~~-- 275 (343)
++++.. ....+++++++..+ .............+++..+..++.||+.||.|||+ .||+||||||+||||+.++
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence 988854 34566667666444 34444444555678999999999999999999998 8999999999999998654
Q ss_pred ----cEEEeccccccccccCCCccCCCCCcceecCCCCCCCCCCCCCCceeeeeeeccc
Q 019304 276 ----SIKIADFGVARIEVQTEGMTPETGTYRWMAPGNSFFSPLPHPSFEHKWSAKESCL 330 (343)
Q Consensus 276 ----~vkl~DFg~a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~~~~~sDi~~~~~ 330 (343)
.+|++|||.+..... .....+||+.|+|||++ ....++.++|+|++..
T Consensus 166 ~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG~ 217 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVL-----LGAPWGCGADIWSTAC 217 (362)
T ss_dssp TTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHH-----HTCCCCTHHHHHHHHH
T ss_pred cccceeeEeeccccccccc--ccccccccccccChhhc-----cccCCCccccccchHH
Confidence 399999999975433 34556899999999999 7788999999996433
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=6.9e-25 Score=186.15 Aligned_cols=137 Identities=15% Similarity=0.155 Sum_probs=105.9
Q ss_pred ccccccccccceEEEEEEE-CCceEEEEEeeCCCCC------------hhHHHHHHHHHHHHHHHHhcCCCCCcceEEEE
Q 019304 138 NMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENN------------PEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (343)
Q Consensus 138 ~~~~~lg~G~fg~Vy~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 204 (343)
.++++||+|+||.||+|+. +|+.||||+++..... ..........+.+|...+.++.|++++..++.
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 3678999999999999987 7899999987643211 00111223456678999999999999998865
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecccc
Q 019304 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (343)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~giiHrDlkp~NILv~~~~~vkl~DFg~ 284 (343)
.. .+++|||+++..+.+ ++......++.|++.+|.|||++||+||||||+|||++++ .++|+|||.
T Consensus 83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred cC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 32 279999998865422 3444567889999999999999999999999999999865 589999999
Q ss_pred cccc
Q 019304 285 ARIE 288 (343)
Q Consensus 285 a~~~ 288 (343)
|+..
T Consensus 149 a~~~ 152 (191)
T d1zara2 149 SVEV 152 (191)
T ss_dssp CEET
T ss_pred cccC
Confidence 9754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.72 E-value=2.7e-08 Score=86.06 Aligned_cols=139 Identities=17% Similarity=0.146 Sum_probs=89.9
Q ss_pred ccccccccccccceEEEEEEECCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeEEEE
Q 019304 136 KLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIV 214 (343)
Q Consensus 136 ~~~~~~~lg~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~iv 214 (343)
.++..+..+.++.+.||+...+++.+.+|+......... ..+.+|...+..+. +--+.+++.++...+..++|
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~------~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT------YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTST------TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccch------hhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 334444444455578999888888889998864432221 13567777776663 33467788888888888999
Q ss_pred EEecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 019304 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-------------------------------------- 256 (343)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-------------------------------------- 256 (343)
|++++|.++.+..... .. ...++.+++..+..||+
T Consensus 89 ~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 9999997775443110 11 11122222233333331
Q ss_pred ---------------------CCceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 257 ---------------------LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 257 ---------------------~giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
..++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1279999999999999877778999998865
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.14 E-value=4.2e-06 Score=71.41 Aligned_cols=136 Identities=15% Similarity=0.103 Sum_probs=81.2
Q ss_pred cccccc-eEEEEEEEC-CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC--CCCcceEEEEEEeCCeEEEEEEec
Q 019304 143 FAQGAF-GKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVRFIGACRKRMVWCIVTEYA 218 (343)
Q Consensus 143 lg~G~f-g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~iv~E~~ 218 (343)
+..|.. +.||+...+ +..+.+|........ .+..|...++.+. .-.+.+++.+..+.+..++|||++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i 88 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 88 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEee
Confidence 344443 679998874 456788876543321 3556777776653 334677888888888889999999
Q ss_pred CCCCHHH--------------HHHhhCC-----CCC--CHHHHHHHH--------------------HHHHHHHHHHHhC
Q 019304 219 KGGSVRQ--------------FLTRRQN-----RAV--PLKLAVKQA--------------------LDVARGMAYVHGL 257 (343)
Q Consensus 219 ~~gsL~~--------------~l~~~~~-----~~~--~~~~~~~i~--------------------~qi~~gL~yLH~~ 257 (343)
+|.++.+ .+.+-.. .++ .......-. ......+..+.+.
T Consensus 89 ~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 168 (255)
T d1nd4a_ 89 PGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR 168 (255)
T ss_dssp SSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred eccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHh
Confidence 8855421 1111110 000 111000000 0112223333332
Q ss_pred -------CceeCCCCCCcEEEcCCCcEEEeccccccc
Q 019304 258 -------GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (343)
Q Consensus 258 -------giiHrDlkp~NILv~~~~~vkl~DFg~a~~ 287 (343)
.++|+|+.|.|||++.+..+.|+||+.+..
T Consensus 169 ~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 169 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 379999999999999877788999998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.82 E-value=1e-05 Score=74.10 Aligned_cols=80 Identities=11% Similarity=-0.026 Sum_probs=45.5
Q ss_pred cccccccceEEEEEEE--CCceEEEEEeeCCCCC-hhHHHHHHHHHHHHHHHHhcC-C--CCCcceEEEEEEeCCeEEEE
Q 019304 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENN-PEKAQVMEQQFQQEVMMLATL-K--HLNIVRFIGACRKRMVWCIV 214 (343)
Q Consensus 141 ~~lg~G~fg~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l-~--h~nIv~l~~~~~~~~~~~iv 214 (343)
+.||.|....||+... .++.++||.-.+.... .+.......+...|...|+.+ . ...+++++.+.. ...++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~--~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--EMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--TTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--CCCEEE
Confidence 5689999999999975 4678999965321000 000000002344567666655 2 234666776543 344789
Q ss_pred EEecCCCC
Q 019304 215 TEYAKGGS 222 (343)
Q Consensus 215 ~E~~~~gs 222 (343)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.35 E-value=0.00023 Score=62.98 Aligned_cols=65 Identities=14% Similarity=0.154 Sum_probs=40.1
Q ss_pred eEEEEEEE-CCceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCCCCCc-----ceE--EEEEEeCCeEEEEEEecCC
Q 019304 149 GKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-----VRF--IGACRKRMVWCIVTEYAKG 220 (343)
Q Consensus 149 g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-----v~l--~~~~~~~~~~~iv~E~~~~ 220 (343)
-.||+++. +|+.+++|+.++..... .++..|...+..|....+ +.. -.........+.++++++|
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~-------~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTA-------DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCH-------HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCH-------HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 58999987 78889999987654433 245567666665532211 111 0112335567889999986
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.90 E-value=0.00079 Score=60.99 Aligned_cols=78 Identities=15% Similarity=0.247 Sum_probs=49.3
Q ss_pred cccccccccccccccceEEEEEEEC---------CceEEEEEeeCCCCChhHHHHHHHHHHHHHHHHhcCC-CCCcceEE
Q 019304 133 DLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFI 202 (343)
Q Consensus 133 ~~~~~~~~~~lg~G~fg~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~ 202 (343)
+.+++++ +.|+.|-.-.+|++... .+.|.+++.-... .. ....+|..+++.+. +.-..+++
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~~-------idr~~E~~i~~~ls~~gl~Pkll 111 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TE-------SHLVAESVIFTLLSERHLGPKLY 111 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CH-------HHHHHHHHHHHHHHHTTSSSCEE
T ss_pred CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-hh-------hHHHHHHHHHHHHHhCCCCCeEE
Confidence 3344444 56787888999999863 2457778765322 11 12447888877774 33345778
Q ss_pred EEEEeCCeEEEEEEecCCCCH
Q 019304 203 GACRKRMVWCIVTEYAKGGSV 223 (343)
Q Consensus 203 ~~~~~~~~~~iv~E~~~~gsL 223 (343)
+++.. .+|+||++|..|
T Consensus 112 ~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 112 GIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp EEETT----EEEECCCCEEEC
T ss_pred EEcCC----ceEEEEeccccC
Confidence 77642 589999987443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.86 E-value=0.001 Score=58.06 Aligned_cols=30 Identities=37% Similarity=0.480 Sum_probs=27.2
Q ss_pred CCceeCCCCCCcEEEcCCCcEEEecccccc
Q 019304 257 LGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (343)
Q Consensus 257 ~giiHrDlkp~NILv~~~~~vkl~DFg~a~ 286 (343)
.|+||+|+.++||+++.+...-|+||+.|.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988888999999875
|
| >d2oq1a1 d.93.1.1 (A:5-134) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase zap-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.51 E-value=0.0005 Score=52.26 Aligned_cols=98 Identities=13% Similarity=0.163 Sum_probs=59.9
Q ss_pred cCCCCCCcccccccCCCCeEEEEeecCCCCCCCcccccccCCCCCcCC-Ccceeecceeeec--CCcccc-ccCchHHHH
Q 019304 37 GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDDALAQ 112 (343)
Q Consensus 37 ~~~~~~~~~~~~~s~~~g~~s~s~~~ss~~s~~~~~~~~~~~~~~~~~-~~~s~~~~~~~~~--~~~~~~-~~~~d~l~~ 112 (343)
-.|+|+++.|.+ ..|.+++|+.... .+.|+.|.... +.|++.. ...|. ...+.+ ..+.++|..
T Consensus 28 ~~G~FLVR~S~~---~~g~yvLSv~~~~---------~v~H~~I~~~~~g~~~l~~-~~~F~sl~~Lv~~Y~~~~~gL~~ 94 (130)
T d2oq1a1 28 ADGLFLLRQCLR---SLGGYVLSLVHDV---------RFHHFPIERQLNGTYAIAG-GKAHCGPAELCEFYSRDPDGLPC 94 (130)
T ss_dssp CTTCEEEEECSS---STTCEEEEEEETT---------EEEEEEEEECTTSCEEETT-SCCBSSHHHHHHHHHHCCTTSSS
T ss_pred CCceEEEEecCC---CCccEEEEEeeCC---------ceEEEEEEEcCCCceeccC-CCCcCCHHHHHHHHhhCCCCCCc
Confidence 359999998764 6788999998421 45788886554 5677653 34453 334443 566677777
Q ss_pred HHhcCCCCCCCCCCC-ccceecccccccccccccccceEEEE
Q 019304 113 ALMDHRYPTEGLENY-DEWTIDLRKLNMGTAFAQGAFGKLYR 153 (343)
Q Consensus 113 ~l~~~~~~~~~~~~~-~~~~i~~~~~~~~~~lg~G~fg~Vy~ 153 (343)
.|..|+......... ..|+. +.+.+|+|.||+||+
T Consensus 95 ~L~~P~~r~~~~~~~~~~~~~------~~~~~~~~~~~~~w~ 130 (130)
T d2oq1a1 95 NLRKPCNRPSGLEPQPGVFDC------LRDAMVRDYVRQTWK 130 (130)
T ss_dssp CCCSBCCCCTTCCCBCCHHHH------HHHHHHHHHHHHHHC
T ss_pred cCCccCCCCCCCCCCcchHHH------HHHHHHHhhccCccC
Confidence 777776543322111 11111 336789999998874
|
| >d1blja_ d.93.1.1 (A:) P55 Blk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: P55 Blk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=80.68 E-value=0.13 Score=37.19 Aligned_cols=73 Identities=22% Similarity=0.313 Sum_probs=45.6
Q ss_pred CCCCCCcccccccCCCCeEEEEeecCCCCCCCcccccccCCCCCcCC-Ccceeecceeeec--CCcccc-ccCchHHHHH
Q 019304 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDDALAQA 113 (343)
Q Consensus 38 ~~~~~~~~~~~~s~~~g~~s~s~~~ss~~s~~~~~~~~~~~~~~~~~-~~~s~~~~~~~~~--~~~~~~-~~~~d~l~~~ 113 (343)
.|+|+++.|.. ..|.+.+++...... + ..+.|+.+.... +.|.+. +...|. ...+.+ ..+.++|...
T Consensus 35 ~G~FLVR~S~~---~~g~~~Lsv~~~~~~-~----~~v~H~~i~~~~~g~~~l~-~~~~F~sl~eLV~~y~~~~~gL~~~ 105 (114)
T d1blja_ 35 AGSFLIRESES---NKGAFSLSVKDITTQ-G----EVVKHYKIRSLDNGGYYIS-PRITFPTLQALVQHYSKKGDGLCQK 105 (114)
T ss_dssp TTCEEBCBCTT---CSSCEEEEECBCCTT-T----CBCCCEEEEEETTTEEEEE-TTEEESSHHHHHHHHHHCCSSSSSC
T ss_pred CceEEEeccCC---CCCCeEEEEEeeccC-C----CEEEEEEEEEcCCCCEEec-CCceECCHHHHHHHHhhCCCCCCcc
Confidence 59999998764 678899999854321 1 246777777654 567775 334453 334433 5555666666
Q ss_pred HhcCCC
Q 019304 114 LMDHRY 119 (343)
Q Consensus 114 l~~~~~ 119 (343)
|..||.
T Consensus 106 L~~PC~ 111 (114)
T d1blja_ 106 LTLPCV 111 (114)
T ss_dssp CCCCSC
T ss_pred CCccCc
Confidence 666654
|